data_2k1j_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k1j _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo . . . . . 0 CA--C 1.535 0.546 0 CA-C-O 121.054 0.356 . . . . 0.0 111.593 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 81.7 p -129.35 173.86 10.15 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.091 1.356 . . . . 0.0 110.559 -171.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -133.56 -81.97 0.47 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 117.464 -1.255 . . . . 0.0 113.283 -168.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.3 t -55.53 166.65 0.61 Allowed 'General case' 0 C--N 1.35 0.607 0 C-N-CA 124.996 1.318 . . . . 0.0 112.814 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 4.1 pp -58.86 -11.45 3.3 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.695 1.198 . . . . 0.0 112.806 170.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 73.6 m -76.38 -19.48 58.12 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.501 1.92 . . . . 0.0 113.042 175.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 17.0 m170 57.75 62.07 2.22 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.846 2.059 . . . . 0.0 111.56 -173.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.5 162.42 25.67 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.337 1.455 . . . . 0.0 112.277 176.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -66.77 179.92 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 125.912 1.685 . . . . 0.0 112.367 -176.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 87.4 p -49.04 153.48 0.9 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.195 2.198 . . . . 0.0 113.913 175.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -158.24 170.84 21.36 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.7 1.6 . . . . 0.0 110.761 -167.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -77.2 -62.35 2.47 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 119.196 -0.78 . . . . 0.0 113.569 -170.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -105.89 121.87 44.95 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 117.815 0.808 . . . . 0.0 110.63 -172.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -143.88 145.89 32.62 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -167.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 15.6 tt -142.64 154.28 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.412 1.485 . . . . 0.0 109.28 169.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -133.25 144.99 17.07 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 123.727 0.68 . . . . 0.0 112.242 -169.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 11.9 t -67.99 145.92 54.05 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-O 122.036 0.922 . . . . 0.0 110.467 -174.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -94.4 2.46 55.78 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 113.509 -1.678 . . . . 0.0 112.694 -171.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -77.63 147.06 74.23 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 119.172 0.896 . . . . 0.0 110.473 177.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -76.71 8.07 3.23 Favored 'Trans proline' 0 CA--C 1.547 1.14 0 C-N-CA 123.542 2.828 . . . . 0.0 111.775 167.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -127.46 -6.77 5.81 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.344 1.857 . . . . 0.0 112.436 -171.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 37.9 t -64.45 131.22 46.52 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.651 0.78 . . . . 0.0 109.742 175.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.7 t -109.15 9.72 26.06 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.42 1.488 . . . . 0.0 111.743 -173.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 32.7 mm -121.95 -31.92 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 126.058 1.743 . . . . 0.0 109.677 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 51.6 -15.7 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 131.318 3.847 . . . . 0.0 119.327 175.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 58.1 m95 -139.04 151.04 46.47 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.713 1.605 . . . . 0.0 110.578 178.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -152.95 152.69 31.73 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.175 1.39 . . . . 0.0 110.233 -171.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -76.28 149.4 37.12 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.407 -0.815 . . . . 0.0 108.959 169.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 8.9 m-30 -52.31 -51.2 60.0 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.829 167.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.82 -14.08 62.28 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 118.361 -0.828 . . . . 0.0 113.2 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 9.4 m -79.04 -2.42 40.3 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 119.586 1.085 . . . . 0.0 112.511 172.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 1.2 p -126.61 -14.08 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.32 1.448 . . . . 0.0 112.456 169.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 97.16 20.33 23.54 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 125.485 1.517 . . . . 0.0 113.642 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 10.9 mt -75.41 160.31 30.39 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.803 1.301 . . . . 0.0 111.544 178.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 38.4 m -132.31 -10.74 3.26 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.288 1.835 . . . . 0.0 110.648 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 77.5 p -142.27 -174.88 4.24 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.798 2.039 . . . . 0.0 109.15 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -120.92 98.66 47.46 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 123.856 0.862 . . . . 0.0 110.451 -176.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -70.94 170.68 17.4 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.685 2.257 . . . . 0.0 111.002 169.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 -141.74 133.54 27.22 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.716 1.206 . . . . 0.0 108.492 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 129.85 -163.57 22.8 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 126.022 1.772 . . . . 0.0 110.85 -174.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -61.8 115.63 4.16 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.109 0.963 . . . . 0.0 109.284 169.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 53.0 t90 -132.93 142.7 49.03 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.31 1.844 . . . . 0.0 107.825 175.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -125.49 139.37 53.69 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.154 0.981 . . . . 0.0 110.801 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 7.4 p -71.46 173.36 5.22 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 125.888 1.675 . . . . 0.0 111.888 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -70.31 -33.2 14.94 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 121.217 1.278 . . . . 0.0 113.655 -168.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -75.13 -4.72 40.35 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 173.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 22.2 m -112.99 -17.95 12.33 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.745 1.218 . . . . 0.0 113.459 -171.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 22.1 t -152.94 -35.18 0.11 Allowed 'General case' 0 C--N 1.343 0.303 0 CA-C-N 119.093 0.861 . . . . 0.0 113.294 177.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -72.41 -14.59 61.74 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 118.23 0.468 . . . . 0.0 112.164 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 . . . . . 0 CA--C 1.542 0.664 0 C-N-CA 124.494 1.117 . . . . 0.0 111.804 177.323 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo . . . . . 0 CA--C 1.535 0.548 0 CA-C-O 121.755 0.648 . . . . 0.0 112.77 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 34.2 p -142.83 175.32 9.91 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.116 1.766 . . . . 0.0 109.223 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -136.3 -67.34 0.52 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.995 0.918 . . . . 0.0 111.573 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . 0.429 ' SG ' ' HB2' ' A' ' 201' ' ' CYS . 4.5 p -56.71 163.72 1.76 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 128.388 2.675 . . . . 0.0 113.811 176.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.3 pp -77.02 -1.13 27.31 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.865 -1.062 . . . . 0.0 111.704 167.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . 0.429 ' HB2' ' SG ' ' A' ' 199' ' ' CYS . 77.0 m -75.45 -29.16 59.56 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.943 0.897 . . . . 0.0 110.2 168.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . 0.302 89.1 m-70 71.1 54.69 0.23 Allowed 'General case' 0 C--N 1.342 0.255 0 C-N-CA 127.619 2.367 . . . . 0.0 113.689 169.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -137.49 172.69 12.6 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.617 166.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -63.16 174.37 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 125.189 1.396 . . . . 0.0 111.877 -175.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 83.5 p -47.81 156.71 0.31 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.935 2.094 . . . . 0.0 115.063 -174.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -144.36 163.49 33.59 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.477 1.511 . . . . 0.0 111.101 -168.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -61.5 -40.7 99.05 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.851 1.215 . . . . 0.0 114.702 -169.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -130.54 122.91 28.44 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.115 0.966 . . . . 0.0 110.355 -173.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 1.4 mtm -139.69 144.5 37.6 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -167.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 21.2 tt -136.82 146.37 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 125.605 1.562 . . . . 0.0 110.232 171.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -124.2 139.54 12.01 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.573 1.082 . . . . 0.0 112.819 -170.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . 0.597 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 4.5 m -76.09 125.09 28.49 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 125.746 1.618 . . . . 0.0 111.441 -168.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -74.54 4.59 5.84 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.718 1.607 . . . . 0.0 113.21 -177.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -69.13 148.19 97.62 Favored Pre-proline 0 CA--C 1.538 0.51 0 O-C-N 121.29 -0.881 . . . . 0.0 111.018 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -81.36 3.85 7.47 Favored 'Trans proline' 0 CA--C 1.549 1.253 0 C-N-CA 123.2 2.6 . . . . 0.0 111.666 166.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -134.67 -10.42 2.41 Favored 'General case' 0 C--N 1.35 0.61 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 -169.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 36.9 t -64.13 135.28 56.2 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 119.438 1.017 . . . . 0.0 110.811 -177.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.7 t -110.97 10.9 22.2 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.779 1.632 . . . . 0.0 111.498 -173.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 36.5 mm -117.19 -42.46 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 125.263 1.425 . . . . 0.0 108.581 171.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 49.8 -10.18 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 131.068 3.747 . . . . 0.0 119.309 172.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -139.14 140.96 38.05 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 127.051 2.14 . . . . 0.0 109.913 169.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . 0.597 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 8.4 m-85 -147.45 150.83 35.36 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.81 1.644 . . . . 0.0 108.866 -169.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -66.01 153.2 42.83 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 166.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -52.7 -49.41 65.4 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 166.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -69.43 -12.81 61.96 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 1.8 t -68.17 -14.91 63.33 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.752 0.705 . . . . 0.0 112.71 171.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 6.4 p -126.55 -10.11 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 126.479 1.912 . . . . 0.0 112.539 174.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 91.76 20.26 37.69 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.623 1.582 . . . . 0.0 113.469 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 5.9 mt -69.57 160.7 31.02 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.643 1.222 . . . . 0.0 112.018 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 96.9 m -139.35 -29.21 0.75 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.163 1.385 . . . . 0.0 111.307 -174.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 88.0 m -140.96 123.59 16.04 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 125.117 1.367 . . . . 0.0 107.582 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -65.9 121.66 76.99 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 123.96 0.904 . . . . 0.0 111.712 -169.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -78.77 -174.96 2.49 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 124.253 3.302 . . . . 0.0 111.228 170.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 3.1 ttp85 -145.53 151.41 38.1 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.794 1.238 . . . . 0.0 108.811 170.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 94.99 -155.88 21.64 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.817 1.199 . . . . 0.0 111.48 -177.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -57.21 108.92 0.58 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.526 1.53 . . . . 0.0 110.952 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 65.7 t90 -131.06 129.2 41.65 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 126.049 1.739 . . . . 0.0 107.952 169.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -117.75 126.1 51.84 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . 0.437 ' HB3' ' SG ' ' A' ' 212' ' ' CYS . 3.3 p -58.46 171.87 0.56 Allowed Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 127.689 2.396 . . . . 0.0 113.876 -173.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.19 -33.78 38.74 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 121.323 1.349 . . . . 0.0 112.767 -170.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 66.7 mtt180 -79.06 9.19 4.62 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.805 1.242 . . . . 0.0 112.785 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 27.6 m -131.05 -12.21 3.66 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.216 1.806 . . . . 0.0 114.1 -174.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 33.2 t -152.79 -39.59 0.1 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.882 0.873 . . . . 0.0 112.388 178.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -77.89 -13.34 59.92 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -175.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 . . . . . 0 CA--C 1.538 0.488 0 C-N-CA 123.773 0.829 . . . . 0.0 112.654 172.273 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo . . . . . 0 CA--C 1.535 0.535 0 CA-C-O 120.972 0.322 . . . . 0.0 111.632 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 62.9 p -145.47 174.07 11.46 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.703 1.201 . . . . 0.0 110.502 -175.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -137.51 -80.93 0.36 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.639 -169.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 1.8 t -56.58 167.14 0.77 Allowed 'General case' 0 C--N 1.351 0.649 0 C-N-CA 124.543 1.137 . . . . 0.0 112.942 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.0 pp -58.3 -11.97 3.25 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.031 1.332 . . . . 0.0 112.759 171.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 71.4 m -76.34 -20.43 57.24 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.552 1.941 . . . . 0.0 113.166 176.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 50.8 m170 56.71 65.99 1.28 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.855 2.062 . . . . 0.0 111.585 -170.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.93 157.65 41.03 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.029 1.332 . . . . 0.0 112.338 174.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.502 HG11 ' H ' ' A' ' 205' ' ' SER . 0.7 OUTLIER -67.92 -178.89 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 126.292 1.837 . . . . 0.0 111.113 -177.858 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.502 ' H ' HG11 ' A' ' 204' ' ' VAL . 87.9 p -45.57 149.83 0.54 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 127.47 2.308 . . . . 0.0 113.827 178.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . 0.44 ' CE2' ' HG2' ' A' ' 209' ' ' MET . 16.3 p90 -154.34 165.62 35.77 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.22 1.408 . . . . 0.0 111.077 -167.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -74.91 -41.54 32.88 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 118.511 -1.16 . . . . 0.0 115.204 -168.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -126.35 120.3 29.52 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 118.582 1.191 . . . . 0.0 110.506 -169.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' MET . . . . . 0.44 ' HG2' ' CE2' ' A' ' 206' ' ' TYR . 3.1 mtp -139.74 149.2 43.32 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -165.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 15.2 tt -137.79 155.61 30.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 CA-C-N 113.768 -1.56 . . . . 0.0 109.553 168.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -133.04 138.87 10.47 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.698 1.142 . . . . 0.0 112.51 -171.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . 0.591 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 1.6 m -79.3 126.21 30.5 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.554 1.542 . . . . 0.0 112.311 -167.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -69.67 -1.85 10.13 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.776 2.03 . . . . 0.0 113.718 -176.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -66.56 148.86 98.52 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 123.717 0.807 . . . . 0.0 111.827 -174.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -83.34 7.92 4.92 Favored 'Trans proline' 0 CA--C 1.549 1.25 0 C-N-CA 123.661 2.908 . . . . 0.0 111.404 166.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -144.58 -10.43 0.62 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 -167.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 37.3 t -61.58 133.42 55.65 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 119.562 1.074 . . . . 0.0 110.62 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.9 t -107.16 8.54 30.14 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.652 1.581 . . . . 0.0 111.588 -172.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 41.3 mm -117.66 -42.58 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 125.675 1.59 . . . . 0.0 108.735 174.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 46.95 -9.77 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.834 1 C-N-CA 131.706 4.002 . . . . 0.0 119.703 172.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 63.8 m95 -136.85 135.84 38.25 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.652 1.981 . . . . 0.0 109.166 170.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . 0.591 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 7.6 m-85 -141.45 155.86 45.82 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 125.129 1.371 . . . . 0.0 109.074 -169.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -76.22 149.01 37.28 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 169.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -52.39 -50.61 62.13 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.094 167.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.32 -14.59 62.65 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -177.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 9.5 m -79.14 -4.05 48.53 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 119.676 1.126 . . . . 0.0 112.861 172.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.6 p -123.93 -13.84 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 126.049 1.739 . . . . 0.0 112.383 169.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 96.57 17.53 33.23 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.683 1.611 . . . . 0.0 113.206 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 9.6 mt -73.31 162.67 29.09 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.38 1.09 . . . . 0.0 111.606 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.7 t -139.47 -2.79 1.56 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.923 1.689 . . . . 0.0 112.15 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 46.0 p -143.37 179.77 6.89 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.977 2.111 . . . . 0.0 109.61 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -110.89 92.72 15.36 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 124.707 1.203 . . . . 0.0 109.546 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -69.01 164.68 32.85 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.252 1.968 . . . . 0.0 110.295 169.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 47.9 ttp180 -142.47 131.52 23.16 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 122.211 1.005 . . . . 0.0 109.012 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 135.58 -170.56 23.0 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 126.721 2.105 . . . . 0.0 109.886 -169.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -67.53 121.23 15.37 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.709 0.766 . . . . 0.0 109.892 171.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 47.7 t90 -131.41 141.59 49.88 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.793 2.037 . . . . 0.0 108.313 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -125.08 130.74 52.87 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.29 1.036 . . . . 0.0 108.868 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 2.4 p -61.28 167.63 3.8 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 126.089 1.756 . . . . 0.0 112.705 -175.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -65.61 -33.72 44.43 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 121.29 1.326 . . . . 0.0 112.671 -169.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 75.1 mtt-85 -79.43 6.29 10.6 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.137 0.975 . . . . 0.0 113.049 177.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 22.6 m -125.9 -15.38 5.92 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.835 1.654 . . . . 0.0 114.023 -175.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 22.9 t -150.24 -32.51 0.19 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.89 0.768 . . . . 0.0 112.997 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 30.1 tp60 -86.44 -20.62 27.89 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -176.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 . . . . . 0 CA--C 1.54 0.582 0 C-N-CA 124.556 1.142 . . . . 0.0 112.046 -176.204 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo . . . . . 0 CA--C 1.536 0.591 0 CA-C-O 121.615 0.59 . . . . 0.0 112.205 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 44.6 p -141.59 169.83 16.86 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.033 1.733 . . . . 0.0 108.466 174.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -137.83 -55.13 0.67 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -177.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 201' ' ' CYS . 3.6 p -67.48 165.68 16.23 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 128.531 2.732 . . . . 0.0 113.664 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.4 pp -72.11 -4.71 30.58 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.648 166.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . 0.448 ' HB2' ' SG ' ' A' ' 199' ' ' CYS . 74.1 m -80.07 -25.81 39.9 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.867 1.267 . . . . 0.0 111.342 174.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . 0.285 9.9 m-70 71.37 52.01 0.25 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.886 2.074 . . . . 0.0 112.71 169.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -137.41 171.37 14.58 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.22 167.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.423 HG11 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -63.9 174.12 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 125.349 1.459 . . . . 0.0 111.998 -173.87 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.423 ' H ' HG11 ' A' ' 204' ' ' VAL . 89.4 p -47.57 155.12 0.39 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.339 2.256 . . . . 0.0 115.481 -173.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -145.46 160.41 41.63 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.962 1.705 . . . . 0.0 110.377 -169.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -60.46 -38.77 95.33 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.653 1.12 . . . . 0.0 114.783 -169.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -131.86 121.45 24.08 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.0 0.92 . . . . 0.0 110.722 -171.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 1.4 mtm -138.33 144.92 40.61 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -168.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 21.3 tt -143.33 147.91 19.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 126.358 1.863 . . . . 0.0 109.202 173.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -137.19 145.85 17.68 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 123.698 0.666 . . . . 0.0 113.086 -169.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 6.9 t -72.13 145.3 48.22 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-O 122.234 1.016 . . . . 0.0 111.124 -172.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -77.78 -9.56 59.09 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.648 1.979 . . . . 0.0 113.92 -176.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 56.9 m-20 -76.71 145.91 75.6 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 118.676 0.671 . . . . 0.0 111.782 -169.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.35 8.95 2.69 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 124.072 3.181 . . . . 0.0 112.209 169.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -134.23 -8.8 2.61 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.285 1.834 . . . . 0.0 112.34 -169.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 46.9 t -63.07 125.1 22.9 Favored 'General case' 0 C--N 1.345 0.401 0 C-N-CA 123.52 0.728 . . . . 0.0 109.708 172.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 10.0 t -97.84 1.78 48.59 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.835 1.654 . . . . 0.0 112.014 -172.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 28.3 mm -117.43 -32.03 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 125.949 1.7 . . . . 0.0 109.7 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 50.07 -12.61 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 130.529 3.532 . . . . 0.0 118.985 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 46.3 m95 -141.96 157.18 45.26 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 120.588 1.54 . . . . 0.0 112.104 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -158.72 153.3 24.46 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.203 1.801 . . . . 0.0 109.349 -174.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 62.0 m80 -68.69 155.55 39.88 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 166.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 11.1 m-30 -52.81 -51.11 62.1 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 166.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -68.68 -12.55 61.53 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.893 0.877 . . . . 0.0 113.255 -177.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 1.1 t -67.08 -20.29 65.79 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.488 0.715 . . . . 0.0 112.584 172.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 5.5 p -118.69 -15.48 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 125.971 1.709 . . . . 0.0 112.155 173.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 101.28 16.99 23.55 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.797 1.665 . . . . 0.0 113.665 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 11.7 mt -71.6 166.49 21.74 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.065 1.433 . . . . 0.0 111.652 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 88.2 m -132.42 -14.5 2.91 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.909 1.683 . . . . 0.0 110.828 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 75.9 p -142.03 169.49 17.49 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.996 1.718 . . . . 0.0 109.983 -177.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -98.77 114.4 65.38 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 123.829 0.852 . . . . 0.0 109.13 175.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -75.32 -178.81 4.5 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.991 3.128 . . . . 0.0 110.748 172.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -138.37 129.52 27.19 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.964 0.906 . . . . 0.0 108.868 174.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 123.31 -178.42 16.39 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 125.978 1.752 . . . . 0.0 110.981 -170.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -67.33 137.31 55.94 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 122.298 1.047 . . . . 0.0 110.625 173.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . 0.402 ' CH2' ' HA ' ' A' ' 239' ' ' CYS . 49.4 t90 -141.89 154.88 45.44 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 127.439 2.296 . . . . 0.0 109.109 -176.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -128.42 132.5 48.46 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.9 1.28 . . . . 0.0 110.487 -174.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . 0.402 ' HA ' ' CH2' ' A' ' 237' ' ' TRP . 1.8 p -71.47 170.07 13.22 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.045 1.338 . . . . 0.0 112.186 -178.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.79 -15.28 26.82 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 121.789 1.659 . . . . 0.0 114.09 -169.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -96.92 9.25 42.46 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.882 1.673 . . . . 0.0 111.948 173.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 20.0 m -130.65 -18.32 3.13 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.589 1.556 . . . . 0.0 113.637 -172.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 45.1 t -151.17 -38.67 0.13 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.464 1.029 . . . . 0.0 112.746 174.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 33.2 tp60 -69.11 -19.07 64.04 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.131 0.423 . . . . 0.0 112.004 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 . . . . . 0 CA--C 1.541 0.622 0 C-N-CA 126.564 1.946 . . . . 0.0 113.078 177.656 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo . . . . . 0 CA--C 1.534 0.519 0 CA-C-O 121.272 0.447 . . . . 0.0 111.962 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 63.9 p -144.48 175.23 10.28 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.85 1.26 . . . . 0.0 110.452 -173.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -135.19 -81.2 0.43 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 117.436 -1.269 . . . . 0.0 112.992 -169.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -56.02 168.93 0.42 Allowed 'General case' 0 C--N 1.349 0.581 0 C-N-CA 124.887 1.275 . . . . 0.0 113.32 -177.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.9 pp -57.87 -12.14 2.91 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.015 1.326 . . . . 0.0 113.015 169.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 72.1 m -76.62 -23.74 53.38 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 127.002 2.121 . . . . 0.0 113.261 176.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 17.3 m170 58.85 66.44 1.06 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.574 1.949 . . . . 0.0 111.001 -169.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.18 159.44 36.03 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.966 1.306 . . . . 0.0 112.273 174.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.525 HG11 ' H ' ' A' ' 205' ' ' SER . 0.8 OUTLIER -70.96 -177.96 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 C-N-CA 126.186 1.794 . . . . 0.0 111.231 -175.79 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.525 ' H ' HG11 ' A' ' 204' ' ' VAL . 49.6 m -46.83 151.69 0.58 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 128.289 2.636 . . . . 0.0 114.221 -178.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . 0.423 ' CE2' ' HG2' ' A' ' 209' ' ' MET . 11.9 p90 -155.7 162.95 40.46 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.742 1.617 . . . . 0.0 110.819 -168.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -70.59 -47.17 43.14 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-O 118.695 -1.058 . . . . 0.0 114.526 -169.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -127.94 123.0 33.83 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.376 1.088 . . . . 0.0 110.289 -169.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' MET . . . . . 0.423 ' HG2' ' CE2' ' A' ' 206' ' ' TYR . 5.1 mtp -135.17 153.63 51.9 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -165.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 18.4 tt -142.94 158.81 18.13 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 C-N-CA 126.799 2.04 . . . . 0.0 108.752 169.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -141.64 143.42 13.04 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 123.564 0.602 . . . . 0.0 111.79 -173.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 4.1 t -71.55 142.32 50.07 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-O 121.674 0.749 . . . . 0.0 111.04 -173.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -75.97 -10.65 59.59 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.682 1.593 . . . . 0.0 114.036 -174.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 18.8 m-20 -78.84 145.04 65.38 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 118.66 0.664 . . . . 0.0 112.064 -167.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -75.64 1.98 7.44 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 123.603 2.869 . . . . 0.0 111.989 168.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -118.77 -6.61 10.58 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.217 1.807 . . . . 0.0 112.224 -175.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 39.0 t -64.91 136.86 57.32 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.305 1.042 . . . . 0.0 109.682 173.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 8.5 t -121.05 12.4 11.13 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.805 1.642 . . . . 0.0 111.202 -175.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 36.4 mm -119.98 -32.88 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 126.206 1.802 . . . . 0.0 109.383 175.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 50.83 -16.27 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.687 1 C-N-CA 131.769 4.028 . . . . 0.0 119.309 175.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 61.5 m95 -140.86 150.81 43.73 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 125.549 1.54 . . . . 0.0 110.188 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -154.31 154.44 33.37 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.288 1.435 . . . . 0.0 110.278 -170.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -79.07 143.92 35.11 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 168.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -51.67 -50.07 61.13 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.337 167.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -68.88 -13.93 62.72 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.747 1.018 . . . . 0.0 113.747 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.38 -21.94 59.42 Favored 'General case' 0 C--N 1.349 0.55 0 CA-C-N 119.942 1.247 . . . . 0.0 112.647 174.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.6 p -104.9 -13.46 9.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 125.604 1.562 . . . . 0.0 111.785 170.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 90.68 20.3 41.02 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.83 1.681 . . . . 0.0 113.24 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 12.9 mt -73.45 157.82 36.12 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 118.873 1.336 . . . . 0.0 111.382 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 69.0 p -131.52 -1.33 3.9 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.293 1.837 . . . . 0.0 111.403 176.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 60.5 p -145.23 175.69 10.09 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.551 2.34 . . . . 0.0 108.956 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -119.13 125.44 27.62 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 123.946 0.899 . . . . 0.0 109.515 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -76.17 -171.09 0.98 Allowed 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 124.513 3.475 . . . . 0.0 111.127 174.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -148.3 138.72 22.75 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.187 0.995 . . . . 0.0 109.34 178.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 102.58 -62.23 0.48 Allowed Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.919 1.723 . . . . 0.0 112.065 173.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -148.74 142.27 25.37 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 125.475 1.51 . . . . 0.0 110.306 -178.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . 0.404 ' CH2' ' HA ' ' A' ' 239' ' ' CYS . 77.6 t90 -150.73 154.02 36.6 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 126.223 1.809 . . . . 0.0 109.834 171.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -128.42 127.51 42.7 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.054 1.342 . . . . 0.0 109.919 -177.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . 0.404 ' HA ' ' CH2' ' A' ' 237' ' ' TRP . 0.5 OUTLIER -65.62 167.54 10.75 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 124.79 1.236 . . . . 0.0 113.311 -177.115 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -74.29 -0.65 9.92 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.507 2.138 . . . . 0.0 114.19 -174.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 35.0 mtp180 -123.9 27.39 7.25 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.02 1.328 . . . . 0.0 111.322 168.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 10.3 m -131.67 -14.89 3.16 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 126.357 1.863 . . . . 0.0 112.224 173.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 41.9 t -149.17 -34.82 0.19 Allowed 'General case' 0 C--N 1.345 0.402 0 CA-C-N 118.994 0.815 . . . . 0.0 112.704 174.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -75.27 -12.98 60.39 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -176.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 . . . . . 0 CA--C 1.543 0.676 0 CA-C-N 118.936 0.789 . . . . 0.0 112.75 169.95 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo . . . . . 0 CA--C 1.535 0.553 0 CA-C-O 121.003 0.335 . . . . 0.0 111.693 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 80.4 p -144.41 172.76 12.5 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.767 1.227 . . . . 0.0 110.377 -175.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -136.38 -81.18 0.39 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 117.511 -1.233 . . . . 0.0 113.076 -169.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.8 t -55.43 166.55 0.61 Allowed 'General case' 0 C--N 1.35 0.594 0 C-N-CA 125.161 1.385 . . . . 0.0 112.871 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 4.7 pp -59.52 -9.72 2.78 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.543 1.137 . . . . 0.0 112.873 170.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 73.3 m -77.06 -20.87 55.3 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.694 1.997 . . . . 0.0 113.052 174.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 13.3 m170 59.2 62.55 1.8 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.881 2.072 . . . . 0.0 111.499 -173.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.31 160.43 32.21 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.269 1.428 . . . . 0.0 112.409 176.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.472 HG11 ' H ' ' A' ' 205' ' ' SER . 0.3 OUTLIER -69.2 -179.62 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 126.366 1.866 . . . . 0.0 111.718 -176.325 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.472 ' H ' HG11 ' A' ' 204' ' ' VAL . 80.4 p -45.67 150.16 0.53 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.873 2.469 . . . . 0.0 114.329 178.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . 0.4 ' CE2' ' CD2' ' A' ' 223' ' ' HIS . 10.1 p90 -155.37 168.69 26.28 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.767 1.627 . . . . 0.0 110.875 -167.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -76.04 -43.68 21.04 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 118.676 -1.069 . . . . 0.0 115.101 -168.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -127.73 121.78 31.18 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 118.425 1.113 . . . . 0.0 110.784 -169.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -143.76 146.74 33.36 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -165.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 13.6 tt -143.7 154.9 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 125.8 1.64 . . . . 0.0 109.346 168.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -136.23 147.01 19.0 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 123.741 0.686 . . . . 0.0 112.299 -169.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 6.1 t -70.12 144.47 52.05 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-O 122.179 0.99 . . . . 0.0 111.058 -174.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -79.14 -5.94 55.34 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.763 2.025 . . . . 0.0 113.671 -174.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 60.6 m-20 -82.22 145.48 52.51 Favored Pre-proline 0 CA--C 1.535 0.404 0 CA-C-N 118.81 0.732 . . . . 0.0 111.464 -169.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -76.74 6.28 4.24 Favored 'Trans proline' 0 CA--C 1.547 1.133 0 C-N-CA 123.544 2.829 . . . . 0.0 111.702 167.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -124.18 -9.23 7.61 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.301 1.841 . . . . 0.0 112.502 -172.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 43.9 t -64.92 133.6 52.17 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.239 1.016 . . . . 0.0 109.893 175.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 37.9 m -110.39 8.39 23.25 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.531 1.532 . . . . 0.0 111.845 -174.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 33.3 mm -119.83 -33.06 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 126.256 1.822 . . . . 0.0 109.446 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 50.14 -15.7 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.659 1 C-N-CA 131.757 4.023 . . . . 0.0 119.338 177.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 58.3 m95 -140.47 152.14 45.4 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.795 1.638 . . . . 0.0 110.437 178.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -153.07 154.95 35.91 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.333 1.453 . . . . 0.0 110.015 -173.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . 0.4 ' CD2' ' CE2' ' A' ' 206' ' ' TYR . 19.5 m170 -77.71 149.75 34.56 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 170.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -53.71 -50.75 65.22 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.634 167.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -69.91 -14.82 62.91 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 118.296 -0.859 . . . . 0.0 113.229 -177.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 7.4 m -78.85 -6.46 56.12 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 119.667 1.122 . . . . 0.0 112.858 173.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.3 p -121.17 -12.58 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 125.864 1.666 . . . . 0.0 112.065 169.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 92.96 19.86 35.3 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.524 1.535 . . . . 0.0 113.313 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 6.2 mt -72.51 158.29 36.0 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 118.397 1.098 . . . . 0.0 111.082 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 68.7 p -134.14 1.9 3.28 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.195 1.798 . . . . 0.0 111.263 176.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 81.9 p -142.95 179.89 6.76 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.051 2.141 . . . . 0.0 109.664 -175.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -121.65 89.55 47.63 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 124.603 1.161 . . . . 0.0 109.055 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.65 169.04 18.29 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.801 2.334 . . . . 0.0 111.304 174.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -140.02 133.7 30.39 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 124.917 1.287 . . . . 0.0 108.564 -177.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 126.46 -169.59 18.38 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 126.319 1.914 . . . . 0.0 110.277 -169.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.95 130.4 43.91 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 122.093 0.949 . . . . 0.0 109.195 169.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 53.0 t90 -136.74 146.63 46.03 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 127.072 2.149 . . . . 0.0 108.312 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -129.97 131.65 46.0 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.678 1.191 . . . . 0.0 109.637 -173.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 1.5 p -68.78 166.68 24.9 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 124.27 1.028 . . . . 0.0 112.074 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.37 9.43 2.52 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.539 2.159 . . . . 0.0 114.57 -175.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -122.79 15.93 10.17 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.512 1.925 . . . . 0.0 110.856 171.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 30.1 m -133.19 -22.76 1.98 Allowed 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.962 1.705 . . . . 0.0 113.111 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.1 t -153.71 -34.07 0.11 Allowed 'General case' 0 C--N 1.346 0.426 0 CA-C-N 119.724 1.147 . . . . 0.0 113.501 173.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 10.7 tp60 -76.03 -8.05 56.08 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.928 0.785 . . . . 0.0 112.006 176.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 . . . . . 0 CA--C 1.542 0.645 0 C-N-CA 125.057 1.343 . . . . 0.0 111.628 169.815 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo . . . . . 0 CA--C 1.537 0.639 0 CA-C-O 121.252 0.438 . . . . 0.0 111.431 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 49.0 p -143.31 173.14 11.86 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.573 1.549 . . . . 0.0 109.108 -177.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -139.46 -67.29 0.45 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.83 0.852 . . . . 0.0 111.782 -173.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . 0.428 ' SG ' ' HB2' ' A' ' 201' ' ' CYS . 4.6 p -59.37 165.15 2.89 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 128.484 2.714 . . . . 0.0 113.595 176.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 2.9 pp -77.66 -0.36 26.37 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.595 167.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . 0.428 ' HB2' ' SG ' ' A' ' 199' ' ' CYS . 74.2 m -76.78 -28.22 55.58 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.889 0.875 . . . . 0.0 110.226 168.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . 0.293 93.4 m-70 72.45 52.2 0.17 Allowed 'General case' 0 C--N 1.342 0.242 0 C-N-CA 127.828 2.451 . . . . 0.0 113.84 169.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -136.85 173.61 11.51 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.528 1.131 . . . . 0.0 109.864 166.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.443 HG11 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -62.55 174.49 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 125.238 1.415 . . . . 0.0 111.813 -176.17 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.443 ' H ' HG11 ' A' ' 204' ' ' VAL . 80.5 p -47.94 157.44 0.28 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.516 2.326 . . . . 0.0 114.899 -175.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -142.36 163.2 33.49 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.82 1.648 . . . . 0.0 110.984 -168.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -61.3 -42.31 99.74 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.824 1.202 . . . . 0.0 114.37 -169.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -127.98 124.12 36.47 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.462 1.105 . . . . 0.0 110.116 -178.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 1.6 mtm -138.42 145.63 41.2 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.003 -168.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 21.4 tt -137.06 144.67 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 125.126 1.37 . . . . 0.0 110.53 172.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -120.24 139.68 13.92 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 125.238 1.399 . . . . 0.0 112.241 -171.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . 0.576 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 1.2 m -80.0 123.88 28.21 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.737 1.615 . . . . 0.0 111.451 -167.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.25 14.48 1.19 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.256 1.422 . . . . 0.0 112.458 -175.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -74.23 148.77 86.58 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 124.295 1.038 . . . . 0.0 111.484 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -84.92 8.92 4.37 Favored 'Trans proline' 0 CA--C 1.551 1.347 0 C-N-CA 123.342 2.695 . . . . 0.0 110.944 165.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -134.58 -16.71 2.03 Favored 'General case' 0 C--N 1.351 0.631 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -168.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 28.2 t -65.59 135.6 55.29 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 123.594 0.758 . . . . 0.0 111.119 -172.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 10.2 t -110.77 12.08 22.48 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.726 1.61 . . . . 0.0 111.588 -174.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 34.0 mm -122.06 -40.96 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 125.758 1.623 . . . . 0.0 108.852 174.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 48.36 -7.75 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 131.424 3.89 . . . . 0.0 119.435 172.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 49.3 m95 -140.49 140.31 35.28 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 126.904 2.082 . . . . 0.0 110.211 169.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . 0.576 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 8.4 m-85 -148.93 153.4 37.93 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 125.441 1.496 . . . . 0.0 109.141 -169.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -66.73 151.75 46.81 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 166.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 12.2 m-30 -51.19 -50.82 58.29 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.757 166.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.07 -12.38 61.56 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -178.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 1.9 t -67.63 -18.12 64.85 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.821 0.737 . . . . 0.0 112.588 172.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.4 p -121.3 -15.61 6.8 Favored 'Isoleucine or valine' 0 C--N 1.345 0.396 0 C-N-CA 126.039 1.736 . . . . 0.0 112.396 175.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 102.32 17.33 20.27 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.693 1.616 . . . . 0.0 113.653 178.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 20.3 mt -71.32 158.63 36.01 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.244 1.522 . . . . 0.0 111.414 177.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 71.2 m -136.12 -23.44 1.32 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.727 1.611 . . . . 0.0 111.135 -177.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 92.2 m -140.04 137.13 34.35 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 125.957 1.703 . . . . 0.0 107.264 176.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 55.4 tttm -67.72 125.51 91.38 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-O 118.871 -0.585 . . . . 0.0 110.954 -173.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -77.84 -170.09 0.89 Allowed 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 124.151 3.234 . . . . 0.0 111.191 173.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 17.5 tpp180 -142.78 138.98 30.81 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.134 1.374 . . . . 0.0 108.118 178.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 81.32 -159.46 41.03 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.552 1.072 . . . . 0.0 112.754 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 27.6 mttp -50.65 120.72 4.96 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 126.753 2.021 . . . . 0.0 112.848 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . 0.427 ' CZ2' ' HA ' ' A' ' 239' ' ' CYS . 62.7 t90 -138.48 138.47 38.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.239 1.816 . . . . 0.0 109.012 173.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -120.53 127.39 52.13 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.707 1.203 . . . . 0.0 108.405 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . 0.427 ' HA ' ' CZ2' ' A' ' 237' ' ' TRP . 14.7 p -59.25 172.51 0.58 Allowed Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 127.851 2.46 . . . . 0.0 114.334 -173.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 43.1 Cg_endo -64.2 -38.64 34.7 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 121.658 1.572 . . . . 0.0 113.14 -168.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 66.0 mtt85 -88.02 20.53 3.09 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.42 1.009 . . . . 0.0 112.554 177.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 16.7 m -131.3 -10.4 3.69 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 126.316 1.846 . . . . 0.0 113.344 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 22.7 t -157.08 -39.59 0.07 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.144 0.884 . . . . 0.0 113.147 174.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -75.2 -15.04 60.58 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.537 0.735 . . . . 0.0 112.525 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 . . . . . 0 C--O 1.234 0.28 0 C-N-CA 128.26 2.624 . . . . 0.0 106.026 -175.351 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo . . . . . 0 CA--C 1.536 0.613 0 CA-C-O 121.496 0.54 . . . . 0.0 112.657 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 34.7 p -144.77 172.98 12.25 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.094 1.757 . . . . 0.0 109.284 -177.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -139.04 -54.1 0.58 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . 0.443 ' SG ' ' HB2' ' A' ' 201' ' ' CYS . 2.4 p -68.82 165.62 19.33 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 128.431 2.693 . . . . 0.0 113.272 178.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.5 pp -71.94 -5.62 36.07 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.77 166.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . 0.443 ' HB2' ' SG ' ' A' ' 199' ' ' CYS . 74.8 m -78.07 -29.09 48.97 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.807 1.243 . . . . 0.0 110.831 173.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . 0.303 90.9 m-70 71.09 54.86 0.23 Allowed 'General case' 0 C--N 1.34 0.167 0 C-N-CA 127.529 2.332 . . . . 0.0 113.391 169.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -136.6 171.37 14.59 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.44 -1.254 . . . . 0.0 109.697 166.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.446 HG11 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -64.97 175.97 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 125.274 1.43 . . . . 0.0 112.105 -173.18 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.446 ' H ' HG11 ' A' ' 204' ' ' VAL . 20.3 m -43.39 152.78 0.12 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 128.421 2.689 . . . . 0.0 115.569 -173.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -147.63 157.05 43.38 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.59 1.556 . . . . 0.0 110.497 -172.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -65.75 -38.53 94.54 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.432 1.015 . . . . 0.0 115.095 -169.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 26.8 pt-20 -119.33 122.08 41.05 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 118.164 0.982 . . . . 0.0 110.345 -174.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 14.6 mtp -141.84 141.14 33.09 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -167.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 16.8 tt -144.17 151.53 16.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 125.817 1.647 . . . . 0.0 109.636 169.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -138.29 145.98 17.61 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 123.874 0.75 . . . . 0.0 112.629 -169.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 6.5 t -69.88 145.78 51.74 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-O 122.228 1.013 . . . . 0.0 111.182 -172.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -81.29 -6.5 58.95 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.713 2.005 . . . . 0.0 113.442 -175.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -78.78 146.08 67.94 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 118.696 0.68 . . . . 0.0 111.568 -169.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.95 6.71 4.03 Favored 'Trans proline' 0 CA--C 1.547 1.172 0 C-N-CA 123.58 2.853 . . . . 0.0 111.718 167.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -126.72 -7.71 6.18 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.137 1.775 . . . . 0.0 112.628 -172.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 39.0 t -66.02 133.39 50.69 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.074 0.95 . . . . 0.0 109.791 174.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 50.2 m -112.1 10.47 20.32 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.639 1.576 . . . . 0.0 111.708 -174.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 22.0 mm -120.32 -33.62 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 125.905 1.682 . . . . 0.0 109.472 175.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 50.33 -10.21 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 130.624 3.57 . . . . 0.0 118.917 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 54.9 m95 -144.5 156.9 44.39 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.395 1.478 . . . . 0.0 111.83 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -158.88 154.35 25.88 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.362 1.865 . . . . 0.0 109.377 -176.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 44.3 m80 -69.37 154.51 41.91 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 166.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 13.9 m-30 -52.33 -50.68 61.82 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 166.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -69.5 -13.08 62.15 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 4.8 t -69.16 -19.1 64.0 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.646 0.778 . . . . 0.0 112.476 172.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.0 p -114.82 -21.52 5.3 Favored 'Isoleucine or valine' 0 C--N 1.347 0.466 0 C-N-CA 125.605 1.562 . . . . 0.0 112.275 172.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 105.71 17.95 12.46 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 126.029 1.776 . . . . 0.0 113.752 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 13.5 mt -71.76 162.53 29.31 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.271 1.536 . . . . 0.0 111.854 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 36.0 m -138.42 -24.81 0.95 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.348 1.459 . . . . 0.0 111.417 -176.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 46.2 p -139.15 140.59 37.93 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.681 1.592 . . . . 0.0 108.432 176.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -78.14 119.22 76.53 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 123.413 0.685 . . . . 0.0 112.03 -169.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -81.21 175.93 9.27 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.692 2.928 . . . . 0.0 111.015 169.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 13.5 ttp85 -145.0 134.78 23.54 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 124.035 0.934 . . . . 0.0 109.019 172.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 127.38 -165.07 20.65 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.807 1.67 . . . . 0.0 111.136 -175.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.72 120.91 10.99 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 124.203 1.001 . . . . 0.0 109.686 171.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 58.5 t90 -138.56 144.29 39.8 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 127.257 2.223 . . . . 0.0 108.482 175.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -120.27 135.85 54.86 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.468 1.107 . . . . 0.0 109.309 -178.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -67.46 168.78 10.72 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 124.279 1.031 . . . . 0.0 111.72 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.38 -36.09 28.59 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.108 1.205 . . . . 0.0 112.681 -172.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 67.6 mtt-85 -75.55 0.06 18.67 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.373 1.069 . . . . 0.0 113.405 175.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 24.7 m -115.06 -21.27 10.1 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.029 1.331 . . . . 0.0 113.821 -176.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.1 t -151.22 -28.14 0.2 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.545 1.066 . . . . 0.0 113.56 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -76.57 -13.54 60.07 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.903 0.774 . . . . 0.0 112.299 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 . . . . . 0 CA--C 1.542 0.65 0 C-N-CA 123.706 0.803 . . . . 0.0 112.54 169.6 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 CA--C 1.535 0.542 0 CA-C-O 120.967 0.32 . . . . 0.0 111.78 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 68.0 p -146.57 175.02 10.89 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.743 1.217 . . . . 0.0 110.66 -174.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -137.61 -83.66 0.32 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 117.337 -1.316 . . . . 0.0 112.588 -170.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.1 t -55.67 168.21 0.45 Allowed 'General case' 0 C--N 1.352 0.692 0 CA-C-N 119.844 1.202 . . . . 0.0 113.336 -177.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.1 pp -57.49 -12.73 2.87 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.882 1.273 . . . . 0.0 112.861 170.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 71.7 m -76.82 -19.87 57.04 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.899 2.079 . . . . 0.0 113.275 176.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 22.3 m170 57.86 64.01 1.65 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.907 2.083 . . . . 0.0 111.543 -173.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.77 157.61 40.97 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.124 1.37 . . . . 0.0 112.561 175.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.484 HG11 ' H ' ' A' ' 205' ' ' SER . 0.4 OUTLIER -68.57 -178.72 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 126.45 1.9 . . . . 0.0 111.325 -177.873 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.484 ' H ' HG11 ' A' ' 204' ' ' VAL . 49.8 m -42.35 145.65 0.38 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 128.012 2.525 . . . . 0.0 113.472 177.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . 0.414 ' CE2' ' HG2' ' A' ' 209' ' ' MET . 13.2 p90 -152.03 165.31 35.07 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.837 1.255 . . . . 0.0 111.935 -167.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -67.98 -47.91 57.25 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.76 1.172 . . . . 0.0 115.018 -168.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -127.8 125.38 39.72 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 118.401 1.1 . . . . 0.0 109.849 -170.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' MET . . . . . 0.414 ' HG2' ' CE2' ' A' ' 206' ' ' TYR . 9.1 mtp -140.47 147.9 40.32 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -166.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 17.0 tt -135.05 155.68 38.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 125.843 1.657 . . . . 0.0 109.557 168.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -132.73 139.18 10.72 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.668 1.127 . . . . 0.0 112.45 -172.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . 0.592 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 1.8 m -79.51 127.12 31.75 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 125.487 1.515 . . . . 0.0 112.19 -167.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -70.22 -3.61 17.81 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.35 1.86 . . . . 0.0 113.692 -175.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -67.77 146.95 98.61 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 123.547 0.739 . . . . 0.0 111.469 -174.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.83 5.65 6.18 Favored 'Trans proline' 0 CA--C 1.55 1.3 0 C-N-CA 123.138 2.559 . . . . 0.0 111.372 166.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -134.13 -13.51 2.42 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 125.21 1.404 . . . . 0.0 114.381 -169.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 36.8 t -63.72 132.57 51.43 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 118.973 0.806 . . . . 0.0 110.335 -176.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 69.7 m -109.29 11.72 25.17 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 113.637 -1.62 . . . . 0.0 111.602 -173.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 39.4 mm -119.3 -41.35 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 125.838 1.655 . . . . 0.0 108.604 173.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 47.67 -9.47 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.832 1 C-N-CA 131.717 4.007 . . . . 0.0 119.725 171.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -139.83 135.95 33.51 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.744 2.017 . . . . 0.0 109.197 172.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . 0.592 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 6.4 m-85 -143.47 155.82 44.47 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.376 1.471 . . . . 0.0 109.53 -169.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 21.9 m80 -73.55 148.62 42.84 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 168.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 16.8 m-30 -52.19 -51.11 60.11 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.751 167.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.19 -14.34 62.59 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -177.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 2.8 m -78.12 -8.56 58.42 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 119.76 1.164 . . . . 0.0 112.777 173.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.7 p -119.07 -14.08 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 126.009 1.724 . . . . 0.0 112.198 169.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 96.8 17.4 33.01 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.693 1.616 . . . . 0.0 113.306 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 12.5 mt -71.55 160.37 32.81 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.582 1.191 . . . . 0.0 111.272 176.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 16.0 m -134.03 -1.4 2.98 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.998 1.719 . . . . 0.0 110.37 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 9.3 t -150.58 177.11 10.35 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.284 1.834 . . . . 0.0 109.674 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -108.92 105.67 57.54 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 124.305 1.042 . . . . 0.0 109.391 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.48 175.52 10.53 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.221 2.614 . . . . 0.0 111.435 173.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -140.1 133.57 30.06 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 124.856 1.262 . . . . 0.0 108.229 173.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 124.24 -175.89 16.95 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 126.156 1.836 . . . . 0.0 110.845 -170.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -66.69 131.65 46.43 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.996 0.903 . . . . 0.0 110.368 173.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . 0.406 ' CZ2' ' HA ' ' A' ' 239' ' ' CYS . 52.8 t90 -136.99 141.55 42.57 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 127.011 2.125 . . . . 0.0 108.779 177.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -124.5 127.38 47.37 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.467 1.107 . . . . 0.0 108.828 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . 0.406 ' HA ' ' CZ2' ' A' ' 237' ' ' TRP . 6.2 p -60.73 167.57 3.29 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 126.465 1.906 . . . . 0.0 113.299 -173.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -65.33 -30.3 53.94 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.491 1.461 . . . . 0.0 112.809 -170.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 53.7 mtt-85 -86.96 13.58 8.87 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.302 1.041 . . . . 0.0 112.747 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 20.1 m -131.01 -14.03 3.51 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.159 1.784 . . . . 0.0 113.518 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 32.1 t -149.33 -39.47 0.15 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.72 0.808 . . . . 0.0 112.414 -178.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -82.09 -11.38 58.8 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -175.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 . . . . . 0 CA--C 1.544 0.717 0 C-N-CA 123.92 0.888 . . . . 0.0 112.717 172.164 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo . . . . . 0 CA--C 1.535 0.566 0 CA-C-O 121.244 0.435 . . . . 0.0 112.063 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 72.9 p -144.23 175.96 9.69 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.904 1.281 . . . . 0.0 110.453 -174.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -136.66 -80.68 0.39 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 117.275 -1.345 . . . . 0.0 113.213 -171.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 3.1 t -55.97 167.81 0.55 Allowed 'General case' 0 C--N 1.35 0.609 0 CA-C-N 119.963 1.256 . . . . 0.0 113.115 -176.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.9 pp -59.4 -10.06 2.89 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.417 1.087 . . . . 0.0 112.717 169.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 75.2 m -77.04 -21.86 53.86 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.658 1.983 . . . . 0.0 113.19 174.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 54.29 68.83 0.79 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.752 2.021 . . . . 0.0 111.629 -170.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.9 160.6 33.06 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.688 1.595 . . . . 0.0 111.468 173.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.499 HG11 ' H ' ' A' ' 205' ' ' SER . 0.6 OUTLIER -70.29 -178.94 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 125.62 1.568 . . . . 0.0 111.142 -178.158 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.499 ' H ' HG11 ' A' ' 204' ' ' VAL . 28.3 m -46.34 151.05 0.56 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 128.093 2.557 . . . . 0.0 114.348 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -154.17 168.47 26.41 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.351 1.46 . . . . 0.0 111.413 -169.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -70.61 -50.85 23.4 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.379 0.99 . . . . 0.0 114.651 -169.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -125.53 122.34 36.29 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 118.091 0.945 . . . . 0.0 110.297 -170.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -144.09 147.01 33.19 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -166.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 16.2 tt -142.04 152.77 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 125.47 1.508 . . . . 0.0 109.783 169.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -132.35 147.01 18.65 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 124.051 0.834 . . . . 0.0 112.456 -169.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 7.0 t -71.2 143.4 50.48 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-O 122.019 0.914 . . . . 0.0 111.369 -172.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -79.36 -8.98 59.48 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.786 2.034 . . . . 0.0 114.193 -176.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -74.39 144.03 80.51 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 119.458 1.027 . . . . 0.0 111.041 -174.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -75.63 6.02 3.92 Favored 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 123.471 2.781 . . . . 0.0 111.802 168.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -124.89 -6.19 7.36 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.533 1.933 . . . . 0.0 112.28 -173.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 49.8 t -63.7 133.42 53.55 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.899 0.879 . . . . 0.0 109.703 174.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 10.4 t -114.75 11.24 16.75 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.644 1.578 . . . . 0.0 111.611 -174.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 33.0 mm -120.25 -31.97 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 126.229 1.812 . . . . 0.0 109.411 176.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 50.36 -13.81 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 131.539 3.936 . . . . 0.0 119.204 176.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 58.2 m95 -143.62 152.53 41.49 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.645 1.578 . . . . 0.0 110.755 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -154.33 150.87 28.43 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.376 1.471 . . . . 0.0 110.473 -174.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -71.59 150.17 44.96 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.26 0.552 . . . . 0.0 109.816 168.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 11.4 m-30 -53.49 -51.28 63.29 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.469 167.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.82 -12.85 61.48 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 1.7 m -76.56 -12.31 60.0 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.771 1.169 . . . . 0.0 112.299 172.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.56 -15.46 9.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 126.172 1.789 . . . . 0.0 112.185 171.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 95.07 20.43 28.1 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.792 1.663 . . . . 0.0 113.663 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 20.4 mt -71.49 157.98 37.06 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.987 1.394 . . . . 0.0 111.407 177.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 91.4 m -131.41 -25.09 2.21 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.828 1.651 . . . . 0.0 110.772 -177.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 61.1 p -138.73 150.85 46.59 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.182 1.793 . . . . 0.0 108.271 172.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -79.77 119.34 76.44 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-O 118.533 -0.746 . . . . 0.0 110.756 -174.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -76.67 165.92 28.02 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 122.922 2.415 . . . . 0.0 110.39 169.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -138.03 130.92 29.9 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-O 122.195 0.997 . . . . 0.0 109.06 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 127.82 -165.9 20.68 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 126.757 2.123 . . . . 0.0 109.407 -168.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.92 142.7 54.67 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 122.469 1.128 . . . . 0.0 109.771 169.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 55.0 t90 -147.31 146.15 29.61 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 127.254 2.222 . . . . 0.0 108.203 -177.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -124.13 137.2 54.58 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.421 1.089 . . . . 0.0 110.197 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -69.08 169.91 10.25 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 125.186 1.394 . . . . 0.0 112.581 -177.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -74.51 1.04 7.89 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.398 2.066 . . . . 0.0 114.506 -175.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -117.63 16.72 14.52 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.53 1.932 . . . . 0.0 110.883 172.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 22.2 m -134.39 -16.99 2.07 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.367 1.867 . . . . 0.0 112.744 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 32.8 t -154.01 -40.91 0.09 Allowed 'General case' 0 C--N 1.345 0.377 0 CA-C-N 118.975 0.807 . . . . 0.0 112.775 175.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -74.82 -6.16 47.49 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 . . . . . 0 CA--C 1.548 0.884 0 C-N-CA 126.186 1.795 . . . . 0.0 112.671 173.298 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo . . . . . 0 CA--C 1.536 0.607 0 CA-C-O 121.235 0.431 . . . . 0.0 111.719 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 66.0 p -143.69 175.02 10.29 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.009 1.324 . . . . 0.0 110.188 -176.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -133.98 -83.83 0.44 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 117.293 -1.337 . . . . 0.0 113.05 -169.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.4 t -55.28 170.19 0.23 Allowed 'General case' 0 C--N 1.351 0.651 0 C-N-CA 124.948 1.299 . . . . 0.0 113.901 -175.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.3 pp -58.38 -14.12 6.87 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.32 1.048 . . . . 0.0 112.605 169.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 75.2 m -75.79 -23.66 55.9 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.029 2.132 . . . . 0.0 112.895 174.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 53.08 69.42 0.7 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 127.434 2.294 . . . . 0.0 112.156 -171.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.46 160.63 28.99 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.091 1.756 . . . . 0.0 111.37 172.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.51 HG12 ' H ' ' A' ' 205' ' ' SER . 0.8 OUTLIER -69.24 -178.67 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 125.705 1.602 . . . . 0.0 110.883 -178.875 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.51 ' H ' HG12 ' A' ' 204' ' ' VAL . 85.8 p -44.3 148.2 0.47 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.566 2.347 . . . . 0.0 113.713 178.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -152.44 168.96 23.78 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.723 1.209 . . . . 0.0 112.168 -167.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -69.11 -53.05 20.23 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.807 1.194 . . . . 0.0 114.743 -168.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -125.07 125.64 44.12 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 118.271 1.036 . . . . 0.0 109.711 -172.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -142.55 145.54 33.71 Favored 'General case' 0 C--N 1.34 0.169 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -166.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 20.6 tt -134.8 150.77 30.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 125.705 1.602 . . . . 0.0 109.644 173.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -128.59 139.06 10.73 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 124.528 1.061 . . . . 0.0 112.576 -171.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . 0.6 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 5.5 m -75.11 125.78 29.66 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 125.362 1.465 . . . . 0.0 111.325 -168.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -70.03 -4.04 19.09 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.495 1.518 . . . . 0.0 113.452 -177.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -68.02 145.6 97.81 Favored Pre-proline 0 CA--C 1.538 0.518 0 O-C-N 121.544 -0.723 . . . . 0.0 110.905 -175.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -80.92 8.32 4.39 Favored 'Trans proline' 0 CA--C 1.549 1.258 0 C-N-CA 123.049 2.499 . . . . 0.0 111.296 166.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -133.81 -14.06 2.47 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 125.21 1.404 . . . . 0.0 114.323 -169.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.5 t -65.29 134.33 53.36 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 123.721 0.809 . . . . 0.0 110.699 -176.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 96.6 p -107.27 7.97 29.61 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.972 1.709 . . . . 0.0 112.188 -173.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 37.5 mm -118.95 -41.03 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 125.815 1.646 . . . . 0.0 108.676 177.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 48.16 -8.55 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 131.461 3.904 . . . . 0.0 119.697 170.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 61.7 m95 -141.28 137.43 32.48 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.781 2.032 . . . . 0.0 109.625 171.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . 0.6 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 6.9 m-85 -145.46 156.96 44.06 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 125.738 1.615 . . . . 0.0 109.69 -169.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 33.1 m80 -73.97 149.07 41.55 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 167.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -51.7 -52.03 51.43 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.746 167.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.78 -13.82 62.19 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -177.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 2.1 m -77.54 -11.13 59.82 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.785 1.175 . . . . 0.0 112.594 173.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 10.6 p -116.09 -16.47 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 125.799 1.64 . . . . 0.0 112.134 170.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 102.27 14.87 27.15 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.781 1.657 . . . . 0.0 113.395 177.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 26.0 mt -72.89 160.06 32.73 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.828 1.314 . . . . 0.0 110.928 175.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 67.4 p -131.71 -7.96 3.6 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.833 1.653 . . . . 0.0 111.598 177.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 73.8 p -144.73 166.2 25.9 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.006 2.122 . . . . 0.0 108.766 177.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -90.21 121.17 68.93 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-O 118.821 -0.609 . . . . 0.0 109.497 175.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -75.91 178.94 6.78 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.569 2.846 . . . . 0.0 110.78 169.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -141.59 132.55 26.03 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 170.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 120.69 -170.88 14.55 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 126.06 1.79 . . . . 0.0 110.166 -168.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.5 144.98 53.04 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 122.252 1.025 . . . . 0.0 110.849 174.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . 0.437 ' CZ2' ' HA ' ' A' ' 239' ' ' CYS . 60.2 t90 -145.93 138.96 25.88 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.994 2.118 . . . . 0.0 109.406 177.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 14.4 m-30 -118.4 131.91 56.27 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.717 1.207 . . . . 0.0 109.261 175.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . 0.437 ' HA ' ' CZ2' ' A' ' 237' ' ' TRP . 4.0 p -63.32 173.23 1.25 Allowed Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 127.61 2.364 . . . . 0.0 114.675 -174.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.87 -3.33 13.4 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.815 2.343 . . . . 0.0 114.858 -171.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -111.61 13.62 21.26 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.589 1.555 . . . . 0.0 111.234 174.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 39.0 m -135.94 -16.0 1.73 Allowed 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.565 1.946 . . . . 0.0 113.234 -174.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 46.6 t -150.98 -41.6 0.12 Allowed 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.763 0.825 . . . . 0.0 112.446 177.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -71.71 -23.43 61.63 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.012 0.369 . . . . 0.0 111.527 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 CA--C 1.541 0.605 0 C-N-CA 126.547 1.939 . . . . 0.0 113.42 175.364 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo . . . . . 0 N--CA 1.457 -0.643 0 N-CA-C 110.587 -0.582 . . . . 0.0 110.587 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 80.4 p -141.68 172.22 12.98 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.47 1.108 . . . . 0.0 110.005 -177.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -134.47 -83.97 0.43 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 117.316 -1.325 . . . . 0.0 112.885 -168.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 1.9 t -55.17 168.5 0.33 Allowed 'General case' 0 C--N 1.351 0.667 0 C-N-CA 124.957 1.303 . . . . 0.0 113.274 -176.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.2 pp -57.05 -12.42 2.08 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.23 1.412 . . . . 0.0 113.145 170.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 71.3 m -78.76 -18.94 53.38 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.593 1.957 . . . . 0.0 113.208 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 23.3 m170 57.32 62.21 2.26 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.874 2.069 . . . . 0.0 111.663 -173.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.65 158.75 33.95 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.022 1.329 . . . . 0.0 112.435 176.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.478 HG11 ' H ' ' A' ' 205' ' ' SER . 0.3 OUTLIER -69.17 -179.4 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 126.355 1.862 . . . . 0.0 111.366 -176.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.478 ' H ' HG11 ' A' ' 204' ' ' VAL . 79.5 p -45.37 147.62 0.77 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.42 2.288 . . . . 0.0 113.911 178.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -154.08 173.54 15.9 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.537 1.535 . . . . 0.0 111.223 -167.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -80.96 -71.36 1.29 Allowed Glycine 0 CA--C 1.528 0.893 0 C-N-CA 123.831 0.729 . . . . 0.0 112.959 -170.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -91.84 120.4 32.51 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 123.632 0.773 . . . . 0.0 111.117 -174.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -142.02 143.86 33.36 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -168.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 19.8 tt -134.97 150.36 29.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 125.541 1.537 . . . . 0.0 109.939 172.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -127.99 139.29 10.99 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.788 1.185 . . . . 0.0 112.641 -171.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . 0.592 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 1.9 m -78.75 126.12 30.29 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.582 1.553 . . . . 0.0 111.802 -168.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.39 -2.36 10.77 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.58 1.952 . . . . 0.0 113.808 -175.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -66.49 149.98 97.63 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 123.769 0.828 . . . . 0.0 112.12 -174.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -83.76 7.76 5.01 Favored 'Trans proline' 0 CA--C 1.549 1.262 0 C-N-CA 123.725 2.95 . . . . 0.0 111.342 166.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -144.39 -10.86 0.63 Allowed 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 -167.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 36.7 t -60.93 134.09 56.74 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 119.465 1.03 . . . . 0.0 110.468 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.5 t -110.47 14.24 22.57 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.762 1.625 . . . . 0.0 111.124 -173.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 51.7 mt -122.75 -41.97 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 125.327 1.451 . . . . 0.0 108.577 172.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 47.63 -8.59 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 131.351 3.861 . . . . 0.0 119.552 172.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 62.3 m95 -139.62 136.07 33.98 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 126.497 1.919 . . . . 0.0 109.603 170.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . 0.592 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 7.2 m-85 -142.49 158.69 43.42 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 125.572 1.549 . . . . 0.0 109.179 -169.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -78.45 148.14 33.68 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 169.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -51.74 -51.37 56.68 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.937 167.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.84 -13.23 61.62 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -176.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 4.8 m -78.29 -8.1 57.99 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.81 1.186 . . . . 0.0 112.608 172.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.8 p -120.9 -12.68 8.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 126.319 1.847 . . . . 0.0 112.185 170.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 94.28 18.24 36.98 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.693 1.616 . . . . 0.0 113.4 178.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 19.4 mt -72.05 158.34 36.13 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.749 1.275 . . . . 0.0 111.327 176.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 59.7 m -134.86 -18.38 1.86 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.782 1.633 . . . . 0.0 111.145 -177.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 62.7 m -144.33 139.62 28.63 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 125.692 1.597 . . . . 0.0 107.82 178.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -70.58 122.6 87.1 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 123.519 0.727 . . . . 0.0 110.836 -176.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -81.48 -179.8 5.21 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.769 2.979 . . . . 0.0 111.617 173.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -139.62 135.82 33.71 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.031 1.332 . . . . 0.0 107.475 169.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 116.54 -174.61 15.32 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.405 1.478 . . . . 0.0 111.747 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -62.34 122.72 16.38 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.883 1.273 . . . . 0.0 111.09 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . 0.401 ' CZ2' ' HA ' ' A' ' 239' ' ' CYS . 44.7 t90 -132.98 143.02 49.17 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 127.201 2.2 . . . . 0.0 108.6 178.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -126.92 126.77 43.81 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.564 1.146 . . . . 0.0 109.003 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . 0.401 ' HA ' ' CZ2' ' A' ' 237' ' ' TRP . 5.8 p -61.23 169.08 2.38 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 126.857 2.063 . . . . 0.0 114.007 -172.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.44 1.48 6.14 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.559 2.173 . . . . 0.0 115.221 -171.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 38.3 mtp180 -117.42 17.58 14.55 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.224 1.41 . . . . 0.0 112.106 170.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 31.7 m -133.52 -14.0 2.57 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.434 1.894 . . . . 0.0 112.763 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 33.0 t -147.87 -33.06 0.26 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.058 0.943 . . . . 0.0 112.195 177.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -86.8 -13.48 44.99 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -173.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 . . . . . 0 CA--C 1.544 0.738 0 CA-C-N 119.443 1.02 . . . . 0.0 112.531 169.493 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo . . . . . 0 CA--C 1.535 0.557 0 CA-C-O 121.172 0.405 . . . . 0.0 111.978 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 65.6 p -146.04 176.39 9.75 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.864 1.266 . . . . 0.0 110.536 -173.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -135.34 -83.59 0.41 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 117.508 -1.234 . . . . 0.0 112.707 -169.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.0 t -55.88 167.81 0.54 Allowed 'General case' 0 C--N 1.351 0.66 0 CA-C-N 119.741 1.155 . . . . 0.0 113.129 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 2.9 pp -57.66 -12.66 3.05 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.92 1.288 . . . . 0.0 112.768 171.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 74.6 m -76.64 -19.65 57.56 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.544 1.938 . . . . 0.0 113.214 176.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 29.9 m170 56.8 64.52 1.64 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.729 2.011 . . . . 0.0 111.396 -172.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.41 156.98 39.71 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.231 1.412 . . . . 0.0 112.13 174.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.521 HG11 ' H ' ' A' ' 205' ' ' SER . 0.9 OUTLIER -69.61 -178.21 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 126.114 1.766 . . . . 0.0 110.916 -178.39 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.521 ' H ' HG11 ' A' ' 204' ' ' VAL . 88.0 p -45.51 148.77 0.64 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.53 2.332 . . . . 0.0 113.964 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -154.97 173.67 16.22 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.276 1.43 . . . . 0.0 111.346 -167.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -80.75 -73.2 1.18 Allowed Glycine 0 C--N 1.341 0.852 0 C-N-CA 123.877 0.751 . . . . 0.0 112.784 -171.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -88.54 119.44 29.0 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.597 0.759 . . . . 0.0 111.238 -176.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -142.52 143.77 32.66 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -169.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 21.3 tt -136.53 152.0 28.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 125.729 1.612 . . . . 0.0 109.706 173.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -129.5 139.23 10.8 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.514 1.054 . . . . 0.0 112.914 -172.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . 0.602 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 7.3 m -75.77 127.74 33.68 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.898 1.679 . . . . 0.0 111.548 -168.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -71.02 -1.86 13.52 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.973 1.709 . . . . 0.0 113.591 -177.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -67.02 148.15 98.94 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 123.661 0.784 . . . . 0.0 111.523 -175.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -82.43 8.05 4.77 Favored 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 123.592 2.861 . . . . 0.0 111.631 167.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -144.16 -9.87 0.67 Allowed 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -167.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.8 t -62.39 133.47 55.1 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 119.607 1.094 . . . . 0.0 110.443 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 9.4 t -106.21 4.65 29.13 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.705 1.602 . . . . 0.0 111.687 -173.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 42.8 mm -112.18 -42.32 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 125.736 1.614 . . . . 0.0 108.777 175.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 48.82 -11.15 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 131.556 3.943 . . . . 0.0 119.597 171.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -138.8 137.82 36.99 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.778 2.031 . . . . 0.0 109.387 170.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . 0.602 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 7.3 m-85 -144.39 157.08 44.44 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.527 1.531 . . . . 0.0 109.654 -169.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 47.0 m80 -74.46 149.75 40.21 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 167.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 10.0 m-30 -51.4 -52.81 42.71 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.727 167.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.47 -12.44 61.39 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 118.253 -0.88 . . . . 0.0 113.253 -176.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 2.0 m -77.43 -8.49 57.81 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.759 1.163 . . . . 0.0 112.5 172.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.6 p -121.77 -14.08 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 126.082 1.753 . . . . 0.0 112.514 170.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 98.66 16.53 31.12 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 125.856 1.693 . . . . 0.0 113.513 178.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 19.6 mt -71.49 162.17 29.87 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.908 1.354 . . . . 0.0 111.66 177.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.7 t -139.22 -14.5 1.14 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.51 1.524 . . . . 0.0 112.512 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 59.7 m -146.86 139.54 25.05 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.019 1.728 . . . . 0.0 107.287 177.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -69.35 119.5 70.86 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-O 118.721 -0.657 . . . . 0.0 110.55 -177.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -78.29 174.63 12.13 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.463 2.776 . . . . 0.0 110.67 170.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 30.1 ttp-105 -143.16 130.98 21.49 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 121.923 0.868 . . . . 0.0 108.795 170.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 126.4 -174.38 17.96 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 126.343 1.925 . . . . 0.0 110.409 -169.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -66.4 128.84 37.73 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.18 0.992 . . . . 0.0 110.761 175.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 54.8 t90 -135.74 145.01 46.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 127.304 2.242 . . . . 0.0 109.134 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -130.6 124.8 32.54 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.691 1.196 . . . . 0.0 109.6 -176.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . 0.4 ' HB3' ' SG ' ' A' ' 212' ' ' CYS . 1.9 p -61.25 172.92 0.81 Allowed Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 128.1 2.56 . . . . 0.0 114.835 -171.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -76.06 12.82 1.4 Allowed 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.608 2.872 . . . . 0.0 115.365 -171.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 35.8 mtp180 -125.53 13.82 8.15 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.716 1.606 . . . . 0.0 111.058 169.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 66.6 m -135.73 -22.28 1.45 Allowed 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.939 1.695 . . . . 0.0 113.714 -174.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 27.8 t -151.65 -42.08 0.11 Allowed 'General case' 0 C--N 1.342 0.278 0 CA-C-N 119.004 0.82 . . . . 0.0 112.614 175.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 7.7 tm0? -77.25 -13.85 59.86 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 119.337 -0.363 . . . . 0.0 111.65 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 . . . . . 0 CA--C 1.539 0.537 0 C-N-CA 124.842 1.257 . . . . 0.0 113.18 178.809 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo . . . . . 0 CA--C 1.536 0.588 0 CA-C-O 121.095 0.373 . . . . 0.0 111.554 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 67.6 p -145.07 173.6 11.77 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.578 1.151 . . . . 0.0 110.715 -175.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -136.79 -83.27 0.36 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 117.355 -1.307 . . . . 0.0 112.565 -170.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.0 t -55.6 168.21 0.44 Allowed 'General case' 0 C--N 1.351 0.641 0 C-N-CA 125.013 1.325 . . . . 0.0 113.378 -176.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.0 pp -57.45 -12.69 2.79 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.079 1.352 . . . . 0.0 113.031 170.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 72.7 m -77.17 -19.9 56.17 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.461 1.904 . . . . 0.0 113.223 176.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 21.8 m170 57.75 63.92 1.69 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.868 2.067 . . . . 0.0 111.565 -172.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.22 158.13 38.96 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.079 1.352 . . . . 0.0 112.496 175.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.506 HG12 ' H ' ' A' ' 205' ' ' SER . 0.9 OUTLIER -67.83 -179.1 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 126.389 1.876 . . . . 0.0 111.144 -177.82 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.506 ' H ' HG12 ' A' ' 204' ' ' VAL . 88.3 p -46.31 150.17 0.66 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.562 2.345 . . . . 0.0 113.84 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . 0.434 ' CE2' ' HG2' ' A' ' 209' ' ' MET . 18.3 p90 -155.55 164.87 38.09 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.127 1.371 . . . . 0.0 111.227 -167.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -73.8 -49.44 13.85 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 118.666 -1.074 . . . . 0.0 114.814 -169.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -117.2 121.33 40.92 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 118.478 1.139 . . . . 0.0 110.362 -170.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' MET . . . . . 0.434 ' HG2' ' CE2' ' A' ' 206' ' ' TYR . 2.8 mtp -140.48 148.66 41.46 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -166.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 14.5 tt -136.91 156.55 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 125.57 1.548 . . . . 0.0 109.32 168.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -133.75 139.18 10.68 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.488 1.042 . . . . 0.0 112.4 -171.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . 0.586 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 1.1 m -79.61 125.99 30.32 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.191 1.397 . . . . 0.0 112.233 -167.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -69.37 -4.96 20.49 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.598 1.959 . . . . 0.0 113.888 -175.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -66.43 145.65 98.98 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.424 0.689 . . . . 0.0 111.396 -173.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -81.92 9.21 4.04 Favored 'Trans proline' 0 CA--C 1.551 1.343 0 C-N-CA 123.074 2.516 . . . . 0.0 110.946 165.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -134.41 -15.56 2.17 Favored 'General case' 0 C--N 1.35 0.614 0 C-N-CA 125.407 1.483 . . . . 0.0 114.365 -169.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 35.6 t -65.05 136.13 56.39 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 123.905 0.882 . . . . 0.0 110.611 -175.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.4 t -113.07 14.57 19.59 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.721 1.608 . . . . 0.0 111.217 -174.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 51.3 mt -123.2 -42.34 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 125.363 1.465 . . . . 0.0 108.71 173.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 47.28 -7.59 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 131.453 3.901 . . . . 0.0 119.59 171.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 66.1 m95 -139.0 134.84 33.6 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.466 1.907 . . . . 0.0 109.259 170.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . 0.586 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 7.8 m-85 -142.01 157.09 45.34 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.362 1.465 . . . . 0.0 109.075 -169.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -77.0 148.6 36.15 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 169.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 14.4 m-30 -51.92 -51.62 55.69 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.89 167.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.51 -14.18 62.41 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 6.5 m -79.38 -6.67 57.32 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 119.748 1.158 . . . . 0.0 112.766 173.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.9 p -120.87 -12.62 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 125.965 1.706 . . . . 0.0 112.113 169.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 96.31 16.87 36.07 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.509 1.528 . . . . 0.0 113.317 178.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 13.7 mt -71.82 159.46 34.27 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.581 1.191 . . . . 0.0 111.068 175.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 24.4 m -133.17 -5.52 3.04 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.115 1.766 . . . . 0.0 110.41 177.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 80.1 p -142.51 179.62 6.85 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.815 2.046 . . . . 0.0 109.398 -178.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -112.33 97.32 39.18 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 124.232 1.013 . . . . 0.0 109.528 178.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -70.6 167.73 24.71 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.425 2.084 . . . . 0.0 110.255 169.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -140.69 131.72 26.22 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.981 0.896 . . . . 0.0 109.084 175.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 138.88 -173.43 22.62 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 126.577 2.037 . . . . 0.0 109.688 -169.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -70.83 126.99 31.11 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.729 0.776 . . . . 0.0 109.68 170.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 39.0 t90 -133.51 144.58 49.5 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.864 2.066 . . . . 0.0 108.493 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -126.21 131.2 52.02 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.568 1.147 . . . . 0.0 108.935 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 3.7 p -61.82 167.04 5.08 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 126.106 1.763 . . . . 0.0 112.63 -175.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.77 -36.41 32.19 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.026 1.15 . . . . 0.0 112.097 -170.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 60.8 mtt-85 -78.31 10.93 2.66 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.496 1.119 . . . . 0.0 112.907 178.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 19.1 m -129.37 -13.56 4.36 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.431 1.892 . . . . 0.0 113.883 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 35.7 t -149.77 -42.43 0.14 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.884 0.766 . . . . 0.0 112.561 -176.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 47.3 tp60 -75.2 -18.43 60.15 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 118.494 -0.765 . . . . 0.0 112.834 -177.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 . . . . . 0 CA--C 1.538 0.504 0 CA-C-N 119.371 0.987 . . . . 0.0 111.709 172.828 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo . . . . . 0 CA--C 1.535 0.564 0 CA-C-O 121.157 0.399 . . . . 0.0 112.063 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 64.4 p -144.43 175.22 10.28 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.067 1.347 . . . . 0.0 110.327 -174.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -134.4 -81.26 0.45 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 117.328 -1.32 . . . . 0.0 113.26 -170.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.9 t -54.77 167.09 0.4 Allowed 'General case' 0 C--N 1.35 0.594 0 C-N-CA 125.078 1.351 . . . . 0.0 113.174 -176.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 4.2 pp -60.17 -11.0 5.11 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.207 1.003 . . . . 0.0 112.715 169.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 72.3 m -74.38 -24.0 59.07 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.551 1.94 . . . . 0.0 112.906 172.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 54.63 69.65 0.7 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 127.291 2.236 . . . . 0.0 111.925 -170.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.6 162.21 27.82 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.832 1.653 . . . . 0.0 111.689 173.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.455 HG11 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -70.28 -177.9 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 126.04 1.736 . . . . 0.0 111.686 -176.469 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.455 ' H ' HG11 ' A' ' 204' ' ' VAL . 40.5 m -44.34 150.34 0.32 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 128.2 2.6 . . . . 0.0 114.497 177.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -158.06 170.27 22.67 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.034 1.733 . . . . 0.0 110.553 -169.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -78.38 -66.52 1.73 Allowed Glycine 0 CA--C 1.529 0.956 0 CA-C-O 119.438 -0.645 . . . . 0.0 113.149 -170.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -100.54 122.41 43.19 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 123.684 0.794 . . . . 0.0 110.745 -173.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -144.11 146.52 32.85 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -167.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 13.7 tt -144.01 153.96 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 125.006 1.322 . . . . 0.0 109.922 169.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -132.81 145.47 17.42 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 123.97 0.795 . . . . 0.0 112.01 -170.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 4.2 t -70.07 142.76 52.63 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.971 0.891 . . . . 0.0 110.863 -173.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -78.32 -5.43 52.11 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.109 1.764 . . . . 0.0 113.57 -174.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 -80.77 144.63 56.28 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 118.816 0.734 . . . . 0.0 111.231 -169.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -75.67 4.84 4.73 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 123.564 2.843 . . . . 0.0 112.071 168.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -122.95 -6.61 8.44 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.214 1.806 . . . . 0.0 112.358 -173.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 36.7 t -65.25 136.5 56.68 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.305 1.042 . . . . 0.0 109.782 174.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 8.7 t -119.05 10.75 12.24 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.83 1.652 . . . . 0.0 111.248 -175.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 35.5 mm -118.64 -32.82 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 126.197 1.799 . . . . 0.0 109.261 175.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 50.02 -13.64 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.617 1 C-N-CA 131.769 4.028 . . . . 0.0 119.378 175.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 63.1 m95 -143.1 152.03 41.38 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.89 1.676 . . . . 0.0 110.365 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -154.05 154.66 34.08 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.555 1.542 . . . . 0.0 109.885 -172.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -77.47 148.8 35.18 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 170.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -52.62 -51.55 59.52 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.782 168.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.69 -13.25 61.68 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 118.325 -0.845 . . . . 0.0 113.261 -177.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 5.3 m -78.23 -6.11 53.94 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 119.713 1.142 . . . . 0.0 112.633 172.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 6.2 p -121.86 -16.77 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 125.659 1.584 . . . . 0.0 112.232 169.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 99.79 17.85 24.53 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.776 1.655 . . . . 0.0 113.667 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 18.9 mt -71.15 158.0 37.19 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 119.01 1.405 . . . . 0.0 111.104 177.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 90.0 m -134.53 -22.97 1.67 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.692 1.597 . . . . 0.0 110.973 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 48.6 p -140.73 143.57 35.07 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.91 1.684 . . . . 0.0 108.455 174.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -70.05 126.19 92.32 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-O 118.688 -0.672 . . . . 0.0 110.573 -176.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -76.57 -172.42 1.39 Allowed 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 123.813 3.009 . . . . 0.0 111.278 171.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -144.28 139.14 28.41 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 124.816 1.246 . . . . 0.0 108.466 176.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 97.23 -170.32 25.83 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.357 1.456 . . . . 0.0 111.675 -172.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -57.79 138.4 55.63 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.885 1.274 . . . . 0.0 111.177 175.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 52.6 t90 -142.25 153.8 44.23 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 127.301 2.24 . . . . 0.0 109.032 -177.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -130.71 132.76 45.55 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.853 1.261 . . . . 0.0 110.59 -174.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -67.08 167.35 14.71 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.232 1.013 . . . . 0.0 111.651 177.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.73 -27.0 27.16 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.303 1.335 . . . . 0.0 113.354 -172.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -87.3 9.8 19.23 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.435 1.094 . . . . 0.0 112.369 174.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 17.3 m -126.38 -17.58 5.12 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.565 1.546 . . . . 0.0 113.784 -176.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 33.8 t -152.97 -36.1 0.11 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.542 1.065 . . . . 0.0 112.959 174.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -68.49 -19.7 64.55 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 118.292 0.496 . . . . 0.0 112.134 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 . . . . . 0 CA--C 1.542 0.668 0 C-N-CA 125.009 1.323 . . . . 0.0 112.326 177.488 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo . . . . . 0 CA--C 1.534 0.499 0 CA-C-O 121.28 0.45 . . . . 0.0 111.942 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 71.2 p -144.49 175.43 10.13 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.902 1.281 . . . . 0.0 110.54 -172.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -136.57 -79.62 0.4 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 117.215 -1.374 . . . . 0.0 113.095 -170.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -56.31 169.09 0.45 Allowed 'General case' 0 C--N 1.349 0.572 0 CA-C-N 120.013 1.279 . . . . 0.0 113.403 -175.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 4.6 pp -57.95 -11.13 2.15 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.897 1.279 . . . . 0.0 113.147 169.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 71.6 m -78.66 -23.3 45.81 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 126.927 2.091 . . . . 0.0 113.416 176.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 33.7 m170 59.02 66.61 1.03 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.473 1.909 . . . . 0.0 110.835 -169.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.1 160.84 32.5 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.823 1.249 . . . . 0.0 112.247 174.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.51 HG11 ' H ' ' A' ' 205' ' ' SER . 0.6 OUTLIER -69.05 -179.26 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 126.125 1.77 . . . . 0.0 111.355 -175.994 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.51 ' H ' HG11 ' A' ' 204' ' ' VAL . 84.8 p -47.91 153.65 0.61 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.82 2.448 . . . . 0.0 114.689 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -154.87 169.16 24.66 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.223 1.809 . . . . 0.0 110.484 -169.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -79.52 -40.4 15.57 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.673 -1.07 . . . . 0.0 115.29 -168.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.12 119.0 21.29 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 118.57 1.185 . . . . 0.0 110.137 -168.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -142.08 152.37 43.24 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -164.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 15.7 tt -148.49 153.23 11.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 126.091 1.756 . . . . 0.0 109.516 167.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -131.99 146.45 18.07 Favored Glycine 0 C--N 1.336 0.529 0 C-N-CA 124.267 0.937 . . . . 0.0 111.634 -170.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 3.9 t -70.29 140.84 52.38 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-O 121.941 0.876 . . . . 0.0 111.042 -171.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -76.87 -5.09 46.99 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.311 1.844 . . . . 0.0 113.842 -174.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -78.45 147.59 72.22 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 118.846 0.748 . . . . 0.0 111.633 -169.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.51 8.42 2.99 Favored 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 124.135 3.223 . . . . 0.0 112.589 169.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -133.32 -9.53 2.91 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.011 1.724 . . . . 0.0 112.394 -169.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.9 t -61.22 133.91 56.44 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.932 0.893 . . . . 0.0 109.845 173.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 68.6 m -119.83 14.9 12.56 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.921 1.688 . . . . 0.0 111.171 -175.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 37.6 mm -119.99 -32.39 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 126.739 2.016 . . . . 0.0 109.164 174.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 51.51 -15.68 0.0 OUTLIER 'General case' 0 C--N 1.35 0.587 1 C-N-CA 131.955 4.102 . . . . 0.0 119.305 173.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -143.01 151.04 40.4 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.64 1.576 . . . . 0.0 110.587 178.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -153.01 155.24 36.54 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.782 1.233 . . . . 0.0 110.418 -173.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -79.29 146.74 32.8 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 169.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -53.47 -48.78 68.58 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.463 168.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.07 -14.85 62.86 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.77 -13.54 60.3 Favored 'General case' 0 C--N 1.348 0.535 0 CA-C-N 119.712 1.142 . . . . 0.0 112.711 173.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.7 p -115.04 -13.33 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 126.014 1.725 . . . . 0.0 111.801 172.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 91.65 20.11 38.52 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 125.869 1.7 . . . . 0.0 113.49 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 12.0 mt -75.36 160.06 30.73 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-N 118.747 1.273 . . . . 0.0 111.801 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 91.1 m -133.87 -20.2 1.99 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.862 1.665 . . . . 0.0 111.131 -177.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 89.3 m -142.03 135.74 29.54 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 125.577 1.551 . . . . 0.0 107.906 178.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -70.55 115.69 37.8 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 125.208 1.403 . . . . 0.0 111.545 -176.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -79.87 162.17 23.89 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.025 2.483 . . . . 0.0 110.049 168.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 65.4 ttp85 -150.34 136.7 18.8 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-O 121.891 0.853 . . . . 0.0 110.232 -178.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 136.86 -61.84 0.6 Allowed Glycine 0 CA--C 1.529 0.906 0 C-N-CA 127.347 2.403 . . . . 0.0 108.758 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -161.54 145.68 12.94 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 126.614 1.966 . . . . 0.0 108.514 168.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 68.4 t90 -146.89 153.16 39.81 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 125.838 1.655 . . . . 0.0 109.417 -177.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -128.89 128.95 44.84 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.856 1.263 . . . . 0.0 110.037 -175.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.17 168.39 7.78 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 124.526 1.131 . . . . 0.0 112.246 178.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.91 -28.89 35.42 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 121.347 1.365 . . . . 0.0 112.684 -174.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 26.5 mtp180 -88.19 13.36 11.55 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.54 1.136 . . . . 0.0 112.877 175.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 16.1 m -129.28 -15.74 4.08 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.707 1.603 . . . . 0.0 113.364 -178.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 35.9 t -151.67 -33.28 0.14 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.077 0.853 . . . . 0.0 112.991 175.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -74.26 -13.97 60.85 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 118.872 0.76 . . . . 0.0 112.684 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 . . . . . 0 CA--C 1.545 0.772 0 CA-C-N 119.231 0.923 . . . . 0.0 112.912 169.802 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo . . . . . 0 CA--C 1.535 0.528 0 N-CA-C 111.104 -0.383 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 69.3 p -144.89 173.66 11.68 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.512 1.125 . . . . 0.0 110.67 -176.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -135.09 -76.92 0.45 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 117.189 -1.386 . . . . 0.0 112.524 178.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 1.9 t -58.66 169.18 1.0 Allowed 'General case' 0 C--N 1.35 0.604 0 CA-C-N 119.935 1.243 . . . . 0.0 113.841 -172.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.1 pp -57.47 -13.37 3.53 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.109 1.363 . . . . 0.0 112.769 169.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 84.5 m -78.12 -19.47 54.02 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.331 1.853 . . . . 0.0 113.208 175.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 52.87 66.68 1.16 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.989 2.116 . . . . 0.0 112.332 -172.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.35 160.22 33.74 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.662 1.985 . . . . 0.0 111.136 174.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.466 HG11 ' H ' ' A' ' 205' ' ' SER . 0.3 OUTLIER -66.0 -179.89 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 125.846 1.658 . . . . 0.0 111.524 -179.82 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.466 ' H ' HG11 ' A' ' 204' ' ' VAL . 24.6 m -47.24 150.81 0.79 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.146 2.178 . . . . 0.0 113.931 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -151.79 166.67 30.67 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.655 1.582 . . . . 0.0 110.926 -173.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -76.23 -60.68 3.01 Favored Glycine 0 C--N 1.342 0.894 0 C-N-CA 124.252 0.929 . . . . 0.0 113.352 -171.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . 0.4 ' HB2' ' CD2' ' A' ' 224' ' ' PHE . 3.1 pt-20 -79.29 121.52 25.2 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.331 1.052 . . . . 0.0 111.063 177.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 14.3 mtp -143.88 139.71 29.37 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -173.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 20.3 tt -138.63 145.99 27.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 125.284 1.433 . . . . 0.0 109.844 168.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -125.19 137.29 10.29 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.779 1.18 . . . . 0.0 112.438 -169.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . 0.59 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 2.0 m -78.22 124.11 27.69 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 125.26 1.424 . . . . 0.0 111.564 -168.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -69.64 -3.61 15.82 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.187 1.795 . . . . 0.0 113.564 -175.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -65.78 147.28 98.82 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 123.36 0.664 . . . . 0.0 111.485 -174.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -81.33 5.1 6.48 Favored 'Trans proline' 0 CA--C 1.55 1.284 0 C-N-CA 122.909 2.406 . . . . 0.0 111.511 166.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -134.59 -11.51 2.39 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 125.215 1.406 . . . . 0.0 114.448 -169.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 36.3 t -64.19 135.45 56.31 Favored 'General case' 0 C--N 1.344 0.326 0 CA-C-N 119.257 0.935 . . . . 0.0 110.608 -177.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.4 t -112.8 14.53 19.9 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.917 1.687 . . . . 0.0 111.361 -174.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 48.9 mt -122.02 -42.05 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 125.428 1.491 . . . . 0.0 108.527 172.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 48.83 -11.24 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 131.646 3.978 . . . . 0.0 119.687 170.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 52.3 m95 -138.83 136.82 36.01 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.654 1.982 . . . . 0.0 110.042 169.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . 0.59 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 5.2 m-85 -142.72 156.23 44.99 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 125.698 1.599 . . . . 0.0 109.303 -169.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -71.77 149.02 45.75 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 167.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . 0.4 ' CD2' ' HB2' ' A' ' 208' ' ' GLU . 17.4 m-30 -50.88 -50.93 56.06 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.708 165.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.16 -13.64 62.01 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -177.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 2.0 m -78.04 -6.33 54.21 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.885 1.22 . . . . 0.0 112.785 172.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.4 p -121.84 -13.07 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 126.132 1.773 . . . . 0.0 111.995 169.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 97.73 14.83 39.02 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.829 1.681 . . . . 0.0 113.446 177.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 29.8 mt -73.93 161.88 29.66 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 118.92 1.36 . . . . 0.0 111.329 177.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 67.4 p -132.75 -10.88 3.08 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.819 1.648 . . . . 0.0 111.64 176.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 53.2 p -145.72 151.09 37.44 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.652 1.981 . . . . 0.0 108.576 177.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -81.27 128.37 70.61 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-O 118.776 -0.631 . . . . 0.0 110.103 178.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -77.3 -178.35 4.52 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.635 2.89 . . . . 0.0 110.774 169.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 53.2 ttt180 -141.48 131.94 25.29 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 169.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 121.26 -168.77 14.28 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 126.064 1.793 . . . . 0.0 109.889 -168.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.28 145.0 51.6 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 122.242 1.02 . . . . 0.0 110.832 174.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . 0.448 ' CZ2' ' HA ' ' A' ' 239' ' ' CYS . 62.1 t90 -146.2 137.37 24.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 127.116 2.167 . . . . 0.0 108.915 175.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -114.27 136.72 52.65 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.96 0.904 . . . . 0.0 108.94 171.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . 0.448 ' HA ' ' CZ2' ' A' ' 237' ' ' TRP . 5.0 p -63.32 168.72 4.67 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 126.308 1.843 . . . . 0.0 113.094 -177.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -67.08 -33.37 31.93 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 121.306 1.337 . . . . 0.0 112.442 -171.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 -72.59 1.29 8.49 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.175 1.39 . . . . 0.0 113.079 176.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 21.6 m -127.84 -13.39 5.24 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.033 1.733 . . . . 0.0 113.982 -172.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 34.9 t -150.61 -40.9 0.13 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.717 0.689 . . . . 0.0 112.291 -177.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 40.4 tp60 -76.53 -16.25 59.67 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 118.792 -0.623 . . . . 0.0 112.679 -177.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 . . . . . 0 CA--C 1.541 0.603 0 C-N-CA 124.184 0.993 . . . . 0.0 113.027 172.354 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo . . . . . 0 CA--C 1.536 0.623 0 N-CA-C 111.075 -0.394 . . . . 0.0 111.075 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 71.3 p -143.07 173.46 11.54 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.638 1.175 . . . . 0.0 110.118 -177.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -135.77 -82.68 0.4 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 117.414 -1.279 . . . . 0.0 113.274 -168.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.4 t -54.28 166.03 0.46 Allowed 'General case' 0 C--N 1.35 0.614 0 C-N-CA 125.05 1.34 . . . . 0.0 112.731 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.9 pp -58.9 -11.12 2.95 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.471 1.108 . . . . 0.0 112.87 170.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 75.1 m -76.04 -19.93 58.21 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.667 1.987 . . . . 0.0 113.171 175.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 21.4 m170 57.9 62.92 1.93 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.996 2.118 . . . . 0.0 111.785 -173.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.7 159.65 33.09 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.356 1.462 . . . . 0.0 112.32 175.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.472 HG11 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -70.7 -178.45 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 126.267 1.827 . . . . 0.0 111.472 -176.811 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.472 ' H ' HG11 ' A' ' 204' ' ' VAL . 49.4 m -43.87 148.15 0.41 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 128.024 2.53 . . . . 0.0 113.915 178.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . 0.404 ' CE2' ' CD2' ' A' ' 223' ' ' HIS . 10.3 p90 -154.4 167.4 30.14 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.498 1.519 . . . . 0.0 111.103 -167.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -73.17 -43.86 37.75 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-O 118.719 -1.045 . . . . 0.0 115.136 -168.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -129.88 122.96 29.66 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 118.368 1.084 . . . . 0.0 110.654 -169.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -143.05 146.65 34.02 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -165.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 16.2 tt -140.62 155.94 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 126.278 1.831 . . . . 0.0 109.511 169.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -136.18 144.97 16.87 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 123.921 0.772 . . . . 0.0 112.261 -173.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 7.4 t -69.34 145.32 53.06 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-O 122.184 0.993 . . . . 0.0 110.938 -174.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -80.64 -6.75 58.79 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.704 2.001 . . . . 0.0 113.508 -174.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -80.55 145.78 59.63 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 118.557 0.617 . . . . 0.0 111.675 -169.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.42 6.13 4.21 Favored 'Trans proline' 0 CA--C 1.547 1.145 0 C-N-CA 123.629 2.886 . . . . 0.0 111.779 168.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -126.34 -8.12 6.39 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.074 1.749 . . . . 0.0 112.815 -172.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.9 t -65.4 133.36 51.17 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.822 0.849 . . . . 0.0 109.576 175.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 10.7 t -113.21 10.96 18.63 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.626 1.571 . . . . 0.0 111.702 -175.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 35.0 mm -118.84 -33.39 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 126.393 1.877 . . . . 0.0 109.242 176.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 50.45 -15.17 0.0 OUTLIER 'General case' 0 C--N 1.351 0.667 0 C-N-CA 131.591 3.956 . . . . 0.0 119.253 176.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -141.12 152.33 44.64 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.897 1.679 . . . . 0.0 110.427 178.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -154.22 154.49 33.58 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.71 1.604 . . . . 0.0 110.109 -170.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . 0.404 ' CD2' ' CE2' ' A' ' 206' ' ' TYR . 20.2 m170 -78.34 148.64 33.68 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 170.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -53.78 -50.69 65.51 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.719 167.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.62 -13.22 61.69 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 118.258 -0.877 . . . . 0.0 113.312 -176.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 3.5 m -76.41 -11.25 59.86 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.737 1.153 . . . . 0.0 112.441 172.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.2 p -117.69 -15.84 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 126.193 1.797 . . . . 0.0 112.269 171.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 94.87 20.06 29.64 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.888 1.709 . . . . 0.0 113.485 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 13.9 mt -71.61 156.98 38.78 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 118.854 1.327 . . . . 0.0 111.335 178.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 82.7 p -137.83 -11.84 1.52 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.419 1.487 . . . . 0.0 112.435 -178.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 59.2 m -148.48 134.07 18.75 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 126.263 1.825 . . . . 0.0 107.232 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -73.59 120.49 81.44 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 123.541 0.736 . . . . 0.0 111.587 -173.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -82.11 177.32 7.36 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.705 2.937 . . . . 0.0 111.194 170.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 36.0 ttp180 -142.58 135.0 27.78 Favored 'General case' 0 C--N 1.344 0.346 0 C-N-CA 124.239 1.016 . . . . 0.0 108.453 170.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 125.92 -167.49 18.31 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.65 1.595 . . . . 0.0 111.485 -177.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -59.39 119.41 7.41 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 124.601 1.16 . . . . 0.0 109.76 172.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . 0.403 ' CH2' ' HA ' ' A' ' 239' ' ' CYS . 62.2 t90 -136.62 138.86 41.61 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 127.029 2.132 . . . . 0.0 108.103 175.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -115.88 132.71 56.56 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.346 1.059 . . . . 0.0 108.748 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . 0.403 ' HA ' ' CH2' ' A' ' 237' ' ' TRP . 1.8 p -68.05 166.62 22.51 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 124.731 1.212 . . . . 0.0 112.467 -175.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -73.93 3.9 4.63 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.615 2.21 . . . . 0.0 114.698 -173.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 38.2 mtp180 -122.47 21.23 10.27 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.374 1.87 . . . . 0.0 111.017 171.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 18.6 m -133.45 -20.33 2.09 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.275 1.83 . . . . 0.0 112.506 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 31.2 t -150.29 -36.29 0.15 Allowed 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.635 1.107 . . . . 0.0 113.029 177.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 24.6 tp60 -74.17 -14.07 60.9 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.339 0.518 . . . . 0.0 112.087 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 . . . . . 0 CA--C 1.543 0.709 0 C-N-CA 125.793 1.637 . . . . 0.0 113.18 179.087 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo . . . . . 0 CA--C 1.536 0.594 0 N-CA-C 110.667 -0.551 . . . . 0.0 110.667 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 74.4 p -142.53 172.35 12.81 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.395 1.078 . . . . 0.0 110.204 -176.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -135.56 -83.88 0.39 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 117.327 -1.32 . . . . 0.0 112.765 -168.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.0 t -55.82 168.48 0.44 Allowed 'General case' 0 C--N 1.351 0.646 0 CA-C-N 119.784 1.175 . . . . 0.0 113.173 -177.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.3 pp -57.24 -12.6 2.44 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.839 1.255 . . . . 0.0 112.902 170.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 75.2 m -77.6 -18.62 56.67 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.02 2.128 . . . . 0.0 113.171 176.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 27.6 m170 56.65 61.98 2.45 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.887 2.075 . . . . 0.0 111.729 -173.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.38 158.96 34.57 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.287 1.435 . . . . 0.0 112.306 176.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.464 HG11 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -69.76 -178.97 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 126.347 1.859 . . . . 0.0 111.432 -177.192 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.464 ' H ' HG11 ' A' ' 204' ' ' VAL . 93.6 p -44.04 148.14 0.44 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.354 2.262 . . . . 0.0 113.754 177.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -153.04 167.02 30.6 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.775 1.23 . . . . 0.0 111.963 -167.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -68.79 -49.44 42.59 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.718 1.152 . . . . 0.0 114.68 -168.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -128.01 125.09 38.74 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 118.206 1.003 . . . . 0.0 109.978 -171.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -142.88 145.84 33.5 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -166.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 19.7 tt -134.64 150.57 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 125.5 1.52 . . . . 0.0 109.878 172.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -127.45 138.93 10.8 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.729 1.157 . . . . 0.0 112.575 -170.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . 0.59 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 2.2 m -77.86 126.09 30.33 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.568 1.547 . . . . 0.0 111.453 -168.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -70.18 -0.03 7.1 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.373 1.869 . . . . 0.0 113.533 -175.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -67.36 149.09 98.58 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 123.785 0.834 . . . . 0.0 111.635 -176.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -83.37 8.19 4.76 Favored 'Trans proline' 0 CA--C 1.549 1.235 0 C-N-CA 123.656 2.904 . . . . 0.0 111.431 166.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -144.52 -10.94 0.62 Allowed 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 -167.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 37.2 t -61.38 132.43 53.49 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 119.469 1.031 . . . . 0.0 110.671 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 9.3 t -103.95 4.45 34.67 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.696 1.599 . . . . 0.0 111.786 -172.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 41.8 mm -114.67 -41.81 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 125.599 1.559 . . . . 0.0 108.773 175.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 46.98 -8.08 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 131.567 3.947 . . . . 0.0 119.8 171.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 60.9 m95 -140.71 136.6 32.75 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 126.993 2.117 . . . . 0.0 109.391 171.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . 0.59 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 6.3 m-85 -144.75 153.93 42.2 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 125.47 1.508 . . . . 0.0 109.529 -169.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 29.1 m80 -70.93 149.41 46.74 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 168.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -52.37 -51.27 59.85 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 115.19 -0.913 . . . . 0.0 109.626 167.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.22 -14.22 62.52 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -177.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 3.3 m -78.08 -7.03 56.42 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.753 1.16 . . . . 0.0 112.628 172.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.2 p -122.19 -10.76 8.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 126.241 1.816 . . . . 0.0 112.276 169.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 94.16 16.52 43.72 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.736 1.636 . . . . 0.0 113.374 178.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 10.2 mt -70.48 157.65 37.48 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.554 1.177 . . . . 0.0 111.176 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 73.4 m -131.19 -5.02 3.86 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.369 1.868 . . . . 0.0 110.214 177.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 81.9 p -141.55 -175.31 4.32 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.007 2.123 . . . . 0.0 109.206 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -124.84 111.1 27.41 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 124.033 0.933 . . . . 0.0 109.077 177.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -74.19 177.4 8.31 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.473 2.782 . . . . 0.0 111.235 173.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 60.4 ttt-85 -139.1 132.2 29.65 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 171.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 115.97 -170.29 13.28 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.579 1.561 . . . . 0.0 110.855 -169.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.6 135.77 57.03 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.47 1.108 . . . . 0.0 111.468 177.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 58.2 t90 -142.49 143.84 32.73 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 127.556 2.342 . . . . 0.0 108.853 173.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -128.29 128.85 45.4 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.313 1.045 . . . . 0.0 109.372 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 3.7 p -62.71 170.12 2.73 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 126.681 1.992 . . . . 0.0 113.845 -172.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.1 0.23 8.69 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.672 2.248 . . . . 0.0 115.788 -169.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 76.5 mtm180 -117.97 17.01 14.22 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.224 1.41 . . . . 0.0 111.251 171.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 33.9 m -131.32 -17.67 2.96 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 126.166 1.786 . . . . 0.0 113.305 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 36.6 t -152.61 -40.02 0.1 Allowed 'General case' 0 C--N 1.343 0.292 0 CA-C-N 118.976 0.807 . . . . 0.0 112.55 176.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -74.82 -16.18 60.71 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 119.177 -0.439 . . . . 0.0 112.167 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.54 0.56 0 C-N-CA 124.376 1.071 . . . . 0.0 112.697 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo . . . . . 0 N--CA 1.455 -0.765 0 N-CA-C 109.795 -0.887 . . . . 0.0 109.795 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 64.7 p -141.21 171.87 13.46 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.064 0.946 . . . . 0.0 110.118 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -133.45 -83.98 0.46 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 117.145 -1.407 . . . . 0.0 113.046 -168.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.3 t -55.13 170.11 0.21 Allowed 'General case' 0 C--N 1.35 0.602 0 C-N-CA 124.841 1.256 . . . . 0.0 113.784 -175.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.2 pp -58.49 -13.91 6.67 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.175 0.99 . . . . 0.0 112.624 169.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 73.0 m -75.83 -23.4 55.75 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.887 2.075 . . . . 0.0 112.835 173.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 52.93 69.15 0.73 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 127.56 2.344 . . . . 0.0 112.045 -171.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.43 160.45 28.17 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.887 1.675 . . . . 0.0 111.203 173.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.468 HG11 ' H ' ' A' ' 205' ' ' SER . 0.3 OUTLIER -68.51 -179.84 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 125.548 1.539 . . . . 0.0 111.129 -178.928 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.468 ' H ' HG11 ' A' ' 204' ' ' VAL . 83.2 p -44.39 145.82 0.78 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.972 2.109 . . . . 0.0 113.374 177.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . 0.432 ' CE2' ' HG2' ' A' ' 209' ' ' MET . 13.3 p90 -152.98 164.35 38.14 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.992 1.317 . . . . 0.0 111.466 -167.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -72.36 -60.51 4.05 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.273 0.939 . . . . 0.0 114.095 -169.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -99.26 120.83 40.19 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 118.048 0.924 . . . . 0.0 110.284 -174.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' MET . . . . . 0.432 ' HG2' ' CE2' ' A' ' 206' ' ' TYR . 17.6 mtp -141.51 143.1 33.63 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 -168.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 19.0 tt -134.64 157.94 41.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 126.185 1.794 . . . . 0.0 108.995 169.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -135.24 139.79 11.12 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 124.129 0.871 . . . . 0.0 112.466 -174.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . 0.606 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 5.6 m -75.47 124.82 27.81 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 125.029 1.331 . . . . 0.0 110.901 -168.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -71.88 -0.7 11.97 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.398 1.479 . . . . 0.0 113.221 -176.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -66.81 146.47 99.08 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 123.616 0.766 . . . . 0.0 111.065 -177.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -81.17 6.95 5.24 Favored 'Trans proline' 0 CA--C 1.549 1.271 0 C-N-CA 123.029 2.486 . . . . 0.0 111.376 166.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -134.44 -13.38 2.33 Favored 'General case' 0 C--N 1.35 0.593 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -169.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.5 t -64.63 135.09 55.57 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 119.145 0.884 . . . . 0.0 110.524 -175.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 32.2 m -108.32 7.69 27.32 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.766 1.626 . . . . 0.0 111.923 -174.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 37.8 mm -117.09 -41.2 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 125.732 1.613 . . . . 0.0 108.647 175.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 48.31 -9.71 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 131.623 3.969 . . . . 0.0 119.818 169.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -140.75 136.1 32.19 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.663 1.985 . . . . 0.0 109.032 171.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . 0.606 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 6.9 m-85 -144.56 156.8 44.32 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 125.939 1.695 . . . . 0.0 109.609 -169.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -73.24 148.9 43.24 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 167.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -51.63 -52.12 50.27 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.8 166.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.21 -12.99 61.77 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -177.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 2.0 m -77.56 -6.29 53.17 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.823 1.192 . . . . 0.0 112.665 172.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.62 -11.74 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 126.242 1.817 . . . . 0.0 112.396 170.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 96.3 16.33 38.02 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.604 1.574 . . . . 0.0 113.563 177.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 24.8 mt -72.4 163.29 28.23 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.777 1.289 . . . . 0.0 111.33 175.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 39.7 m -134.62 -21.69 1.72 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.595 1.558 . . . . 0.0 111.08 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 58.1 p -141.01 151.01 43.76 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 125.998 1.719 . . . . 0.0 108.826 176.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -76.55 125.56 87.24 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-O 118.846 -0.597 . . . . 0.0 110.248 -178.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -77.9 179.55 6.4 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.802 3.001 . . . . 0.0 111.441 174.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.08 125.37 21.74 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 124.966 1.307 . . . . 0.0 107.784 172.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 122.55 -174.8 16.36 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.545 1.545 . . . . 0.0 110.779 -169.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.25 142.19 55.69 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 122.133 0.968 . . . . 0.0 110.618 175.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . 0.401 ' CZ2' ' HA ' ' A' ' 239' ' ' CYS . 62.9 t90 -140.31 139.46 35.45 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.646 1.978 . . . . 0.0 109.234 175.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -125.43 123.56 39.53 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.029 1.331 . . . . 0.0 108.196 -178.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . 0.43 ' HB3' ' SG ' ' A' ' 212' ' ' CYS . 5.0 p -60.61 172.72 0.75 Allowed Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 127.799 2.44 . . . . 0.0 114.776 -170.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -73.28 -0.35 9.06 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.778 2.319 . . . . 0.0 115.783 -169.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -117.48 15.95 14.67 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.617 1.567 . . . . 0.0 111.212 172.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 27.0 m -133.53 -15.94 2.4 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.725 2.01 . . . . 0.0 112.723 -176.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 35.1 t -151.1 -42.87 0.12 Allowed 'General case' 0 C--N 1.342 0.272 0 C-N-CA 123.857 0.863 . . . . 0.0 112.061 177.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -75.11 -13.65 60.5 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 . . . . . 0 CA--C 1.538 0.486 0 C-N-CA 126.178 1.791 . . . . 0.0 111.35 172.328 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo . . . . . 0 CA--C 1.535 0.567 0 CA-C-O 121.964 0.735 . . . . 0.0 113.005 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 32.6 p -142.53 179.12 7.15 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.451 1.9 . . . . 0.0 108.819 -178.495 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -138.08 -63.74 0.55 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.636 0.774 . . . . 0.0 111.83 176.042 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . 0.436 ' SG ' ' HB2' ' A' ' 201' ' ' CYS . 4.8 p -59.8 165.6 3.04 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 128.489 2.716 . . . . 0.0 114.094 179.714 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 2.7 pp -77.93 0.53 23.85 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.565 167.319 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . 0.436 ' HB2' ' SG ' ' A' ' 199' ' ' CYS . 80.3 m -78.26 -26.93 47.41 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.917 0.887 . . . . 0.0 110.4 168.711 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . 0.282 82.3 m-70 70.32 53.4 0.33 Allowed 'General case' 0 C--N 1.343 0.286 0 C-N-CA 127.29 2.236 . . . . 0.0 113.095 169.605 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.24 172.9 12.22 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.608 -1.178 . . . . 0.0 109.587 166.882 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.432 HG11 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -62.49 174.09 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 125.229 1.412 . . . . 0.0 111.862 -174.981 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.432 ' H ' HG11 ' A' ' 204' ' ' VAL . 88.6 p -50.76 158.73 0.62 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.759 2.024 . . . . 0.0 114.833 -173.725 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -139.32 160.08 40.65 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.03 1.732 . . . . 0.0 110.484 -169.192 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -63.97 -35.36 91.9 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.36 0.981 . . . . 0.0 113.85 -171.279 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.05 118.04 16.34 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 124.589 1.156 . . . . 0.0 109.337 -170.767 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 1.3 mtm -135.68 151.2 49.96 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.074 -0.966 . . . . 0.0 113.329 -165.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 19.3 tt -142.71 146.36 22.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.274 0 C-N-CA 125.511 1.524 . . . . 0.0 110.794 169.076 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -122.53 142.44 14.78 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 125.189 1.376 . . . . 0.0 112.755 -170.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . 0.573 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 1.9 m -79.5 127.27 31.93 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 126.074 1.75 . . . . 0.0 112.051 -167.302 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -69.58 -0.99 7.59 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.28 1.832 . . . . 0.0 113.751 -176.61 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -68.42 146.36 97.79 Favored Pre-proline 0 CA--C 1.539 0.521 0 O-C-N 121.469 -0.769 . . . . 0.0 111.283 -175.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -82.01 6.75 5.49 Favored 'Trans proline' 0 CA--C 1.551 1.337 0 C-N-CA 123.1 2.534 . . . . 0.0 111.208 165.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -135.02 -13.15 2.15 Favored 'General case' 0 C--N 1.351 0.638 0 C-N-CA 125.25 1.42 . . . . 0.0 114.703 -169.261 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 36.5 t -64.92 134.31 53.69 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 119.139 0.881 . . . . 0.0 110.57 -176.126 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.9 t -108.71 8.61 26.95 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.679 1.591 . . . . 0.0 111.535 -173.275 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 38.9 mm -116.84 -42.29 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 125.728 1.611 . . . . 0.0 108.659 173.604 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 47.32 -7.68 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.737 1 C-N-CA 131.817 4.047 . . . . 0.0 119.453 171.838 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 51.2 m95 -140.85 139.82 34.51 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.851 2.06 . . . . 0.0 109.827 169.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . 0.573 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 6.7 m-85 -147.34 153.01 39.16 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.485 1.514 . . . . 0.0 108.479 -169.859 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -67.08 150.98 48.44 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 166.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -54.07 -47.76 71.36 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.915 167.037 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -69.44 -14.81 63.09 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 178.402 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 5.4 t -68.79 -18.56 64.21 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.841 0.856 . . . . 0.0 112.422 173.138 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.9 p -117.36 -12.62 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 126.244 1.818 . . . . 0.0 112.137 173.233 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 93.55 18.6 37.81 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.827 1.679 . . . . 0.0 113.512 179.069 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 11.5 mt -72.12 157.44 37.77 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-N 119.006 1.403 . . . . 0.0 111.419 178.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 39.7 m -131.95 0.57 3.87 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.384 1.874 . . . . 0.0 110.185 179.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 9.5 t -148.41 172.62 14.14 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.095 1.758 . . . . 0.0 109.876 179.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -110.18 94.28 17.78 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 125.164 1.386 . . . . 0.0 108.986 179.613 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.98 162.15 41.1 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.693 2.262 . . . . 0.0 110.937 170.109 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -145.4 134.55 22.78 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 124.333 1.053 . . . . 0.0 109.242 -178.654 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 138.22 -64.07 0.56 Allowed Glycine 0 CA--C 1.525 0.683 0 C-N-CA 127.13 2.3 . . . . 0.0 108.519 179.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -167.99 149.9 5.42 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 126.011 1.724 . . . . 0.0 110.486 169.611 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . 0.4 ' CZ2' ' HA ' ' A' ' 239' ' ' CYS . 48.3 t90 -146.46 148.63 32.45 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 126.701 2.0 . . . . 0.0 109.128 178.811 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -129.35 130.82 46.56 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.343 1.057 . . . . 0.0 109.701 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . 0.4 ' HA ' ' CZ2' ' A' ' 237' ' ' TRP . 3.9 p -65.5 170.62 4.42 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 126.7 2.0 . . . . 0.0 113.716 -173.152 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -70.09 -19.64 34.31 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.052 1.835 . . . . 0.0 113.768 -170.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 16.8 mmp_? -87.2 3.45 46.44 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.536 1.534 . . . . 0.0 112.606 175.207 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 34.6 m -132.94 -17.61 2.42 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.618 1.567 . . . . 0.0 113.931 -169.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 29.0 t -149.9 -33.76 0.18 Allowed 'General case' 0 C--N 1.342 0.255 0 CA-C-N 118.862 0.755 . . . . 0.0 112.973 -177.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -70.97 -23.78 62.28 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 118.211 -0.9 . . . . 0.0 111.329 177.143 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 . . . . . 0 C--N 1.348 0.527 0 C-N-CA 125.675 1.59 . . . . 0.0 113.56 175.114 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 CA--C 1.535 0.536 0 CA-C-O 121.296 0.457 . . . . 0.0 112.082 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 66.4 p -143.77 175.09 10.25 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.098 1.359 . . . . 0.0 110.335 -175.544 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -135.51 -79.89 0.43 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 117.291 -1.338 . . . . 0.0 112.537 -173.109 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.1 t -55.38 164.6 0.94 Allowed 'General case' 0 C--N 1.349 0.566 0 CA-C-N 119.692 1.133 . . . . 0.0 112.784 -177.35 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.17 -5.36 3.15 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.005 0.922 . . . . 0.0 112.849 170.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 89.0 m -76.35 -21.97 55.46 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.165 1.786 . . . . 0.0 113.141 169.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 55.93 69.25 0.76 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 127.051 2.141 . . . . 0.0 111.951 -169.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.82 159.05 37.76 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.488 1.515 . . . . 0.0 111.886 172.317 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.493 HG11 ' H ' ' A' ' 205' ' ' SER . 0.7 OUTLIER -67.78 -177.9 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 126.263 1.825 . . . . 0.0 110.934 -179.039 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.493 ' H ' HG11 ' A' ' 204' ' ' VAL . 88.3 p -44.1 149.43 0.34 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.416 2.287 . . . . 0.0 113.9 176.054 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -153.53 168.92 24.55 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.205 1.402 . . . . 0.0 111.583 -167.226 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -72.66 -49.25 19.19 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-O 118.811 -0.994 . . . . 0.0 114.638 -169.092 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -124.96 121.78 35.44 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 118.233 1.016 . . . . 0.0 110.136 -170.062 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -140.36 146.32 38.26 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -166.016 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 20.1 tt -135.25 150.21 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 125.533 1.533 . . . . 0.0 109.802 170.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -127.33 138.84 10.76 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.539 1.066 . . . . 0.0 112.2 -172.798 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . 0.601 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 3.0 m -76.16 123.42 25.82 Favored 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 125.06 1.344 . . . . 0.0 110.779 -168.738 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -72.54 4.32 4.0 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.915 1.686 . . . . 0.0 112.938 -175.817 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -68.3 149.17 98.17 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 124.214 1.006 . . . . 0.0 111.469 -179.612 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -81.85 1.04 9.5 Favored 'Trans proline' 0 CA--C 1.549 1.235 0 C-N-CA 123.184 2.589 . . . . 0.0 111.831 166.447 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -135.53 -7.82 2.2 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -169.33 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.2 t -63.42 134.64 56.02 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 119.84 1.2 . . . . 0.0 110.836 -178.464 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 10.7 t -107.98 9.17 28.62 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.71 1.604 . . . . 0.0 111.712 -173.095 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 38.2 mm -118.64 -41.36 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 125.419 1.488 . . . . 0.0 108.771 173.678 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 48.11 -9.14 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 131.537 3.935 . . . . 0.0 119.644 171.014 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 60.9 m95 -139.8 136.29 33.91 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.834 2.054 . . . . 0.0 109.411 170.156 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . 0.601 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 7.2 m-85 -143.85 154.91 43.86 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 125.599 1.56 . . . . 0.0 109.276 -169.212 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 20.7 m170 -72.84 148.75 44.17 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 169.113 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 15.4 m-30 -51.93 -50.58 60.88 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.937 167.685 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.13 -14.0 62.14 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -177.721 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 7.5 m -78.37 -1.93 35.78 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.799 1.181 . . . . 0.0 112.657 172.714 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 6.1 p -128.22 -13.64 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 125.841 1.656 . . . . 0.0 112.659 169.11 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 99.53 16.44 29.23 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.66 1.6 . . . . 0.0 113.535 178.135 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 18.5 mt -74.39 163.19 28.08 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.799 1.299 . . . . 0.0 111.537 177.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 41.6 m -136.51 -21.81 1.31 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.581 1.552 . . . . 0.0 111.256 -178.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 89.1 m -141.03 142.77 34.18 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 125.713 1.605 . . . . 0.0 108.033 -179.207 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -68.45 120.53 75.78 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 123.957 0.903 . . . . 0.0 110.459 -178.721 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -79.46 -174.21 2.18 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.785 2.99 . . . . 0.0 111.135 173.655 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -143.96 133.68 23.72 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.58 1.152 . . . . 0.0 108.439 174.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 105.46 -169.05 15.86 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.114 1.34 . . . . 0.0 112.199 -176.234 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.83 123.61 15.63 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 125.712 1.605 . . . . 0.0 110.953 178.046 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 61.1 t90 -134.18 133.95 41.54 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.424 1.89 . . . . 0.0 108.865 171.042 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -119.08 128.25 54.15 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.696 1.198 . . . . 0.0 108.086 178.41 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 12.3 p -62.1 172.55 1.16 Allowed Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 127.382 2.273 . . . . 0.0 113.865 -173.124 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.31 -26.05 35.75 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 121.653 1.569 . . . . 0.0 114.423 -169.376 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -82.34 6.65 16.32 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.821 1.249 . . . . 0.0 112.931 173.696 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 32.9 m -134.41 -15.09 2.2 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.385 1.474 . . . . 0.0 114.223 -170.19 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.6 t -152.27 -31.0 0.15 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.924 0.783 . . . . 0.0 112.885 179.056 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -86.24 -12.3 50.04 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 118.83 -0.605 . . . . 0.0 112.624 -177.247 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 . . . . . 0 C--N 1.346 0.437 0 C-N-CA 123.744 0.818 . . . . 0.0 109.916 -178.594 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo . . . . . 0 CA--C 1.535 0.557 0 CA-C-O 121.216 0.423 . . . . 0.0 111.87 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 72.0 p -143.18 174.42 10.72 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.834 1.254 . . . . 0.0 110.613 -173.204 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -135.27 -79.17 0.44 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 117.389 -1.291 . . . . 0.0 113.312 -171.329 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.5 t -56.64 168.61 0.57 Allowed 'General case' 0 C--N 1.349 0.574 0 C-N-CA 124.998 1.319 . . . . 0.0 113.374 -174.823 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 4.3 pp -59.17 -11.81 4.34 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.439 1.096 . . . . 0.0 112.744 169.299 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 73.4 m -76.09 -24.39 55.03 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.649 1.98 . . . . 0.0 112.927 173.483 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 55.04 69.57 0.72 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 127.218 2.207 . . . . 0.0 111.621 -170.063 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.48 163.61 25.53 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.556 1.542 . . . . 0.0 111.557 173.344 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.496 HG11 ' H ' ' A' ' 205' ' ' SER . 0.4 OUTLIER -68.88 -179.44 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 125.694 1.597 . . . . 0.0 111.427 -176.738 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.496 ' H ' HG11 ' A' ' 204' ' ' VAL . 83.6 p -47.61 153.37 0.57 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.587 2.355 . . . . 0.0 114.592 178.461 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -154.49 167.47 29.95 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.278 1.831 . . . . 0.0 110.395 -169.062 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -77.93 -39.5 23.95 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 118.673 -1.07 . . . . 0.0 115.224 -168.697 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.65 118.93 19.75 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.614 1.207 . . . . 0.0 110.199 -168.49 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -141.81 152.29 43.56 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -164.282 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 15.2 tt -147.84 152.54 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 126.055 1.742 . . . . 0.0 109.859 168.168 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -132.44 146.66 18.37 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 124.118 0.866 . . . . 0.0 112.04 -169.819 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 4.2 t -70.48 144.08 51.52 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-O 122.016 0.913 . . . . 0.0 111.368 -172.158 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -78.91 -8.54 58.95 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.265 1.826 . . . . 0.0 113.686 -174.536 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 25.6 m-20 -77.28 146.1 73.81 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-N 118.533 0.606 . . . . 0.0 111.933 -168.361 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.4 8.83 2.76 Favored 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 124.135 3.223 . . . . 0.0 112.372 169.047 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -132.69 -8.19 3.19 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.365 1.866 . . . . 0.0 112.191 -170.478 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 39.0 t -62.97 136.12 57.67 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.956 0.902 . . . . 0.0 109.864 172.585 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.9 t -121.24 14.31 11.28 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.885 1.674 . . . . 0.0 111.062 -176.003 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 35.9 mm -119.6 -32.67 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 126.646 1.978 . . . . 0.0 109.235 175.41 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 51.26 -16.52 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.664 1 C-N-CA 132.007 4.123 . . . . 0.0 119.292 174.702 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 55.0 m95 -141.93 151.51 42.66 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.843 1.657 . . . . 0.0 110.468 179.007 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -153.68 154.86 34.92 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.103 1.361 . . . . 0.0 110.152 -172.265 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -77.18 147.65 36.36 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 169.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -54.75 -49.53 70.63 Favored 'General case' 0 C--O 1.222 -0.342 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.928 167.665 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -68.6 -16.14 63.76 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -179.551 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 2.6 m -76.66 -18.37 58.6 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 119.866 1.212 . . . . 0.0 112.616 174.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.8 p -105.5 -14.49 8.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 124.913 1.285 . . . . 0.0 111.524 168.686 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 92.58 20.88 33.22 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.786 1.66 . . . . 0.0 113.378 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 10.1 mt -74.91 157.61 34.74 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 118.738 1.269 . . . . 0.0 111.35 178.508 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 50.0 m -127.76 -9.55 5.55 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.34 1.856 . . . . 0.0 110.265 179.422 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 77.3 p -140.91 178.05 7.62 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.786 2.035 . . . . 0.0 109.427 179.143 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -110.94 107.21 57.81 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 124.1 0.96 . . . . 0.0 108.926 178.145 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -71.28 176.46 7.87 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.547 2.831 . . . . 0.0 111.848 175.547 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.14 133.22 36.99 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.042 1.337 . . . . 0.0 108.256 -175.123 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 107.41 -162.8 13.23 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.413 1.482 . . . . 0.0 111.464 -174.657 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -61.25 127.18 30.25 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.0 1.32 . . . . 0.0 109.195 173.731 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -132.26 149.18 52.43 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.397 1.879 . . . . 0.0 109.118 178.377 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -128.68 130.29 46.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.116 1.366 . . . . 0.0 109.994 -174.152 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.26 167.41 10.23 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.411 175.211 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.66 -37.49 16.34 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 120.907 1.071 . . . . 0.0 111.972 -174.051 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 64.9 mtp85 -72.84 1.89 7.77 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.063 1.345 . . . . 0.0 113.084 176.073 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 9.2 m -120.13 -13.9 8.9 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.401 1.481 . . . . 0.0 114.328 -175.041 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 33.3 t -151.92 -38.52 0.12 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.545 1.066 . . . . 0.0 113.12 176.552 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -73.62 -27.88 61.51 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.372 0.669 . . . . 0.0 112.174 -178.68 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 . . . . . 0 CA--C 1.543 0.687 0 C-N-CA 124.97 1.308 . . . . 0.0 112.834 -174.702 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo . . . . . 0 CA--C 1.536 0.582 0 CA-C-O 121.776 0.656 . . . . 0.0 113.135 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 33.8 p -140.99 175.14 9.86 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.36 1.864 . . . . 0.0 108.97 178.46 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -135.36 -68.71 0.51 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.842 0.857 . . . . 0.0 111.166 176.022 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . 0.424 ' SG ' ' HB2' ' A' ' 201' ' ' CYS . 5.5 p -53.74 163.71 0.66 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 128.352 2.661 . . . . 0.0 114.089 177.253 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.0 pp -77.17 -1.5 29.68 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.781 167.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . 0.424 ' HB2' ' SG ' ' A' ' 199' ' ' CYS . 78.2 m -75.19 -28.73 60.13 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.942 0.897 . . . . 0.0 110.207 168.551 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . 0.297 88.3 m-70 70.48 54.72 0.29 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 127.727 2.411 . . . . 0.0 113.309 169.605 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -137.3 172.88 12.33 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 114.559 -1.201 . . . . 0.0 109.484 166.726 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.417 HG11 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -62.67 173.88 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 125.116 1.366 . . . . 0.0 111.803 -174.961 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.417 ' H ' HG11 ' A' ' 204' ' ' VAL . 87.7 p -50.62 158.58 0.62 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.73 2.012 . . . . 0.0 114.889 -173.793 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -139.85 161.22 38.1 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.016 1.726 . . . . 0.0 110.708 -169.118 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -64.14 -35.76 92.39 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.449 1.023 . . . . 0.0 113.838 -171.651 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.63 118.48 17.24 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 124.495 1.118 . . . . 0.0 109.289 -170.74 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 1.2 mtm -134.36 149.58 50.85 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.203 -0.908 . . . . 0.0 113.402 -166.096 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 21.3 tt -139.71 145.5 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 C-N-CA 125.758 1.623 . . . . 0.0 110.544 169.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -124.91 139.54 11.78 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.873 1.225 . . . . 0.0 112.732 -170.429 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . 0.597 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 2.8 m -78.27 124.93 28.64 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 126.078 1.751 . . . . 0.0 111.664 -167.715 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -70.43 -2.77 14.82 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.064 1.745 . . . . 0.0 113.467 -176.898 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -62.72 149.07 90.15 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 123.724 0.81 . . . . 0.0 111.598 -174.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -81.23 6.75 5.39 Favored 'Trans proline' 0 CA--C 1.548 1.2 0 C-N-CA 123.491 2.794 . . . . 0.0 111.798 167.464 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -146.37 -8.85 0.51 Allowed 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -167.75 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 37.3 t -61.35 134.35 56.84 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-N 119.866 1.212 . . . . 0.0 110.851 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 27.1 m -108.14 7.67 27.68 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.647 1.579 . . . . 0.0 111.657 -173.155 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 39.1 mm -116.33 -42.22 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 125.668 1.587 . . . . 0.0 108.536 175.007 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 48.7 -9.62 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 131.509 3.924 . . . . 0.0 119.49 171.191 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 50.2 m95 -140.15 140.46 35.96 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.94 2.096 . . . . 0.0 109.662 169.632 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . 0.597 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 6.8 m-85 -147.71 155.18 41.47 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.936 1.694 . . . . 0.0 108.604 -169.481 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -68.68 150.39 47.99 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 166.245 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -53.64 -48.06 69.72 Favored 'General case' 0 C--O 1.223 -0.334 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 166.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -68.55 -15.13 63.43 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 178.625 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 8.7 t -68.93 -24.71 64.32 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.075 0.852 . . . . 0.0 112.261 174.205 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.3 p -106.61 -15.8 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.787 1.635 . . . . 0.0 112.119 171.204 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 97.05 17.66 31.6 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.956 1.741 . . . . 0.0 113.487 178.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 16.8 mt -72.91 158.5 35.38 Favored 'General case' 0 C--N 1.345 0.411 0 CA-C-N 119.093 1.446 . . . . 0.0 111.543 178.527 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.5 t -135.86 -0.53 2.55 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.153 1.781 . . . . 0.0 111.794 179.408 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 40.1 p -143.41 162.18 36.45 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.056 2.142 . . . . 0.0 109.279 175.43 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -98.05 114.42 65.08 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 123.811 0.844 . . . . 0.0 109.613 178.043 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -78.24 179.02 6.89 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 123.758 2.972 . . . . 0.0 111.531 175.502 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 15.3 ttm180 -139.36 135.32 33.59 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.028 1.331 . . . . 0.0 107.489 169.685 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 117.14 -166.84 12.52 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.314 1.435 . . . . 0.0 111.476 -176.573 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -65.88 120.58 13.32 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.629 1.172 . . . . 0.0 110.128 177.028 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . 0.41 ' CZ2' ' HA ' ' A' ' 239' ' ' CYS . 70.0 t90 -129.27 137.66 51.19 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 126.111 1.764 . . . . 0.0 108.984 174.195 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -125.97 125.14 42.23 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.778 1.231 . . . . 0.0 108.681 -178.027 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . 0.41 ' HA ' ' CZ2' ' A' ' 237' ' ' TRP . 2.9 p -59.18 171.97 0.64 Allowed Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 127.7 2.4 . . . . 0.0 114.412 -172.429 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -68.3 -23.43 38.59 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 121.761 1.641 . . . . 0.0 113.913 -169.628 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -92.41 12.65 22.0 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.645 1.178 . . . . 0.0 112.583 174.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 27.6 m -131.7 -14.21 3.22 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.018 1.727 . . . . 0.0 113.397 -176.664 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 32.4 t -149.69 -40.1 0.14 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.838 0.855 . . . . 0.0 112.012 178.618 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -77.63 -13.71 59.83 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -175.041 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 . . . . . 0 CA--C 1.541 0.609 0 C-N-CA 123.996 0.918 . . . . 0.0 112.863 171.604 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo . . . . . 0 CA--C 1.535 0.529 0 CA-C-O 121.348 0.478 . . . . 0.0 112.229 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 33.4 p -145.28 173.96 11.52 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.924 1.689 . . . . 0.0 109.308 -178.087 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -135.83 -72.79 0.46 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.952 0.901 . . . . 0.0 112.392 -176.829 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 199' ' ' CYS . . . . . 0.419 ' SG ' ' HB2' ' A' ' 201' ' ' CYS . 2.6 p -51.62 163.6 0.28 Allowed 'General case' 0 C--N 1.339 0.111 0 C-N-CA 129.342 3.057 . . . . 0.0 114.627 176.203 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 4.1 pp -69.5 -7.62 39.73 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.982 167.352 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 201' ' ' CYS . . . . . 0.419 ' HB2' ' SG ' ' A' ' 199' ' ' CYS . 83.3 m -77.06 -30.39 55.52 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.59 1.156 . . . . 0.0 111.017 172.488 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . 0.291 89.2 m-70 69.14 57.93 0.36 Allowed 'General case' 0 C--N 1.339 0.15 0 C-N-CA 127.487 2.315 . . . . 0.0 113.267 169.809 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -136.42 171.61 14.22 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 114.119 -1.401 . . . . 0.0 109.427 166.398 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 204' ' ' VAL . . . . . 0.445 HG11 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -64.23 175.71 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 125.093 1.357 . . . . 0.0 111.939 -175.311 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 205' ' ' SER . . . . . 0.445 ' H ' HG11 ' A' ' 204' ' ' VAL . 20.1 m -45.19 154.42 0.16 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 128.128 2.571 . . . . 0.0 115.245 -173.53 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -142.08 158.45 43.74 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.107 1.763 . . . . 0.0 110.037 -173.569 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -62.66 -36.34 93.13 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.188 0.899 . . . . 0.0 114.08 -169.801 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.96 117.95 15.31 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 124.446 1.098 . . . . 0.0 109.742 -170.354 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 1.4 mtm -136.33 150.4 48.84 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.257 -0.883 . . . . 0.0 113.107 -166.801 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 13.1 tt -146.68 149.65 15.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 126.363 1.865 . . . . 0.0 110.077 169.38 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -134.02 147.23 18.99 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 124.063 0.84 . . . . 0.0 112.767 -169.538 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 3.0 t -70.8 143.69 51.07 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-O 121.893 0.854 . . . . 0.0 111.073 -173.128 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -83.9 -6.03 59.34 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 113.529 -1.669 . . . . 0.0 113.252 -174.261 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 22.9 m-20 -73.98 147.61 86.22 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 118.589 0.631 . . . . 0.0 111.696 -168.701 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -75.78 8.9 2.5 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 124.116 3.211 . . . . 0.0 112.554 169.343 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -135.25 -6.7 2.3 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.107 1.763 . . . . 0.0 112.327 -170.044 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.7 t -62.98 136.03 57.62 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.035 0.934 . . . . 0.0 110.01 172.998 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 11.8 t -118.9 12.79 12.97 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.771 1.629 . . . . 0.0 111.202 -175.846 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 25.5 mm -122.14 -32.18 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 126.065 1.746 . . . . 0.0 109.608 177.491 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 50.49 -11.29 0.0 OUTLIER 'General case' 0 C--N 1.349 0.576 0 C-N-CA 131.065 3.746 . . . . 0.0 119.131 177.359 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 52.4 m95 -145.59 156.09 43.46 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.768 1.627 . . . . 0.0 111.417 179.403 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -158.81 155.4 27.81 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 126.716 2.006 . . . . 0.0 109.081 -175.402 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 51.4 m80 -70.8 151.35 44.91 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 166.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -55.47 -47.06 76.69 Favored 'General case' 0 C--O 1.223 -0.29 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 166.592 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -66.73 -14.21 62.28 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 177.504 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 2.6 t -67.09 -31.29 71.68 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.24 0.927 . . . . 0.0 112.106 174.016 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.4 p -101.28 -14.41 8.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 125.964 1.705 . . . . 0.0 112.216 171.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 89.81 22.57 35.85 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.697 1.618 . . . . 0.0 113.256 -178.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 8.8 mt -69.83 157.94 36.43 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-N 118.886 1.343 . . . . 0.0 111.59 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 74.7 p -128.36 -1.9 5.62 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.047 1.739 . . . . 0.0 111.605 -178.252 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 11.3 t -152.76 170.16 20.98 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.151 1.78 . . . . 0.0 109.578 178.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -97.92 110.49 55.84 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.25 1.02 . . . . 0.0 108.876 175.231 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -71.34 -176.23 1.85 Allowed 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 124.016 3.144 . . . . 0.0 111.788 174.148 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -142.85 135.4 27.67 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.606 1.162 . . . . 0.0 108.668 -176.048 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 93.82 -172.52 32.63 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 125.041 1.305 . . . . 0.0 111.452 -170.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.36 136.02 49.64 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.926 1.291 . . . . 0.0 111.716 176.425 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 237' ' ' TRP . . . . . 0.429 ' CH2' ' HA ' ' A' ' 239' ' ' CYS . 61.6 t90 -139.9 153.11 46.89 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 127.15 2.18 . . . . 0.0 108.972 -177.813 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -128.69 130.7 47.52 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.86 1.264 . . . . 0.0 110.048 -173.303 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 239' ' ' CYS . . . . . 0.429 ' HA ' ' CH2' ' A' ' 237' ' ' TRP . 0.5 OUTLIER -66.27 169.1 7.83 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.839 1.256 . . . . 0.0 112.985 -177.131 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.9 0.72 8.95 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.479 2.12 . . . . 0.0 114.65 -171.412 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 81.8 mtt-85 -128.68 24.31 5.76 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.835 1.254 . . . . 0.0 110.541 168.741 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 11.6 m -123.79 -17.13 6.45 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 126.494 1.918 . . . . 0.0 112.059 171.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 36.8 t -150.92 -32.03 0.17 Allowed 'General case' 0 C--N 1.348 0.529 0 CA-C-N 119.477 1.035 . . . . 0.0 113.316 173.418 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -70.58 -18.42 62.9 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 118.969 0.804 . . . . 0.0 112.462 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 . . . . . 0 CA--C 1.542 0.638 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 172.082 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 77.2 mtm . . . . . 0 N--CA 1.476 0.871 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 56.38 -164.03 0.15 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.554 1.542 . . . . 0.0 112.857 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -131.52 66.33 78.08 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.077 1.351 . . . . 0.0 109.263 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -70.16 168.52 21.84 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 123.601 2.867 . . . . 0.0 112.088 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.447 HG11 ' H ' ' A' ' 192' ' ' ASP . 1.4 t -140.88 176.49 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 125.963 1.705 . . . . 0.0 107.456 -178.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.447 ' H ' HG11 ' A' ' 191' ' ' VAL . 10.6 m-20 -54.59 157.72 4.91 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 127.006 2.123 . . . . 0.0 112.956 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -71.41 10.28 0.78 Allowed 'Trans proline' 0 CA--C 1.546 1.125 0 C-N-CA 123.859 3.039 . . . . 0.0 112.926 169.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -117.96 36.03 4.49 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.853 2.061 . . . . 0.0 110.325 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -133.09 97.01 16.99 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 125.748 1.619 . . . . 0.0 108.384 -171.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.53 149.28 23.94 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.592 2.862 . . . . 0.0 111.593 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 81.7 p -129.35 173.86 10.15 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.091 1.356 . . . . 0.0 110.559 -171.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -133.56 -81.97 0.47 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 117.464 -1.255 . . . . 0.0 113.283 -168.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.3 t -55.53 166.65 0.61 Allowed 'General case' 0 C--N 1.35 0.607 0 C-N-CA 124.996 1.318 . . . . 0.0 112.814 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 4.1 pp -58.86 -11.45 3.3 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.695 1.198 . . . . 0.0 112.806 170.51 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 73.6 m -76.38 -19.48 58.12 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.501 1.92 . . . . 0.0 113.042 175.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 17.0 m170 57.75 62.07 2.22 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.846 2.059 . . . . 0.0 111.56 -173.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.5 162.42 25.67 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.337 1.455 . . . . 0.0 112.277 176.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -66.77 179.92 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 125.912 1.685 . . . . 0.0 112.367 -176.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 87.4 p -49.04 153.48 0.9 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.195 2.198 . . . . 0.0 113.913 175.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -158.24 170.84 21.36 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.7 1.6 . . . . 0.0 110.761 -167.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -77.2 -62.35 2.47 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 119.196 -0.78 . . . . 0.0 113.569 -170.005 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -105.89 121.87 44.95 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 117.815 0.808 . . . . 0.0 110.63 -172.151 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -143.88 145.89 32.62 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -167.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 15.6 tt -142.64 154.28 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.412 1.485 . . . . 0.0 109.28 169.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -133.25 144.99 17.07 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 123.727 0.68 . . . . 0.0 112.242 -169.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 11.9 t -67.99 145.92 54.05 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-O 122.036 0.922 . . . . 0.0 110.467 -174.106 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -94.4 2.46 55.78 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 113.509 -1.678 . . . . 0.0 112.694 -171.53 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -77.63 147.06 74.23 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 119.172 0.896 . . . . 0.0 110.473 177.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -76.71 8.07 3.23 Favored 'Trans proline' 0 CA--C 1.547 1.14 0 C-N-CA 123.542 2.828 . . . . 0.0 111.775 167.77 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -127.46 -6.77 5.81 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.344 1.857 . . . . 0.0 112.436 -171.532 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 37.9 t -64.45 131.22 46.52 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.651 0.78 . . . . 0.0 109.742 175.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.7 t -109.15 9.72 26.06 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.42 1.488 . . . . 0.0 111.743 -173.577 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 32.7 mm -121.95 -31.92 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 126.058 1.743 . . . . 0.0 109.677 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 51.6 -15.7 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 131.318 3.847 . . . . 0.0 119.327 175.413 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 58.1 m95 -139.04 151.04 46.47 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.713 1.605 . . . . 0.0 110.578 178.088 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -152.95 152.69 31.73 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.175 1.39 . . . . 0.0 110.233 -171.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -76.28 149.4 37.12 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.407 -0.815 . . . . 0.0 108.959 169.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 8.9 m-30 -52.31 -51.2 60.0 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.829 167.731 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.82 -14.08 62.28 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 118.361 -0.828 . . . . 0.0 113.2 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 9.4 m -79.04 -2.42 40.3 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 119.586 1.085 . . . . 0.0 112.511 172.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 1.2 p -126.61 -14.08 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.32 1.448 . . . . 0.0 112.456 169.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 97.16 20.33 23.54 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 125.485 1.517 . . . . 0.0 113.642 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 10.9 mt -75.41 160.31 30.39 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.803 1.301 . . . . 0.0 111.544 178.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 38.4 m -132.31 -10.74 3.26 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.288 1.835 . . . . 0.0 110.648 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 77.5 p -142.27 -174.88 4.24 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.798 2.039 . . . . 0.0 109.15 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -120.92 98.66 47.46 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 123.856 0.862 . . . . 0.0 110.451 -176.103 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -70.94 170.68 17.4 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.685 2.257 . . . . 0.0 111.002 169.803 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 -141.74 133.54 27.22 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.716 1.206 . . . . 0.0 108.492 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 129.85 -163.57 22.8 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 126.022 1.772 . . . . 0.0 110.85 -174.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -61.8 115.63 4.16 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.109 0.963 . . . . 0.0 109.284 169.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 53.0 t90 -132.93 142.7 49.03 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.31 1.844 . . . . 0.0 107.825 175.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -125.49 139.37 53.69 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.154 0.981 . . . . 0.0 110.801 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 7.4 p -71.46 173.36 5.22 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 125.888 1.675 . . . . 0.0 111.888 -179.174 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -70.31 -33.2 14.94 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 121.217 1.278 . . . . 0.0 113.655 -168.86 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -75.13 -4.72 40.35 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 173.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 22.2 m -112.99 -17.95 12.33 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.745 1.218 . . . . 0.0 113.459 -171.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 22.1 t -152.94 -35.18 0.11 Allowed 'General case' 0 C--N 1.343 0.303 0 CA-C-N 119.093 0.861 . . . . 0.0 113.294 177.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -72.41 -14.59 61.74 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 118.23 0.468 . . . . 0.0 112.164 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -64.71 -25.06 67.77 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.494 1.117 . . . . 0.0 111.804 177.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -80.1 53.03 1.64 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.793 1.637 . . . . 0.0 111.407 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -140.36 37.31 1.88 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.673 1.589 . . . . 0.0 109.81 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm 51.12 63.84 2.08 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.46 1.904 . . . . 0.0 112.001 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? . . . . . 0 C--O 1.251 1.143 0 C-N-CA 126.551 1.941 . . . . 0.0 111.204 179.737 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.479 0.98 0 CA-C-O 118.725 -0.655 . . . . 0.0 111.915 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -141.95 160.66 39.75 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.721 1.209 . . . . 0.0 110.508 -176.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 65.6 mtt -144.28 154.69 57.61 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 125.538 1.535 . . . . 0.0 110.168 -178.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -74.07 84.19 1.53 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 124.382 3.388 . . . . 0.0 109.899 172.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . 0.313 2.7 m 53.43 148.61 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 130.537 3.535 . . . . 0.0 115.394 -169.069 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -71.33 154.34 93.69 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.55 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.39 8.14 2.32 Favored 'Trans proline' 0 CA--C 1.547 1.146 0 C-N-CA 123.632 2.888 . . . . 0.0 112.245 168.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -120.18 33.34 5.64 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.805 2.042 . . . . 0.0 110.606 -176.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -141.88 125.18 9.67 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 125.539 1.536 . . . . 0.0 108.481 -170.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -71.12 161.11 47.05 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.106 2.538 . . . . 0.0 112.77 -177.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 34.2 p -142.83 175.32 9.91 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.116 1.766 . . . . 0.0 109.223 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -136.3 -67.34 0.52 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.995 0.918 . . . . 0.0 111.573 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . 0.429 ' SG ' ' HB2' ' A' ' 201' ' ' CYS . 4.5 p -56.71 163.72 1.76 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 128.388 2.675 . . . . 0.0 113.811 176.308 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.3 pp -77.02 -1.13 27.31 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.865 -1.062 . . . . 0.0 111.704 167.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . 0.429 ' HB2' ' SG ' ' A' ' 199' ' ' CYS . 77.0 m -75.45 -29.16 59.56 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.943 0.897 . . . . 0.0 110.2 168.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . 0.302 89.1 m-70 71.1 54.69 0.23 Allowed 'General case' 0 C--N 1.342 0.255 0 C-N-CA 127.619 2.367 . . . . 0.0 113.689 169.468 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -137.49 172.69 12.6 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.617 166.491 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -63.16 174.37 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 125.189 1.396 . . . . 0.0 111.877 -175.384 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 83.5 p -47.81 156.71 0.31 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.935 2.094 . . . . 0.0 115.063 -174.34 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -144.36 163.49 33.59 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.477 1.511 . . . . 0.0 111.101 -168.54 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -61.5 -40.7 99.05 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.851 1.215 . . . . 0.0 114.702 -169.441 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -130.54 122.91 28.44 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.115 0.966 . . . . 0.0 110.355 -173.514 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 1.4 mtm -139.69 144.5 37.6 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -167.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 21.2 tt -136.82 146.37 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 125.605 1.562 . . . . 0.0 110.232 171.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -124.2 139.54 12.01 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.573 1.082 . . . . 0.0 112.819 -170.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . 0.597 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 4.5 m -76.09 125.09 28.49 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 125.746 1.618 . . . . 0.0 111.441 -168.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -74.54 4.59 5.84 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.718 1.607 . . . . 0.0 113.21 -177.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -69.13 148.19 97.62 Favored Pre-proline 0 CA--C 1.538 0.51 0 O-C-N 121.29 -0.881 . . . . 0.0 111.018 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -81.36 3.85 7.47 Favored 'Trans proline' 0 CA--C 1.549 1.253 0 C-N-CA 123.2 2.6 . . . . 0.0 111.666 166.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -134.67 -10.42 2.41 Favored 'General case' 0 C--N 1.35 0.61 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 -169.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 36.9 t -64.13 135.28 56.2 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 119.438 1.017 . . . . 0.0 110.811 -177.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.7 t -110.97 10.9 22.2 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.779 1.632 . . . . 0.0 111.498 -173.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 36.5 mm -117.19 -42.46 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 125.263 1.425 . . . . 0.0 108.581 171.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 49.8 -10.18 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 131.068 3.747 . . . . 0.0 119.309 172.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -139.14 140.96 38.05 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 127.051 2.14 . . . . 0.0 109.913 169.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . 0.597 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 8.4 m-85 -147.45 150.83 35.36 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.81 1.644 . . . . 0.0 108.866 -169.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -66.01 153.2 42.83 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 166.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -52.7 -49.41 65.4 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 166.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -69.43 -12.81 61.96 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 1.8 t -68.17 -14.91 63.33 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.752 0.705 . . . . 0.0 112.71 171.332 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 6.4 p -126.55 -10.11 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 126.479 1.912 . . . . 0.0 112.539 174.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 91.76 20.26 37.69 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.623 1.582 . . . . 0.0 113.469 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 5.9 mt -69.57 160.7 31.02 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.643 1.222 . . . . 0.0 112.018 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 96.9 m -139.35 -29.21 0.75 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.163 1.385 . . . . 0.0 111.307 -174.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 88.0 m -140.96 123.59 16.04 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 125.117 1.367 . . . . 0.0 107.582 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -65.9 121.66 76.99 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 123.96 0.904 . . . . 0.0 111.712 -169.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -78.77 -174.96 2.49 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 124.253 3.302 . . . . 0.0 111.228 170.708 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 3.1 ttp85 -145.53 151.41 38.1 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.794 1.238 . . . . 0.0 108.811 170.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 94.99 -155.88 21.64 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.817 1.199 . . . . 0.0 111.48 -177.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -57.21 108.92 0.58 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.526 1.53 . . . . 0.0 110.952 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 65.7 t90 -131.06 129.2 41.65 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 126.049 1.739 . . . . 0.0 107.952 169.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -117.75 126.1 51.84 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . 0.437 ' HB3' ' SG ' ' A' ' 212' ' ' CYS . 3.3 p -58.46 171.87 0.56 Allowed Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 127.689 2.396 . . . . 0.0 113.876 -173.616 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -66.19 -33.78 38.74 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 121.323 1.349 . . . . 0.0 112.767 -170.285 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 66.7 mtt180 -79.06 9.19 4.62 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.805 1.242 . . . . 0.0 112.785 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 27.6 m -131.05 -12.21 3.66 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.216 1.806 . . . . 0.0 114.1 -174.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 33.2 t -152.79 -39.59 0.1 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.882 0.873 . . . . 0.0 112.388 178.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -77.89 -13.34 59.92 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -175.953 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -64.78 -15.81 62.15 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.773 0.829 . . . . 0.0 112.654 172.273 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 51.0 ttt85 -62.5 -12.36 21.83 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.223 1.409 . . . . 0.0 112.765 169.762 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -128.23 1.37 5.77 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.739 1.616 . . . . 0.0 112.881 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? 38.79 80.92 0.03 OUTLIER 'General case' 0 C--N 1.35 0.599 0 C-N-CA 127.426 2.29 . . . . 0.0 113.56 172.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 63.1 tttp . . . . . 0 C--O 1.249 1.066 0 CA-C-O 116.677 -1.63 . . . . 0.0 110.14 -178.899 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 53.9 ttm . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -156.55 46.84 0.44 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.312 1.045 . . . . 0.0 110.312 -173.117 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 25.7 ttt -138.74 75.42 36.96 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 124.103 0.961 . . . . 0.0 110.405 -175.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -74.06 178.62 6.67 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.86 3.04 . . . . 0.0 111.634 173.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 5.4 m -133.86 140.02 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 126.226 1.81 . . . . 0.0 108.325 175.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -66.49 158.11 79.83 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 125.483 1.513 . . . . 0.0 112.293 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -73.18 5.98 2.83 Favored 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 123.602 2.868 . . . . 0.0 112.316 168.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -116.16 34.77 4.82 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.932 2.093 . . . . 0.0 110.332 -177.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 31.1 tp10 -143.46 129.91 10.36 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 125.849 1.66 . . . . 0.0 108.048 -171.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -71.0 154.57 62.78 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.937 2.424 . . . . 0.0 111.632 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 62.9 p -145.47 174.07 11.46 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.703 1.201 . . . . 0.0 110.502 -175.372 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -137.51 -80.93 0.36 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.639 -169.904 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 1.8 t -56.58 167.14 0.77 Allowed 'General case' 0 C--N 1.351 0.649 0 C-N-CA 124.543 1.137 . . . . 0.0 112.942 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.0 pp -58.3 -11.97 3.25 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.031 1.332 . . . . 0.0 112.759 171.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 71.4 m -76.34 -20.43 57.24 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.552 1.941 . . . . 0.0 113.166 176.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 50.8 m170 56.71 65.99 1.28 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.855 2.062 . . . . 0.0 111.585 -170.047 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.93 157.65 41.03 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.029 1.332 . . . . 0.0 112.338 174.001 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.502 HG11 ' H ' ' A' ' 205' ' ' SER . 0.7 OUTLIER -67.92 -178.89 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 126.292 1.837 . . . . 0.0 111.113 -177.858 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.502 ' H ' HG11 ' A' ' 204' ' ' VAL . 87.9 p -45.57 149.83 0.54 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 127.47 2.308 . . . . 0.0 113.827 178.641 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . 0.44 ' CE2' ' HG2' ' A' ' 209' ' ' MET . 16.3 p90 -154.34 165.62 35.77 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.22 1.408 . . . . 0.0 111.077 -167.493 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -74.91 -41.54 32.88 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 118.511 -1.16 . . . . 0.0 115.204 -168.777 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -126.35 120.3 29.52 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 118.582 1.191 . . . . 0.0 110.506 -169.449 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' MET . . . . . 0.44 ' HG2' ' CE2' ' A' ' 206' ' ' TYR . 3.1 mtp -139.74 149.2 43.32 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -165.833 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 15.2 tt -137.79 155.61 30.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 CA-C-N 113.768 -1.56 . . . . 0.0 109.553 168.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -133.04 138.87 10.47 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.698 1.142 . . . . 0.0 112.51 -171.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . 0.591 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 1.6 m -79.3 126.21 30.5 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.554 1.542 . . . . 0.0 112.311 -167.675 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -69.67 -1.85 10.13 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.776 2.03 . . . . 0.0 113.718 -176.238 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -66.56 148.86 98.52 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 123.717 0.807 . . . . 0.0 111.827 -174.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -83.34 7.92 4.92 Favored 'Trans proline' 0 CA--C 1.549 1.25 0 C-N-CA 123.661 2.908 . . . . 0.0 111.404 166.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -144.58 -10.43 0.62 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 -167.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 37.3 t -61.58 133.42 55.65 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 119.562 1.074 . . . . 0.0 110.62 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.9 t -107.16 8.54 30.14 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.652 1.581 . . . . 0.0 111.588 -172.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 41.3 mm -117.66 -42.58 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 125.675 1.59 . . . . 0.0 108.735 174.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 46.95 -9.77 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.834 1 C-N-CA 131.706 4.002 . . . . 0.0 119.703 172.803 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 63.8 m95 -136.85 135.84 38.25 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.652 1.981 . . . . 0.0 109.166 170.171 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . 0.591 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 7.6 m-85 -141.45 155.86 45.82 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 125.129 1.371 . . . . 0.0 109.074 -169.323 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -76.22 149.01 37.28 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 169.174 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -52.39 -50.61 62.13 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.094 167.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.32 -14.59 62.65 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -177.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 9.5 m -79.14 -4.05 48.53 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 119.676 1.126 . . . . 0.0 112.861 172.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.6 p -123.93 -13.84 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 126.049 1.739 . . . . 0.0 112.383 169.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 96.57 17.53 33.23 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.683 1.611 . . . . 0.0 113.206 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 9.6 mt -73.31 162.67 29.09 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.38 1.09 . . . . 0.0 111.606 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.7 t -139.47 -2.79 1.56 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.923 1.689 . . . . 0.0 112.15 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 46.0 p -143.37 179.77 6.89 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.977 2.111 . . . . 0.0 109.61 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -110.89 92.72 15.36 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 124.707 1.203 . . . . 0.0 109.546 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -69.01 164.68 32.85 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.252 1.968 . . . . 0.0 110.295 169.656 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 47.9 ttp180 -142.47 131.52 23.16 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 122.211 1.005 . . . . 0.0 109.012 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 135.58 -170.56 23.0 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 126.721 2.105 . . . . 0.0 109.886 -169.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -67.53 121.23 15.37 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.709 0.766 . . . . 0.0 109.892 171.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 47.7 t90 -131.41 141.59 49.88 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.793 2.037 . . . . 0.0 108.313 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -125.08 130.74 52.87 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.29 1.036 . . . . 0.0 108.868 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 2.4 p -61.28 167.63 3.8 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 126.089 1.756 . . . . 0.0 112.705 -175.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -65.61 -33.72 44.43 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 121.29 1.326 . . . . 0.0 112.671 -169.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 75.1 mtt-85 -79.43 6.29 10.6 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.137 0.975 . . . . 0.0 113.049 177.778 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 22.6 m -125.9 -15.38 5.92 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.835 1.654 . . . . 0.0 114.023 -175.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 22.9 t -150.24 -32.51 0.19 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.89 0.768 . . . . 0.0 112.997 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 30.1 tp60 -86.44 -20.62 27.89 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -176.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -75.69 -20.05 58.68 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.556 1.142 . . . . 0.0 112.046 -176.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 59.6 ttt85 -79.75 83.16 5.74 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.374 1.469 . . . . 0.0 108.822 170.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -146.06 56.35 1.19 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.462 1.105 . . . . 0.0 110.493 -170.77 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -78.03 75.97 4.56 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.75 1.22 . . . . 0.0 108.306 169.786 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . 0.419 ' HB2' ' HZ3' ' A' ' 249' ' ' LYS . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.175 0 C-N-CA 126.784 2.034 . . . . 0.0 110.193 -168.342 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 63.4 mtt . . . . . 0 N--CA 1.477 0.879 0 CA-C-O 118.992 -0.528 . . . . 0.0 110.961 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -61.27 100.26 0.12 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.111 1.764 . . . . 0.0 111.747 -175.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.457 ' H ' ' HD2' ' A' ' 190' ' ' PRO . 1.7 mmt -156.4 -50.33 0.01 OUTLIER Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 126.194 1.798 . . . . 0.0 111.231 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.457 ' HD2' ' H ' ' A' ' 189' ' ' MET . 86.5 Cg_endo -79.74 99.51 1.21 Allowed 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.578 2.186 . . . . 0.0 110.678 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 2.3 m -139.89 126.02 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 125.679 1.591 . . . . 0.0 108.516 176.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -75.4 156.4 85.36 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 124.598 1.159 . . . . 0.0 111.417 178.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -72.0 -4.33 14.94 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 123.506 2.804 . . . . 0.0 112.807 169.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -71.39 85.05 0.81 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.976 2.11 . . . . 0.0 110.295 177.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -142.49 125.27 9.19 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 124.979 1.312 . . . . 0.0 108.821 -177.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -79.41 166.18 22.48 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.179 2.586 . . . . 0.0 112.205 -178.107 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 44.6 p -141.59 169.83 16.86 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.033 1.733 . . . . 0.0 108.466 174.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -137.83 -55.13 0.67 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -177.402 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 201' ' ' CYS . 3.6 p -67.48 165.68 16.23 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 128.531 2.732 . . . . 0.0 113.664 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.4 pp -72.11 -4.71 30.58 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.648 166.517 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . 0.448 ' HB2' ' SG ' ' A' ' 199' ' ' CYS . 74.1 m -80.07 -25.81 39.9 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.867 1.267 . . . . 0.0 111.342 174.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . 0.285 9.9 m-70 71.37 52.01 0.25 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.886 2.074 . . . . 0.0 112.71 169.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -137.41 171.37 14.58 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.22 167.104 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.423 HG11 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -63.9 174.12 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 125.349 1.459 . . . . 0.0 111.998 -173.87 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.423 ' H ' HG11 ' A' ' 204' ' ' VAL . 89.4 p -47.57 155.12 0.39 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.339 2.256 . . . . 0.0 115.481 -173.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -145.46 160.41 41.63 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.962 1.705 . . . . 0.0 110.377 -169.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -60.46 -38.77 95.33 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.653 1.12 . . . . 0.0 114.783 -169.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -131.86 121.45 24.08 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.0 0.92 . . . . 0.0 110.722 -171.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 1.4 mtm -138.33 144.92 40.61 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -168.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 21.3 tt -143.33 147.91 19.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 126.358 1.863 . . . . 0.0 109.202 173.497 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -137.19 145.85 17.68 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 123.698 0.666 . . . . 0.0 113.086 -169.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 6.9 t -72.13 145.3 48.22 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-O 122.234 1.016 . . . . 0.0 111.124 -172.201 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -77.78 -9.56 59.09 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.648 1.979 . . . . 0.0 113.92 -176.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 56.9 m-20 -76.71 145.91 75.6 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 118.676 0.671 . . . . 0.0 111.782 -169.121 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.35 8.95 2.69 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 124.072 3.181 . . . . 0.0 112.209 169.003 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -134.23 -8.8 2.61 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.285 1.834 . . . . 0.0 112.34 -169.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 46.9 t -63.07 125.1 22.9 Favored 'General case' 0 C--N 1.345 0.401 0 C-N-CA 123.52 0.728 . . . . 0.0 109.708 172.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 10.0 t -97.84 1.78 48.59 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.835 1.654 . . . . 0.0 112.014 -172.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 28.3 mm -117.43 -32.03 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 125.949 1.7 . . . . 0.0 109.7 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 50.07 -12.61 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 130.529 3.532 . . . . 0.0 118.985 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 46.3 m95 -141.96 157.18 45.26 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 120.588 1.54 . . . . 0.0 112.104 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -158.72 153.3 24.46 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.203 1.801 . . . . 0.0 109.349 -174.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 62.0 m80 -68.69 155.55 39.88 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 166.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 11.1 m-30 -52.81 -51.11 62.1 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 166.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -68.68 -12.55 61.53 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.893 0.877 . . . . 0.0 113.255 -177.894 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 1.1 t -67.08 -20.29 65.79 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.488 0.715 . . . . 0.0 112.584 172.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 5.5 p -118.69 -15.48 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 125.971 1.709 . . . . 0.0 112.155 173.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 101.28 16.99 23.55 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.797 1.665 . . . . 0.0 113.665 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 11.7 mt -71.6 166.49 21.74 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.065 1.433 . . . . 0.0 111.652 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 88.2 m -132.42 -14.5 2.91 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.909 1.683 . . . . 0.0 110.828 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 75.9 p -142.03 169.49 17.49 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.996 1.718 . . . . 0.0 109.983 -177.453 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -98.77 114.4 65.38 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 123.829 0.852 . . . . 0.0 109.13 175.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -75.32 -178.81 4.5 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.991 3.128 . . . . 0.0 110.748 172.181 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -138.37 129.52 27.19 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.964 0.906 . . . . 0.0 108.868 174.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 123.31 -178.42 16.39 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 125.978 1.752 . . . . 0.0 110.981 -170.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -67.33 137.31 55.94 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 122.298 1.047 . . . . 0.0 110.625 173.097 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . 0.402 ' CH2' ' HA ' ' A' ' 239' ' ' CYS . 49.4 t90 -141.89 154.88 45.44 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 127.439 2.296 . . . . 0.0 109.109 -176.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -128.42 132.5 48.46 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.9 1.28 . . . . 0.0 110.487 -174.481 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . 0.402 ' HA ' ' CH2' ' A' ' 237' ' ' TRP . 1.8 p -71.47 170.07 13.22 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.045 1.338 . . . . 0.0 112.186 -178.172 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.79 -15.28 26.82 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 121.789 1.659 . . . . 0.0 114.09 -169.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -96.92 9.25 42.46 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.882 1.673 . . . . 0.0 111.948 173.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 20.0 m -130.65 -18.32 3.13 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.589 1.556 . . . . 0.0 113.637 -172.722 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 45.1 t -151.17 -38.67 0.13 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.464 1.029 . . . . 0.0 112.746 174.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 33.2 tp60 -69.11 -19.07 64.04 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.131 0.423 . . . . 0.0 112.004 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -62.45 -18.86 62.74 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.564 1.946 . . . . 0.0 113.078 177.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 82.4 mtt85 -86.1 24.78 1.26 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.497 1.519 . . . . 0.0 112.868 -178.652 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -131.72 115.69 16.33 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 124.815 1.246 . . . . 0.0 108.639 171.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -73.2 98.11 2.55 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.173 1.389 . . . . 0.0 109.938 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt . . . . . 0 C--O 1.25 1.114 0 C-N-CA 126.005 1.722 . . . . 0.0 109.131 -178.911 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.475 0.792 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -140.1 -107.52 0.16 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.066 0.946 . . . . 0.0 108.828 -169.022 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 64.5 mtt -140.73 59.51 11.58 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 125.179 1.392 . . . . 0.0 109.942 178.874 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.13 -42.05 6.45 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.795 2.33 . . . . 0.0 112.662 -175.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -155.75 144.98 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 128.537 2.735 . . . . 0.0 107.458 175.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -84.53 154.09 62.07 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 123.942 0.897 . . . . 0.0 110.56 169.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -74.58 5.65 3.66 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 123.616 2.878 . . . . 0.0 112.35 169.082 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -114.45 38.76 2.98 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.877 2.071 . . . . 0.0 110.172 -174.807 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -140.69 127.92 12.15 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 125.436 1.494 . . . . 0.0 108.205 -169.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -70.51 158.17 56.75 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.883 2.389 . . . . 0.0 111.962 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 63.9 p -144.48 175.23 10.28 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.85 1.26 . . . . 0.0 110.452 -173.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -135.19 -81.2 0.43 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 117.436 -1.269 . . . . 0.0 112.992 -169.031 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -56.02 168.93 0.42 Allowed 'General case' 0 C--N 1.349 0.581 0 C-N-CA 124.887 1.275 . . . . 0.0 113.32 -177.435 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.9 pp -57.87 -12.14 2.91 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.015 1.326 . . . . 0.0 113.015 169.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 72.1 m -76.62 -23.74 53.38 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 127.002 2.121 . . . . 0.0 113.261 176.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 17.3 m170 58.85 66.44 1.06 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.574 1.949 . . . . 0.0 111.001 -169.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.18 159.44 36.03 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.966 1.306 . . . . 0.0 112.273 174.281 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.525 HG11 ' H ' ' A' ' 205' ' ' SER . 0.8 OUTLIER -70.96 -177.96 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 C-N-CA 126.186 1.794 . . . . 0.0 111.231 -175.79 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.525 ' H ' HG11 ' A' ' 204' ' ' VAL . 49.6 m -46.83 151.69 0.58 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 128.289 2.636 . . . . 0.0 114.221 -178.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . 0.423 ' CE2' ' HG2' ' A' ' 209' ' ' MET . 11.9 p90 -155.7 162.95 40.46 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.742 1.617 . . . . 0.0 110.819 -168.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -70.59 -47.17 43.14 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-O 118.695 -1.058 . . . . 0.0 114.526 -169.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -127.94 123.0 33.83 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.376 1.088 . . . . 0.0 110.289 -169.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' MET . . . . . 0.423 ' HG2' ' CE2' ' A' ' 206' ' ' TYR . 5.1 mtp -135.17 153.63 51.9 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -165.844 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 18.4 tt -142.94 158.81 18.13 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 C-N-CA 126.799 2.04 . . . . 0.0 108.752 169.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -141.64 143.42 13.04 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 123.564 0.602 . . . . 0.0 111.79 -173.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 4.1 t -71.55 142.32 50.07 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-O 121.674 0.749 . . . . 0.0 111.04 -173.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -75.97 -10.65 59.59 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.682 1.593 . . . . 0.0 114.036 -174.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 18.8 m-20 -78.84 145.04 65.38 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 118.66 0.664 . . . . 0.0 112.064 -167.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -75.64 1.98 7.44 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 123.603 2.869 . . . . 0.0 111.989 168.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -118.77 -6.61 10.58 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.217 1.807 . . . . 0.0 112.224 -175.141 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 39.0 t -64.91 136.86 57.32 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.305 1.042 . . . . 0.0 109.682 173.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 8.5 t -121.05 12.4 11.13 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.805 1.642 . . . . 0.0 111.202 -175.56 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 36.4 mm -119.98 -32.88 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 126.206 1.802 . . . . 0.0 109.383 175.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 50.83 -16.27 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.687 1 C-N-CA 131.769 4.028 . . . . 0.0 119.309 175.439 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 61.5 m95 -140.86 150.81 43.73 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 125.549 1.54 . . . . 0.0 110.188 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -154.31 154.44 33.37 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.288 1.435 . . . . 0.0 110.278 -170.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -79.07 143.92 35.11 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 168.839 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -51.67 -50.07 61.13 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.337 167.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -68.88 -13.93 62.72 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.747 1.018 . . . . 0.0 113.747 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.38 -21.94 59.42 Favored 'General case' 0 C--N 1.349 0.55 0 CA-C-N 119.942 1.247 . . . . 0.0 112.647 174.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.6 p -104.9 -13.46 9.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 125.604 1.562 . . . . 0.0 111.785 170.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 90.68 20.3 41.02 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.83 1.681 . . . . 0.0 113.24 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 12.9 mt -73.45 157.82 36.12 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 118.873 1.336 . . . . 0.0 111.382 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 69.0 p -131.52 -1.33 3.9 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.293 1.837 . . . . 0.0 111.403 176.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 60.5 p -145.23 175.69 10.09 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.551 2.34 . . . . 0.0 108.956 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -119.13 125.44 27.62 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 123.946 0.899 . . . . 0.0 109.515 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -76.17 -171.09 0.98 Allowed 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 124.513 3.475 . . . . 0.0 111.127 174.026 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -148.3 138.72 22.75 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.187 0.995 . . . . 0.0 109.34 178.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 102.58 -62.23 0.48 Allowed Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.919 1.723 . . . . 0.0 112.065 173.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -148.74 142.27 25.37 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 125.475 1.51 . . . . 0.0 110.306 -178.47 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . 0.404 ' CH2' ' HA ' ' A' ' 239' ' ' CYS . 77.6 t90 -150.73 154.02 36.6 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 126.223 1.809 . . . . 0.0 109.834 171.793 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -128.42 127.51 42.7 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.054 1.342 . . . . 0.0 109.919 -177.135 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . 0.404 ' HA ' ' CH2' ' A' ' 237' ' ' TRP . 0.5 OUTLIER -65.62 167.54 10.75 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 124.79 1.236 . . . . 0.0 113.311 -177.115 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -74.29 -0.65 9.92 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.507 2.138 . . . . 0.0 114.19 -174.2 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 35.0 mtp180 -123.9 27.39 7.25 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.02 1.328 . . . . 0.0 111.322 168.662 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 10.3 m -131.67 -14.89 3.16 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 126.357 1.863 . . . . 0.0 112.224 173.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 41.9 t -149.17 -34.82 0.19 Allowed 'General case' 0 C--N 1.345 0.402 0 CA-C-N 118.994 0.815 . . . . 0.0 112.704 174.868 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -75.27 -12.98 60.39 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -176.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -66.52 -9.14 31.75 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.936 0.789 . . . . 0.0 112.75 169.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 56.1 ttt180 -75.33 -20.87 58.81 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.564 1.146 . . . . 0.0 112.423 173.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -142.74 63.24 1.39 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.459 1.503 . . . . 0.0 109.947 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -62.72 139.43 58.67 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.986 0.915 . . . . 0.0 110.118 174.522 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 26.3 tptp . . . . . 0 C--O 1.251 1.162 0 CA-C-O 116.589 -1.672 . . . . 0.0 110.44 -173.943 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 60.1 ttm . . . . . 0 N--CA 1.476 0.837 0 CA-C-O 119.476 -0.297 . . . . 0.0 110.565 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -147.89 -176.19 5.17 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.498 1.519 . . . . 0.0 110.383 -174.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 25.7 ttt 50.26 68.47 3.39 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 125.999 1.72 . . . . 0.0 112.016 -175.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -80.65 45.39 1.97 Allowed 'Trans proline' 0 CA--C 1.547 1.158 0 C-N-CA 125.23 3.953 . . . . 0.0 112.866 -172.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 2.7 m -125.79 109.97 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 125.739 1.616 . . . . 0.0 108.999 -177.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -70.46 156.6 91.66 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 125.016 1.326 . . . . 0.0 112.262 -177.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -73.28 2.71 5.33 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 123.956 3.104 . . . . 0.0 113.08 170.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -70.97 81.38 0.66 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.658 1.983 . . . . 0.0 110.367 177.587 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -152.37 138.39 11.72 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 125.544 1.537 . . . . 0.0 108.307 -170.766 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -71.46 152.55 60.37 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.765 2.31 . . . . 0.0 111.693 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 80.4 p -144.41 172.76 12.5 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.767 1.227 . . . . 0.0 110.377 -175.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -136.38 -81.18 0.39 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 117.511 -1.233 . . . . 0.0 113.076 -169.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.8 t -55.43 166.55 0.61 Allowed 'General case' 0 C--N 1.35 0.594 0 C-N-CA 125.161 1.385 . . . . 0.0 112.871 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 4.7 pp -59.52 -9.72 2.78 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.543 1.137 . . . . 0.0 112.873 170.115 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 73.3 m -77.06 -20.87 55.3 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.694 1.997 . . . . 0.0 113.052 174.82 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 13.3 m170 59.2 62.55 1.8 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.881 2.072 . . . . 0.0 111.499 -173.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.31 160.43 32.21 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.269 1.428 . . . . 0.0 112.409 176.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.472 HG11 ' H ' ' A' ' 205' ' ' SER . 0.3 OUTLIER -69.2 -179.62 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 126.366 1.866 . . . . 0.0 111.718 -176.325 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.472 ' H ' HG11 ' A' ' 204' ' ' VAL . 80.4 p -45.67 150.16 0.53 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.873 2.469 . . . . 0.0 114.329 178.125 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . 0.4 ' CE2' ' CD2' ' A' ' 223' ' ' HIS . 10.1 p90 -155.37 168.69 26.28 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.767 1.627 . . . . 0.0 110.875 -167.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -76.04 -43.68 21.04 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 118.676 -1.069 . . . . 0.0 115.101 -168.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -127.73 121.78 31.18 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 118.425 1.113 . . . . 0.0 110.784 -169.454 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -143.76 146.74 33.36 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -165.762 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 13.6 tt -143.7 154.9 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 125.8 1.64 . . . . 0.0 109.346 168.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -136.23 147.01 19.0 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 123.741 0.686 . . . . 0.0 112.299 -169.621 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 6.1 t -70.12 144.47 52.05 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-O 122.179 0.99 . . . . 0.0 111.058 -174.015 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -79.14 -5.94 55.34 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.763 2.025 . . . . 0.0 113.671 -174.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 60.6 m-20 -82.22 145.48 52.51 Favored Pre-proline 0 CA--C 1.535 0.404 0 CA-C-N 118.81 0.732 . . . . 0.0 111.464 -169.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -76.74 6.28 4.24 Favored 'Trans proline' 0 CA--C 1.547 1.133 0 C-N-CA 123.544 2.829 . . . . 0.0 111.702 167.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -124.18 -9.23 7.61 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.301 1.841 . . . . 0.0 112.502 -172.303 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 43.9 t -64.92 133.6 52.17 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.239 1.016 . . . . 0.0 109.893 175.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 37.9 m -110.39 8.39 23.25 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.531 1.532 . . . . 0.0 111.845 -174.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 33.3 mm -119.83 -33.06 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 126.256 1.822 . . . . 0.0 109.446 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 50.14 -15.7 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.659 1 C-N-CA 131.757 4.023 . . . . 0.0 119.338 177.118 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 58.3 m95 -140.47 152.14 45.4 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.795 1.638 . . . . 0.0 110.437 178.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -153.07 154.95 35.91 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.333 1.453 . . . . 0.0 110.015 -173.039 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . 0.4 ' CD2' ' CE2' ' A' ' 206' ' ' TYR . 19.5 m170 -77.71 149.75 34.56 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 170.599 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -53.71 -50.75 65.22 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.634 167.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -69.91 -14.82 62.91 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 118.296 -0.859 . . . . 0.0 113.229 -177.342 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 7.4 m -78.85 -6.46 56.12 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 119.667 1.122 . . . . 0.0 112.858 173.146 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.3 p -121.17 -12.58 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 125.864 1.666 . . . . 0.0 112.065 169.28 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 92.96 19.86 35.3 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.524 1.535 . . . . 0.0 113.313 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 6.2 mt -72.51 158.29 36.0 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 118.397 1.098 . . . . 0.0 111.082 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 68.7 p -134.14 1.9 3.28 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.195 1.798 . . . . 0.0 111.263 176.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 81.9 p -142.95 179.89 6.76 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.051 2.141 . . . . 0.0 109.664 -175.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -121.65 89.55 47.63 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 124.603 1.161 . . . . 0.0 109.055 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.65 169.04 18.29 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.801 2.334 . . . . 0.0 111.304 174.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -140.02 133.7 30.39 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 124.917 1.287 . . . . 0.0 108.564 -177.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 126.46 -169.59 18.38 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 126.319 1.914 . . . . 0.0 110.277 -169.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.95 130.4 43.91 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 122.093 0.949 . . . . 0.0 109.195 169.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 53.0 t90 -136.74 146.63 46.03 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 127.072 2.149 . . . . 0.0 108.312 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -129.97 131.65 46.0 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.678 1.191 . . . . 0.0 109.637 -173.549 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 1.5 p -68.78 166.68 24.9 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 124.27 1.028 . . . . 0.0 112.074 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.37 9.43 2.52 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.539 2.159 . . . . 0.0 114.57 -175.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -122.79 15.93 10.17 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.512 1.925 . . . . 0.0 110.856 171.062 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 30.1 m -133.19 -22.76 1.98 Allowed 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.962 1.705 . . . . 0.0 113.111 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.1 t -153.71 -34.07 0.11 Allowed 'General case' 0 C--N 1.346 0.426 0 CA-C-N 119.724 1.147 . . . . 0.0 113.501 173.6 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 10.7 tp60 -76.03 -8.05 56.08 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.928 0.785 . . . . 0.0 112.006 176.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -67.83 -26.37 66.02 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.057 1.343 . . . . 0.0 111.628 169.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -75.85 163.24 27.42 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.356 1.462 . . . . 0.0 110.087 171.066 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 27.3 tptt -110.44 104.73 13.51 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.393 1.077 . . . . 0.0 108.557 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt 43.78 72.62 0.18 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.671 1.988 . . . . 0.0 112.302 -170.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? . . . . . 0 C--O 1.25 1.108 0 CA-C-O 116.704 -1.617 . . . . 0.0 110.789 175.966 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 47.9 ttp . . . . . 0 N--CA 1.474 0.736 0 CA-C-O 121.273 0.558 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -73.67 110.24 7.81 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.505 1.522 . . . . 0.0 110.329 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' MET . . . . . 0.492 ' H ' ' HD2' ' A' ' 190' ' ' PRO . 54.2 mtm -146.0 -49.4 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.659 0 CA-C-O 116.85 -1.548 . . . . 0.0 111.922 177.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . 0.492 ' HD2' ' H ' ' A' ' 189' ' ' MET . 87.3 Cg_endo -77.18 -12.25 17.47 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 122.152 1.901 . . . . 0.0 112.92 174.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 14.4 p -158.01 158.25 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 127.102 2.161 . . . . 0.0 107.831 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -56.42 158.46 7.88 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 126.388 1.875 . . . . 0.0 112.367 173.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -72.15 11.55 0.73 Allowed 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 123.777 2.985 . . . . 0.0 112.896 169.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -129.96 111.3 12.4 Favored 'General case' 0 C--N 1.343 0.31 0 C-N-CA 126.509 1.924 . . . . 0.0 107.642 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -149.47 131.22 7.52 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.762 1.225 . . . . 0.0 108.803 -177.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.99 151.61 35.36 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.982 2.455 . . . . 0.0 111.431 176.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 49.0 p -143.31 173.14 11.86 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.573 1.549 . . . . 0.0 109.108 -177.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -139.46 -67.29 0.45 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.83 0.852 . . . . 0.0 111.782 -173.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . 0.428 ' SG ' ' HB2' ' A' ' 201' ' ' CYS . 4.6 p -59.37 165.15 2.89 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 128.484 2.714 . . . . 0.0 113.595 176.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 2.9 pp -77.66 -0.36 26.37 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.595 167.454 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . 0.428 ' HB2' ' SG ' ' A' ' 199' ' ' CYS . 74.2 m -76.78 -28.22 55.58 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.889 0.875 . . . . 0.0 110.226 168.377 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . 0.293 93.4 m-70 72.45 52.2 0.17 Allowed 'General case' 0 C--N 1.342 0.242 0 C-N-CA 127.828 2.451 . . . . 0.0 113.84 169.001 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -136.85 173.61 11.51 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.528 1.131 . . . . 0.0 109.864 166.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.443 HG11 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -62.55 174.49 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 125.238 1.415 . . . . 0.0 111.813 -176.17 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.443 ' H ' HG11 ' A' ' 204' ' ' VAL . 80.5 p -47.94 157.44 0.28 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.516 2.326 . . . . 0.0 114.899 -175.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -142.36 163.2 33.49 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.82 1.648 . . . . 0.0 110.984 -168.583 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -61.3 -42.31 99.74 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.824 1.202 . . . . 0.0 114.37 -169.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -127.98 124.12 36.47 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.462 1.105 . . . . 0.0 110.116 -178.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 1.6 mtm -138.42 145.63 41.2 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.003 -168.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 21.4 tt -137.06 144.67 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 125.126 1.37 . . . . 0.0 110.53 172.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -120.24 139.68 13.92 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 125.238 1.399 . . . . 0.0 112.241 -171.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . 0.576 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 1.2 m -80.0 123.88 28.21 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.737 1.615 . . . . 0.0 111.451 -167.657 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.25 14.48 1.19 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.256 1.422 . . . . 0.0 112.458 -175.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -74.23 148.77 86.58 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 124.295 1.038 . . . . 0.0 111.484 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -84.92 8.92 4.37 Favored 'Trans proline' 0 CA--C 1.551 1.347 0 C-N-CA 123.342 2.695 . . . . 0.0 110.944 165.116 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -134.58 -16.71 2.03 Favored 'General case' 0 C--N 1.351 0.631 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -168.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 28.2 t -65.59 135.6 55.29 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 123.594 0.758 . . . . 0.0 111.119 -172.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 10.2 t -110.77 12.08 22.48 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.726 1.61 . . . . 0.0 111.588 -174.482 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 34.0 mm -122.06 -40.96 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 125.758 1.623 . . . . 0.0 108.852 174.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 48.36 -7.75 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 131.424 3.89 . . . . 0.0 119.435 172.203 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 49.3 m95 -140.49 140.31 35.28 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 126.904 2.082 . . . . 0.0 110.211 169.58 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . 0.576 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 8.4 m-85 -148.93 153.4 37.93 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 125.441 1.496 . . . . 0.0 109.141 -169.935 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -66.73 151.75 46.81 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 166.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 12.2 m-30 -51.19 -50.82 58.29 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.757 166.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.07 -12.38 61.56 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -178.651 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 1.9 t -67.63 -18.12 64.85 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.821 0.737 . . . . 0.0 112.588 172.132 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.4 p -121.3 -15.61 6.8 Favored 'Isoleucine or valine' 0 C--N 1.345 0.396 0 C-N-CA 126.039 1.736 . . . . 0.0 112.396 175.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 102.32 17.33 20.27 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.693 1.616 . . . . 0.0 113.653 178.127 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 20.3 mt -71.32 158.63 36.01 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.244 1.522 . . . . 0.0 111.414 177.101 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 71.2 m -136.12 -23.44 1.32 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.727 1.611 . . . . 0.0 111.135 -177.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 92.2 m -140.04 137.13 34.35 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 125.957 1.703 . . . . 0.0 107.264 176.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 55.4 tttm -67.72 125.51 91.38 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-O 118.871 -0.585 . . . . 0.0 110.954 -173.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -77.84 -170.09 0.89 Allowed 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 124.151 3.234 . . . . 0.0 111.191 173.567 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 17.5 tpp180 -142.78 138.98 30.81 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.134 1.374 . . . . 0.0 108.118 178.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 81.32 -159.46 41.03 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.552 1.072 . . . . 0.0 112.754 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 27.6 mttp -50.65 120.72 4.96 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 126.753 2.021 . . . . 0.0 112.848 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . 0.427 ' CZ2' ' HA ' ' A' ' 239' ' ' CYS . 62.7 t90 -138.48 138.47 38.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.239 1.816 . . . . 0.0 109.012 173.89 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -120.53 127.39 52.13 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.707 1.203 . . . . 0.0 108.405 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . 0.427 ' HA ' ' CZ2' ' A' ' 237' ' ' TRP . 14.7 p -59.25 172.51 0.58 Allowed Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 127.851 2.46 . . . . 0.0 114.334 -173.811 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 43.1 Cg_endo -64.2 -38.64 34.7 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 121.658 1.572 . . . . 0.0 113.14 -168.045 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 66.0 mtt85 -88.02 20.53 3.09 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.42 1.009 . . . . 0.0 112.554 177.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 16.7 m -131.3 -10.4 3.69 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 126.316 1.846 . . . . 0.0 113.344 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 22.7 t -157.08 -39.59 0.07 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.144 0.884 . . . . 0.0 113.147 174.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -75.2 -15.04 60.58 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.537 0.735 . . . . 0.0 112.525 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -153.02 141.5 20.76 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 128.26 2.624 . . . . 0.0 106.026 -175.351 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 18.0 ttp180 -101.01 34.54 2.47 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.191 0.997 . . . . 0.0 111.776 -169.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -59.87 -30.71 69.17 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.7 1.6 . . . . 0.0 113.16 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 16.2 ttpp -150.8 50.42 0.86 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.702 1.201 . . . . 0.0 109.893 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp . . . . . 0 C--O 1.25 1.09 0 CA-C-O 116.199 -1.858 . . . . 0.0 111.204 -177.143 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 23.5 mmt . . . . . 0 N--CA 1.478 0.938 0 N-CA-C 110.788 -0.079 . . . . 0.0 110.788 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 54.31 29.26 10.49 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.552 1.541 . . . . 0.0 113.32 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 93.8 mtp -69.81 153.79 95.24 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 125.42 1.488 . . . . 0.0 111.695 -173.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -80.84 30.79 0.51 Allowed 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 124.789 3.66 . . . . 0.0 113.63 -174.618 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 2.5 m -121.98 97.59 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 125.545 1.538 . . . . 0.0 109.619 -175.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -69.8 156.79 91.12 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 125.207 1.403 . . . . 0.0 111.882 178.456 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -72.6 0.31 7.75 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 123.807 3.005 . . . . 0.0 113.055 170.719 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -71.49 80.11 0.79 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.643 1.977 . . . . 0.0 110.369 177.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -151.1 137.11 11.01 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 125.141 1.377 . . . . 0.0 108.776 -170.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.28 159.89 46.13 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.979 2.452 . . . . 0.0 112.657 -176.209 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 34.7 p -144.77 172.98 12.25 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.094 1.757 . . . . 0.0 109.284 -177.843 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -139.04 -54.1 0.58 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . 0.443 ' SG ' ' HB2' ' A' ' 201' ' ' CYS . 2.4 p -68.82 165.62 19.33 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 128.431 2.693 . . . . 0.0 113.272 178.491 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.5 pp -71.94 -5.62 36.07 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.77 166.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . 0.443 ' HB2' ' SG ' ' A' ' 199' ' ' CYS . 74.8 m -78.07 -29.09 48.97 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.807 1.243 . . . . 0.0 110.831 173.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . 0.303 90.9 m-70 71.09 54.86 0.23 Allowed 'General case' 0 C--N 1.34 0.167 0 C-N-CA 127.529 2.332 . . . . 0.0 113.391 169.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -136.6 171.37 14.59 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.44 -1.254 . . . . 0.0 109.697 166.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.446 HG11 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -64.97 175.97 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 125.274 1.43 . . . . 0.0 112.105 -173.18 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.446 ' H ' HG11 ' A' ' 204' ' ' VAL . 20.3 m -43.39 152.78 0.12 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 128.421 2.689 . . . . 0.0 115.569 -173.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -147.63 157.05 43.38 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.59 1.556 . . . . 0.0 110.497 -172.001 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -65.75 -38.53 94.54 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.432 1.015 . . . . 0.0 115.095 -169.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 26.8 pt-20 -119.33 122.08 41.05 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 118.164 0.982 . . . . 0.0 110.345 -174.758 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 14.6 mtp -141.84 141.14 33.09 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -167.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 16.8 tt -144.17 151.53 16.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 125.817 1.647 . . . . 0.0 109.636 169.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -138.29 145.98 17.61 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 123.874 0.75 . . . . 0.0 112.629 -169.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 6.5 t -69.88 145.78 51.74 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-O 122.228 1.013 . . . . 0.0 111.182 -172.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -81.29 -6.5 58.95 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.713 2.005 . . . . 0.0 113.442 -175.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -78.78 146.08 67.94 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 118.696 0.68 . . . . 0.0 111.568 -169.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.95 6.71 4.03 Favored 'Trans proline' 0 CA--C 1.547 1.172 0 C-N-CA 123.58 2.853 . . . . 0.0 111.718 167.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -126.72 -7.71 6.18 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.137 1.775 . . . . 0.0 112.628 -172.173 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 39.0 t -66.02 133.39 50.69 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.074 0.95 . . . . 0.0 109.791 174.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 50.2 m -112.1 10.47 20.32 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.639 1.576 . . . . 0.0 111.708 -174.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 22.0 mm -120.32 -33.62 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 125.905 1.682 . . . . 0.0 109.472 175.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 50.33 -10.21 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 130.624 3.57 . . . . 0.0 118.917 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 54.9 m95 -144.5 156.9 44.39 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.395 1.478 . . . . 0.0 111.83 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -158.88 154.35 25.88 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.362 1.865 . . . . 0.0 109.377 -176.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 44.3 m80 -69.37 154.51 41.91 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 166.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 13.9 m-30 -52.33 -50.68 61.82 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 166.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -69.5 -13.08 62.15 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 4.8 t -69.16 -19.1 64.0 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.646 0.778 . . . . 0.0 112.476 172.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.0 p -114.82 -21.52 5.3 Favored 'Isoleucine or valine' 0 C--N 1.347 0.466 0 C-N-CA 125.605 1.562 . . . . 0.0 112.275 172.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 105.71 17.95 12.46 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 126.029 1.776 . . . . 0.0 113.752 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 13.5 mt -71.76 162.53 29.31 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.271 1.536 . . . . 0.0 111.854 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 36.0 m -138.42 -24.81 0.95 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.348 1.459 . . . . 0.0 111.417 -176.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 46.2 p -139.15 140.59 37.93 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.681 1.592 . . . . 0.0 108.432 176.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -78.14 119.22 76.53 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 123.413 0.685 . . . . 0.0 112.03 -169.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -81.21 175.93 9.27 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.692 2.928 . . . . 0.0 111.015 169.21 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 13.5 ttp85 -145.0 134.78 23.54 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 124.035 0.934 . . . . 0.0 109.019 172.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 127.38 -165.07 20.65 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.807 1.67 . . . . 0.0 111.136 -175.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.72 120.91 10.99 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 124.203 1.001 . . . . 0.0 109.686 171.272 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 58.5 t90 -138.56 144.29 39.8 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 127.257 2.223 . . . . 0.0 108.482 175.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -120.27 135.85 54.86 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.468 1.107 . . . . 0.0 109.309 -178.101 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -67.46 168.78 10.72 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 124.279 1.031 . . . . 0.0 111.72 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.38 -36.09 28.59 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.108 1.205 . . . . 0.0 112.681 -172.137 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 67.6 mtt-85 -75.55 0.06 18.67 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.373 1.069 . . . . 0.0 113.405 175.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 24.7 m -115.06 -21.27 10.1 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.029 1.331 . . . . 0.0 113.821 -176.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.1 t -151.22 -28.14 0.2 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.545 1.066 . . . . 0.0 113.56 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -76.57 -13.54 60.07 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.903 0.774 . . . . 0.0 112.299 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -71.59 -10.46 59.8 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.706 0.803 . . . . 0.0 112.54 169.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -81.66 28.97 0.39 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.986 1.315 . . . . 0.0 111.833 173.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -58.0 -19.35 30.34 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.26 1.824 . . . . 0.0 113.627 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -76.86 76.57 3.46 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.164 1.386 . . . . 0.0 109.746 169.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 56.0 tttp . . . . . 0 C--O 1.252 1.212 0 C-N-CA 127.177 2.191 . . . . 0.0 112.158 -173.268 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 20.8 ptp . . . . . 0 N--CA 1.478 0.931 0 CA-C-O 121.948 0.88 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -79.2 155.86 28.44 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.692 1.197 . . . . 0.0 111.761 -172.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 17.6 ptm -149.01 76.26 9.58 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 124.857 1.263 . . . . 0.0 109.593 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -77.19 29.95 0.42 Allowed 'Trans proline' 0 CA--C 1.548 1.218 0 C-N-CA 124.754 3.636 . . . . 0.0 112.865 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 2.8 m -135.33 122.67 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 126.539 1.936 . . . . 0.0 108.978 -171.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -77.34 157.27 80.75 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 125.089 1.355 . . . . 0.0 111.711 178.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -73.42 0.84 7.48 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.82 3.013 . . . . 0.0 113.07 170.034 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -71.33 83.5 0.77 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.789 2.035 . . . . 0.0 110.268 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -151.52 137.56 11.26 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 125.361 1.464 . . . . 0.0 108.592 -171.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.95 154.02 52.9 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.893 2.396 . . . . 0.0 111.78 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 68.0 p -146.57 175.02 10.89 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.743 1.217 . . . . 0.0 110.66 -174.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -137.61 -83.66 0.32 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 117.337 -1.316 . . . . 0.0 112.588 -170.463 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.1 t -55.67 168.21 0.45 Allowed 'General case' 0 C--N 1.352 0.692 0 CA-C-N 119.844 1.202 . . . . 0.0 113.336 -177.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.1 pp -57.49 -12.73 2.87 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.882 1.273 . . . . 0.0 112.861 170.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 71.7 m -76.82 -19.87 57.04 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.899 2.079 . . . . 0.0 113.275 176.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 22.3 m170 57.86 64.01 1.65 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.907 2.083 . . . . 0.0 111.543 -173.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.77 157.61 40.97 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.124 1.37 . . . . 0.0 112.561 175.484 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.484 HG11 ' H ' ' A' ' 205' ' ' SER . 0.4 OUTLIER -68.57 -178.72 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 126.45 1.9 . . . . 0.0 111.325 -177.873 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.484 ' H ' HG11 ' A' ' 204' ' ' VAL . 49.8 m -42.35 145.65 0.38 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 128.012 2.525 . . . . 0.0 113.472 177.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . 0.414 ' CE2' ' HG2' ' A' ' 209' ' ' MET . 13.2 p90 -152.03 165.31 35.07 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.837 1.255 . . . . 0.0 111.935 -167.605 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -67.98 -47.91 57.25 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.76 1.172 . . . . 0.0 115.018 -168.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -127.8 125.38 39.72 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 118.401 1.1 . . . . 0.0 109.849 -170.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' MET . . . . . 0.414 ' HG2' ' CE2' ' A' ' 206' ' ' TYR . 9.1 mtp -140.47 147.9 40.32 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -166.312 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 17.0 tt -135.05 155.68 38.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 125.843 1.657 . . . . 0.0 109.557 168.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -132.73 139.18 10.72 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.668 1.127 . . . . 0.0 112.45 -172.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . 0.592 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 1.8 m -79.51 127.12 31.75 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 125.487 1.515 . . . . 0.0 112.19 -167.674 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -70.22 -3.61 17.81 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.35 1.86 . . . . 0.0 113.692 -175.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -67.77 146.95 98.61 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 123.547 0.739 . . . . 0.0 111.469 -174.825 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.83 5.65 6.18 Favored 'Trans proline' 0 CA--C 1.55 1.3 0 C-N-CA 123.138 2.559 . . . . 0.0 111.372 166.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -134.13 -13.51 2.42 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 125.21 1.404 . . . . 0.0 114.381 -169.45 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 36.8 t -63.72 132.57 51.43 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 118.973 0.806 . . . . 0.0 110.335 -176.702 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 69.7 m -109.29 11.72 25.17 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 113.637 -1.62 . . . . 0.0 111.602 -173.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 39.4 mm -119.3 -41.35 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 125.838 1.655 . . . . 0.0 108.604 173.177 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 47.67 -9.47 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.832 1 C-N-CA 131.717 4.007 . . . . 0.0 119.725 171.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -139.83 135.95 33.51 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.744 2.017 . . . . 0.0 109.197 172.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . 0.592 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 6.4 m-85 -143.47 155.82 44.47 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.376 1.471 . . . . 0.0 109.53 -169.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 21.9 m80 -73.55 148.62 42.84 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 168.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 16.8 m-30 -52.19 -51.11 60.11 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.751 167.057 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.19 -14.34 62.59 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -177.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 2.8 m -78.12 -8.56 58.42 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 119.76 1.164 . . . . 0.0 112.777 173.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.7 p -119.07 -14.08 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 126.009 1.724 . . . . 0.0 112.198 169.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 96.8 17.4 33.01 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.693 1.616 . . . . 0.0 113.306 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 12.5 mt -71.55 160.37 32.81 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.582 1.191 . . . . 0.0 111.272 176.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 16.0 m -134.03 -1.4 2.98 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.998 1.719 . . . . 0.0 110.37 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 9.3 t -150.58 177.11 10.35 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.284 1.834 . . . . 0.0 109.674 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -108.92 105.67 57.54 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 124.305 1.042 . . . . 0.0 109.391 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.48 175.52 10.53 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.221 2.614 . . . . 0.0 111.435 173.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -140.1 133.57 30.06 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 124.856 1.262 . . . . 0.0 108.229 173.428 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 124.24 -175.89 16.95 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 126.156 1.836 . . . . 0.0 110.845 -170.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -66.69 131.65 46.43 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.996 0.903 . . . . 0.0 110.368 173.605 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . 0.406 ' CZ2' ' HA ' ' A' ' 239' ' ' CYS . 52.8 t90 -136.99 141.55 42.57 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 127.011 2.125 . . . . 0.0 108.779 177.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -124.5 127.38 47.37 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.467 1.107 . . . . 0.0 108.828 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . 0.406 ' HA ' ' CZ2' ' A' ' 237' ' ' TRP . 6.2 p -60.73 167.57 3.29 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 126.465 1.906 . . . . 0.0 113.299 -173.251 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 33.4 Cg_endo -65.33 -30.3 53.94 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.491 1.461 . . . . 0.0 112.809 -170.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 53.7 mtt-85 -86.96 13.58 8.87 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.302 1.041 . . . . 0.0 112.747 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 20.1 m -131.01 -14.03 3.51 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.159 1.784 . . . . 0.0 113.518 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 32.1 t -149.33 -39.47 0.15 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.72 0.808 . . . . 0.0 112.414 -178.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -82.09 -11.38 58.8 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -175.15 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -69.11 -8.48 45.74 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.92 0.888 . . . . 0.0 112.717 172.164 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -63.2 104.56 0.6 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.463 1.505 . . . . 0.0 110.724 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt 50.09 29.4 3.53 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.858 2.063 . . . . 0.0 113.926 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -154.44 143.37 21.01 Favored 'General case' 0 C--N 1.343 0.324 0 C-N-CA 124.73 1.212 . . . . 0.0 109.737 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 83.3 tttt . . . . . 0 C--O 1.251 1.15 0 C-N-CA 124.754 1.222 . . . . 0.0 108.619 169.009 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 20.8 mmt . . . . . 0 N--CA 1.475 0.809 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -140.98 5.79 1.95 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.957 1.303 . . . . 0.0 111.683 -169.473 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 89.8 mtp -146.65 159.66 43.54 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 126.512 1.925 . . . . 0.0 109.421 -176.179 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -74.34 14.81 0.7 Allowed 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 124.172 3.248 . . . . 0.0 113.517 175.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.15 137.43 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 126.712 2.005 . . . . 0.0 108.782 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -66.1 161.44 55.93 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 126.343 1.857 . . . . 0.0 111.875 175.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -70.28 -7.4 21.13 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 123.084 2.523 . . . . 0.0 112.212 168.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -88.18 38.59 0.86 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.089 2.156 . . . . 0.0 111.068 178.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 28.8 tp10 -143.03 129.35 10.46 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 125.689 1.596 . . . . 0.0 108.103 -170.895 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -70.57 159.04 54.14 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.016 2.477 . . . . 0.0 112.063 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 72.9 p -144.23 175.96 9.69 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.904 1.281 . . . . 0.0 110.453 -174.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -136.66 -80.68 0.39 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 117.275 -1.345 . . . . 0.0 113.213 -171.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 3.1 t -55.97 167.81 0.55 Allowed 'General case' 0 C--N 1.35 0.609 0 CA-C-N 119.963 1.256 . . . . 0.0 113.115 -176.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.9 pp -59.4 -10.06 2.89 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.417 1.087 . . . . 0.0 112.717 169.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 75.2 m -77.04 -21.86 53.86 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.658 1.983 . . . . 0.0 113.19 174.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 54.29 68.83 0.79 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.752 2.021 . . . . 0.0 111.629 -170.068 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.9 160.6 33.06 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.688 1.595 . . . . 0.0 111.468 173.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.499 HG11 ' H ' ' A' ' 205' ' ' SER . 0.6 OUTLIER -70.29 -178.94 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 125.62 1.568 . . . . 0.0 111.142 -178.158 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.499 ' H ' HG11 ' A' ' 204' ' ' VAL . 28.3 m -46.34 151.05 0.56 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 128.093 2.557 . . . . 0.0 114.348 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -154.17 168.47 26.41 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.351 1.46 . . . . 0.0 111.413 -169.263 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -70.61 -50.85 23.4 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.379 0.99 . . . . 0.0 114.651 -169.004 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -125.53 122.34 36.29 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 118.091 0.945 . . . . 0.0 110.297 -170.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -144.09 147.01 33.19 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -166.433 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 16.2 tt -142.04 152.77 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 125.47 1.508 . . . . 0.0 109.783 169.146 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -132.35 147.01 18.65 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 124.051 0.834 . . . . 0.0 112.456 -169.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 7.0 t -71.2 143.4 50.48 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-O 122.019 0.914 . . . . 0.0 111.369 -172.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -79.36 -8.98 59.48 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.786 2.034 . . . . 0.0 114.193 -176.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -74.39 144.03 80.51 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 119.458 1.027 . . . . 0.0 111.041 -174.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -75.63 6.02 3.92 Favored 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 123.471 2.781 . . . . 0.0 111.802 168.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -124.89 -6.19 7.36 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.533 1.933 . . . . 0.0 112.28 -173.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 49.8 t -63.7 133.42 53.55 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.899 0.879 . . . . 0.0 109.703 174.385 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 10.4 t -114.75 11.24 16.75 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.644 1.578 . . . . 0.0 111.611 -174.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 33.0 mm -120.25 -31.97 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 126.229 1.812 . . . . 0.0 109.411 176.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 50.36 -13.81 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 131.539 3.936 . . . . 0.0 119.204 176.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 58.2 m95 -143.62 152.53 41.49 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.645 1.578 . . . . 0.0 110.755 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -154.33 150.87 28.43 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.376 1.471 . . . . 0.0 110.473 -174.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -71.59 150.17 44.96 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.26 0.552 . . . . 0.0 109.816 168.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 11.4 m-30 -53.49 -51.28 63.29 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.469 167.247 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.82 -12.85 61.48 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 1.7 m -76.56 -12.31 60.0 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.771 1.169 . . . . 0.0 112.299 172.449 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.56 -15.46 9.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 126.172 1.789 . . . . 0.0 112.185 171.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 95.07 20.43 28.1 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.792 1.663 . . . . 0.0 113.663 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 20.4 mt -71.49 157.98 37.06 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.987 1.394 . . . . 0.0 111.407 177.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 91.4 m -131.41 -25.09 2.21 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.828 1.651 . . . . 0.0 110.772 -177.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 61.1 p -138.73 150.85 46.59 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.182 1.793 . . . . 0.0 108.271 172.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -79.77 119.34 76.44 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-O 118.533 -0.746 . . . . 0.0 110.756 -174.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -76.67 165.92 28.02 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 122.922 2.415 . . . . 0.0 110.39 169.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -138.03 130.92 29.9 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-O 122.195 0.997 . . . . 0.0 109.06 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 127.82 -165.9 20.68 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 126.757 2.123 . . . . 0.0 109.407 -168.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.92 142.7 54.67 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 122.469 1.128 . . . . 0.0 109.771 169.614 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 55.0 t90 -147.31 146.15 29.61 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 127.254 2.222 . . . . 0.0 108.203 -177.438 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -124.13 137.2 54.58 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.421 1.089 . . . . 0.0 110.197 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -69.08 169.91 10.25 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 125.186 1.394 . . . . 0.0 112.581 -177.31 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -74.51 1.04 7.89 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.398 2.066 . . . . 0.0 114.506 -175.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -117.63 16.72 14.52 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.53 1.932 . . . . 0.0 110.883 172.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 22.2 m -134.39 -16.99 2.07 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.367 1.867 . . . . 0.0 112.744 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 32.8 t -154.01 -40.91 0.09 Allowed 'General case' 0 C--N 1.345 0.377 0 CA-C-N 118.975 0.807 . . . . 0.0 112.775 175.622 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -74.82 -6.16 47.49 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -71.36 4.41 2.96 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.186 1.795 . . . . 0.0 112.671 173.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 52.7 ttm-85 -142.99 154.54 44.12 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.793 2.037 . . . . 0.0 109.437 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -132.13 40.04 3.37 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.855 1.662 . . . . 0.0 110.41 -176.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -149.86 130.13 13.72 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.343 1.457 . . . . 0.0 108.555 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 59.3 tttm . . . . . 0 C--O 1.25 1.091 0 CA-C-O 115.961 -1.971 . . . . 0.0 111.589 -169.97 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 98.5 mtp . . . . . 0 N--CA 1.477 0.879 0 CA-C-O 119.393 -0.337 . . . . 0.0 110.451 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -60.83 149.65 35.32 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.822 1.249 . . . . 0.0 112.195 176.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 53.3 mtt -146.8 87.8 6.19 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 125.59 1.556 . . . . 0.0 107.884 176.729 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.72 -11.59 32.29 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.094 2.529 . . . . 0.0 112.849 175.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 12.7 p -153.83 151.55 11.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 127.186 2.195 . . . . 0.0 107.479 169.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -64.63 151.48 92.0 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 124.504 1.121 . . . . 0.0 111.707 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.16 8.54 2.07 Favored 'Trans proline' 0 CA--C 1.546 1.109 0 C-N-CA 123.894 3.063 . . . . 0.0 112.526 169.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -116.73 37.33 3.82 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.633 1.973 . . . . 0.0 110.543 -173.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -138.95 111.05 7.96 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 125.192 1.397 . . . . 0.0 108.83 -169.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.09 159.76 49.17 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.899 2.399 . . . . 0.0 111.719 177.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 66.0 p -143.69 175.02 10.29 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.009 1.324 . . . . 0.0 110.188 -176.482 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -133.98 -83.83 0.44 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 117.293 -1.337 . . . . 0.0 113.05 -169.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.4 t -55.28 170.19 0.23 Allowed 'General case' 0 C--N 1.351 0.651 0 C-N-CA 124.948 1.299 . . . . 0.0 113.901 -175.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.3 pp -58.38 -14.12 6.87 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.32 1.048 . . . . 0.0 112.605 169.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 75.2 m -75.79 -23.66 55.9 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.029 2.132 . . . . 0.0 112.895 174.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 53.08 69.42 0.7 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 127.434 2.294 . . . . 0.0 112.156 -171.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.46 160.63 28.99 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.091 1.756 . . . . 0.0 111.37 172.844 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.51 HG12 ' H ' ' A' ' 205' ' ' SER . 0.8 OUTLIER -69.24 -178.67 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 125.705 1.602 . . . . 0.0 110.883 -178.875 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.51 ' H ' HG12 ' A' ' 204' ' ' VAL . 85.8 p -44.3 148.2 0.47 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.566 2.347 . . . . 0.0 113.713 178.263 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -152.44 168.96 23.78 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.723 1.209 . . . . 0.0 112.168 -167.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -69.11 -53.05 20.23 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.807 1.194 . . . . 0.0 114.743 -168.905 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -125.07 125.64 44.12 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 118.271 1.036 . . . . 0.0 109.711 -172.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -142.55 145.54 33.71 Favored 'General case' 0 C--N 1.34 0.169 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -166.781 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 20.6 tt -134.8 150.77 30.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 125.705 1.602 . . . . 0.0 109.644 173.159 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -128.59 139.06 10.73 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 124.528 1.061 . . . . 0.0 112.576 -171.597 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . 0.6 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 5.5 m -75.11 125.78 29.66 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 125.362 1.465 . . . . 0.0 111.325 -168.356 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -70.03 -4.04 19.09 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.495 1.518 . . . . 0.0 113.452 -177.541 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -68.02 145.6 97.81 Favored Pre-proline 0 CA--C 1.538 0.518 0 O-C-N 121.544 -0.723 . . . . 0.0 110.905 -175.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -80.92 8.32 4.39 Favored 'Trans proline' 0 CA--C 1.549 1.258 0 C-N-CA 123.049 2.499 . . . . 0.0 111.296 166.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -133.81 -14.06 2.47 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 125.21 1.404 . . . . 0.0 114.323 -169.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.5 t -65.29 134.33 53.36 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 123.721 0.809 . . . . 0.0 110.699 -176.207 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 96.6 p -107.27 7.97 29.61 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.972 1.709 . . . . 0.0 112.188 -173.736 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 37.5 mm -118.95 -41.03 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 125.815 1.646 . . . . 0.0 108.676 177.164 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 48.16 -8.55 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 131.461 3.904 . . . . 0.0 119.697 170.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 61.7 m95 -141.28 137.43 32.48 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.781 2.032 . . . . 0.0 109.625 171.513 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . 0.6 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 6.9 m-85 -145.46 156.96 44.06 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 125.738 1.615 . . . . 0.0 109.69 -169.634 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 33.1 m80 -73.97 149.07 41.55 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 167.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -51.7 -52.03 51.43 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.746 167.124 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.78 -13.82 62.19 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -177.139 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 2.1 m -77.54 -11.13 59.82 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.785 1.175 . . . . 0.0 112.594 173.554 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 10.6 p -116.09 -16.47 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 125.799 1.64 . . . . 0.0 112.134 170.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 102.27 14.87 27.15 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.781 1.657 . . . . 0.0 113.395 177.804 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 26.0 mt -72.89 160.06 32.73 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.828 1.314 . . . . 0.0 110.928 175.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 67.4 p -131.71 -7.96 3.6 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.833 1.653 . . . . 0.0 111.598 177.234 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 73.8 p -144.73 166.2 25.9 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.006 2.122 . . . . 0.0 108.766 177.256 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -90.21 121.17 68.93 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-O 118.821 -0.609 . . . . 0.0 109.497 175.281 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -75.91 178.94 6.78 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.569 2.846 . . . . 0.0 110.78 169.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -141.59 132.55 26.03 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 170.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 120.69 -170.88 14.55 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 126.06 1.79 . . . . 0.0 110.166 -168.856 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.5 144.98 53.04 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 122.252 1.025 . . . . 0.0 110.849 174.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . 0.437 ' CZ2' ' HA ' ' A' ' 239' ' ' CYS . 60.2 t90 -145.93 138.96 25.88 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.994 2.118 . . . . 0.0 109.406 177.753 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 14.4 m-30 -118.4 131.91 56.27 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.717 1.207 . . . . 0.0 109.261 175.044 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . 0.437 ' HA ' ' CZ2' ' A' ' 237' ' ' TRP . 4.0 p -63.32 173.23 1.25 Allowed Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 127.61 2.364 . . . . 0.0 114.675 -174.195 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -72.87 -3.33 13.4 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.815 2.343 . . . . 0.0 114.858 -171.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -111.61 13.62 21.26 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.589 1.555 . . . . 0.0 111.234 174.034 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 39.0 m -135.94 -16.0 1.73 Allowed 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.565 1.946 . . . . 0.0 113.234 -174.338 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 46.6 t -150.98 -41.6 0.12 Allowed 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.763 0.825 . . . . 0.0 112.446 177.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -71.71 -23.43 61.63 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.012 0.369 . . . . 0.0 111.527 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -65.19 -7.67 13.82 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.547 1.939 . . . . 0.0 113.42 175.364 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 31.7 ttt-85 -127.37 23.85 6.33 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.29 1.436 . . . . 0.0 111.032 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -130.86 -21.65 2.7 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.272 1.829 . . . . 0.0 111.539 176.897 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -154.11 147.32 24.77 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.347 1.459 . . . . 0.0 109.436 177.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? . . . . . 0 C--O 1.253 1.287 0 C-N-CA 124.667 1.187 . . . . 0.0 108.718 169.324 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 99.8 mtp . . . . . 0 N--CA 1.476 0.856 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -163.83 170.38 16.93 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.403 1.481 . . . . 0.0 110.035 -169.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 42.06 65.85 4.54 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 126.448 1.899 . . . . 0.0 112.614 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -74.41 77.78 2.83 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 124.877 3.718 . . . . 0.0 111.917 -173.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 192' ' ' ASP . 9.5 p -153.26 -174.74 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 127.161 2.184 . . . . 0.0 107.546 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . 0.402 ' H ' HG22 ' A' ' 191' ' ' VAL . 9.5 m-20 -52.87 153.55 5.86 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 126.131 1.772 . . . . 0.0 112.698 176.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -71.46 5.98 2.12 Favored 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 123.889 3.059 . . . . 0.0 112.992 172.205 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -106.2 62.61 0.65 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.737 2.015 . . . . 0.0 108.985 -176.172 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -132.86 106.57 12.69 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 125.068 1.347 . . . . 0.0 108.361 -172.375 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -75.04 157.13 42.79 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.65 2.233 . . . . 0.0 110.587 174.653 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 80.4 p -141.68 172.22 12.98 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.47 1.108 . . . . 0.0 110.005 -177.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -134.47 -83.97 0.43 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 117.316 -1.325 . . . . 0.0 112.885 -168.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 1.9 t -55.17 168.5 0.33 Allowed 'General case' 0 C--N 1.351 0.667 0 C-N-CA 124.957 1.303 . . . . 0.0 113.274 -176.564 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.2 pp -57.05 -12.42 2.08 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.23 1.412 . . . . 0.0 113.145 170.404 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 71.3 m -78.76 -18.94 53.38 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.593 1.957 . . . . 0.0 113.208 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 23.3 m170 57.32 62.21 2.26 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.874 2.069 . . . . 0.0 111.663 -173.053 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.65 158.75 33.95 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.022 1.329 . . . . 0.0 112.435 176.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.478 HG11 ' H ' ' A' ' 205' ' ' SER . 0.3 OUTLIER -69.17 -179.4 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 126.355 1.862 . . . . 0.0 111.366 -176.976 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.478 ' H ' HG11 ' A' ' 204' ' ' VAL . 79.5 p -45.37 147.62 0.77 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.42 2.288 . . . . 0.0 113.911 178.316 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -154.08 173.54 15.9 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.537 1.535 . . . . 0.0 111.223 -167.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -80.96 -71.36 1.29 Allowed Glycine 0 CA--C 1.528 0.893 0 C-N-CA 123.831 0.729 . . . . 0.0 112.959 -170.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -91.84 120.4 32.51 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 123.632 0.773 . . . . 0.0 111.117 -174.284 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -142.02 143.86 33.36 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -168.611 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 19.8 tt -134.97 150.36 29.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 125.541 1.537 . . . . 0.0 109.939 172.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -127.99 139.29 10.99 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.788 1.185 . . . . 0.0 112.641 -171.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . 0.592 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 1.9 m -78.75 126.12 30.29 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.582 1.553 . . . . 0.0 111.802 -168.078 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.39 -2.36 10.77 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.58 1.952 . . . . 0.0 113.808 -175.601 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -66.49 149.98 97.63 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 123.769 0.828 . . . . 0.0 112.12 -174.264 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -83.76 7.76 5.01 Favored 'Trans proline' 0 CA--C 1.549 1.262 0 C-N-CA 123.725 2.95 . . . . 0.0 111.342 166.613 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -144.39 -10.86 0.63 Allowed 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 -167.531 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 36.7 t -60.93 134.09 56.74 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 119.465 1.03 . . . . 0.0 110.468 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.5 t -110.47 14.24 22.57 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.762 1.625 . . . . 0.0 111.124 -173.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 51.7 mt -122.75 -41.97 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 125.327 1.451 . . . . 0.0 108.577 172.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 47.63 -8.59 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 131.351 3.861 . . . . 0.0 119.552 172.117 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 62.3 m95 -139.62 136.07 33.98 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 126.497 1.919 . . . . 0.0 109.603 170.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . 0.592 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 7.2 m-85 -142.49 158.69 43.42 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 125.572 1.549 . . . . 0.0 109.179 -169.17 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -78.45 148.14 33.68 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 169.75 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -51.74 -51.37 56.68 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.937 167.789 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.84 -13.23 61.62 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -176.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 4.8 m -78.29 -8.1 57.99 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.81 1.186 . . . . 0.0 112.608 172.648 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.8 p -120.9 -12.68 8.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 126.319 1.847 . . . . 0.0 112.185 170.815 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 94.28 18.24 36.98 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.693 1.616 . . . . 0.0 113.4 178.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 19.4 mt -72.05 158.34 36.13 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.749 1.275 . . . . 0.0 111.327 176.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 59.7 m -134.86 -18.38 1.86 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.782 1.633 . . . . 0.0 111.145 -177.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 62.7 m -144.33 139.62 28.63 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 125.692 1.597 . . . . 0.0 107.82 178.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -70.58 122.6 87.1 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 123.519 0.727 . . . . 0.0 110.836 -176.218 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -81.48 -179.8 5.21 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.769 2.979 . . . . 0.0 111.617 173.08 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -139.62 135.82 33.71 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.031 1.332 . . . . 0.0 107.475 169.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 116.54 -174.61 15.32 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.405 1.478 . . . . 0.0 111.747 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -62.34 122.72 16.38 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.883 1.273 . . . . 0.0 111.09 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . 0.401 ' CZ2' ' HA ' ' A' ' 239' ' ' CYS . 44.7 t90 -132.98 143.02 49.17 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 127.201 2.2 . . . . 0.0 108.6 178.089 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -126.92 126.77 43.81 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.564 1.146 . . . . 0.0 109.003 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . 0.401 ' HA ' ' CZ2' ' A' ' 237' ' ' TRP . 5.8 p -61.23 169.08 2.38 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 126.857 2.063 . . . . 0.0 114.007 -172.05 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 57.5 Cg_endo -72.44 1.48 6.14 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.559 2.173 . . . . 0.0 115.221 -171.068 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 38.3 mtp180 -117.42 17.58 14.55 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.224 1.41 . . . . 0.0 112.106 170.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 31.7 m -133.52 -14.0 2.57 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.434 1.894 . . . . 0.0 112.763 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 33.0 t -147.87 -33.06 0.26 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.058 0.943 . . . . 0.0 112.195 177.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -86.8 -13.48 44.99 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -173.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -72.04 -0.76 12.49 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 119.443 1.02 . . . . 0.0 112.531 169.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -63.47 122.86 17.3 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 168.427 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt 48.65 56.14 8.04 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.381 1.473 . . . . 0.0 112.11 -169.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -55.76 138.04 48.57 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.606 1.162 . . . . 0.0 109.598 172.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.158 0 C-N-CA 126.015 1.726 . . . . 0.0 109.838 -167.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 93.0 mtp . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -155.33 131.1 9.91 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.306 1.043 . . . . 0.0 109.432 172.661 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 18.8 ptm -160.55 91.11 1.66 Allowed Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 125.072 1.349 . . . . 0.0 108.774 172.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -74.44 10.95 1.39 Allowed 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 123.755 2.97 . . . . 0.0 113.171 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 10.6 m -138.52 154.01 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 C-N-CA 127.999 2.519 . . . . 0.0 108.22 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -64.48 156.84 75.57 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 125.379 1.472 . . . . 0.0 111.809 175.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -71.9 -7.35 20.93 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 123.155 2.57 . . . . 0.0 112.041 168.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -93.6 72.55 4.33 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.878 2.071 . . . . 0.0 108.734 179.295 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -142.98 128.19 10.02 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.905 1.282 . . . . 0.0 108.351 -169.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -70.94 155.59 61.77 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.942 2.428 . . . . 0.0 111.978 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 65.6 p -146.04 176.39 9.75 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.864 1.266 . . . . 0.0 110.536 -173.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -135.34 -83.59 0.41 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 117.508 -1.234 . . . . 0.0 112.707 -169.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.0 t -55.88 167.81 0.54 Allowed 'General case' 0 C--N 1.351 0.66 0 CA-C-N 119.741 1.155 . . . . 0.0 113.129 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 2.9 pp -57.66 -12.66 3.05 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.92 1.288 . . . . 0.0 112.768 171.105 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 74.6 m -76.64 -19.65 57.56 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.544 1.938 . . . . 0.0 113.214 176.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 29.9 m170 56.8 64.52 1.64 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.729 2.011 . . . . 0.0 111.396 -172.251 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.41 156.98 39.71 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.231 1.412 . . . . 0.0 112.13 174.577 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.521 HG11 ' H ' ' A' ' 205' ' ' SER . 0.9 OUTLIER -69.61 -178.21 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 126.114 1.766 . . . . 0.0 110.916 -178.39 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.521 ' H ' HG11 ' A' ' 204' ' ' VAL . 88.0 p -45.51 148.77 0.64 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.53 2.332 . . . . 0.0 113.964 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -154.97 173.67 16.22 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.276 1.43 . . . . 0.0 111.346 -167.64 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -80.75 -73.2 1.18 Allowed Glycine 0 C--N 1.341 0.852 0 C-N-CA 123.877 0.751 . . . . 0.0 112.784 -171.005 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -88.54 119.44 29.0 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.597 0.759 . . . . 0.0 111.238 -176.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -142.52 143.77 32.66 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -169.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 21.3 tt -136.53 152.0 28.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 125.729 1.612 . . . . 0.0 109.706 173.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -129.5 139.23 10.8 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.514 1.054 . . . . 0.0 112.914 -172.004 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . 0.602 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 7.3 m -75.77 127.74 33.68 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.898 1.679 . . . . 0.0 111.548 -168.57 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -71.02 -1.86 13.52 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.973 1.709 . . . . 0.0 113.591 -177.157 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -67.02 148.15 98.94 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 123.661 0.784 . . . . 0.0 111.523 -175.377 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -82.43 8.05 4.77 Favored 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 123.592 2.861 . . . . 0.0 111.631 167.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -144.16 -9.87 0.67 Allowed 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -167.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.8 t -62.39 133.47 55.1 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 119.607 1.094 . . . . 0.0 110.443 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 9.4 t -106.21 4.65 29.13 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.705 1.602 . . . . 0.0 111.687 -173.439 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 42.8 mm -112.18 -42.32 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 125.736 1.614 . . . . 0.0 108.777 175.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 48.82 -11.15 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 131.556 3.943 . . . . 0.0 119.597 171.544 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -138.8 137.82 36.99 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.778 2.031 . . . . 0.0 109.387 170.838 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . 0.602 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 7.3 m-85 -144.39 157.08 44.44 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.527 1.531 . . . . 0.0 109.654 -169.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 47.0 m80 -74.46 149.75 40.21 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 167.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 10.0 m-30 -51.4 -52.81 42.71 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.727 167.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.47 -12.44 61.39 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 118.253 -0.88 . . . . 0.0 113.253 -176.395 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 2.0 m -77.43 -8.49 57.81 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.759 1.163 . . . . 0.0 112.5 172.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.6 p -121.77 -14.08 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 126.082 1.753 . . . . 0.0 112.514 170.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 98.66 16.53 31.12 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 125.856 1.693 . . . . 0.0 113.513 178.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 19.6 mt -71.49 162.17 29.87 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.908 1.354 . . . . 0.0 111.66 177.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.7 t -139.22 -14.5 1.14 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.51 1.524 . . . . 0.0 112.512 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 59.7 m -146.86 139.54 25.05 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.019 1.728 . . . . 0.0 107.287 177.189 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -69.35 119.5 70.86 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-O 118.721 -0.657 . . . . 0.0 110.55 -177.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -78.29 174.63 12.13 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.463 2.776 . . . . 0.0 110.67 170.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 30.1 ttp-105 -143.16 130.98 21.49 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 121.923 0.868 . . . . 0.0 108.795 170.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 126.4 -174.38 17.96 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 126.343 1.925 . . . . 0.0 110.409 -169.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -66.4 128.84 37.73 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.18 0.992 . . . . 0.0 110.761 175.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 54.8 t90 -135.74 145.01 46.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 127.304 2.242 . . . . 0.0 109.134 178.168 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -130.6 124.8 32.54 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.691 1.196 . . . . 0.0 109.6 -176.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . 0.4 ' HB3' ' SG ' ' A' ' 212' ' ' CYS . 1.9 p -61.25 172.92 0.81 Allowed Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 128.1 2.56 . . . . 0.0 114.835 -171.474 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -76.06 12.82 1.4 Allowed 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.608 2.872 . . . . 0.0 115.365 -171.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 35.8 mtp180 -125.53 13.82 8.15 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.716 1.606 . . . . 0.0 111.058 169.055 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 66.6 m -135.73 -22.28 1.45 Allowed 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.939 1.695 . . . . 0.0 113.714 -174.448 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 27.8 t -151.65 -42.08 0.11 Allowed 'General case' 0 C--N 1.342 0.278 0 CA-C-N 119.004 0.82 . . . . 0.0 112.614 175.526 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 7.7 tm0? -77.25 -13.85 59.86 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 119.337 -0.363 . . . . 0.0 111.65 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -58.65 -27.72 65.03 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.842 1.257 . . . . 0.0 113.18 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 95.1 mtm-85 -77.92 4.29 12.4 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.406 1.483 . . . . 0.0 113.314 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -138.64 -36.87 0.55 Allowed 'General case' 0 C--N 1.344 0.347 0 C-N-CA 124.288 1.035 . . . . 0.0 112.177 -173.1 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 25.1 tptt -159.78 175.82 12.68 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.828 0.851 . . . . 0.0 110.981 176.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.147 0 C-N-CA 126.16 1.784 . . . . 0.0 107.339 178.058 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 21.6 ptp . . . . . 0 N--CA 1.478 0.94 0 CA-C-O 118.46 -0.781 . . . . 0.0 112.708 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -139.18 154.79 48.11 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.725 1.21 . . . . 0.0 110.246 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.94 158.94 31.49 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 125.213 1.405 . . . . 0.0 110.39 -175.504 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -67.74 149.39 78.67 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.743 2.295 . . . . 0.0 110.586 169.689 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . 0.306 2.8 m 51.92 153.76 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 130.002 3.321 . . . . 0.0 115.751 -169.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -64.93 154.27 86.63 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.919 179.027 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -74.79 8.35 2.38 Favored 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 123.631 2.887 . . . . 0.0 112.231 169.124 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -119.65 38.53 3.87 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.97 2.108 . . . . 0.0 110.012 -176.132 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -125.74 99.22 32.79 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 125.365 1.466 . . . . 0.0 108.674 -169.538 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -73.08 159.56 47.41 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.128 2.552 . . . . 0.0 111.554 -178.388 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 67.6 p -145.07 173.6 11.77 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.578 1.151 . . . . 0.0 110.715 -175.015 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -136.79 -83.27 0.36 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 117.355 -1.307 . . . . 0.0 112.565 -170.231 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.0 t -55.6 168.21 0.44 Allowed 'General case' 0 C--N 1.351 0.641 0 C-N-CA 125.013 1.325 . . . . 0.0 113.378 -176.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.0 pp -57.45 -12.69 2.79 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.079 1.352 . . . . 0.0 113.031 170.511 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 72.7 m -77.17 -19.9 56.17 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.461 1.904 . . . . 0.0 113.223 176.301 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 21.8 m170 57.75 63.92 1.69 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.868 2.067 . . . . 0.0 111.565 -172.11 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.22 158.13 38.96 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.079 1.352 . . . . 0.0 112.496 175.585 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.506 HG12 ' H ' ' A' ' 205' ' ' SER . 0.9 OUTLIER -67.83 -179.1 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 126.389 1.876 . . . . 0.0 111.144 -177.82 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.506 ' H ' HG12 ' A' ' 204' ' ' VAL . 88.3 p -46.31 150.17 0.66 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.562 2.345 . . . . 0.0 113.84 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . 0.434 ' CE2' ' HG2' ' A' ' 209' ' ' MET . 18.3 p90 -155.55 164.87 38.09 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.127 1.371 . . . . 0.0 111.227 -167.512 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -73.8 -49.44 13.85 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 118.666 -1.074 . . . . 0.0 114.814 -169.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -117.2 121.33 40.92 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 118.478 1.139 . . . . 0.0 110.362 -170.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' MET . . . . . 0.434 ' HG2' ' CE2' ' A' ' 206' ' ' TYR . 2.8 mtp -140.48 148.66 41.46 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -166.255 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 14.5 tt -136.91 156.55 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 125.57 1.548 . . . . 0.0 109.32 168.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -133.75 139.18 10.68 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.488 1.042 . . . . 0.0 112.4 -171.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . 0.586 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 1.1 m -79.61 125.99 30.32 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.191 1.397 . . . . 0.0 112.233 -167.605 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -69.37 -4.96 20.49 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.598 1.959 . . . . 0.0 113.888 -175.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -66.43 145.65 98.98 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.424 0.689 . . . . 0.0 111.396 -173.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -81.92 9.21 4.04 Favored 'Trans proline' 0 CA--C 1.551 1.343 0 C-N-CA 123.074 2.516 . . . . 0.0 110.946 165.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -134.41 -15.56 2.17 Favored 'General case' 0 C--N 1.35 0.614 0 C-N-CA 125.407 1.483 . . . . 0.0 114.365 -169.271 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 35.6 t -65.05 136.13 56.39 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 123.905 0.882 . . . . 0.0 110.611 -175.915 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.4 t -113.07 14.57 19.59 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.721 1.608 . . . . 0.0 111.217 -174.274 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 51.3 mt -123.2 -42.34 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 125.363 1.465 . . . . 0.0 108.71 173.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 47.28 -7.59 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 131.453 3.901 . . . . 0.0 119.59 171.534 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 66.1 m95 -139.0 134.84 33.6 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.466 1.907 . . . . 0.0 109.259 170.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . 0.586 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 7.8 m-85 -142.01 157.09 45.34 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.362 1.465 . . . . 0.0 109.075 -169.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -77.0 148.6 36.15 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 169.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 14.4 m-30 -51.92 -51.62 55.69 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.89 167.441 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.51 -14.18 62.41 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.387 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 6.5 m -79.38 -6.67 57.32 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 119.748 1.158 . . . . 0.0 112.766 173.247 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.9 p -120.87 -12.62 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 125.965 1.706 . . . . 0.0 112.113 169.62 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 96.31 16.87 36.07 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.509 1.528 . . . . 0.0 113.317 178.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 13.7 mt -71.82 159.46 34.27 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.581 1.191 . . . . 0.0 111.068 175.71 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 24.4 m -133.17 -5.52 3.04 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.115 1.766 . . . . 0.0 110.41 177.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 80.1 p -142.51 179.62 6.85 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.815 2.046 . . . . 0.0 109.398 -178.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -112.33 97.32 39.18 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 124.232 1.013 . . . . 0.0 109.528 178.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -70.6 167.73 24.71 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.425 2.084 . . . . 0.0 110.255 169.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -140.69 131.72 26.22 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.981 0.896 . . . . 0.0 109.084 175.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 138.88 -173.43 22.62 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 126.577 2.037 . . . . 0.0 109.688 -169.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -70.83 126.99 31.11 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.729 0.776 . . . . 0.0 109.68 170.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 39.0 t90 -133.51 144.58 49.5 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.864 2.066 . . . . 0.0 108.493 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -126.21 131.2 52.02 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.568 1.147 . . . . 0.0 108.935 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 3.7 p -61.82 167.04 5.08 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 126.106 1.763 . . . . 0.0 112.63 -175.616 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.77 -36.41 32.19 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.026 1.15 . . . . 0.0 112.097 -170.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 60.8 mtt-85 -78.31 10.93 2.66 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.496 1.119 . . . . 0.0 112.907 178.708 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 19.1 m -129.37 -13.56 4.36 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.431 1.892 . . . . 0.0 113.883 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 35.7 t -149.77 -42.43 0.14 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.884 0.766 . . . . 0.0 112.561 -176.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 47.3 tp60 -75.2 -18.43 60.15 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 118.494 -0.765 . . . . 0.0 112.834 -177.415 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -63.11 -22.18 66.69 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.371 0.987 . . . . 0.0 111.709 172.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -86.38 15.32 5.48 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.84 1.256 . . . . 0.0 112.609 175.638 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -137.77 -67.93 0.47 Allowed 'General case' 0 C--N 1.345 0.405 0 C-N-CA 125.307 1.443 . . . . 0.0 109.001 175.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -165.19 92.34 0.56 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.496 1.518 . . . . 0.0 109.369 176.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? . . . . . 0 C--O 1.249 1.071 0 C-N-CA 128.249 2.62 . . . . 0.0 114.901 175.958 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 76.3 mtm . . . . . 0 N--CA 1.476 0.844 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -159.7 170.06 22.35 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.156 1.382 . . . . 0.0 110.273 -169.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -62.75 144.97 96.18 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 123.925 0.89 . . . . 0.0 111.921 -178.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.62 117.26 4.71 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.112 2.541 . . . . 0.0 110.119 174.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 2.4 m -142.66 129.76 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 C-N-CA 125.562 1.545 . . . . 0.0 108.595 177.586 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -76.96 156.4 82.35 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 124.583 1.153 . . . . 0.0 111.327 177.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -72.98 0.34 7.94 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.759 2.972 . . . . 0.0 113.04 170.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -71.92 80.8 0.91 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.75 2.02 . . . . 0.0 110.529 178.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -151.53 138.66 12.14 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 125.569 1.548 . . . . 0.0 108.282 -172.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -70.66 154.89 63.9 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.796 2.33 . . . . 0.0 112.063 -178.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 64.4 p -144.43 175.22 10.28 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.067 1.347 . . . . 0.0 110.327 -174.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -134.4 -81.26 0.45 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 117.328 -1.32 . . . . 0.0 113.26 -170.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.9 t -54.77 167.09 0.4 Allowed 'General case' 0 C--N 1.35 0.594 0 C-N-CA 125.078 1.351 . . . . 0.0 113.174 -176.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 4.2 pp -60.17 -11.0 5.11 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.207 1.003 . . . . 0.0 112.715 169.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 72.3 m -74.38 -24.0 59.07 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.551 1.94 . . . . 0.0 112.906 172.377 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 54.63 69.65 0.7 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 127.291 2.236 . . . . 0.0 111.925 -170.268 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.6 162.21 27.82 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.832 1.653 . . . . 0.0 111.689 173.219 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.455 HG11 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -70.28 -177.9 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 126.04 1.736 . . . . 0.0 111.686 -176.469 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.455 ' H ' HG11 ' A' ' 204' ' ' VAL . 40.5 m -44.34 150.34 0.32 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 128.2 2.6 . . . . 0.0 114.497 177.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -158.06 170.27 22.67 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.034 1.733 . . . . 0.0 110.553 -169.394 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -78.38 -66.52 1.73 Allowed Glycine 0 CA--C 1.529 0.956 0 CA-C-O 119.438 -0.645 . . . . 0.0 113.149 -170.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -100.54 122.41 43.19 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 123.684 0.794 . . . . 0.0 110.745 -173.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -144.11 146.52 32.85 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -167.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 13.7 tt -144.01 153.96 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 125.006 1.322 . . . . 0.0 109.922 169.116 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -132.81 145.47 17.42 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 123.97 0.795 . . . . 0.0 112.01 -170.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 4.2 t -70.07 142.76 52.63 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.971 0.891 . . . . 0.0 110.863 -173.599 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -78.32 -5.43 52.11 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.109 1.764 . . . . 0.0 113.57 -174.232 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 -80.77 144.63 56.28 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 118.816 0.734 . . . . 0.0 111.231 -169.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -75.67 4.84 4.73 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 123.564 2.843 . . . . 0.0 112.071 168.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -122.95 -6.61 8.44 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.214 1.806 . . . . 0.0 112.358 -173.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 36.7 t -65.25 136.5 56.68 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.305 1.042 . . . . 0.0 109.782 174.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 8.7 t -119.05 10.75 12.24 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.83 1.652 . . . . 0.0 111.248 -175.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 35.5 mm -118.64 -32.82 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 126.197 1.799 . . . . 0.0 109.261 175.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 50.02 -13.64 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.617 1 C-N-CA 131.769 4.028 . . . . 0.0 119.378 175.669 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 63.1 m95 -143.1 152.03 41.38 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.89 1.676 . . . . 0.0 110.365 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -154.05 154.66 34.08 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.555 1.542 . . . . 0.0 109.885 -172.258 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -77.47 148.8 35.18 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 170.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -52.62 -51.55 59.52 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.782 168.02 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.69 -13.25 61.68 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 118.325 -0.845 . . . . 0.0 113.261 -177.104 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 5.3 m -78.23 -6.11 53.94 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 119.713 1.142 . . . . 0.0 112.633 172.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 6.2 p -121.86 -16.77 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 125.659 1.584 . . . . 0.0 112.232 169.8 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 99.79 17.85 24.53 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.776 1.655 . . . . 0.0 113.667 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 18.9 mt -71.15 158.0 37.19 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 119.01 1.405 . . . . 0.0 111.104 177.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 90.0 m -134.53 -22.97 1.67 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.692 1.597 . . . . 0.0 110.973 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 48.6 p -140.73 143.57 35.07 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.91 1.684 . . . . 0.0 108.455 174.714 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -70.05 126.19 92.32 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-O 118.688 -0.672 . . . . 0.0 110.573 -176.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -76.57 -172.42 1.39 Allowed 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 123.813 3.009 . . . . 0.0 111.278 171.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -144.28 139.14 28.41 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 124.816 1.246 . . . . 0.0 108.466 176.246 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 97.23 -170.32 25.83 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.357 1.456 . . . . 0.0 111.675 -172.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -57.79 138.4 55.63 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.885 1.274 . . . . 0.0 111.177 175.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 52.6 t90 -142.25 153.8 44.23 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 127.301 2.24 . . . . 0.0 109.032 -177.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -130.71 132.76 45.55 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.853 1.261 . . . . 0.0 110.59 -174.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -67.08 167.35 14.71 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.232 1.013 . . . . 0.0 111.651 177.071 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.73 -27.0 27.16 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.303 1.335 . . . . 0.0 113.354 -172.707 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -87.3 9.8 19.23 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.435 1.094 . . . . 0.0 112.369 174.821 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 17.3 m -126.38 -17.58 5.12 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.565 1.546 . . . . 0.0 113.784 -176.111 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 33.8 t -152.97 -36.1 0.11 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.542 1.065 . . . . 0.0 112.959 174.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -68.49 -19.7 64.55 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 118.292 0.496 . . . . 0.0 112.134 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -60.15 -22.2 62.58 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.009 1.323 . . . . 0.0 112.326 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -61.17 -22.24 64.54 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.826 1.65 . . . . 0.0 113.437 177.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -139.28 -9.79 1.27 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.265 1.026 . . . . 0.0 113.638 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -150.78 110.33 4.02 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-N 119.139 0.881 . . . . 0.0 110.218 -178.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 8.4 tmtm? . . . . . 0 C--O 1.252 1.233 0 C-N-CA 125.197 1.399 . . . . 0.0 109.156 169.433 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 94.1 mtp . . . . . 0 N--CA 1.477 0.924 0 CA-C-O 121.09 0.471 . . . . 0.0 111.248 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -138.78 20.93 2.68 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.617 1.967 . . . . 0.0 110.961 -171.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 64.7 mtt -133.91 157.59 77.41 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 125.336 1.455 . . . . 0.0 110.623 -168.163 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -77.23 23.47 0.53 Allowed 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 124.553 3.502 . . . . 0.0 113.599 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 3.4 m -132.2 135.73 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 126.617 1.967 . . . . 0.0 108.551 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -69.37 161.27 74.77 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 125.973 1.709 . . . . 0.0 111.905 176.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -71.72 -8.35 22.96 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 123.014 2.476 . . . . 0.0 111.735 167.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 61.7 m-80 -89.01 40.58 0.99 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 127.452 2.301 . . . . 0.0 110.822 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 27.2 tp10 -140.14 127.86 12.73 Favored Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 125.672 1.589 . . . . 0.0 107.95 -170.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -70.49 156.69 60.91 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.87 2.38 . . . . 0.0 111.942 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 71.2 p -144.49 175.43 10.13 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.902 1.281 . . . . 0.0 110.54 -172.106 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -136.57 -79.62 0.4 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 117.215 -1.374 . . . . 0.0 113.095 -170.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -56.31 169.09 0.45 Allowed 'General case' 0 C--N 1.349 0.572 0 CA-C-N 120.013 1.279 . . . . 0.0 113.403 -175.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 4.6 pp -57.95 -11.13 2.15 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.897 1.279 . . . . 0.0 113.147 169.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 71.6 m -78.66 -23.3 45.81 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 126.927 2.091 . . . . 0.0 113.416 176.261 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 33.7 m170 59.02 66.61 1.03 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.473 1.909 . . . . 0.0 110.835 -169.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.1 160.84 32.5 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.823 1.249 . . . . 0.0 112.247 174.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.51 HG11 ' H ' ' A' ' 205' ' ' SER . 0.6 OUTLIER -69.05 -179.26 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 126.125 1.77 . . . . 0.0 111.355 -175.994 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.51 ' H ' HG11 ' A' ' 204' ' ' VAL . 84.8 p -47.91 153.65 0.61 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.82 2.448 . . . . 0.0 114.689 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -154.87 169.16 24.66 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.223 1.809 . . . . 0.0 110.484 -169.18 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -79.52 -40.4 15.57 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.673 -1.07 . . . . 0.0 115.29 -168.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.12 119.0 21.29 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 118.57 1.185 . . . . 0.0 110.137 -168.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -142.08 152.37 43.24 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -164.197 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 15.7 tt -148.49 153.23 11.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 126.091 1.756 . . . . 0.0 109.516 167.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -131.99 146.45 18.07 Favored Glycine 0 C--N 1.336 0.529 0 C-N-CA 124.267 0.937 . . . . 0.0 111.634 -170.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 3.9 t -70.29 140.84 52.38 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-O 121.941 0.876 . . . . 0.0 111.042 -171.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -76.87 -5.09 46.99 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.311 1.844 . . . . 0.0 113.842 -174.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -78.45 147.59 72.22 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 118.846 0.748 . . . . 0.0 111.633 -169.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.51 8.42 2.99 Favored 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 124.135 3.223 . . . . 0.0 112.589 169.398 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -133.32 -9.53 2.91 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.011 1.724 . . . . 0.0 112.394 -169.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.9 t -61.22 133.91 56.44 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.932 0.893 . . . . 0.0 109.845 173.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 68.6 m -119.83 14.9 12.56 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.921 1.688 . . . . 0.0 111.171 -175.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 37.6 mm -119.99 -32.39 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 126.739 2.016 . . . . 0.0 109.164 174.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 51.51 -15.68 0.0 OUTLIER 'General case' 0 C--N 1.35 0.587 1 C-N-CA 131.955 4.102 . . . . 0.0 119.305 173.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -143.01 151.04 40.4 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.64 1.576 . . . . 0.0 110.587 178.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -153.01 155.24 36.54 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.782 1.233 . . . . 0.0 110.418 -173.248 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -79.29 146.74 32.8 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 169.34 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -53.47 -48.78 68.58 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.463 168.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.07 -14.85 62.86 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.77 -13.54 60.3 Favored 'General case' 0 C--N 1.348 0.535 0 CA-C-N 119.712 1.142 . . . . 0.0 112.711 173.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.7 p -115.04 -13.33 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 126.014 1.725 . . . . 0.0 111.801 172.126 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 91.65 20.11 38.52 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 125.869 1.7 . . . . 0.0 113.49 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 12.0 mt -75.36 160.06 30.73 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-N 118.747 1.273 . . . . 0.0 111.801 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 91.1 m -133.87 -20.2 1.99 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.862 1.665 . . . . 0.0 111.131 -177.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 89.3 m -142.03 135.74 29.54 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 125.577 1.551 . . . . 0.0 107.906 178.079 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -70.55 115.69 37.8 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 125.208 1.403 . . . . 0.0 111.545 -176.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -79.87 162.17 23.89 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.025 2.483 . . . . 0.0 110.049 168.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 65.4 ttp85 -150.34 136.7 18.8 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-O 121.891 0.853 . . . . 0.0 110.232 -178.489 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 136.86 -61.84 0.6 Allowed Glycine 0 CA--C 1.529 0.906 0 C-N-CA 127.347 2.403 . . . . 0.0 108.758 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -161.54 145.68 12.94 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 126.614 1.966 . . . . 0.0 108.514 168.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 68.4 t90 -146.89 153.16 39.81 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 125.838 1.655 . . . . 0.0 109.417 -177.295 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -128.89 128.95 44.84 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.856 1.263 . . . . 0.0 110.037 -175.078 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.17 168.39 7.78 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 124.526 1.131 . . . . 0.0 112.246 178.044 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.91 -28.89 35.42 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 121.347 1.365 . . . . 0.0 112.684 -174.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 26.5 mtp180 -88.19 13.36 11.55 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.54 1.136 . . . . 0.0 112.877 175.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 16.1 m -129.28 -15.74 4.08 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.707 1.603 . . . . 0.0 113.364 -178.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 35.9 t -151.67 -33.28 0.14 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.077 0.853 . . . . 0.0 112.991 175.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -74.26 -13.97 60.85 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 118.872 0.76 . . . . 0.0 112.684 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -68.17 -5.21 16.84 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 119.231 0.923 . . . . 0.0 112.912 169.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -68.58 -22.74 64.44 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.585 1.154 . . . . 0.0 112.016 169.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -146.59 71.82 1.26 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.336 1.454 . . . . 0.0 108.965 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.17 143.75 57.52 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.644 1.178 . . . . 0.0 111.036 178.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 96.5 mttt . . . . . 0 C--O 1.251 1.176 0 C-N-CA 125.727 1.611 . . . . 0.0 109.125 177.983 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.475 0.821 0 CA-C-O 119.328 -0.368 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -137.98 164.38 29.19 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.471 1.508 . . . . 0.0 110.459 -177.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 5.5 ptp -154.3 56.35 1.5 Allowed Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.371 1.068 . . . . 0.0 111.797 -169.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.98 -47.21 3.82 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.044 2.496 . . . . 0.0 112.964 -173.699 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 2.1 m -155.67 153.56 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 128.022 2.529 . . . . 0.0 108.539 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -73.89 160.17 82.51 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 124.93 1.292 . . . . 0.0 110.698 168.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -74.86 15.5 0.71 Allowed 'Trans proline' 0 CA--C 1.55 1.276 0 C-N-CA 123.726 2.951 . . . . 0.0 112.16 168.428 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -126.07 -158.96 0.88 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.761 2.424 . . . . 0.0 108.535 -177.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -142.65 130.68 11.39 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 125.495 1.518 . . . . 0.0 108.684 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -74.73 153.46 43.24 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.102 2.535 . . . . 0.0 111.104 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 69.3 p -144.89 173.66 11.68 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.512 1.125 . . . . 0.0 110.67 -176.082 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -135.09 -76.92 0.45 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 117.189 -1.386 . . . . 0.0 112.524 178.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 1.9 t -58.66 169.18 1.0 Allowed 'General case' 0 C--N 1.35 0.604 0 CA-C-N 119.935 1.243 . . . . 0.0 113.841 -172.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.1 pp -57.47 -13.37 3.53 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.109 1.363 . . . . 0.0 112.769 169.543 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 84.5 m -78.12 -19.47 54.02 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.331 1.853 . . . . 0.0 113.208 175.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 52.87 66.68 1.16 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.989 2.116 . . . . 0.0 112.332 -172.323 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.35 160.22 33.74 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.662 1.985 . . . . 0.0 111.136 174.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.466 HG11 ' H ' ' A' ' 205' ' ' SER . 0.3 OUTLIER -66.0 -179.89 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 125.846 1.658 . . . . 0.0 111.524 -179.82 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.466 ' H ' HG11 ' A' ' 204' ' ' VAL . 24.6 m -47.24 150.81 0.79 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.146 2.178 . . . . 0.0 113.931 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -151.79 166.67 30.67 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.655 1.582 . . . . 0.0 110.926 -173.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -76.23 -60.68 3.01 Favored Glycine 0 C--N 1.342 0.894 0 C-N-CA 124.252 0.929 . . . . 0.0 113.352 -171.235 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . 0.4 ' HB2' ' CD2' ' A' ' 224' ' ' PHE . 3.1 pt-20 -79.29 121.52 25.2 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.331 1.052 . . . . 0.0 111.063 177.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 14.3 mtp -143.88 139.71 29.37 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -173.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 20.3 tt -138.63 145.99 27.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 125.284 1.433 . . . . 0.0 109.844 168.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -125.19 137.29 10.29 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.779 1.18 . . . . 0.0 112.438 -169.696 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . 0.59 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 2.0 m -78.22 124.11 27.69 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 125.26 1.424 . . . . 0.0 111.564 -168.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -69.64 -3.61 15.82 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.187 1.795 . . . . 0.0 113.564 -175.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -65.78 147.28 98.82 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 123.36 0.664 . . . . 0.0 111.485 -174.893 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -81.33 5.1 6.48 Favored 'Trans proline' 0 CA--C 1.55 1.284 0 C-N-CA 122.909 2.406 . . . . 0.0 111.511 166.374 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -134.59 -11.51 2.39 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 125.215 1.406 . . . . 0.0 114.448 -169.508 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 36.3 t -64.19 135.45 56.31 Favored 'General case' 0 C--N 1.344 0.326 0 CA-C-N 119.257 0.935 . . . . 0.0 110.608 -177.546 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.4 t -112.8 14.53 19.9 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.917 1.687 . . . . 0.0 111.361 -174.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 48.9 mt -122.02 -42.05 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 125.428 1.491 . . . . 0.0 108.527 172.889 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 48.83 -11.24 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 131.646 3.978 . . . . 0.0 119.687 170.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 52.3 m95 -138.83 136.82 36.01 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.654 1.982 . . . . 0.0 110.042 169.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . 0.59 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 5.2 m-85 -142.72 156.23 44.99 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 125.698 1.599 . . . . 0.0 109.303 -169.874 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -71.77 149.02 45.75 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 167.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . 0.4 ' CD2' ' HB2' ' A' ' 208' ' ' GLU . 17.4 m-30 -50.88 -50.93 56.06 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.708 165.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.16 -13.64 62.01 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -177.29 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 2.0 m -78.04 -6.33 54.21 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.885 1.22 . . . . 0.0 112.785 172.784 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.4 p -121.84 -13.07 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 126.132 1.773 . . . . 0.0 111.995 169.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 97.73 14.83 39.02 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.829 1.681 . . . . 0.0 113.446 177.265 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 29.8 mt -73.93 161.88 29.66 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 118.92 1.36 . . . . 0.0 111.329 177.426 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 67.4 p -132.75 -10.88 3.08 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.819 1.648 . . . . 0.0 111.64 176.276 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 53.2 p -145.72 151.09 37.44 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.652 1.981 . . . . 0.0 108.576 177.138 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -81.27 128.37 70.61 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-O 118.776 -0.631 . . . . 0.0 110.103 178.436 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -77.3 -178.35 4.52 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.635 2.89 . . . . 0.0 110.774 169.542 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 53.2 ttt180 -141.48 131.94 25.29 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 169.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 121.26 -168.77 14.28 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 126.064 1.793 . . . . 0.0 109.889 -168.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.28 145.0 51.6 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 122.242 1.02 . . . . 0.0 110.832 174.441 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . 0.448 ' CZ2' ' HA ' ' A' ' 239' ' ' CYS . 62.1 t90 -146.2 137.37 24.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 127.116 2.167 . . . . 0.0 108.915 175.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -114.27 136.72 52.65 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.96 0.904 . . . . 0.0 108.94 171.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . 0.448 ' HA ' ' CZ2' ' A' ' 237' ' ' TRP . 5.0 p -63.32 168.72 4.67 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 126.308 1.843 . . . . 0.0 113.094 -177.893 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -67.08 -33.37 31.93 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 121.306 1.337 . . . . 0.0 112.442 -171.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 -72.59 1.29 8.49 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.175 1.39 . . . . 0.0 113.079 176.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 21.6 m -127.84 -13.39 5.24 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.033 1.733 . . . . 0.0 113.982 -172.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 34.9 t -150.61 -40.9 0.13 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.717 0.689 . . . . 0.0 112.291 -177.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 40.4 tp60 -76.53 -16.25 59.67 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 118.792 -0.623 . . . . 0.0 112.679 -177.089 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -64.99 -12.18 47.3 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.184 0.993 . . . . 0.0 113.027 172.354 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 38.6 ttt-85 -72.62 -0.91 14.24 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.194 0.998 . . . . 0.0 112.139 169.4 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -140.91 175.48 9.58 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.768 2.427 . . . . 0.0 108.498 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -68.46 110.45 4.16 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.822 1.249 . . . . 0.0 109.167 176.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 23.1 tptm . . . . . 0 C--O 1.25 1.122 0 C-N-CA 127.942 2.497 . . . . 0.0 113.717 -179.827 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.88 0 CA-C-O 120.752 0.31 . . . . 0.0 111.511 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -131.49 12.43 4.96 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.355 1.862 . . . . 0.0 111.832 -172.707 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 19.4 ptp -140.09 73.66 31.94 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 125.63 1.572 . . . . 0.0 110.085 -169.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -76.25 68.2 6.78 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 125.028 3.819 . . . . 0.0 111.175 178.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 14.9 p -151.51 149.94 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 125.694 1.598 . . . . 0.0 109.227 -176.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -65.05 151.94 92.43 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.64 1.576 . . . . 0.0 112.343 179.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -74.34 -5.48 17.0 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 123.642 2.895 . . . . 0.0 112.165 168.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -91.31 40.48 1.03 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.903 2.081 . . . . 0.0 111.198 -174.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -141.95 118.25 7.14 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 124.705 1.202 . . . . 0.0 109.22 -169.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -77.27 158.64 33.34 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.047 2.498 . . . . 0.0 111.075 176.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 71.3 p -143.07 173.46 11.54 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.638 1.175 . . . . 0.0 110.118 -177.661 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -135.77 -82.68 0.4 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 117.414 -1.279 . . . . 0.0 113.274 -168.641 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.4 t -54.28 166.03 0.46 Allowed 'General case' 0 C--N 1.35 0.614 0 C-N-CA 125.05 1.34 . . . . 0.0 112.731 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.9 pp -58.9 -11.12 2.95 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.471 1.108 . . . . 0.0 112.87 170.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 75.1 m -76.04 -19.93 58.21 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.667 1.987 . . . . 0.0 113.171 175.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 21.4 m170 57.9 62.92 1.93 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.996 2.118 . . . . 0.0 111.785 -173.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.7 159.65 33.09 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.356 1.462 . . . . 0.0 112.32 175.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.472 HG11 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -70.7 -178.45 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 126.267 1.827 . . . . 0.0 111.472 -176.811 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.472 ' H ' HG11 ' A' ' 204' ' ' VAL . 49.4 m -43.87 148.15 0.41 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 128.024 2.53 . . . . 0.0 113.915 178.281 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . 0.404 ' CE2' ' CD2' ' A' ' 223' ' ' HIS . 10.3 p90 -154.4 167.4 30.14 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.498 1.519 . . . . 0.0 111.103 -167.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -73.17 -43.86 37.75 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-O 118.719 -1.045 . . . . 0.0 115.136 -168.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -129.88 122.96 29.66 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 118.368 1.084 . . . . 0.0 110.654 -169.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -143.05 146.65 34.02 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -165.803 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 16.2 tt -140.62 155.94 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 126.278 1.831 . . . . 0.0 109.511 169.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -136.18 144.97 16.87 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 123.921 0.772 . . . . 0.0 112.261 -173.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 7.4 t -69.34 145.32 53.06 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-O 122.184 0.993 . . . . 0.0 110.938 -174.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -80.64 -6.75 58.79 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.704 2.001 . . . . 0.0 113.508 -174.241 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -80.55 145.78 59.63 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 118.557 0.617 . . . . 0.0 111.675 -169.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.42 6.13 4.21 Favored 'Trans proline' 0 CA--C 1.547 1.145 0 C-N-CA 123.629 2.886 . . . . 0.0 111.779 168.271 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -126.34 -8.12 6.39 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.074 1.749 . . . . 0.0 112.815 -172.367 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.9 t -65.4 133.36 51.17 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.822 0.849 . . . . 0.0 109.576 175.116 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 10.7 t -113.21 10.96 18.63 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.626 1.571 . . . . 0.0 111.702 -175.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 35.0 mm -118.84 -33.39 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 126.393 1.877 . . . . 0.0 109.242 176.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 50.45 -15.17 0.0 OUTLIER 'General case' 0 C--N 1.351 0.667 0 C-N-CA 131.591 3.956 . . . . 0.0 119.253 176.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -141.12 152.33 44.64 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.897 1.679 . . . . 0.0 110.427 178.424 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -154.22 154.49 33.58 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.71 1.604 . . . . 0.0 110.109 -170.326 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . 0.404 ' CD2' ' CE2' ' A' ' 206' ' ' TYR . 20.2 m170 -78.34 148.64 33.68 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 170.747 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -53.78 -50.69 65.51 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.719 167.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.62 -13.22 61.69 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 118.258 -0.877 . . . . 0.0 113.312 -176.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 3.5 m -76.41 -11.25 59.86 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.737 1.153 . . . . 0.0 112.441 172.457 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.2 p -117.69 -15.84 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 126.193 1.797 . . . . 0.0 112.269 171.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 94.87 20.06 29.64 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.888 1.709 . . . . 0.0 113.485 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 13.9 mt -71.61 156.98 38.78 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 118.854 1.327 . . . . 0.0 111.335 178.428 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 82.7 p -137.83 -11.84 1.52 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.419 1.487 . . . . 0.0 112.435 -178.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 59.2 m -148.48 134.07 18.75 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 126.263 1.825 . . . . 0.0 107.232 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -73.59 120.49 81.44 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 123.541 0.736 . . . . 0.0 111.587 -173.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -82.11 177.32 7.36 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.705 2.937 . . . . 0.0 111.194 170.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 36.0 ttp180 -142.58 135.0 27.78 Favored 'General case' 0 C--N 1.344 0.346 0 C-N-CA 124.239 1.016 . . . . 0.0 108.453 170.658 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 125.92 -167.49 18.31 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.65 1.595 . . . . 0.0 111.485 -177.024 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -59.39 119.41 7.41 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 124.601 1.16 . . . . 0.0 109.76 172.508 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . 0.403 ' CH2' ' HA ' ' A' ' 239' ' ' CYS . 62.2 t90 -136.62 138.86 41.61 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 127.029 2.132 . . . . 0.0 108.103 175.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -115.88 132.71 56.56 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.346 1.059 . . . . 0.0 108.748 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . 0.403 ' HA ' ' CH2' ' A' ' 237' ' ' TRP . 1.8 p -68.05 166.62 22.51 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 124.731 1.212 . . . . 0.0 112.467 -175.76 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -73.93 3.9 4.63 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.615 2.21 . . . . 0.0 114.698 -173.323 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 38.2 mtp180 -122.47 21.23 10.27 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.374 1.87 . . . . 0.0 111.017 171.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 18.6 m -133.45 -20.33 2.09 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.275 1.83 . . . . 0.0 112.506 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 31.2 t -150.29 -36.29 0.15 Allowed 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.635 1.107 . . . . 0.0 113.029 177.151 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 24.6 tp60 -74.17 -14.07 60.9 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.339 0.518 . . . . 0.0 112.087 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -74.99 -0.83 20.11 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.793 1.637 . . . . 0.0 113.18 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -57.03 118.4 4.96 Favored 'General case' 0 C--N 1.347 0.457 0 C-N-CA 124.58 1.152 . . . . 0.0 110.846 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -149.73 -33.21 0.19 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.773 1.629 . . . . 0.0 110.492 -178.599 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.64 147.79 50.63 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.748 1.219 . . . . 0.0 109.672 168.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 13.9 mptt . . . . . 0 C--O 1.25 1.103 0 CA-C-O 117.74 -1.124 . . . . 0.0 109.17 -176.372 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 22.3 ptp . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 121.175 0.512 . . . . 0.0 110.277 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -144.91 163.63 33.57 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.103 0.961 . . . . 0.0 111.312 -167.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -67.98 157.12 87.91 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 124.648 1.179 . . . . 0.0 110.937 173.069 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -75.24 13.54 1.06 Allowed 'Trans proline' 0 CA--C 1.547 1.129 0 C-N-CA 124.367 3.378 . . . . 0.0 113.139 173.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 14.7 p -147.17 158.59 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 126.921 2.088 . . . . 0.0 108.161 -178.536 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -53.23 152.2 8.44 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 126.839 2.055 . . . . 0.0 113.715 -175.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -72.42 -5.86 17.96 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.728 2.952 . . . . 0.0 112.526 169.578 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -81.95 41.35 0.66 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.11 2.164 . . . . 0.0 111.183 178.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -142.13 115.17 6.46 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 125.343 1.457 . . . . 0.0 108.726 -169.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.51 155.91 40.68 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.804 2.336 . . . . 0.0 110.667 174.415 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 74.4 p -142.53 172.35 12.81 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.395 1.078 . . . . 0.0 110.204 -176.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -135.56 -83.88 0.39 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 117.327 -1.32 . . . . 0.0 112.765 -168.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.0 t -55.82 168.48 0.44 Allowed 'General case' 0 C--N 1.351 0.646 0 CA-C-N 119.784 1.175 . . . . 0.0 113.173 -177.133 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.3 pp -57.24 -12.6 2.44 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.839 1.255 . . . . 0.0 112.902 170.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 75.2 m -77.6 -18.62 56.67 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.02 2.128 . . . . 0.0 113.171 176.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 27.6 m170 56.65 61.98 2.45 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.887 2.075 . . . . 0.0 111.729 -173.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.38 158.96 34.57 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.287 1.435 . . . . 0.0 112.306 176.838 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.464 HG11 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -69.76 -178.97 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 126.347 1.859 . . . . 0.0 111.432 -177.192 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.464 ' H ' HG11 ' A' ' 204' ' ' VAL . 93.6 p -44.04 148.14 0.44 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.354 2.262 . . . . 0.0 113.754 177.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -153.04 167.02 30.6 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.775 1.23 . . . . 0.0 111.963 -167.086 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -68.79 -49.44 42.59 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.718 1.152 . . . . 0.0 114.68 -168.948 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -128.01 125.09 38.74 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 118.206 1.003 . . . . 0.0 109.978 -171.328 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -142.88 145.84 33.5 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -166.638 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 19.7 tt -134.64 150.57 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 125.5 1.52 . . . . 0.0 109.878 172.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -127.45 138.93 10.8 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.729 1.157 . . . . 0.0 112.575 -170.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . 0.59 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 2.2 m -77.86 126.09 30.33 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.568 1.547 . . . . 0.0 111.453 -168.233 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -70.18 -0.03 7.1 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.373 1.869 . . . . 0.0 113.533 -175.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -67.36 149.09 98.58 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 123.785 0.834 . . . . 0.0 111.635 -176.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -83.37 8.19 4.76 Favored 'Trans proline' 0 CA--C 1.549 1.235 0 C-N-CA 123.656 2.904 . . . . 0.0 111.431 166.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -144.52 -10.94 0.62 Allowed 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 -167.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 37.2 t -61.38 132.43 53.49 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 119.469 1.031 . . . . 0.0 110.671 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 9.3 t -103.95 4.45 34.67 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.696 1.599 . . . . 0.0 111.786 -172.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 41.8 mm -114.67 -41.81 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 125.599 1.559 . . . . 0.0 108.773 175.332 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 46.98 -8.08 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 131.567 3.947 . . . . 0.0 119.8 171.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 60.9 m95 -140.71 136.6 32.75 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 126.993 2.117 . . . . 0.0 109.391 171.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . 0.59 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 6.3 m-85 -144.75 153.93 42.2 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 125.47 1.508 . . . . 0.0 109.529 -169.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 29.1 m80 -70.93 149.41 46.74 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 168.418 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -52.37 -51.27 59.85 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 115.19 -0.913 . . . . 0.0 109.626 167.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.22 -14.22 62.52 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -177.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 3.3 m -78.08 -7.03 56.42 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.753 1.16 . . . . 0.0 112.628 172.638 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.2 p -122.19 -10.76 8.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 126.241 1.816 . . . . 0.0 112.276 169.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 94.16 16.52 43.72 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.736 1.636 . . . . 0.0 113.374 178.374 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 10.2 mt -70.48 157.65 37.48 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.554 1.177 . . . . 0.0 111.176 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 73.4 m -131.19 -5.02 3.86 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.369 1.868 . . . . 0.0 110.214 177.223 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 81.9 p -141.55 -175.31 4.32 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.007 2.123 . . . . 0.0 109.206 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -124.84 111.1 27.41 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 124.033 0.933 . . . . 0.0 109.077 177.122 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -74.19 177.4 8.31 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.473 2.782 . . . . 0.0 111.235 173.833 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 60.4 ttt-85 -139.1 132.2 29.65 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 171.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 115.97 -170.29 13.28 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.579 1.561 . . . . 0.0 110.855 -169.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.6 135.77 57.03 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.47 1.108 . . . . 0.0 111.468 177.967 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 58.2 t90 -142.49 143.84 32.73 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 127.556 2.342 . . . . 0.0 108.853 173.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -128.29 128.85 45.4 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.313 1.045 . . . . 0.0 109.372 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 3.7 p -62.71 170.12 2.73 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 126.681 1.992 . . . . 0.0 113.845 -172.244 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -74.1 0.23 8.69 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.672 2.248 . . . . 0.0 115.788 -169.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 76.5 mtm180 -117.97 17.01 14.22 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.224 1.41 . . . . 0.0 111.251 171.65 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 33.9 m -131.32 -17.67 2.96 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 126.166 1.786 . . . . 0.0 113.305 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 36.6 t -152.61 -40.02 0.1 Allowed 'General case' 0 C--N 1.343 0.292 0 CA-C-N 118.976 0.807 . . . . 0.0 112.55 176.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -74.82 -16.18 60.71 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 119.177 -0.439 . . . . 0.0 112.167 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.85 -24.31 67.7 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.376 1.071 . . . . 0.0 112.697 -178.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -81.71 14.66 2.52 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.84 1.256 . . . . 0.0 113.273 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.6 -16.59 61.31 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.593 1.157 . . . . 0.0 113.962 -178.54 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -151.06 134.95 16.57 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.982 1.313 . . . . 0.0 108.645 177.424 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt . . . . . 0 C--O 1.251 1.165 0 C-N-CA 126.706 2.002 . . . . 0.0 111.935 -176.149 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.476 0.871 0 CA-C-O 119.131 -0.462 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.82 -32.84 71.02 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.182 1.393 . . . . 0.0 113.599 -172.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 65.8 mtt 34.0 67.61 1.19 Allowed Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 127.743 2.417 . . . . 0.0 113.679 174.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -76.63 22.99 0.51 Allowed 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 124.849 3.699 . . . . 0.0 113.7 -174.157 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 13.0 p -146.15 153.77 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 125.961 1.704 . . . . 0.0 108.916 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -57.39 153.63 26.84 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 126.687 1.995 . . . . 0.0 113.144 -177.242 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -71.87 -7.24 20.72 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.61 2.874 . . . . 0.0 112.287 168.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 -82.04 45.09 0.89 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.324 2.25 . . . . 0.0 110.795 177.09 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -136.51 106.84 9.21 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 125.355 1.462 . . . . 0.0 108.326 -170.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -73.23 151.66 49.24 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.261 1.974 . . . . 0.0 109.795 170.449 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 64.7 p -141.21 171.87 13.46 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.064 0.946 . . . . 0.0 110.118 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -133.45 -83.98 0.46 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 117.145 -1.407 . . . . 0.0 113.046 -168.421 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.3 t -55.13 170.11 0.21 Allowed 'General case' 0 C--N 1.35 0.602 0 C-N-CA 124.841 1.256 . . . . 0.0 113.784 -175.626 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.2 pp -58.49 -13.91 6.67 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.175 0.99 . . . . 0.0 112.624 169.476 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 73.0 m -75.83 -23.4 55.75 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.887 2.075 . . . . 0.0 112.835 173.748 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 52.93 69.15 0.73 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 127.56 2.344 . . . . 0.0 112.045 -171.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.43 160.45 28.17 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.887 1.675 . . . . 0.0 111.203 173.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.468 HG11 ' H ' ' A' ' 205' ' ' SER . 0.3 OUTLIER -68.51 -179.84 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 125.548 1.539 . . . . 0.0 111.129 -178.928 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.468 ' H ' HG11 ' A' ' 204' ' ' VAL . 83.2 p -44.39 145.82 0.78 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.972 2.109 . . . . 0.0 113.374 177.984 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . 0.432 ' CE2' ' HG2' ' A' ' 209' ' ' MET . 13.3 p90 -152.98 164.35 38.14 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.992 1.317 . . . . 0.0 111.466 -167.211 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -72.36 -60.51 4.05 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.273 0.939 . . . . 0.0 114.095 -169.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 22.9 pt-20 -99.26 120.83 40.19 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 118.048 0.924 . . . . 0.0 110.284 -174.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' MET . . . . . 0.432 ' HG2' ' CE2' ' A' ' 206' ' ' TYR . 17.6 mtp -141.51 143.1 33.63 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 -168.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 19.0 tt -134.64 157.94 41.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 126.185 1.794 . . . . 0.0 108.995 169.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -135.24 139.79 11.12 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 124.129 0.871 . . . . 0.0 112.466 -174.602 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . 0.606 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 5.6 m -75.47 124.82 27.81 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 125.029 1.331 . . . . 0.0 110.901 -168.515 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -71.88 -0.7 11.97 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.398 1.479 . . . . 0.0 113.221 -176.19 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -66.81 146.47 99.08 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 123.616 0.766 . . . . 0.0 111.065 -177.365 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -81.17 6.95 5.24 Favored 'Trans proline' 0 CA--C 1.549 1.271 0 C-N-CA 123.029 2.486 . . . . 0.0 111.376 166.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -134.44 -13.38 2.33 Favored 'General case' 0 C--N 1.35 0.593 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -169.317 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.5 t -64.63 135.09 55.57 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 119.145 0.884 . . . . 0.0 110.524 -175.88 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 32.2 m -108.32 7.69 27.32 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.766 1.626 . . . . 0.0 111.923 -174.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 37.8 mm -117.09 -41.2 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 125.732 1.613 . . . . 0.0 108.647 175.791 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 48.31 -9.71 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 131.623 3.969 . . . . 0.0 119.818 169.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -140.75 136.1 32.19 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.663 1.985 . . . . 0.0 109.032 171.84 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . 0.606 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 6.9 m-85 -144.56 156.8 44.32 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 125.939 1.695 . . . . 0.0 109.609 -169.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -73.24 148.9 43.24 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 167.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -51.63 -52.12 50.27 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.8 166.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.21 -12.99 61.77 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -177.074 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 2.0 m -77.56 -6.29 53.17 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.823 1.192 . . . . 0.0 112.665 172.312 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.62 -11.74 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 126.242 1.817 . . . . 0.0 112.396 170.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 96.3 16.33 38.02 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.604 1.574 . . . . 0.0 113.563 177.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 24.8 mt -72.4 163.29 28.23 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.777 1.289 . . . . 0.0 111.33 175.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 39.7 m -134.62 -21.69 1.72 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.595 1.558 . . . . 0.0 111.08 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 58.1 p -141.01 151.01 43.76 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 125.998 1.719 . . . . 0.0 108.826 176.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -76.55 125.56 87.24 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-O 118.846 -0.597 . . . . 0.0 110.248 -178.55 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -77.9 179.55 6.4 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.802 3.001 . . . . 0.0 111.441 174.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.08 125.37 21.74 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 124.966 1.307 . . . . 0.0 107.784 172.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 122.55 -174.8 16.36 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.545 1.545 . . . . 0.0 110.779 -169.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.25 142.19 55.69 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 122.133 0.968 . . . . 0.0 110.618 175.142 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . 0.401 ' CZ2' ' HA ' ' A' ' 239' ' ' CYS . 62.9 t90 -140.31 139.46 35.45 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.646 1.978 . . . . 0.0 109.234 175.257 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -125.43 123.56 39.53 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.029 1.331 . . . . 0.0 108.196 -178.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . 0.43 ' HB3' ' SG ' ' A' ' 212' ' ' CYS . 5.0 p -60.61 172.72 0.75 Allowed Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 127.799 2.44 . . . . 0.0 114.776 -170.46 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 68.5 Cg_endo -73.28 -0.35 9.06 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.778 2.319 . . . . 0.0 115.783 -169.275 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -117.48 15.95 14.67 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.617 1.567 . . . . 0.0 111.212 172.208 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 27.0 m -133.53 -15.94 2.4 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.725 2.01 . . . . 0.0 112.723 -176.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 35.1 t -151.1 -42.87 0.12 Allowed 'General case' 0 C--N 1.342 0.272 0 C-N-CA 123.857 0.863 . . . . 0.0 112.061 177.087 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -75.11 -13.65 60.5 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -53.69 -36.13 61.86 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.178 1.791 . . . . 0.0 111.35 172.328 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 46.2 ttm-85 -70.45 0.56 6.43 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.183 1.793 . . . . 0.0 113.754 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -129.47 -30.15 2.14 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.554 1.542 . . . . 0.0 111.186 175.411 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -151.57 108.3 3.51 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.885 1.274 . . . . 0.0 108.43 173.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm . . . . . 0 C--O 1.252 1.228 0 C-N-CA 125.292 1.437 . . . . 0.0 111.166 176.784 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 63.2 ttp . . . . . 0 N--CA 1.475 0.8 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -163.58 175.0 11.08 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.881 1.272 . . . . 0.0 110.758 -168.333 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -137.41 154.35 75.26 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 125.453 1.501 . . . . 0.0 109.84 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -72.6 -2.12 11.34 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 123.918 3.079 . . . . 0.0 113.879 178.853 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 7.1 p -146.25 139.07 20.27 Favored 'Isoleucine or valine' 0 C--N 1.341 0.237 0 C-N-CA 125.367 1.467 . . . . 0.0 108.521 170.805 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -74.98 155.55 86.52 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 124.991 1.316 . . . . 0.0 112.09 -175.059 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.12 3.54 5.04 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 123.475 2.784 . . . . 0.0 112.046 168.301 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -115.79 30.69 7.19 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.814 2.046 . . . . 0.0 110.822 -178.464 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -143.45 129.91 10.38 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 126.099 1.76 . . . . 0.0 108.158 -173.633 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.4 164.57 34.7 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.154 2.57 . . . . 0.0 113.005 -176.102 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 32.6 p -142.53 179.12 7.15 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.451 1.9 . . . . 0.0 108.819 -178.495 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -138.08 -63.74 0.55 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.636 0.774 . . . . 0.0 111.83 176.042 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . 0.436 ' SG ' ' HB2' ' A' ' 201' ' ' CYS . 4.8 p -59.8 165.6 3.04 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 128.489 2.716 . . . . 0.0 114.094 179.714 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 2.7 pp -77.93 0.53 23.85 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.565 167.319 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . 0.436 ' HB2' ' SG ' ' A' ' 199' ' ' CYS . 80.3 m -78.26 -26.93 47.41 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.917 0.887 . . . . 0.0 110.4 168.711 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . 0.282 82.3 m-70 70.32 53.4 0.33 Allowed 'General case' 0 C--N 1.343 0.286 0 C-N-CA 127.29 2.236 . . . . 0.0 113.095 169.605 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.24 172.9 12.22 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.608 -1.178 . . . . 0.0 109.587 166.882 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.432 HG11 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -62.49 174.09 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 125.229 1.412 . . . . 0.0 111.862 -174.981 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.432 ' H ' HG11 ' A' ' 204' ' ' VAL . 88.6 p -50.76 158.73 0.62 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.759 2.024 . . . . 0.0 114.833 -173.725 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -139.32 160.08 40.65 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.03 1.732 . . . . 0.0 110.484 -169.192 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -63.97 -35.36 91.9 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.36 0.981 . . . . 0.0 113.85 -171.279 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.05 118.04 16.34 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 124.589 1.156 . . . . 0.0 109.337 -170.767 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 1.3 mtm -135.68 151.2 49.96 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.074 -0.966 . . . . 0.0 113.329 -165.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 19.3 tt -142.71 146.36 22.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.274 0 C-N-CA 125.511 1.524 . . . . 0.0 110.794 169.076 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -122.53 142.44 14.78 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 125.189 1.376 . . . . 0.0 112.755 -170.938 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . 0.573 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 1.9 m -79.5 127.27 31.93 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 126.074 1.75 . . . . 0.0 112.051 -167.302 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -69.58 -0.99 7.59 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.28 1.832 . . . . 0.0 113.751 -176.61 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -68.42 146.36 97.79 Favored Pre-proline 0 CA--C 1.539 0.521 0 O-C-N 121.469 -0.769 . . . . 0.0 111.283 -175.893 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -82.01 6.75 5.49 Favored 'Trans proline' 0 CA--C 1.551 1.337 0 C-N-CA 123.1 2.534 . . . . 0.0 111.208 165.909 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -135.02 -13.15 2.15 Favored 'General case' 0 C--N 1.351 0.638 0 C-N-CA 125.25 1.42 . . . . 0.0 114.703 -169.261 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 36.5 t -64.92 134.31 53.69 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 119.139 0.881 . . . . 0.0 110.57 -176.126 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.9 t -108.71 8.61 26.95 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.679 1.591 . . . . 0.0 111.535 -173.275 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 38.9 mm -116.84 -42.29 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 125.728 1.611 . . . . 0.0 108.659 173.604 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 47.32 -7.68 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.737 1 C-N-CA 131.817 4.047 . . . . 0.0 119.453 171.838 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 51.2 m95 -140.85 139.82 34.51 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.851 2.06 . . . . 0.0 109.827 169.84 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . 0.573 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 6.7 m-85 -147.34 153.01 39.16 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.485 1.514 . . . . 0.0 108.479 -169.859 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -67.08 150.98 48.44 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 166.912 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -54.07 -47.76 71.36 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.915 167.037 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -69.44 -14.81 63.09 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 178.402 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 5.4 t -68.79 -18.56 64.21 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.841 0.856 . . . . 0.0 112.422 173.138 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.9 p -117.36 -12.62 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 126.244 1.818 . . . . 0.0 112.137 173.233 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 93.55 18.6 37.81 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.827 1.679 . . . . 0.0 113.512 179.069 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 11.5 mt -72.12 157.44 37.77 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-N 119.006 1.403 . . . . 0.0 111.419 178.92 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 39.7 m -131.95 0.57 3.87 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.384 1.874 . . . . 0.0 110.185 179.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 9.5 t -148.41 172.62 14.14 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.095 1.758 . . . . 0.0 109.876 179.91 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -110.18 94.28 17.78 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 125.164 1.386 . . . . 0.0 108.986 179.613 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.98 162.15 41.1 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.693 2.262 . . . . 0.0 110.937 170.109 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -145.4 134.55 22.78 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 124.333 1.053 . . . . 0.0 109.242 -178.654 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 138.22 -64.07 0.56 Allowed Glycine 0 CA--C 1.525 0.683 0 C-N-CA 127.13 2.3 . . . . 0.0 108.519 179.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -167.99 149.9 5.42 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 126.011 1.724 . . . . 0.0 110.486 169.611 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . 0.4 ' CZ2' ' HA ' ' A' ' 239' ' ' CYS . 48.3 t90 -146.46 148.63 32.45 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 126.701 2.0 . . . . 0.0 109.128 178.811 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -129.35 130.82 46.56 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.343 1.057 . . . . 0.0 109.701 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . 0.4 ' HA ' ' CZ2' ' A' ' 237' ' ' TRP . 3.9 p -65.5 170.62 4.42 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 126.7 2.0 . . . . 0.0 113.716 -173.152 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 59.4 Cg_endo -70.09 -19.64 34.31 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.052 1.835 . . . . 0.0 113.768 -170.814 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 16.8 mmp_? -87.2 3.45 46.44 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.536 1.534 . . . . 0.0 112.606 175.207 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 34.6 m -132.94 -17.61 2.42 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.618 1.567 . . . . 0.0 113.931 -169.789 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 29.0 t -149.9 -33.76 0.18 Allowed 'General case' 0 C--N 1.342 0.255 0 CA-C-N 118.862 0.755 . . . . 0.0 112.973 -177.731 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -70.97 -23.78 62.28 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 118.211 -0.9 . . . . 0.0 111.329 177.143 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -50.21 -28.89 8.31 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 125.675 1.59 . . . . 0.0 113.56 175.114 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -64.76 131.71 47.58 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.347 1.059 . . . . 0.0 109.907 178.162 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? 75.27 -37.58 0.34 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.98 2.512 . . . . 0.0 113.435 -175.084 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -159.22 136.34 9.69 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.219 1.008 . . . . 0.0 110.218 179.607 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 116.852 -1.546 . . . . 0.0 111.319 171.683 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 63.2 ttp . . . . . 0 N--CA 1.476 0.828 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -166.74 -174.48 2.77 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.11 1.364 . . . . 0.0 110.45 -168.301 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -133.56 105.74 11.94 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 125.406 1.482 . . . . 0.0 107.629 169.786 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -80.01 14.78 1.82 Allowed 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 124.05 3.167 . . . . 0.0 113.324 -172.778 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 5.3 m -136.37 137.76 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 126.536 1.934 . . . . 0.0 108.665 -174.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -67.71 159.16 80.23 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 125.829 1.651 . . . . 0.0 112.075 178.534 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -72.61 2.37 5.29 Favored 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 123.436 2.757 . . . . 0.0 112.111 168.223 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -108.9 35.22 3.31 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.987 2.115 . . . . 0.0 110.481 -177.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -141.75 128.94 11.53 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 125.944 1.698 . . . . 0.0 107.893 -172.295 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.69 157.47 60.42 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.952 2.435 . . . . 0.0 112.082 -178.644 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 66.4 p -143.77 175.09 10.25 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.098 1.359 . . . . 0.0 110.335 -175.544 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -135.51 -79.89 0.43 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 117.291 -1.338 . . . . 0.0 112.537 -173.109 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.1 t -55.38 164.6 0.94 Allowed 'General case' 0 C--N 1.349 0.566 0 CA-C-N 119.692 1.133 . . . . 0.0 112.784 -177.35 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.17 -5.36 3.15 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.005 0.922 . . . . 0.0 112.849 170.98 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 89.0 m -76.35 -21.97 55.46 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.165 1.786 . . . . 0.0 113.141 169.8 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 55.93 69.25 0.76 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 127.051 2.141 . . . . 0.0 111.951 -169.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.82 159.05 37.76 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.488 1.515 . . . . 0.0 111.886 172.317 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.493 HG11 ' H ' ' A' ' 205' ' ' SER . 0.7 OUTLIER -67.78 -177.9 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 126.263 1.825 . . . . 0.0 110.934 -179.039 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.493 ' H ' HG11 ' A' ' 204' ' ' VAL . 88.3 p -44.1 149.43 0.34 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.416 2.287 . . . . 0.0 113.9 176.054 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -153.53 168.92 24.55 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.205 1.402 . . . . 0.0 111.583 -167.226 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -72.66 -49.25 19.19 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-O 118.811 -0.994 . . . . 0.0 114.638 -169.092 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -124.96 121.78 35.44 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 118.233 1.016 . . . . 0.0 110.136 -170.062 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -140.36 146.32 38.26 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -166.016 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 20.1 tt -135.25 150.21 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 125.533 1.533 . . . . 0.0 109.802 170.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -127.33 138.84 10.76 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.539 1.066 . . . . 0.0 112.2 -172.798 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . 0.601 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 3.0 m -76.16 123.42 25.82 Favored 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 125.06 1.344 . . . . 0.0 110.779 -168.738 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -72.54 4.32 4.0 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.915 1.686 . . . . 0.0 112.938 -175.817 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -68.3 149.17 98.17 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 124.214 1.006 . . . . 0.0 111.469 -179.612 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -81.85 1.04 9.5 Favored 'Trans proline' 0 CA--C 1.549 1.235 0 C-N-CA 123.184 2.589 . . . . 0.0 111.831 166.447 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -135.53 -7.82 2.2 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -169.33 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.2 t -63.42 134.64 56.02 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 119.84 1.2 . . . . 0.0 110.836 -178.464 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 10.7 t -107.98 9.17 28.62 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.71 1.604 . . . . 0.0 111.712 -173.095 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 38.2 mm -118.64 -41.36 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 125.419 1.488 . . . . 0.0 108.771 173.678 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 48.11 -9.14 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 131.537 3.935 . . . . 0.0 119.644 171.014 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 60.9 m95 -139.8 136.29 33.91 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.834 2.054 . . . . 0.0 109.411 170.156 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . 0.601 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 7.2 m-85 -143.85 154.91 43.86 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 125.599 1.56 . . . . 0.0 109.276 -169.212 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 20.7 m170 -72.84 148.75 44.17 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 169.113 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 15.4 m-30 -51.93 -50.58 60.88 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.937 167.685 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.13 -14.0 62.14 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -177.721 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 7.5 m -78.37 -1.93 35.78 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.799 1.181 . . . . 0.0 112.657 172.714 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 6.1 p -128.22 -13.64 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 125.841 1.656 . . . . 0.0 112.659 169.11 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 99.53 16.44 29.23 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.66 1.6 . . . . 0.0 113.535 178.135 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 18.5 mt -74.39 163.19 28.08 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.799 1.299 . . . . 0.0 111.537 177.708 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 41.6 m -136.51 -21.81 1.31 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.581 1.552 . . . . 0.0 111.256 -178.987 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 89.1 m -141.03 142.77 34.18 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 125.713 1.605 . . . . 0.0 108.033 -179.207 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -68.45 120.53 75.78 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 123.957 0.903 . . . . 0.0 110.459 -178.721 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -79.46 -174.21 2.18 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.785 2.99 . . . . 0.0 111.135 173.655 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -143.96 133.68 23.72 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.58 1.152 . . . . 0.0 108.439 174.847 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 105.46 -169.05 15.86 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.114 1.34 . . . . 0.0 112.199 -176.234 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.83 123.61 15.63 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 125.712 1.605 . . . . 0.0 110.953 178.046 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 61.1 t90 -134.18 133.95 41.54 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.424 1.89 . . . . 0.0 108.865 171.042 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -119.08 128.25 54.15 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.696 1.198 . . . . 0.0 108.086 178.41 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 12.3 p -62.1 172.55 1.16 Allowed Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 127.382 2.273 . . . . 0.0 113.865 -173.124 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.31 -26.05 35.75 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 121.653 1.569 . . . . 0.0 114.423 -169.376 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -82.34 6.65 16.32 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.821 1.249 . . . . 0.0 112.931 173.696 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 32.9 m -134.41 -15.09 2.2 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.385 1.474 . . . . 0.0 114.223 -170.19 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.6 t -152.27 -31.0 0.15 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.924 0.783 . . . . 0.0 112.885 179.056 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -86.24 -12.3 50.04 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 118.83 -0.605 . . . . 0.0 112.624 -177.247 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -63.84 -61.15 2.48 Favored 'General case' 0 C--N 1.346 0.437 0 C-N-CA 123.744 0.818 . . . . 0.0 109.916 -178.594 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 24.4 ttp180 37.92 40.72 0.3 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 128.426 2.69 . . . . 0.0 115.598 170.794 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 16.4 ttpp -147.94 -13.2 0.37 Allowed 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -177.258 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 3.8 tmtm? -146.93 33.49 0.92 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.515 1.126 . . . . 0.0 111.238 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.252 1.217 0 C-N-CA 127.715 2.406 . . . . 0.0 112.176 178.898 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 15.1 tpt . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -145.33 114.87 7.2 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.734 0.814 . . . . 0.0 109.654 -168.798 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 18.8 ptp -157.55 123.04 2.38 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 124.6 1.16 . . . . 0.0 109.12 171.826 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -82.3 9.13 4.13 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.9 3.066 . . . . 0.0 113.114 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 4.3 m -138.19 145.07 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 C-N-CA 126.523 1.929 . . . . 0.0 109.078 -173.068 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -67.49 160.51 71.83 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 126.181 1.793 . . . . 0.0 111.97 175.73 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.31 3.52 4.05 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 123.439 2.759 . . . . 0.0 112.33 168.268 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -109.63 37.27 2.68 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.021 2.128 . . . . 0.0 110.33 -177.769 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -136.46 115.13 10.62 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 125.859 1.663 . . . . 0.0 107.927 -171.273 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -70.27 159.34 53.36 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.975 2.45 . . . . 0.0 111.87 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 72.0 p -143.18 174.42 10.72 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.834 1.254 . . . . 0.0 110.613 -173.204 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -135.27 -79.17 0.44 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 117.389 -1.291 . . . . 0.0 113.312 -171.329 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.5 t -56.64 168.61 0.57 Allowed 'General case' 0 C--N 1.349 0.574 0 C-N-CA 124.998 1.319 . . . . 0.0 113.374 -174.823 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 4.3 pp -59.17 -11.81 4.34 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.439 1.096 . . . . 0.0 112.744 169.299 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 73.4 m -76.09 -24.39 55.03 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.649 1.98 . . . . 0.0 112.927 173.483 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 55.04 69.57 0.72 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 127.218 2.207 . . . . 0.0 111.621 -170.063 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.48 163.61 25.53 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.556 1.542 . . . . 0.0 111.557 173.344 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.496 HG11 ' H ' ' A' ' 205' ' ' SER . 0.4 OUTLIER -68.88 -179.44 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 125.694 1.597 . . . . 0.0 111.427 -176.738 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.496 ' H ' HG11 ' A' ' 204' ' ' VAL . 83.6 p -47.61 153.37 0.57 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.587 2.355 . . . . 0.0 114.592 178.461 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -154.49 167.47 29.95 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.278 1.831 . . . . 0.0 110.395 -169.062 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -77.93 -39.5 23.95 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 118.673 -1.07 . . . . 0.0 115.224 -168.697 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.65 118.93 19.75 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.614 1.207 . . . . 0.0 110.199 -168.49 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -141.81 152.29 43.56 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -164.282 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 15.2 tt -147.84 152.54 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 126.055 1.742 . . . . 0.0 109.859 168.168 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -132.44 146.66 18.37 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 124.118 0.866 . . . . 0.0 112.04 -169.819 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 4.2 t -70.48 144.08 51.52 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-O 122.016 0.913 . . . . 0.0 111.368 -172.158 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -78.91 -8.54 58.95 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.265 1.826 . . . . 0.0 113.686 -174.536 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 25.6 m-20 -77.28 146.1 73.81 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-N 118.533 0.606 . . . . 0.0 111.933 -168.361 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.4 8.83 2.76 Favored 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 124.135 3.223 . . . . 0.0 112.372 169.047 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -132.69 -8.19 3.19 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.365 1.866 . . . . 0.0 112.191 -170.478 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 39.0 t -62.97 136.12 57.67 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.956 0.902 . . . . 0.0 109.864 172.585 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.9 t -121.24 14.31 11.28 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.885 1.674 . . . . 0.0 111.062 -176.003 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 35.9 mm -119.6 -32.67 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 126.646 1.978 . . . . 0.0 109.235 175.41 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 51.26 -16.52 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.664 1 C-N-CA 132.007 4.123 . . . . 0.0 119.292 174.702 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 55.0 m95 -141.93 151.51 42.66 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.843 1.657 . . . . 0.0 110.468 179.007 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -153.68 154.86 34.92 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.103 1.361 . . . . 0.0 110.152 -172.265 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -77.18 147.65 36.36 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 169.767 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -54.75 -49.53 70.63 Favored 'General case' 0 C--O 1.222 -0.342 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.928 167.665 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -68.6 -16.14 63.76 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -179.551 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 2.6 m -76.66 -18.37 58.6 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 119.866 1.212 . . . . 0.0 112.616 174.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.8 p -105.5 -14.49 8.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 124.913 1.285 . . . . 0.0 111.524 168.686 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 92.58 20.88 33.22 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.786 1.66 . . . . 0.0 113.378 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 10.1 mt -74.91 157.61 34.74 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 118.738 1.269 . . . . 0.0 111.35 178.508 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 50.0 m -127.76 -9.55 5.55 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.34 1.856 . . . . 0.0 110.265 179.422 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 77.3 p -140.91 178.05 7.62 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.786 2.035 . . . . 0.0 109.427 179.143 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -110.94 107.21 57.81 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 124.1 0.96 . . . . 0.0 108.926 178.145 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -71.28 176.46 7.87 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.547 2.831 . . . . 0.0 111.848 175.547 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.14 133.22 36.99 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.042 1.337 . . . . 0.0 108.256 -175.123 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 107.41 -162.8 13.23 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.413 1.482 . . . . 0.0 111.464 -174.657 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -61.25 127.18 30.25 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.0 1.32 . . . . 0.0 109.195 173.731 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -132.26 149.18 52.43 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.397 1.879 . . . . 0.0 109.118 178.377 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -128.68 130.29 46.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.116 1.366 . . . . 0.0 109.994 -174.152 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.26 167.41 10.23 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.411 175.211 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.66 -37.49 16.34 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 120.907 1.071 . . . . 0.0 111.972 -174.051 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 64.9 mtp85 -72.84 1.89 7.77 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.063 1.345 . . . . 0.0 113.084 176.073 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 9.2 m -120.13 -13.9 8.9 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.401 1.481 . . . . 0.0 114.328 -175.041 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 33.3 t -151.92 -38.52 0.12 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.545 1.066 . . . . 0.0 113.12 176.552 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -73.62 -27.88 61.51 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.372 0.669 . . . . 0.0 112.174 -178.68 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -78.6 2.07 20.55 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.97 1.308 . . . . 0.0 112.834 -174.702 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 30.2 ttp-105 -52.05 -44.42 64.25 Favored 'General case' 0 C--N 1.347 0.486 0 C-N-CA 125.088 1.355 . . . . 0.0 112.409 179.106 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? 29.84 61.11 0.18 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 128.182 2.593 . . . . 0.0 114.386 169.787 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 82.7 tttt 55.94 73.36 0.44 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.863 1.665 . . . . 0.0 112.267 -173.513 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 85.4 tttt . . . . . 0 C--O 1.25 1.127 0 C-N-CA 127.894 2.478 . . . . 0.0 113.774 -179.423 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 N--CA 1.476 0.848 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -143.62 129.41 19.36 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.874 0.87 . . . . 0.0 109.637 -169.02 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 18.1 ptm -154.67 106.15 2.34 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.782 1.233 . . . . 0.0 108.733 177.454 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -78.98 15.72 1.46 Allowed 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 124.019 3.146 . . . . 0.0 112.81 178.826 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 11.3 m -137.65 147.34 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 C-N-CA 127.415 2.286 . . . . 0.0 108.264 -174.102 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -70.66 157.16 90.79 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 125.107 1.363 . . . . 0.0 111.738 176.509 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -72.43 -0.19 8.37 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 123.329 2.686 . . . . 0.0 112.219 168.188 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -105.29 58.26 0.68 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 127.061 2.145 . . . . 0.0 109.069 -178.598 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -135.62 132.82 19.83 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 125.186 1.394 . . . . 0.0 108.491 -170.517 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -76.12 168.05 24.79 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.874 2.383 . . . . 0.0 113.135 -170.538 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 33.8 p -140.99 175.14 9.86 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.36 1.864 . . . . 0.0 108.97 178.46 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -135.36 -68.71 0.51 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.842 0.857 . . . . 0.0 111.166 176.022 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . 0.424 ' SG ' ' HB2' ' A' ' 201' ' ' CYS . 5.5 p -53.74 163.71 0.66 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 128.352 2.661 . . . . 0.0 114.089 177.253 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.0 pp -77.17 -1.5 29.68 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.781 167.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . 0.424 ' HB2' ' SG ' ' A' ' 199' ' ' CYS . 78.2 m -75.19 -28.73 60.13 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.942 0.897 . . . . 0.0 110.207 168.551 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . 0.297 88.3 m-70 70.48 54.72 0.29 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 127.727 2.411 . . . . 0.0 113.309 169.605 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -137.3 172.88 12.33 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 114.559 -1.201 . . . . 0.0 109.484 166.726 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.417 HG11 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -62.67 173.88 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 125.116 1.366 . . . . 0.0 111.803 -174.961 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.417 ' H ' HG11 ' A' ' 204' ' ' VAL . 87.7 p -50.62 158.58 0.62 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.73 2.012 . . . . 0.0 114.889 -173.793 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -139.85 161.22 38.1 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.016 1.726 . . . . 0.0 110.708 -169.118 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -64.14 -35.76 92.39 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.449 1.023 . . . . 0.0 113.838 -171.651 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.63 118.48 17.24 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 124.495 1.118 . . . . 0.0 109.289 -170.74 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 1.2 mtm -134.36 149.58 50.85 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.203 -0.908 . . . . 0.0 113.402 -166.096 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 21.3 tt -139.71 145.5 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 C-N-CA 125.758 1.623 . . . . 0.0 110.544 169.987 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -124.91 139.54 11.78 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.873 1.225 . . . . 0.0 112.732 -170.429 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . 0.597 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 2.8 m -78.27 124.93 28.64 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 126.078 1.751 . . . . 0.0 111.664 -167.715 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -70.43 -2.77 14.82 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.064 1.745 . . . . 0.0 113.467 -176.898 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -62.72 149.07 90.15 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 123.724 0.81 . . . . 0.0 111.598 -174.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -81.23 6.75 5.39 Favored 'Trans proline' 0 CA--C 1.548 1.2 0 C-N-CA 123.491 2.794 . . . . 0.0 111.798 167.464 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -146.37 -8.85 0.51 Allowed 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -167.75 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 37.3 t -61.35 134.35 56.84 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-N 119.866 1.212 . . . . 0.0 110.851 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 27.1 m -108.14 7.67 27.68 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.647 1.579 . . . . 0.0 111.657 -173.155 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 39.1 mm -116.33 -42.22 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 125.668 1.587 . . . . 0.0 108.536 175.007 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 48.7 -9.62 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 131.509 3.924 . . . . 0.0 119.49 171.191 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 50.2 m95 -140.15 140.46 35.96 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.94 2.096 . . . . 0.0 109.662 169.632 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . 0.597 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 6.8 m-85 -147.71 155.18 41.47 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.936 1.694 . . . . 0.0 108.604 -169.481 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -68.68 150.39 47.99 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 166.245 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -53.64 -48.06 69.72 Favored 'General case' 0 C--O 1.223 -0.334 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 166.786 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -68.55 -15.13 63.43 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 178.625 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 8.7 t -68.93 -24.71 64.32 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.075 0.852 . . . . 0.0 112.261 174.205 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.3 p -106.61 -15.8 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.787 1.635 . . . . 0.0 112.119 171.204 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 97.05 17.66 31.6 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.956 1.741 . . . . 0.0 113.487 178.897 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 16.8 mt -72.91 158.5 35.38 Favored 'General case' 0 C--N 1.345 0.411 0 CA-C-N 119.093 1.446 . . . . 0.0 111.543 178.527 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.5 t -135.86 -0.53 2.55 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.153 1.781 . . . . 0.0 111.794 179.408 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 40.1 p -143.41 162.18 36.45 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.056 2.142 . . . . 0.0 109.279 175.43 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -98.05 114.42 65.08 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 123.811 0.844 . . . . 0.0 109.613 178.043 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -78.24 179.02 6.89 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 123.758 2.972 . . . . 0.0 111.531 175.502 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 15.3 ttm180 -139.36 135.32 33.59 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.028 1.331 . . . . 0.0 107.489 169.685 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 117.14 -166.84 12.52 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.314 1.435 . . . . 0.0 111.476 -176.573 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -65.88 120.58 13.32 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.629 1.172 . . . . 0.0 110.128 177.028 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . 0.41 ' CZ2' ' HA ' ' A' ' 239' ' ' CYS . 70.0 t90 -129.27 137.66 51.19 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 126.111 1.764 . . . . 0.0 108.984 174.195 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -125.97 125.14 42.23 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.778 1.231 . . . . 0.0 108.681 -178.027 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . 0.41 ' HA ' ' CZ2' ' A' ' 237' ' ' TRP . 2.9 p -59.18 171.97 0.64 Allowed Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 127.7 2.4 . . . . 0.0 114.412 -172.429 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -68.3 -23.43 38.59 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 121.761 1.641 . . . . 0.0 113.913 -169.628 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -92.41 12.65 22.0 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.645 1.178 . . . . 0.0 112.583 174.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 27.6 m -131.7 -14.21 3.22 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.018 1.727 . . . . 0.0 113.397 -176.664 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 32.4 t -149.69 -40.1 0.14 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.838 0.855 . . . . 0.0 112.012 178.618 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -77.63 -13.71 59.83 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -175.041 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -65.81 -12.43 54.17 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.996 0.918 . . . . 0.0 112.863 171.604 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -75.12 76.91 2.28 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.225 1.41 . . . . 0.0 110.032 172.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -151.25 -37.38 0.13 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.099 1.36 . . . . 0.0 111.015 178.274 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -77.38 116.41 17.95 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.825 0.85 . . . . 0.0 109.261 175.894 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? . . . . . 0 C--O 1.252 1.223 0 C-N-CA 126.876 2.07 . . . . 0.0 112.077 -175.041 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 63.4 mtt . . . . . 0 N--CA 1.474 0.757 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -155.02 166.59 33.12 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.236 1.414 . . . . 0.0 110.199 -175.46 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.74 154.51 30.33 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 124.523 1.129 . . . . 0.0 110.707 -176.069 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -81.16 32.54 0.52 Allowed 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 124.647 3.565 . . . . 0.0 112.987 -178.459 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.23 140.19 24.54 Favored 'Isoleucine or valine' 0 C--N 1.342 0.255 0 C-N-CA 125.02 1.328 . . . . 0.0 109.592 -179.599 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -71.98 157.98 88.51 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 126.003 1.721 . . . . 0.0 112.237 -177.102 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -72.32 -0.05 8.11 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 123.7 2.933 . . . . 0.0 112.993 169.643 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -71.04 79.63 0.66 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.82 2.048 . . . . 0.0 110.374 176.571 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -151.78 137.25 10.95 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 125.134 1.374 . . . . 0.0 108.627 -170.443 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.75 154.87 54.24 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.859 2.373 . . . . 0.0 112.229 -177.984 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 33.4 p -145.28 173.96 11.52 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.924 1.689 . . . . 0.0 109.308 -178.087 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -135.83 -72.79 0.46 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.952 0.901 . . . . 0.0 112.392 -176.829 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 199' ' ' CYS . . . . . 0.419 ' SG ' ' HB2' ' A' ' 201' ' ' CYS . 2.6 p -51.62 163.6 0.28 Allowed 'General case' 0 C--N 1.339 0.111 0 C-N-CA 129.342 3.057 . . . . 0.0 114.627 176.203 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 4.1 pp -69.5 -7.62 39.73 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.982 167.352 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 201' ' ' CYS . . . . . 0.419 ' HB2' ' SG ' ' A' ' 199' ' ' CYS . 83.3 m -77.06 -30.39 55.52 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.59 1.156 . . . . 0.0 111.017 172.488 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . 0.291 89.2 m-70 69.14 57.93 0.36 Allowed 'General case' 0 C--N 1.339 0.15 0 C-N-CA 127.487 2.315 . . . . 0.0 113.267 169.809 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -136.42 171.61 14.22 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 114.119 -1.401 . . . . 0.0 109.427 166.398 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 204' ' ' VAL . . . . . 0.445 HG11 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -64.23 175.71 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 125.093 1.357 . . . . 0.0 111.939 -175.311 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 205' ' ' SER . . . . . 0.445 ' H ' HG11 ' A' ' 204' ' ' VAL . 20.1 m -45.19 154.42 0.16 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 128.128 2.571 . . . . 0.0 115.245 -173.53 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -142.08 158.45 43.74 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.107 1.763 . . . . 0.0 110.037 -173.569 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -62.66 -36.34 93.13 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.188 0.899 . . . . 0.0 114.08 -169.801 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.96 117.95 15.31 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 124.446 1.098 . . . . 0.0 109.742 -170.354 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 1.4 mtm -136.33 150.4 48.84 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.257 -0.883 . . . . 0.0 113.107 -166.801 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 13.1 tt -146.68 149.65 15.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 126.363 1.865 . . . . 0.0 110.077 169.38 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -134.02 147.23 18.99 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 124.063 0.84 . . . . 0.0 112.767 -169.538 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 3.0 t -70.8 143.69 51.07 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-O 121.893 0.854 . . . . 0.0 111.073 -173.128 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -83.9 -6.03 59.34 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 113.529 -1.669 . . . . 0.0 113.252 -174.261 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 22.9 m-20 -73.98 147.61 86.22 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 118.589 0.631 . . . . 0.0 111.696 -168.701 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -75.78 8.9 2.5 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 124.116 3.211 . . . . 0.0 112.554 169.343 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -135.25 -6.7 2.3 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.107 1.763 . . . . 0.0 112.327 -170.044 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.7 t -62.98 136.03 57.62 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.035 0.934 . . . . 0.0 110.01 172.998 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 11.8 t -118.9 12.79 12.97 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.771 1.629 . . . . 0.0 111.202 -175.846 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 25.5 mm -122.14 -32.18 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 126.065 1.746 . . . . 0.0 109.608 177.491 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 50.49 -11.29 0.0 OUTLIER 'General case' 0 C--N 1.349 0.576 0 C-N-CA 131.065 3.746 . . . . 0.0 119.131 177.359 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 52.4 m95 -145.59 156.09 43.46 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.768 1.627 . . . . 0.0 111.417 179.403 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -158.81 155.4 27.81 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 126.716 2.006 . . . . 0.0 109.081 -175.402 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 51.4 m80 -70.8 151.35 44.91 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 166.932 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -55.47 -47.06 76.69 Favored 'General case' 0 C--O 1.223 -0.29 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 166.592 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -66.73 -14.21 62.28 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 177.504 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 2.6 t -67.09 -31.29 71.68 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.24 0.927 . . . . 0.0 112.106 174.016 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.4 p -101.28 -14.41 8.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 125.964 1.705 . . . . 0.0 112.216 171.665 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 89.81 22.57 35.85 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.697 1.618 . . . . 0.0 113.256 -178.967 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 8.8 mt -69.83 157.94 36.43 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-N 118.886 1.343 . . . . 0.0 111.59 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 74.7 p -128.36 -1.9 5.62 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.047 1.739 . . . . 0.0 111.605 -178.252 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 11.3 t -152.76 170.16 20.98 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.151 1.78 . . . . 0.0 109.578 178.923 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -97.92 110.49 55.84 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.25 1.02 . . . . 0.0 108.876 175.231 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -71.34 -176.23 1.85 Allowed 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 124.016 3.144 . . . . 0.0 111.788 174.148 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -142.85 135.4 27.67 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.606 1.162 . . . . 0.0 108.668 -176.048 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 93.82 -172.52 32.63 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 125.041 1.305 . . . . 0.0 111.452 -170.917 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.36 136.02 49.64 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.926 1.291 . . . . 0.0 111.716 176.425 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 237' ' ' TRP . . . . . 0.429 ' CH2' ' HA ' ' A' ' 239' ' ' CYS . 61.6 t90 -139.9 153.11 46.89 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 127.15 2.18 . . . . 0.0 108.972 -177.813 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -128.69 130.7 47.52 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.86 1.264 . . . . 0.0 110.048 -173.303 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 239' ' ' CYS . . . . . 0.429 ' HA ' ' CH2' ' A' ' 237' ' ' TRP . 0.5 OUTLIER -66.27 169.1 7.83 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.839 1.256 . . . . 0.0 112.985 -177.131 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.9 0.72 8.95 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.479 2.12 . . . . 0.0 114.65 -171.412 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 81.8 mtt-85 -128.68 24.31 5.76 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.835 1.254 . . . . 0.0 110.541 168.741 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 11.6 m -123.79 -17.13 6.45 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 126.494 1.918 . . . . 0.0 112.059 171.974 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 36.8 t -150.92 -32.03 0.17 Allowed 'General case' 0 C--N 1.348 0.529 0 CA-C-N 119.477 1.035 . . . . 0.0 113.316 173.418 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -70.58 -18.42 62.9 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 118.969 0.804 . . . . 0.0 112.462 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -70.35 -5.68 29.84 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 172.082 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 46.9 ttm-85 -60.19 -22.23 62.7 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 119.22 0.918 . . . . 0.0 112.228 169.56 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -112.48 -81.19 0.59 Allowed 'General case' 0 C--N 1.343 0.283 0 C-N-CA 124.365 1.066 . . . . 0.0 108.191 -179.792 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -168.81 142.78 3.06 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.004 1.721 . . . . 0.0 108.001 173.143 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.172 0 CA-C-O 116.578 -1.677 . . . . 0.0 110.625 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo . . . . . 0 CA--C 1.535 0.546 0 CA-C-O 121.054 0.356 . . . . 0.0 111.593 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 81.7 p -129.35 173.86 10.15 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.091 1.356 . . . . 0.0 110.559 -171.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -133.56 -81.97 0.47 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 117.464 -1.255 . . . . 0.0 113.283 -168.932 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.3 t -55.53 166.65 0.61 Allowed 'General case' 0 C--N 1.35 0.607 0 C-N-CA 124.996 1.318 . . . . 0.0 112.814 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 4.1 pp -58.86 -11.45 3.3 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.695 1.198 . . . . 0.0 112.806 170.51 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 73.6 m -76.38 -19.48 58.12 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.501 1.92 . . . . 0.0 113.042 175.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 17.0 m170 57.75 62.07 2.22 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.846 2.059 . . . . 0.0 111.56 -173.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.5 162.42 25.67 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.337 1.455 . . . . 0.0 112.277 176.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -66.77 179.92 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 125.912 1.685 . . . . 0.0 112.367 -176.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 87.4 p -49.04 153.48 0.9 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.195 2.198 . . . . 0.0 113.913 175.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -158.24 170.84 21.36 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.7 1.6 . . . . 0.0 110.761 -167.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -77.2 -62.35 2.47 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 119.196 -0.78 . . . . 0.0 113.569 -170.005 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -105.89 121.87 44.95 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 117.815 0.808 . . . . 0.0 110.63 -172.151 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -143.88 145.89 32.62 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -167.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 15.6 tt -142.64 154.28 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.412 1.485 . . . . 0.0 109.28 169.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -133.25 144.99 17.07 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 123.727 0.68 . . . . 0.0 112.242 -169.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 11.9 t -67.99 145.92 54.05 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-O 122.036 0.922 . . . . 0.0 110.467 -174.106 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -94.4 2.46 55.78 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 113.509 -1.678 . . . . 0.0 112.694 -171.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -77.63 147.06 74.23 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 119.172 0.896 . . . . 0.0 110.473 177.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -76.71 8.07 3.23 Favored 'Trans proline' 0 CA--C 1.547 1.14 0 C-N-CA 123.542 2.828 . . . . 0.0 111.775 167.77 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -127.46 -6.77 5.81 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.344 1.857 . . . . 0.0 112.436 -171.532 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 37.9 t -64.45 131.22 46.52 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.651 0.78 . . . . 0.0 109.742 175.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.7 t -109.15 9.72 26.06 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.42 1.488 . . . . 0.0 111.743 -173.577 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 32.7 mm -121.95 -31.92 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 126.058 1.743 . . . . 0.0 109.677 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 51.6 -15.7 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 131.318 3.847 . . . . 0.0 119.327 175.413 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 58.1 m95 -139.04 151.04 46.47 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.713 1.605 . . . . 0.0 110.578 178.088 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -152.95 152.69 31.73 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.175 1.39 . . . . 0.0 110.233 -171.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -76.28 149.4 37.12 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.407 -0.815 . . . . 0.0 108.959 169.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 8.9 m-30 -52.31 -51.2 60.0 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.829 167.731 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.82 -14.08 62.28 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 118.361 -0.828 . . . . 0.0 113.2 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 9.4 m -79.04 -2.42 40.3 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 119.586 1.085 . . . . 0.0 112.511 172.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 1.2 p -126.61 -14.08 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.32 1.448 . . . . 0.0 112.456 169.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 97.16 20.33 23.54 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 125.485 1.517 . . . . 0.0 113.642 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 10.9 mt -75.41 160.31 30.39 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.803 1.301 . . . . 0.0 111.544 178.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 38.4 m -132.31 -10.74 3.26 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.288 1.835 . . . . 0.0 110.648 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 77.5 p -142.27 -174.88 4.24 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.798 2.039 . . . . 0.0 109.15 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -120.92 98.66 47.46 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 123.856 0.862 . . . . 0.0 110.451 -176.103 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -70.94 170.68 17.4 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.685 2.257 . . . . 0.0 111.002 169.803 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 -141.74 133.54 27.22 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.716 1.206 . . . . 0.0 108.492 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 129.85 -163.57 22.8 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 126.022 1.772 . . . . 0.0 110.85 -174.127 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -61.8 115.63 4.16 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.109 0.963 . . . . 0.0 109.284 169.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 53.0 t90 -132.93 142.7 49.03 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.31 1.844 . . . . 0.0 107.825 175.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -125.49 139.37 53.69 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.154 0.981 . . . . 0.0 110.801 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 239' ' ' CYS . . . . . 0.4 ' HB2' ' HD2' ' A' ' 240' ' ' PRO . 7.4 p -71.46 173.36 5.22 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 125.888 1.675 . . . . 0.0 111.888 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 68.8 Cg_endo -70.31 -33.2 14.94 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 121.217 1.278 . . . . 0.0 113.655 -168.86 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -75.13 -4.72 40.35 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 173.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 22.2 m -112.99 -17.95 12.33 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.745 1.218 . . . . 0.0 113.459 -171.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 22.1 t -152.94 -35.18 0.11 Allowed 'General case' 0 C--N 1.343 0.303 0 CA-C-N 119.093 0.861 . . . . 0.0 113.294 177.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -72.41 -14.59 61.74 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 118.23 0.468 . . . . 0.0 112.164 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 . . . . . 0 CA--C 1.542 0.664 0 C-N-CA 124.494 1.117 . . . . 0.0 111.804 177.323 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo . . . . . 0 CA--C 1.535 0.548 0 CA-C-O 121.755 0.648 . . . . 0.0 112.77 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 34.2 p -142.83 175.32 9.91 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.116 1.766 . . . . 0.0 109.223 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -136.3 -67.34 0.52 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.995 0.918 . . . . 0.0 111.573 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' CYS . . . . . 0.438 ' SG ' ' HB2' ' A' ' 201' ' ' CYS . 4.5 p -56.71 163.72 1.76 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 128.388 2.675 . . . . 0.0 113.811 176.308 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.3 pp -77.02 -1.13 27.31 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.865 -1.062 . . . . 0.0 111.704 167.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' CYS . . . . . 0.438 ' HB2' ' SG ' ' A' ' 199' ' ' CYS . 77.0 m -75.45 -29.16 59.56 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.943 0.897 . . . . 0.0 110.2 168.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . 0.302 89.1 m-70 71.1 54.69 0.23 Allowed 'General case' 0 C--N 1.342 0.255 0 C-N-CA 127.619 2.367 . . . . 0.0 113.689 169.468 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -137.49 172.69 12.6 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.617 166.491 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.409 HG23 ' H ' ' A' ' 204' ' ' VAL . 0.2 OUTLIER -63.16 174.37 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 125.189 1.396 . . . . 0.0 111.877 -175.384 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.409 ' H ' HG12 ' A' ' 204' ' ' VAL . 83.5 p -47.81 156.71 0.31 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.935 2.094 . . . . 0.0 115.063 -174.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -144.36 163.49 33.59 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.477 1.511 . . . . 0.0 111.101 -168.54 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -61.5 -40.7 99.05 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.851 1.215 . . . . 0.0 114.702 -169.441 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -130.54 122.91 28.44 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.115 0.966 . . . . 0.0 110.355 -173.514 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 1.4 mtm -139.69 144.5 37.6 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -167.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 21.2 tt -136.82 146.37 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 125.605 1.562 . . . . 0.0 110.232 171.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -124.2 139.54 12.01 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.573 1.082 . . . . 0.0 112.819 -170.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' CYS . . . . . 0.597 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 4.5 m -76.09 125.09 28.49 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 125.746 1.618 . . . . 0.0 111.441 -168.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -74.54 4.59 5.84 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.718 1.607 . . . . 0.0 113.21 -177.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -69.13 148.19 97.62 Favored Pre-proline 0 CA--C 1.538 0.51 0 O-C-N 121.29 -0.881 . . . . 0.0 111.018 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -81.36 3.85 7.47 Favored 'Trans proline' 0 CA--C 1.549 1.253 0 C-N-CA 123.2 2.6 . . . . 0.0 111.666 166.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -134.67 -10.42 2.41 Favored 'General case' 0 C--N 1.35 0.61 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 -169.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 36.9 t -64.13 135.28 56.2 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 119.438 1.017 . . . . 0.0 110.811 -177.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.7 t -110.97 10.9 22.2 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.779 1.632 . . . . 0.0 111.498 -173.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 36.5 mm -117.19 -42.46 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 125.263 1.425 . . . . 0.0 108.581 171.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 49.8 -10.18 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 131.068 3.747 . . . . 0.0 119.309 172.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -139.14 140.96 38.05 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 127.051 2.14 . . . . 0.0 109.913 169.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' PHE . . . . . 0.597 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 8.4 m-85 -147.45 150.83 35.36 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.81 1.644 . . . . 0.0 108.866 -169.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 45.8 m-70 -66.01 153.2 42.83 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 166.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -52.7 -49.41 65.4 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 166.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -69.43 -12.81 61.96 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 1.8 t -68.17 -14.91 63.33 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.752 0.705 . . . . 0.0 112.71 171.332 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 6.4 p -126.55 -10.11 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 126.479 1.912 . . . . 0.0 112.539 174.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 91.76 20.26 37.69 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.623 1.582 . . . . 0.0 113.469 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 5.9 mt -69.57 160.7 31.02 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.643 1.222 . . . . 0.0 112.018 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 96.9 m -139.35 -29.21 0.75 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.163 1.385 . . . . 0.0 111.307 -174.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 88.0 m -140.96 123.59 16.04 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 125.117 1.367 . . . . 0.0 107.582 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -65.9 121.66 76.99 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 123.96 0.904 . . . . 0.0 111.712 -169.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -78.77 -174.96 2.49 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 124.253 3.302 . . . . 0.0 111.228 170.708 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 3.1 ttp85 -145.53 151.41 38.1 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.794 1.238 . . . . 0.0 108.811 170.873 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 94.99 -155.88 21.64 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.817 1.199 . . . . 0.0 111.48 -177.314 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -57.21 108.92 0.58 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.526 1.53 . . . . 0.0 110.952 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' TRP . . . . . 0.457 ' HZ3' ' HG ' ' A' ' 212' ' ' CYS . 65.7 t90 -131.06 129.2 41.65 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 126.049 1.739 . . . . 0.0 107.952 169.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -117.75 126.1 51.84 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 239' ' ' CYS . . . . . 0.469 ' HB3' ' SG ' ' A' ' 212' ' ' CYS . 3.3 p -58.46 171.87 0.56 Allowed Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 127.689 2.396 . . . . 0.0 113.876 -173.616 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.444 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 37.0 Cg_endo -66.19 -33.78 38.74 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 121.323 1.349 . . . . 0.0 112.767 -170.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 66.7 mtt180 -79.06 9.19 4.62 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.805 1.242 . . . . 0.0 112.785 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 27.6 m -131.05 -12.21 3.66 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.216 1.806 . . . . 0.0 114.1 -174.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 33.2 t -152.79 -39.59 0.1 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.882 0.873 . . . . 0.0 112.388 178.561 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -77.89 -13.34 59.92 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -175.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 . . . . . 0 CA--C 1.538 0.488 0 C-N-CA 123.773 0.829 . . . . 0.0 112.654 172.273 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo . . . . . 0 CA--C 1.535 0.535 0 CA-C-O 120.972 0.322 . . . . 0.0 111.632 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 62.9 p -145.47 174.07 11.46 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.703 1.201 . . . . 0.0 110.502 -175.372 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -137.51 -80.93 0.36 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.639 -169.904 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 1.8 t -56.58 167.14 0.77 Allowed 'General case' 0 C--N 1.351 0.649 0 C-N-CA 124.543 1.137 . . . . 0.0 112.942 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.0 pp -58.3 -11.97 3.25 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.031 1.332 . . . . 0.0 112.759 171.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 71.4 m -76.34 -20.43 57.24 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.552 1.941 . . . . 0.0 113.166 176.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 50.8 m170 56.71 65.99 1.28 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.855 2.062 . . . . 0.0 111.585 -170.047 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.93 157.65 41.03 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.029 1.332 . . . . 0.0 112.338 174.001 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.513 HG12 ' H ' ' A' ' 205' ' ' SER . 0.7 OUTLIER -67.92 -178.89 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 126.292 1.837 . . . . 0.0 111.113 -177.858 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.513 ' H ' HG12 ' A' ' 204' ' ' VAL . 87.9 p -45.57 149.83 0.54 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 127.47 2.308 . . . . 0.0 113.827 178.641 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' TYR . . . . . 0.469 ' CE2' ' HG2' ' A' ' 209' ' ' MET . 16.3 p90 -154.34 165.62 35.77 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.22 1.408 . . . . 0.0 111.077 -167.493 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -74.91 -41.54 32.88 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 118.511 -1.16 . . . . 0.0 115.204 -168.777 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -126.35 120.3 29.52 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 118.582 1.191 . . . . 0.0 110.506 -169.449 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' MET . . . . . 0.469 ' HG2' ' CE2' ' A' ' 206' ' ' TYR . 3.1 mtp -139.74 149.2 43.32 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -165.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 15.2 tt -137.79 155.61 30.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 CA-C-N 113.768 -1.56 . . . . 0.0 109.553 168.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -133.04 138.87 10.47 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.698 1.142 . . . . 0.0 112.51 -171.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' CYS . . . . . 0.591 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 1.6 m -79.3 126.21 30.5 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.554 1.542 . . . . 0.0 112.311 -167.675 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -69.67 -1.85 10.13 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.776 2.03 . . . . 0.0 113.718 -176.238 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -66.56 148.86 98.52 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 123.717 0.807 . . . . 0.0 111.827 -174.926 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -83.34 7.92 4.92 Favored 'Trans proline' 0 CA--C 1.549 1.25 0 C-N-CA 123.661 2.908 . . . . 0.0 111.404 166.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -144.58 -10.43 0.62 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 -167.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 37.3 t -61.58 133.42 55.65 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 119.562 1.074 . . . . 0.0 110.62 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.9 t -107.16 8.54 30.14 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.652 1.581 . . . . 0.0 111.588 -172.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 41.3 mm -117.66 -42.58 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 125.675 1.59 . . . . 0.0 108.735 174.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 46.95 -9.77 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.834 1 C-N-CA 131.706 4.002 . . . . 0.0 119.703 172.803 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 63.8 m95 -136.85 135.84 38.25 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.652 1.981 . . . . 0.0 109.166 170.171 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' PHE . . . . . 0.591 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 7.6 m-85 -141.45 155.86 45.82 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 125.129 1.371 . . . . 0.0 109.074 -169.323 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -76.22 149.01 37.28 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 169.174 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -52.39 -50.61 62.13 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.094 167.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.32 -14.59 62.65 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -177.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 9.5 m -79.14 -4.05 48.53 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 119.676 1.126 . . . . 0.0 112.861 172.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.6 p -123.93 -13.84 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 126.049 1.739 . . . . 0.0 112.383 169.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 96.57 17.53 33.23 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.683 1.611 . . . . 0.0 113.206 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 9.6 mt -73.31 162.67 29.09 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.38 1.09 . . . . 0.0 111.606 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.7 t -139.47 -2.79 1.56 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.923 1.689 . . . . 0.0 112.15 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 46.0 p -143.37 179.77 6.89 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.977 2.111 . . . . 0.0 109.61 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -110.89 92.72 15.36 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 124.707 1.203 . . . . 0.0 109.546 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -69.01 164.68 32.85 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.252 1.968 . . . . 0.0 110.295 169.656 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 47.9 ttp180 -142.47 131.52 23.16 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 122.211 1.005 . . . . 0.0 109.012 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 135.58 -170.56 23.0 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 126.721 2.105 . . . . 0.0 109.886 -169.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -67.53 121.23 15.37 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.709 0.766 . . . . 0.0 109.892 171.172 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 47.7 t90 -131.41 141.59 49.88 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.793 2.037 . . . . 0.0 108.313 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -125.08 130.74 52.87 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.29 1.036 . . . . 0.0 108.868 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 2.4 p -61.28 167.63 3.8 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 126.089 1.756 . . . . 0.0 112.705 -175.5 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -65.61 -33.72 44.43 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 121.29 1.326 . . . . 0.0 112.671 -169.833 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 75.1 mtt-85 -79.43 6.29 10.6 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.137 0.975 . . . . 0.0 113.049 177.778 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 22.6 m -125.9 -15.38 5.92 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.835 1.654 . . . . 0.0 114.023 -175.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 22.9 t -150.24 -32.51 0.19 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.89 0.768 . . . . 0.0 112.997 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 30.1 tp60 -86.44 -20.62 27.89 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -176.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 . . . . . 0 CA--C 1.54 0.582 0 C-N-CA 124.556 1.142 . . . . 0.0 112.046 -176.204 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo . . . . . 0 CA--C 1.536 0.591 0 CA-C-O 121.615 0.59 . . . . 0.0 112.205 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 44.6 p -141.59 169.83 16.86 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.033 1.733 . . . . 0.0 108.466 174.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -137.83 -55.13 0.67 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -177.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' CYS . . . . . 0.452 ' SG ' ' HB2' ' A' ' 201' ' ' CYS . 3.6 p -67.48 165.68 16.23 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 128.531 2.732 . . . . 0.0 113.664 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.4 pp -72.11 -4.71 30.58 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.648 166.517 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' CYS . . . . . 0.452 ' HB2' ' SG ' ' A' ' 199' ' ' CYS . 74.1 m -80.07 -25.81 39.9 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.867 1.267 . . . . 0.0 111.342 174.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . 0.285 9.9 m-70 71.37 52.01 0.25 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.886 2.074 . . . . 0.0 112.71 169.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -137.41 171.37 14.58 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.22 167.104 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.416 HG12 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -63.9 174.12 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 125.349 1.459 . . . . 0.0 111.998 -173.87 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.416 ' H ' HG12 ' A' ' 204' ' ' VAL . 89.4 p -47.57 155.12 0.39 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.339 2.256 . . . . 0.0 115.481 -173.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -145.46 160.41 41.63 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.962 1.705 . . . . 0.0 110.377 -169.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -60.46 -38.77 95.33 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.653 1.12 . . . . 0.0 114.783 -169.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -131.86 121.45 24.08 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.0 0.92 . . . . 0.0 110.722 -171.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 1.4 mtm -138.33 144.92 40.61 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -168.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 21.3 tt -143.33 147.91 19.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 126.358 1.863 . . . . 0.0 109.202 173.497 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -137.19 145.85 17.68 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 123.698 0.666 . . . . 0.0 113.086 -169.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 6.9 t -72.13 145.3 48.22 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-O 122.234 1.016 . . . . 0.0 111.124 -172.201 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -77.78 -9.56 59.09 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.648 1.979 . . . . 0.0 113.92 -176.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -76.71 145.91 75.6 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 118.676 0.671 . . . . 0.0 111.782 -169.121 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.35 8.95 2.69 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 124.072 3.181 . . . . 0.0 112.209 169.003 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -134.23 -8.8 2.61 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.285 1.834 . . . . 0.0 112.34 -169.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 46.9 t -63.07 125.1 22.9 Favored 'General case' 0 C--N 1.345 0.401 0 C-N-CA 123.52 0.728 . . . . 0.0 109.708 172.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 10.0 t -97.84 1.78 48.59 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.835 1.654 . . . . 0.0 112.014 -172.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 28.3 mm -117.43 -32.03 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 125.949 1.7 . . . . 0.0 109.7 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 50.07 -12.61 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 130.529 3.532 . . . . 0.0 118.985 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 46.3 m95 -141.96 157.18 45.26 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 120.588 1.54 . . . . 0.0 112.104 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -158.72 153.3 24.46 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.203 1.801 . . . . 0.0 109.349 -174.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 38.2 m-70 -68.69 155.55 39.88 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 166.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 11.1 m-30 -52.81 -51.11 62.1 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 166.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -68.68 -12.55 61.53 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.893 0.877 . . . . 0.0 113.255 -177.894 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 1.1 t -67.08 -20.29 65.79 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.488 0.715 . . . . 0.0 112.584 172.536 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 5.5 p -118.69 -15.48 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 125.971 1.709 . . . . 0.0 112.155 173.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 101.28 16.99 23.55 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.797 1.665 . . . . 0.0 113.665 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 11.7 mt -71.6 166.49 21.74 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.065 1.433 . . . . 0.0 111.652 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 88.2 m -132.42 -14.5 2.91 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.909 1.683 . . . . 0.0 110.828 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 75.9 p -142.03 169.49 17.49 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.996 1.718 . . . . 0.0 109.983 -177.453 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -98.77 114.4 65.38 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 123.829 0.852 . . . . 0.0 109.13 175.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -75.32 -178.81 4.5 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.991 3.128 . . . . 0.0 110.748 172.181 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -138.37 129.52 27.19 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.964 0.906 . . . . 0.0 108.868 174.148 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 123.31 -178.42 16.39 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 125.978 1.752 . . . . 0.0 110.981 -170.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -67.33 137.31 55.94 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 122.298 1.047 . . . . 0.0 110.625 173.097 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 49.4 t90 -141.89 154.88 45.44 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 127.439 2.296 . . . . 0.0 109.109 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -128.42 132.5 48.46 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.9 1.28 . . . . 0.0 110.487 -174.481 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 1.8 p -71.47 170.07 13.22 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.045 1.338 . . . . 0.0 112.186 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.79 -15.28 26.82 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 121.789 1.659 . . . . 0.0 114.09 -169.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -96.92 9.25 42.46 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.882 1.673 . . . . 0.0 111.948 173.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 20.0 m -130.65 -18.32 3.13 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.589 1.556 . . . . 0.0 113.637 -172.722 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 45.1 t -151.17 -38.67 0.13 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.464 1.029 . . . . 0.0 112.746 174.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 33.2 tp60 -69.11 -19.07 64.04 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.131 0.423 . . . . 0.0 112.004 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 . . . . . 0 CA--C 1.541 0.622 0 C-N-CA 126.564 1.946 . . . . 0.0 113.078 177.656 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo . . . . . 0 CA--C 1.534 0.519 0 CA-C-O 121.272 0.447 . . . . 0.0 111.962 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 63.9 p -144.48 175.23 10.28 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.85 1.26 . . . . 0.0 110.452 -173.77 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -135.19 -81.2 0.43 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 117.436 -1.269 . . . . 0.0 112.992 -169.031 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -56.02 168.93 0.42 Allowed 'General case' 0 C--N 1.349 0.581 0 C-N-CA 124.887 1.275 . . . . 0.0 113.32 -177.435 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.9 pp -57.87 -12.14 2.91 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.015 1.326 . . . . 0.0 113.015 169.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 72.1 m -76.62 -23.74 53.38 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 127.002 2.121 . . . . 0.0 113.261 176.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 17.3 m170 58.85 66.44 1.06 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.574 1.949 . . . . 0.0 111.001 -169.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.18 159.44 36.03 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.966 1.306 . . . . 0.0 112.273 174.281 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.577 HG12 ' H ' ' A' ' 205' ' ' SER . 0.8 OUTLIER -70.96 -177.96 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 C-N-CA 126.186 1.794 . . . . 0.0 111.231 -175.79 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.577 ' H ' HG12 ' A' ' 204' ' ' VAL . 49.6 m -46.83 151.69 0.58 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 128.289 2.636 . . . . 0.0 114.221 -178.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' TYR . . . . . 0.454 ' CE2' ' HG2' ' A' ' 209' ' ' MET . 11.9 p90 -155.7 162.95 40.46 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.742 1.617 . . . . 0.0 110.819 -168.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -70.59 -47.17 43.14 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-O 118.695 -1.058 . . . . 0.0 114.526 -169.402 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -127.94 123.0 33.83 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.376 1.088 . . . . 0.0 110.289 -169.53 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' MET . . . . . 0.454 ' HG2' ' CE2' ' A' ' 206' ' ' TYR . 5.1 mtp -135.17 153.63 51.9 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -165.844 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 18.4 tt -142.94 158.81 18.13 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 C-N-CA 126.799 2.04 . . . . 0.0 108.752 169.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -141.64 143.42 13.04 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 123.564 0.602 . . . . 0.0 111.79 -173.74 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 4.1 t -71.55 142.32 50.07 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-O 121.674 0.749 . . . . 0.0 111.04 -173.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -75.97 -10.65 59.59 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.682 1.593 . . . . 0.0 114.036 -174.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -78.84 145.04 65.38 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 118.66 0.664 . . . . 0.0 112.064 -167.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -75.64 1.98 7.44 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 123.603 2.869 . . . . 0.0 111.989 168.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -118.77 -6.61 10.58 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.217 1.807 . . . . 0.0 112.224 -175.141 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 39.0 t -64.91 136.86 57.32 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.305 1.042 . . . . 0.0 109.682 173.93 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 8.5 t -121.05 12.4 11.13 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.805 1.642 . . . . 0.0 111.202 -175.56 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 36.4 mm -119.98 -32.88 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 126.206 1.802 . . . . 0.0 109.383 175.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 50.83 -16.27 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.687 1 C-N-CA 131.769 4.028 . . . . 0.0 119.309 175.439 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 61.5 m95 -140.86 150.81 43.73 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 125.549 1.54 . . . . 0.0 110.188 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -154.31 154.44 33.37 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.288 1.435 . . . . 0.0 110.278 -170.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -79.07 143.92 35.11 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 168.839 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -51.67 -50.07 61.13 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.337 167.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -68.88 -13.93 62.72 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.747 1.018 . . . . 0.0 113.747 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.38 -21.94 59.42 Favored 'General case' 0 C--N 1.349 0.55 0 CA-C-N 119.942 1.247 . . . . 0.0 112.647 174.235 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.6 p -104.9 -13.46 9.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 125.604 1.562 . . . . 0.0 111.785 170.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 90.68 20.3 41.02 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.83 1.681 . . . . 0.0 113.24 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 12.9 mt -73.45 157.82 36.12 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 118.873 1.336 . . . . 0.0 111.382 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 69.0 p -131.52 -1.33 3.9 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.293 1.837 . . . . 0.0 111.403 176.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 60.5 p -145.23 175.69 10.09 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.551 2.34 . . . . 0.0 108.956 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -119.13 125.44 27.62 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 123.946 0.899 . . . . 0.0 109.515 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -76.17 -171.09 0.98 Allowed 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 124.513 3.475 . . . . 0.0 111.127 174.026 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -148.3 138.72 22.75 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.187 0.995 . . . . 0.0 109.34 178.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 102.58 -62.23 0.48 Allowed Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.919 1.723 . . . . 0.0 112.065 173.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -148.74 142.27 25.37 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 125.475 1.51 . . . . 0.0 110.306 -178.47 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 77.6 t90 -150.73 154.02 36.6 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 126.223 1.809 . . . . 0.0 109.834 171.793 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -128.42 127.51 42.7 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.054 1.342 . . . . 0.0 109.919 -177.135 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.62 167.54 10.75 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 124.79 1.236 . . . . 0.0 113.311 -177.115 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -74.29 -0.65 9.92 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.507 2.138 . . . . 0.0 114.19 -174.2 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 35.0 mtp180 -123.9 27.39 7.25 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.02 1.328 . . . . 0.0 111.322 168.662 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 10.3 m -131.67 -14.89 3.16 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 126.357 1.863 . . . . 0.0 112.224 173.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 41.9 t -149.17 -34.82 0.19 Allowed 'General case' 0 C--N 1.345 0.402 0 CA-C-N 118.994 0.815 . . . . 0.0 112.704 174.868 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -75.27 -12.98 60.39 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -176.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 . . . . . 0 CA--C 1.543 0.676 0 CA-C-N 118.936 0.789 . . . . 0.0 112.75 169.95 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo . . . . . 0 CA--C 1.535 0.553 0 CA-C-O 121.003 0.335 . . . . 0.0 111.693 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 80.4 p -144.41 172.76 12.5 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.767 1.227 . . . . 0.0 110.377 -175.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -136.38 -81.18 0.39 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 117.511 -1.233 . . . . 0.0 113.076 -169.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.8 t -55.43 166.55 0.61 Allowed 'General case' 0 C--N 1.35 0.594 0 C-N-CA 125.161 1.385 . . . . 0.0 112.871 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 4.7 pp -59.52 -9.72 2.78 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.543 1.137 . . . . 0.0 112.873 170.115 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 73.3 m -77.06 -20.87 55.3 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.694 1.997 . . . . 0.0 113.052 174.82 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 13.3 m170 59.2 62.55 1.8 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.881 2.072 . . . . 0.0 111.499 -173.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.31 160.43 32.21 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.269 1.428 . . . . 0.0 112.409 176.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.487 HG12 ' H ' ' A' ' 205' ' ' SER . 0.3 OUTLIER -69.2 -179.62 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 126.366 1.866 . . . . 0.0 111.718 -176.325 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.487 ' H ' HG12 ' A' ' 204' ' ' VAL . 80.4 p -45.67 150.16 0.53 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.873 2.469 . . . . 0.0 114.329 178.125 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' TYR . . . . . 0.4 ' CE2' ' CD2' ' A' ' 223' ' ' HIS . 10.1 p90 -155.37 168.69 26.28 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.767 1.627 . . . . 0.0 110.875 -167.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -76.04 -43.68 21.04 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 118.676 -1.069 . . . . 0.0 115.101 -168.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -127.73 121.78 31.18 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 118.425 1.113 . . . . 0.0 110.784 -169.454 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -143.76 146.74 33.36 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -165.762 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 13.6 tt -143.7 154.9 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 125.8 1.64 . . . . 0.0 109.346 168.459 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -136.23 147.01 19.0 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 123.741 0.686 . . . . 0.0 112.299 -169.621 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 6.1 t -70.12 144.47 52.05 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-O 122.179 0.99 . . . . 0.0 111.058 -174.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -79.14 -5.94 55.34 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.763 2.025 . . . . 0.0 113.671 -174.091 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -82.22 145.48 52.51 Favored Pre-proline 0 CA--C 1.535 0.404 0 CA-C-N 118.81 0.732 . . . . 0.0 111.464 -169.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -76.74 6.28 4.24 Favored 'Trans proline' 0 CA--C 1.547 1.133 0 C-N-CA 123.544 2.829 . . . . 0.0 111.702 167.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -124.18 -9.23 7.61 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.301 1.841 . . . . 0.0 112.502 -172.303 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 43.9 t -64.92 133.6 52.17 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.239 1.016 . . . . 0.0 109.893 175.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 37.9 m -110.39 8.39 23.25 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.531 1.532 . . . . 0.0 111.845 -174.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 33.3 mm -119.83 -33.06 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 126.256 1.822 . . . . 0.0 109.446 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 50.14 -15.7 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.659 1 C-N-CA 131.757 4.023 . . . . 0.0 119.338 177.118 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 58.3 m95 -140.47 152.14 45.4 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.795 1.638 . . . . 0.0 110.437 178.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -153.07 154.95 35.91 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.333 1.453 . . . . 0.0 110.015 -173.039 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' HIS . . . . . 0.4 ' CD2' ' CE2' ' A' ' 206' ' ' TYR . 19.5 m170 -77.71 149.75 34.56 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 170.599 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -53.71 -50.75 65.22 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.634 167.723 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -69.91 -14.82 62.91 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 118.296 -0.859 . . . . 0.0 113.229 -177.342 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 7.4 m -78.85 -6.46 56.12 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 119.667 1.122 . . . . 0.0 112.858 173.146 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.3 p -121.17 -12.58 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 125.864 1.666 . . . . 0.0 112.065 169.28 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 92.96 19.86 35.3 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.524 1.535 . . . . 0.0 113.313 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 6.2 mt -72.51 158.29 36.0 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 118.397 1.098 . . . . 0.0 111.082 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 68.7 p -134.14 1.9 3.28 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.195 1.798 . . . . 0.0 111.263 176.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 81.9 p -142.95 179.89 6.76 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.051 2.141 . . . . 0.0 109.664 -175.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -121.65 89.55 47.63 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 124.603 1.161 . . . . 0.0 109.055 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.65 169.04 18.29 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.801 2.334 . . . . 0.0 111.304 174.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -140.02 133.7 30.39 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 124.917 1.287 . . . . 0.0 108.564 -177.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 126.46 -169.59 18.38 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 126.319 1.914 . . . . 0.0 110.277 -169.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.95 130.4 43.91 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 122.093 0.949 . . . . 0.0 109.195 169.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 53.0 t90 -136.74 146.63 46.03 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 127.072 2.149 . . . . 0.0 108.312 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -129.97 131.65 46.0 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.678 1.191 . . . . 0.0 109.637 -173.549 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 1.5 p -68.78 166.68 24.9 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 124.27 1.028 . . . . 0.0 112.074 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.37 9.43 2.52 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.539 2.159 . . . . 0.0 114.57 -175.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -122.79 15.93 10.17 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.512 1.925 . . . . 0.0 110.856 171.062 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 30.1 m -133.19 -22.76 1.98 Allowed 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.962 1.705 . . . . 0.0 113.111 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.1 t -153.71 -34.07 0.11 Allowed 'General case' 0 C--N 1.346 0.426 0 CA-C-N 119.724 1.147 . . . . 0.0 113.501 173.6 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 10.7 tp60 -76.03 -8.05 56.08 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.928 0.785 . . . . 0.0 112.006 176.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 . . . . . 0 CA--C 1.542 0.645 0 C-N-CA 125.057 1.343 . . . . 0.0 111.628 169.815 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo . . . . . 0 CA--C 1.537 0.639 0 CA-C-O 121.252 0.438 . . . . 0.0 111.431 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 49.0 p -143.31 173.14 11.86 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.573 1.549 . . . . 0.0 109.108 -177.461 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -139.46 -67.29 0.45 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.83 0.852 . . . . 0.0 111.782 -173.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' CYS . . . . . 0.438 ' SG ' ' HB2' ' A' ' 201' ' ' CYS . 4.6 p -59.37 165.15 2.89 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 128.484 2.714 . . . . 0.0 113.595 176.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 2.9 pp -77.66 -0.36 26.37 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.595 167.454 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' CYS . . . . . 0.438 ' HB2' ' SG ' ' A' ' 199' ' ' CYS . 74.2 m -76.78 -28.22 55.58 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.889 0.875 . . . . 0.0 110.226 168.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . 0.293 93.4 m-70 72.45 52.2 0.17 Allowed 'General case' 0 C--N 1.342 0.242 0 C-N-CA 127.828 2.451 . . . . 0.0 113.84 169.001 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -136.85 173.61 11.51 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.528 1.131 . . . . 0.0 109.864 166.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.473 HG12 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -62.55 174.49 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 125.238 1.415 . . . . 0.0 111.813 -176.17 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.473 ' H ' HG12 ' A' ' 204' ' ' VAL . 80.5 p -47.94 157.44 0.28 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.516 2.326 . . . . 0.0 114.899 -175.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -142.36 163.2 33.49 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.82 1.648 . . . . 0.0 110.984 -168.583 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -61.3 -42.31 99.74 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.824 1.202 . . . . 0.0 114.37 -169.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -127.98 124.12 36.47 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.462 1.105 . . . . 0.0 110.116 -178.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 1.6 mtm -138.42 145.63 41.2 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.003 -168.278 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 21.4 tt -137.06 144.67 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 125.126 1.37 . . . . 0.0 110.53 172.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -120.24 139.68 13.92 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 125.238 1.399 . . . . 0.0 112.241 -171.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' CYS . . . . . 0.576 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 1.2 m -80.0 123.88 28.21 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.737 1.615 . . . . 0.0 111.451 -167.657 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.25 14.48 1.19 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.256 1.422 . . . . 0.0 112.458 -175.532 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -74.23 148.77 86.58 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 124.295 1.038 . . . . 0.0 111.484 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -84.92 8.92 4.37 Favored 'Trans proline' 0 CA--C 1.551 1.347 0 C-N-CA 123.342 2.695 . . . . 0.0 110.944 165.116 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -134.58 -16.71 2.03 Favored 'General case' 0 C--N 1.351 0.631 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -168.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 28.2 t -65.59 135.6 55.29 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 123.594 0.758 . . . . 0.0 111.119 -172.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 10.2 t -110.77 12.08 22.48 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.726 1.61 . . . . 0.0 111.588 -174.482 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 34.0 mm -122.06 -40.96 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 125.758 1.623 . . . . 0.0 108.852 174.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 48.36 -7.75 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 131.424 3.89 . . . . 0.0 119.435 172.203 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 49.3 m95 -140.49 140.31 35.28 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 126.904 2.082 . . . . 0.0 110.211 169.58 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' PHE . . . . . 0.576 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 8.4 m-85 -148.93 153.4 37.93 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 125.441 1.496 . . . . 0.0 109.141 -169.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -66.73 151.75 46.81 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 166.743 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 12.2 m-30 -51.19 -50.82 58.29 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.757 166.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.07 -12.38 61.56 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -178.651 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 1.9 t -67.63 -18.12 64.85 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.821 0.737 . . . . 0.0 112.588 172.132 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.4 p -121.3 -15.61 6.8 Favored 'Isoleucine or valine' 0 C--N 1.345 0.396 0 C-N-CA 126.039 1.736 . . . . 0.0 112.396 175.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 102.32 17.33 20.27 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.693 1.616 . . . . 0.0 113.653 178.127 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 20.3 mt -71.32 158.63 36.01 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.244 1.522 . . . . 0.0 111.414 177.101 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 71.2 m -136.12 -23.44 1.32 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.727 1.611 . . . . 0.0 111.135 -177.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 92.2 m -140.04 137.13 34.35 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 125.957 1.703 . . . . 0.0 107.264 176.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 55.4 tttm -67.72 125.51 91.38 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-O 118.871 -0.585 . . . . 0.0 110.954 -173.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -77.84 -170.09 0.89 Allowed 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 124.151 3.234 . . . . 0.0 111.191 173.567 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 17.5 tpp180 -142.78 138.98 30.81 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.134 1.374 . . . . 0.0 108.118 178.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 81.32 -159.46 41.03 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.552 1.072 . . . . 0.0 112.754 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 27.6 mttp -50.65 120.72 4.96 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 126.753 2.021 . . . . 0.0 112.848 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 62.7 t90 -138.48 138.47 38.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.239 1.816 . . . . 0.0 109.012 173.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -120.53 127.39 52.13 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.707 1.203 . . . . 0.0 108.405 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 239' ' ' CYS . . . . . 0.543 ' HB2' ' HD2' ' A' ' 240' ' ' PRO . 14.7 p -59.25 172.51 0.58 Allowed Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 127.851 2.46 . . . . 0.0 114.334 -173.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.543 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 43.1 Cg_endo -64.2 -38.64 34.7 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 121.658 1.572 . . . . 0.0 113.14 -168.045 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 66.0 mtt85 -88.02 20.53 3.09 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.42 1.009 . . . . 0.0 112.554 177.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 16.7 m -131.3 -10.4 3.69 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 126.316 1.846 . . . . 0.0 113.344 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 22.7 t -157.08 -39.59 0.07 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.144 0.884 . . . . 0.0 113.147 174.874 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -75.2 -15.04 60.58 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.537 0.735 . . . . 0.0 112.525 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 . . . . . 0 C--O 1.234 0.28 0 C-N-CA 128.26 2.624 . . . . 0.0 106.026 -175.351 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo . . . . . 0 CA--C 1.536 0.613 0 CA-C-O 121.496 0.54 . . . . 0.0 112.657 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 34.7 p -144.77 172.98 12.25 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.094 1.757 . . . . 0.0 109.284 -177.843 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -139.04 -54.1 0.58 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' CYS . . . . . 0.45 ' SG ' ' HB2' ' A' ' 201' ' ' CYS . 2.4 p -68.82 165.62 19.33 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 128.431 2.693 . . . . 0.0 113.272 178.491 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.5 pp -71.94 -5.62 36.07 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.77 166.736 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' CYS . . . . . 0.45 ' HB2' ' SG ' ' A' ' 199' ' ' CYS . 74.8 m -78.07 -29.09 48.97 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.807 1.243 . . . . 0.0 110.831 173.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . 0.303 90.9 m-70 71.09 54.86 0.23 Allowed 'General case' 0 C--N 1.34 0.167 0 C-N-CA 127.529 2.332 . . . . 0.0 113.391 169.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -136.6 171.37 14.59 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.44 -1.254 . . . . 0.0 109.697 166.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.483 HG12 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -64.97 175.97 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 125.274 1.43 . . . . 0.0 112.105 -173.18 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.483 ' H ' HG12 ' A' ' 204' ' ' VAL . 20.3 m -43.39 152.78 0.12 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 128.421 2.689 . . . . 0.0 115.569 -173.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' TYR . . . . . 0.411 ' CD1' ' HG2' ' A' ' 209' ' ' MET . 7.4 p90 -147.63 157.05 43.38 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.59 1.556 . . . . 0.0 110.497 -172.001 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -65.75 -38.53 94.54 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.432 1.015 . . . . 0.0 115.095 -169.125 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 26.8 pt-20 -119.33 122.08 41.05 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 118.164 0.982 . . . . 0.0 110.345 -174.758 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' MET . . . . . 0.411 ' HG2' ' CD1' ' A' ' 206' ' ' TYR . 14.6 mtp -141.84 141.14 33.09 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -167.67 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 16.8 tt -144.17 151.53 16.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 125.817 1.647 . . . . 0.0 109.636 169.436 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -138.29 145.98 17.61 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 123.874 0.75 . . . . 0.0 112.629 -169.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 6.5 t -69.88 145.78 51.74 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-O 122.228 1.013 . . . . 0.0 111.182 -172.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -81.29 -6.5 58.95 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.713 2.005 . . . . 0.0 113.442 -175.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -78.78 146.08 67.94 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 118.696 0.68 . . . . 0.0 111.568 -169.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.95 6.71 4.03 Favored 'Trans proline' 0 CA--C 1.547 1.172 0 C-N-CA 123.58 2.853 . . . . 0.0 111.718 167.782 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -126.72 -7.71 6.18 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.137 1.775 . . . . 0.0 112.628 -172.173 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 39.0 t -66.02 133.39 50.69 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.074 0.95 . . . . 0.0 109.791 174.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 50.2 m -112.1 10.47 20.32 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.639 1.576 . . . . 0.0 111.708 -174.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 22.0 mm -120.32 -33.62 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 125.905 1.682 . . . . 0.0 109.472 175.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 50.33 -10.21 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 130.624 3.57 . . . . 0.0 118.917 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 54.9 m95 -144.5 156.9 44.39 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.395 1.478 . . . . 0.0 111.83 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -158.88 154.35 25.88 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.362 1.865 . . . . 0.0 109.377 -176.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 30.6 m-70 -69.37 154.51 41.91 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 166.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 13.9 m-30 -52.33 -50.68 61.82 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 166.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -69.5 -13.08 62.15 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 4.8 t -69.16 -19.1 64.0 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.646 0.778 . . . . 0.0 112.476 172.86 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.0 p -114.82 -21.52 5.3 Favored 'Isoleucine or valine' 0 C--N 1.347 0.466 0 C-N-CA 125.605 1.562 . . . . 0.0 112.275 172.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 105.71 17.95 12.46 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 126.029 1.776 . . . . 0.0 113.752 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 13.5 mt -71.76 162.53 29.31 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.271 1.536 . . . . 0.0 111.854 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 36.0 m -138.42 -24.81 0.95 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.348 1.459 . . . . 0.0 111.417 -176.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 46.2 p -139.15 140.59 37.93 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.681 1.592 . . . . 0.0 108.432 176.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -78.14 119.22 76.53 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 123.413 0.685 . . . . 0.0 112.03 -169.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -81.21 175.93 9.27 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.692 2.928 . . . . 0.0 111.015 169.21 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 13.5 ttp85 -145.0 134.78 23.54 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 124.035 0.934 . . . . 0.0 109.019 172.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 127.38 -165.07 20.65 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.807 1.67 . . . . 0.0 111.136 -175.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.72 120.91 10.99 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 124.203 1.001 . . . . 0.0 109.686 171.272 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 58.5 t90 -138.56 144.29 39.8 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 127.257 2.223 . . . . 0.0 108.482 175.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -120.27 135.85 54.86 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.468 1.107 . . . . 0.0 109.309 -178.101 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -67.46 168.78 10.72 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 124.279 1.031 . . . . 0.0 111.72 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.38 -36.09 28.59 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.108 1.205 . . . . 0.0 112.681 -172.137 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 67.6 mtt-85 -75.55 0.06 18.67 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.373 1.069 . . . . 0.0 113.405 175.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 24.7 m -115.06 -21.27 10.1 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.029 1.331 . . . . 0.0 113.821 -176.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.1 t -151.22 -28.14 0.2 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.545 1.066 . . . . 0.0 113.56 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -76.57 -13.54 60.07 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.903 0.774 . . . . 0.0 112.299 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 . . . . . 0 CA--C 1.542 0.65 0 C-N-CA 123.706 0.803 . . . . 0.0 112.54 169.6 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 CA--C 1.535 0.542 0 CA-C-O 120.967 0.32 . . . . 0.0 111.78 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 68.0 p -146.57 175.02 10.89 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.743 1.217 . . . . 0.0 110.66 -174.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -137.61 -83.66 0.32 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 117.337 -1.316 . . . . 0.0 112.588 -170.463 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.1 t -55.67 168.21 0.45 Allowed 'General case' 0 C--N 1.352 0.692 0 CA-C-N 119.844 1.202 . . . . 0.0 113.336 -177.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.1 pp -57.49 -12.73 2.87 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.882 1.273 . . . . 0.0 112.861 170.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' CYS . . . . . 0.407 ' HB2' ' NE2' ' A' ' 203' ' ' GLN . 71.7 m -76.82 -19.87 57.04 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.899 2.079 . . . . 0.0 113.275 176.258 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 22.3 m170 57.86 64.01 1.65 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.907 2.083 . . . . 0.0 111.543 -173.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' GLN . . . . . 0.407 ' NE2' ' HB2' ' A' ' 201' ' ' CYS . 0.4 OUTLIER -128.77 157.61 40.97 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.124 1.37 . . . . 0.0 112.561 175.484 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.5 HG12 ' H ' ' A' ' 205' ' ' SER . 0.4 OUTLIER -68.57 -178.72 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 126.45 1.9 . . . . 0.0 111.325 -177.873 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.5 ' H ' HG12 ' A' ' 204' ' ' VAL . 49.8 m -42.35 145.65 0.38 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 128.012 2.525 . . . . 0.0 113.472 177.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' TYR . . . . . 0.44 ' CE2' ' HG2' ' A' ' 209' ' ' MET . 13.2 p90 -152.03 165.31 35.07 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.837 1.255 . . . . 0.0 111.935 -167.605 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -67.98 -47.91 57.25 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.76 1.172 . . . . 0.0 115.018 -168.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -127.8 125.38 39.72 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 118.401 1.1 . . . . 0.0 109.849 -170.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' MET . . . . . 0.44 ' HG2' ' CE2' ' A' ' 206' ' ' TYR . 9.1 mtp -140.47 147.9 40.32 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -166.312 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 17.0 tt -135.05 155.68 38.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 125.843 1.657 . . . . 0.0 109.557 168.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -132.73 139.18 10.72 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.668 1.127 . . . . 0.0 112.45 -172.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' CYS . . . . . 0.592 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 1.8 m -79.51 127.12 31.75 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 125.487 1.515 . . . . 0.0 112.19 -167.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -70.22 -3.61 17.81 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.35 1.86 . . . . 0.0 113.692 -175.582 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -67.77 146.95 98.61 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 123.547 0.739 . . . . 0.0 111.469 -174.825 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.83 5.65 6.18 Favored 'Trans proline' 0 CA--C 1.55 1.3 0 C-N-CA 123.138 2.559 . . . . 0.0 111.372 166.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -134.13 -13.51 2.42 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 125.21 1.404 . . . . 0.0 114.381 -169.45 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 36.8 t -63.72 132.57 51.43 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 118.973 0.806 . . . . 0.0 110.335 -176.702 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 69.7 m -109.29 11.72 25.17 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 113.637 -1.62 . . . . 0.0 111.602 -173.22 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 39.4 mm -119.3 -41.35 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 125.838 1.655 . . . . 0.0 108.604 173.177 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 47.67 -9.47 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.832 1 C-N-CA 131.717 4.007 . . . . 0.0 119.725 171.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -139.83 135.95 33.51 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.744 2.017 . . . . 0.0 109.197 172.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' PHE . . . . . 0.592 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 6.4 m-85 -143.47 155.82 44.47 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.376 1.471 . . . . 0.0 109.53 -169.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 18.2 m-70 -73.55 148.62 42.84 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 168.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 16.8 m-30 -52.19 -51.11 60.11 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.751 167.057 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.19 -14.34 62.59 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -177.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 2.8 m -78.12 -8.56 58.42 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 119.76 1.164 . . . . 0.0 112.777 173.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.7 p -119.07 -14.08 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 126.009 1.724 . . . . 0.0 112.198 169.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 96.8 17.4 33.01 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.693 1.616 . . . . 0.0 113.306 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 12.5 mt -71.55 160.37 32.81 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.582 1.191 . . . . 0.0 111.272 176.677 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 16.0 m -134.03 -1.4 2.98 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.998 1.719 . . . . 0.0 110.37 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 9.3 t -150.58 177.11 10.35 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.284 1.834 . . . . 0.0 109.674 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -108.92 105.67 57.54 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 124.305 1.042 . . . . 0.0 109.391 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.48 175.52 10.53 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.221 2.614 . . . . 0.0 111.435 173.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -140.1 133.57 30.06 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 124.856 1.262 . . . . 0.0 108.229 173.428 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 124.24 -175.89 16.95 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 126.156 1.836 . . . . 0.0 110.845 -170.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -66.69 131.65 46.43 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.996 0.903 . . . . 0.0 110.368 173.605 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 52.8 t90 -136.99 141.55 42.57 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 127.011 2.125 . . . . 0.0 108.779 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -124.5 127.38 47.37 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.467 1.107 . . . . 0.0 108.828 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 239' ' ' CYS . . . . . 0.414 ' HB2' ' HD2' ' A' ' 240' ' ' PRO . 6.2 p -60.73 167.57 3.29 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 126.465 1.906 . . . . 0.0 113.299 -173.251 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.414 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 33.4 Cg_endo -65.33 -30.3 53.94 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.491 1.461 . . . . 0.0 112.809 -170.977 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 53.7 mtt-85 -86.96 13.58 8.87 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.302 1.041 . . . . 0.0 112.747 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 20.1 m -131.01 -14.03 3.51 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.159 1.784 . . . . 0.0 113.518 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 32.1 t -149.33 -39.47 0.15 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.72 0.808 . . . . 0.0 112.414 -178.061 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -82.09 -11.38 58.8 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -175.15 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 . . . . . 0 CA--C 1.544 0.717 0 C-N-CA 123.92 0.888 . . . . 0.0 112.717 172.164 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo . . . . . 0 CA--C 1.535 0.566 0 CA-C-O 121.244 0.435 . . . . 0.0 112.063 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 72.9 p -144.23 175.96 9.69 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.904 1.281 . . . . 0.0 110.453 -174.6 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -136.66 -80.68 0.39 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 117.275 -1.345 . . . . 0.0 113.213 -171.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 3.1 t -55.97 167.81 0.55 Allowed 'General case' 0 C--N 1.35 0.609 0 CA-C-N 119.963 1.256 . . . . 0.0 113.115 -176.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.9 pp -59.4 -10.06 2.89 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.417 1.087 . . . . 0.0 112.717 169.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 75.2 m -77.04 -21.86 53.86 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.658 1.983 . . . . 0.0 113.19 174.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 54.29 68.83 0.79 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.752 2.021 . . . . 0.0 111.629 -170.068 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.9 160.6 33.06 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.688 1.595 . . . . 0.0 111.468 173.088 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.531 HG12 ' H ' ' A' ' 205' ' ' SER . 0.6 OUTLIER -70.29 -178.94 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 125.62 1.568 . . . . 0.0 111.142 -178.158 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.531 ' H ' HG12 ' A' ' 204' ' ' VAL . 28.3 m -46.34 151.05 0.56 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 128.093 2.557 . . . . 0.0 114.348 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -154.17 168.47 26.41 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.351 1.46 . . . . 0.0 111.413 -169.263 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -70.61 -50.85 23.4 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.379 0.99 . . . . 0.0 114.651 -169.004 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -125.53 122.34 36.29 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 118.091 0.945 . . . . 0.0 110.297 -170.12 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -144.09 147.01 33.19 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -166.433 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 16.2 tt -142.04 152.77 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 125.47 1.508 . . . . 0.0 109.783 169.146 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -132.35 147.01 18.65 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 124.051 0.834 . . . . 0.0 112.456 -169.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 7.0 t -71.2 143.4 50.48 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-O 122.019 0.914 . . . . 0.0 111.369 -172.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -79.36 -8.98 59.48 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.786 2.034 . . . . 0.0 114.193 -176.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -74.39 144.03 80.51 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 119.458 1.027 . . . . 0.0 111.041 -174.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -75.63 6.02 3.92 Favored 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 123.471 2.781 . . . . 0.0 111.802 168.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -124.89 -6.19 7.36 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.533 1.933 . . . . 0.0 112.28 -173.775 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 49.8 t -63.7 133.42 53.55 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.899 0.879 . . . . 0.0 109.703 174.385 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 10.4 t -114.75 11.24 16.75 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.644 1.578 . . . . 0.0 111.611 -174.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 33.0 mm -120.25 -31.97 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 126.229 1.812 . . . . 0.0 109.411 176.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 50.36 -13.81 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 131.539 3.936 . . . . 0.0 119.204 176.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 58.2 m95 -143.62 152.53 41.49 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.645 1.578 . . . . 0.0 110.755 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -154.33 150.87 28.43 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.376 1.471 . . . . 0.0 110.473 -174.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -71.59 150.17 44.96 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.26 0.552 . . . . 0.0 109.816 168.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 11.4 m-30 -53.49 -51.28 63.29 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.469 167.247 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.82 -12.85 61.48 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 1.7 m -76.56 -12.31 60.0 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.771 1.169 . . . . 0.0 112.299 172.449 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.56 -15.46 9.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 126.172 1.789 . . . . 0.0 112.185 171.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 95.07 20.43 28.1 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.792 1.663 . . . . 0.0 113.663 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 20.4 mt -71.49 157.98 37.06 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.987 1.394 . . . . 0.0 111.407 177.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 91.4 m -131.41 -25.09 2.21 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.828 1.651 . . . . 0.0 110.772 -177.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 61.1 p -138.73 150.85 46.59 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.182 1.793 . . . . 0.0 108.271 172.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -79.77 119.34 76.44 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-O 118.533 -0.746 . . . . 0.0 110.756 -174.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -76.67 165.92 28.02 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 122.922 2.415 . . . . 0.0 110.39 169.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -138.03 130.92 29.9 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-O 122.195 0.997 . . . . 0.0 109.06 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 127.82 -165.9 20.68 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 126.757 2.123 . . . . 0.0 109.407 -168.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.92 142.7 54.67 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 122.469 1.128 . . . . 0.0 109.771 169.614 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 55.0 t90 -147.31 146.15 29.61 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 127.254 2.222 . . . . 0.0 108.203 -177.438 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -124.13 137.2 54.58 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.421 1.089 . . . . 0.0 110.197 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -69.08 169.91 10.25 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 125.186 1.394 . . . . 0.0 112.581 -177.31 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -74.51 1.04 7.89 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.398 2.066 . . . . 0.0 114.506 -175.393 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -117.63 16.72 14.52 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.53 1.932 . . . . 0.0 110.883 172.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 22.2 m -134.39 -16.99 2.07 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.367 1.867 . . . . 0.0 112.744 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 32.8 t -154.01 -40.91 0.09 Allowed 'General case' 0 C--N 1.345 0.377 0 CA-C-N 118.975 0.807 . . . . 0.0 112.775 175.622 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -74.82 -6.16 47.49 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 . . . . . 0 CA--C 1.548 0.884 0 C-N-CA 126.186 1.795 . . . . 0.0 112.671 173.298 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo . . . . . 0 CA--C 1.536 0.607 0 CA-C-O 121.235 0.431 . . . . 0.0 111.719 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 66.0 p -143.69 175.02 10.29 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.009 1.324 . . . . 0.0 110.188 -176.482 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -133.98 -83.83 0.44 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 117.293 -1.337 . . . . 0.0 113.05 -169.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.4 t -55.28 170.19 0.23 Allowed 'General case' 0 C--N 1.351 0.651 0 C-N-CA 124.948 1.299 . . . . 0.0 113.901 -175.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.3 pp -58.38 -14.12 6.87 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.32 1.048 . . . . 0.0 112.605 169.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 75.2 m -75.79 -23.66 55.9 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.029 2.132 . . . . 0.0 112.895 174.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 53.08 69.42 0.7 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 127.434 2.294 . . . . 0.0 112.156 -171.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -125.46 160.63 28.99 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.091 1.756 . . . . 0.0 111.37 172.844 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.538 HG12 ' H ' ' A' ' 205' ' ' SER . 0.8 OUTLIER -69.24 -178.67 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 125.705 1.602 . . . . 0.0 110.883 -178.875 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.538 ' H ' HG12 ' A' ' 204' ' ' VAL . 85.8 p -44.3 148.2 0.47 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.566 2.347 . . . . 0.0 113.713 178.263 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -152.44 168.96 23.78 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.723 1.209 . . . . 0.0 112.168 -167.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -69.11 -53.05 20.23 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.807 1.194 . . . . 0.0 114.743 -168.905 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -125.07 125.64 44.12 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 118.271 1.036 . . . . 0.0 109.711 -172.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -142.55 145.54 33.71 Favored 'General case' 0 C--N 1.34 0.169 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -166.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 20.6 tt -134.8 150.77 30.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 125.705 1.602 . . . . 0.0 109.644 173.159 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -128.59 139.06 10.73 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 124.528 1.061 . . . . 0.0 112.576 -171.597 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' CYS . . . . . 0.6 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 5.5 m -75.11 125.78 29.66 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 125.362 1.465 . . . . 0.0 111.325 -168.356 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -70.03 -4.04 19.09 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.495 1.518 . . . . 0.0 113.452 -177.541 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -68.02 145.6 97.81 Favored Pre-proline 0 CA--C 1.538 0.518 0 O-C-N 121.544 -0.723 . . . . 0.0 110.905 -175.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -80.92 8.32 4.39 Favored 'Trans proline' 0 CA--C 1.549 1.258 0 C-N-CA 123.049 2.499 . . . . 0.0 111.296 166.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -133.81 -14.06 2.47 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 125.21 1.404 . . . . 0.0 114.323 -169.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.5 t -65.29 134.33 53.36 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 123.721 0.809 . . . . 0.0 110.699 -176.207 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 96.6 p -107.27 7.97 29.61 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.972 1.709 . . . . 0.0 112.188 -173.736 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 37.5 mm -118.95 -41.03 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 125.815 1.646 . . . . 0.0 108.676 177.164 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 48.16 -8.55 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 131.461 3.904 . . . . 0.0 119.697 170.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 61.7 m95 -141.28 137.43 32.48 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.781 2.032 . . . . 0.0 109.625 171.513 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' PHE . . . . . 0.6 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 6.9 m-85 -145.46 156.96 44.06 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 125.738 1.615 . . . . 0.0 109.69 -169.634 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 22.1 m-70 -73.97 149.07 41.55 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 167.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -51.7 -52.03 51.43 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.746 167.124 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.78 -13.82 62.19 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -177.139 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 2.1 m -77.54 -11.13 59.82 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.785 1.175 . . . . 0.0 112.594 173.554 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 10.6 p -116.09 -16.47 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 125.799 1.64 . . . . 0.0 112.134 170.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 102.27 14.87 27.15 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.781 1.657 . . . . 0.0 113.395 177.804 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 26.0 mt -72.89 160.06 32.73 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.828 1.314 . . . . 0.0 110.928 175.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 67.4 p -131.71 -7.96 3.6 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.833 1.653 . . . . 0.0 111.598 177.234 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 73.8 p -144.73 166.2 25.9 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.006 2.122 . . . . 0.0 108.766 177.256 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -90.21 121.17 68.93 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-O 118.821 -0.609 . . . . 0.0 109.497 175.281 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -75.91 178.94 6.78 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.569 2.846 . . . . 0.0 110.78 169.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -141.59 132.55 26.03 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 170.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 120.69 -170.88 14.55 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 126.06 1.79 . . . . 0.0 110.166 -168.856 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.5 144.98 53.04 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 122.252 1.025 . . . . 0.0 110.849 174.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 237' ' ' TRP . . . . . 0.494 ' HZ3' ' HG ' ' A' ' 212' ' ' CYS . 60.2 t90 -145.93 138.96 25.88 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.994 2.118 . . . . 0.0 109.406 177.753 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 14.4 m-30 -118.4 131.91 56.27 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.717 1.207 . . . . 0.0 109.261 175.044 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 239' ' ' CYS . . . . . 0.475 ' HB2' ' HD2' ' A' ' 240' ' ' PRO . 4.0 p -63.32 173.23 1.25 Allowed Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 127.61 2.364 . . . . 0.0 114.675 -174.195 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 72.6 Cg_endo -72.87 -3.33 13.4 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.815 2.343 . . . . 0.0 114.858 -171.034 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -111.61 13.62 21.26 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.589 1.555 . . . . 0.0 111.234 174.034 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 39.0 m -135.94 -16.0 1.73 Allowed 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.565 1.946 . . . . 0.0 113.234 -174.338 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 46.6 t -150.98 -41.6 0.12 Allowed 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.763 0.825 . . . . 0.0 112.446 177.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -71.71 -23.43 61.63 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.012 0.369 . . . . 0.0 111.527 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 CA--C 1.541 0.605 0 C-N-CA 126.547 1.939 . . . . 0.0 113.42 175.364 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo . . . . . 0 N--CA 1.457 -0.643 0 N-CA-C 110.587 -0.582 . . . . 0.0 110.587 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 80.4 p -141.68 172.22 12.98 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.47 1.108 . . . . 0.0 110.005 -177.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -134.47 -83.97 0.43 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 117.316 -1.325 . . . . 0.0 112.885 -168.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' CYS . . . . . 0.419 ' H ' HE22 ' A' ' 203' ' ' GLN . 1.9 t -55.17 168.5 0.33 Allowed 'General case' 0 C--N 1.351 0.667 0 C-N-CA 124.957 1.303 . . . . 0.0 113.274 -176.564 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.2 pp -57.05 -12.42 2.08 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.23 1.412 . . . . 0.0 113.145 170.404 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 71.3 m -78.76 -18.94 53.38 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.593 1.957 . . . . 0.0 113.208 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 23.3 m170 57.32 62.21 2.26 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.874 2.069 . . . . 0.0 111.663 -173.053 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' GLN . . . . . 0.419 HE22 ' H ' ' A' ' 199' ' ' CYS . 0.0 OUTLIER -125.65 158.75 33.95 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.022 1.329 . . . . 0.0 112.435 176.6 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.47 HG12 ' H ' ' A' ' 205' ' ' SER . 0.3 OUTLIER -69.17 -179.4 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 126.355 1.862 . . . . 0.0 111.366 -176.976 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.47 ' H ' HG12 ' A' ' 204' ' ' VAL . 79.5 p -45.37 147.62 0.77 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.42 2.288 . . . . 0.0 113.911 178.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -154.08 173.54 15.9 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.537 1.535 . . . . 0.0 111.223 -167.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -80.96 -71.36 1.29 Allowed Glycine 0 CA--C 1.528 0.893 0 C-N-CA 123.831 0.729 . . . . 0.0 112.959 -170.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -91.84 120.4 32.51 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 123.632 0.773 . . . . 0.0 111.117 -174.284 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -142.02 143.86 33.36 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -168.611 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 19.8 tt -134.97 150.36 29.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 125.541 1.537 . . . . 0.0 109.939 172.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -127.99 139.29 10.99 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.788 1.185 . . . . 0.0 112.641 -171.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' CYS . . . . . 0.592 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 1.9 m -78.75 126.12 30.29 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.582 1.553 . . . . 0.0 111.802 -168.078 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.39 -2.36 10.77 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.58 1.952 . . . . 0.0 113.808 -175.601 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -66.49 149.98 97.63 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 123.769 0.828 . . . . 0.0 112.12 -174.264 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -83.76 7.76 5.01 Favored 'Trans proline' 0 CA--C 1.549 1.262 0 C-N-CA 123.725 2.95 . . . . 0.0 111.342 166.613 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -144.39 -10.86 0.63 Allowed 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 -167.531 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 36.7 t -60.93 134.09 56.74 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 119.465 1.03 . . . . 0.0 110.468 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.5 t -110.47 14.24 22.57 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.762 1.625 . . . . 0.0 111.124 -173.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 51.7 mt -122.75 -41.97 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 125.327 1.451 . . . . 0.0 108.577 172.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 47.63 -8.59 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 131.351 3.861 . . . . 0.0 119.552 172.117 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 62.3 m95 -139.62 136.07 33.98 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 126.497 1.919 . . . . 0.0 109.603 170.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' PHE . . . . . 0.592 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 7.2 m-85 -142.49 158.69 43.42 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 125.572 1.549 . . . . 0.0 109.179 -169.17 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -78.45 148.14 33.68 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 169.75 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -51.74 -51.37 56.68 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.937 167.789 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.84 -13.23 61.62 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -176.914 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 4.8 m -78.29 -8.1 57.99 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.81 1.186 . . . . 0.0 112.608 172.648 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.8 p -120.9 -12.68 8.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 126.319 1.847 . . . . 0.0 112.185 170.815 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 94.28 18.24 36.98 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.693 1.616 . . . . 0.0 113.4 178.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 19.4 mt -72.05 158.34 36.13 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.749 1.275 . . . . 0.0 111.327 176.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 59.7 m -134.86 -18.38 1.86 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.782 1.633 . . . . 0.0 111.145 -177.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 62.7 m -144.33 139.62 28.63 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 125.692 1.597 . . . . 0.0 107.82 178.166 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -70.58 122.6 87.1 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 123.519 0.727 . . . . 0.0 110.836 -176.218 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -81.48 -179.8 5.21 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.769 2.979 . . . . 0.0 111.617 173.08 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -139.62 135.82 33.71 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.031 1.332 . . . . 0.0 107.475 169.615 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 116.54 -174.61 15.32 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.405 1.478 . . . . 0.0 111.747 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -62.34 122.72 16.38 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.883 1.273 . . . . 0.0 111.09 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 44.7 t90 -132.98 143.02 49.17 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 127.201 2.2 . . . . 0.0 108.6 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -126.92 126.77 43.81 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.564 1.146 . . . . 0.0 109.003 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 239' ' ' CYS . . . . . 0.424 ' HB2' ' HD2' ' A' ' 240' ' ' PRO . 5.8 p -61.23 169.08 2.38 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 126.857 2.063 . . . . 0.0 114.007 -172.05 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.424 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 57.5 Cg_endo -72.44 1.48 6.14 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.559 2.173 . . . . 0.0 115.221 -171.068 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 38.3 mtp180 -117.42 17.58 14.55 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.224 1.41 . . . . 0.0 112.106 170.805 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 31.7 m -133.52 -14.0 2.57 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.434 1.894 . . . . 0.0 112.763 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 33.0 t -147.87 -33.06 0.26 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.058 0.943 . . . . 0.0 112.195 177.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -86.8 -13.48 44.99 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -173.794 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 . . . . . 0 CA--C 1.544 0.738 0 CA-C-N 119.443 1.02 . . . . 0.0 112.531 169.493 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo . . . . . 0 CA--C 1.535 0.557 0 CA-C-O 121.172 0.405 . . . . 0.0 111.978 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 65.6 p -146.04 176.39 9.75 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.864 1.266 . . . . 0.0 110.536 -173.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -135.34 -83.59 0.41 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 117.508 -1.234 . . . . 0.0 112.707 -169.886 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.0 t -55.88 167.81 0.54 Allowed 'General case' 0 C--N 1.351 0.66 0 CA-C-N 119.741 1.155 . . . . 0.0 113.129 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 2.9 pp -57.66 -12.66 3.05 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.92 1.288 . . . . 0.0 112.768 171.105 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 74.6 m -76.64 -19.65 57.56 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.544 1.938 . . . . 0.0 113.214 176.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 29.9 m170 56.8 64.52 1.64 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.729 2.011 . . . . 0.0 111.396 -172.251 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.41 156.98 39.71 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.231 1.412 . . . . 0.0 112.13 174.577 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.553 HG12 ' H ' ' A' ' 205' ' ' SER . 0.9 OUTLIER -69.61 -178.21 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 126.114 1.766 . . . . 0.0 110.916 -178.39 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.553 ' H ' HG12 ' A' ' 204' ' ' VAL . 88.0 p -45.51 148.77 0.64 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.53 2.332 . . . . 0.0 113.964 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -154.97 173.67 16.22 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.276 1.43 . . . . 0.0 111.346 -167.64 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -80.75 -73.2 1.18 Allowed Glycine 0 C--N 1.341 0.852 0 C-N-CA 123.877 0.751 . . . . 0.0 112.784 -171.005 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -88.54 119.44 29.0 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.597 0.759 . . . . 0.0 111.238 -176.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -142.52 143.77 32.66 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -169.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 21.3 tt -136.53 152.0 28.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 125.729 1.612 . . . . 0.0 109.706 173.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -129.5 139.23 10.8 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.514 1.054 . . . . 0.0 112.914 -172.004 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' CYS . . . . . 0.602 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 7.3 m -75.77 127.74 33.68 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.898 1.679 . . . . 0.0 111.548 -168.57 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -71.02 -1.86 13.52 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.973 1.709 . . . . 0.0 113.591 -177.157 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -67.02 148.15 98.94 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 123.661 0.784 . . . . 0.0 111.523 -175.377 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -82.43 8.05 4.77 Favored 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 123.592 2.861 . . . . 0.0 111.631 167.135 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -144.16 -9.87 0.67 Allowed 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -167.613 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.8 t -62.39 133.47 55.1 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 119.607 1.094 . . . . 0.0 110.443 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 9.4 t -106.21 4.65 29.13 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.705 1.602 . . . . 0.0 111.687 -173.439 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 42.8 mm -112.18 -42.32 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 125.736 1.614 . . . . 0.0 108.777 175.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 48.82 -11.15 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 131.556 3.943 . . . . 0.0 119.597 171.544 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -138.8 137.82 36.99 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.778 2.031 . . . . 0.0 109.387 170.838 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' PHE . . . . . 0.602 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 7.3 m-85 -144.39 157.08 44.44 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.527 1.531 . . . . 0.0 109.654 -169.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 47.0 m80 -74.46 149.75 40.21 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 167.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 10.0 m-30 -51.4 -52.81 42.71 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.727 167.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.47 -12.44 61.39 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 118.253 -0.88 . . . . 0.0 113.253 -176.395 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 2.0 m -77.43 -8.49 57.81 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.759 1.163 . . . . 0.0 112.5 172.009 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.6 p -121.77 -14.08 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 126.082 1.753 . . . . 0.0 112.514 170.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 98.66 16.53 31.12 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 125.856 1.693 . . . . 0.0 113.513 178.058 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 19.6 mt -71.49 162.17 29.87 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.908 1.354 . . . . 0.0 111.66 177.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.7 t -139.22 -14.5 1.14 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.51 1.524 . . . . 0.0 112.512 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 59.7 m -146.86 139.54 25.05 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.019 1.728 . . . . 0.0 107.287 177.189 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -69.35 119.5 70.86 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-O 118.721 -0.657 . . . . 0.0 110.55 -177.099 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -78.29 174.63 12.13 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.463 2.776 . . . . 0.0 110.67 170.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 30.1 ttp-105 -143.16 130.98 21.49 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 121.923 0.868 . . . . 0.0 108.795 170.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 126.4 -174.38 17.96 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 126.343 1.925 . . . . 0.0 110.409 -169.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -66.4 128.84 37.73 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.18 0.992 . . . . 0.0 110.761 175.173 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 237' ' ' TRP . . . . . 0.429 ' HZ3' ' HG ' ' A' ' 212' ' ' CYS . 54.8 t90 -135.74 145.01 46.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 127.304 2.242 . . . . 0.0 109.134 178.168 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -130.6 124.8 32.54 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.691 1.196 . . . . 0.0 109.6 -176.589 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 239' ' ' CYS . . . . . 0.429 ' HB3' ' SG ' ' A' ' 212' ' ' CYS . 1.9 p -61.25 172.92 0.81 Allowed Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 128.1 2.56 . . . . 0.0 114.835 -171.474 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 94.7 Cg_endo -76.06 12.82 1.4 Allowed 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.608 2.872 . . . . 0.0 115.365 -171.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 35.8 mtp180 -125.53 13.82 8.15 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.716 1.606 . . . . 0.0 111.058 169.055 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 66.6 m -135.73 -22.28 1.45 Allowed 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.939 1.695 . . . . 0.0 113.714 -174.448 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 27.8 t -151.65 -42.08 0.11 Allowed 'General case' 0 C--N 1.342 0.278 0 CA-C-N 119.004 0.82 . . . . 0.0 112.614 175.526 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 7.7 tm0? -77.25 -13.85 59.86 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 119.337 -0.363 . . . . 0.0 111.65 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 . . . . . 0 CA--C 1.539 0.537 0 C-N-CA 124.842 1.257 . . . . 0.0 113.18 178.809 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo . . . . . 0 CA--C 1.536 0.588 0 CA-C-O 121.095 0.373 . . . . 0.0 111.554 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 67.6 p -145.07 173.6 11.77 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.578 1.151 . . . . 0.0 110.715 -175.015 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -136.79 -83.27 0.36 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 117.355 -1.307 . . . . 0.0 112.565 -170.231 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.0 t -55.6 168.21 0.44 Allowed 'General case' 0 C--N 1.351 0.641 0 C-N-CA 125.013 1.325 . . . . 0.0 113.378 -176.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.0 pp -57.45 -12.69 2.79 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.079 1.352 . . . . 0.0 113.031 170.511 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 72.7 m -77.17 -19.9 56.17 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.461 1.904 . . . . 0.0 113.223 176.301 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 21.8 m170 57.75 63.92 1.69 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.868 2.067 . . . . 0.0 111.565 -172.11 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.22 158.13 38.96 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.079 1.352 . . . . 0.0 112.496 175.585 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.544 HG12 ' H ' ' A' ' 205' ' ' SER . 0.9 OUTLIER -67.83 -179.1 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 126.389 1.876 . . . . 0.0 111.144 -177.82 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.544 ' H ' HG12 ' A' ' 204' ' ' VAL . 88.3 p -46.31 150.17 0.66 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.562 2.345 . . . . 0.0 113.84 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' TYR . . . . . 0.466 ' CE2' ' HG2' ' A' ' 209' ' ' MET . 18.3 p90 -155.55 164.87 38.09 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.127 1.371 . . . . 0.0 111.227 -167.512 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -73.8 -49.44 13.85 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 118.666 -1.074 . . . . 0.0 114.814 -169.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -117.2 121.33 40.92 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 118.478 1.139 . . . . 0.0 110.362 -170.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' MET . . . . . 0.466 ' HG2' ' CE2' ' A' ' 206' ' ' TYR . 2.8 mtp -140.48 148.66 41.46 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -166.255 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 14.5 tt -136.91 156.55 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 125.57 1.548 . . . . 0.0 109.32 168.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -133.75 139.18 10.68 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.488 1.042 . . . . 0.0 112.4 -171.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' CYS . . . . . 0.586 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 1.1 m -79.61 125.99 30.32 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.191 1.397 . . . . 0.0 112.233 -167.605 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -69.37 -4.96 20.49 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.598 1.959 . . . . 0.0 113.888 -175.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -66.43 145.65 98.98 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.424 0.689 . . . . 0.0 111.396 -173.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -81.92 9.21 4.04 Favored 'Trans proline' 0 CA--C 1.551 1.343 0 C-N-CA 123.074 2.516 . . . . 0.0 110.946 165.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -134.41 -15.56 2.17 Favored 'General case' 0 C--N 1.35 0.614 0 C-N-CA 125.407 1.483 . . . . 0.0 114.365 -169.271 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 35.6 t -65.05 136.13 56.39 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 123.905 0.882 . . . . 0.0 110.611 -175.915 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.4 t -113.07 14.57 19.59 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.721 1.608 . . . . 0.0 111.217 -174.274 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 51.3 mt -123.2 -42.34 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 125.363 1.465 . . . . 0.0 108.71 173.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 47.28 -7.59 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 131.453 3.901 . . . . 0.0 119.59 171.534 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 66.1 m95 -139.0 134.84 33.6 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.466 1.907 . . . . 0.0 109.259 170.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' PHE . . . . . 0.586 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 7.8 m-85 -142.01 157.09 45.34 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.362 1.465 . . . . 0.0 109.075 -169.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -77.0 148.6 36.15 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 169.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 14.4 m-30 -51.92 -51.62 55.69 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.89 167.441 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.51 -14.18 62.41 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.387 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 6.5 m -79.38 -6.67 57.32 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 119.748 1.158 . . . . 0.0 112.766 173.247 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.9 p -120.87 -12.62 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 125.965 1.706 . . . . 0.0 112.113 169.62 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 96.31 16.87 36.07 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.509 1.528 . . . . 0.0 113.317 178.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 13.7 mt -71.82 159.46 34.27 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.581 1.191 . . . . 0.0 111.068 175.71 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 24.4 m -133.17 -5.52 3.04 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.115 1.766 . . . . 0.0 110.41 177.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 80.1 p -142.51 179.62 6.85 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.815 2.046 . . . . 0.0 109.398 -178.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -112.33 97.32 39.18 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 124.232 1.013 . . . . 0.0 109.528 178.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -70.6 167.73 24.71 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.425 2.084 . . . . 0.0 110.255 169.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -140.69 131.72 26.22 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.981 0.896 . . . . 0.0 109.084 175.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 138.88 -173.43 22.62 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 126.577 2.037 . . . . 0.0 109.688 -169.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -70.83 126.99 31.11 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.729 0.776 . . . . 0.0 109.68 170.922 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 39.0 t90 -133.51 144.58 49.5 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.864 2.066 . . . . 0.0 108.493 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -126.21 131.2 52.02 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.568 1.147 . . . . 0.0 108.935 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 3.7 p -61.82 167.04 5.08 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 126.106 1.763 . . . . 0.0 112.63 -175.616 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.77 -36.41 32.19 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.026 1.15 . . . . 0.0 112.097 -170.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 60.8 mtt-85 -78.31 10.93 2.66 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.496 1.119 . . . . 0.0 112.907 178.708 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 19.1 m -129.37 -13.56 4.36 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.431 1.892 . . . . 0.0 113.883 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 35.7 t -149.77 -42.43 0.14 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.884 0.766 . . . . 0.0 112.561 -176.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 47.3 tp60 -75.2 -18.43 60.15 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 118.494 -0.765 . . . . 0.0 112.834 -177.415 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 . . . . . 0 CA--C 1.538 0.504 0 CA-C-N 119.371 0.987 . . . . 0.0 111.709 172.828 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo . . . . . 0 CA--C 1.535 0.564 0 CA-C-O 121.157 0.399 . . . . 0.0 112.063 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 64.4 p -144.43 175.22 10.28 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.067 1.347 . . . . 0.0 110.327 -174.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -134.4 -81.26 0.45 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 117.328 -1.32 . . . . 0.0 113.26 -170.859 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.9 t -54.77 167.09 0.4 Allowed 'General case' 0 C--N 1.35 0.594 0 C-N-CA 125.078 1.351 . . . . 0.0 113.174 -176.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 4.2 pp -60.17 -11.0 5.11 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.207 1.003 . . . . 0.0 112.715 169.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 72.3 m -74.38 -24.0 59.07 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.551 1.94 . . . . 0.0 112.906 172.377 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 54.63 69.65 0.7 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 127.291 2.236 . . . . 0.0 111.925 -170.268 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.6 162.21 27.82 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.832 1.653 . . . . 0.0 111.689 173.219 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.477 HG12 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -70.28 -177.9 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 126.04 1.736 . . . . 0.0 111.686 -176.469 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.477 ' H ' HG12 ' A' ' 204' ' ' VAL . 40.5 m -44.34 150.34 0.32 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 128.2 2.6 . . . . 0.0 114.497 177.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -158.06 170.27 22.67 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.034 1.733 . . . . 0.0 110.553 -169.394 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -78.38 -66.52 1.73 Allowed Glycine 0 CA--C 1.529 0.956 0 CA-C-O 119.438 -0.645 . . . . 0.0 113.149 -170.023 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -100.54 122.41 43.19 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 123.684 0.794 . . . . 0.0 110.745 -173.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -144.11 146.52 32.85 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -167.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 13.7 tt -144.01 153.96 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 125.006 1.322 . . . . 0.0 109.922 169.116 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -132.81 145.47 17.42 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 123.97 0.795 . . . . 0.0 112.01 -170.092 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 4.2 t -70.07 142.76 52.63 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.971 0.891 . . . . 0.0 110.863 -173.599 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -78.32 -5.43 52.11 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.109 1.764 . . . . 0.0 113.57 -174.232 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -80.77 144.63 56.28 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 118.816 0.734 . . . . 0.0 111.231 -169.494 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -75.67 4.84 4.73 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 123.564 2.843 . . . . 0.0 112.071 168.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -122.95 -6.61 8.44 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.214 1.806 . . . . 0.0 112.358 -173.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 36.7 t -65.25 136.5 56.68 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.305 1.042 . . . . 0.0 109.782 174.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 8.7 t -119.05 10.75 12.24 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.83 1.652 . . . . 0.0 111.248 -175.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 35.5 mm -118.64 -32.82 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 126.197 1.799 . . . . 0.0 109.261 175.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 50.02 -13.64 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.617 1 C-N-CA 131.769 4.028 . . . . 0.0 119.378 175.669 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 63.1 m95 -143.1 152.03 41.38 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.89 1.676 . . . . 0.0 110.365 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -154.05 154.66 34.08 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.555 1.542 . . . . 0.0 109.885 -172.258 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -77.47 148.8 35.18 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 170.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -52.62 -51.55 59.52 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.782 168.02 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.69 -13.25 61.68 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 118.325 -0.845 . . . . 0.0 113.261 -177.104 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 5.3 m -78.23 -6.11 53.94 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 119.713 1.142 . . . . 0.0 112.633 172.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 6.2 p -121.86 -16.77 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 125.659 1.584 . . . . 0.0 112.232 169.8 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 99.79 17.85 24.53 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.776 1.655 . . . . 0.0 113.667 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 18.9 mt -71.15 158.0 37.19 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 119.01 1.405 . . . . 0.0 111.104 177.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 90.0 m -134.53 -22.97 1.67 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.692 1.597 . . . . 0.0 110.973 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 48.6 p -140.73 143.57 35.07 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.91 1.684 . . . . 0.0 108.455 174.714 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -70.05 126.19 92.32 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-O 118.688 -0.672 . . . . 0.0 110.573 -176.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -76.57 -172.42 1.39 Allowed 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 123.813 3.009 . . . . 0.0 111.278 171.245 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -144.28 139.14 28.41 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 124.816 1.246 . . . . 0.0 108.466 176.246 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 97.23 -170.32 25.83 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.357 1.456 . . . . 0.0 111.675 -172.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -57.79 138.4 55.63 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.885 1.274 . . . . 0.0 111.177 175.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 52.6 t90 -142.25 153.8 44.23 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 127.301 2.24 . . . . 0.0 109.032 -177.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -130.71 132.76 45.55 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.853 1.261 . . . . 0.0 110.59 -174.996 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -67.08 167.35 14.71 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.232 1.013 . . . . 0.0 111.651 177.071 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.73 -27.0 27.16 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.303 1.335 . . . . 0.0 113.354 -172.707 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -87.3 9.8 19.23 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.435 1.094 . . . . 0.0 112.369 174.821 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 17.3 m -126.38 -17.58 5.12 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.565 1.546 . . . . 0.0 113.784 -176.111 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 33.8 t -152.97 -36.1 0.11 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.542 1.065 . . . . 0.0 112.959 174.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -68.49 -19.7 64.55 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 118.292 0.496 . . . . 0.0 112.134 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 . . . . . 0 CA--C 1.542 0.668 0 C-N-CA 125.009 1.323 . . . . 0.0 112.326 177.488 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo . . . . . 0 CA--C 1.534 0.499 0 CA-C-O 121.28 0.45 . . . . 0.0 111.942 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 71.2 p -144.49 175.43 10.13 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.902 1.281 . . . . 0.0 110.54 -172.106 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -136.57 -79.62 0.4 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 117.215 -1.374 . . . . 0.0 113.095 -170.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' CYS . . . . . 0.41 ' H ' HE22 ' A' ' 203' ' ' GLN . 0.8 OUTLIER -56.31 169.09 0.45 Allowed 'General case' 0 C--N 1.349 0.572 0 CA-C-N 120.013 1.279 . . . . 0.0 113.403 -175.573 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 4.6 pp -57.95 -11.13 2.15 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.897 1.279 . . . . 0.0 113.147 169.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 71.6 m -78.66 -23.3 45.81 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 126.927 2.091 . . . . 0.0 113.416 176.261 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 33.7 m170 59.02 66.61 1.03 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.473 1.909 . . . . 0.0 110.835 -169.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' GLN . . . . . 0.41 HE22 ' H ' ' A' ' 199' ' ' CYS . 0.0 OUTLIER -130.1 160.84 32.5 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.823 1.249 . . . . 0.0 112.247 174.048 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.536 HG12 ' H ' ' A' ' 205' ' ' SER . 0.6 OUTLIER -69.05 -179.26 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 126.125 1.77 . . . . 0.0 111.355 -175.994 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.536 ' H ' HG12 ' A' ' 204' ' ' VAL . 84.8 p -47.91 153.65 0.61 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.82 2.448 . . . . 0.0 114.689 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -154.87 169.16 24.66 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.223 1.809 . . . . 0.0 110.484 -169.18 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -79.52 -40.4 15.57 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.673 -1.07 . . . . 0.0 115.29 -168.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.12 119.0 21.29 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 118.57 1.185 . . . . 0.0 110.137 -168.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -142.08 152.37 43.24 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -164.197 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 15.7 tt -148.49 153.23 11.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 126.091 1.756 . . . . 0.0 109.516 167.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -131.99 146.45 18.07 Favored Glycine 0 C--N 1.336 0.529 0 C-N-CA 124.267 0.937 . . . . 0.0 111.634 -170.433 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 3.9 t -70.29 140.84 52.38 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-O 121.941 0.876 . . . . 0.0 111.042 -171.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -76.87 -5.09 46.99 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.311 1.844 . . . . 0.0 113.842 -174.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -78.45 147.59 72.22 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 118.846 0.748 . . . . 0.0 111.633 -169.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.51 8.42 2.99 Favored 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 124.135 3.223 . . . . 0.0 112.589 169.398 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -133.32 -9.53 2.91 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.011 1.724 . . . . 0.0 112.394 -169.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.9 t -61.22 133.91 56.44 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.932 0.893 . . . . 0.0 109.845 173.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 68.6 m -119.83 14.9 12.56 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.921 1.688 . . . . 0.0 111.171 -175.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 37.6 mm -119.99 -32.39 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 126.739 2.016 . . . . 0.0 109.164 174.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 51.51 -15.68 0.0 OUTLIER 'General case' 0 C--N 1.35 0.587 1 C-N-CA 131.955 4.102 . . . . 0.0 119.305 173.986 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -143.01 151.04 40.4 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.64 1.576 . . . . 0.0 110.587 178.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -153.01 155.24 36.54 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.782 1.233 . . . . 0.0 110.418 -173.248 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -79.29 146.74 32.8 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 169.34 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -53.47 -48.78 68.58 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.463 168.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.07 -14.85 62.86 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.77 -13.54 60.3 Favored 'General case' 0 C--N 1.348 0.535 0 CA-C-N 119.712 1.142 . . . . 0.0 112.711 173.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.7 p -115.04 -13.33 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 126.014 1.725 . . . . 0.0 111.801 172.126 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 91.65 20.11 38.52 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 125.869 1.7 . . . . 0.0 113.49 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 12.0 mt -75.36 160.06 30.73 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-N 118.747 1.273 . . . . 0.0 111.801 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 91.1 m -133.87 -20.2 1.99 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.862 1.665 . . . . 0.0 111.131 -177.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 89.3 m -142.03 135.74 29.54 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 125.577 1.551 . . . . 0.0 107.906 178.079 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -70.55 115.69 37.8 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 125.208 1.403 . . . . 0.0 111.545 -176.417 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -79.87 162.17 23.89 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.025 2.483 . . . . 0.0 110.049 168.209 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 65.4 ttp85 -150.34 136.7 18.8 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-O 121.891 0.853 . . . . 0.0 110.232 -178.489 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 136.86 -61.84 0.6 Allowed Glycine 0 CA--C 1.529 0.906 0 C-N-CA 127.347 2.403 . . . . 0.0 108.758 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -161.54 145.68 12.94 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 126.614 1.966 . . . . 0.0 108.514 168.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 68.4 t90 -146.89 153.16 39.81 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 125.838 1.655 . . . . 0.0 109.417 -177.295 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -128.89 128.95 44.84 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.856 1.263 . . . . 0.0 110.037 -175.078 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.17 168.39 7.78 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 124.526 1.131 . . . . 0.0 112.246 178.044 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.91 -28.89 35.42 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 121.347 1.365 . . . . 0.0 112.684 -174.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 26.5 mtp180 -88.19 13.36 11.55 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.54 1.136 . . . . 0.0 112.877 175.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 16.1 m -129.28 -15.74 4.08 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.707 1.603 . . . . 0.0 113.364 -178.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 35.9 t -151.67 -33.28 0.14 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.077 0.853 . . . . 0.0 112.991 175.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -74.26 -13.97 60.85 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 118.872 0.76 . . . . 0.0 112.684 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 . . . . . 0 CA--C 1.545 0.772 0 CA-C-N 119.231 0.923 . . . . 0.0 112.912 169.802 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo . . . . . 0 CA--C 1.535 0.528 0 N-CA-C 111.104 -0.383 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 69.3 p -144.89 173.66 11.68 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.512 1.125 . . . . 0.0 110.67 -176.082 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -135.09 -76.92 0.45 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 117.189 -1.386 . . . . 0.0 112.524 178.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 1.9 t -58.66 169.18 1.0 Allowed 'General case' 0 C--N 1.35 0.604 0 CA-C-N 119.935 1.243 . . . . 0.0 113.841 -172.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.1 pp -57.47 -13.37 3.53 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.109 1.363 . . . . 0.0 112.769 169.543 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' CYS . . . . . 0.403 ' HB2' ' NE2' ' A' ' 203' ' ' GLN . 84.5 m -78.12 -19.47 54.02 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.331 1.853 . . . . 0.0 113.208 175.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 52.87 66.68 1.16 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.989 2.116 . . . . 0.0 112.332 -172.323 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' GLN . . . . . 0.403 ' NE2' ' HB2' ' A' ' 201' ' ' CYS . 0.7 OUTLIER -129.35 160.22 33.74 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.662 1.985 . . . . 0.0 111.136 174.531 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.471 HG12 ' H ' ' A' ' 205' ' ' SER . 0.3 OUTLIER -66.0 -179.89 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 125.846 1.658 . . . . 0.0 111.524 -179.82 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.471 ' H ' HG12 ' A' ' 204' ' ' VAL . 24.6 m -47.24 150.81 0.79 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.146 2.178 . . . . 0.0 113.931 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -151.79 166.67 30.67 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.655 1.582 . . . . 0.0 110.926 -173.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -76.23 -60.68 3.01 Favored Glycine 0 C--N 1.342 0.894 0 C-N-CA 124.252 0.929 . . . . 0.0 113.352 -171.235 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.425 ' HB2' ' CD2' ' A' ' 224' ' ' PHE . 3.1 pt-20 -79.29 121.52 25.2 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.331 1.052 . . . . 0.0 111.063 177.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 14.3 mtp -143.88 139.71 29.37 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -173.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 20.3 tt -138.63 145.99 27.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 125.284 1.433 . . . . 0.0 109.844 168.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -125.19 137.29 10.29 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.779 1.18 . . . . 0.0 112.438 -169.696 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' CYS . . . . . 0.59 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 2.0 m -78.22 124.11 27.69 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 125.26 1.424 . . . . 0.0 111.564 -168.074 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -69.64 -3.61 15.82 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.187 1.795 . . . . 0.0 113.564 -175.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -65.78 147.28 98.82 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 123.36 0.664 . . . . 0.0 111.485 -174.893 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -81.33 5.1 6.48 Favored 'Trans proline' 0 CA--C 1.55 1.284 0 C-N-CA 122.909 2.406 . . . . 0.0 111.511 166.374 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -134.59 -11.51 2.39 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 125.215 1.406 . . . . 0.0 114.448 -169.508 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 36.3 t -64.19 135.45 56.31 Favored 'General case' 0 C--N 1.344 0.326 0 CA-C-N 119.257 0.935 . . . . 0.0 110.608 -177.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.4 t -112.8 14.53 19.9 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.917 1.687 . . . . 0.0 111.361 -174.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 48.9 mt -122.02 -42.05 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 125.428 1.491 . . . . 0.0 108.527 172.889 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 48.83 -11.24 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 131.646 3.978 . . . . 0.0 119.687 170.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 52.3 m95 -138.83 136.82 36.01 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.654 1.982 . . . . 0.0 110.042 169.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 222' ' ' PHE . . . . . 0.59 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 5.2 m-85 -142.72 156.23 44.99 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 125.698 1.599 . . . . 0.0 109.303 -169.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 23.2 m-70 -71.77 149.02 45.75 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 167.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' PHE . . . . . 0.425 ' CD2' ' HB2' ' A' ' 208' ' ' GLU . 17.4 m-30 -50.88 -50.93 56.06 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.708 165.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.16 -13.64 62.01 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -177.29 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 2.0 m -78.04 -6.33 54.21 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.885 1.22 . . . . 0.0 112.785 172.784 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.4 p -121.84 -13.07 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 126.132 1.773 . . . . 0.0 111.995 169.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 97.73 14.83 39.02 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.829 1.681 . . . . 0.0 113.446 177.265 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 29.8 mt -73.93 161.88 29.66 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 118.92 1.36 . . . . 0.0 111.329 177.426 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 67.4 p -132.75 -10.88 3.08 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.819 1.648 . . . . 0.0 111.64 176.276 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 53.2 p -145.72 151.09 37.44 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.652 1.981 . . . . 0.0 108.576 177.138 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -81.27 128.37 70.61 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-O 118.776 -0.631 . . . . 0.0 110.103 178.436 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -77.3 -178.35 4.52 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.635 2.89 . . . . 0.0 110.774 169.542 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 53.2 ttt180 -141.48 131.94 25.29 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 169.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 121.26 -168.77 14.28 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 126.064 1.793 . . . . 0.0 109.889 -168.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.28 145.0 51.6 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 122.242 1.02 . . . . 0.0 110.832 174.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 237' ' ' TRP . . . . . 0.496 ' HZ3' ' HG ' ' A' ' 212' ' ' CYS . 62.1 t90 -146.2 137.37 24.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 127.116 2.167 . . . . 0.0 108.915 175.009 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -114.27 136.72 52.65 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.96 0.904 . . . . 0.0 108.94 171.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 239' ' ' CYS . . . . . 0.411 ' HB2' ' HD2' ' A' ' 240' ' ' PRO . 5.0 p -63.32 168.72 4.67 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 126.308 1.843 . . . . 0.0 113.094 -177.893 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 36.3 Cg_endo -67.08 -33.37 31.93 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 121.306 1.337 . . . . 0.0 112.442 -171.166 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 -72.59 1.29 8.49 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.175 1.39 . . . . 0.0 113.079 176.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 21.6 m -127.84 -13.39 5.24 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.033 1.733 . . . . 0.0 113.982 -172.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 34.9 t -150.61 -40.9 0.13 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.717 0.689 . . . . 0.0 112.291 -177.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 40.4 tp60 -76.53 -16.25 59.67 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 118.792 -0.623 . . . . 0.0 112.679 -177.089 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 . . . . . 0 CA--C 1.541 0.603 0 C-N-CA 124.184 0.993 . . . . 0.0 113.027 172.354 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo . . . . . 0 CA--C 1.536 0.623 0 N-CA-C 111.075 -0.394 . . . . 0.0 111.075 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 71.3 p -143.07 173.46 11.54 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.638 1.175 . . . . 0.0 110.118 -177.661 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -135.77 -82.68 0.4 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 117.414 -1.279 . . . . 0.0 113.274 -168.641 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.4 t -54.28 166.03 0.46 Allowed 'General case' 0 C--N 1.35 0.614 0 C-N-CA 125.05 1.34 . . . . 0.0 112.731 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.9 pp -58.9 -11.12 2.95 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.471 1.108 . . . . 0.0 112.87 170.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 75.1 m -76.04 -19.93 58.21 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.667 1.987 . . . . 0.0 113.171 175.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 21.4 m170 57.9 62.92 1.93 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.996 2.118 . . . . 0.0 111.785 -173.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.7 159.65 33.09 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.356 1.462 . . . . 0.0 112.32 175.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.492 HG12 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -70.7 -178.45 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 126.267 1.827 . . . . 0.0 111.472 -176.811 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.492 ' H ' HG12 ' A' ' 204' ' ' VAL . 49.4 m -43.87 148.15 0.41 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 128.024 2.53 . . . . 0.0 113.915 178.281 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 206' ' ' TYR . . . . . 0.404 ' CE2' ' CD2' ' A' ' 223' ' ' HIS . 10.3 p90 -154.4 167.4 30.14 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.498 1.519 . . . . 0.0 111.103 -167.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -73.17 -43.86 37.75 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-O 118.719 -1.045 . . . . 0.0 115.136 -168.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -129.88 122.96 29.66 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 118.368 1.084 . . . . 0.0 110.654 -169.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -143.05 146.65 34.02 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -165.803 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 16.2 tt -140.62 155.94 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 126.278 1.831 . . . . 0.0 109.511 169.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -136.18 144.97 16.87 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 123.921 0.772 . . . . 0.0 112.261 -173.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 7.4 t -69.34 145.32 53.06 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-O 122.184 0.993 . . . . 0.0 110.938 -174.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -80.64 -6.75 58.79 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.704 2.001 . . . . 0.0 113.508 -174.241 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -80.55 145.78 59.63 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 118.557 0.617 . . . . 0.0 111.675 -169.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.42 6.13 4.21 Favored 'Trans proline' 0 CA--C 1.547 1.145 0 C-N-CA 123.629 2.886 . . . . 0.0 111.779 168.271 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -126.34 -8.12 6.39 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.074 1.749 . . . . 0.0 112.815 -172.367 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.9 t -65.4 133.36 51.17 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.822 0.849 . . . . 0.0 109.576 175.116 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 10.7 t -113.21 10.96 18.63 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.626 1.571 . . . . 0.0 111.702 -175.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 35.0 mm -118.84 -33.39 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 126.393 1.877 . . . . 0.0 109.242 176.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 50.45 -15.17 0.0 OUTLIER 'General case' 0 C--N 1.351 0.667 0 C-N-CA 131.591 3.956 . . . . 0.0 119.253 176.106 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -141.12 152.33 44.64 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.897 1.679 . . . . 0.0 110.427 178.424 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -154.22 154.49 33.58 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.71 1.604 . . . . 0.0 110.109 -170.326 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 223' ' ' HIS . . . . . 0.404 ' CD2' ' CE2' ' A' ' 206' ' ' TYR . 20.2 m170 -78.34 148.64 33.68 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 170.747 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -53.78 -50.69 65.51 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.719 167.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.62 -13.22 61.69 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 118.258 -0.877 . . . . 0.0 113.312 -176.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 3.5 m -76.41 -11.25 59.86 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.737 1.153 . . . . 0.0 112.441 172.457 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.2 p -117.69 -15.84 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 126.193 1.797 . . . . 0.0 112.269 171.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 94.87 20.06 29.64 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.888 1.709 . . . . 0.0 113.485 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 13.9 mt -71.61 156.98 38.78 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 118.854 1.327 . . . . 0.0 111.335 178.428 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 82.7 p -137.83 -11.84 1.52 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.419 1.487 . . . . 0.0 112.435 -178.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 59.2 m -148.48 134.07 18.75 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 126.263 1.825 . . . . 0.0 107.232 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -73.59 120.49 81.44 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 123.541 0.736 . . . . 0.0 111.587 -173.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -82.11 177.32 7.36 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.705 2.937 . . . . 0.0 111.194 170.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 36.0 ttp180 -142.58 135.0 27.78 Favored 'General case' 0 C--N 1.344 0.346 0 C-N-CA 124.239 1.016 . . . . 0.0 108.453 170.658 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 125.92 -167.49 18.31 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.65 1.595 . . . . 0.0 111.485 -177.024 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -59.39 119.41 7.41 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 124.601 1.16 . . . . 0.0 109.76 172.508 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 62.2 t90 -136.62 138.86 41.61 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 127.029 2.132 . . . . 0.0 108.103 175.634 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -115.88 132.71 56.56 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.346 1.059 . . . . 0.0 108.748 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 1.8 p -68.05 166.62 22.51 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 124.731 1.212 . . . . 0.0 112.467 -175.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -73.93 3.9 4.63 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.615 2.21 . . . . 0.0 114.698 -173.323 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 38.2 mtp180 -122.47 21.23 10.27 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.374 1.87 . . . . 0.0 111.017 171.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 18.6 m -133.45 -20.33 2.09 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.275 1.83 . . . . 0.0 112.506 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 31.2 t -150.29 -36.29 0.15 Allowed 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.635 1.107 . . . . 0.0 113.029 177.151 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 24.6 tp60 -74.17 -14.07 60.9 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.339 0.518 . . . . 0.0 112.087 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 . . . . . 0 CA--C 1.543 0.709 0 C-N-CA 125.793 1.637 . . . . 0.0 113.18 179.087 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo . . . . . 0 CA--C 1.536 0.594 0 N-CA-C 110.667 -0.551 . . . . 0.0 110.667 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 74.4 p -142.53 172.35 12.81 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.395 1.078 . . . . 0.0 110.204 -176.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -135.56 -83.88 0.39 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 117.327 -1.32 . . . . 0.0 112.765 -168.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.0 t -55.82 168.48 0.44 Allowed 'General case' 0 C--N 1.351 0.646 0 CA-C-N 119.784 1.175 . . . . 0.0 113.173 -177.133 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.3 pp -57.24 -12.6 2.44 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.839 1.255 . . . . 0.0 112.902 170.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' CYS . . . . . 0.404 ' HB2' ' NE2' ' A' ' 203' ' ' GLN . 75.2 m -77.6 -18.62 56.67 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.02 2.128 . . . . 0.0 113.171 176.802 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 27.6 m170 56.65 61.98 2.45 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.887 2.075 . . . . 0.0 111.729 -173.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' GLN . . . . . 0.404 ' NE2' ' HB2' ' A' ' 201' ' ' CYS . 0.4 OUTLIER -126.38 158.96 34.57 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.287 1.435 . . . . 0.0 112.306 176.838 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.47 HG12 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -69.76 -178.97 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 126.347 1.859 . . . . 0.0 111.432 -177.192 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.47 ' H ' HG12 ' A' ' 204' ' ' VAL . 93.6 p -44.04 148.14 0.44 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.354 2.262 . . . . 0.0 113.754 177.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -153.04 167.02 30.6 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.775 1.23 . . . . 0.0 111.963 -167.086 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -68.79 -49.44 42.59 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.718 1.152 . . . . 0.0 114.68 -168.948 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -128.01 125.09 38.74 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 118.206 1.003 . . . . 0.0 109.978 -171.328 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -142.88 145.84 33.5 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -166.638 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 19.7 tt -134.64 150.57 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 125.5 1.52 . . . . 0.0 109.878 172.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -127.45 138.93 10.8 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.729 1.157 . . . . 0.0 112.575 -170.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' CYS . . . . . 0.59 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 2.2 m -77.86 126.09 30.33 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.568 1.547 . . . . 0.0 111.453 -168.233 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -70.18 -0.03 7.1 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.373 1.869 . . . . 0.0 113.533 -175.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -67.36 149.09 98.58 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 123.785 0.834 . . . . 0.0 111.635 -176.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -83.37 8.19 4.76 Favored 'Trans proline' 0 CA--C 1.549 1.235 0 C-N-CA 123.656 2.904 . . . . 0.0 111.431 166.89 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -144.52 -10.94 0.62 Allowed 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 -167.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 37.2 t -61.38 132.43 53.49 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 119.469 1.031 . . . . 0.0 110.671 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 9.3 t -103.95 4.45 34.67 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.696 1.599 . . . . 0.0 111.786 -172.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 41.8 mm -114.67 -41.81 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 125.599 1.559 . . . . 0.0 108.773 175.332 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 46.98 -8.08 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 131.567 3.947 . . . . 0.0 119.8 171.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 60.9 m95 -140.71 136.6 32.75 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 126.993 2.117 . . . . 0.0 109.391 171.659 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 222' ' ' PHE . . . . . 0.59 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 6.3 m-85 -144.75 153.93 42.2 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 125.47 1.508 . . . . 0.0 109.529 -169.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 20.3 m-70 -70.93 149.41 46.74 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 168.418 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -52.37 -51.27 59.85 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 115.19 -0.913 . . . . 0.0 109.626 167.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.22 -14.22 62.52 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -177.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 3.3 m -78.08 -7.03 56.42 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.753 1.16 . . . . 0.0 112.628 172.638 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.2 p -122.19 -10.76 8.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 126.241 1.816 . . . . 0.0 112.276 169.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 94.16 16.52 43.72 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.736 1.636 . . . . 0.0 113.374 178.374 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 10.2 mt -70.48 157.65 37.48 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.554 1.177 . . . . 0.0 111.176 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 73.4 m -131.19 -5.02 3.86 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.369 1.868 . . . . 0.0 110.214 177.223 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 81.9 p -141.55 -175.31 4.32 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.007 2.123 . . . . 0.0 109.206 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -124.84 111.1 27.41 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 124.033 0.933 . . . . 0.0 109.077 177.122 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -74.19 177.4 8.31 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.473 2.782 . . . . 0.0 111.235 173.833 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 60.4 ttt-85 -139.1 132.2 29.65 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 171.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 115.97 -170.29 13.28 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.579 1.561 . . . . 0.0 110.855 -169.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.6 135.77 57.03 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.47 1.108 . . . . 0.0 111.468 177.967 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 237' ' ' TRP . . . . . 0.438 ' HZ3' ' HG ' ' A' ' 212' ' ' CYS . 58.2 t90 -142.49 143.84 32.73 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 127.556 2.342 . . . . 0.0 108.853 173.752 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -128.29 128.85 45.4 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.313 1.045 . . . . 0.0 109.372 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 239' ' ' CYS . . . . . 0.421 ' HB2' ' HD2' ' A' ' 240' ' ' PRO . 3.7 p -62.71 170.12 2.73 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 126.681 1.992 . . . . 0.0 113.845 -172.244 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.421 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 72.9 Cg_endo -74.1 0.23 8.69 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.672 2.248 . . . . 0.0 115.788 -169.226 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 76.5 mtm180 -117.97 17.01 14.22 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.224 1.41 . . . . 0.0 111.251 171.65 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 33.9 m -131.32 -17.67 2.96 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 126.166 1.786 . . . . 0.0 113.305 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 36.6 t -152.61 -40.02 0.1 Allowed 'General case' 0 C--N 1.343 0.292 0 CA-C-N 118.976 0.807 . . . . 0.0 112.55 176.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -74.82 -16.18 60.71 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 119.177 -0.439 . . . . 0.0 112.167 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.54 0.56 0 C-N-CA 124.376 1.071 . . . . 0.0 112.697 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo . . . . . 0 N--CA 1.455 -0.765 0 N-CA-C 109.795 -0.887 . . . . 0.0 109.795 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 64.7 p -141.21 171.87 13.46 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.064 0.946 . . . . 0.0 110.118 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -133.45 -83.98 0.46 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 117.145 -1.407 . . . . 0.0 113.046 -168.421 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' CYS . . . . . 0.484 ' H ' HE22 ' A' ' 203' ' ' GLN . 2.3 t -55.13 170.11 0.21 Allowed 'General case' 0 C--N 1.35 0.602 0 C-N-CA 124.841 1.256 . . . . 0.0 113.784 -175.626 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.2 pp -58.49 -13.91 6.67 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.175 0.99 . . . . 0.0 112.624 169.476 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 73.0 m -75.83 -23.4 55.75 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.887 2.075 . . . . 0.0 112.835 173.748 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 52.93 69.15 0.73 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 127.56 2.344 . . . . 0.0 112.045 -171.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' GLN . . . . . 0.484 HE22 ' H ' ' A' ' 199' ' ' CYS . 0.0 OUTLIER -124.43 160.45 28.17 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.887 1.675 . . . . 0.0 111.203 173.716 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.467 HG12 ' H ' ' A' ' 205' ' ' SER . 0.3 OUTLIER -68.51 -179.84 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 125.548 1.539 . . . . 0.0 111.129 -178.928 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.467 ' H ' HG12 ' A' ' 204' ' ' VAL . 83.2 p -44.39 145.82 0.78 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.972 2.109 . . . . 0.0 113.374 177.984 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 206' ' ' TYR . . . . . 0.455 ' CE2' ' HG2' ' A' ' 209' ' ' MET . 13.3 p90 -152.98 164.35 38.14 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.992 1.317 . . . . 0.0 111.466 -167.211 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -72.36 -60.51 4.05 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.273 0.939 . . . . 0.0 114.095 -169.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' GLU . . . . . 0.411 ' HB2' ' CD2' ' A' ' 224' ' ' PHE . 22.9 pt-20 -99.26 120.83 40.19 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 118.048 0.924 . . . . 0.0 110.284 -174.431 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 209' ' ' MET . . . . . 0.455 ' HG2' ' CE2' ' A' ' 206' ' ' TYR . 17.6 mtp -141.51 143.1 33.63 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 -168.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 19.0 tt -134.64 157.94 41.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 126.185 1.794 . . . . 0.0 108.995 169.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -135.24 139.79 11.12 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 124.129 0.871 . . . . 0.0 112.466 -174.602 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' CYS . . . . . 0.606 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 5.6 m -75.47 124.82 27.81 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 125.029 1.331 . . . . 0.0 110.901 -168.515 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -71.88 -0.7 11.97 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.398 1.479 . . . . 0.0 113.221 -176.19 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -66.81 146.47 99.08 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 123.616 0.766 . . . . 0.0 111.065 -177.365 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -81.17 6.95 5.24 Favored 'Trans proline' 0 CA--C 1.549 1.271 0 C-N-CA 123.029 2.486 . . . . 0.0 111.376 166.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -134.44 -13.38 2.33 Favored 'General case' 0 C--N 1.35 0.593 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -169.317 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.5 t -64.63 135.09 55.57 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 119.145 0.884 . . . . 0.0 110.524 -175.88 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 32.2 m -108.32 7.69 27.32 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.766 1.626 . . . . 0.0 111.923 -174.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 37.8 mm -117.09 -41.2 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 125.732 1.613 . . . . 0.0 108.647 175.791 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 48.31 -9.71 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 131.623 3.969 . . . . 0.0 119.818 169.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -140.75 136.1 32.19 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.663 1.985 . . . . 0.0 109.032 171.84 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 222' ' ' PHE . . . . . 0.606 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 6.9 m-85 -144.56 156.8 44.32 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 125.939 1.695 . . . . 0.0 109.609 -169.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -73.24 148.9 43.24 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 167.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' PHE . . . . . 0.411 ' CD2' ' HB2' ' A' ' 208' ' ' GLU . 15.5 m-30 -51.63 -52.12 50.27 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.8 166.389 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.21 -12.99 61.77 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -177.074 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 2.0 m -77.56 -6.29 53.17 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.823 1.192 . . . . 0.0 112.665 172.312 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.62 -11.74 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 126.242 1.817 . . . . 0.0 112.396 170.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 96.3 16.33 38.02 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.604 1.574 . . . . 0.0 113.563 177.601 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 24.8 mt -72.4 163.29 28.23 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.777 1.289 . . . . 0.0 111.33 175.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 39.7 m -134.62 -21.69 1.72 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.595 1.558 . . . . 0.0 111.08 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 58.1 p -141.01 151.01 43.76 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 125.998 1.719 . . . . 0.0 108.826 176.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -76.55 125.56 87.24 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-O 118.846 -0.597 . . . . 0.0 110.248 -178.55 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -77.9 179.55 6.4 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.802 3.001 . . . . 0.0 111.441 174.518 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.08 125.37 21.74 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 124.966 1.307 . . . . 0.0 107.784 172.035 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 122.55 -174.8 16.36 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.545 1.545 . . . . 0.0 110.779 -169.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.25 142.19 55.69 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 122.133 0.968 . . . . 0.0 110.618 175.142 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 237' ' ' TRP . . . . . 0.446 ' HZ3' ' HG ' ' A' ' 212' ' ' CYS . 62.9 t90 -140.31 139.46 35.45 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.646 1.978 . . . . 0.0 109.234 175.257 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -125.43 123.56 39.53 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.029 1.331 . . . . 0.0 108.196 -178.028 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 239' ' ' CYS . . . . . 0.462 ' HB3' ' SG ' ' A' ' 212' ' ' CYS . 5.0 p -60.61 172.72 0.75 Allowed Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 127.799 2.44 . . . . 0.0 114.776 -170.46 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.447 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 68.5 Cg_endo -73.28 -0.35 9.06 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.778 2.319 . . . . 0.0 115.783 -169.275 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -117.48 15.95 14.67 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.617 1.567 . . . . 0.0 111.212 172.208 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 27.0 m -133.53 -15.94 2.4 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.725 2.01 . . . . 0.0 112.723 -176.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 35.1 t -151.1 -42.87 0.12 Allowed 'General case' 0 C--N 1.342 0.272 0 C-N-CA 123.857 0.863 . . . . 0.0 112.061 177.087 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -75.11 -13.65 60.5 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 . . . . . 0 CA--C 1.538 0.486 0 C-N-CA 126.178 1.791 . . . . 0.0 111.35 172.328 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo . . . . . 0 CA--C 1.535 0.567 0 CA-C-O 121.964 0.735 . . . . 0.0 113.005 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 32.6 p -142.53 179.12 7.15 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.451 1.9 . . . . 0.0 108.819 -178.495 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -138.08 -63.74 0.55 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.636 0.774 . . . . 0.0 111.83 176.042 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 199' ' ' CYS . . . . . 0.446 ' SG ' ' HB2' ' A' ' 201' ' ' CYS . 4.8 p -59.8 165.6 3.04 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 128.489 2.716 . . . . 0.0 114.094 179.714 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 2.7 pp -77.93 0.53 23.85 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.565 167.319 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 201' ' ' CYS . . . . . 0.446 ' HB2' ' SG ' ' A' ' 199' ' ' CYS . 80.3 m -78.26 -26.93 47.41 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.917 0.887 . . . . 0.0 110.4 168.711 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . 0.282 82.3 m-70 70.32 53.4 0.33 Allowed 'General case' 0 C--N 1.343 0.286 0 C-N-CA 127.29 2.236 . . . . 0.0 113.095 169.605 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.24 172.9 12.22 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.608 -1.178 . . . . 0.0 109.587 166.882 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.436 HG12 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -62.49 174.09 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 125.229 1.412 . . . . 0.0 111.862 -174.981 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.436 ' H ' HG12 ' A' ' 204' ' ' VAL . 88.6 p -50.76 158.73 0.62 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.759 2.024 . . . . 0.0 114.833 -173.725 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -139.32 160.08 40.65 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.03 1.732 . . . . 0.0 110.484 -169.192 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -63.97 -35.36 91.9 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.36 0.981 . . . . 0.0 113.85 -171.279 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.05 118.04 16.34 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 124.589 1.156 . . . . 0.0 109.337 -170.767 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 1.3 mtm -135.68 151.2 49.96 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.074 -0.966 . . . . 0.0 113.329 -165.984 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 19.3 tt -142.71 146.36 22.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.274 0 C-N-CA 125.511 1.524 . . . . 0.0 110.794 169.076 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -122.53 142.44 14.78 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 125.189 1.376 . . . . 0.0 112.755 -170.938 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 212' ' ' CYS . . . . . 0.573 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 1.9 m -79.5 127.27 31.93 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 126.074 1.75 . . . . 0.0 112.051 -167.302 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -69.58 -0.99 7.59 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.28 1.832 . . . . 0.0 113.751 -176.61 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -68.42 146.36 97.79 Favored Pre-proline 0 CA--C 1.539 0.521 0 O-C-N 121.469 -0.769 . . . . 0.0 111.283 -175.893 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -82.01 6.75 5.49 Favored 'Trans proline' 0 CA--C 1.551 1.337 0 C-N-CA 123.1 2.534 . . . . 0.0 111.208 165.909 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -135.02 -13.15 2.15 Favored 'General case' 0 C--N 1.351 0.638 0 C-N-CA 125.25 1.42 . . . . 0.0 114.703 -169.261 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 36.5 t -64.92 134.31 53.69 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 119.139 0.881 . . . . 0.0 110.57 -176.126 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.9 t -108.71 8.61 26.95 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.679 1.591 . . . . 0.0 111.535 -173.275 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 38.9 mm -116.84 -42.29 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 125.728 1.611 . . . . 0.0 108.659 173.604 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 47.32 -7.68 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.737 1 C-N-CA 131.817 4.047 . . . . 0.0 119.453 171.838 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 51.2 m95 -140.85 139.82 34.51 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.851 2.06 . . . . 0.0 109.827 169.84 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 222' ' ' PHE . . . . . 0.573 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 6.7 m-85 -147.34 153.01 39.16 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.485 1.514 . . . . 0.0 108.479 -169.859 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 22.0 m-70 -67.08 150.98 48.44 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 166.912 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -54.07 -47.76 71.36 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.915 167.037 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -69.44 -14.81 63.09 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 178.402 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 5.4 t -68.79 -18.56 64.21 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.841 0.856 . . . . 0.0 112.422 173.138 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.9 p -117.36 -12.62 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 126.244 1.818 . . . . 0.0 112.137 173.233 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 93.55 18.6 37.81 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.827 1.679 . . . . 0.0 113.512 179.069 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 11.5 mt -72.12 157.44 37.77 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-N 119.006 1.403 . . . . 0.0 111.419 178.92 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 39.7 m -131.95 0.57 3.87 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.384 1.874 . . . . 0.0 110.185 179.801 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 9.5 t -148.41 172.62 14.14 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.095 1.758 . . . . 0.0 109.876 179.91 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -110.18 94.28 17.78 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 125.164 1.386 . . . . 0.0 108.986 179.613 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.98 162.15 41.1 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.693 2.262 . . . . 0.0 110.937 170.109 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -145.4 134.55 22.78 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 124.333 1.053 . . . . 0.0 109.242 -178.654 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 138.22 -64.07 0.56 Allowed Glycine 0 CA--C 1.525 0.683 0 C-N-CA 127.13 2.3 . . . . 0.0 108.519 179.783 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -167.99 149.9 5.42 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 126.011 1.724 . . . . 0.0 110.486 169.611 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 48.3 t90 -146.46 148.63 32.45 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 126.701 2.0 . . . . 0.0 109.128 178.811 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -129.35 130.82 46.56 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.343 1.057 . . . . 0.0 109.701 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 239' ' ' CYS . . . . . 0.422 ' HB2' ' HD2' ' A' ' 240' ' ' PRO . 3.9 p -65.5 170.62 4.42 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 126.7 2.0 . . . . 0.0 113.716 -173.152 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 59.4 Cg_endo -70.09 -19.64 34.31 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.052 1.835 . . . . 0.0 113.768 -170.814 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 16.8 mmp_? -87.2 3.45 46.44 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.536 1.534 . . . . 0.0 112.606 175.207 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 34.6 m -132.94 -17.61 2.42 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.618 1.567 . . . . 0.0 113.931 -169.789 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 29.0 t -149.9 -33.76 0.18 Allowed 'General case' 0 C--N 1.342 0.255 0 CA-C-N 118.862 0.755 . . . . 0.0 112.973 -177.731 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -70.97 -23.78 62.28 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 118.211 -0.9 . . . . 0.0 111.329 177.143 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 . . . . . 0 C--N 1.348 0.527 0 C-N-CA 125.675 1.59 . . . . 0.0 113.56 175.114 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 CA--C 1.535 0.536 0 CA-C-O 121.296 0.457 . . . . 0.0 112.082 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 66.4 p -143.77 175.09 10.25 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.098 1.359 . . . . 0.0 110.335 -175.544 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -135.51 -79.89 0.43 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 117.291 -1.338 . . . . 0.0 112.537 -173.109 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.1 t -55.38 164.6 0.94 Allowed 'General case' 0 C--N 1.349 0.566 0 CA-C-N 119.692 1.133 . . . . 0.0 112.784 -177.35 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.17 -5.36 3.15 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.005 0.922 . . . . 0.0 112.849 170.98 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 89.0 m -76.35 -21.97 55.46 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.165 1.786 . . . . 0.0 113.141 169.8 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 55.93 69.25 0.76 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 127.051 2.141 . . . . 0.0 111.951 -169.824 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.82 159.05 37.76 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.488 1.515 . . . . 0.0 111.886 172.317 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.506 HG12 ' H ' ' A' ' 205' ' ' SER . 0.7 OUTLIER -67.78 -177.9 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 126.263 1.825 . . . . 0.0 110.934 -179.039 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.506 ' H ' HG12 ' A' ' 204' ' ' VAL . 88.3 p -44.1 149.43 0.34 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.416 2.287 . . . . 0.0 113.9 176.054 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -153.53 168.92 24.55 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.205 1.402 . . . . 0.0 111.583 -167.226 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -72.66 -49.25 19.19 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-O 118.811 -0.994 . . . . 0.0 114.638 -169.092 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -124.96 121.78 35.44 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 118.233 1.016 . . . . 0.0 110.136 -170.062 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -140.36 146.32 38.26 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -166.016 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 20.1 tt -135.25 150.21 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 125.533 1.533 . . . . 0.0 109.802 170.901 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -127.33 138.84 10.76 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.539 1.066 . . . . 0.0 112.2 -172.798 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 212' ' ' CYS . . . . . 0.601 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 3.0 m -76.16 123.42 25.82 Favored 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 125.06 1.344 . . . . 0.0 110.779 -168.738 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -72.54 4.32 4.0 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.915 1.686 . . . . 0.0 112.938 -175.817 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -68.3 149.17 98.17 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 124.214 1.006 . . . . 0.0 111.469 -179.612 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -81.85 1.04 9.5 Favored 'Trans proline' 0 CA--C 1.549 1.235 0 C-N-CA 123.184 2.589 . . . . 0.0 111.831 166.447 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -135.53 -7.82 2.2 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -169.33 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.2 t -63.42 134.64 56.02 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 119.84 1.2 . . . . 0.0 110.836 -178.464 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 10.7 t -107.98 9.17 28.62 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.71 1.604 . . . . 0.0 111.712 -173.095 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 38.2 mm -118.64 -41.36 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 125.419 1.488 . . . . 0.0 108.771 173.678 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 48.11 -9.14 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 131.537 3.935 . . . . 0.0 119.644 171.014 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 60.9 m95 -139.8 136.29 33.91 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.834 2.054 . . . . 0.0 109.411 170.156 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 222' ' ' PHE . . . . . 0.601 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 7.2 m-85 -143.85 154.91 43.86 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 125.599 1.56 . . . . 0.0 109.276 -169.212 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 20.7 m170 -72.84 148.75 44.17 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 169.113 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 15.4 m-30 -51.93 -50.58 60.88 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.937 167.685 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.13 -14.0 62.14 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -177.721 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 7.5 m -78.37 -1.93 35.78 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.799 1.181 . . . . 0.0 112.657 172.714 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 6.1 p -128.22 -13.64 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 125.841 1.656 . . . . 0.0 112.659 169.11 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 99.53 16.44 29.23 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.66 1.6 . . . . 0.0 113.535 178.135 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 18.5 mt -74.39 163.19 28.08 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.799 1.299 . . . . 0.0 111.537 177.708 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 41.6 m -136.51 -21.81 1.31 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.581 1.552 . . . . 0.0 111.256 -178.987 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 89.1 m -141.03 142.77 34.18 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 125.713 1.605 . . . . 0.0 108.033 -179.207 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -68.45 120.53 75.78 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 123.957 0.903 . . . . 0.0 110.459 -178.721 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -79.46 -174.21 2.18 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.785 2.99 . . . . 0.0 111.135 173.655 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -143.96 133.68 23.72 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.58 1.152 . . . . 0.0 108.439 174.847 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 105.46 -169.05 15.86 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.114 1.34 . . . . 0.0 112.199 -176.234 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.83 123.61 15.63 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 125.712 1.605 . . . . 0.0 110.953 178.046 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 237' ' ' TRP . . . . . 0.411 ' HZ3' ' HG ' ' A' ' 212' ' ' CYS . 61.1 t90 -134.18 133.95 41.54 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.424 1.89 . . . . 0.0 108.865 171.042 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -119.08 128.25 54.15 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.696 1.198 . . . . 0.0 108.086 178.41 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 239' ' ' CYS . . . . . 0.467 ' HB2' ' HD2' ' A' ' 240' ' ' PRO . 12.3 p -62.1 172.55 1.16 Allowed Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 127.382 2.273 . . . . 0.0 113.865 -173.124 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 42.2 Cg_endo -68.31 -26.05 35.75 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 121.653 1.569 . . . . 0.0 114.423 -169.376 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -82.34 6.65 16.32 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.821 1.249 . . . . 0.0 112.931 173.696 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 32.9 m -134.41 -15.09 2.2 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.385 1.474 . . . . 0.0 114.223 -170.19 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.6 t -152.27 -31.0 0.15 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.924 0.783 . . . . 0.0 112.885 179.056 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -86.24 -12.3 50.04 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 118.83 -0.605 . . . . 0.0 112.624 -177.247 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 . . . . . 0 C--N 1.346 0.437 0 C-N-CA 123.744 0.818 . . . . 0.0 109.916 -178.594 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo . . . . . 0 CA--C 1.535 0.557 0 CA-C-O 121.216 0.423 . . . . 0.0 111.87 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 72.0 p -143.18 174.42 10.72 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.834 1.254 . . . . 0.0 110.613 -173.204 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -135.27 -79.17 0.44 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 117.389 -1.291 . . . . 0.0 113.312 -171.329 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.5 t -56.64 168.61 0.57 Allowed 'General case' 0 C--N 1.349 0.574 0 C-N-CA 124.998 1.319 . . . . 0.0 113.374 -174.823 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 4.3 pp -59.17 -11.81 4.34 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.439 1.096 . . . . 0.0 112.744 169.299 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 73.4 m -76.09 -24.39 55.03 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.649 1.98 . . . . 0.0 112.927 173.483 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 55.04 69.57 0.72 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 127.218 2.207 . . . . 0.0 111.621 -170.063 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.48 163.61 25.53 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.556 1.542 . . . . 0.0 111.557 173.344 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.513 HG12 ' H ' ' A' ' 205' ' ' SER . 0.4 OUTLIER -68.88 -179.44 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 125.694 1.597 . . . . 0.0 111.427 -176.738 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.513 ' H ' HG12 ' A' ' 204' ' ' VAL . 83.6 p -47.61 153.37 0.57 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.587 2.355 . . . . 0.0 114.592 178.461 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -154.49 167.47 29.95 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.278 1.831 . . . . 0.0 110.395 -169.062 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -77.93 -39.5 23.95 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 118.673 -1.07 . . . . 0.0 115.224 -168.697 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.65 118.93 19.75 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.614 1.207 . . . . 0.0 110.199 -168.49 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -141.81 152.29 43.56 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -164.282 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 15.2 tt -147.84 152.54 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 126.055 1.742 . . . . 0.0 109.859 168.168 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -132.44 146.66 18.37 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 124.118 0.866 . . . . 0.0 112.04 -169.819 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 4.2 t -70.48 144.08 51.52 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-O 122.016 0.913 . . . . 0.0 111.368 -172.158 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -78.91 -8.54 58.95 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.265 1.826 . . . . 0.0 113.686 -174.536 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -77.28 146.1 73.81 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-N 118.533 0.606 . . . . 0.0 111.933 -168.361 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.4 8.83 2.76 Favored 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 124.135 3.223 . . . . 0.0 112.372 169.047 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -132.69 -8.19 3.19 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.365 1.866 . . . . 0.0 112.191 -170.478 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 39.0 t -62.97 136.12 57.67 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.956 0.902 . . . . 0.0 109.864 172.585 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.9 t -121.24 14.31 11.28 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.885 1.674 . . . . 0.0 111.062 -176.003 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 35.9 mm -119.6 -32.67 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 126.646 1.978 . . . . 0.0 109.235 175.41 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 51.26 -16.52 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.664 1 C-N-CA 132.007 4.123 . . . . 0.0 119.292 174.702 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 55.0 m95 -141.93 151.51 42.66 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.843 1.657 . . . . 0.0 110.468 179.007 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -153.68 154.86 34.92 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.103 1.361 . . . . 0.0 110.152 -172.265 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -77.18 147.65 36.36 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 169.767 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -54.75 -49.53 70.63 Favored 'General case' 0 C--O 1.222 -0.342 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.928 167.665 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -68.6 -16.14 63.76 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -179.551 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 2.6 m -76.66 -18.37 58.6 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 119.866 1.212 . . . . 0.0 112.616 174.787 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.8 p -105.5 -14.49 8.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 124.913 1.285 . . . . 0.0 111.524 168.686 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 92.58 20.88 33.22 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.786 1.66 . . . . 0.0 113.378 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 10.1 mt -74.91 157.61 34.74 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 118.738 1.269 . . . . 0.0 111.35 178.508 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 50.0 m -127.76 -9.55 5.55 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.34 1.856 . . . . 0.0 110.265 179.422 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 77.3 p -140.91 178.05 7.62 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.786 2.035 . . . . 0.0 109.427 179.143 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -110.94 107.21 57.81 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 124.1 0.96 . . . . 0.0 108.926 178.145 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -71.28 176.46 7.87 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.547 2.831 . . . . 0.0 111.848 175.547 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.14 133.22 36.99 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.042 1.337 . . . . 0.0 108.256 -175.123 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 107.41 -162.8 13.23 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.413 1.482 . . . . 0.0 111.464 -174.657 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -61.25 127.18 30.25 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.0 1.32 . . . . 0.0 109.195 173.731 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -132.26 149.18 52.43 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.397 1.879 . . . . 0.0 109.118 178.377 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -128.68 130.29 46.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.116 1.366 . . . . 0.0 109.994 -174.152 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.26 167.41 10.23 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.411 175.211 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.66 -37.49 16.34 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 120.907 1.071 . . . . 0.0 111.972 -174.051 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 64.9 mtp85 -72.84 1.89 7.77 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.063 1.345 . . . . 0.0 113.084 176.073 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 9.2 m -120.13 -13.9 8.9 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.401 1.481 . . . . 0.0 114.328 -175.041 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 33.3 t -151.92 -38.52 0.12 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.545 1.066 . . . . 0.0 113.12 176.552 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -73.62 -27.88 61.51 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.372 0.669 . . . . 0.0 112.174 -178.68 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 . . . . . 0 CA--C 1.543 0.687 0 C-N-CA 124.97 1.308 . . . . 0.0 112.834 -174.702 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo . . . . . 0 CA--C 1.536 0.582 0 CA-C-O 121.776 0.656 . . . . 0.0 113.135 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 33.8 p -140.99 175.14 9.86 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.36 1.864 . . . . 0.0 108.97 178.46 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -135.36 -68.71 0.51 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.842 0.857 . . . . 0.0 111.166 176.022 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 199' ' ' CYS . . . . . 0.432 ' SG ' ' HB2' ' A' ' 201' ' ' CYS . 5.5 p -53.74 163.71 0.66 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 128.352 2.661 . . . . 0.0 114.089 177.253 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.0 pp -77.17 -1.5 29.68 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.781 167.86 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 201' ' ' CYS . . . . . 0.432 ' HB2' ' SG ' ' A' ' 199' ' ' CYS . 78.2 m -75.19 -28.73 60.13 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.942 0.897 . . . . 0.0 110.207 168.551 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . 0.297 88.3 m-70 70.48 54.72 0.29 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 127.727 2.411 . . . . 0.0 113.309 169.605 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -137.3 172.88 12.33 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 114.559 -1.201 . . . . 0.0 109.484 166.726 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.421 HG12 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -62.67 173.88 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 125.116 1.366 . . . . 0.0 111.803 -174.961 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.421 ' H ' HG12 ' A' ' 204' ' ' VAL . 87.7 p -50.62 158.58 0.62 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.73 2.012 . . . . 0.0 114.889 -173.793 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -139.85 161.22 38.1 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.016 1.726 . . . . 0.0 110.708 -169.118 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -64.14 -35.76 92.39 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.449 1.023 . . . . 0.0 113.838 -171.651 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.63 118.48 17.24 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 124.495 1.118 . . . . 0.0 109.289 -170.74 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 1.2 mtm -134.36 149.58 50.85 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.203 -0.908 . . . . 0.0 113.402 -166.096 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 21.3 tt -139.71 145.5 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 C-N-CA 125.758 1.623 . . . . 0.0 110.544 169.987 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -124.91 139.54 11.78 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.873 1.225 . . . . 0.0 112.732 -170.429 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 212' ' ' CYS . . . . . 0.597 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 2.8 m -78.27 124.93 28.64 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 126.078 1.751 . . . . 0.0 111.664 -167.715 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -70.43 -2.77 14.82 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.064 1.745 . . . . 0.0 113.467 -176.898 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -62.72 149.07 90.15 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 123.724 0.81 . . . . 0.0 111.598 -174.704 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -81.23 6.75 5.39 Favored 'Trans proline' 0 CA--C 1.548 1.2 0 C-N-CA 123.491 2.794 . . . . 0.0 111.798 167.464 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -146.37 -8.85 0.51 Allowed 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -167.75 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 37.3 t -61.35 134.35 56.84 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-N 119.866 1.212 . . . . 0.0 110.851 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 27.1 m -108.14 7.67 27.68 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.647 1.579 . . . . 0.0 111.657 -173.155 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 39.1 mm -116.33 -42.22 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 125.668 1.587 . . . . 0.0 108.536 175.007 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 48.7 -9.62 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 131.509 3.924 . . . . 0.0 119.49 171.191 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 50.2 m95 -140.15 140.46 35.96 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.94 2.096 . . . . 0.0 109.662 169.632 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 222' ' ' PHE . . . . . 0.597 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 6.8 m-85 -147.71 155.18 41.47 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.936 1.694 . . . . 0.0 108.604 -169.481 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 35.2 m-70 -68.68 150.39 47.99 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 166.245 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -53.64 -48.06 69.72 Favored 'General case' 0 C--O 1.223 -0.334 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 166.786 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -68.55 -15.13 63.43 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 178.625 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 8.7 t -68.93 -24.71 64.32 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.075 0.852 . . . . 0.0 112.261 174.205 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.3 p -106.61 -15.8 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.787 1.635 . . . . 0.0 112.119 171.204 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 97.05 17.66 31.6 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.956 1.741 . . . . 0.0 113.487 178.897 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 16.8 mt -72.91 158.5 35.38 Favored 'General case' 0 C--N 1.345 0.411 0 CA-C-N 119.093 1.446 . . . . 0.0 111.543 178.527 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.5 t -135.86 -0.53 2.55 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.153 1.781 . . . . 0.0 111.794 179.408 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 40.1 p -143.41 162.18 36.45 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.056 2.142 . . . . 0.0 109.279 175.43 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -98.05 114.42 65.08 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 123.811 0.844 . . . . 0.0 109.613 178.043 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -78.24 179.02 6.89 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 123.758 2.972 . . . . 0.0 111.531 175.502 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 15.3 ttm180 -139.36 135.32 33.59 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.028 1.331 . . . . 0.0 107.489 169.685 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 117.14 -166.84 12.52 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.314 1.435 . . . . 0.0 111.476 -176.573 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -65.88 120.58 13.32 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.629 1.172 . . . . 0.0 110.128 177.028 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 70.0 t90 -129.27 137.66 51.19 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 126.111 1.764 . . . . 0.0 108.984 174.195 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -125.97 125.14 42.23 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.778 1.231 . . . . 0.0 108.681 -178.027 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 239' ' ' CYS . . . . . 0.442 ' HB2' ' HD2' ' A' ' 240' ' ' PRO . 2.9 p -59.18 171.97 0.64 Allowed Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 127.7 2.4 . . . . 0.0 114.412 -172.429 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 240' ' ' PRO . . . . . 0.442 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 43.1 Cg_endo -68.3 -23.43 38.59 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 121.761 1.641 . . . . 0.0 113.913 -169.628 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -92.41 12.65 22.0 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.645 1.178 . . . . 0.0 112.583 174.86 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 27.6 m -131.7 -14.21 3.22 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.018 1.727 . . . . 0.0 113.397 -176.664 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 32.4 t -149.69 -40.1 0.14 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.838 0.855 . . . . 0.0 112.012 178.618 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -77.63 -13.71 59.83 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -175.041 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 . . . . . 0 CA--C 1.541 0.609 0 C-N-CA 123.996 0.918 . . . . 0.0 112.863 171.604 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo . . . . . 0 CA--C 1.535 0.529 0 CA-C-O 121.348 0.478 . . . . 0.0 112.229 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 33.4 p -145.28 173.96 11.52 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.924 1.689 . . . . 0.0 109.308 -178.087 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -135.83 -72.79 0.46 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.952 0.901 . . . . 0.0 112.392 -176.829 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 199' ' ' CYS . . . . . 0.424 ' SG ' ' HB2' ' A' ' 201' ' ' CYS . 2.6 p -51.62 163.6 0.28 Allowed 'General case' 0 C--N 1.339 0.111 0 C-N-CA 129.342 3.057 . . . . 0.0 114.627 176.203 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 4.1 pp -69.5 -7.62 39.73 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.982 167.352 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 201' ' ' CYS . . . . . 0.424 ' HB2' ' SG ' ' A' ' 199' ' ' CYS . 83.3 m -77.06 -30.39 55.52 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.59 1.156 . . . . 0.0 111.017 172.488 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . 0.291 89.2 m-70 69.14 57.93 0.36 Allowed 'General case' 0 C--N 1.339 0.15 0 C-N-CA 127.487 2.315 . . . . 0.0 113.267 169.809 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -136.42 171.61 14.22 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 114.119 -1.401 . . . . 0.0 109.427 166.398 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 204' ' ' VAL . . . . . 0.488 HG12 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -64.23 175.71 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 125.093 1.357 . . . . 0.0 111.939 -175.311 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 205' ' ' SER . . . . . 0.488 ' H ' HG12 ' A' ' 204' ' ' VAL . 20.1 m -45.19 154.42 0.16 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 128.128 2.571 . . . . 0.0 115.245 -173.53 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -142.08 158.45 43.74 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.107 1.763 . . . . 0.0 110.037 -173.569 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -62.66 -36.34 93.13 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.188 0.899 . . . . 0.0 114.08 -169.801 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.96 117.95 15.31 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 124.446 1.098 . . . . 0.0 109.742 -170.354 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 1.4 mtm -136.33 150.4 48.84 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.257 -0.883 . . . . 0.0 113.107 -166.801 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 13.1 tt -146.68 149.65 15.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 126.363 1.865 . . . . 0.0 110.077 169.38 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -134.02 147.23 18.99 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 124.063 0.84 . . . . 0.0 112.767 -169.538 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 3.0 t -70.8 143.69 51.07 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-O 121.893 0.854 . . . . 0.0 111.073 -173.128 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -83.9 -6.03 59.34 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 113.529 -1.669 . . . . 0.0 113.252 -174.261 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -73.98 147.61 86.22 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 118.589 0.631 . . . . 0.0 111.696 -168.701 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -75.78 8.9 2.5 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 124.116 3.211 . . . . 0.0 112.554 169.343 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -135.25 -6.7 2.3 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.107 1.763 . . . . 0.0 112.327 -170.044 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.7 t -62.98 136.03 57.62 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.035 0.934 . . . . 0.0 110.01 172.998 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 11.8 t -118.9 12.79 12.97 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.771 1.629 . . . . 0.0 111.202 -175.846 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 25.5 mm -122.14 -32.18 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 126.065 1.746 . . . . 0.0 109.608 177.491 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 50.49 -11.29 0.0 OUTLIER 'General case' 0 C--N 1.349 0.576 0 C-N-CA 131.065 3.746 . . . . 0.0 119.131 177.359 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 52.4 m95 -145.59 156.09 43.46 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.768 1.627 . . . . 0.0 111.417 179.403 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -158.81 155.4 27.81 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 126.716 2.006 . . . . 0.0 109.081 -175.402 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 46.1 m-70 -70.8 151.35 44.91 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 166.932 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -55.47 -47.06 76.69 Favored 'General case' 0 C--O 1.223 -0.29 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 166.592 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -66.73 -14.21 62.28 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 177.504 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 2.6 t -67.09 -31.29 71.68 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.24 0.927 . . . . 0.0 112.106 174.016 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.4 p -101.28 -14.41 8.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 125.964 1.705 . . . . 0.0 112.216 171.665 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 89.81 22.57 35.85 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.697 1.618 . . . . 0.0 113.256 -178.967 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 8.8 mt -69.83 157.94 36.43 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-N 118.886 1.343 . . . . 0.0 111.59 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 74.7 p -128.36 -1.9 5.62 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.047 1.739 . . . . 0.0 111.605 -178.252 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 11.3 t -152.76 170.16 20.98 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.151 1.78 . . . . 0.0 109.578 178.923 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -97.92 110.49 55.84 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.25 1.02 . . . . 0.0 108.876 175.231 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -71.34 -176.23 1.85 Allowed 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 124.016 3.144 . . . . 0.0 111.788 174.148 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -142.85 135.4 27.67 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.606 1.162 . . . . 0.0 108.668 -176.048 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 93.82 -172.52 32.63 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 125.041 1.305 . . . . 0.0 111.452 -170.917 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.36 136.02 49.64 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.926 1.291 . . . . 0.0 111.716 176.425 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 61.6 t90 -139.9 153.11 46.89 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 127.15 2.18 . . . . 0.0 108.972 -177.813 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -128.69 130.7 47.52 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.86 1.264 . . . . 0.0 110.048 -173.303 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -66.27 169.1 7.83 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.839 1.256 . . . . 0.0 112.985 -177.131 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.9 0.72 8.95 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.479 2.12 . . . . 0.0 114.65 -171.412 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 81.8 mtt-85 -128.68 24.31 5.76 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.835 1.254 . . . . 0.0 110.541 168.741 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 11.6 m -123.79 -17.13 6.45 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 126.494 1.918 . . . . 0.0 112.059 171.974 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 36.8 t -150.92 -32.03 0.17 Allowed 'General case' 0 C--N 1.348 0.529 0 CA-C-N 119.477 1.035 . . . . 0.0 113.316 173.418 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -70.58 -18.42 62.9 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 118.969 0.804 . . . . 0.0 112.462 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 . . . . . 0 CA--C 1.542 0.638 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 172.082 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 77.2 mtm . . . . . 0 N--CA 1.476 0.871 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 56.38 -164.03 0.15 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.554 1.542 . . . . 0.0 112.857 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -131.52 66.33 78.08 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.077 1.351 . . . . 0.0 109.263 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -70.16 168.52 21.84 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 123.601 2.867 . . . . 0.0 112.088 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.483 HG12 ' H ' ' A' ' 192' ' ' ASP . 1.4 t -140.88 176.49 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 125.963 1.705 . . . . 0.0 107.456 -178.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.483 ' H ' HG12 ' A' ' 191' ' ' VAL . 10.6 m-20 -54.59 157.72 4.91 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 127.006 2.123 . . . . 0.0 112.956 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -71.41 10.28 0.78 Allowed 'Trans proline' 0 CA--C 1.546 1.125 0 C-N-CA 123.859 3.039 . . . . 0.0 112.926 169.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -117.96 36.03 4.49 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.853 2.061 . . . . 0.0 110.325 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -133.09 97.01 16.99 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 125.748 1.619 . . . . 0.0 108.384 -171.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.53 149.28 23.94 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.592 2.862 . . . . 0.0 111.593 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 81.7 p -129.35 173.86 10.15 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.091 1.356 . . . . 0.0 110.559 -171.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -133.56 -81.97 0.47 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 117.464 -1.255 . . . . 0.0 113.283 -168.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.3 t -55.53 166.65 0.61 Allowed 'General case' 0 C--N 1.35 0.607 0 C-N-CA 124.996 1.318 . . . . 0.0 112.814 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 4.1 pp -58.86 -11.45 3.3 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.695 1.198 . . . . 0.0 112.806 170.51 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 73.6 m -76.38 -19.48 58.12 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.501 1.92 . . . . 0.0 113.042 175.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 17.0 m170 57.75 62.07 2.22 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.846 2.059 . . . . 0.0 111.56 -173.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.5 162.42 25.67 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.337 1.455 . . . . 0.0 112.277 176.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -66.77 179.92 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 125.912 1.685 . . . . 0.0 112.367 -176.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 87.4 p -49.04 153.48 0.9 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.195 2.198 . . . . 0.0 113.913 175.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -158.24 170.84 21.36 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.7 1.6 . . . . 0.0 110.761 -167.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -77.2 -62.35 2.47 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 119.196 -0.78 . . . . 0.0 113.569 -170.005 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -105.89 121.87 44.95 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 117.815 0.808 . . . . 0.0 110.63 -172.151 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -143.88 145.89 32.62 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -167.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 15.6 tt -142.64 154.28 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.412 1.485 . . . . 0.0 109.28 169.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -133.25 144.99 17.07 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 123.727 0.68 . . . . 0.0 112.242 -169.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 11.9 t -67.99 145.92 54.05 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-O 122.036 0.922 . . . . 0.0 110.467 -174.106 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -94.4 2.46 55.78 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 113.509 -1.678 . . . . 0.0 112.694 -171.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -77.63 147.06 74.23 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 119.172 0.896 . . . . 0.0 110.473 177.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -76.71 8.07 3.23 Favored 'Trans proline' 0 CA--C 1.547 1.14 0 C-N-CA 123.542 2.828 . . . . 0.0 111.775 167.77 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -127.46 -6.77 5.81 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.344 1.857 . . . . 0.0 112.436 -171.532 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 37.9 t -64.45 131.22 46.52 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.651 0.78 . . . . 0.0 109.742 175.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.7 t -109.15 9.72 26.06 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.42 1.488 . . . . 0.0 111.743 -173.577 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 32.7 mm -121.95 -31.92 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 126.058 1.743 . . . . 0.0 109.677 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 51.6 -15.7 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 131.318 3.847 . . . . 0.0 119.327 175.413 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 58.1 m95 -139.04 151.04 46.47 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.713 1.605 . . . . 0.0 110.578 178.088 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -152.95 152.69 31.73 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.175 1.39 . . . . 0.0 110.233 -171.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -76.28 149.4 37.12 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.407 -0.815 . . . . 0.0 108.959 169.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 8.9 m-30 -52.31 -51.2 60.0 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.829 167.731 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.82 -14.08 62.28 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 118.361 -0.828 . . . . 0.0 113.2 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 9.4 m -79.04 -2.42 40.3 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 119.586 1.085 . . . . 0.0 112.511 172.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 1.2 p -126.61 -14.08 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.32 1.448 . . . . 0.0 112.456 169.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 97.16 20.33 23.54 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 125.485 1.517 . . . . 0.0 113.642 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 10.9 mt -75.41 160.31 30.39 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.803 1.301 . . . . 0.0 111.544 178.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 38.4 m -132.31 -10.74 3.26 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.288 1.835 . . . . 0.0 110.648 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 77.5 p -142.27 -174.88 4.24 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.798 2.039 . . . . 0.0 109.15 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -120.92 98.66 47.46 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 123.856 0.862 . . . . 0.0 110.451 -176.103 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -70.94 170.68 17.4 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.685 2.257 . . . . 0.0 111.002 169.803 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 -141.74 133.54 27.22 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.716 1.206 . . . . 0.0 108.492 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 129.85 -163.57 22.8 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 126.022 1.772 . . . . 0.0 110.85 -174.127 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -61.8 115.63 4.16 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.109 0.963 . . . . 0.0 109.284 169.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 53.0 t90 -132.93 142.7 49.03 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.31 1.844 . . . . 0.0 107.825 175.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -125.49 139.37 53.69 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.154 0.981 . . . . 0.0 110.801 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 239' ' ' CYS . . . . . 0.4 ' HB2' ' HD2' ' A' ' 240' ' ' PRO . 7.4 p -71.46 173.36 5.22 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 125.888 1.675 . . . . 0.0 111.888 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 68.8 Cg_endo -70.31 -33.2 14.94 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 121.217 1.278 . . . . 0.0 113.655 -168.86 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -75.13 -4.72 40.35 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 173.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 22.2 m -112.99 -17.95 12.33 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.745 1.218 . . . . 0.0 113.459 -171.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 22.1 t -152.94 -35.18 0.11 Allowed 'General case' 0 C--N 1.343 0.303 0 CA-C-N 119.093 0.861 . . . . 0.0 113.294 177.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -72.41 -14.59 61.74 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 118.23 0.468 . . . . 0.0 112.164 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -64.71 -25.06 67.77 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.494 1.117 . . . . 0.0 111.804 177.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -80.1 53.03 1.64 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.793 1.637 . . . . 0.0 111.407 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -140.36 37.31 1.88 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.673 1.589 . . . . 0.0 109.81 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm 51.12 63.84 2.08 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.46 1.904 . . . . 0.0 112.001 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? . . . . . 0 C--O 1.251 1.143 0 C-N-CA 126.551 1.941 . . . . 0.0 111.204 179.737 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.479 0.98 0 CA-C-O 118.725 -0.655 . . . . 0.0 111.915 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -141.95 160.66 39.75 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.721 1.209 . . . . 0.0 110.508 -176.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 65.6 mtt -144.28 154.69 57.61 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 125.538 1.535 . . . . 0.0 110.168 -178.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -74.07 84.19 1.53 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 124.382 3.388 . . . . 0.0 109.899 172.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . 0.313 2.7 m 53.43 148.61 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 130.537 3.535 . . . . 0.0 115.394 -169.069 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -71.33 154.34 93.69 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.55 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.39 8.14 2.32 Favored 'Trans proline' 0 CA--C 1.547 1.146 0 C-N-CA 123.632 2.888 . . . . 0.0 112.245 168.885 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -120.18 33.34 5.64 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.805 2.042 . . . . 0.0 110.606 -176.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -141.88 125.18 9.67 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 125.539 1.536 . . . . 0.0 108.481 -170.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -71.12 161.11 47.05 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.106 2.538 . . . . 0.0 112.77 -177.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 34.2 p -142.83 175.32 9.91 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.116 1.766 . . . . 0.0 109.223 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -136.3 -67.34 0.52 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.995 0.918 . . . . 0.0 111.573 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.438 ' SG ' ' HB2' ' A' ' 201' ' ' CYS . 4.5 p -56.71 163.72 1.76 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 128.388 2.675 . . . . 0.0 113.811 176.308 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.3 pp -77.02 -1.13 27.31 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.865 -1.062 . . . . 0.0 111.704 167.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' CYS . . . . . 0.438 ' HB2' ' SG ' ' A' ' 199' ' ' CYS . 77.0 m -75.45 -29.16 59.56 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.943 0.897 . . . . 0.0 110.2 168.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . 0.302 89.1 m-70 71.1 54.69 0.23 Allowed 'General case' 0 C--N 1.342 0.255 0 C-N-CA 127.619 2.367 . . . . 0.0 113.689 169.468 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -137.49 172.69 12.6 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.617 166.491 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.409 HG23 ' H ' ' A' ' 204' ' ' VAL . 0.2 OUTLIER -63.16 174.37 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 125.189 1.396 . . . . 0.0 111.877 -175.384 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.409 ' H ' HG12 ' A' ' 204' ' ' VAL . 83.5 p -47.81 156.71 0.31 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.935 2.094 . . . . 0.0 115.063 -174.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -144.36 163.49 33.59 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.477 1.511 . . . . 0.0 111.101 -168.54 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -61.5 -40.7 99.05 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.851 1.215 . . . . 0.0 114.702 -169.441 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -130.54 122.91 28.44 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.115 0.966 . . . . 0.0 110.355 -173.514 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 1.4 mtm -139.69 144.5 37.6 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -167.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 21.2 tt -136.82 146.37 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 125.605 1.562 . . . . 0.0 110.232 171.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -124.2 139.54 12.01 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.573 1.082 . . . . 0.0 112.819 -170.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' CYS . . . . . 0.597 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 4.5 m -76.09 125.09 28.49 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 125.746 1.618 . . . . 0.0 111.441 -168.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -74.54 4.59 5.84 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.718 1.607 . . . . 0.0 113.21 -177.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -69.13 148.19 97.62 Favored Pre-proline 0 CA--C 1.538 0.51 0 O-C-N 121.29 -0.881 . . . . 0.0 111.018 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -81.36 3.85 7.47 Favored 'Trans proline' 0 CA--C 1.549 1.253 0 C-N-CA 123.2 2.6 . . . . 0.0 111.666 166.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -134.67 -10.42 2.41 Favored 'General case' 0 C--N 1.35 0.61 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 -169.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 36.9 t -64.13 135.28 56.2 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 119.438 1.017 . . . . 0.0 110.811 -177.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.7 t -110.97 10.9 22.2 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.779 1.632 . . . . 0.0 111.498 -173.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 36.5 mm -117.19 -42.46 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 125.263 1.425 . . . . 0.0 108.581 171.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 49.8 -10.18 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 131.068 3.747 . . . . 0.0 119.309 172.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -139.14 140.96 38.05 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 127.051 2.14 . . . . 0.0 109.913 169.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' PHE . . . . . 0.597 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 8.4 m-85 -147.45 150.83 35.36 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.81 1.644 . . . . 0.0 108.866 -169.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -66.01 153.2 42.83 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 166.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -52.7 -49.41 65.4 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 166.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -69.43 -12.81 61.96 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 1.8 t -68.17 -14.91 63.33 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.752 0.705 . . . . 0.0 112.71 171.332 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 6.4 p -126.55 -10.11 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 126.479 1.912 . . . . 0.0 112.539 174.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 91.76 20.26 37.69 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.623 1.582 . . . . 0.0 113.469 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 5.9 mt -69.57 160.7 31.02 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.643 1.222 . . . . 0.0 112.018 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 96.9 m -139.35 -29.21 0.75 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.163 1.385 . . . . 0.0 111.307 -174.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 88.0 m -140.96 123.59 16.04 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 125.117 1.367 . . . . 0.0 107.582 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -65.9 121.66 76.99 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 123.96 0.904 . . . . 0.0 111.712 -169.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -78.77 -174.96 2.49 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 124.253 3.302 . . . . 0.0 111.228 170.708 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 3.1 ttp85 -145.53 151.41 38.1 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.794 1.238 . . . . 0.0 108.811 170.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 94.99 -155.88 21.64 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.817 1.199 . . . . 0.0 111.48 -177.314 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -57.21 108.92 0.58 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.526 1.53 . . . . 0.0 110.952 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' TRP . . . . . 0.457 ' HZ3' ' HG ' ' A' ' 212' ' ' CYS . 65.7 t90 -131.06 129.2 41.65 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 126.049 1.739 . . . . 0.0 107.952 169.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -117.75 126.1 51.84 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 239' ' ' CYS . . . . . 0.469 ' HB3' ' SG ' ' A' ' 212' ' ' CYS . 3.3 p -58.46 171.87 0.56 Allowed Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 127.689 2.396 . . . . 0.0 113.876 -173.616 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.444 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 37.0 Cg_endo -66.19 -33.78 38.74 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 121.323 1.349 . . . . 0.0 112.767 -170.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 66.7 mtt180 -79.06 9.19 4.62 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.805 1.242 . . . . 0.0 112.785 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 27.6 m -131.05 -12.21 3.66 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.216 1.806 . . . . 0.0 114.1 -174.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 33.2 t -152.79 -39.59 0.1 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.882 0.873 . . . . 0.0 112.388 178.561 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -77.89 -13.34 59.92 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -175.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -64.78 -15.81 62.15 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.773 0.829 . . . . 0.0 112.654 172.273 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 51.0 ttt85 -62.5 -12.36 21.83 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.223 1.409 . . . . 0.0 112.765 169.762 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -128.23 1.37 5.77 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.739 1.616 . . . . 0.0 112.881 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? 38.79 80.92 0.03 OUTLIER 'General case' 0 C--N 1.35 0.599 0 C-N-CA 127.426 2.29 . . . . 0.0 113.56 172.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 63.1 tttp . . . . . 0 C--O 1.249 1.066 0 CA-C-O 116.677 -1.63 . . . . 0.0 110.14 -178.899 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 53.9 ttm . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -156.55 46.84 0.44 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.312 1.045 . . . . 0.0 110.312 -173.117 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 25.7 ttt -138.74 75.42 36.96 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 124.103 0.961 . . . . 0.0 110.405 -175.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -74.06 178.62 6.67 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.86 3.04 . . . . 0.0 111.634 173.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 5.4 m -133.86 140.02 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 126.226 1.81 . . . . 0.0 108.325 175.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -66.49 158.11 79.83 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 125.483 1.513 . . . . 0.0 112.293 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -73.18 5.98 2.83 Favored 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 123.602 2.868 . . . . 0.0 112.316 168.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -116.16 34.77 4.82 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.932 2.093 . . . . 0.0 110.332 -177.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 31.1 tp10 -143.46 129.91 10.36 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 125.849 1.66 . . . . 0.0 108.048 -171.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -71.0 154.57 62.78 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.937 2.424 . . . . 0.0 111.632 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 62.9 p -145.47 174.07 11.46 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.703 1.201 . . . . 0.0 110.502 -175.372 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -137.51 -80.93 0.36 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.639 -169.904 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 1.8 t -56.58 167.14 0.77 Allowed 'General case' 0 C--N 1.351 0.649 0 C-N-CA 124.543 1.137 . . . . 0.0 112.942 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.0 pp -58.3 -11.97 3.25 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.031 1.332 . . . . 0.0 112.759 171.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 71.4 m -76.34 -20.43 57.24 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.552 1.941 . . . . 0.0 113.166 176.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 50.8 m170 56.71 65.99 1.28 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.855 2.062 . . . . 0.0 111.585 -170.047 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.93 157.65 41.03 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.029 1.332 . . . . 0.0 112.338 174.001 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.513 HG12 ' H ' ' A' ' 205' ' ' SER . 0.7 OUTLIER -67.92 -178.89 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 126.292 1.837 . . . . 0.0 111.113 -177.858 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.513 ' H ' HG12 ' A' ' 204' ' ' VAL . 87.9 p -45.57 149.83 0.54 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 127.47 2.308 . . . . 0.0 113.827 178.641 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' TYR . . . . . 0.469 ' CE2' ' HG2' ' A' ' 209' ' ' MET . 16.3 p90 -154.34 165.62 35.77 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.22 1.408 . . . . 0.0 111.077 -167.493 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -74.91 -41.54 32.88 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 118.511 -1.16 . . . . 0.0 115.204 -168.777 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -126.35 120.3 29.52 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 118.582 1.191 . . . . 0.0 110.506 -169.449 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' MET . . . . . 0.469 ' HG2' ' CE2' ' A' ' 206' ' ' TYR . 3.1 mtp -139.74 149.2 43.32 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -165.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 15.2 tt -137.79 155.61 30.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 CA-C-N 113.768 -1.56 . . . . 0.0 109.553 168.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -133.04 138.87 10.47 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.698 1.142 . . . . 0.0 112.51 -171.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' CYS . . . . . 0.591 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 1.6 m -79.3 126.21 30.5 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.554 1.542 . . . . 0.0 112.311 -167.675 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -69.67 -1.85 10.13 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.776 2.03 . . . . 0.0 113.718 -176.238 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -66.56 148.86 98.52 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 123.717 0.807 . . . . 0.0 111.827 -174.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -83.34 7.92 4.92 Favored 'Trans proline' 0 CA--C 1.549 1.25 0 C-N-CA 123.661 2.908 . . . . 0.0 111.404 166.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -144.58 -10.43 0.62 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 -167.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 37.3 t -61.58 133.42 55.65 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 119.562 1.074 . . . . 0.0 110.62 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.9 t -107.16 8.54 30.14 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.652 1.581 . . . . 0.0 111.588 -172.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 41.3 mm -117.66 -42.58 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 125.675 1.59 . . . . 0.0 108.735 174.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 46.95 -9.77 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.834 1 C-N-CA 131.706 4.002 . . . . 0.0 119.703 172.803 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 63.8 m95 -136.85 135.84 38.25 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.652 1.981 . . . . 0.0 109.166 170.171 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' PHE . . . . . 0.591 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 7.6 m-85 -141.45 155.86 45.82 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 125.129 1.371 . . . . 0.0 109.074 -169.323 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -76.22 149.01 37.28 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 169.174 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -52.39 -50.61 62.13 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.094 167.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.32 -14.59 62.65 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -177.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 9.5 m -79.14 -4.05 48.53 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 119.676 1.126 . . . . 0.0 112.861 172.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.6 p -123.93 -13.84 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 126.049 1.739 . . . . 0.0 112.383 169.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 96.57 17.53 33.23 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.683 1.611 . . . . 0.0 113.206 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 9.6 mt -73.31 162.67 29.09 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.38 1.09 . . . . 0.0 111.606 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.7 t -139.47 -2.79 1.56 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.923 1.689 . . . . 0.0 112.15 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 46.0 p -143.37 179.77 6.89 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.977 2.111 . . . . 0.0 109.61 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -110.89 92.72 15.36 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 124.707 1.203 . . . . 0.0 109.546 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -69.01 164.68 32.85 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.252 1.968 . . . . 0.0 110.295 169.656 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 47.9 ttp180 -142.47 131.52 23.16 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 122.211 1.005 . . . . 0.0 109.012 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 135.58 -170.56 23.0 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 126.721 2.105 . . . . 0.0 109.886 -169.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -67.53 121.23 15.37 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.709 0.766 . . . . 0.0 109.892 171.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 47.7 t90 -131.41 141.59 49.88 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.793 2.037 . . . . 0.0 108.313 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -125.08 130.74 52.87 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.29 1.036 . . . . 0.0 108.868 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 2.4 p -61.28 167.63 3.8 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 126.089 1.756 . . . . 0.0 112.705 -175.5 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -65.61 -33.72 44.43 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 121.29 1.326 . . . . 0.0 112.671 -169.833 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 75.1 mtt-85 -79.43 6.29 10.6 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.137 0.975 . . . . 0.0 113.049 177.778 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 22.6 m -125.9 -15.38 5.92 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.835 1.654 . . . . 0.0 114.023 -175.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 22.9 t -150.24 -32.51 0.19 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.89 0.768 . . . . 0.0 112.997 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 30.1 tp60 -86.44 -20.62 27.89 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -176.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -75.69 -20.05 58.68 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.556 1.142 . . . . 0.0 112.046 -176.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 59.6 ttt85 -79.75 83.16 5.74 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.374 1.469 . . . . 0.0 108.822 170.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -146.06 56.35 1.19 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.462 1.105 . . . . 0.0 110.493 -170.77 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -78.03 75.97 4.56 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.75 1.22 . . . . 0.0 108.306 169.786 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.175 0 C-N-CA 126.784 2.034 . . . . 0.0 110.193 -168.342 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 63.4 mtt . . . . . 0 N--CA 1.477 0.879 0 CA-C-O 118.992 -0.528 . . . . 0.0 110.961 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -61.27 100.26 0.12 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.111 1.764 . . . . 0.0 111.747 -175.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.522 ' H ' ' HD2' ' A' ' 190' ' ' PRO . 1.7 mmt -156.4 -50.33 0.01 OUTLIER Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 126.194 1.798 . . . . 0.0 111.231 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.522 ' HD2' ' H ' ' A' ' 189' ' ' MET . 86.5 Cg_endo -79.74 99.51 1.21 Allowed 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.578 2.186 . . . . 0.0 110.678 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 2.3 m -139.89 126.02 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 125.679 1.591 . . . . 0.0 108.516 176.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -75.4 156.4 85.36 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 124.598 1.159 . . . . 0.0 111.417 178.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -72.0 -4.33 14.94 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 123.506 2.804 . . . . 0.0 112.807 169.873 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -71.39 85.05 0.81 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.976 2.11 . . . . 0.0 110.295 177.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -142.49 125.27 9.19 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 124.979 1.312 . . . . 0.0 108.821 -177.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -79.41 166.18 22.48 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.179 2.586 . . . . 0.0 112.205 -178.107 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 44.6 p -141.59 169.83 16.86 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.033 1.733 . . . . 0.0 108.466 174.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -137.83 -55.13 0.67 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -177.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.452 ' SG ' ' HB2' ' A' ' 201' ' ' CYS . 3.6 p -67.48 165.68 16.23 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 128.531 2.732 . . . . 0.0 113.664 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.4 pp -72.11 -4.71 30.58 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.648 166.517 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' CYS . . . . . 0.452 ' HB2' ' SG ' ' A' ' 199' ' ' CYS . 74.1 m -80.07 -25.81 39.9 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.867 1.267 . . . . 0.0 111.342 174.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . 0.285 9.9 m-70 71.37 52.01 0.25 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.886 2.074 . . . . 0.0 112.71 169.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -137.41 171.37 14.58 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.22 167.104 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.416 HG12 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -63.9 174.12 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 125.349 1.459 . . . . 0.0 111.998 -173.87 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.416 ' H ' HG12 ' A' ' 204' ' ' VAL . 89.4 p -47.57 155.12 0.39 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.339 2.256 . . . . 0.0 115.481 -173.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -145.46 160.41 41.63 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.962 1.705 . . . . 0.0 110.377 -169.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -60.46 -38.77 95.33 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.653 1.12 . . . . 0.0 114.783 -169.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -131.86 121.45 24.08 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.0 0.92 . . . . 0.0 110.722 -171.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 1.4 mtm -138.33 144.92 40.61 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -168.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 21.3 tt -143.33 147.91 19.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 126.358 1.863 . . . . 0.0 109.202 173.497 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -137.19 145.85 17.68 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 123.698 0.666 . . . . 0.0 113.086 -169.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 6.9 t -72.13 145.3 48.22 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-O 122.234 1.016 . . . . 0.0 111.124 -172.201 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -77.78 -9.56 59.09 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.648 1.979 . . . . 0.0 113.92 -176.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -76.71 145.91 75.6 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 118.676 0.671 . . . . 0.0 111.782 -169.121 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.35 8.95 2.69 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 124.072 3.181 . . . . 0.0 112.209 169.003 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -134.23 -8.8 2.61 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.285 1.834 . . . . 0.0 112.34 -169.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 46.9 t -63.07 125.1 22.9 Favored 'General case' 0 C--N 1.345 0.401 0 C-N-CA 123.52 0.728 . . . . 0.0 109.708 172.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 10.0 t -97.84 1.78 48.59 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.835 1.654 . . . . 0.0 112.014 -172.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 28.3 mm -117.43 -32.03 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 125.949 1.7 . . . . 0.0 109.7 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 50.07 -12.61 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 130.529 3.532 . . . . 0.0 118.985 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 46.3 m95 -141.96 157.18 45.26 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 120.588 1.54 . . . . 0.0 112.104 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -158.72 153.3 24.46 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.203 1.801 . . . . 0.0 109.349 -174.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 62.0 m80 -68.69 155.55 39.88 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 166.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 11.1 m-30 -52.81 -51.11 62.1 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 166.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -68.68 -12.55 61.53 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.893 0.877 . . . . 0.0 113.255 -177.894 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 1.1 t -67.08 -20.29 65.79 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.488 0.715 . . . . 0.0 112.584 172.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 5.5 p -118.69 -15.48 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 125.971 1.709 . . . . 0.0 112.155 173.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 101.28 16.99 23.55 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.797 1.665 . . . . 0.0 113.665 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 11.7 mt -71.6 166.49 21.74 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.065 1.433 . . . . 0.0 111.652 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 88.2 m -132.42 -14.5 2.91 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.909 1.683 . . . . 0.0 110.828 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 75.9 p -142.03 169.49 17.49 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.996 1.718 . . . . 0.0 109.983 -177.453 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -98.77 114.4 65.38 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 123.829 0.852 . . . . 0.0 109.13 175.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -75.32 -178.81 4.5 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.991 3.128 . . . . 0.0 110.748 172.181 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -138.37 129.52 27.19 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.964 0.906 . . . . 0.0 108.868 174.148 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 123.31 -178.42 16.39 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 125.978 1.752 . . . . 0.0 110.981 -170.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -67.33 137.31 55.94 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 122.298 1.047 . . . . 0.0 110.625 173.097 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 49.4 t90 -141.89 154.88 45.44 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 127.439 2.296 . . . . 0.0 109.109 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -128.42 132.5 48.46 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.9 1.28 . . . . 0.0 110.487 -174.481 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 1.8 p -71.47 170.07 13.22 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.045 1.338 . . . . 0.0 112.186 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.79 -15.28 26.82 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 121.789 1.659 . . . . 0.0 114.09 -169.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -96.92 9.25 42.46 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.882 1.673 . . . . 0.0 111.948 173.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 20.0 m -130.65 -18.32 3.13 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.589 1.556 . . . . 0.0 113.637 -172.722 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 45.1 t -151.17 -38.67 0.13 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.464 1.029 . . . . 0.0 112.746 174.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 33.2 tp60 -69.11 -19.07 64.04 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.131 0.423 . . . . 0.0 112.004 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -62.45 -18.86 62.74 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.564 1.946 . . . . 0.0 113.078 177.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 82.4 mtt85 -86.1 24.78 1.26 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.497 1.519 . . . . 0.0 112.868 -178.652 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -131.72 115.69 16.33 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 124.815 1.246 . . . . 0.0 108.639 171.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -73.2 98.11 2.55 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.173 1.389 . . . . 0.0 109.938 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt . . . . . 0 C--O 1.25 1.114 0 C-N-CA 126.005 1.722 . . . . 0.0 109.131 -178.911 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.475 0.792 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -140.1 -107.52 0.16 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.066 0.946 . . . . 0.0 108.828 -169.022 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 64.5 mtt -140.73 59.51 11.58 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 125.179 1.392 . . . . 0.0 109.942 178.874 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.13 -42.05 6.45 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.795 2.33 . . . . 0.0 112.662 -175.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -155.75 144.98 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 128.537 2.735 . . . . 0.0 107.458 175.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -84.53 154.09 62.07 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 123.942 0.897 . . . . 0.0 110.56 169.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -74.58 5.65 3.66 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 123.616 2.878 . . . . 0.0 112.35 169.082 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -114.45 38.76 2.98 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.877 2.071 . . . . 0.0 110.172 -174.807 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -140.69 127.92 12.15 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 125.436 1.494 . . . . 0.0 108.205 -169.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -70.51 158.17 56.75 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.883 2.389 . . . . 0.0 111.962 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 63.9 p -144.48 175.23 10.28 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.85 1.26 . . . . 0.0 110.452 -173.77 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -135.19 -81.2 0.43 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 117.436 -1.269 . . . . 0.0 112.992 -169.031 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -56.02 168.93 0.42 Allowed 'General case' 0 C--N 1.349 0.581 0 C-N-CA 124.887 1.275 . . . . 0.0 113.32 -177.435 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.9 pp -57.87 -12.14 2.91 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.015 1.326 . . . . 0.0 113.015 169.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 72.1 m -76.62 -23.74 53.38 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 127.002 2.121 . . . . 0.0 113.261 176.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 17.3 m170 58.85 66.44 1.06 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.574 1.949 . . . . 0.0 111.001 -169.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.18 159.44 36.03 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.966 1.306 . . . . 0.0 112.273 174.281 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.577 HG12 ' H ' ' A' ' 205' ' ' SER . 0.8 OUTLIER -70.96 -177.96 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 C-N-CA 126.186 1.794 . . . . 0.0 111.231 -175.79 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.577 ' H ' HG12 ' A' ' 204' ' ' VAL . 49.6 m -46.83 151.69 0.58 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 128.289 2.636 . . . . 0.0 114.221 -178.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' TYR . . . . . 0.454 ' CE2' ' HG2' ' A' ' 209' ' ' MET . 11.9 p90 -155.7 162.95 40.46 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.742 1.617 . . . . 0.0 110.819 -168.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -70.59 -47.17 43.14 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-O 118.695 -1.058 . . . . 0.0 114.526 -169.402 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -127.94 123.0 33.83 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.376 1.088 . . . . 0.0 110.289 -169.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' MET . . . . . 0.454 ' HG2' ' CE2' ' A' ' 206' ' ' TYR . 5.1 mtp -135.17 153.63 51.9 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -165.844 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 18.4 tt -142.94 158.81 18.13 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 C-N-CA 126.799 2.04 . . . . 0.0 108.752 169.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -141.64 143.42 13.04 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 123.564 0.602 . . . . 0.0 111.79 -173.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 4.1 t -71.55 142.32 50.07 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-O 121.674 0.749 . . . . 0.0 111.04 -173.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -75.97 -10.65 59.59 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.682 1.593 . . . . 0.0 114.036 -174.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -78.84 145.04 65.38 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 118.66 0.664 . . . . 0.0 112.064 -167.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -75.64 1.98 7.44 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 123.603 2.869 . . . . 0.0 111.989 168.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -118.77 -6.61 10.58 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.217 1.807 . . . . 0.0 112.224 -175.141 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 39.0 t -64.91 136.86 57.32 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.305 1.042 . . . . 0.0 109.682 173.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 8.5 t -121.05 12.4 11.13 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.805 1.642 . . . . 0.0 111.202 -175.56 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 36.4 mm -119.98 -32.88 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 126.206 1.802 . . . . 0.0 109.383 175.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 50.83 -16.27 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.687 1 C-N-CA 131.769 4.028 . . . . 0.0 119.309 175.439 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 61.5 m95 -140.86 150.81 43.73 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 125.549 1.54 . . . . 0.0 110.188 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -154.31 154.44 33.37 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.288 1.435 . . . . 0.0 110.278 -170.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -79.07 143.92 35.11 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 168.839 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -51.67 -50.07 61.13 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.337 167.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -68.88 -13.93 62.72 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.747 1.018 . . . . 0.0 113.747 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.38 -21.94 59.42 Favored 'General case' 0 C--N 1.349 0.55 0 CA-C-N 119.942 1.247 . . . . 0.0 112.647 174.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.6 p -104.9 -13.46 9.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 125.604 1.562 . . . . 0.0 111.785 170.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 90.68 20.3 41.02 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.83 1.681 . . . . 0.0 113.24 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 12.9 mt -73.45 157.82 36.12 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 118.873 1.336 . . . . 0.0 111.382 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 69.0 p -131.52 -1.33 3.9 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.293 1.837 . . . . 0.0 111.403 176.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 60.5 p -145.23 175.69 10.09 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.551 2.34 . . . . 0.0 108.956 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -119.13 125.44 27.62 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 123.946 0.899 . . . . 0.0 109.515 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -76.17 -171.09 0.98 Allowed 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 124.513 3.475 . . . . 0.0 111.127 174.026 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -148.3 138.72 22.75 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.187 0.995 . . . . 0.0 109.34 178.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 102.58 -62.23 0.48 Allowed Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.919 1.723 . . . . 0.0 112.065 173.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -148.74 142.27 25.37 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 125.475 1.51 . . . . 0.0 110.306 -178.47 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 77.6 t90 -150.73 154.02 36.6 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 126.223 1.809 . . . . 0.0 109.834 171.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -128.42 127.51 42.7 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.054 1.342 . . . . 0.0 109.919 -177.135 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.62 167.54 10.75 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 124.79 1.236 . . . . 0.0 113.311 -177.115 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -74.29 -0.65 9.92 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.507 2.138 . . . . 0.0 114.19 -174.2 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 35.0 mtp180 -123.9 27.39 7.25 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.02 1.328 . . . . 0.0 111.322 168.662 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 10.3 m -131.67 -14.89 3.16 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 126.357 1.863 . . . . 0.0 112.224 173.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 41.9 t -149.17 -34.82 0.19 Allowed 'General case' 0 C--N 1.345 0.402 0 CA-C-N 118.994 0.815 . . . . 0.0 112.704 174.868 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -75.27 -12.98 60.39 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -176.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -66.52 -9.14 31.75 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.936 0.789 . . . . 0.0 112.75 169.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 56.1 ttt180 -75.33 -20.87 58.81 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.564 1.146 . . . . 0.0 112.423 173.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -142.74 63.24 1.39 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.459 1.503 . . . . 0.0 109.947 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -62.72 139.43 58.67 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.986 0.915 . . . . 0.0 110.118 174.522 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 26.3 tptp . . . . . 0 C--O 1.251 1.162 0 CA-C-O 116.589 -1.672 . . . . 0.0 110.44 -173.943 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 60.1 ttm . . . . . 0 N--CA 1.476 0.837 0 CA-C-O 119.476 -0.297 . . . . 0.0 110.565 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -147.89 -176.19 5.17 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.498 1.519 . . . . 0.0 110.383 -174.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 25.7 ttt 50.26 68.47 3.39 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 125.999 1.72 . . . . 0.0 112.016 -175.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -80.65 45.39 1.97 Allowed 'Trans proline' 0 CA--C 1.547 1.158 0 C-N-CA 125.23 3.953 . . . . 0.0 112.866 -172.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 2.7 m -125.79 109.97 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 125.739 1.616 . . . . 0.0 108.999 -177.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -70.46 156.6 91.66 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 125.016 1.326 . . . . 0.0 112.262 -177.055 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -73.28 2.71 5.33 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 123.956 3.104 . . . . 0.0 113.08 170.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -70.97 81.38 0.66 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.658 1.983 . . . . 0.0 110.367 177.587 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -152.37 138.39 11.72 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 125.544 1.537 . . . . 0.0 108.307 -170.766 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -71.46 152.55 60.37 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.765 2.31 . . . . 0.0 111.693 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 80.4 p -144.41 172.76 12.5 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.767 1.227 . . . . 0.0 110.377 -175.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -136.38 -81.18 0.39 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 117.511 -1.233 . . . . 0.0 113.076 -169.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.8 t -55.43 166.55 0.61 Allowed 'General case' 0 C--N 1.35 0.594 0 C-N-CA 125.161 1.385 . . . . 0.0 112.871 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 4.7 pp -59.52 -9.72 2.78 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.543 1.137 . . . . 0.0 112.873 170.115 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 73.3 m -77.06 -20.87 55.3 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.694 1.997 . . . . 0.0 113.052 174.82 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 13.3 m170 59.2 62.55 1.8 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.881 2.072 . . . . 0.0 111.499 -173.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.31 160.43 32.21 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.269 1.428 . . . . 0.0 112.409 176.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.487 HG12 ' H ' ' A' ' 205' ' ' SER . 0.3 OUTLIER -69.2 -179.62 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 126.366 1.866 . . . . 0.0 111.718 -176.325 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.487 ' H ' HG12 ' A' ' 204' ' ' VAL . 80.4 p -45.67 150.16 0.53 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.873 2.469 . . . . 0.0 114.329 178.125 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -155.37 168.69 26.28 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.767 1.627 . . . . 0.0 110.875 -167.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -76.04 -43.68 21.04 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 118.676 -1.069 . . . . 0.0 115.101 -168.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -127.73 121.78 31.18 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 118.425 1.113 . . . . 0.0 110.784 -169.454 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -143.76 146.74 33.36 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -165.762 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 13.6 tt -143.7 154.9 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 125.8 1.64 . . . . 0.0 109.346 168.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -136.23 147.01 19.0 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 123.741 0.686 . . . . 0.0 112.299 -169.621 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 6.1 t -70.12 144.47 52.05 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-O 122.179 0.99 . . . . 0.0 111.058 -174.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -79.14 -5.94 55.34 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.763 2.025 . . . . 0.0 113.671 -174.091 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -82.22 145.48 52.51 Favored Pre-proline 0 CA--C 1.535 0.404 0 CA-C-N 118.81 0.732 . . . . 0.0 111.464 -169.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -76.74 6.28 4.24 Favored 'Trans proline' 0 CA--C 1.547 1.133 0 C-N-CA 123.544 2.829 . . . . 0.0 111.702 167.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -124.18 -9.23 7.61 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.301 1.841 . . . . 0.0 112.502 -172.303 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 43.9 t -64.92 133.6 52.17 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.239 1.016 . . . . 0.0 109.893 175.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 37.9 m -110.39 8.39 23.25 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.531 1.532 . . . . 0.0 111.845 -174.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 33.3 mm -119.83 -33.06 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 126.256 1.822 . . . . 0.0 109.446 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 50.14 -15.7 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.659 1 C-N-CA 131.757 4.023 . . . . 0.0 119.338 177.118 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 58.3 m95 -140.47 152.14 45.4 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.795 1.638 . . . . 0.0 110.437 178.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -153.07 154.95 35.91 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.333 1.453 . . . . 0.0 110.015 -173.039 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -77.71 149.75 34.56 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 170.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -53.71 -50.75 65.22 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.634 167.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -69.91 -14.82 62.91 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 118.296 -0.859 . . . . 0.0 113.229 -177.342 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 7.4 m -78.85 -6.46 56.12 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 119.667 1.122 . . . . 0.0 112.858 173.146 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.3 p -121.17 -12.58 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 125.864 1.666 . . . . 0.0 112.065 169.28 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 92.96 19.86 35.3 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.524 1.535 . . . . 0.0 113.313 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 6.2 mt -72.51 158.29 36.0 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 118.397 1.098 . . . . 0.0 111.082 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 68.7 p -134.14 1.9 3.28 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.195 1.798 . . . . 0.0 111.263 176.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 81.9 p -142.95 179.89 6.76 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.051 2.141 . . . . 0.0 109.664 -175.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -121.65 89.55 47.63 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 124.603 1.161 . . . . 0.0 109.055 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.65 169.04 18.29 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.801 2.334 . . . . 0.0 111.304 174.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -140.02 133.7 30.39 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 124.917 1.287 . . . . 0.0 108.564 -177.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 126.46 -169.59 18.38 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 126.319 1.914 . . . . 0.0 110.277 -169.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.95 130.4 43.91 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 122.093 0.949 . . . . 0.0 109.195 169.821 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 53.0 t90 -136.74 146.63 46.03 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 127.072 2.149 . . . . 0.0 108.312 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -129.97 131.65 46.0 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.678 1.191 . . . . 0.0 109.637 -173.549 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 1.5 p -68.78 166.68 24.9 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 124.27 1.028 . . . . 0.0 112.074 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.37 9.43 2.52 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.539 2.159 . . . . 0.0 114.57 -175.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -122.79 15.93 10.17 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.512 1.925 . . . . 0.0 110.856 171.062 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 30.1 m -133.19 -22.76 1.98 Allowed 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.962 1.705 . . . . 0.0 113.111 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.1 t -153.71 -34.07 0.11 Allowed 'General case' 0 C--N 1.346 0.426 0 CA-C-N 119.724 1.147 . . . . 0.0 113.501 173.6 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 10.7 tp60 -76.03 -8.05 56.08 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.928 0.785 . . . . 0.0 112.006 176.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -67.83 -26.37 66.02 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.057 1.343 . . . . 0.0 111.628 169.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -75.85 163.24 27.42 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.356 1.462 . . . . 0.0 110.087 171.066 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 27.3 tptt -110.44 104.73 13.51 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.393 1.077 . . . . 0.0 108.557 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt 43.78 72.62 0.18 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.671 1.988 . . . . 0.0 112.302 -170.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? . . . . . 0 C--O 1.25 1.108 0 CA-C-O 116.704 -1.617 . . . . 0.0 110.789 175.966 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 47.9 ttp . . . . . 0 N--CA 1.474 0.736 0 CA-C-O 121.273 0.558 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -73.67 110.24 7.81 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.505 1.522 . . . . 0.0 110.329 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 189' ' ' MET . . . . . 0.576 ' H ' ' HD2' ' A' ' 190' ' ' PRO . 54.2 mtm -146.0 -49.4 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.659 0 CA-C-O 116.85 -1.548 . . . . 0.0 111.922 177.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 190' ' ' PRO . . . . . 0.576 ' HD2' ' H ' ' A' ' 189' ' ' MET . 87.3 Cg_endo -77.18 -12.25 17.47 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 122.152 1.901 . . . . 0.0 112.92 174.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 14.4 p -158.01 158.25 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 127.102 2.161 . . . . 0.0 107.831 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -56.42 158.46 7.88 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 126.388 1.875 . . . . 0.0 112.367 173.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -72.15 11.55 0.73 Allowed 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 123.777 2.985 . . . . 0.0 112.896 169.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -129.96 111.3 12.4 Favored 'General case' 0 C--N 1.343 0.31 0 C-N-CA 126.509 1.924 . . . . 0.0 107.642 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -149.47 131.22 7.52 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.762 1.225 . . . . 0.0 108.803 -177.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.99 151.61 35.36 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.982 2.455 . . . . 0.0 111.431 176.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 49.0 p -143.31 173.14 11.86 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.573 1.549 . . . . 0.0 109.108 -177.461 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -139.46 -67.29 0.45 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.83 0.852 . . . . 0.0 111.782 -173.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.438 ' SG ' ' HB2' ' A' ' 201' ' ' CYS . 4.6 p -59.37 165.15 2.89 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 128.484 2.714 . . . . 0.0 113.595 176.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 2.9 pp -77.66 -0.36 26.37 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.595 167.454 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' CYS . . . . . 0.438 ' HB2' ' SG ' ' A' ' 199' ' ' CYS . 74.2 m -76.78 -28.22 55.58 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.889 0.875 . . . . 0.0 110.226 168.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . 0.293 93.4 m-70 72.45 52.2 0.17 Allowed 'General case' 0 C--N 1.342 0.242 0 C-N-CA 127.828 2.451 . . . . 0.0 113.84 169.001 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -136.85 173.61 11.51 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.528 1.131 . . . . 0.0 109.864 166.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.473 HG12 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -62.55 174.49 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 125.238 1.415 . . . . 0.0 111.813 -176.17 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.473 ' H ' HG12 ' A' ' 204' ' ' VAL . 80.5 p -47.94 157.44 0.28 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.516 2.326 . . . . 0.0 114.899 -175.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -142.36 163.2 33.49 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.82 1.648 . . . . 0.0 110.984 -168.583 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -61.3 -42.31 99.74 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.824 1.202 . . . . 0.0 114.37 -169.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -127.98 124.12 36.47 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.462 1.105 . . . . 0.0 110.116 -178.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 1.6 mtm -138.42 145.63 41.2 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.003 -168.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 21.4 tt -137.06 144.67 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 125.126 1.37 . . . . 0.0 110.53 172.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -120.24 139.68 13.92 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 125.238 1.399 . . . . 0.0 112.241 -171.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' CYS . . . . . 0.576 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 1.2 m -80.0 123.88 28.21 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.737 1.615 . . . . 0.0 111.451 -167.657 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.25 14.48 1.19 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.256 1.422 . . . . 0.0 112.458 -175.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -74.23 148.77 86.58 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 124.295 1.038 . . . . 0.0 111.484 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -84.92 8.92 4.37 Favored 'Trans proline' 0 CA--C 1.551 1.347 0 C-N-CA 123.342 2.695 . . . . 0.0 110.944 165.116 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -134.58 -16.71 2.03 Favored 'General case' 0 C--N 1.351 0.631 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -168.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 28.2 t -65.59 135.6 55.29 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 123.594 0.758 . . . . 0.0 111.119 -172.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 10.2 t -110.77 12.08 22.48 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.726 1.61 . . . . 0.0 111.588 -174.482 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 34.0 mm -122.06 -40.96 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 125.758 1.623 . . . . 0.0 108.852 174.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 48.36 -7.75 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 131.424 3.89 . . . . 0.0 119.435 172.203 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 49.3 m95 -140.49 140.31 35.28 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 126.904 2.082 . . . . 0.0 110.211 169.58 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' PHE . . . . . 0.576 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 8.4 m-85 -148.93 153.4 37.93 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 125.441 1.496 . . . . 0.0 109.141 -169.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -66.73 151.75 46.81 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 166.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 12.2 m-30 -51.19 -50.82 58.29 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.757 166.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.07 -12.38 61.56 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -178.651 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 1.9 t -67.63 -18.12 64.85 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.821 0.737 . . . . 0.0 112.588 172.132 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.4 p -121.3 -15.61 6.8 Favored 'Isoleucine or valine' 0 C--N 1.345 0.396 0 C-N-CA 126.039 1.736 . . . . 0.0 112.396 175.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 102.32 17.33 20.27 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.693 1.616 . . . . 0.0 113.653 178.127 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 20.3 mt -71.32 158.63 36.01 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.244 1.522 . . . . 0.0 111.414 177.101 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 71.2 m -136.12 -23.44 1.32 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.727 1.611 . . . . 0.0 111.135 -177.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 92.2 m -140.04 137.13 34.35 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 125.957 1.703 . . . . 0.0 107.264 176.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 55.4 tttm -67.72 125.51 91.38 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-O 118.871 -0.585 . . . . 0.0 110.954 -173.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -77.84 -170.09 0.89 Allowed 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 124.151 3.234 . . . . 0.0 111.191 173.567 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 17.5 tpp180 -142.78 138.98 30.81 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.134 1.374 . . . . 0.0 108.118 178.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 81.32 -159.46 41.03 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.552 1.072 . . . . 0.0 112.754 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 27.6 mttp -50.65 120.72 4.96 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 126.753 2.021 . . . . 0.0 112.848 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 62.7 t90 -138.48 138.47 38.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.239 1.816 . . . . 0.0 109.012 173.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -120.53 127.39 52.13 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.707 1.203 . . . . 0.0 108.405 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 239' ' ' CYS . . . . . 0.543 ' HB2' ' HD2' ' A' ' 240' ' ' PRO . 14.7 p -59.25 172.51 0.58 Allowed Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 127.851 2.46 . . . . 0.0 114.334 -173.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.543 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 43.1 Cg_endo -64.2 -38.64 34.7 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 121.658 1.572 . . . . 0.0 113.14 -168.045 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 66.0 mtt85 -88.02 20.53 3.09 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.42 1.009 . . . . 0.0 112.554 177.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 16.7 m -131.3 -10.4 3.69 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 126.316 1.846 . . . . 0.0 113.344 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 22.7 t -157.08 -39.59 0.07 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.144 0.884 . . . . 0.0 113.147 174.874 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -75.2 -15.04 60.58 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.537 0.735 . . . . 0.0 112.525 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -153.02 141.5 20.76 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 128.26 2.624 . . . . 0.0 106.026 -175.351 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 18.0 ttp180 -101.01 34.54 2.47 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.191 0.997 . . . . 0.0 111.776 -169.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -59.87 -30.71 69.17 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.7 1.6 . . . . 0.0 113.16 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 16.2 ttpp -150.8 50.42 0.86 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.702 1.201 . . . . 0.0 109.893 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp . . . . . 0 C--O 1.25 1.09 0 CA-C-O 116.199 -1.858 . . . . 0.0 111.204 -177.143 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 23.5 mmt . . . . . 0 N--CA 1.478 0.938 0 N-CA-C 110.788 -0.079 . . . . 0.0 110.788 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 54.31 29.26 10.49 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.552 1.541 . . . . 0.0 113.32 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 93.8 mtp -69.81 153.79 95.24 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 125.42 1.488 . . . . 0.0 111.695 -173.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -80.84 30.79 0.51 Allowed 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 124.789 3.66 . . . . 0.0 113.63 -174.618 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 2.5 m -121.98 97.59 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 125.545 1.538 . . . . 0.0 109.619 -175.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -69.8 156.79 91.12 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 125.207 1.403 . . . . 0.0 111.882 178.456 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -72.6 0.31 7.75 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 123.807 3.005 . . . . 0.0 113.055 170.719 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -71.49 80.11 0.79 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.643 1.977 . . . . 0.0 110.369 177.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -151.1 137.11 11.01 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 125.141 1.377 . . . . 0.0 108.776 -170.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.28 159.89 46.13 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.979 2.452 . . . . 0.0 112.657 -176.209 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 34.7 p -144.77 172.98 12.25 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.094 1.757 . . . . 0.0 109.284 -177.843 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -139.04 -54.1 0.58 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.45 ' SG ' ' HB2' ' A' ' 201' ' ' CYS . 2.4 p -68.82 165.62 19.33 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 128.431 2.693 . . . . 0.0 113.272 178.491 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.5 pp -71.94 -5.62 36.07 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.77 166.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' CYS . . . . . 0.45 ' HB2' ' SG ' ' A' ' 199' ' ' CYS . 74.8 m -78.07 -29.09 48.97 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.807 1.243 . . . . 0.0 110.831 173.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . 0.303 90.9 m-70 71.09 54.86 0.23 Allowed 'General case' 0 C--N 1.34 0.167 0 C-N-CA 127.529 2.332 . . . . 0.0 113.391 169.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -136.6 171.37 14.59 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.44 -1.254 . . . . 0.0 109.697 166.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.483 HG12 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -64.97 175.97 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 125.274 1.43 . . . . 0.0 112.105 -173.18 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.483 ' H ' HG12 ' A' ' 204' ' ' VAL . 20.3 m -43.39 152.78 0.12 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 128.421 2.689 . . . . 0.0 115.569 -173.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' TYR . . . . . 0.411 ' CD1' ' HG2' ' A' ' 209' ' ' MET . 7.4 p90 -147.63 157.05 43.38 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.59 1.556 . . . . 0.0 110.497 -172.001 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -65.75 -38.53 94.54 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.432 1.015 . . . . 0.0 115.095 -169.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 26.8 pt-20 -119.33 122.08 41.05 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 118.164 0.982 . . . . 0.0 110.345 -174.758 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' MET . . . . . 0.411 ' HG2' ' CD1' ' A' ' 206' ' ' TYR . 14.6 mtp -141.84 141.14 33.09 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -167.67 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 16.8 tt -144.17 151.53 16.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 125.817 1.647 . . . . 0.0 109.636 169.436 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -138.29 145.98 17.61 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 123.874 0.75 . . . . 0.0 112.629 -169.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 6.5 t -69.88 145.78 51.74 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-O 122.228 1.013 . . . . 0.0 111.182 -172.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -81.29 -6.5 58.95 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.713 2.005 . . . . 0.0 113.442 -175.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 7.7 m120 -78.78 146.08 67.94 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 118.696 0.68 . . . . 0.0 111.568 -169.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.95 6.71 4.03 Favored 'Trans proline' 0 CA--C 1.547 1.172 0 C-N-CA 123.58 2.853 . . . . 0.0 111.718 167.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -126.72 -7.71 6.18 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.137 1.775 . . . . 0.0 112.628 -172.173 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 39.0 t -66.02 133.39 50.69 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.074 0.95 . . . . 0.0 109.791 174.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 50.2 m -112.1 10.47 20.32 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.639 1.576 . . . . 0.0 111.708 -174.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 22.0 mm -120.32 -33.62 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 125.905 1.682 . . . . 0.0 109.472 175.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 50.33 -10.21 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 130.624 3.57 . . . . 0.0 118.917 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 54.9 m95 -144.5 156.9 44.39 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.395 1.478 . . . . 0.0 111.83 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -158.88 154.35 25.88 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.362 1.865 . . . . 0.0 109.377 -176.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 44.3 m80 -69.37 154.51 41.91 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 166.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 13.9 m-30 -52.33 -50.68 61.82 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 166.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -69.5 -13.08 62.15 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 4.8 t -69.16 -19.1 64.0 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.646 0.778 . . . . 0.0 112.476 172.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.0 p -114.82 -21.52 5.3 Favored 'Isoleucine or valine' 0 C--N 1.347 0.466 0 C-N-CA 125.605 1.562 . . . . 0.0 112.275 172.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 105.71 17.95 12.46 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 126.029 1.776 . . . . 0.0 113.752 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 13.5 mt -71.76 162.53 29.31 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.271 1.536 . . . . 0.0 111.854 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 36.0 m -138.42 -24.81 0.95 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.348 1.459 . . . . 0.0 111.417 -176.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 46.2 p -139.15 140.59 37.93 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.681 1.592 . . . . 0.0 108.432 176.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -78.14 119.22 76.53 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 123.413 0.685 . . . . 0.0 112.03 -169.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -81.21 175.93 9.27 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.692 2.928 . . . . 0.0 111.015 169.21 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 13.5 ttp85 -145.0 134.78 23.54 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 124.035 0.934 . . . . 0.0 109.019 172.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 127.38 -165.07 20.65 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.807 1.67 . . . . 0.0 111.136 -175.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.72 120.91 10.99 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 124.203 1.001 . . . . 0.0 109.686 171.272 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 58.5 t90 -138.56 144.29 39.8 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 127.257 2.223 . . . . 0.0 108.482 175.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -120.27 135.85 54.86 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.468 1.107 . . . . 0.0 109.309 -178.101 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -67.46 168.78 10.72 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 124.279 1.031 . . . . 0.0 111.72 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.38 -36.09 28.59 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.108 1.205 . . . . 0.0 112.681 -172.137 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 67.6 mtt-85 -75.55 0.06 18.67 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.373 1.069 . . . . 0.0 113.405 175.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 24.7 m -115.06 -21.27 10.1 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.029 1.331 . . . . 0.0 113.821 -176.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.1 t -151.22 -28.14 0.2 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.545 1.066 . . . . 0.0 113.56 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -76.57 -13.54 60.07 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.903 0.774 . . . . 0.0 112.299 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -71.59 -10.46 59.8 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.706 0.803 . . . . 0.0 112.54 169.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -81.66 28.97 0.39 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.986 1.315 . . . . 0.0 111.833 173.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -58.0 -19.35 30.34 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.26 1.824 . . . . 0.0 113.627 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -76.86 76.57 3.46 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.164 1.386 . . . . 0.0 109.746 169.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 56.0 tttp . . . . . 0 C--O 1.252 1.212 0 C-N-CA 127.177 2.191 . . . . 0.0 112.158 -173.268 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 20.8 ptp . . . . . 0 N--CA 1.478 0.931 0 CA-C-O 121.948 0.88 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -79.2 155.86 28.44 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.692 1.197 . . . . 0.0 111.761 -172.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 17.6 ptm -149.01 76.26 9.58 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 124.857 1.263 . . . . 0.0 109.593 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -77.19 29.95 0.42 Allowed 'Trans proline' 0 CA--C 1.548 1.218 0 C-N-CA 124.754 3.636 . . . . 0.0 112.865 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 2.8 m -135.33 122.67 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 126.539 1.936 . . . . 0.0 108.978 -171.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -77.34 157.27 80.75 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 125.089 1.355 . . . . 0.0 111.711 178.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -73.42 0.84 7.48 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.82 3.013 . . . . 0.0 113.07 170.034 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -71.33 83.5 0.77 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.789 2.035 . . . . 0.0 110.268 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -151.52 137.56 11.26 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 125.361 1.464 . . . . 0.0 108.592 -171.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.95 154.02 52.9 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.893 2.396 . . . . 0.0 111.78 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 68.0 p -146.57 175.02 10.89 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.743 1.217 . . . . 0.0 110.66 -174.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -137.61 -83.66 0.32 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 117.337 -1.316 . . . . 0.0 112.588 -170.463 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.1 t -55.67 168.21 0.45 Allowed 'General case' 0 C--N 1.352 0.692 0 CA-C-N 119.844 1.202 . . . . 0.0 113.336 -177.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.1 pp -57.49 -12.73 2.87 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.882 1.273 . . . . 0.0 112.861 170.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 71.7 m -76.82 -19.87 57.04 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.899 2.079 . . . . 0.0 113.275 176.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 22.3 m170 57.86 64.01 1.65 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.907 2.083 . . . . 0.0 111.543 -173.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.77 157.61 40.97 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.124 1.37 . . . . 0.0 112.561 175.484 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.5 HG12 ' H ' ' A' ' 205' ' ' SER . 0.4 OUTLIER -68.57 -178.72 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 126.45 1.9 . . . . 0.0 111.325 -177.873 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.5 ' H ' HG12 ' A' ' 204' ' ' VAL . 49.8 m -42.35 145.65 0.38 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 128.012 2.525 . . . . 0.0 113.472 177.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' TYR . . . . . 0.44 ' CE2' ' HG2' ' A' ' 209' ' ' MET . 13.2 p90 -152.03 165.31 35.07 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.837 1.255 . . . . 0.0 111.935 -167.605 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -67.98 -47.91 57.25 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.76 1.172 . . . . 0.0 115.018 -168.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -127.8 125.38 39.72 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 118.401 1.1 . . . . 0.0 109.849 -170.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' MET . . . . . 0.44 ' HG2' ' CE2' ' A' ' 206' ' ' TYR . 9.1 mtp -140.47 147.9 40.32 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -166.312 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 17.0 tt -135.05 155.68 38.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 125.843 1.657 . . . . 0.0 109.557 168.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -132.73 139.18 10.72 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.668 1.127 . . . . 0.0 112.45 -172.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' CYS . . . . . 0.592 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 1.8 m -79.51 127.12 31.75 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 125.487 1.515 . . . . 0.0 112.19 -167.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -70.22 -3.61 17.81 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.35 1.86 . . . . 0.0 113.692 -175.582 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -67.77 146.95 98.61 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 123.547 0.739 . . . . 0.0 111.469 -174.825 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.83 5.65 6.18 Favored 'Trans proline' 0 CA--C 1.55 1.3 0 C-N-CA 123.138 2.559 . . . . 0.0 111.372 166.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -134.13 -13.51 2.42 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 125.21 1.404 . . . . 0.0 114.381 -169.45 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 36.8 t -63.72 132.57 51.43 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 118.973 0.806 . . . . 0.0 110.335 -176.702 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 69.7 m -109.29 11.72 25.17 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 113.637 -1.62 . . . . 0.0 111.602 -173.22 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 39.4 mm -119.3 -41.35 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 125.838 1.655 . . . . 0.0 108.604 173.177 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 47.67 -9.47 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.832 1 C-N-CA 131.717 4.007 . . . . 0.0 119.725 171.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -139.83 135.95 33.51 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.744 2.017 . . . . 0.0 109.197 172.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' PHE . . . . . 0.592 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 6.4 m-85 -143.47 155.82 44.47 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.376 1.471 . . . . 0.0 109.53 -169.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 21.9 m80 -73.55 148.62 42.84 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 168.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 16.8 m-30 -52.19 -51.11 60.11 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.751 167.057 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.19 -14.34 62.59 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -177.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 2.8 m -78.12 -8.56 58.42 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 119.76 1.164 . . . . 0.0 112.777 173.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.7 p -119.07 -14.08 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 126.009 1.724 . . . . 0.0 112.198 169.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 96.8 17.4 33.01 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.693 1.616 . . . . 0.0 113.306 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 12.5 mt -71.55 160.37 32.81 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.582 1.191 . . . . 0.0 111.272 176.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 16.0 m -134.03 -1.4 2.98 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.998 1.719 . . . . 0.0 110.37 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 9.3 t -150.58 177.11 10.35 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.284 1.834 . . . . 0.0 109.674 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -108.92 105.67 57.54 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 124.305 1.042 . . . . 0.0 109.391 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.48 175.52 10.53 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.221 2.614 . . . . 0.0 111.435 173.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -140.1 133.57 30.06 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 124.856 1.262 . . . . 0.0 108.229 173.428 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 124.24 -175.89 16.95 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 126.156 1.836 . . . . 0.0 110.845 -170.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -66.69 131.65 46.43 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.996 0.903 . . . . 0.0 110.368 173.605 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 52.8 t90 -136.99 141.55 42.57 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 127.011 2.125 . . . . 0.0 108.779 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -124.5 127.38 47.37 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.467 1.107 . . . . 0.0 108.828 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 239' ' ' CYS . . . . . 0.414 ' HB2' ' HD2' ' A' ' 240' ' ' PRO . 6.2 p -60.73 167.57 3.29 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 126.465 1.906 . . . . 0.0 113.299 -173.251 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.414 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 33.4 Cg_endo -65.33 -30.3 53.94 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.491 1.461 . . . . 0.0 112.809 -170.977 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 53.7 mtt-85 -86.96 13.58 8.87 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.302 1.041 . . . . 0.0 112.747 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 20.1 m -131.01 -14.03 3.51 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.159 1.784 . . . . 0.0 113.518 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 32.1 t -149.33 -39.47 0.15 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.72 0.808 . . . . 0.0 112.414 -178.061 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -82.09 -11.38 58.8 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -175.15 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -69.11 -8.48 45.74 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.92 0.888 . . . . 0.0 112.717 172.164 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -63.2 104.56 0.6 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.463 1.505 . . . . 0.0 110.724 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt 50.09 29.4 3.53 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.858 2.063 . . . . 0.0 113.926 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -154.44 143.37 21.01 Favored 'General case' 0 C--N 1.343 0.324 0 C-N-CA 124.73 1.212 . . . . 0.0 109.737 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 83.3 tttt . . . . . 0 C--O 1.251 1.15 0 C-N-CA 124.754 1.222 . . . . 0.0 108.619 169.009 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 20.8 mmt . . . . . 0 N--CA 1.475 0.809 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -140.98 5.79 1.95 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.957 1.303 . . . . 0.0 111.683 -169.473 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 89.8 mtp -146.65 159.66 43.54 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 126.512 1.925 . . . . 0.0 109.421 -176.179 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -74.34 14.81 0.7 Allowed 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 124.172 3.248 . . . . 0.0 113.517 175.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.15 137.43 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 126.712 2.005 . . . . 0.0 108.782 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -66.1 161.44 55.93 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 126.343 1.857 . . . . 0.0 111.875 175.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -70.28 -7.4 21.13 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 123.084 2.523 . . . . 0.0 112.212 168.389 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -88.18 38.59 0.86 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.089 2.156 . . . . 0.0 111.068 178.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 28.8 tp10 -143.03 129.35 10.46 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 125.689 1.596 . . . . 0.0 108.103 -170.895 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -70.57 159.04 54.14 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.016 2.477 . . . . 0.0 112.063 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 72.9 p -144.23 175.96 9.69 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.904 1.281 . . . . 0.0 110.453 -174.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -136.66 -80.68 0.39 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 117.275 -1.345 . . . . 0.0 113.213 -171.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 3.1 t -55.97 167.81 0.55 Allowed 'General case' 0 C--N 1.35 0.609 0 CA-C-N 119.963 1.256 . . . . 0.0 113.115 -176.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.9 pp -59.4 -10.06 2.89 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.417 1.087 . . . . 0.0 112.717 169.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 75.2 m -77.04 -21.86 53.86 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.658 1.983 . . . . 0.0 113.19 174.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 54.29 68.83 0.79 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.752 2.021 . . . . 0.0 111.629 -170.068 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.9 160.6 33.06 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.688 1.595 . . . . 0.0 111.468 173.088 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.531 HG12 ' H ' ' A' ' 205' ' ' SER . 0.6 OUTLIER -70.29 -178.94 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 125.62 1.568 . . . . 0.0 111.142 -178.158 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.531 ' H ' HG12 ' A' ' 204' ' ' VAL . 28.3 m -46.34 151.05 0.56 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 128.093 2.557 . . . . 0.0 114.348 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -154.17 168.47 26.41 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.351 1.46 . . . . 0.0 111.413 -169.263 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -70.61 -50.85 23.4 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.379 0.99 . . . . 0.0 114.651 -169.004 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -125.53 122.34 36.29 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 118.091 0.945 . . . . 0.0 110.297 -170.12 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -144.09 147.01 33.19 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -166.433 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 16.2 tt -142.04 152.77 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 125.47 1.508 . . . . 0.0 109.783 169.146 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -132.35 147.01 18.65 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 124.051 0.834 . . . . 0.0 112.456 -169.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 7.0 t -71.2 143.4 50.48 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-O 122.019 0.914 . . . . 0.0 111.369 -172.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -79.36 -8.98 59.48 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.786 2.034 . . . . 0.0 114.193 -176.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -74.39 144.03 80.51 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 119.458 1.027 . . . . 0.0 111.041 -174.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -75.63 6.02 3.92 Favored 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 123.471 2.781 . . . . 0.0 111.802 168.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -124.89 -6.19 7.36 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.533 1.933 . . . . 0.0 112.28 -173.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 49.8 t -63.7 133.42 53.55 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.899 0.879 . . . . 0.0 109.703 174.385 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 10.4 t -114.75 11.24 16.75 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.644 1.578 . . . . 0.0 111.611 -174.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 33.0 mm -120.25 -31.97 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 126.229 1.812 . . . . 0.0 109.411 176.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 50.36 -13.81 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 131.539 3.936 . . . . 0.0 119.204 176.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 58.2 m95 -143.62 152.53 41.49 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.645 1.578 . . . . 0.0 110.755 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -154.33 150.87 28.43 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.376 1.471 . . . . 0.0 110.473 -174.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -71.59 150.17 44.96 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.26 0.552 . . . . 0.0 109.816 168.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 11.4 m-30 -53.49 -51.28 63.29 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.469 167.247 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.82 -12.85 61.48 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 1.7 m -76.56 -12.31 60.0 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.771 1.169 . . . . 0.0 112.299 172.449 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.56 -15.46 9.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 126.172 1.789 . . . . 0.0 112.185 171.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 95.07 20.43 28.1 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.792 1.663 . . . . 0.0 113.663 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 20.4 mt -71.49 157.98 37.06 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.987 1.394 . . . . 0.0 111.407 177.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 91.4 m -131.41 -25.09 2.21 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.828 1.651 . . . . 0.0 110.772 -177.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 61.1 p -138.73 150.85 46.59 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.182 1.793 . . . . 0.0 108.271 172.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -79.77 119.34 76.44 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-O 118.533 -0.746 . . . . 0.0 110.756 -174.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -76.67 165.92 28.02 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 122.922 2.415 . . . . 0.0 110.39 169.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -138.03 130.92 29.9 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-O 122.195 0.997 . . . . 0.0 109.06 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 127.82 -165.9 20.68 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 126.757 2.123 . . . . 0.0 109.407 -168.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.92 142.7 54.67 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 122.469 1.128 . . . . 0.0 109.771 169.614 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 55.0 t90 -147.31 146.15 29.61 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 127.254 2.222 . . . . 0.0 108.203 -177.438 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -124.13 137.2 54.58 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.421 1.089 . . . . 0.0 110.197 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -69.08 169.91 10.25 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 125.186 1.394 . . . . 0.0 112.581 -177.31 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -74.51 1.04 7.89 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.398 2.066 . . . . 0.0 114.506 -175.393 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -117.63 16.72 14.52 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.53 1.932 . . . . 0.0 110.883 172.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 22.2 m -134.39 -16.99 2.07 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.367 1.867 . . . . 0.0 112.744 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 32.8 t -154.01 -40.91 0.09 Allowed 'General case' 0 C--N 1.345 0.377 0 CA-C-N 118.975 0.807 . . . . 0.0 112.775 175.622 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -74.82 -6.16 47.49 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -71.36 4.41 2.96 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.186 1.795 . . . . 0.0 112.671 173.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 52.7 ttm-85 -142.99 154.54 44.12 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.793 2.037 . . . . 0.0 109.437 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -132.13 40.04 3.37 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.855 1.662 . . . . 0.0 110.41 -176.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -149.86 130.13 13.72 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.343 1.457 . . . . 0.0 108.555 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 59.3 tttm . . . . . 0 C--O 1.25 1.091 0 CA-C-O 115.961 -1.971 . . . . 0.0 111.589 -169.97 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 98.5 mtp . . . . . 0 N--CA 1.477 0.879 0 CA-C-O 119.393 -0.337 . . . . 0.0 110.451 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -60.83 149.65 35.32 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.822 1.249 . . . . 0.0 112.195 176.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 53.3 mtt -146.8 87.8 6.19 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 125.59 1.556 . . . . 0.0 107.884 176.729 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.72 -11.59 32.29 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.094 2.529 . . . . 0.0 112.849 175.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 12.7 p -153.83 151.55 11.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 127.186 2.195 . . . . 0.0 107.479 169.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -64.63 151.48 92.0 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 124.504 1.121 . . . . 0.0 111.707 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.16 8.54 2.07 Favored 'Trans proline' 0 CA--C 1.546 1.109 0 C-N-CA 123.894 3.063 . . . . 0.0 112.526 169.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -116.73 37.33 3.82 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.633 1.973 . . . . 0.0 110.543 -173.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -138.95 111.05 7.96 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 125.192 1.397 . . . . 0.0 108.83 -169.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.09 159.76 49.17 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.899 2.399 . . . . 0.0 111.719 177.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 66.0 p -143.69 175.02 10.29 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.009 1.324 . . . . 0.0 110.188 -176.482 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -133.98 -83.83 0.44 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 117.293 -1.337 . . . . 0.0 113.05 -169.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.446 ' H ' HE22 ' A' ' 203' ' ' GLN . 2.4 t -55.28 170.19 0.23 Allowed 'General case' 0 C--N 1.351 0.651 0 C-N-CA 124.948 1.299 . . . . 0.0 113.901 -175.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.3 pp -58.38 -14.12 6.87 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.32 1.048 . . . . 0.0 112.605 169.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 75.2 m -75.79 -23.66 55.9 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.029 2.132 . . . . 0.0 112.895 174.168 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 53.08 69.42 0.7 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 127.434 2.294 . . . . 0.0 112.156 -171.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' GLN . . . . . 0.446 HE22 ' H ' ' A' ' 199' ' ' CYS . 0.0 OUTLIER -125.46 160.63 28.99 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.091 1.756 . . . . 0.0 111.37 172.844 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.538 HG12 ' H ' ' A' ' 205' ' ' SER . 0.8 OUTLIER -69.24 -178.67 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 125.705 1.602 . . . . 0.0 110.883 -178.875 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.538 ' H ' HG12 ' A' ' 204' ' ' VAL . 85.8 p -44.3 148.2 0.47 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.566 2.347 . . . . 0.0 113.713 178.263 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -152.44 168.96 23.78 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.723 1.209 . . . . 0.0 112.168 -167.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -69.11 -53.05 20.23 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.807 1.194 . . . . 0.0 114.743 -168.905 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -125.07 125.64 44.12 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 118.271 1.036 . . . . 0.0 109.711 -172.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -142.55 145.54 33.71 Favored 'General case' 0 C--N 1.34 0.169 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -166.781 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 20.6 tt -134.8 150.77 30.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 125.705 1.602 . . . . 0.0 109.644 173.159 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -128.59 139.06 10.73 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 124.528 1.061 . . . . 0.0 112.576 -171.597 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' CYS . . . . . 0.6 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 5.5 m -75.11 125.78 29.66 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 125.362 1.465 . . . . 0.0 111.325 -168.356 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -70.03 -4.04 19.09 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.495 1.518 . . . . 0.0 113.452 -177.541 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -68.02 145.6 97.81 Favored Pre-proline 0 CA--C 1.538 0.518 0 O-C-N 121.544 -0.723 . . . . 0.0 110.905 -175.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -80.92 8.32 4.39 Favored 'Trans proline' 0 CA--C 1.549 1.258 0 C-N-CA 123.049 2.499 . . . . 0.0 111.296 166.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -133.81 -14.06 2.47 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 125.21 1.404 . . . . 0.0 114.323 -169.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.5 t -65.29 134.33 53.36 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 123.721 0.809 . . . . 0.0 110.699 -176.207 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 96.6 p -107.27 7.97 29.61 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.972 1.709 . . . . 0.0 112.188 -173.736 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 37.5 mm -118.95 -41.03 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 125.815 1.646 . . . . 0.0 108.676 177.164 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 48.16 -8.55 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 131.461 3.904 . . . . 0.0 119.697 170.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 61.7 m95 -141.28 137.43 32.48 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.781 2.032 . . . . 0.0 109.625 171.513 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' PHE . . . . . 0.6 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 6.9 m-85 -145.46 156.96 44.06 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 125.738 1.615 . . . . 0.0 109.69 -169.634 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 33.1 m80 -73.97 149.07 41.55 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 167.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -51.7 -52.03 51.43 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.746 167.124 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.78 -13.82 62.19 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -177.139 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 2.1 m -77.54 -11.13 59.82 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.785 1.175 . . . . 0.0 112.594 173.554 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 10.6 p -116.09 -16.47 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 125.799 1.64 . . . . 0.0 112.134 170.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 102.27 14.87 27.15 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.781 1.657 . . . . 0.0 113.395 177.804 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 26.0 mt -72.89 160.06 32.73 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.828 1.314 . . . . 0.0 110.928 175.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 67.4 p -131.71 -7.96 3.6 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.833 1.653 . . . . 0.0 111.598 177.234 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 73.8 p -144.73 166.2 25.9 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.006 2.122 . . . . 0.0 108.766 177.256 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -90.21 121.17 68.93 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-O 118.821 -0.609 . . . . 0.0 109.497 175.281 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -75.91 178.94 6.78 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.569 2.846 . . . . 0.0 110.78 169.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -141.59 132.55 26.03 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 170.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 120.69 -170.88 14.55 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 126.06 1.79 . . . . 0.0 110.166 -168.856 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.5 144.98 53.04 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 122.252 1.025 . . . . 0.0 110.849 174.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 237' ' ' TRP . . . . . 0.494 ' HZ3' ' HG ' ' A' ' 212' ' ' CYS . 60.2 t90 -145.93 138.96 25.88 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.994 2.118 . . . . 0.0 109.406 177.753 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 14.4 m-30 -118.4 131.91 56.27 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.717 1.207 . . . . 0.0 109.261 175.044 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 239' ' ' CYS . . . . . 0.475 ' HB2' ' HD2' ' A' ' 240' ' ' PRO . 4.0 p -63.32 173.23 1.25 Allowed Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 127.61 2.364 . . . . 0.0 114.675 -174.195 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 72.6 Cg_endo -72.87 -3.33 13.4 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.815 2.343 . . . . 0.0 114.858 -171.034 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -111.61 13.62 21.26 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.589 1.555 . . . . 0.0 111.234 174.034 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 39.0 m -135.94 -16.0 1.73 Allowed 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.565 1.946 . . . . 0.0 113.234 -174.338 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 46.6 t -150.98 -41.6 0.12 Allowed 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.763 0.825 . . . . 0.0 112.446 177.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -71.71 -23.43 61.63 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.012 0.369 . . . . 0.0 111.527 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -65.19 -7.67 13.82 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.547 1.939 . . . . 0.0 113.42 175.364 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 31.7 ttt-85 -127.37 23.85 6.33 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.29 1.436 . . . . 0.0 111.032 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -130.86 -21.65 2.7 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.272 1.829 . . . . 0.0 111.539 176.897 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -154.11 147.32 24.77 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.347 1.459 . . . . 0.0 109.436 177.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? . . . . . 0 C--O 1.253 1.287 0 C-N-CA 124.667 1.187 . . . . 0.0 108.718 169.324 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 99.8 mtp . . . . . 0 N--CA 1.476 0.856 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -163.83 170.38 16.93 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.403 1.481 . . . . 0.0 110.035 -169.131 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 42.06 65.85 4.54 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 126.448 1.899 . . . . 0.0 112.614 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -74.41 77.78 2.83 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 124.877 3.718 . . . . 0.0 111.917 -173.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' VAL . . . . . 0.555 HG22 ' H ' ' A' ' 192' ' ' ASP . 9.5 p -153.26 -174.74 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 127.161 2.184 . . . . 0.0 107.546 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' ASP . . . . . 0.555 ' H ' HG22 ' A' ' 191' ' ' VAL . 9.5 m-20 -52.87 153.55 5.86 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 126.131 1.772 . . . . 0.0 112.698 176.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -71.46 5.98 2.12 Favored 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 123.889 3.059 . . . . 0.0 112.992 172.205 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -106.2 62.61 0.65 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.737 2.015 . . . . 0.0 108.985 -176.172 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -132.86 106.57 12.69 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 125.068 1.347 . . . . 0.0 108.361 -172.375 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -75.04 157.13 42.79 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.65 2.233 . . . . 0.0 110.587 174.653 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 80.4 p -141.68 172.22 12.98 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.47 1.108 . . . . 0.0 110.005 -177.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -134.47 -83.97 0.43 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 117.316 -1.325 . . . . 0.0 112.885 -168.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.419 ' H ' HE22 ' A' ' 203' ' ' GLN . 1.9 t -55.17 168.5 0.33 Allowed 'General case' 0 C--N 1.351 0.667 0 C-N-CA 124.957 1.303 . . . . 0.0 113.274 -176.564 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.2 pp -57.05 -12.42 2.08 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.23 1.412 . . . . 0.0 113.145 170.404 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 71.3 m -78.76 -18.94 53.38 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.593 1.957 . . . . 0.0 113.208 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 23.3 m170 57.32 62.21 2.26 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.874 2.069 . . . . 0.0 111.663 -173.053 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' GLN . . . . . 0.419 HE22 ' H ' ' A' ' 199' ' ' CYS . 0.0 OUTLIER -125.65 158.75 33.95 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.022 1.329 . . . . 0.0 112.435 176.6 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.47 HG12 ' H ' ' A' ' 205' ' ' SER . 0.3 OUTLIER -69.17 -179.4 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 126.355 1.862 . . . . 0.0 111.366 -176.976 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.47 ' H ' HG12 ' A' ' 204' ' ' VAL . 79.5 p -45.37 147.62 0.77 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.42 2.288 . . . . 0.0 113.911 178.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -154.08 173.54 15.9 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.537 1.535 . . . . 0.0 111.223 -167.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -80.96 -71.36 1.29 Allowed Glycine 0 CA--C 1.528 0.893 0 C-N-CA 123.831 0.729 . . . . 0.0 112.959 -170.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -91.84 120.4 32.51 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 123.632 0.773 . . . . 0.0 111.117 -174.284 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -142.02 143.86 33.36 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -168.611 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 19.8 tt -134.97 150.36 29.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 125.541 1.537 . . . . 0.0 109.939 172.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -127.99 139.29 10.99 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.788 1.185 . . . . 0.0 112.641 -171.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' CYS . . . . . 0.592 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 1.9 m -78.75 126.12 30.29 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.582 1.553 . . . . 0.0 111.802 -168.078 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.39 -2.36 10.77 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.58 1.952 . . . . 0.0 113.808 -175.601 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -66.49 149.98 97.63 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 123.769 0.828 . . . . 0.0 112.12 -174.264 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -83.76 7.76 5.01 Favored 'Trans proline' 0 CA--C 1.549 1.262 0 C-N-CA 123.725 2.95 . . . . 0.0 111.342 166.613 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -144.39 -10.86 0.63 Allowed 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 -167.531 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 36.7 t -60.93 134.09 56.74 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 119.465 1.03 . . . . 0.0 110.468 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.5 t -110.47 14.24 22.57 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.762 1.625 . . . . 0.0 111.124 -173.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 51.7 mt -122.75 -41.97 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 125.327 1.451 . . . . 0.0 108.577 172.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 47.63 -8.59 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 131.351 3.861 . . . . 0.0 119.552 172.117 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 62.3 m95 -139.62 136.07 33.98 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 126.497 1.919 . . . . 0.0 109.603 170.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' PHE . . . . . 0.592 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 7.2 m-85 -142.49 158.69 43.42 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 125.572 1.549 . . . . 0.0 109.179 -169.17 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -78.45 148.14 33.68 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 169.75 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -51.74 -51.37 56.68 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.937 167.789 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.84 -13.23 61.62 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -176.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 4.8 m -78.29 -8.1 57.99 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.81 1.186 . . . . 0.0 112.608 172.648 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.8 p -120.9 -12.68 8.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 126.319 1.847 . . . . 0.0 112.185 170.815 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 94.28 18.24 36.98 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.693 1.616 . . . . 0.0 113.4 178.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 19.4 mt -72.05 158.34 36.13 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.749 1.275 . . . . 0.0 111.327 176.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 59.7 m -134.86 -18.38 1.86 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.782 1.633 . . . . 0.0 111.145 -177.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 62.7 m -144.33 139.62 28.63 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 125.692 1.597 . . . . 0.0 107.82 178.166 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -70.58 122.6 87.1 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 123.519 0.727 . . . . 0.0 110.836 -176.218 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -81.48 -179.8 5.21 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.769 2.979 . . . . 0.0 111.617 173.08 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -139.62 135.82 33.71 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.031 1.332 . . . . 0.0 107.475 169.615 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 116.54 -174.61 15.32 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.405 1.478 . . . . 0.0 111.747 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -62.34 122.72 16.38 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.883 1.273 . . . . 0.0 111.09 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 44.7 t90 -132.98 143.02 49.17 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 127.201 2.2 . . . . 0.0 108.6 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -126.92 126.77 43.81 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.564 1.146 . . . . 0.0 109.003 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 239' ' ' CYS . . . . . 0.424 ' HB2' ' HD2' ' A' ' 240' ' ' PRO . 5.8 p -61.23 169.08 2.38 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 126.857 2.063 . . . . 0.0 114.007 -172.05 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.424 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 57.5 Cg_endo -72.44 1.48 6.14 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.559 2.173 . . . . 0.0 115.221 -171.068 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 38.3 mtp180 -117.42 17.58 14.55 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.224 1.41 . . . . 0.0 112.106 170.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 31.7 m -133.52 -14.0 2.57 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.434 1.894 . . . . 0.0 112.763 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 33.0 t -147.87 -33.06 0.26 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.058 0.943 . . . . 0.0 112.195 177.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -86.8 -13.48 44.99 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -173.794 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -72.04 -0.76 12.49 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 119.443 1.02 . . . . 0.0 112.531 169.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -63.47 122.86 17.3 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 168.427 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt 48.65 56.14 8.04 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.381 1.473 . . . . 0.0 112.11 -169.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -55.76 138.04 48.57 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.606 1.162 . . . . 0.0 109.598 172.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.158 0 C-N-CA 126.015 1.726 . . . . 0.0 109.838 -167.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 93.0 mtp . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -155.33 131.1 9.91 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.306 1.043 . . . . 0.0 109.432 172.661 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 18.8 ptm -160.55 91.11 1.66 Allowed Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 125.072 1.349 . . . . 0.0 108.774 172.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -74.44 10.95 1.39 Allowed 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 123.755 2.97 . . . . 0.0 113.171 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 10.6 m -138.52 154.01 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 C-N-CA 127.999 2.519 . . . . 0.0 108.22 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -64.48 156.84 75.57 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 125.379 1.472 . . . . 0.0 111.809 175.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -71.9 -7.35 20.93 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 123.155 2.57 . . . . 0.0 112.041 168.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -93.6 72.55 4.33 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.878 2.071 . . . . 0.0 108.734 179.295 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -142.98 128.19 10.02 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.905 1.282 . . . . 0.0 108.351 -169.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -70.94 155.59 61.77 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.942 2.428 . . . . 0.0 111.978 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 65.6 p -146.04 176.39 9.75 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.864 1.266 . . . . 0.0 110.536 -173.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -135.34 -83.59 0.41 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 117.508 -1.234 . . . . 0.0 112.707 -169.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.0 t -55.88 167.81 0.54 Allowed 'General case' 0 C--N 1.351 0.66 0 CA-C-N 119.741 1.155 . . . . 0.0 113.129 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 2.9 pp -57.66 -12.66 3.05 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.92 1.288 . . . . 0.0 112.768 171.105 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 74.6 m -76.64 -19.65 57.56 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.544 1.938 . . . . 0.0 113.214 176.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 29.9 m170 56.8 64.52 1.64 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.729 2.011 . . . . 0.0 111.396 -172.251 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.41 156.98 39.71 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.231 1.412 . . . . 0.0 112.13 174.577 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.553 HG12 ' H ' ' A' ' 205' ' ' SER . 0.9 OUTLIER -69.61 -178.21 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 126.114 1.766 . . . . 0.0 110.916 -178.39 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.553 ' H ' HG12 ' A' ' 204' ' ' VAL . 88.0 p -45.51 148.77 0.64 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.53 2.332 . . . . 0.0 113.964 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -154.97 173.67 16.22 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.276 1.43 . . . . 0.0 111.346 -167.64 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -80.75 -73.2 1.18 Allowed Glycine 0 C--N 1.341 0.852 0 C-N-CA 123.877 0.751 . . . . 0.0 112.784 -171.005 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -88.54 119.44 29.0 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.597 0.759 . . . . 0.0 111.238 -176.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -142.52 143.77 32.66 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -169.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 21.3 tt -136.53 152.0 28.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 125.729 1.612 . . . . 0.0 109.706 173.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -129.5 139.23 10.8 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.514 1.054 . . . . 0.0 112.914 -172.004 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' CYS . . . . . 0.602 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 7.3 m -75.77 127.74 33.68 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.898 1.679 . . . . 0.0 111.548 -168.57 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -71.02 -1.86 13.52 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.973 1.709 . . . . 0.0 113.591 -177.157 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -67.02 148.15 98.94 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 123.661 0.784 . . . . 0.0 111.523 -175.377 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -82.43 8.05 4.77 Favored 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 123.592 2.861 . . . . 0.0 111.631 167.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -144.16 -9.87 0.67 Allowed 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -167.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.8 t -62.39 133.47 55.1 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 119.607 1.094 . . . . 0.0 110.443 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 9.4 t -106.21 4.65 29.13 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.705 1.602 . . . . 0.0 111.687 -173.439 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 42.8 mm -112.18 -42.32 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 125.736 1.614 . . . . 0.0 108.777 175.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 48.82 -11.15 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 131.556 3.943 . . . . 0.0 119.597 171.544 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -138.8 137.82 36.99 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.778 2.031 . . . . 0.0 109.387 170.838 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' PHE . . . . . 0.602 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 7.3 m-85 -144.39 157.08 44.44 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.527 1.531 . . . . 0.0 109.654 -169.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 47.0 m80 -74.46 149.75 40.21 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 167.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 10.0 m-30 -51.4 -52.81 42.71 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.727 167.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.47 -12.44 61.39 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 118.253 -0.88 . . . . 0.0 113.253 -176.395 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 2.0 m -77.43 -8.49 57.81 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.759 1.163 . . . . 0.0 112.5 172.009 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.6 p -121.77 -14.08 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 126.082 1.753 . . . . 0.0 112.514 170.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 98.66 16.53 31.12 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 125.856 1.693 . . . . 0.0 113.513 178.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 19.6 mt -71.49 162.17 29.87 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.908 1.354 . . . . 0.0 111.66 177.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.7 t -139.22 -14.5 1.14 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.51 1.524 . . . . 0.0 112.512 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 59.7 m -146.86 139.54 25.05 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.019 1.728 . . . . 0.0 107.287 177.189 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -69.35 119.5 70.86 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-O 118.721 -0.657 . . . . 0.0 110.55 -177.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -78.29 174.63 12.13 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.463 2.776 . . . . 0.0 110.67 170.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 30.1 ttp-105 -143.16 130.98 21.49 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 121.923 0.868 . . . . 0.0 108.795 170.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 126.4 -174.38 17.96 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 126.343 1.925 . . . . 0.0 110.409 -169.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -66.4 128.84 37.73 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.18 0.992 . . . . 0.0 110.761 175.173 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 237' ' ' TRP . . . . . 0.429 ' HZ3' ' HG ' ' A' ' 212' ' ' CYS . 54.8 t90 -135.74 145.01 46.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 127.304 2.242 . . . . 0.0 109.134 178.168 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -130.6 124.8 32.54 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.691 1.196 . . . . 0.0 109.6 -176.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 239' ' ' CYS . . . . . 0.429 ' HB3' ' SG ' ' A' ' 212' ' ' CYS . 1.9 p -61.25 172.92 0.81 Allowed Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 128.1 2.56 . . . . 0.0 114.835 -171.474 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 94.7 Cg_endo -76.06 12.82 1.4 Allowed 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.608 2.872 . . . . 0.0 115.365 -171.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 35.8 mtp180 -125.53 13.82 8.15 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.716 1.606 . . . . 0.0 111.058 169.055 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 66.6 m -135.73 -22.28 1.45 Allowed 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.939 1.695 . . . . 0.0 113.714 -174.448 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 27.8 t -151.65 -42.08 0.11 Allowed 'General case' 0 C--N 1.342 0.278 0 CA-C-N 119.004 0.82 . . . . 0.0 112.614 175.526 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 7.7 tm0? -77.25 -13.85 59.86 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 119.337 -0.363 . . . . 0.0 111.65 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -58.65 -27.72 65.03 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.842 1.257 . . . . 0.0 113.18 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 95.1 mtm-85 -77.92 4.29 12.4 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.406 1.483 . . . . 0.0 113.314 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -138.64 -36.87 0.55 Allowed 'General case' 0 C--N 1.344 0.347 0 C-N-CA 124.288 1.035 . . . . 0.0 112.177 -173.1 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 25.1 tptt -159.78 175.82 12.68 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.828 0.851 . . . . 0.0 110.981 176.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.147 0 C-N-CA 126.16 1.784 . . . . 0.0 107.339 178.058 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 21.6 ptp . . . . . 0 N--CA 1.478 0.94 0 CA-C-O 118.46 -0.781 . . . . 0.0 112.708 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -139.18 154.79 48.11 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.725 1.21 . . . . 0.0 110.246 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.94 158.94 31.49 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 125.213 1.405 . . . . 0.0 110.39 -175.504 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -67.74 149.39 78.67 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.743 2.295 . . . . 0.0 110.586 169.689 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . 0.306 2.8 m 51.92 153.76 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 130.002 3.321 . . . . 0.0 115.751 -169.733 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -64.93 154.27 86.63 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.919 179.027 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -74.79 8.35 2.38 Favored 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 123.631 2.887 . . . . 0.0 112.231 169.124 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -119.65 38.53 3.87 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.97 2.108 . . . . 0.0 110.012 -176.132 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -125.74 99.22 32.79 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 125.365 1.466 . . . . 0.0 108.674 -169.538 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -73.08 159.56 47.41 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.128 2.552 . . . . 0.0 111.554 -178.388 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 67.6 p -145.07 173.6 11.77 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.578 1.151 . . . . 0.0 110.715 -175.015 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -136.79 -83.27 0.36 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 117.355 -1.307 . . . . 0.0 112.565 -170.231 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.0 t -55.6 168.21 0.44 Allowed 'General case' 0 C--N 1.351 0.641 0 C-N-CA 125.013 1.325 . . . . 0.0 113.378 -176.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.0 pp -57.45 -12.69 2.79 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.079 1.352 . . . . 0.0 113.031 170.511 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 72.7 m -77.17 -19.9 56.17 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.461 1.904 . . . . 0.0 113.223 176.301 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 21.8 m170 57.75 63.92 1.69 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.868 2.067 . . . . 0.0 111.565 -172.11 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.22 158.13 38.96 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.079 1.352 . . . . 0.0 112.496 175.585 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.544 HG12 ' H ' ' A' ' 205' ' ' SER . 0.9 OUTLIER -67.83 -179.1 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 126.389 1.876 . . . . 0.0 111.144 -177.82 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.544 ' H ' HG12 ' A' ' 204' ' ' VAL . 88.3 p -46.31 150.17 0.66 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.562 2.345 . . . . 0.0 113.84 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' TYR . . . . . 0.466 ' CE2' ' HG2' ' A' ' 209' ' ' MET . 18.3 p90 -155.55 164.87 38.09 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.127 1.371 . . . . 0.0 111.227 -167.512 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -73.8 -49.44 13.85 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 118.666 -1.074 . . . . 0.0 114.814 -169.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -117.2 121.33 40.92 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 118.478 1.139 . . . . 0.0 110.362 -170.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' MET . . . . . 0.466 ' HG2' ' CE2' ' A' ' 206' ' ' TYR . 2.8 mtp -140.48 148.66 41.46 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -166.255 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 14.5 tt -136.91 156.55 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 125.57 1.548 . . . . 0.0 109.32 168.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -133.75 139.18 10.68 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.488 1.042 . . . . 0.0 112.4 -171.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' CYS . . . . . 0.586 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 1.1 m -79.61 125.99 30.32 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.191 1.397 . . . . 0.0 112.233 -167.605 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -69.37 -4.96 20.49 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.598 1.959 . . . . 0.0 113.888 -175.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -66.43 145.65 98.98 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.424 0.689 . . . . 0.0 111.396 -173.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -81.92 9.21 4.04 Favored 'Trans proline' 0 CA--C 1.551 1.343 0 C-N-CA 123.074 2.516 . . . . 0.0 110.946 165.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -134.41 -15.56 2.17 Favored 'General case' 0 C--N 1.35 0.614 0 C-N-CA 125.407 1.483 . . . . 0.0 114.365 -169.271 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 35.6 t -65.05 136.13 56.39 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 123.905 0.882 . . . . 0.0 110.611 -175.915 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.4 t -113.07 14.57 19.59 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.721 1.608 . . . . 0.0 111.217 -174.274 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 51.3 mt -123.2 -42.34 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 125.363 1.465 . . . . 0.0 108.71 173.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 47.28 -7.59 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 131.453 3.901 . . . . 0.0 119.59 171.534 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 66.1 m95 -139.0 134.84 33.6 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.466 1.907 . . . . 0.0 109.259 170.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' PHE . . . . . 0.586 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 7.8 m-85 -142.01 157.09 45.34 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.362 1.465 . . . . 0.0 109.075 -169.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -77.0 148.6 36.15 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 169.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 14.4 m-30 -51.92 -51.62 55.69 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.89 167.441 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.51 -14.18 62.41 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.387 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 6.5 m -79.38 -6.67 57.32 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 119.748 1.158 . . . . 0.0 112.766 173.247 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.9 p -120.87 -12.62 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 125.965 1.706 . . . . 0.0 112.113 169.62 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 96.31 16.87 36.07 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.509 1.528 . . . . 0.0 113.317 178.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 13.7 mt -71.82 159.46 34.27 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.581 1.191 . . . . 0.0 111.068 175.71 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 24.4 m -133.17 -5.52 3.04 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.115 1.766 . . . . 0.0 110.41 177.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 80.1 p -142.51 179.62 6.85 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.815 2.046 . . . . 0.0 109.398 -178.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -112.33 97.32 39.18 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 124.232 1.013 . . . . 0.0 109.528 178.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -70.6 167.73 24.71 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.425 2.084 . . . . 0.0 110.255 169.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -140.69 131.72 26.22 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.981 0.896 . . . . 0.0 109.084 175.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 138.88 -173.43 22.62 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 126.577 2.037 . . . . 0.0 109.688 -169.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -70.83 126.99 31.11 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.729 0.776 . . . . 0.0 109.68 170.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 39.0 t90 -133.51 144.58 49.5 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.864 2.066 . . . . 0.0 108.493 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -126.21 131.2 52.02 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.568 1.147 . . . . 0.0 108.935 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 3.7 p -61.82 167.04 5.08 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 126.106 1.763 . . . . 0.0 112.63 -175.616 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.77 -36.41 32.19 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.026 1.15 . . . . 0.0 112.097 -170.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 60.8 mtt-85 -78.31 10.93 2.66 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.496 1.119 . . . . 0.0 112.907 178.708 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 19.1 m -129.37 -13.56 4.36 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.431 1.892 . . . . 0.0 113.883 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 35.7 t -149.77 -42.43 0.14 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.884 0.766 . . . . 0.0 112.561 -176.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 47.3 tp60 -75.2 -18.43 60.15 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 118.494 -0.765 . . . . 0.0 112.834 -177.415 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -63.11 -22.18 66.69 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.371 0.987 . . . . 0.0 111.709 172.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -86.38 15.32 5.48 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.84 1.256 . . . . 0.0 112.609 175.638 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -137.77 -67.93 0.47 Allowed 'General case' 0 C--N 1.345 0.405 0 C-N-CA 125.307 1.443 . . . . 0.0 109.001 175.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -165.19 92.34 0.56 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.496 1.518 . . . . 0.0 109.369 176.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? . . . . . 0 C--O 1.249 1.071 0 C-N-CA 128.249 2.62 . . . . 0.0 114.901 175.958 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 76.3 mtm . . . . . 0 N--CA 1.476 0.844 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -159.7 170.06 22.35 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.156 1.382 . . . . 0.0 110.273 -169.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -62.75 144.97 96.18 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 123.925 0.89 . . . . 0.0 111.921 -178.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.62 117.26 4.71 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.112 2.541 . . . . 0.0 110.119 174.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 2.4 m -142.66 129.76 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 C-N-CA 125.562 1.545 . . . . 0.0 108.595 177.586 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -76.96 156.4 82.35 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 124.583 1.153 . . . . 0.0 111.327 177.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -72.98 0.34 7.94 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.759 2.972 . . . . 0.0 113.04 170.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -71.92 80.8 0.91 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.75 2.02 . . . . 0.0 110.529 178.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -151.53 138.66 12.14 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 125.569 1.548 . . . . 0.0 108.282 -172.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -70.66 154.89 63.9 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.796 2.33 . . . . 0.0 112.063 -178.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 64.4 p -144.43 175.22 10.28 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.067 1.347 . . . . 0.0 110.327 -174.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -134.4 -81.26 0.45 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 117.328 -1.32 . . . . 0.0 113.26 -170.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.9 t -54.77 167.09 0.4 Allowed 'General case' 0 C--N 1.35 0.594 0 C-N-CA 125.078 1.351 . . . . 0.0 113.174 -176.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 4.2 pp -60.17 -11.0 5.11 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.207 1.003 . . . . 0.0 112.715 169.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 72.3 m -74.38 -24.0 59.07 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.551 1.94 . . . . 0.0 112.906 172.377 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 54.63 69.65 0.7 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 127.291 2.236 . . . . 0.0 111.925 -170.268 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.6 162.21 27.82 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.832 1.653 . . . . 0.0 111.689 173.219 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.477 HG12 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -70.28 -177.9 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 126.04 1.736 . . . . 0.0 111.686 -176.469 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.477 ' H ' HG12 ' A' ' 204' ' ' VAL . 40.5 m -44.34 150.34 0.32 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 128.2 2.6 . . . . 0.0 114.497 177.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -158.06 170.27 22.67 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.034 1.733 . . . . 0.0 110.553 -169.394 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -78.38 -66.52 1.73 Allowed Glycine 0 CA--C 1.529 0.956 0 CA-C-O 119.438 -0.645 . . . . 0.0 113.149 -170.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -100.54 122.41 43.19 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 123.684 0.794 . . . . 0.0 110.745 -173.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -144.11 146.52 32.85 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -167.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 13.7 tt -144.01 153.96 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 125.006 1.322 . . . . 0.0 109.922 169.116 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -132.81 145.47 17.42 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 123.97 0.795 . . . . 0.0 112.01 -170.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 4.2 t -70.07 142.76 52.63 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.971 0.891 . . . . 0.0 110.863 -173.599 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -78.32 -5.43 52.11 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.109 1.764 . . . . 0.0 113.57 -174.232 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 6.4 m120 -80.77 144.63 56.28 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 118.816 0.734 . . . . 0.0 111.231 -169.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -75.67 4.84 4.73 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 123.564 2.843 . . . . 0.0 112.071 168.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -122.95 -6.61 8.44 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.214 1.806 . . . . 0.0 112.358 -173.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 36.7 t -65.25 136.5 56.68 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.305 1.042 . . . . 0.0 109.782 174.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 8.7 t -119.05 10.75 12.24 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.83 1.652 . . . . 0.0 111.248 -175.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 35.5 mm -118.64 -32.82 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 126.197 1.799 . . . . 0.0 109.261 175.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 50.02 -13.64 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.617 1 C-N-CA 131.769 4.028 . . . . 0.0 119.378 175.669 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 63.1 m95 -143.1 152.03 41.38 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.89 1.676 . . . . 0.0 110.365 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -154.05 154.66 34.08 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.555 1.542 . . . . 0.0 109.885 -172.258 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 1.1 m-70 -77.47 148.8 35.18 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 170.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -52.62 -51.55 59.52 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.782 168.02 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.69 -13.25 61.68 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 118.325 -0.845 . . . . 0.0 113.261 -177.104 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 5.3 m -78.23 -6.11 53.94 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 119.713 1.142 . . . . 0.0 112.633 172.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 6.2 p -121.86 -16.77 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 125.659 1.584 . . . . 0.0 112.232 169.8 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 99.79 17.85 24.53 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.776 1.655 . . . . 0.0 113.667 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 18.9 mt -71.15 158.0 37.19 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 119.01 1.405 . . . . 0.0 111.104 177.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 90.0 m -134.53 -22.97 1.67 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.692 1.597 . . . . 0.0 110.973 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 48.6 p -140.73 143.57 35.07 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.91 1.684 . . . . 0.0 108.455 174.714 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -70.05 126.19 92.32 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-O 118.688 -0.672 . . . . 0.0 110.573 -176.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -76.57 -172.42 1.39 Allowed 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 123.813 3.009 . . . . 0.0 111.278 171.245 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -144.28 139.14 28.41 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 124.816 1.246 . . . . 0.0 108.466 176.246 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 97.23 -170.32 25.83 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.357 1.456 . . . . 0.0 111.675 -172.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -57.79 138.4 55.63 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.885 1.274 . . . . 0.0 111.177 175.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 52.6 t90 -142.25 153.8 44.23 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 127.301 2.24 . . . . 0.0 109.032 -177.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -130.71 132.76 45.55 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.853 1.261 . . . . 0.0 110.59 -174.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -67.08 167.35 14.71 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.232 1.013 . . . . 0.0 111.651 177.071 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.73 -27.0 27.16 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.303 1.335 . . . . 0.0 113.354 -172.707 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -87.3 9.8 19.23 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.435 1.094 . . . . 0.0 112.369 174.821 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 17.3 m -126.38 -17.58 5.12 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.565 1.546 . . . . 0.0 113.784 -176.111 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 33.8 t -152.97 -36.1 0.11 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.542 1.065 . . . . 0.0 112.959 174.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -68.49 -19.7 64.55 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 118.292 0.496 . . . . 0.0 112.134 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -60.15 -22.2 62.58 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.009 1.323 . . . . 0.0 112.326 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -61.17 -22.24 64.54 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.826 1.65 . . . . 0.0 113.437 177.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -139.28 -9.79 1.27 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.265 1.026 . . . . 0.0 113.638 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -150.78 110.33 4.02 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-N 119.139 0.881 . . . . 0.0 110.218 -178.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 8.4 tmtm? . . . . . 0 C--O 1.252 1.233 0 C-N-CA 125.197 1.399 . . . . 0.0 109.156 169.433 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 94.1 mtp . . . . . 0 N--CA 1.477 0.924 0 CA-C-O 121.09 0.471 . . . . 0.0 111.248 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -138.78 20.93 2.68 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.617 1.967 . . . . 0.0 110.961 -171.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 64.7 mtt -133.91 157.59 77.41 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 125.336 1.455 . . . . 0.0 110.623 -168.163 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -77.23 23.47 0.53 Allowed 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 124.553 3.502 . . . . 0.0 113.599 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 3.4 m -132.2 135.73 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 126.617 1.967 . . . . 0.0 108.551 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -69.37 161.27 74.77 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 125.973 1.709 . . . . 0.0 111.905 176.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -71.72 -8.35 22.96 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 123.014 2.476 . . . . 0.0 111.735 167.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 61.7 m-80 -89.01 40.58 0.99 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 127.452 2.301 . . . . 0.0 110.822 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 27.2 tp10 -140.14 127.86 12.73 Favored Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 125.672 1.589 . . . . 0.0 107.95 -170.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -70.49 156.69 60.91 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.87 2.38 . . . . 0.0 111.942 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 71.2 p -144.49 175.43 10.13 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.902 1.281 . . . . 0.0 110.54 -172.106 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -136.57 -79.62 0.4 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 117.215 -1.374 . . . . 0.0 113.095 -170.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.41 ' H ' HE22 ' A' ' 203' ' ' GLN . 0.8 OUTLIER -56.31 169.09 0.45 Allowed 'General case' 0 C--N 1.349 0.572 0 CA-C-N 120.013 1.279 . . . . 0.0 113.403 -175.573 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 4.6 pp -57.95 -11.13 2.15 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.897 1.279 . . . . 0.0 113.147 169.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 71.6 m -78.66 -23.3 45.81 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 126.927 2.091 . . . . 0.0 113.416 176.261 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 33.7 m170 59.02 66.61 1.03 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.473 1.909 . . . . 0.0 110.835 -169.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' GLN . . . . . 0.41 HE22 ' H ' ' A' ' 199' ' ' CYS . 0.0 OUTLIER -130.1 160.84 32.5 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.823 1.249 . . . . 0.0 112.247 174.048 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.536 HG12 ' H ' ' A' ' 205' ' ' SER . 0.6 OUTLIER -69.05 -179.26 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 126.125 1.77 . . . . 0.0 111.355 -175.994 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.536 ' H ' HG12 ' A' ' 204' ' ' VAL . 84.8 p -47.91 153.65 0.61 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.82 2.448 . . . . 0.0 114.689 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -154.87 169.16 24.66 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.223 1.809 . . . . 0.0 110.484 -169.18 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -79.52 -40.4 15.57 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.673 -1.07 . . . . 0.0 115.29 -168.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.12 119.0 21.29 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 118.57 1.185 . . . . 0.0 110.137 -168.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -142.08 152.37 43.24 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -164.197 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 15.7 tt -148.49 153.23 11.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 126.091 1.756 . . . . 0.0 109.516 167.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -131.99 146.45 18.07 Favored Glycine 0 C--N 1.336 0.529 0 C-N-CA 124.267 0.937 . . . . 0.0 111.634 -170.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 3.9 t -70.29 140.84 52.38 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-O 121.941 0.876 . . . . 0.0 111.042 -171.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -76.87 -5.09 46.99 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.311 1.844 . . . . 0.0 113.842 -174.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -78.45 147.59 72.22 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 118.846 0.748 . . . . 0.0 111.633 -169.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.51 8.42 2.99 Favored 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 124.135 3.223 . . . . 0.0 112.589 169.398 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -133.32 -9.53 2.91 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.011 1.724 . . . . 0.0 112.394 -169.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.9 t -61.22 133.91 56.44 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.932 0.893 . . . . 0.0 109.845 173.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 68.6 m -119.83 14.9 12.56 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.921 1.688 . . . . 0.0 111.171 -175.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 37.6 mm -119.99 -32.39 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 126.739 2.016 . . . . 0.0 109.164 174.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 51.51 -15.68 0.0 OUTLIER 'General case' 0 C--N 1.35 0.587 1 C-N-CA 131.955 4.102 . . . . 0.0 119.305 173.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -143.01 151.04 40.4 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.64 1.576 . . . . 0.0 110.587 178.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -153.01 155.24 36.54 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.782 1.233 . . . . 0.0 110.418 -173.248 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -79.29 146.74 32.8 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 169.34 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -53.47 -48.78 68.58 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.463 168.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.07 -14.85 62.86 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.77 -13.54 60.3 Favored 'General case' 0 C--N 1.348 0.535 0 CA-C-N 119.712 1.142 . . . . 0.0 112.711 173.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.7 p -115.04 -13.33 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 126.014 1.725 . . . . 0.0 111.801 172.126 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 91.65 20.11 38.52 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 125.869 1.7 . . . . 0.0 113.49 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 12.0 mt -75.36 160.06 30.73 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-N 118.747 1.273 . . . . 0.0 111.801 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 91.1 m -133.87 -20.2 1.99 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.862 1.665 . . . . 0.0 111.131 -177.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 89.3 m -142.03 135.74 29.54 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 125.577 1.551 . . . . 0.0 107.906 178.079 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -70.55 115.69 37.8 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 125.208 1.403 . . . . 0.0 111.545 -176.417 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -79.87 162.17 23.89 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.025 2.483 . . . . 0.0 110.049 168.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 65.4 ttp85 -150.34 136.7 18.8 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-O 121.891 0.853 . . . . 0.0 110.232 -178.489 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 136.86 -61.84 0.6 Allowed Glycine 0 CA--C 1.529 0.906 0 C-N-CA 127.347 2.403 . . . . 0.0 108.758 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -161.54 145.68 12.94 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 126.614 1.966 . . . . 0.0 108.514 168.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 68.4 t90 -146.89 153.16 39.81 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 125.838 1.655 . . . . 0.0 109.417 -177.295 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -128.89 128.95 44.84 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.856 1.263 . . . . 0.0 110.037 -175.078 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.17 168.39 7.78 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 124.526 1.131 . . . . 0.0 112.246 178.044 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.91 -28.89 35.42 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 121.347 1.365 . . . . 0.0 112.684 -174.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 26.5 mtp180 -88.19 13.36 11.55 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.54 1.136 . . . . 0.0 112.877 175.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 16.1 m -129.28 -15.74 4.08 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.707 1.603 . . . . 0.0 113.364 -178.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 35.9 t -151.67 -33.28 0.14 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.077 0.853 . . . . 0.0 112.991 175.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -74.26 -13.97 60.85 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 118.872 0.76 . . . . 0.0 112.684 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -68.17 -5.21 16.84 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 119.231 0.923 . . . . 0.0 112.912 169.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -68.58 -22.74 64.44 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.585 1.154 . . . . 0.0 112.016 169.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -146.59 71.82 1.26 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.336 1.454 . . . . 0.0 108.965 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.17 143.75 57.52 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.644 1.178 . . . . 0.0 111.036 178.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 96.5 mttt . . . . . 0 C--O 1.251 1.176 0 C-N-CA 125.727 1.611 . . . . 0.0 109.125 177.983 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.475 0.821 0 CA-C-O 119.328 -0.368 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -137.98 164.38 29.19 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.471 1.508 . . . . 0.0 110.459 -177.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 5.5 ptp -154.3 56.35 1.5 Allowed Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.371 1.068 . . . . 0.0 111.797 -169.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.98 -47.21 3.82 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.044 2.496 . . . . 0.0 112.964 -173.699 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 2.1 m -155.67 153.56 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 128.022 2.529 . . . . 0.0 108.539 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -73.89 160.17 82.51 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 124.93 1.292 . . . . 0.0 110.698 168.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -74.86 15.5 0.71 Allowed 'Trans proline' 0 CA--C 1.55 1.276 0 C-N-CA 123.726 2.951 . . . . 0.0 112.16 168.428 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -126.07 -158.96 0.88 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.761 2.424 . . . . 0.0 108.535 -177.603 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -142.65 130.68 11.39 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 125.495 1.518 . . . . 0.0 108.684 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -74.73 153.46 43.24 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.102 2.535 . . . . 0.0 111.104 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 69.3 p -144.89 173.66 11.68 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.512 1.125 . . . . 0.0 110.67 -176.082 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -135.09 -76.92 0.45 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 117.189 -1.386 . . . . 0.0 112.524 178.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 1.9 t -58.66 169.18 1.0 Allowed 'General case' 0 C--N 1.35 0.604 0 CA-C-N 119.935 1.243 . . . . 0.0 113.841 -172.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.1 pp -57.47 -13.37 3.53 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.109 1.363 . . . . 0.0 112.769 169.543 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 84.5 m -78.12 -19.47 54.02 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.331 1.853 . . . . 0.0 113.208 175.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 52.87 66.68 1.16 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.989 2.116 . . . . 0.0 112.332 -172.323 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.35 160.22 33.74 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.662 1.985 . . . . 0.0 111.136 174.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.471 HG12 ' H ' ' A' ' 205' ' ' SER . 0.3 OUTLIER -66.0 -179.89 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 125.846 1.658 . . . . 0.0 111.524 -179.82 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.471 ' H ' HG12 ' A' ' 204' ' ' VAL . 24.6 m -47.24 150.81 0.79 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.146 2.178 . . . . 0.0 113.931 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -151.79 166.67 30.67 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.655 1.582 . . . . 0.0 110.926 -173.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -76.23 -60.68 3.01 Favored Glycine 0 C--N 1.342 0.894 0 C-N-CA 124.252 0.929 . . . . 0.0 113.352 -171.235 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.425 ' HB2' ' CD2' ' A' ' 224' ' ' PHE . 3.1 pt-20 -79.29 121.52 25.2 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.331 1.052 . . . . 0.0 111.063 177.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 14.3 mtp -143.88 139.71 29.37 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -173.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 20.3 tt -138.63 145.99 27.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 125.284 1.433 . . . . 0.0 109.844 168.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -125.19 137.29 10.29 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.779 1.18 . . . . 0.0 112.438 -169.696 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' CYS . . . . . 0.59 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 2.0 m -78.22 124.11 27.69 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 125.26 1.424 . . . . 0.0 111.564 -168.074 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -69.64 -3.61 15.82 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.187 1.795 . . . . 0.0 113.564 -175.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -65.78 147.28 98.82 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 123.36 0.664 . . . . 0.0 111.485 -174.893 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -81.33 5.1 6.48 Favored 'Trans proline' 0 CA--C 1.55 1.284 0 C-N-CA 122.909 2.406 . . . . 0.0 111.511 166.374 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -134.59 -11.51 2.39 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 125.215 1.406 . . . . 0.0 114.448 -169.508 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 36.3 t -64.19 135.45 56.31 Favored 'General case' 0 C--N 1.344 0.326 0 CA-C-N 119.257 0.935 . . . . 0.0 110.608 -177.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.4 t -112.8 14.53 19.9 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.917 1.687 . . . . 0.0 111.361 -174.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 48.9 mt -122.02 -42.05 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 125.428 1.491 . . . . 0.0 108.527 172.889 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 48.83 -11.24 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 131.646 3.978 . . . . 0.0 119.687 170.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 52.3 m95 -138.83 136.82 36.01 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.654 1.982 . . . . 0.0 110.042 169.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' PHE . . . . . 0.59 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 5.2 m-85 -142.72 156.23 44.99 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 125.698 1.599 . . . . 0.0 109.303 -169.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -71.77 149.02 45.75 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 167.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' PHE . . . . . 0.425 ' CD2' ' HB2' ' A' ' 208' ' ' GLU . 17.4 m-30 -50.88 -50.93 56.06 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.708 165.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.16 -13.64 62.01 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -177.29 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 2.0 m -78.04 -6.33 54.21 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.885 1.22 . . . . 0.0 112.785 172.784 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.4 p -121.84 -13.07 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 126.132 1.773 . . . . 0.0 111.995 169.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 97.73 14.83 39.02 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.829 1.681 . . . . 0.0 113.446 177.265 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 29.8 mt -73.93 161.88 29.66 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 118.92 1.36 . . . . 0.0 111.329 177.426 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 67.4 p -132.75 -10.88 3.08 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.819 1.648 . . . . 0.0 111.64 176.276 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 53.2 p -145.72 151.09 37.44 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.652 1.981 . . . . 0.0 108.576 177.138 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -81.27 128.37 70.61 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-O 118.776 -0.631 . . . . 0.0 110.103 178.436 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -77.3 -178.35 4.52 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.635 2.89 . . . . 0.0 110.774 169.542 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 53.2 ttt180 -141.48 131.94 25.29 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 169.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 121.26 -168.77 14.28 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 126.064 1.793 . . . . 0.0 109.889 -168.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.28 145.0 51.6 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 122.242 1.02 . . . . 0.0 110.832 174.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 237' ' ' TRP . . . . . 0.496 ' HZ3' ' HG ' ' A' ' 212' ' ' CYS . 62.1 t90 -146.2 137.37 24.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 127.116 2.167 . . . . 0.0 108.915 175.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -114.27 136.72 52.65 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.96 0.904 . . . . 0.0 108.94 171.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 239' ' ' CYS . . . . . 0.411 ' HB2' ' HD2' ' A' ' 240' ' ' PRO . 5.0 p -63.32 168.72 4.67 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 126.308 1.843 . . . . 0.0 113.094 -177.893 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 36.3 Cg_endo -67.08 -33.37 31.93 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 121.306 1.337 . . . . 0.0 112.442 -171.166 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 -72.59 1.29 8.49 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.175 1.39 . . . . 0.0 113.079 176.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 21.6 m -127.84 -13.39 5.24 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.033 1.733 . . . . 0.0 113.982 -172.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 34.9 t -150.61 -40.9 0.13 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.717 0.689 . . . . 0.0 112.291 -177.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 40.4 tp60 -76.53 -16.25 59.67 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 118.792 -0.623 . . . . 0.0 112.679 -177.089 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -64.99 -12.18 47.3 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.184 0.993 . . . . 0.0 113.027 172.354 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 38.6 ttt-85 -72.62 -0.91 14.24 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.194 0.998 . . . . 0.0 112.139 169.4 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -140.91 175.48 9.58 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.768 2.427 . . . . 0.0 108.498 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -68.46 110.45 4.16 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.822 1.249 . . . . 0.0 109.167 176.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 23.1 tptm . . . . . 0 C--O 1.25 1.122 0 C-N-CA 127.942 2.497 . . . . 0.0 113.717 -179.827 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.88 0 CA-C-O 120.752 0.31 . . . . 0.0 111.511 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -131.49 12.43 4.96 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.355 1.862 . . . . 0.0 111.832 -172.707 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 19.4 ptp -140.09 73.66 31.94 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 125.63 1.572 . . . . 0.0 110.085 -169.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -76.25 68.2 6.78 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 125.028 3.819 . . . . 0.0 111.175 178.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 14.9 p -151.51 149.94 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 125.694 1.598 . . . . 0.0 109.227 -176.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -65.05 151.94 92.43 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.64 1.576 . . . . 0.0 112.343 179.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -74.34 -5.48 17.0 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 123.642 2.895 . . . . 0.0 112.165 168.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -91.31 40.48 1.03 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.903 2.081 . . . . 0.0 111.198 -174.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -141.95 118.25 7.14 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 124.705 1.202 . . . . 0.0 109.22 -169.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -77.27 158.64 33.34 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.047 2.498 . . . . 0.0 111.075 176.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 71.3 p -143.07 173.46 11.54 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.638 1.175 . . . . 0.0 110.118 -177.661 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -135.77 -82.68 0.4 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 117.414 -1.279 . . . . 0.0 113.274 -168.641 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.4 t -54.28 166.03 0.46 Allowed 'General case' 0 C--N 1.35 0.614 0 C-N-CA 125.05 1.34 . . . . 0.0 112.731 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.9 pp -58.9 -11.12 2.95 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.471 1.108 . . . . 0.0 112.87 170.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 75.1 m -76.04 -19.93 58.21 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.667 1.987 . . . . 0.0 113.171 175.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 21.4 m170 57.9 62.92 1.93 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.996 2.118 . . . . 0.0 111.785 -173.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.7 159.65 33.09 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.356 1.462 . . . . 0.0 112.32 175.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.492 HG12 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -70.7 -178.45 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 126.267 1.827 . . . . 0.0 111.472 -176.811 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.492 ' H ' HG12 ' A' ' 204' ' ' VAL . 49.4 m -43.87 148.15 0.41 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 128.024 2.53 . . . . 0.0 113.915 178.281 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 10.3 p90 -154.4 167.4 30.14 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.498 1.519 . . . . 0.0 111.103 -167.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -73.17 -43.86 37.75 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-O 118.719 -1.045 . . . . 0.0 115.136 -168.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -129.88 122.96 29.66 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 118.368 1.084 . . . . 0.0 110.654 -169.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -143.05 146.65 34.02 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -165.803 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 16.2 tt -140.62 155.94 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 126.278 1.831 . . . . 0.0 109.511 169.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -136.18 144.97 16.87 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 123.921 0.772 . . . . 0.0 112.261 -173.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 7.4 t -69.34 145.32 53.06 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-O 122.184 0.993 . . . . 0.0 110.938 -174.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -80.64 -6.75 58.79 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.704 2.001 . . . . 0.0 113.508 -174.241 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -80.55 145.78 59.63 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 118.557 0.617 . . . . 0.0 111.675 -169.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.42 6.13 4.21 Favored 'Trans proline' 0 CA--C 1.547 1.145 0 C-N-CA 123.629 2.886 . . . . 0.0 111.779 168.271 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -126.34 -8.12 6.39 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.074 1.749 . . . . 0.0 112.815 -172.367 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.9 t -65.4 133.36 51.17 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.822 0.849 . . . . 0.0 109.576 175.116 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 10.7 t -113.21 10.96 18.63 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.626 1.571 . . . . 0.0 111.702 -175.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 35.0 mm -118.84 -33.39 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 126.393 1.877 . . . . 0.0 109.242 176.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 50.45 -15.17 0.0 OUTLIER 'General case' 0 C--N 1.351 0.667 0 C-N-CA 131.591 3.956 . . . . 0.0 119.253 176.106 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -141.12 152.33 44.64 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.897 1.679 . . . . 0.0 110.427 178.424 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -154.22 154.49 33.58 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.71 1.604 . . . . 0.0 110.109 -170.326 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 1.2 m-70 -78.34 148.64 33.68 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 170.747 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -53.78 -50.69 65.51 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.719 167.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.62 -13.22 61.69 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 118.258 -0.877 . . . . 0.0 113.312 -176.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 3.5 m -76.41 -11.25 59.86 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.737 1.153 . . . . 0.0 112.441 172.457 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.2 p -117.69 -15.84 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 126.193 1.797 . . . . 0.0 112.269 171.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 94.87 20.06 29.64 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.888 1.709 . . . . 0.0 113.485 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 13.9 mt -71.61 156.98 38.78 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 118.854 1.327 . . . . 0.0 111.335 178.428 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 82.7 p -137.83 -11.84 1.52 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.419 1.487 . . . . 0.0 112.435 -178.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 59.2 m -148.48 134.07 18.75 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 126.263 1.825 . . . . 0.0 107.232 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -73.59 120.49 81.44 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 123.541 0.736 . . . . 0.0 111.587 -173.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -82.11 177.32 7.36 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.705 2.937 . . . . 0.0 111.194 170.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 36.0 ttp180 -142.58 135.0 27.78 Favored 'General case' 0 C--N 1.344 0.346 0 C-N-CA 124.239 1.016 . . . . 0.0 108.453 170.658 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 125.92 -167.49 18.31 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.65 1.595 . . . . 0.0 111.485 -177.024 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -59.39 119.41 7.41 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 124.601 1.16 . . . . 0.0 109.76 172.508 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 62.2 t90 -136.62 138.86 41.61 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 127.029 2.132 . . . . 0.0 108.103 175.634 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -115.88 132.71 56.56 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.346 1.059 . . . . 0.0 108.748 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 1.8 p -68.05 166.62 22.51 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 124.731 1.212 . . . . 0.0 112.467 -175.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -73.93 3.9 4.63 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.615 2.21 . . . . 0.0 114.698 -173.323 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 38.2 mtp180 -122.47 21.23 10.27 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.374 1.87 . . . . 0.0 111.017 171.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 18.6 m -133.45 -20.33 2.09 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.275 1.83 . . . . 0.0 112.506 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 31.2 t -150.29 -36.29 0.15 Allowed 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.635 1.107 . . . . 0.0 113.029 177.151 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 24.6 tp60 -74.17 -14.07 60.9 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.339 0.518 . . . . 0.0 112.087 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -74.99 -0.83 20.11 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.793 1.637 . . . . 0.0 113.18 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -57.03 118.4 4.96 Favored 'General case' 0 C--N 1.347 0.457 0 C-N-CA 124.58 1.152 . . . . 0.0 110.846 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -149.73 -33.21 0.19 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.773 1.629 . . . . 0.0 110.492 -178.599 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.64 147.79 50.63 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.748 1.219 . . . . 0.0 109.672 168.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 13.9 mptt . . . . . 0 C--O 1.25 1.103 0 CA-C-O 117.74 -1.124 . . . . 0.0 109.17 -176.372 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 22.3 ptp . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 121.175 0.512 . . . . 0.0 110.277 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -144.91 163.63 33.57 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.103 0.961 . . . . 0.0 111.312 -167.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -67.98 157.12 87.91 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 124.648 1.179 . . . . 0.0 110.937 173.069 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -75.24 13.54 1.06 Allowed 'Trans proline' 0 CA--C 1.547 1.129 0 C-N-CA 124.367 3.378 . . . . 0.0 113.139 173.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 14.7 p -147.17 158.59 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 126.921 2.088 . . . . 0.0 108.161 -178.536 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -53.23 152.2 8.44 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 126.839 2.055 . . . . 0.0 113.715 -175.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -72.42 -5.86 17.96 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.728 2.952 . . . . 0.0 112.526 169.578 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -81.95 41.35 0.66 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.11 2.164 . . . . 0.0 111.183 178.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -142.13 115.17 6.46 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 125.343 1.457 . . . . 0.0 108.726 -169.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.51 155.91 40.68 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.804 2.336 . . . . 0.0 110.667 174.415 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 74.4 p -142.53 172.35 12.81 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.395 1.078 . . . . 0.0 110.204 -176.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -135.56 -83.88 0.39 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 117.327 -1.32 . . . . 0.0 112.765 -168.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.405 ' H ' HE22 ' A' ' 203' ' ' GLN . 2.0 t -55.82 168.48 0.44 Allowed 'General case' 0 C--N 1.351 0.646 0 CA-C-N 119.784 1.175 . . . . 0.0 113.173 -177.133 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.3 pp -57.24 -12.6 2.44 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.839 1.255 . . . . 0.0 112.902 170.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 75.2 m -77.6 -18.62 56.67 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.02 2.128 . . . . 0.0 113.171 176.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 27.6 m170 56.65 61.98 2.45 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.887 2.075 . . . . 0.0 111.729 -173.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' GLN . . . . . 0.405 HE22 ' H ' ' A' ' 199' ' ' CYS . 0.0 OUTLIER -126.38 158.96 34.57 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.287 1.435 . . . . 0.0 112.306 176.838 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.47 HG12 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -69.76 -178.97 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 126.347 1.859 . . . . 0.0 111.432 -177.192 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.47 ' H ' HG12 ' A' ' 204' ' ' VAL . 93.6 p -44.04 148.14 0.44 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.354 2.262 . . . . 0.0 113.754 177.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -153.04 167.02 30.6 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.775 1.23 . . . . 0.0 111.963 -167.086 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -68.79 -49.44 42.59 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.718 1.152 . . . . 0.0 114.68 -168.948 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -128.01 125.09 38.74 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 118.206 1.003 . . . . 0.0 109.978 -171.328 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -142.88 145.84 33.5 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -166.638 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 19.7 tt -134.64 150.57 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 125.5 1.52 . . . . 0.0 109.878 172.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -127.45 138.93 10.8 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.729 1.157 . . . . 0.0 112.575 -170.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' CYS . . . . . 0.59 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 2.2 m -77.86 126.09 30.33 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.568 1.547 . . . . 0.0 111.453 -168.233 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -70.18 -0.03 7.1 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.373 1.869 . . . . 0.0 113.533 -175.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -67.36 149.09 98.58 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 123.785 0.834 . . . . 0.0 111.635 -176.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -83.37 8.19 4.76 Favored 'Trans proline' 0 CA--C 1.549 1.235 0 C-N-CA 123.656 2.904 . . . . 0.0 111.431 166.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -144.52 -10.94 0.62 Allowed 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 -167.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 37.2 t -61.38 132.43 53.49 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 119.469 1.031 . . . . 0.0 110.671 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 9.3 t -103.95 4.45 34.67 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.696 1.599 . . . . 0.0 111.786 -172.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 41.8 mm -114.67 -41.81 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 125.599 1.559 . . . . 0.0 108.773 175.332 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 46.98 -8.08 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 131.567 3.947 . . . . 0.0 119.8 171.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 60.9 m95 -140.71 136.6 32.75 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 126.993 2.117 . . . . 0.0 109.391 171.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' PHE . . . . . 0.59 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 6.3 m-85 -144.75 153.93 42.2 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 125.47 1.508 . . . . 0.0 109.529 -169.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 29.1 m80 -70.93 149.41 46.74 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 168.418 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -52.37 -51.27 59.85 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 115.19 -0.913 . . . . 0.0 109.626 167.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.22 -14.22 62.52 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -177.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 3.3 m -78.08 -7.03 56.42 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.753 1.16 . . . . 0.0 112.628 172.638 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.2 p -122.19 -10.76 8.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 126.241 1.816 . . . . 0.0 112.276 169.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 94.16 16.52 43.72 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.736 1.636 . . . . 0.0 113.374 178.374 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 10.2 mt -70.48 157.65 37.48 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.554 1.177 . . . . 0.0 111.176 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 73.4 m -131.19 -5.02 3.86 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.369 1.868 . . . . 0.0 110.214 177.223 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 81.9 p -141.55 -175.31 4.32 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.007 2.123 . . . . 0.0 109.206 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -124.84 111.1 27.41 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 124.033 0.933 . . . . 0.0 109.077 177.122 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -74.19 177.4 8.31 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.473 2.782 . . . . 0.0 111.235 173.833 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 60.4 ttt-85 -139.1 132.2 29.65 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 171.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 115.97 -170.29 13.28 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.579 1.561 . . . . 0.0 110.855 -169.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.6 135.77 57.03 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.47 1.108 . . . . 0.0 111.468 177.967 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 237' ' ' TRP . . . . . 0.438 ' HZ3' ' HG ' ' A' ' 212' ' ' CYS . 58.2 t90 -142.49 143.84 32.73 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 127.556 2.342 . . . . 0.0 108.853 173.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -128.29 128.85 45.4 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.313 1.045 . . . . 0.0 109.372 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 239' ' ' CYS . . . . . 0.421 ' HB2' ' HD2' ' A' ' 240' ' ' PRO . 3.7 p -62.71 170.12 2.73 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 126.681 1.992 . . . . 0.0 113.845 -172.244 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.421 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 72.9 Cg_endo -74.1 0.23 8.69 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.672 2.248 . . . . 0.0 115.788 -169.226 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 76.5 mtm180 -117.97 17.01 14.22 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.224 1.41 . . . . 0.0 111.251 171.65 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 33.9 m -131.32 -17.67 2.96 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 126.166 1.786 . . . . 0.0 113.305 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 36.6 t -152.61 -40.02 0.1 Allowed 'General case' 0 C--N 1.343 0.292 0 CA-C-N 118.976 0.807 . . . . 0.0 112.55 176.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -74.82 -16.18 60.71 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 119.177 -0.439 . . . . 0.0 112.167 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.85 -24.31 67.7 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.376 1.071 . . . . 0.0 112.697 -178.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -81.71 14.66 2.52 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.84 1.256 . . . . 0.0 113.273 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.6 -16.59 61.31 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.593 1.157 . . . . 0.0 113.962 -178.54 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -151.06 134.95 16.57 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.982 1.313 . . . . 0.0 108.645 177.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt . . . . . 0 C--O 1.251 1.165 0 C-N-CA 126.706 2.002 . . . . 0.0 111.935 -176.149 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.476 0.871 0 CA-C-O 119.131 -0.462 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.82 -32.84 71.02 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.182 1.393 . . . . 0.0 113.599 -172.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 65.8 mtt 34.0 67.61 1.19 Allowed Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 127.743 2.417 . . . . 0.0 113.679 174.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -76.63 22.99 0.51 Allowed 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 124.849 3.699 . . . . 0.0 113.7 -174.157 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 13.0 p -146.15 153.77 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 125.961 1.704 . . . . 0.0 108.916 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -57.39 153.63 26.84 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 126.687 1.995 . . . . 0.0 113.144 -177.242 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -71.87 -7.24 20.72 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.61 2.874 . . . . 0.0 112.287 168.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 -82.04 45.09 0.89 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.324 2.25 . . . . 0.0 110.795 177.09 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -136.51 106.84 9.21 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 125.355 1.462 . . . . 0.0 108.326 -170.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -73.23 151.66 49.24 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.261 1.974 . . . . 0.0 109.795 170.449 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 64.7 p -141.21 171.87 13.46 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.064 0.946 . . . . 0.0 110.118 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -133.45 -83.98 0.46 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 117.145 -1.407 . . . . 0.0 113.046 -168.421 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.484 ' H ' HE22 ' A' ' 203' ' ' GLN . 2.3 t -55.13 170.11 0.21 Allowed 'General case' 0 C--N 1.35 0.602 0 C-N-CA 124.841 1.256 . . . . 0.0 113.784 -175.626 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.2 pp -58.49 -13.91 6.67 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.175 0.99 . . . . 0.0 112.624 169.476 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 73.0 m -75.83 -23.4 55.75 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.887 2.075 . . . . 0.0 112.835 173.748 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 52.93 69.15 0.73 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 127.56 2.344 . . . . 0.0 112.045 -171.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' GLN . . . . . 0.484 HE22 ' H ' ' A' ' 199' ' ' CYS . 0.0 OUTLIER -124.43 160.45 28.17 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.887 1.675 . . . . 0.0 111.203 173.716 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.467 HG12 ' H ' ' A' ' 205' ' ' SER . 0.3 OUTLIER -68.51 -179.84 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 125.548 1.539 . . . . 0.0 111.129 -178.928 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.467 ' H ' HG12 ' A' ' 204' ' ' VAL . 83.2 p -44.39 145.82 0.78 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.972 2.109 . . . . 0.0 113.374 177.984 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' TYR . . . . . 0.455 ' CE2' ' HG2' ' A' ' 209' ' ' MET . 13.3 p90 -152.98 164.35 38.14 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.992 1.317 . . . . 0.0 111.466 -167.211 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -72.36 -60.51 4.05 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.273 0.939 . . . . 0.0 114.095 -169.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' GLU . . . . . 0.411 ' HB2' ' CD2' ' A' ' 224' ' ' PHE . 22.9 pt-20 -99.26 120.83 40.19 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 118.048 0.924 . . . . 0.0 110.284 -174.431 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 209' ' ' MET . . . . . 0.455 ' HG2' ' CE2' ' A' ' 206' ' ' TYR . 17.6 mtp -141.51 143.1 33.63 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 -168.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 19.0 tt -134.64 157.94 41.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 126.185 1.794 . . . . 0.0 108.995 169.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -135.24 139.79 11.12 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 124.129 0.871 . . . . 0.0 112.466 -174.602 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' CYS . . . . . 0.606 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 5.6 m -75.47 124.82 27.81 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 125.029 1.331 . . . . 0.0 110.901 -168.515 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -71.88 -0.7 11.97 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.398 1.479 . . . . 0.0 113.221 -176.19 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -66.81 146.47 99.08 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 123.616 0.766 . . . . 0.0 111.065 -177.365 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -81.17 6.95 5.24 Favored 'Trans proline' 0 CA--C 1.549 1.271 0 C-N-CA 123.029 2.486 . . . . 0.0 111.376 166.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -134.44 -13.38 2.33 Favored 'General case' 0 C--N 1.35 0.593 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -169.317 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.5 t -64.63 135.09 55.57 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 119.145 0.884 . . . . 0.0 110.524 -175.88 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 32.2 m -108.32 7.69 27.32 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.766 1.626 . . . . 0.0 111.923 -174.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 37.8 mm -117.09 -41.2 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 125.732 1.613 . . . . 0.0 108.647 175.791 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 48.31 -9.71 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 131.623 3.969 . . . . 0.0 119.818 169.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -140.75 136.1 32.19 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.663 1.985 . . . . 0.0 109.032 171.84 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' PHE . . . . . 0.606 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 6.9 m-85 -144.56 156.8 44.32 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 125.939 1.695 . . . . 0.0 109.609 -169.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -73.24 148.9 43.24 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 167.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' PHE . . . . . 0.411 ' CD2' ' HB2' ' A' ' 208' ' ' GLU . 15.5 m-30 -51.63 -52.12 50.27 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.8 166.389 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.21 -12.99 61.77 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -177.074 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 2.0 m -77.56 -6.29 53.17 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.823 1.192 . . . . 0.0 112.665 172.312 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.62 -11.74 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 126.242 1.817 . . . . 0.0 112.396 170.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 96.3 16.33 38.02 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.604 1.574 . . . . 0.0 113.563 177.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 24.8 mt -72.4 163.29 28.23 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.777 1.289 . . . . 0.0 111.33 175.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 39.7 m -134.62 -21.69 1.72 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.595 1.558 . . . . 0.0 111.08 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 58.1 p -141.01 151.01 43.76 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 125.998 1.719 . . . . 0.0 108.826 176.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -76.55 125.56 87.24 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-O 118.846 -0.597 . . . . 0.0 110.248 -178.55 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -77.9 179.55 6.4 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.802 3.001 . . . . 0.0 111.441 174.518 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.08 125.37 21.74 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 124.966 1.307 . . . . 0.0 107.784 172.035 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 122.55 -174.8 16.36 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.545 1.545 . . . . 0.0 110.779 -169.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.25 142.19 55.69 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 122.133 0.968 . . . . 0.0 110.618 175.142 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 237' ' ' TRP . . . . . 0.446 ' HZ3' ' HG ' ' A' ' 212' ' ' CYS . 62.9 t90 -140.31 139.46 35.45 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.646 1.978 . . . . 0.0 109.234 175.257 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -125.43 123.56 39.53 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.029 1.331 . . . . 0.0 108.196 -178.028 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 239' ' ' CYS . . . . . 0.462 ' HB3' ' SG ' ' A' ' 212' ' ' CYS . 5.0 p -60.61 172.72 0.75 Allowed Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 127.799 2.44 . . . . 0.0 114.776 -170.46 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.447 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 68.5 Cg_endo -73.28 -0.35 9.06 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.778 2.319 . . . . 0.0 115.783 -169.275 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -117.48 15.95 14.67 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.617 1.567 . . . . 0.0 111.212 172.208 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 27.0 m -133.53 -15.94 2.4 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.725 2.01 . . . . 0.0 112.723 -176.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 35.1 t -151.1 -42.87 0.12 Allowed 'General case' 0 C--N 1.342 0.272 0 C-N-CA 123.857 0.863 . . . . 0.0 112.061 177.087 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -75.11 -13.65 60.5 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -53.69 -36.13 61.86 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.178 1.791 . . . . 0.0 111.35 172.328 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 46.2 ttm-85 -70.45 0.56 6.43 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.183 1.793 . . . . 0.0 113.754 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -129.47 -30.15 2.14 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.554 1.542 . . . . 0.0 111.186 175.411 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -151.57 108.3 3.51 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.885 1.274 . . . . 0.0 108.43 173.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm . . . . . 0 C--O 1.252 1.228 0 C-N-CA 125.292 1.437 . . . . 0.0 111.166 176.784 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 63.2 ttp . . . . . 0 N--CA 1.475 0.8 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -163.58 175.0 11.08 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.881 1.272 . . . . 0.0 110.758 -168.333 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -137.41 154.35 75.26 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 125.453 1.501 . . . . 0.0 109.84 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -72.6 -2.12 11.34 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 123.918 3.079 . . . . 0.0 113.879 178.853 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 7.1 p -146.25 139.07 20.27 Favored 'Isoleucine or valine' 0 C--N 1.341 0.237 0 C-N-CA 125.367 1.467 . . . . 0.0 108.521 170.805 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -74.98 155.55 86.52 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 124.991 1.316 . . . . 0.0 112.09 -175.059 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.12 3.54 5.04 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 123.475 2.784 . . . . 0.0 112.046 168.301 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -115.79 30.69 7.19 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.814 2.046 . . . . 0.0 110.822 -178.464 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -143.45 129.91 10.38 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 126.099 1.76 . . . . 0.0 108.158 -173.633 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.4 164.57 34.7 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.154 2.57 . . . . 0.0 113.005 -176.102 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 32.6 p -142.53 179.12 7.15 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.451 1.9 . . . . 0.0 108.819 -178.495 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -138.08 -63.74 0.55 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.636 0.774 . . . . 0.0 111.83 176.042 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.446 ' SG ' ' HB2' ' A' ' 201' ' ' CYS . 4.8 p -59.8 165.6 3.04 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 128.489 2.716 . . . . 0.0 114.094 179.714 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 2.7 pp -77.93 0.53 23.85 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.565 167.319 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 201' ' ' CYS . . . . . 0.446 ' HB2' ' SG ' ' A' ' 199' ' ' CYS . 80.3 m -78.26 -26.93 47.41 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.917 0.887 . . . . 0.0 110.4 168.711 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . 0.282 82.3 m-70 70.32 53.4 0.33 Allowed 'General case' 0 C--N 1.343 0.286 0 C-N-CA 127.29 2.236 . . . . 0.0 113.095 169.605 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.24 172.9 12.22 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.608 -1.178 . . . . 0.0 109.587 166.882 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.436 HG12 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -62.49 174.09 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 125.229 1.412 . . . . 0.0 111.862 -174.981 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.436 ' H ' HG12 ' A' ' 204' ' ' VAL . 88.6 p -50.76 158.73 0.62 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.759 2.024 . . . . 0.0 114.833 -173.725 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -139.32 160.08 40.65 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.03 1.732 . . . . 0.0 110.484 -169.192 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -63.97 -35.36 91.9 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.36 0.981 . . . . 0.0 113.85 -171.279 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.05 118.04 16.34 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 124.589 1.156 . . . . 0.0 109.337 -170.767 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 1.3 mtm -135.68 151.2 49.96 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.074 -0.966 . . . . 0.0 113.329 -165.984 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 19.3 tt -142.71 146.36 22.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.274 0 C-N-CA 125.511 1.524 . . . . 0.0 110.794 169.076 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -122.53 142.44 14.78 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 125.189 1.376 . . . . 0.0 112.755 -170.938 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 212' ' ' CYS . . . . . 0.573 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 1.9 m -79.5 127.27 31.93 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 126.074 1.75 . . . . 0.0 112.051 -167.302 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -69.58 -0.99 7.59 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.28 1.832 . . . . 0.0 113.751 -176.61 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -68.42 146.36 97.79 Favored Pre-proline 0 CA--C 1.539 0.521 0 O-C-N 121.469 -0.769 . . . . 0.0 111.283 -175.893 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -82.01 6.75 5.49 Favored 'Trans proline' 0 CA--C 1.551 1.337 0 C-N-CA 123.1 2.534 . . . . 0.0 111.208 165.909 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -135.02 -13.15 2.15 Favored 'General case' 0 C--N 1.351 0.638 0 C-N-CA 125.25 1.42 . . . . 0.0 114.703 -169.261 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 36.5 t -64.92 134.31 53.69 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 119.139 0.881 . . . . 0.0 110.57 -176.126 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.9 t -108.71 8.61 26.95 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.679 1.591 . . . . 0.0 111.535 -173.275 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 38.9 mm -116.84 -42.29 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 125.728 1.611 . . . . 0.0 108.659 173.604 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 47.32 -7.68 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.737 1 C-N-CA 131.817 4.047 . . . . 0.0 119.453 171.838 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 51.2 m95 -140.85 139.82 34.51 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.851 2.06 . . . . 0.0 109.827 169.84 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 222' ' ' PHE . . . . . 0.573 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 6.7 m-85 -147.34 153.01 39.16 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.485 1.514 . . . . 0.0 108.479 -169.859 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -67.08 150.98 48.44 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 166.912 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -54.07 -47.76 71.36 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.915 167.037 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -69.44 -14.81 63.09 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 178.402 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 5.4 t -68.79 -18.56 64.21 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.841 0.856 . . . . 0.0 112.422 173.138 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.9 p -117.36 -12.62 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 126.244 1.818 . . . . 0.0 112.137 173.233 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 93.55 18.6 37.81 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.827 1.679 . . . . 0.0 113.512 179.069 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 11.5 mt -72.12 157.44 37.77 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-N 119.006 1.403 . . . . 0.0 111.419 178.92 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 39.7 m -131.95 0.57 3.87 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.384 1.874 . . . . 0.0 110.185 179.801 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 9.5 t -148.41 172.62 14.14 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.095 1.758 . . . . 0.0 109.876 179.91 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -110.18 94.28 17.78 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 125.164 1.386 . . . . 0.0 108.986 179.613 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.98 162.15 41.1 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.693 2.262 . . . . 0.0 110.937 170.109 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -145.4 134.55 22.78 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 124.333 1.053 . . . . 0.0 109.242 -178.654 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 138.22 -64.07 0.56 Allowed Glycine 0 CA--C 1.525 0.683 0 C-N-CA 127.13 2.3 . . . . 0.0 108.519 179.783 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -167.99 149.9 5.42 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 126.011 1.724 . . . . 0.0 110.486 169.611 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 48.3 t90 -146.46 148.63 32.45 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 126.701 2.0 . . . . 0.0 109.128 178.811 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -129.35 130.82 46.56 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.343 1.057 . . . . 0.0 109.701 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 239' ' ' CYS . . . . . 0.422 ' HB2' ' HD2' ' A' ' 240' ' ' PRO . 3.9 p -65.5 170.62 4.42 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 126.7 2.0 . . . . 0.0 113.716 -173.152 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 59.4 Cg_endo -70.09 -19.64 34.31 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.052 1.835 . . . . 0.0 113.768 -170.814 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 16.8 mmp_? -87.2 3.45 46.44 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.536 1.534 . . . . 0.0 112.606 175.207 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 34.6 m -132.94 -17.61 2.42 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.618 1.567 . . . . 0.0 113.931 -169.789 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 29.0 t -149.9 -33.76 0.18 Allowed 'General case' 0 C--N 1.342 0.255 0 CA-C-N 118.862 0.755 . . . . 0.0 112.973 -177.731 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -70.97 -23.78 62.28 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 118.211 -0.9 . . . . 0.0 111.329 177.143 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -50.21 -28.89 8.31 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 125.675 1.59 . . . . 0.0 113.56 175.114 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -64.76 131.71 47.58 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.347 1.059 . . . . 0.0 109.907 178.162 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? 75.27 -37.58 0.34 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.98 2.512 . . . . 0.0 113.435 -175.084 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -159.22 136.34 9.69 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.219 1.008 . . . . 0.0 110.218 179.607 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 116.852 -1.546 . . . . 0.0 111.319 171.683 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 63.2 ttp . . . . . 0 N--CA 1.476 0.828 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -166.74 -174.48 2.77 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.11 1.364 . . . . 0.0 110.45 -168.301 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -133.56 105.74 11.94 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 125.406 1.482 . . . . 0.0 107.629 169.786 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -80.01 14.78 1.82 Allowed 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 124.05 3.167 . . . . 0.0 113.324 -172.778 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 5.3 m -136.37 137.76 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 126.536 1.934 . . . . 0.0 108.665 -174.899 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -67.71 159.16 80.23 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 125.829 1.651 . . . . 0.0 112.075 178.534 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -72.61 2.37 5.29 Favored 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 123.436 2.757 . . . . 0.0 112.111 168.223 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -108.9 35.22 3.31 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.987 2.115 . . . . 0.0 110.481 -177.904 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -141.75 128.94 11.53 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 125.944 1.698 . . . . 0.0 107.893 -172.295 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.69 157.47 60.42 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.952 2.435 . . . . 0.0 112.082 -178.644 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 66.4 p -143.77 175.09 10.25 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.098 1.359 . . . . 0.0 110.335 -175.544 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -135.51 -79.89 0.43 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 117.291 -1.338 . . . . 0.0 112.537 -173.109 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.1 t -55.38 164.6 0.94 Allowed 'General case' 0 C--N 1.349 0.566 0 CA-C-N 119.692 1.133 . . . . 0.0 112.784 -177.35 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.17 -5.36 3.15 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.005 0.922 . . . . 0.0 112.849 170.98 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 89.0 m -76.35 -21.97 55.46 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.165 1.786 . . . . 0.0 113.141 169.8 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 55.93 69.25 0.76 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 127.051 2.141 . . . . 0.0 111.951 -169.824 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.82 159.05 37.76 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.488 1.515 . . . . 0.0 111.886 172.317 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.506 HG12 ' H ' ' A' ' 205' ' ' SER . 0.7 OUTLIER -67.78 -177.9 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 126.263 1.825 . . . . 0.0 110.934 -179.039 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.506 ' H ' HG12 ' A' ' 204' ' ' VAL . 88.3 p -44.1 149.43 0.34 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.416 2.287 . . . . 0.0 113.9 176.054 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -153.53 168.92 24.55 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.205 1.402 . . . . 0.0 111.583 -167.226 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -72.66 -49.25 19.19 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-O 118.811 -0.994 . . . . 0.0 114.638 -169.092 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -124.96 121.78 35.44 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 118.233 1.016 . . . . 0.0 110.136 -170.062 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -140.36 146.32 38.26 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -166.016 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 20.1 tt -135.25 150.21 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 125.533 1.533 . . . . 0.0 109.802 170.901 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -127.33 138.84 10.76 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.539 1.066 . . . . 0.0 112.2 -172.798 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 212' ' ' CYS . . . . . 0.601 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 3.0 m -76.16 123.42 25.82 Favored 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 125.06 1.344 . . . . 0.0 110.779 -168.738 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -72.54 4.32 4.0 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.915 1.686 . . . . 0.0 112.938 -175.817 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -68.3 149.17 98.17 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 124.214 1.006 . . . . 0.0 111.469 -179.612 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -81.85 1.04 9.5 Favored 'Trans proline' 0 CA--C 1.549 1.235 0 C-N-CA 123.184 2.589 . . . . 0.0 111.831 166.447 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -135.53 -7.82 2.2 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -169.33 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.2 t -63.42 134.64 56.02 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 119.84 1.2 . . . . 0.0 110.836 -178.464 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 10.7 t -107.98 9.17 28.62 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.71 1.604 . . . . 0.0 111.712 -173.095 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 38.2 mm -118.64 -41.36 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 125.419 1.488 . . . . 0.0 108.771 173.678 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 48.11 -9.14 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 131.537 3.935 . . . . 0.0 119.644 171.014 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 60.9 m95 -139.8 136.29 33.91 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.834 2.054 . . . . 0.0 109.411 170.156 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 222' ' ' PHE . . . . . 0.601 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 7.2 m-85 -143.85 154.91 43.86 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 125.599 1.56 . . . . 0.0 109.276 -169.212 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 1.3 m-70 -72.84 148.75 44.17 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 169.113 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 15.4 m-30 -51.93 -50.58 60.88 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.937 167.685 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.13 -14.0 62.14 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -177.721 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 7.5 m -78.37 -1.93 35.78 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.799 1.181 . . . . 0.0 112.657 172.714 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 6.1 p -128.22 -13.64 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 125.841 1.656 . . . . 0.0 112.659 169.11 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 99.53 16.44 29.23 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.66 1.6 . . . . 0.0 113.535 178.135 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 18.5 mt -74.39 163.19 28.08 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.799 1.299 . . . . 0.0 111.537 177.708 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 41.6 m -136.51 -21.81 1.31 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.581 1.552 . . . . 0.0 111.256 -178.987 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 89.1 m -141.03 142.77 34.18 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 125.713 1.605 . . . . 0.0 108.033 -179.207 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -68.45 120.53 75.78 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 123.957 0.903 . . . . 0.0 110.459 -178.721 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -79.46 -174.21 2.18 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.785 2.99 . . . . 0.0 111.135 173.655 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -143.96 133.68 23.72 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.58 1.152 . . . . 0.0 108.439 174.847 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 105.46 -169.05 15.86 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.114 1.34 . . . . 0.0 112.199 -176.234 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.83 123.61 15.63 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 125.712 1.605 . . . . 0.0 110.953 178.046 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 237' ' ' TRP . . . . . 0.411 ' HZ3' ' HG ' ' A' ' 212' ' ' CYS . 61.1 t90 -134.18 133.95 41.54 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.424 1.89 . . . . 0.0 108.865 171.042 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -119.08 128.25 54.15 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.696 1.198 . . . . 0.0 108.086 178.41 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 239' ' ' CYS . . . . . 0.467 ' HB2' ' HD2' ' A' ' 240' ' ' PRO . 12.3 p -62.1 172.55 1.16 Allowed Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 127.382 2.273 . . . . 0.0 113.865 -173.124 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 42.2 Cg_endo -68.31 -26.05 35.75 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 121.653 1.569 . . . . 0.0 114.423 -169.376 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -82.34 6.65 16.32 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.821 1.249 . . . . 0.0 112.931 173.696 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 32.9 m -134.41 -15.09 2.2 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.385 1.474 . . . . 0.0 114.223 -170.19 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.6 t -152.27 -31.0 0.15 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.924 0.783 . . . . 0.0 112.885 179.056 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -86.24 -12.3 50.04 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 118.83 -0.605 . . . . 0.0 112.624 -177.247 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -63.84 -61.15 2.48 Favored 'General case' 0 C--N 1.346 0.437 0 C-N-CA 123.744 0.818 . . . . 0.0 109.916 -178.594 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 24.4 ttp180 37.92 40.72 0.3 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 128.426 2.69 . . . . 0.0 115.598 170.794 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 16.4 ttpp -147.94 -13.2 0.37 Allowed 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -177.258 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 3.8 tmtm? -146.93 33.49 0.92 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.515 1.126 . . . . 0.0 111.238 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.252 1.217 0 C-N-CA 127.715 2.406 . . . . 0.0 112.176 178.898 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 15.1 tpt . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -145.33 114.87 7.2 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.734 0.814 . . . . 0.0 109.654 -168.798 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 18.8 ptp -157.55 123.04 2.38 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 124.6 1.16 . . . . 0.0 109.12 171.826 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -82.3 9.13 4.13 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.9 3.066 . . . . 0.0 113.114 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 4.3 m -138.19 145.07 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 C-N-CA 126.523 1.929 . . . . 0.0 109.078 -173.068 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -67.49 160.51 71.83 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 126.181 1.793 . . . . 0.0 111.97 175.73 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.31 3.52 4.05 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 123.439 2.759 . . . . 0.0 112.33 168.268 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -109.63 37.27 2.68 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.021 2.128 . . . . 0.0 110.33 -177.769 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -136.46 115.13 10.62 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 125.859 1.663 . . . . 0.0 107.927 -171.273 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -70.27 159.34 53.36 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.975 2.45 . . . . 0.0 111.87 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 72.0 p -143.18 174.42 10.72 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.834 1.254 . . . . 0.0 110.613 -173.204 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -135.27 -79.17 0.44 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 117.389 -1.291 . . . . 0.0 113.312 -171.329 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.5 t -56.64 168.61 0.57 Allowed 'General case' 0 C--N 1.349 0.574 0 C-N-CA 124.998 1.319 . . . . 0.0 113.374 -174.823 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 4.3 pp -59.17 -11.81 4.34 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.439 1.096 . . . . 0.0 112.744 169.299 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 73.4 m -76.09 -24.39 55.03 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.649 1.98 . . . . 0.0 112.927 173.483 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 55.04 69.57 0.72 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 127.218 2.207 . . . . 0.0 111.621 -170.063 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.48 163.61 25.53 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.556 1.542 . . . . 0.0 111.557 173.344 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.513 HG12 ' H ' ' A' ' 205' ' ' SER . 0.4 OUTLIER -68.88 -179.44 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 125.694 1.597 . . . . 0.0 111.427 -176.738 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.513 ' H ' HG12 ' A' ' 204' ' ' VAL . 83.6 p -47.61 153.37 0.57 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.587 2.355 . . . . 0.0 114.592 178.461 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -154.49 167.47 29.95 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.278 1.831 . . . . 0.0 110.395 -169.062 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -77.93 -39.5 23.95 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 118.673 -1.07 . . . . 0.0 115.224 -168.697 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.65 118.93 19.75 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.614 1.207 . . . . 0.0 110.199 -168.49 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -141.81 152.29 43.56 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -164.282 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 15.2 tt -147.84 152.54 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 126.055 1.742 . . . . 0.0 109.859 168.168 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -132.44 146.66 18.37 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 124.118 0.866 . . . . 0.0 112.04 -169.819 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 4.2 t -70.48 144.08 51.52 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-O 122.016 0.913 . . . . 0.0 111.368 -172.158 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -78.91 -8.54 58.95 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.265 1.826 . . . . 0.0 113.686 -174.536 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -77.28 146.1 73.81 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-N 118.533 0.606 . . . . 0.0 111.933 -168.361 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.4 8.83 2.76 Favored 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 124.135 3.223 . . . . 0.0 112.372 169.047 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -132.69 -8.19 3.19 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.365 1.866 . . . . 0.0 112.191 -170.478 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 39.0 t -62.97 136.12 57.67 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.956 0.902 . . . . 0.0 109.864 172.585 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.9 t -121.24 14.31 11.28 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.885 1.674 . . . . 0.0 111.062 -176.003 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 35.9 mm -119.6 -32.67 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 126.646 1.978 . . . . 0.0 109.235 175.41 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 51.26 -16.52 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.664 1 C-N-CA 132.007 4.123 . . . . 0.0 119.292 174.702 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 55.0 m95 -141.93 151.51 42.66 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.843 1.657 . . . . 0.0 110.468 179.007 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -153.68 154.86 34.92 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.103 1.361 . . . . 0.0 110.152 -172.265 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 1.5 m-70 -77.18 147.65 36.36 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 169.767 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -54.75 -49.53 70.63 Favored 'General case' 0 C--O 1.222 -0.342 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.928 167.665 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -68.6 -16.14 63.76 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -179.551 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 2.6 m -76.66 -18.37 58.6 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 119.866 1.212 . . . . 0.0 112.616 174.787 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.8 p -105.5 -14.49 8.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 124.913 1.285 . . . . 0.0 111.524 168.686 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 92.58 20.88 33.22 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.786 1.66 . . . . 0.0 113.378 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 10.1 mt -74.91 157.61 34.74 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 118.738 1.269 . . . . 0.0 111.35 178.508 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 50.0 m -127.76 -9.55 5.55 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.34 1.856 . . . . 0.0 110.265 179.422 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 77.3 p -140.91 178.05 7.62 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.786 2.035 . . . . 0.0 109.427 179.143 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -110.94 107.21 57.81 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 124.1 0.96 . . . . 0.0 108.926 178.145 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -71.28 176.46 7.87 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.547 2.831 . . . . 0.0 111.848 175.547 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.14 133.22 36.99 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.042 1.337 . . . . 0.0 108.256 -175.123 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 107.41 -162.8 13.23 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.413 1.482 . . . . 0.0 111.464 -174.657 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -61.25 127.18 30.25 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.0 1.32 . . . . 0.0 109.195 173.731 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -132.26 149.18 52.43 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.397 1.879 . . . . 0.0 109.118 178.377 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -128.68 130.29 46.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.116 1.366 . . . . 0.0 109.994 -174.152 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.26 167.41 10.23 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.411 175.211 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.66 -37.49 16.34 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 120.907 1.071 . . . . 0.0 111.972 -174.051 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 64.9 mtp85 -72.84 1.89 7.77 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.063 1.345 . . . . 0.0 113.084 176.073 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 9.2 m -120.13 -13.9 8.9 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.401 1.481 . . . . 0.0 114.328 -175.041 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 33.3 t -151.92 -38.52 0.12 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.545 1.066 . . . . 0.0 113.12 176.552 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -73.62 -27.88 61.51 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.372 0.669 . . . . 0.0 112.174 -178.68 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -78.6 2.07 20.55 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.97 1.308 . . . . 0.0 112.834 -174.702 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 30.2 ttp-105 -52.05 -44.42 64.25 Favored 'General case' 0 C--N 1.347 0.486 0 C-N-CA 125.088 1.355 . . . . 0.0 112.409 179.106 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? 29.84 61.11 0.18 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 128.182 2.593 . . . . 0.0 114.386 169.787 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 82.7 tttt 55.94 73.36 0.44 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.863 1.665 . . . . 0.0 112.267 -173.513 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 85.4 tttt . . . . . 0 C--O 1.25 1.127 0 C-N-CA 127.894 2.478 . . . . 0.0 113.774 -179.423 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 N--CA 1.476 0.848 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -143.62 129.41 19.36 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.874 0.87 . . . . 0.0 109.637 -169.02 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 18.1 ptm -154.67 106.15 2.34 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.782 1.233 . . . . 0.0 108.733 177.454 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -78.98 15.72 1.46 Allowed 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 124.019 3.146 . . . . 0.0 112.81 178.826 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 11.3 m -137.65 147.34 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 C-N-CA 127.415 2.286 . . . . 0.0 108.264 -174.102 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -70.66 157.16 90.79 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 125.107 1.363 . . . . 0.0 111.738 176.509 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -72.43 -0.19 8.37 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 123.329 2.686 . . . . 0.0 112.219 168.188 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -105.29 58.26 0.68 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 127.061 2.145 . . . . 0.0 109.069 -178.598 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -135.62 132.82 19.83 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 125.186 1.394 . . . . 0.0 108.491 -170.517 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -76.12 168.05 24.79 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.874 2.383 . . . . 0.0 113.135 -170.538 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 33.8 p -140.99 175.14 9.86 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.36 1.864 . . . . 0.0 108.97 178.46 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -135.36 -68.71 0.51 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.842 0.857 . . . . 0.0 111.166 176.022 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.432 ' SG ' ' HB2' ' A' ' 201' ' ' CYS . 5.5 p -53.74 163.71 0.66 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 128.352 2.661 . . . . 0.0 114.089 177.253 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.0 pp -77.17 -1.5 29.68 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.781 167.86 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 201' ' ' CYS . . . . . 0.432 ' HB2' ' SG ' ' A' ' 199' ' ' CYS . 78.2 m -75.19 -28.73 60.13 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.942 0.897 . . . . 0.0 110.207 168.551 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . 0.297 88.3 m-70 70.48 54.72 0.29 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 127.727 2.411 . . . . 0.0 113.309 169.605 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -137.3 172.88 12.33 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 114.559 -1.201 . . . . 0.0 109.484 166.726 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.421 HG12 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -62.67 173.88 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 125.116 1.366 . . . . 0.0 111.803 -174.961 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.421 ' H ' HG12 ' A' ' 204' ' ' VAL . 87.7 p -50.62 158.58 0.62 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.73 2.012 . . . . 0.0 114.889 -173.793 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -139.85 161.22 38.1 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.016 1.726 . . . . 0.0 110.708 -169.118 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -64.14 -35.76 92.39 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.449 1.023 . . . . 0.0 113.838 -171.651 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.63 118.48 17.24 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 124.495 1.118 . . . . 0.0 109.289 -170.74 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 1.2 mtm -134.36 149.58 50.85 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.203 -0.908 . . . . 0.0 113.402 -166.096 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 21.3 tt -139.71 145.5 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 C-N-CA 125.758 1.623 . . . . 0.0 110.544 169.987 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -124.91 139.54 11.78 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.873 1.225 . . . . 0.0 112.732 -170.429 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 212' ' ' CYS . . . . . 0.597 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 2.8 m -78.27 124.93 28.64 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 126.078 1.751 . . . . 0.0 111.664 -167.715 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -70.43 -2.77 14.82 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.064 1.745 . . . . 0.0 113.467 -176.898 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -62.72 149.07 90.15 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 123.724 0.81 . . . . 0.0 111.598 -174.704 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -81.23 6.75 5.39 Favored 'Trans proline' 0 CA--C 1.548 1.2 0 C-N-CA 123.491 2.794 . . . . 0.0 111.798 167.464 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -146.37 -8.85 0.51 Allowed 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -167.75 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 37.3 t -61.35 134.35 56.84 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-N 119.866 1.212 . . . . 0.0 110.851 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 27.1 m -108.14 7.67 27.68 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.647 1.579 . . . . 0.0 111.657 -173.155 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 39.1 mm -116.33 -42.22 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 125.668 1.587 . . . . 0.0 108.536 175.007 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 48.7 -9.62 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 131.509 3.924 . . . . 0.0 119.49 171.191 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 50.2 m95 -140.15 140.46 35.96 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.94 2.096 . . . . 0.0 109.662 169.632 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 222' ' ' PHE . . . . . 0.597 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 6.8 m-85 -147.71 155.18 41.47 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.936 1.694 . . . . 0.0 108.604 -169.481 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -68.68 150.39 47.99 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 166.245 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -53.64 -48.06 69.72 Favored 'General case' 0 C--O 1.223 -0.334 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 166.786 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -68.55 -15.13 63.43 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 178.625 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 8.7 t -68.93 -24.71 64.32 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.075 0.852 . . . . 0.0 112.261 174.205 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.3 p -106.61 -15.8 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.787 1.635 . . . . 0.0 112.119 171.204 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 97.05 17.66 31.6 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.956 1.741 . . . . 0.0 113.487 178.897 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 16.8 mt -72.91 158.5 35.38 Favored 'General case' 0 C--N 1.345 0.411 0 CA-C-N 119.093 1.446 . . . . 0.0 111.543 178.527 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.5 t -135.86 -0.53 2.55 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.153 1.781 . . . . 0.0 111.794 179.408 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 40.1 p -143.41 162.18 36.45 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.056 2.142 . . . . 0.0 109.279 175.43 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -98.05 114.42 65.08 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 123.811 0.844 . . . . 0.0 109.613 178.043 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -78.24 179.02 6.89 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 123.758 2.972 . . . . 0.0 111.531 175.502 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 15.3 ttm180 -139.36 135.32 33.59 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.028 1.331 . . . . 0.0 107.489 169.685 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 117.14 -166.84 12.52 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.314 1.435 . . . . 0.0 111.476 -176.573 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -65.88 120.58 13.32 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.629 1.172 . . . . 0.0 110.128 177.028 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 70.0 t90 -129.27 137.66 51.19 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 126.111 1.764 . . . . 0.0 108.984 174.195 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -125.97 125.14 42.23 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.778 1.231 . . . . 0.0 108.681 -178.027 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 239' ' ' CYS . . . . . 0.442 ' HB2' ' HD2' ' A' ' 240' ' ' PRO . 2.9 p -59.18 171.97 0.64 Allowed Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 127.7 2.4 . . . . 0.0 114.412 -172.429 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 240' ' ' PRO . . . . . 0.442 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 43.1 Cg_endo -68.3 -23.43 38.59 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 121.761 1.641 . . . . 0.0 113.913 -169.628 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -92.41 12.65 22.0 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.645 1.178 . . . . 0.0 112.583 174.86 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 27.6 m -131.7 -14.21 3.22 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.018 1.727 . . . . 0.0 113.397 -176.664 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 32.4 t -149.69 -40.1 0.14 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.838 0.855 . . . . 0.0 112.012 178.618 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -77.63 -13.71 59.83 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -175.041 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -65.81 -12.43 54.17 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.996 0.918 . . . . 0.0 112.863 171.604 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -75.12 76.91 2.28 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.225 1.41 . . . . 0.0 110.032 172.957 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -151.25 -37.38 0.13 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.099 1.36 . . . . 0.0 111.015 178.274 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -77.38 116.41 17.95 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.825 0.85 . . . . 0.0 109.261 175.894 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? . . . . . 0 C--O 1.252 1.223 0 C-N-CA 126.876 2.07 . . . . 0.0 112.077 -175.041 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 63.4 mtt . . . . . 0 N--CA 1.474 0.757 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -155.02 166.59 33.12 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.236 1.414 . . . . 0.0 110.199 -175.46 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.74 154.51 30.33 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 124.523 1.129 . . . . 0.0 110.707 -176.069 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -81.16 32.54 0.52 Allowed 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 124.647 3.565 . . . . 0.0 112.987 -178.459 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.23 140.19 24.54 Favored 'Isoleucine or valine' 0 C--N 1.342 0.255 0 C-N-CA 125.02 1.328 . . . . 0.0 109.592 -179.599 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -71.98 157.98 88.51 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 126.003 1.721 . . . . 0.0 112.237 -177.102 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -72.32 -0.05 8.11 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 123.7 2.933 . . . . 0.0 112.993 169.643 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -71.04 79.63 0.66 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.82 2.048 . . . . 0.0 110.374 176.571 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -151.78 137.25 10.95 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 125.134 1.374 . . . . 0.0 108.627 -170.443 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.75 154.87 54.24 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.859 2.373 . . . . 0.0 112.229 -177.984 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 33.4 p -145.28 173.96 11.52 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.924 1.689 . . . . 0.0 109.308 -178.087 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -135.83 -72.79 0.46 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.952 0.901 . . . . 0.0 112.392 -176.829 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 199' ' ' CYS . . . . . 0.424 ' SG ' ' HB2' ' A' ' 201' ' ' CYS . 2.6 p -51.62 163.6 0.28 Allowed 'General case' 0 C--N 1.339 0.111 0 C-N-CA 129.342 3.057 . . . . 0.0 114.627 176.203 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 4.1 pp -69.5 -7.62 39.73 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.982 167.352 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 201' ' ' CYS . . . . . 0.424 ' HB2' ' SG ' ' A' ' 199' ' ' CYS . 83.3 m -77.06 -30.39 55.52 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.59 1.156 . . . . 0.0 111.017 172.488 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . 0.291 89.2 m-70 69.14 57.93 0.36 Allowed 'General case' 0 C--N 1.339 0.15 0 C-N-CA 127.487 2.315 . . . . 0.0 113.267 169.809 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -136.42 171.61 14.22 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 114.119 -1.401 . . . . 0.0 109.427 166.398 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 204' ' ' VAL . . . . . 0.488 HG12 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -64.23 175.71 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 125.093 1.357 . . . . 0.0 111.939 -175.311 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 205' ' ' SER . . . . . 0.488 ' H ' HG12 ' A' ' 204' ' ' VAL . 20.1 m -45.19 154.42 0.16 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 128.128 2.571 . . . . 0.0 115.245 -173.53 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -142.08 158.45 43.74 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.107 1.763 . . . . 0.0 110.037 -173.569 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -62.66 -36.34 93.13 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.188 0.899 . . . . 0.0 114.08 -169.801 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.96 117.95 15.31 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 124.446 1.098 . . . . 0.0 109.742 -170.354 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 1.4 mtm -136.33 150.4 48.84 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.257 -0.883 . . . . 0.0 113.107 -166.801 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 13.1 tt -146.68 149.65 15.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 126.363 1.865 . . . . 0.0 110.077 169.38 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -134.02 147.23 18.99 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 124.063 0.84 . . . . 0.0 112.767 -169.538 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 3.0 t -70.8 143.69 51.07 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-O 121.893 0.854 . . . . 0.0 111.073 -173.128 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -83.9 -6.03 59.34 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 113.529 -1.669 . . . . 0.0 113.252 -174.261 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 5.7 m120 -73.98 147.61 86.22 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 118.589 0.631 . . . . 0.0 111.696 -168.701 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -75.78 8.9 2.5 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 124.116 3.211 . . . . 0.0 112.554 169.343 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -135.25 -6.7 2.3 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.107 1.763 . . . . 0.0 112.327 -170.044 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.7 t -62.98 136.03 57.62 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.035 0.934 . . . . 0.0 110.01 172.998 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 11.8 t -118.9 12.79 12.97 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.771 1.629 . . . . 0.0 111.202 -175.846 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 25.5 mm -122.14 -32.18 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 126.065 1.746 . . . . 0.0 109.608 177.491 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 50.49 -11.29 0.0 OUTLIER 'General case' 0 C--N 1.349 0.576 0 C-N-CA 131.065 3.746 . . . . 0.0 119.131 177.359 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 52.4 m95 -145.59 156.09 43.46 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.768 1.627 . . . . 0.0 111.417 179.403 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -158.81 155.4 27.81 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 126.716 2.006 . . . . 0.0 109.081 -175.402 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 51.4 m80 -70.8 151.35 44.91 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 166.932 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -55.47 -47.06 76.69 Favored 'General case' 0 C--O 1.223 -0.29 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 166.592 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -66.73 -14.21 62.28 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 177.504 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 2.6 t -67.09 -31.29 71.68 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.24 0.927 . . . . 0.0 112.106 174.016 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.4 p -101.28 -14.41 8.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 125.964 1.705 . . . . 0.0 112.216 171.665 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 89.81 22.57 35.85 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.697 1.618 . . . . 0.0 113.256 -178.967 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 8.8 mt -69.83 157.94 36.43 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-N 118.886 1.343 . . . . 0.0 111.59 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 74.7 p -128.36 -1.9 5.62 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.047 1.739 . . . . 0.0 111.605 -178.252 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 11.3 t -152.76 170.16 20.98 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.151 1.78 . . . . 0.0 109.578 178.923 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -97.92 110.49 55.84 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.25 1.02 . . . . 0.0 108.876 175.231 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -71.34 -176.23 1.85 Allowed 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 124.016 3.144 . . . . 0.0 111.788 174.148 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -142.85 135.4 27.67 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.606 1.162 . . . . 0.0 108.668 -176.048 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 93.82 -172.52 32.63 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 125.041 1.305 . . . . 0.0 111.452 -170.917 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.36 136.02 49.64 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.926 1.291 . . . . 0.0 111.716 176.425 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 61.6 t90 -139.9 153.11 46.89 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 127.15 2.18 . . . . 0.0 108.972 -177.813 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -128.69 130.7 47.52 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.86 1.264 . . . . 0.0 110.048 -173.303 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -66.27 169.1 7.83 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.839 1.256 . . . . 0.0 112.985 -177.131 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.9 0.72 8.95 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.479 2.12 . . . . 0.0 114.65 -171.412 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 81.8 mtt-85 -128.68 24.31 5.76 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.835 1.254 . . . . 0.0 110.541 168.741 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 11.6 m -123.79 -17.13 6.45 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 126.494 1.918 . . . . 0.0 112.059 171.974 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 36.8 t -150.92 -32.03 0.17 Allowed 'General case' 0 C--N 1.348 0.529 0 CA-C-N 119.477 1.035 . . . . 0.0 113.316 173.418 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -70.58 -18.42 62.9 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 118.969 0.804 . . . . 0.0 112.462 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -70.35 -5.68 29.84 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 172.082 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 46.9 ttm-85 -60.19 -22.23 62.7 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 119.22 0.918 . . . . 0.0 112.228 169.56 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -112.48 -81.19 0.59 Allowed 'General case' 0 C--N 1.343 0.283 0 C-N-CA 124.365 1.066 . . . . 0.0 108.191 -179.792 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -168.81 142.78 3.06 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.004 1.721 . . . . 0.0 108.001 173.143 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.172 0 CA-C-O 116.578 -1.677 . . . . 0.0 110.625 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo . . . . . 0 CA--C 1.535 0.546 0 CA-C-O 121.054 0.356 . . . . 0.0 111.593 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 81.7 p -129.35 173.86 10.15 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.091 1.356 . . . . 0.0 110.559 -171.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -133.56 -81.97 0.47 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 117.464 -1.255 . . . . 0.0 113.283 -168.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.3 t -55.53 166.65 0.61 Allowed 'General case' 0 C--N 1.35 0.607 0 C-N-CA 124.996 1.318 . . . . 0.0 112.814 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 4.1 pp -58.86 -11.45 3.3 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.695 1.198 . . . . 0.0 112.806 170.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 73.6 m -76.38 -19.48 58.12 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.501 1.92 . . . . 0.0 113.042 175.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 17.0 m170 57.75 62.07 2.22 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.846 2.059 . . . . 0.0 111.56 -173.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.5 162.42 25.67 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.337 1.455 . . . . 0.0 112.277 176.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -66.77 179.92 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 125.912 1.685 . . . . 0.0 112.367 -176.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 87.4 p -49.04 153.48 0.9 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.195 2.198 . . . . 0.0 113.913 175.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -158.24 170.84 21.36 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.7 1.6 . . . . 0.0 110.761 -167.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -77.2 -62.35 2.47 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 119.196 -0.78 . . . . 0.0 113.569 -170.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -105.89 121.87 44.95 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 117.815 0.808 . . . . 0.0 110.63 -172.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -143.88 145.89 32.62 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -167.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 15.6 tt -142.64 154.28 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.412 1.485 . . . . 0.0 109.28 169.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -133.25 144.99 17.07 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 123.727 0.68 . . . . 0.0 112.242 -169.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 11.9 t -67.99 145.92 54.05 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-O 122.036 0.922 . . . . 0.0 110.467 -174.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -94.4 2.46 55.78 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 113.509 -1.678 . . . . 0.0 112.694 -171.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -77.63 147.06 74.23 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 119.172 0.896 . . . . 0.0 110.473 177.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -76.71 8.07 3.23 Favored 'Trans proline' 0 CA--C 1.547 1.14 0 C-N-CA 123.542 2.828 . . . . 0.0 111.775 167.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -127.46 -6.77 5.81 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.344 1.857 . . . . 0.0 112.436 -171.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 37.9 t -64.45 131.22 46.52 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.651 0.78 . . . . 0.0 109.742 175.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.7 t -109.15 9.72 26.06 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.42 1.488 . . . . 0.0 111.743 -173.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 32.7 mm -121.95 -31.92 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 126.058 1.743 . . . . 0.0 109.677 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 51.6 -15.7 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 131.318 3.847 . . . . 0.0 119.327 175.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 58.1 m95 -139.04 151.04 46.47 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.713 1.605 . . . . 0.0 110.578 178.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -152.95 152.69 31.73 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.175 1.39 . . . . 0.0 110.233 -171.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -76.28 149.4 37.12 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.407 -0.815 . . . . 0.0 108.959 169.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 8.9 m-30 -52.31 -51.2 60.0 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.829 167.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.82 -14.08 62.28 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 118.361 -0.828 . . . . 0.0 113.2 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 9.4 m -79.04 -2.42 40.3 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 119.586 1.085 . . . . 0.0 112.511 172.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 1.2 p -126.61 -14.08 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.32 1.448 . . . . 0.0 112.456 169.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 97.16 20.33 23.54 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 125.485 1.517 . . . . 0.0 113.642 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 10.9 mt -75.41 160.31 30.39 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.803 1.301 . . . . 0.0 111.544 178.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 38.4 m -132.31 -10.74 3.26 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.288 1.835 . . . . 0.0 110.648 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 77.5 p -142.27 -174.88 4.24 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.798 2.039 . . . . 0.0 109.15 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -120.92 98.66 47.46 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 123.856 0.862 . . . . 0.0 110.451 -176.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -70.94 170.68 17.4 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.685 2.257 . . . . 0.0 111.002 169.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 -141.74 133.54 27.22 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.716 1.206 . . . . 0.0 108.492 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 129.85 -163.57 22.8 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 126.022 1.772 . . . . 0.0 110.85 -174.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -61.8 115.63 4.16 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.109 0.963 . . . . 0.0 109.284 169.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 53.0 t90 -132.93 142.7 49.03 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.31 1.844 . . . . 0.0 107.825 175.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -125.49 139.37 53.69 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.154 0.981 . . . . 0.0 110.801 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . 0.4 ' HB2' ' HD2' ' A' ' 240' ' ' PRO . 7.4 p -71.46 173.36 5.22 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 125.888 1.675 . . . . 0.0 111.888 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 68.8 Cg_endo -70.31 -33.2 14.94 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 121.217 1.278 . . . . 0.0 113.655 -168.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -75.13 -4.72 40.35 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 173.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 22.2 m -112.99 -17.95 12.33 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.745 1.218 . . . . 0.0 113.459 -171.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 22.1 t -152.94 -35.18 0.11 Allowed 'General case' 0 C--N 1.343 0.303 0 CA-C-N 119.093 0.861 . . . . 0.0 113.294 177.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -72.41 -14.59 61.74 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 118.23 0.468 . . . . 0.0 112.164 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 . . . . . 0 CA--C 1.542 0.664 0 C-N-CA 124.494 1.117 . . . . 0.0 111.804 177.323 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo . . . . . 0 CA--C 1.535 0.548 0 CA-C-O 121.755 0.648 . . . . 0.0 112.77 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 34.2 p -142.83 175.32 9.91 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.116 1.766 . . . . 0.0 109.223 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -136.3 -67.34 0.52 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.995 0.918 . . . . 0.0 111.573 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.438 ' SG ' ' HB2' ' A' ' 201' ' ' CYS . 4.5 p -56.71 163.72 1.76 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 128.388 2.675 . . . . 0.0 113.811 176.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.3 pp -77.02 -1.13 27.31 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.865 -1.062 . . . . 0.0 111.704 167.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . 0.438 ' HB2' ' SG ' ' A' ' 199' ' ' CYS . 77.0 m -75.45 -29.16 59.56 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.943 0.897 . . . . 0.0 110.2 168.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . 0.302 89.1 m-70 71.1 54.69 0.23 Allowed 'General case' 0 C--N 1.342 0.255 0 C-N-CA 127.619 2.367 . . . . 0.0 113.689 169.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -137.49 172.69 12.6 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.617 166.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.409 HG23 ' H ' ' A' ' 204' ' ' VAL . 0.2 OUTLIER -63.16 174.37 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 125.189 1.396 . . . . 0.0 111.877 -175.384 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.409 ' H ' HG12 ' A' ' 204' ' ' VAL . 83.5 p -47.81 156.71 0.31 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.935 2.094 . . . . 0.0 115.063 -174.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -144.36 163.49 33.59 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.477 1.511 . . . . 0.0 111.101 -168.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -61.5 -40.7 99.05 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.851 1.215 . . . . 0.0 114.702 -169.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -130.54 122.91 28.44 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.115 0.966 . . . . 0.0 110.355 -173.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 1.4 mtm -139.69 144.5 37.6 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -167.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 21.2 tt -136.82 146.37 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 125.605 1.562 . . . . 0.0 110.232 171.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -124.2 139.54 12.01 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.573 1.082 . . . . 0.0 112.819 -170.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . 0.597 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 4.5 m -76.09 125.09 28.49 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 125.746 1.618 . . . . 0.0 111.441 -168.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -74.54 4.59 5.84 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.718 1.607 . . . . 0.0 113.21 -177.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -69.13 148.19 97.62 Favored Pre-proline 0 CA--C 1.538 0.51 0 O-C-N 121.29 -0.881 . . . . 0.0 111.018 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -81.36 3.85 7.47 Favored 'Trans proline' 0 CA--C 1.549 1.253 0 C-N-CA 123.2 2.6 . . . . 0.0 111.666 166.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -134.67 -10.42 2.41 Favored 'General case' 0 C--N 1.35 0.61 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 -169.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 36.9 t -64.13 135.28 56.2 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 119.438 1.017 . . . . 0.0 110.811 -177.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.7 t -110.97 10.9 22.2 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.779 1.632 . . . . 0.0 111.498 -173.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 36.5 mm -117.19 -42.46 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 125.263 1.425 . . . . 0.0 108.581 171.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 49.8 -10.18 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 131.068 3.747 . . . . 0.0 119.309 172.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -139.14 140.96 38.05 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 127.051 2.14 . . . . 0.0 109.913 169.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . 0.597 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 8.4 m-85 -147.45 150.83 35.36 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.81 1.644 . . . . 0.0 108.866 -169.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -66.01 153.2 42.83 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 166.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -52.7 -49.41 65.4 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 166.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -69.43 -12.81 61.96 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 1.8 t -68.17 -14.91 63.33 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.752 0.705 . . . . 0.0 112.71 171.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 6.4 p -126.55 -10.11 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 126.479 1.912 . . . . 0.0 112.539 174.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 91.76 20.26 37.69 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.623 1.582 . . . . 0.0 113.469 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 5.9 mt -69.57 160.7 31.02 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.643 1.222 . . . . 0.0 112.018 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 96.9 m -139.35 -29.21 0.75 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.163 1.385 . . . . 0.0 111.307 -174.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 88.0 m -140.96 123.59 16.04 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 125.117 1.367 . . . . 0.0 107.582 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -65.9 121.66 76.99 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 123.96 0.904 . . . . 0.0 111.712 -169.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -78.77 -174.96 2.49 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 124.253 3.302 . . . . 0.0 111.228 170.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 3.1 ttp85 -145.53 151.41 38.1 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.794 1.238 . . . . 0.0 108.811 170.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 94.99 -155.88 21.64 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.817 1.199 . . . . 0.0 111.48 -177.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -57.21 108.92 0.58 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.526 1.53 . . . . 0.0 110.952 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . 0.457 ' HZ3' ' HG ' ' A' ' 212' ' ' CYS . 65.7 t90 -131.06 129.2 41.65 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 126.049 1.739 . . . . 0.0 107.952 169.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -117.75 126.1 51.84 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . 0.469 ' HB3' ' SG ' ' A' ' 212' ' ' CYS . 3.3 p -58.46 171.87 0.56 Allowed Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 127.689 2.396 . . . . 0.0 113.876 -173.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.444 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 37.0 Cg_endo -66.19 -33.78 38.74 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 121.323 1.349 . . . . 0.0 112.767 -170.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 66.7 mtt180 -79.06 9.19 4.62 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.805 1.242 . . . . 0.0 112.785 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 27.6 m -131.05 -12.21 3.66 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.216 1.806 . . . . 0.0 114.1 -174.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 33.2 t -152.79 -39.59 0.1 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.882 0.873 . . . . 0.0 112.388 178.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -77.89 -13.34 59.92 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -175.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 . . . . . 0 CA--C 1.538 0.488 0 C-N-CA 123.773 0.829 . . . . 0.0 112.654 172.273 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo . . . . . 0 CA--C 1.535 0.535 0 CA-C-O 120.972 0.322 . . . . 0.0 111.632 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 62.9 p -145.47 174.07 11.46 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.703 1.201 . . . . 0.0 110.502 -175.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -137.51 -80.93 0.36 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.639 -169.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 1.8 t -56.58 167.14 0.77 Allowed 'General case' 0 C--N 1.351 0.649 0 C-N-CA 124.543 1.137 . . . . 0.0 112.942 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.0 pp -58.3 -11.97 3.25 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.031 1.332 . . . . 0.0 112.759 171.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 71.4 m -76.34 -20.43 57.24 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.552 1.941 . . . . 0.0 113.166 176.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 50.8 m170 56.71 65.99 1.28 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.855 2.062 . . . . 0.0 111.585 -170.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.93 157.65 41.03 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.029 1.332 . . . . 0.0 112.338 174.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.513 HG12 ' H ' ' A' ' 205' ' ' SER . 0.7 OUTLIER -67.92 -178.89 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 126.292 1.837 . . . . 0.0 111.113 -177.858 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.513 ' H ' HG12 ' A' ' 204' ' ' VAL . 87.9 p -45.57 149.83 0.54 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 127.47 2.308 . . . . 0.0 113.827 178.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . 0.469 ' CE2' ' HG2' ' A' ' 209' ' ' MET . 16.3 p90 -154.34 165.62 35.77 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.22 1.408 . . . . 0.0 111.077 -167.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -74.91 -41.54 32.88 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 118.511 -1.16 . . . . 0.0 115.204 -168.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -126.35 120.3 29.52 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 118.582 1.191 . . . . 0.0 110.506 -169.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . 0.469 ' HG2' ' CE2' ' A' ' 206' ' ' TYR . 3.1 mtp -139.74 149.2 43.32 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -165.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 15.2 tt -137.79 155.61 30.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 CA-C-N 113.768 -1.56 . . . . 0.0 109.553 168.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -133.04 138.87 10.47 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.698 1.142 . . . . 0.0 112.51 -171.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . 0.591 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 1.6 m -79.3 126.21 30.5 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.554 1.542 . . . . 0.0 112.311 -167.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -69.67 -1.85 10.13 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.776 2.03 . . . . 0.0 113.718 -176.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -66.56 148.86 98.52 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 123.717 0.807 . . . . 0.0 111.827 -174.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -83.34 7.92 4.92 Favored 'Trans proline' 0 CA--C 1.549 1.25 0 C-N-CA 123.661 2.908 . . . . 0.0 111.404 166.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -144.58 -10.43 0.62 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 -167.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 37.3 t -61.58 133.42 55.65 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 119.562 1.074 . . . . 0.0 110.62 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.9 t -107.16 8.54 30.14 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.652 1.581 . . . . 0.0 111.588 -172.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 41.3 mm -117.66 -42.58 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 125.675 1.59 . . . . 0.0 108.735 174.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 46.95 -9.77 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.834 1 C-N-CA 131.706 4.002 . . . . 0.0 119.703 172.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 63.8 m95 -136.85 135.84 38.25 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.652 1.981 . . . . 0.0 109.166 170.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . 0.591 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 7.6 m-85 -141.45 155.86 45.82 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 125.129 1.371 . . . . 0.0 109.074 -169.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -76.22 149.01 37.28 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 169.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -52.39 -50.61 62.13 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.094 167.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.32 -14.59 62.65 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -177.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 9.5 m -79.14 -4.05 48.53 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 119.676 1.126 . . . . 0.0 112.861 172.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.6 p -123.93 -13.84 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 126.049 1.739 . . . . 0.0 112.383 169.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 96.57 17.53 33.23 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.683 1.611 . . . . 0.0 113.206 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 9.6 mt -73.31 162.67 29.09 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.38 1.09 . . . . 0.0 111.606 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.7 t -139.47 -2.79 1.56 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.923 1.689 . . . . 0.0 112.15 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 46.0 p -143.37 179.77 6.89 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.977 2.111 . . . . 0.0 109.61 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -110.89 92.72 15.36 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 124.707 1.203 . . . . 0.0 109.546 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -69.01 164.68 32.85 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.252 1.968 . . . . 0.0 110.295 169.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 47.9 ttp180 -142.47 131.52 23.16 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 122.211 1.005 . . . . 0.0 109.012 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 135.58 -170.56 23.0 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 126.721 2.105 . . . . 0.0 109.886 -169.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -67.53 121.23 15.37 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.709 0.766 . . . . 0.0 109.892 171.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 47.7 t90 -131.41 141.59 49.88 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.793 2.037 . . . . 0.0 108.313 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -125.08 130.74 52.87 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.29 1.036 . . . . 0.0 108.868 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 2.4 p -61.28 167.63 3.8 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 126.089 1.756 . . . . 0.0 112.705 -175.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -65.61 -33.72 44.43 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 121.29 1.326 . . . . 0.0 112.671 -169.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 75.1 mtt-85 -79.43 6.29 10.6 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.137 0.975 . . . . 0.0 113.049 177.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 22.6 m -125.9 -15.38 5.92 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.835 1.654 . . . . 0.0 114.023 -175.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 22.9 t -150.24 -32.51 0.19 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.89 0.768 . . . . 0.0 112.997 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 30.1 tp60 -86.44 -20.62 27.89 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -176.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 . . . . . 0 CA--C 1.54 0.582 0 C-N-CA 124.556 1.142 . . . . 0.0 112.046 -176.204 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo . . . . . 0 CA--C 1.536 0.591 0 CA-C-O 121.615 0.59 . . . . 0.0 112.205 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 44.6 p -141.59 169.83 16.86 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.033 1.733 . . . . 0.0 108.466 174.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -137.83 -55.13 0.67 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -177.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.452 ' SG ' ' HB2' ' A' ' 201' ' ' CYS . 3.6 p -67.48 165.68 16.23 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 128.531 2.732 . . . . 0.0 113.664 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.4 pp -72.11 -4.71 30.58 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.648 166.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . 0.452 ' HB2' ' SG ' ' A' ' 199' ' ' CYS . 74.1 m -80.07 -25.81 39.9 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.867 1.267 . . . . 0.0 111.342 174.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . 0.285 9.9 m-70 71.37 52.01 0.25 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.886 2.074 . . . . 0.0 112.71 169.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -137.41 171.37 14.58 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.22 167.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.416 HG12 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -63.9 174.12 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 125.349 1.459 . . . . 0.0 111.998 -173.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.416 ' H ' HG12 ' A' ' 204' ' ' VAL . 89.4 p -47.57 155.12 0.39 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.339 2.256 . . . . 0.0 115.481 -173.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -145.46 160.41 41.63 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.962 1.705 . . . . 0.0 110.377 -169.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -60.46 -38.77 95.33 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.653 1.12 . . . . 0.0 114.783 -169.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -131.86 121.45 24.08 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.0 0.92 . . . . 0.0 110.722 -171.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 1.4 mtm -138.33 144.92 40.61 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -168.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 21.3 tt -143.33 147.91 19.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 126.358 1.863 . . . . 0.0 109.202 173.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -137.19 145.85 17.68 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 123.698 0.666 . . . . 0.0 113.086 -169.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 6.9 t -72.13 145.3 48.22 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-O 122.234 1.016 . . . . 0.0 111.124 -172.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -77.78 -9.56 59.09 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.648 1.979 . . . . 0.0 113.92 -176.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 56.9 m-20 -76.71 145.91 75.6 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 118.676 0.671 . . . . 0.0 111.782 -169.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.35 8.95 2.69 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 124.072 3.181 . . . . 0.0 112.209 169.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -134.23 -8.8 2.61 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.285 1.834 . . . . 0.0 112.34 -169.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 46.9 t -63.07 125.1 22.9 Favored 'General case' 0 C--N 1.345 0.401 0 C-N-CA 123.52 0.728 . . . . 0.0 109.708 172.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 10.0 t -97.84 1.78 48.59 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.835 1.654 . . . . 0.0 112.014 -172.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 28.3 mm -117.43 -32.03 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 125.949 1.7 . . . . 0.0 109.7 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 50.07 -12.61 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 130.529 3.532 . . . . 0.0 118.985 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 46.3 m95 -141.96 157.18 45.26 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 120.588 1.54 . . . . 0.0 112.104 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -158.72 153.3 24.46 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.203 1.801 . . . . 0.0 109.349 -174.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 62.0 m80 -68.69 155.55 39.88 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 166.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 11.1 m-30 -52.81 -51.11 62.1 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 166.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -68.68 -12.55 61.53 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.893 0.877 . . . . 0.0 113.255 -177.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 1.1 t -67.08 -20.29 65.79 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.488 0.715 . . . . 0.0 112.584 172.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 5.5 p -118.69 -15.48 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 125.971 1.709 . . . . 0.0 112.155 173.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 101.28 16.99 23.55 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.797 1.665 . . . . 0.0 113.665 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 11.7 mt -71.6 166.49 21.74 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.065 1.433 . . . . 0.0 111.652 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 88.2 m -132.42 -14.5 2.91 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.909 1.683 . . . . 0.0 110.828 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 75.9 p -142.03 169.49 17.49 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.996 1.718 . . . . 0.0 109.983 -177.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -98.77 114.4 65.38 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 123.829 0.852 . . . . 0.0 109.13 175.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -75.32 -178.81 4.5 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.991 3.128 . . . . 0.0 110.748 172.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -138.37 129.52 27.19 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.964 0.906 . . . . 0.0 108.868 174.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 123.31 -178.42 16.39 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 125.978 1.752 . . . . 0.0 110.981 -170.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -67.33 137.31 55.94 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 122.298 1.047 . . . . 0.0 110.625 173.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 49.4 t90 -141.89 154.88 45.44 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 127.439 2.296 . . . . 0.0 109.109 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -128.42 132.5 48.46 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.9 1.28 . . . . 0.0 110.487 -174.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 1.8 p -71.47 170.07 13.22 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.045 1.338 . . . . 0.0 112.186 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.79 -15.28 26.82 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 121.789 1.659 . . . . 0.0 114.09 -169.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -96.92 9.25 42.46 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.882 1.673 . . . . 0.0 111.948 173.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 20.0 m -130.65 -18.32 3.13 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.589 1.556 . . . . 0.0 113.637 -172.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 45.1 t -151.17 -38.67 0.13 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.464 1.029 . . . . 0.0 112.746 174.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 33.2 tp60 -69.11 -19.07 64.04 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.131 0.423 . . . . 0.0 112.004 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 . . . . . 0 CA--C 1.541 0.622 0 C-N-CA 126.564 1.946 . . . . 0.0 113.078 177.656 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo . . . . . 0 CA--C 1.534 0.519 0 CA-C-O 121.272 0.447 . . . . 0.0 111.962 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 63.9 p -144.48 175.23 10.28 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.85 1.26 . . . . 0.0 110.452 -173.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -135.19 -81.2 0.43 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 117.436 -1.269 . . . . 0.0 112.992 -169.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -56.02 168.93 0.42 Allowed 'General case' 0 C--N 1.349 0.581 0 C-N-CA 124.887 1.275 . . . . 0.0 113.32 -177.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.9 pp -57.87 -12.14 2.91 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.015 1.326 . . . . 0.0 113.015 169.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 72.1 m -76.62 -23.74 53.38 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 127.002 2.121 . . . . 0.0 113.261 176.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 17.3 m170 58.85 66.44 1.06 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.574 1.949 . . . . 0.0 111.001 -169.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.18 159.44 36.03 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.966 1.306 . . . . 0.0 112.273 174.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.577 HG12 ' H ' ' A' ' 205' ' ' SER . 0.8 OUTLIER -70.96 -177.96 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 C-N-CA 126.186 1.794 . . . . 0.0 111.231 -175.79 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.577 ' H ' HG12 ' A' ' 204' ' ' VAL . 49.6 m -46.83 151.69 0.58 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 128.289 2.636 . . . . 0.0 114.221 -178.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . 0.454 ' CE2' ' HG2' ' A' ' 209' ' ' MET . 11.9 p90 -155.7 162.95 40.46 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.742 1.617 . . . . 0.0 110.819 -168.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -70.59 -47.17 43.14 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-O 118.695 -1.058 . . . . 0.0 114.526 -169.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -127.94 123.0 33.83 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.376 1.088 . . . . 0.0 110.289 -169.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . 0.454 ' HG2' ' CE2' ' A' ' 206' ' ' TYR . 5.1 mtp -135.17 153.63 51.9 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -165.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 18.4 tt -142.94 158.81 18.13 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 C-N-CA 126.799 2.04 . . . . 0.0 108.752 169.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -141.64 143.42 13.04 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 123.564 0.602 . . . . 0.0 111.79 -173.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 4.1 t -71.55 142.32 50.07 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-O 121.674 0.749 . . . . 0.0 111.04 -173.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -75.97 -10.65 59.59 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.682 1.593 . . . . 0.0 114.036 -174.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 18.8 m-20 -78.84 145.04 65.38 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 118.66 0.664 . . . . 0.0 112.064 -167.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -75.64 1.98 7.44 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 123.603 2.869 . . . . 0.0 111.989 168.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -118.77 -6.61 10.58 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.217 1.807 . . . . 0.0 112.224 -175.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 39.0 t -64.91 136.86 57.32 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.305 1.042 . . . . 0.0 109.682 173.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 8.5 t -121.05 12.4 11.13 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.805 1.642 . . . . 0.0 111.202 -175.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 36.4 mm -119.98 -32.88 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 126.206 1.802 . . . . 0.0 109.383 175.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 50.83 -16.27 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.687 1 C-N-CA 131.769 4.028 . . . . 0.0 119.309 175.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 61.5 m95 -140.86 150.81 43.73 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 125.549 1.54 . . . . 0.0 110.188 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -154.31 154.44 33.37 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.288 1.435 . . . . 0.0 110.278 -170.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -79.07 143.92 35.11 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 168.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -51.67 -50.07 61.13 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.337 167.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -68.88 -13.93 62.72 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.747 1.018 . . . . 0.0 113.747 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.38 -21.94 59.42 Favored 'General case' 0 C--N 1.349 0.55 0 CA-C-N 119.942 1.247 . . . . 0.0 112.647 174.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.6 p -104.9 -13.46 9.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 125.604 1.562 . . . . 0.0 111.785 170.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 90.68 20.3 41.02 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.83 1.681 . . . . 0.0 113.24 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 12.9 mt -73.45 157.82 36.12 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 118.873 1.336 . . . . 0.0 111.382 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 69.0 p -131.52 -1.33 3.9 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.293 1.837 . . . . 0.0 111.403 176.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 60.5 p -145.23 175.69 10.09 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.551 2.34 . . . . 0.0 108.956 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -119.13 125.44 27.62 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 123.946 0.899 . . . . 0.0 109.515 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -76.17 -171.09 0.98 Allowed 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 124.513 3.475 . . . . 0.0 111.127 174.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -148.3 138.72 22.75 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.187 0.995 . . . . 0.0 109.34 178.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 102.58 -62.23 0.48 Allowed Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.919 1.723 . . . . 0.0 112.065 173.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -148.74 142.27 25.37 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 125.475 1.51 . . . . 0.0 110.306 -178.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 77.6 t90 -150.73 154.02 36.6 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 126.223 1.809 . . . . 0.0 109.834 171.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -128.42 127.51 42.7 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.054 1.342 . . . . 0.0 109.919 -177.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.62 167.54 10.75 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 124.79 1.236 . . . . 0.0 113.311 -177.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -74.29 -0.65 9.92 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.507 2.138 . . . . 0.0 114.19 -174.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 35.0 mtp180 -123.9 27.39 7.25 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.02 1.328 . . . . 0.0 111.322 168.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 10.3 m -131.67 -14.89 3.16 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 126.357 1.863 . . . . 0.0 112.224 173.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 41.9 t -149.17 -34.82 0.19 Allowed 'General case' 0 C--N 1.345 0.402 0 CA-C-N 118.994 0.815 . . . . 0.0 112.704 174.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -75.27 -12.98 60.39 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -176.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 . . . . . 0 CA--C 1.543 0.676 0 CA-C-N 118.936 0.789 . . . . 0.0 112.75 169.95 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo . . . . . 0 CA--C 1.535 0.553 0 CA-C-O 121.003 0.335 . . . . 0.0 111.693 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 80.4 p -144.41 172.76 12.5 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.767 1.227 . . . . 0.0 110.377 -175.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -136.38 -81.18 0.39 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 117.511 -1.233 . . . . 0.0 113.076 -169.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.8 t -55.43 166.55 0.61 Allowed 'General case' 0 C--N 1.35 0.594 0 C-N-CA 125.161 1.385 . . . . 0.0 112.871 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 4.7 pp -59.52 -9.72 2.78 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.543 1.137 . . . . 0.0 112.873 170.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 73.3 m -77.06 -20.87 55.3 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.694 1.997 . . . . 0.0 113.052 174.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 13.3 m170 59.2 62.55 1.8 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.881 2.072 . . . . 0.0 111.499 -173.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.31 160.43 32.21 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.269 1.428 . . . . 0.0 112.409 176.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.487 HG12 ' H ' ' A' ' 205' ' ' SER . 0.3 OUTLIER -69.2 -179.62 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 126.366 1.866 . . . . 0.0 111.718 -176.325 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.487 ' H ' HG12 ' A' ' 204' ' ' VAL . 80.4 p -45.67 150.16 0.53 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.873 2.469 . . . . 0.0 114.329 178.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . 0.4 ' CE2' ' CD2' ' A' ' 223' ' ' HIS . 10.1 p90 -155.37 168.69 26.28 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.767 1.627 . . . . 0.0 110.875 -167.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -76.04 -43.68 21.04 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 118.676 -1.069 . . . . 0.0 115.101 -168.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -127.73 121.78 31.18 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 118.425 1.113 . . . . 0.0 110.784 -169.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -143.76 146.74 33.36 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -165.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 13.6 tt -143.7 154.9 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 125.8 1.64 . . . . 0.0 109.346 168.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -136.23 147.01 19.0 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 123.741 0.686 . . . . 0.0 112.299 -169.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 6.1 t -70.12 144.47 52.05 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-O 122.179 0.99 . . . . 0.0 111.058 -174.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -79.14 -5.94 55.34 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.763 2.025 . . . . 0.0 113.671 -174.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 60.6 m-20 -82.22 145.48 52.51 Favored Pre-proline 0 CA--C 1.535 0.404 0 CA-C-N 118.81 0.732 . . . . 0.0 111.464 -169.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -76.74 6.28 4.24 Favored 'Trans proline' 0 CA--C 1.547 1.133 0 C-N-CA 123.544 2.829 . . . . 0.0 111.702 167.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -124.18 -9.23 7.61 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.301 1.841 . . . . 0.0 112.502 -172.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 43.9 t -64.92 133.6 52.17 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.239 1.016 . . . . 0.0 109.893 175.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 37.9 m -110.39 8.39 23.25 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.531 1.532 . . . . 0.0 111.845 -174.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 33.3 mm -119.83 -33.06 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 126.256 1.822 . . . . 0.0 109.446 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 50.14 -15.7 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.659 1 C-N-CA 131.757 4.023 . . . . 0.0 119.338 177.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 58.3 m95 -140.47 152.14 45.4 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.795 1.638 . . . . 0.0 110.437 178.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -153.07 154.95 35.91 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.333 1.453 . . . . 0.0 110.015 -173.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . 0.4 ' CD2' ' CE2' ' A' ' 206' ' ' TYR . 19.5 m170 -77.71 149.75 34.56 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 170.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -53.71 -50.75 65.22 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.634 167.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -69.91 -14.82 62.91 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 118.296 -0.859 . . . . 0.0 113.229 -177.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 7.4 m -78.85 -6.46 56.12 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 119.667 1.122 . . . . 0.0 112.858 173.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.3 p -121.17 -12.58 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 125.864 1.666 . . . . 0.0 112.065 169.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 92.96 19.86 35.3 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.524 1.535 . . . . 0.0 113.313 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 6.2 mt -72.51 158.29 36.0 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 118.397 1.098 . . . . 0.0 111.082 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 68.7 p -134.14 1.9 3.28 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.195 1.798 . . . . 0.0 111.263 176.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 81.9 p -142.95 179.89 6.76 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.051 2.141 . . . . 0.0 109.664 -175.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -121.65 89.55 47.63 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 124.603 1.161 . . . . 0.0 109.055 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.65 169.04 18.29 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.801 2.334 . . . . 0.0 111.304 174.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -140.02 133.7 30.39 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 124.917 1.287 . . . . 0.0 108.564 -177.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 126.46 -169.59 18.38 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 126.319 1.914 . . . . 0.0 110.277 -169.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.95 130.4 43.91 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 122.093 0.949 . . . . 0.0 109.195 169.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 53.0 t90 -136.74 146.63 46.03 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 127.072 2.149 . . . . 0.0 108.312 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -129.97 131.65 46.0 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.678 1.191 . . . . 0.0 109.637 -173.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 1.5 p -68.78 166.68 24.9 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 124.27 1.028 . . . . 0.0 112.074 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.37 9.43 2.52 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.539 2.159 . . . . 0.0 114.57 -175.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -122.79 15.93 10.17 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.512 1.925 . . . . 0.0 110.856 171.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 30.1 m -133.19 -22.76 1.98 Allowed 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.962 1.705 . . . . 0.0 113.111 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.1 t -153.71 -34.07 0.11 Allowed 'General case' 0 C--N 1.346 0.426 0 CA-C-N 119.724 1.147 . . . . 0.0 113.501 173.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 10.7 tp60 -76.03 -8.05 56.08 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.928 0.785 . . . . 0.0 112.006 176.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 . . . . . 0 CA--C 1.542 0.645 0 C-N-CA 125.057 1.343 . . . . 0.0 111.628 169.815 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo . . . . . 0 CA--C 1.537 0.639 0 CA-C-O 121.252 0.438 . . . . 0.0 111.431 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 49.0 p -143.31 173.14 11.86 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.573 1.549 . . . . 0.0 109.108 -177.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -139.46 -67.29 0.45 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.83 0.852 . . . . 0.0 111.782 -173.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.438 ' SG ' ' HB2' ' A' ' 201' ' ' CYS . 4.6 p -59.37 165.15 2.89 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 128.484 2.714 . . . . 0.0 113.595 176.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 2.9 pp -77.66 -0.36 26.37 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.595 167.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . 0.438 ' HB2' ' SG ' ' A' ' 199' ' ' CYS . 74.2 m -76.78 -28.22 55.58 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.889 0.875 . . . . 0.0 110.226 168.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . 0.293 93.4 m-70 72.45 52.2 0.17 Allowed 'General case' 0 C--N 1.342 0.242 0 C-N-CA 127.828 2.451 . . . . 0.0 113.84 169.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -136.85 173.61 11.51 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.528 1.131 . . . . 0.0 109.864 166.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.473 HG12 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -62.55 174.49 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 125.238 1.415 . . . . 0.0 111.813 -176.17 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.473 ' H ' HG12 ' A' ' 204' ' ' VAL . 80.5 p -47.94 157.44 0.28 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.516 2.326 . . . . 0.0 114.899 -175.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -142.36 163.2 33.49 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.82 1.648 . . . . 0.0 110.984 -168.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -61.3 -42.31 99.74 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.824 1.202 . . . . 0.0 114.37 -169.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -127.98 124.12 36.47 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.462 1.105 . . . . 0.0 110.116 -178.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 1.6 mtm -138.42 145.63 41.2 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.003 -168.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 21.4 tt -137.06 144.67 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 125.126 1.37 . . . . 0.0 110.53 172.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -120.24 139.68 13.92 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 125.238 1.399 . . . . 0.0 112.241 -171.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . 0.576 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 1.2 m -80.0 123.88 28.21 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.737 1.615 . . . . 0.0 111.451 -167.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.25 14.48 1.19 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.256 1.422 . . . . 0.0 112.458 -175.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -74.23 148.77 86.58 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 124.295 1.038 . . . . 0.0 111.484 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -84.92 8.92 4.37 Favored 'Trans proline' 0 CA--C 1.551 1.347 0 C-N-CA 123.342 2.695 . . . . 0.0 110.944 165.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -134.58 -16.71 2.03 Favored 'General case' 0 C--N 1.351 0.631 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -168.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 28.2 t -65.59 135.6 55.29 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 123.594 0.758 . . . . 0.0 111.119 -172.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 10.2 t -110.77 12.08 22.48 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.726 1.61 . . . . 0.0 111.588 -174.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 34.0 mm -122.06 -40.96 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 125.758 1.623 . . . . 0.0 108.852 174.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 48.36 -7.75 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 131.424 3.89 . . . . 0.0 119.435 172.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 49.3 m95 -140.49 140.31 35.28 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 126.904 2.082 . . . . 0.0 110.211 169.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . 0.576 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 8.4 m-85 -148.93 153.4 37.93 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 125.441 1.496 . . . . 0.0 109.141 -169.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -66.73 151.75 46.81 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 166.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 12.2 m-30 -51.19 -50.82 58.29 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.757 166.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.07 -12.38 61.56 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -178.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 1.9 t -67.63 -18.12 64.85 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.821 0.737 . . . . 0.0 112.588 172.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.4 p -121.3 -15.61 6.8 Favored 'Isoleucine or valine' 0 C--N 1.345 0.396 0 C-N-CA 126.039 1.736 . . . . 0.0 112.396 175.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 102.32 17.33 20.27 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.693 1.616 . . . . 0.0 113.653 178.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 20.3 mt -71.32 158.63 36.01 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.244 1.522 . . . . 0.0 111.414 177.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 71.2 m -136.12 -23.44 1.32 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.727 1.611 . . . . 0.0 111.135 -177.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 92.2 m -140.04 137.13 34.35 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 125.957 1.703 . . . . 0.0 107.264 176.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 55.4 tttm -67.72 125.51 91.38 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-O 118.871 -0.585 . . . . 0.0 110.954 -173.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -77.84 -170.09 0.89 Allowed 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 124.151 3.234 . . . . 0.0 111.191 173.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 17.5 tpp180 -142.78 138.98 30.81 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.134 1.374 . . . . 0.0 108.118 178.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 81.32 -159.46 41.03 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.552 1.072 . . . . 0.0 112.754 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 27.6 mttp -50.65 120.72 4.96 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 126.753 2.021 . . . . 0.0 112.848 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 62.7 t90 -138.48 138.47 38.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.239 1.816 . . . . 0.0 109.012 173.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -120.53 127.39 52.13 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.707 1.203 . . . . 0.0 108.405 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . 0.543 ' HB2' ' HD2' ' A' ' 240' ' ' PRO . 14.7 p -59.25 172.51 0.58 Allowed Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 127.851 2.46 . . . . 0.0 114.334 -173.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.543 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 43.1 Cg_endo -64.2 -38.64 34.7 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 121.658 1.572 . . . . 0.0 113.14 -168.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 66.0 mtt85 -88.02 20.53 3.09 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.42 1.009 . . . . 0.0 112.554 177.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 16.7 m -131.3 -10.4 3.69 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 126.316 1.846 . . . . 0.0 113.344 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 22.7 t -157.08 -39.59 0.07 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.144 0.884 . . . . 0.0 113.147 174.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -75.2 -15.04 60.58 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.537 0.735 . . . . 0.0 112.525 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 . . . . . 0 C--O 1.234 0.28 0 C-N-CA 128.26 2.624 . . . . 0.0 106.026 -175.351 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo . . . . . 0 CA--C 1.536 0.613 0 CA-C-O 121.496 0.54 . . . . 0.0 112.657 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 34.7 p -144.77 172.98 12.25 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.094 1.757 . . . . 0.0 109.284 -177.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -139.04 -54.1 0.58 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.45 ' SG ' ' HB2' ' A' ' 201' ' ' CYS . 2.4 p -68.82 165.62 19.33 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 128.431 2.693 . . . . 0.0 113.272 178.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.5 pp -71.94 -5.62 36.07 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.77 166.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . 0.45 ' HB2' ' SG ' ' A' ' 199' ' ' CYS . 74.8 m -78.07 -29.09 48.97 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.807 1.243 . . . . 0.0 110.831 173.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . 0.303 90.9 m-70 71.09 54.86 0.23 Allowed 'General case' 0 C--N 1.34 0.167 0 C-N-CA 127.529 2.332 . . . . 0.0 113.391 169.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -136.6 171.37 14.59 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.44 -1.254 . . . . 0.0 109.697 166.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.483 HG12 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -64.97 175.97 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 125.274 1.43 . . . . 0.0 112.105 -173.18 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.483 ' H ' HG12 ' A' ' 204' ' ' VAL . 20.3 m -43.39 152.78 0.12 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 128.421 2.689 . . . . 0.0 115.569 -173.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . 0.411 ' CD1' ' HG2' ' A' ' 209' ' ' MET . 7.4 p90 -147.63 157.05 43.38 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.59 1.556 . . . . 0.0 110.497 -172.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -65.75 -38.53 94.54 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.432 1.015 . . . . 0.0 115.095 -169.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 26.8 pt-20 -119.33 122.08 41.05 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 118.164 0.982 . . . . 0.0 110.345 -174.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . 0.411 ' HG2' ' CD1' ' A' ' 206' ' ' TYR . 14.6 mtp -141.84 141.14 33.09 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -167.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 16.8 tt -144.17 151.53 16.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 125.817 1.647 . . . . 0.0 109.636 169.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -138.29 145.98 17.61 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 123.874 0.75 . . . . 0.0 112.629 -169.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 6.5 t -69.88 145.78 51.74 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-O 122.228 1.013 . . . . 0.0 111.182 -172.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -81.29 -6.5 58.95 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.713 2.005 . . . . 0.0 113.442 -175.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -78.78 146.08 67.94 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 118.696 0.68 . . . . 0.0 111.568 -169.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.95 6.71 4.03 Favored 'Trans proline' 0 CA--C 1.547 1.172 0 C-N-CA 123.58 2.853 . . . . 0.0 111.718 167.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -126.72 -7.71 6.18 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.137 1.775 . . . . 0.0 112.628 -172.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 39.0 t -66.02 133.39 50.69 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.074 0.95 . . . . 0.0 109.791 174.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 50.2 m -112.1 10.47 20.32 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.639 1.576 . . . . 0.0 111.708 -174.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 22.0 mm -120.32 -33.62 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 125.905 1.682 . . . . 0.0 109.472 175.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 50.33 -10.21 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 130.624 3.57 . . . . 0.0 118.917 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 54.9 m95 -144.5 156.9 44.39 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.395 1.478 . . . . 0.0 111.83 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -158.88 154.35 25.88 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.362 1.865 . . . . 0.0 109.377 -176.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 44.3 m80 -69.37 154.51 41.91 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 166.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 13.9 m-30 -52.33 -50.68 61.82 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 166.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -69.5 -13.08 62.15 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 4.8 t -69.16 -19.1 64.0 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.646 0.778 . . . . 0.0 112.476 172.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.0 p -114.82 -21.52 5.3 Favored 'Isoleucine or valine' 0 C--N 1.347 0.466 0 C-N-CA 125.605 1.562 . . . . 0.0 112.275 172.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 105.71 17.95 12.46 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 126.029 1.776 . . . . 0.0 113.752 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 13.5 mt -71.76 162.53 29.31 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.271 1.536 . . . . 0.0 111.854 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 36.0 m -138.42 -24.81 0.95 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.348 1.459 . . . . 0.0 111.417 -176.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 46.2 p -139.15 140.59 37.93 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.681 1.592 . . . . 0.0 108.432 176.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -78.14 119.22 76.53 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 123.413 0.685 . . . . 0.0 112.03 -169.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -81.21 175.93 9.27 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.692 2.928 . . . . 0.0 111.015 169.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 13.5 ttp85 -145.0 134.78 23.54 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 124.035 0.934 . . . . 0.0 109.019 172.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 127.38 -165.07 20.65 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.807 1.67 . . . . 0.0 111.136 -175.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.72 120.91 10.99 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 124.203 1.001 . . . . 0.0 109.686 171.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 58.5 t90 -138.56 144.29 39.8 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 127.257 2.223 . . . . 0.0 108.482 175.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -120.27 135.85 54.86 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.468 1.107 . . . . 0.0 109.309 -178.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -67.46 168.78 10.72 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 124.279 1.031 . . . . 0.0 111.72 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.38 -36.09 28.59 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.108 1.205 . . . . 0.0 112.681 -172.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 67.6 mtt-85 -75.55 0.06 18.67 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.373 1.069 . . . . 0.0 113.405 175.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 24.7 m -115.06 -21.27 10.1 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.029 1.331 . . . . 0.0 113.821 -176.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.1 t -151.22 -28.14 0.2 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.545 1.066 . . . . 0.0 113.56 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -76.57 -13.54 60.07 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.903 0.774 . . . . 0.0 112.299 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 . . . . . 0 CA--C 1.542 0.65 0 C-N-CA 123.706 0.803 . . . . 0.0 112.54 169.6 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo . . . . . 0 CA--C 1.535 0.542 0 CA-C-O 120.967 0.32 . . . . 0.0 111.78 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 68.0 p -146.57 175.02 10.89 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.743 1.217 . . . . 0.0 110.66 -174.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -137.61 -83.66 0.32 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 117.337 -1.316 . . . . 0.0 112.588 -170.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.1 t -55.67 168.21 0.45 Allowed 'General case' 0 C--N 1.352 0.692 0 CA-C-N 119.844 1.202 . . . . 0.0 113.336 -177.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.1 pp -57.49 -12.73 2.87 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.882 1.273 . . . . 0.0 112.861 170.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 71.7 m -76.82 -19.87 57.04 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.899 2.079 . . . . 0.0 113.275 176.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 22.3 m170 57.86 64.01 1.65 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.907 2.083 . . . . 0.0 111.543 -173.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.77 157.61 40.97 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.124 1.37 . . . . 0.0 112.561 175.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.5 HG12 ' H ' ' A' ' 205' ' ' SER . 0.4 OUTLIER -68.57 -178.72 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 126.45 1.9 . . . . 0.0 111.325 -177.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.5 ' H ' HG12 ' A' ' 204' ' ' VAL . 49.8 m -42.35 145.65 0.38 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 128.012 2.525 . . . . 0.0 113.472 177.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . 0.44 ' CE2' ' HG2' ' A' ' 209' ' ' MET . 13.2 p90 -152.03 165.31 35.07 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.837 1.255 . . . . 0.0 111.935 -167.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -67.98 -47.91 57.25 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.76 1.172 . . . . 0.0 115.018 -168.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -127.8 125.38 39.72 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 118.401 1.1 . . . . 0.0 109.849 -170.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . 0.44 ' HG2' ' CE2' ' A' ' 206' ' ' TYR . 9.1 mtp -140.47 147.9 40.32 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -166.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 17.0 tt -135.05 155.68 38.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 125.843 1.657 . . . . 0.0 109.557 168.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -132.73 139.18 10.72 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.668 1.127 . . . . 0.0 112.45 -172.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . 0.592 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 1.8 m -79.51 127.12 31.75 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 125.487 1.515 . . . . 0.0 112.19 -167.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -70.22 -3.61 17.81 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.35 1.86 . . . . 0.0 113.692 -175.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -67.77 146.95 98.61 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 123.547 0.739 . . . . 0.0 111.469 -174.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.83 5.65 6.18 Favored 'Trans proline' 0 CA--C 1.55 1.3 0 C-N-CA 123.138 2.559 . . . . 0.0 111.372 166.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -134.13 -13.51 2.42 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 125.21 1.404 . . . . 0.0 114.381 -169.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 36.8 t -63.72 132.57 51.43 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 118.973 0.806 . . . . 0.0 110.335 -176.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 69.7 m -109.29 11.72 25.17 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 113.637 -1.62 . . . . 0.0 111.602 -173.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 39.4 mm -119.3 -41.35 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 125.838 1.655 . . . . 0.0 108.604 173.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 47.67 -9.47 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.832 1 C-N-CA 131.717 4.007 . . . . 0.0 119.725 171.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -139.83 135.95 33.51 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.744 2.017 . . . . 0.0 109.197 172.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . 0.592 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 6.4 m-85 -143.47 155.82 44.47 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.376 1.471 . . . . 0.0 109.53 -169.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 21.9 m80 -73.55 148.62 42.84 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 168.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 16.8 m-30 -52.19 -51.11 60.11 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.751 167.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.19 -14.34 62.59 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -177.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 2.8 m -78.12 -8.56 58.42 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 119.76 1.164 . . . . 0.0 112.777 173.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.7 p -119.07 -14.08 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 126.009 1.724 . . . . 0.0 112.198 169.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 96.8 17.4 33.01 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.693 1.616 . . . . 0.0 113.306 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 12.5 mt -71.55 160.37 32.81 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.582 1.191 . . . . 0.0 111.272 176.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 16.0 m -134.03 -1.4 2.98 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.998 1.719 . . . . 0.0 110.37 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 9.3 t -150.58 177.11 10.35 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.284 1.834 . . . . 0.0 109.674 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -108.92 105.67 57.54 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 124.305 1.042 . . . . 0.0 109.391 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.48 175.52 10.53 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.221 2.614 . . . . 0.0 111.435 173.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -140.1 133.57 30.06 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 124.856 1.262 . . . . 0.0 108.229 173.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 124.24 -175.89 16.95 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 126.156 1.836 . . . . 0.0 110.845 -170.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -66.69 131.65 46.43 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.996 0.903 . . . . 0.0 110.368 173.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 52.8 t90 -136.99 141.55 42.57 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 127.011 2.125 . . . . 0.0 108.779 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -124.5 127.38 47.37 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.467 1.107 . . . . 0.0 108.828 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . 0.414 ' HB2' ' HD2' ' A' ' 240' ' ' PRO . 6.2 p -60.73 167.57 3.29 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 126.465 1.906 . . . . 0.0 113.299 -173.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.414 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 33.4 Cg_endo -65.33 -30.3 53.94 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.491 1.461 . . . . 0.0 112.809 -170.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 53.7 mtt-85 -86.96 13.58 8.87 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.302 1.041 . . . . 0.0 112.747 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 20.1 m -131.01 -14.03 3.51 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.159 1.784 . . . . 0.0 113.518 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 32.1 t -149.33 -39.47 0.15 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.72 0.808 . . . . 0.0 112.414 -178.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -82.09 -11.38 58.8 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -175.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 . . . . . 0 CA--C 1.544 0.717 0 C-N-CA 123.92 0.888 . . . . 0.0 112.717 172.164 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo . . . . . 0 CA--C 1.535 0.566 0 CA-C-O 121.244 0.435 . . . . 0.0 112.063 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 72.9 p -144.23 175.96 9.69 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.904 1.281 . . . . 0.0 110.453 -174.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -136.66 -80.68 0.39 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 117.275 -1.345 . . . . 0.0 113.213 -171.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 3.1 t -55.97 167.81 0.55 Allowed 'General case' 0 C--N 1.35 0.609 0 CA-C-N 119.963 1.256 . . . . 0.0 113.115 -176.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.9 pp -59.4 -10.06 2.89 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.417 1.087 . . . . 0.0 112.717 169.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 75.2 m -77.04 -21.86 53.86 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.658 1.983 . . . . 0.0 113.19 174.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 54.29 68.83 0.79 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.752 2.021 . . . . 0.0 111.629 -170.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.9 160.6 33.06 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.688 1.595 . . . . 0.0 111.468 173.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.531 HG12 ' H ' ' A' ' 205' ' ' SER . 0.6 OUTLIER -70.29 -178.94 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 125.62 1.568 . . . . 0.0 111.142 -178.158 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.531 ' H ' HG12 ' A' ' 204' ' ' VAL . 28.3 m -46.34 151.05 0.56 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 128.093 2.557 . . . . 0.0 114.348 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -154.17 168.47 26.41 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.351 1.46 . . . . 0.0 111.413 -169.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -70.61 -50.85 23.4 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.379 0.99 . . . . 0.0 114.651 -169.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -125.53 122.34 36.29 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 118.091 0.945 . . . . 0.0 110.297 -170.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -144.09 147.01 33.19 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -166.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 16.2 tt -142.04 152.77 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 125.47 1.508 . . . . 0.0 109.783 169.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -132.35 147.01 18.65 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 124.051 0.834 . . . . 0.0 112.456 -169.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 7.0 t -71.2 143.4 50.48 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-O 122.019 0.914 . . . . 0.0 111.369 -172.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -79.36 -8.98 59.48 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.786 2.034 . . . . 0.0 114.193 -176.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -74.39 144.03 80.51 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 119.458 1.027 . . . . 0.0 111.041 -174.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -75.63 6.02 3.92 Favored 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 123.471 2.781 . . . . 0.0 111.802 168.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -124.89 -6.19 7.36 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.533 1.933 . . . . 0.0 112.28 -173.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 49.8 t -63.7 133.42 53.55 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.899 0.879 . . . . 0.0 109.703 174.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 10.4 t -114.75 11.24 16.75 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.644 1.578 . . . . 0.0 111.611 -174.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 33.0 mm -120.25 -31.97 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 126.229 1.812 . . . . 0.0 109.411 176.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 50.36 -13.81 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 131.539 3.936 . . . . 0.0 119.204 176.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 58.2 m95 -143.62 152.53 41.49 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.645 1.578 . . . . 0.0 110.755 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -154.33 150.87 28.43 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.376 1.471 . . . . 0.0 110.473 -174.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -71.59 150.17 44.96 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.26 0.552 . . . . 0.0 109.816 168.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 11.4 m-30 -53.49 -51.28 63.29 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.469 167.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.82 -12.85 61.48 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 1.7 m -76.56 -12.31 60.0 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.771 1.169 . . . . 0.0 112.299 172.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.56 -15.46 9.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 126.172 1.789 . . . . 0.0 112.185 171.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 95.07 20.43 28.1 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.792 1.663 . . . . 0.0 113.663 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 20.4 mt -71.49 157.98 37.06 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.987 1.394 . . . . 0.0 111.407 177.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 91.4 m -131.41 -25.09 2.21 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.828 1.651 . . . . 0.0 110.772 -177.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 61.1 p -138.73 150.85 46.59 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.182 1.793 . . . . 0.0 108.271 172.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -79.77 119.34 76.44 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-O 118.533 -0.746 . . . . 0.0 110.756 -174.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -76.67 165.92 28.02 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 122.922 2.415 . . . . 0.0 110.39 169.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -138.03 130.92 29.9 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-O 122.195 0.997 . . . . 0.0 109.06 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 127.82 -165.9 20.68 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 126.757 2.123 . . . . 0.0 109.407 -168.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.92 142.7 54.67 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 122.469 1.128 . . . . 0.0 109.771 169.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 55.0 t90 -147.31 146.15 29.61 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 127.254 2.222 . . . . 0.0 108.203 -177.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -124.13 137.2 54.58 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.421 1.089 . . . . 0.0 110.197 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -69.08 169.91 10.25 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 125.186 1.394 . . . . 0.0 112.581 -177.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -74.51 1.04 7.89 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.398 2.066 . . . . 0.0 114.506 -175.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -117.63 16.72 14.52 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.53 1.932 . . . . 0.0 110.883 172.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 22.2 m -134.39 -16.99 2.07 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.367 1.867 . . . . 0.0 112.744 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 32.8 t -154.01 -40.91 0.09 Allowed 'General case' 0 C--N 1.345 0.377 0 CA-C-N 118.975 0.807 . . . . 0.0 112.775 175.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -74.82 -6.16 47.49 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 . . . . . 0 CA--C 1.548 0.884 0 C-N-CA 126.186 1.795 . . . . 0.0 112.671 173.298 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo . . . . . 0 CA--C 1.536 0.607 0 CA-C-O 121.235 0.431 . . . . 0.0 111.719 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 66.0 p -143.69 175.02 10.29 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.009 1.324 . . . . 0.0 110.188 -176.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -133.98 -83.83 0.44 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 117.293 -1.337 . . . . 0.0 113.05 -169.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.446 ' H ' HE22 ' A' ' 203' ' ' GLN . 2.4 t -55.28 170.19 0.23 Allowed 'General case' 0 C--N 1.351 0.651 0 C-N-CA 124.948 1.299 . . . . 0.0 113.901 -175.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.3 pp -58.38 -14.12 6.87 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.32 1.048 . . . . 0.0 112.605 169.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 75.2 m -75.79 -23.66 55.9 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.029 2.132 . . . . 0.0 112.895 174.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 53.08 69.42 0.7 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 127.434 2.294 . . . . 0.0 112.156 -171.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . 0.446 HE22 ' H ' ' A' ' 199' ' ' CYS . 0.0 OUTLIER -125.46 160.63 28.99 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.091 1.756 . . . . 0.0 111.37 172.844 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.538 HG12 ' H ' ' A' ' 205' ' ' SER . 0.8 OUTLIER -69.24 -178.67 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 125.705 1.602 . . . . 0.0 110.883 -178.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.538 ' H ' HG12 ' A' ' 204' ' ' VAL . 85.8 p -44.3 148.2 0.47 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.566 2.347 . . . . 0.0 113.713 178.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -152.44 168.96 23.78 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.723 1.209 . . . . 0.0 112.168 -167.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -69.11 -53.05 20.23 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.807 1.194 . . . . 0.0 114.743 -168.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -125.07 125.64 44.12 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 118.271 1.036 . . . . 0.0 109.711 -172.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -142.55 145.54 33.71 Favored 'General case' 0 C--N 1.34 0.169 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -166.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 20.6 tt -134.8 150.77 30.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 125.705 1.602 . . . . 0.0 109.644 173.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -128.59 139.06 10.73 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 124.528 1.061 . . . . 0.0 112.576 -171.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . 0.6 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 5.5 m -75.11 125.78 29.66 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 125.362 1.465 . . . . 0.0 111.325 -168.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -70.03 -4.04 19.09 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.495 1.518 . . . . 0.0 113.452 -177.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -68.02 145.6 97.81 Favored Pre-proline 0 CA--C 1.538 0.518 0 O-C-N 121.544 -0.723 . . . . 0.0 110.905 -175.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -80.92 8.32 4.39 Favored 'Trans proline' 0 CA--C 1.549 1.258 0 C-N-CA 123.049 2.499 . . . . 0.0 111.296 166.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -133.81 -14.06 2.47 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 125.21 1.404 . . . . 0.0 114.323 -169.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.5 t -65.29 134.33 53.36 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 123.721 0.809 . . . . 0.0 110.699 -176.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 96.6 p -107.27 7.97 29.61 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.972 1.709 . . . . 0.0 112.188 -173.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 37.5 mm -118.95 -41.03 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 125.815 1.646 . . . . 0.0 108.676 177.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 48.16 -8.55 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 131.461 3.904 . . . . 0.0 119.697 170.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 61.7 m95 -141.28 137.43 32.48 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.781 2.032 . . . . 0.0 109.625 171.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . 0.6 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 6.9 m-85 -145.46 156.96 44.06 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 125.738 1.615 . . . . 0.0 109.69 -169.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 33.1 m80 -73.97 149.07 41.55 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 167.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -51.7 -52.03 51.43 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.746 167.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.78 -13.82 62.19 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -177.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 2.1 m -77.54 -11.13 59.82 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.785 1.175 . . . . 0.0 112.594 173.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 10.6 p -116.09 -16.47 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 125.799 1.64 . . . . 0.0 112.134 170.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 102.27 14.87 27.15 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.781 1.657 . . . . 0.0 113.395 177.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 26.0 mt -72.89 160.06 32.73 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.828 1.314 . . . . 0.0 110.928 175.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 67.4 p -131.71 -7.96 3.6 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.833 1.653 . . . . 0.0 111.598 177.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 73.8 p -144.73 166.2 25.9 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.006 2.122 . . . . 0.0 108.766 177.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -90.21 121.17 68.93 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-O 118.821 -0.609 . . . . 0.0 109.497 175.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -75.91 178.94 6.78 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.569 2.846 . . . . 0.0 110.78 169.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -141.59 132.55 26.03 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 170.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 120.69 -170.88 14.55 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 126.06 1.79 . . . . 0.0 110.166 -168.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.5 144.98 53.04 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 122.252 1.025 . . . . 0.0 110.849 174.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . 0.494 ' HZ3' ' HG ' ' A' ' 212' ' ' CYS . 60.2 t90 -145.93 138.96 25.88 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.994 2.118 . . . . 0.0 109.406 177.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 14.4 m-30 -118.4 131.91 56.27 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.717 1.207 . . . . 0.0 109.261 175.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . 0.475 ' HB2' ' HD2' ' A' ' 240' ' ' PRO . 4.0 p -63.32 173.23 1.25 Allowed Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 127.61 2.364 . . . . 0.0 114.675 -174.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 72.6 Cg_endo -72.87 -3.33 13.4 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.815 2.343 . . . . 0.0 114.858 -171.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -111.61 13.62 21.26 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.589 1.555 . . . . 0.0 111.234 174.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 39.0 m -135.94 -16.0 1.73 Allowed 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.565 1.946 . . . . 0.0 113.234 -174.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 46.6 t -150.98 -41.6 0.12 Allowed 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.763 0.825 . . . . 0.0 112.446 177.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -71.71 -23.43 61.63 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.012 0.369 . . . . 0.0 111.527 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 . . . . . 0 CA--C 1.541 0.605 0 C-N-CA 126.547 1.939 . . . . 0.0 113.42 175.364 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo . . . . . 0 N--CA 1.457 -0.643 0 N-CA-C 110.587 -0.582 . . . . 0.0 110.587 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 80.4 p -141.68 172.22 12.98 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.47 1.108 . . . . 0.0 110.005 -177.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -134.47 -83.97 0.43 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 117.316 -1.325 . . . . 0.0 112.885 -168.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.419 ' H ' HE22 ' A' ' 203' ' ' GLN . 1.9 t -55.17 168.5 0.33 Allowed 'General case' 0 C--N 1.351 0.667 0 C-N-CA 124.957 1.303 . . . . 0.0 113.274 -176.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.2 pp -57.05 -12.42 2.08 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.23 1.412 . . . . 0.0 113.145 170.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 71.3 m -78.76 -18.94 53.38 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.593 1.957 . . . . 0.0 113.208 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 23.3 m170 57.32 62.21 2.26 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.874 2.069 . . . . 0.0 111.663 -173.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . 0.419 HE22 ' H ' ' A' ' 199' ' ' CYS . 0.0 OUTLIER -125.65 158.75 33.95 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.022 1.329 . . . . 0.0 112.435 176.6 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.47 HG12 ' H ' ' A' ' 205' ' ' SER . 0.3 OUTLIER -69.17 -179.4 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 126.355 1.862 . . . . 0.0 111.366 -176.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.47 ' H ' HG12 ' A' ' 204' ' ' VAL . 79.5 p -45.37 147.62 0.77 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.42 2.288 . . . . 0.0 113.911 178.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -154.08 173.54 15.9 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.537 1.535 . . . . 0.0 111.223 -167.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -80.96 -71.36 1.29 Allowed Glycine 0 CA--C 1.528 0.893 0 C-N-CA 123.831 0.729 . . . . 0.0 112.959 -170.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -91.84 120.4 32.51 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 123.632 0.773 . . . . 0.0 111.117 -174.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -142.02 143.86 33.36 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -168.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 19.8 tt -134.97 150.36 29.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 125.541 1.537 . . . . 0.0 109.939 172.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -127.99 139.29 10.99 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.788 1.185 . . . . 0.0 112.641 -171.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . 0.592 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 1.9 m -78.75 126.12 30.29 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.582 1.553 . . . . 0.0 111.802 -168.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.39 -2.36 10.77 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.58 1.952 . . . . 0.0 113.808 -175.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -66.49 149.98 97.63 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 123.769 0.828 . . . . 0.0 112.12 -174.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -83.76 7.76 5.01 Favored 'Trans proline' 0 CA--C 1.549 1.262 0 C-N-CA 123.725 2.95 . . . . 0.0 111.342 166.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -144.39 -10.86 0.63 Allowed 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 -167.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 36.7 t -60.93 134.09 56.74 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 119.465 1.03 . . . . 0.0 110.468 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.5 t -110.47 14.24 22.57 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.762 1.625 . . . . 0.0 111.124 -173.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 51.7 mt -122.75 -41.97 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 125.327 1.451 . . . . 0.0 108.577 172.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 47.63 -8.59 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 131.351 3.861 . . . . 0.0 119.552 172.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 62.3 m95 -139.62 136.07 33.98 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 126.497 1.919 . . . . 0.0 109.603 170.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . 0.592 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 7.2 m-85 -142.49 158.69 43.42 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 125.572 1.549 . . . . 0.0 109.179 -169.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -78.45 148.14 33.68 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 169.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -51.74 -51.37 56.68 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.937 167.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.84 -13.23 61.62 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -176.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 4.8 m -78.29 -8.1 57.99 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.81 1.186 . . . . 0.0 112.608 172.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.8 p -120.9 -12.68 8.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 126.319 1.847 . . . . 0.0 112.185 170.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 94.28 18.24 36.98 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.693 1.616 . . . . 0.0 113.4 178.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 19.4 mt -72.05 158.34 36.13 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.749 1.275 . . . . 0.0 111.327 176.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 59.7 m -134.86 -18.38 1.86 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.782 1.633 . . . . 0.0 111.145 -177.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 62.7 m -144.33 139.62 28.63 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 125.692 1.597 . . . . 0.0 107.82 178.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -70.58 122.6 87.1 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 123.519 0.727 . . . . 0.0 110.836 -176.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -81.48 -179.8 5.21 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.769 2.979 . . . . 0.0 111.617 173.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -139.62 135.82 33.71 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.031 1.332 . . . . 0.0 107.475 169.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 116.54 -174.61 15.32 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.405 1.478 . . . . 0.0 111.747 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -62.34 122.72 16.38 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.883 1.273 . . . . 0.0 111.09 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 44.7 t90 -132.98 143.02 49.17 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 127.201 2.2 . . . . 0.0 108.6 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -126.92 126.77 43.81 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.564 1.146 . . . . 0.0 109.003 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . 0.424 ' HB2' ' HD2' ' A' ' 240' ' ' PRO . 5.8 p -61.23 169.08 2.38 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 126.857 2.063 . . . . 0.0 114.007 -172.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.424 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 57.5 Cg_endo -72.44 1.48 6.14 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.559 2.173 . . . . 0.0 115.221 -171.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 38.3 mtp180 -117.42 17.58 14.55 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.224 1.41 . . . . 0.0 112.106 170.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 31.7 m -133.52 -14.0 2.57 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.434 1.894 . . . . 0.0 112.763 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 33.0 t -147.87 -33.06 0.26 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.058 0.943 . . . . 0.0 112.195 177.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -86.8 -13.48 44.99 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -173.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 . . . . . 0 CA--C 1.544 0.738 0 CA-C-N 119.443 1.02 . . . . 0.0 112.531 169.493 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo . . . . . 0 CA--C 1.535 0.557 0 CA-C-O 121.172 0.405 . . . . 0.0 111.978 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 65.6 p -146.04 176.39 9.75 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.864 1.266 . . . . 0.0 110.536 -173.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -135.34 -83.59 0.41 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 117.508 -1.234 . . . . 0.0 112.707 -169.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.0 t -55.88 167.81 0.54 Allowed 'General case' 0 C--N 1.351 0.66 0 CA-C-N 119.741 1.155 . . . . 0.0 113.129 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 2.9 pp -57.66 -12.66 3.05 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.92 1.288 . . . . 0.0 112.768 171.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 74.6 m -76.64 -19.65 57.56 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.544 1.938 . . . . 0.0 113.214 176.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 29.9 m170 56.8 64.52 1.64 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.729 2.011 . . . . 0.0 111.396 -172.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.41 156.98 39.71 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.231 1.412 . . . . 0.0 112.13 174.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.553 HG12 ' H ' ' A' ' 205' ' ' SER . 0.9 OUTLIER -69.61 -178.21 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 126.114 1.766 . . . . 0.0 110.916 -178.39 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.553 ' H ' HG12 ' A' ' 204' ' ' VAL . 88.0 p -45.51 148.77 0.64 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.53 2.332 . . . . 0.0 113.964 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -154.97 173.67 16.22 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.276 1.43 . . . . 0.0 111.346 -167.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -80.75 -73.2 1.18 Allowed Glycine 0 C--N 1.341 0.852 0 C-N-CA 123.877 0.751 . . . . 0.0 112.784 -171.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -88.54 119.44 29.0 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.597 0.759 . . . . 0.0 111.238 -176.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -142.52 143.77 32.66 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -169.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 21.3 tt -136.53 152.0 28.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 125.729 1.612 . . . . 0.0 109.706 173.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -129.5 139.23 10.8 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.514 1.054 . . . . 0.0 112.914 -172.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . 0.602 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 7.3 m -75.77 127.74 33.68 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.898 1.679 . . . . 0.0 111.548 -168.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -71.02 -1.86 13.52 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.973 1.709 . . . . 0.0 113.591 -177.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -67.02 148.15 98.94 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 123.661 0.784 . . . . 0.0 111.523 -175.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -82.43 8.05 4.77 Favored 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 123.592 2.861 . . . . 0.0 111.631 167.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -144.16 -9.87 0.67 Allowed 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -167.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.8 t -62.39 133.47 55.1 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 119.607 1.094 . . . . 0.0 110.443 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 9.4 t -106.21 4.65 29.13 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.705 1.602 . . . . 0.0 111.687 -173.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 42.8 mm -112.18 -42.32 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 125.736 1.614 . . . . 0.0 108.777 175.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 48.82 -11.15 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 131.556 3.943 . . . . 0.0 119.597 171.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -138.8 137.82 36.99 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.778 2.031 . . . . 0.0 109.387 170.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . 0.602 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 7.3 m-85 -144.39 157.08 44.44 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.527 1.531 . . . . 0.0 109.654 -169.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 47.0 m80 -74.46 149.75 40.21 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 167.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 10.0 m-30 -51.4 -52.81 42.71 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.727 167.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.47 -12.44 61.39 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 118.253 -0.88 . . . . 0.0 113.253 -176.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 2.0 m -77.43 -8.49 57.81 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.759 1.163 . . . . 0.0 112.5 172.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.6 p -121.77 -14.08 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 126.082 1.753 . . . . 0.0 112.514 170.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 98.66 16.53 31.12 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 125.856 1.693 . . . . 0.0 113.513 178.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 19.6 mt -71.49 162.17 29.87 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.908 1.354 . . . . 0.0 111.66 177.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.7 t -139.22 -14.5 1.14 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.51 1.524 . . . . 0.0 112.512 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 59.7 m -146.86 139.54 25.05 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.019 1.728 . . . . 0.0 107.287 177.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -69.35 119.5 70.86 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-O 118.721 -0.657 . . . . 0.0 110.55 -177.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -78.29 174.63 12.13 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.463 2.776 . . . . 0.0 110.67 170.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 30.1 ttp-105 -143.16 130.98 21.49 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 121.923 0.868 . . . . 0.0 108.795 170.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 126.4 -174.38 17.96 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 126.343 1.925 . . . . 0.0 110.409 -169.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -66.4 128.84 37.73 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.18 0.992 . . . . 0.0 110.761 175.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . 0.429 ' HZ3' ' HG ' ' A' ' 212' ' ' CYS . 54.8 t90 -135.74 145.01 46.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 127.304 2.242 . . . . 0.0 109.134 178.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -130.6 124.8 32.54 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.691 1.196 . . . . 0.0 109.6 -176.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . 0.429 ' HB3' ' SG ' ' A' ' 212' ' ' CYS . 1.9 p -61.25 172.92 0.81 Allowed Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 128.1 2.56 . . . . 0.0 114.835 -171.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 94.7 Cg_endo -76.06 12.82 1.4 Allowed 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.608 2.872 . . . . 0.0 115.365 -171.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 35.8 mtp180 -125.53 13.82 8.15 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.716 1.606 . . . . 0.0 111.058 169.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 66.6 m -135.73 -22.28 1.45 Allowed 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.939 1.695 . . . . 0.0 113.714 -174.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 27.8 t -151.65 -42.08 0.11 Allowed 'General case' 0 C--N 1.342 0.278 0 CA-C-N 119.004 0.82 . . . . 0.0 112.614 175.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 7.7 tm0? -77.25 -13.85 59.86 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 119.337 -0.363 . . . . 0.0 111.65 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 . . . . . 0 CA--C 1.539 0.537 0 C-N-CA 124.842 1.257 . . . . 0.0 113.18 178.809 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo . . . . . 0 CA--C 1.536 0.588 0 CA-C-O 121.095 0.373 . . . . 0.0 111.554 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 67.6 p -145.07 173.6 11.77 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.578 1.151 . . . . 0.0 110.715 -175.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -136.79 -83.27 0.36 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 117.355 -1.307 . . . . 0.0 112.565 -170.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.0 t -55.6 168.21 0.44 Allowed 'General case' 0 C--N 1.351 0.641 0 C-N-CA 125.013 1.325 . . . . 0.0 113.378 -176.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.0 pp -57.45 -12.69 2.79 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.079 1.352 . . . . 0.0 113.031 170.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 72.7 m -77.17 -19.9 56.17 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.461 1.904 . . . . 0.0 113.223 176.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 21.8 m170 57.75 63.92 1.69 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.868 2.067 . . . . 0.0 111.565 -172.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.22 158.13 38.96 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.079 1.352 . . . . 0.0 112.496 175.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.544 HG12 ' H ' ' A' ' 205' ' ' SER . 0.9 OUTLIER -67.83 -179.1 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 126.389 1.876 . . . . 0.0 111.144 -177.82 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.544 ' H ' HG12 ' A' ' 204' ' ' VAL . 88.3 p -46.31 150.17 0.66 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.562 2.345 . . . . 0.0 113.84 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . 0.466 ' CE2' ' HG2' ' A' ' 209' ' ' MET . 18.3 p90 -155.55 164.87 38.09 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.127 1.371 . . . . 0.0 111.227 -167.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -73.8 -49.44 13.85 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 118.666 -1.074 . . . . 0.0 114.814 -169.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -117.2 121.33 40.92 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 118.478 1.139 . . . . 0.0 110.362 -170.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . 0.466 ' HG2' ' CE2' ' A' ' 206' ' ' TYR . 2.8 mtp -140.48 148.66 41.46 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -166.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 14.5 tt -136.91 156.55 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 125.57 1.548 . . . . 0.0 109.32 168.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -133.75 139.18 10.68 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.488 1.042 . . . . 0.0 112.4 -171.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . 0.586 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 1.1 m -79.61 125.99 30.32 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.191 1.397 . . . . 0.0 112.233 -167.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -69.37 -4.96 20.49 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.598 1.959 . . . . 0.0 113.888 -175.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -66.43 145.65 98.98 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.424 0.689 . . . . 0.0 111.396 -173.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -81.92 9.21 4.04 Favored 'Trans proline' 0 CA--C 1.551 1.343 0 C-N-CA 123.074 2.516 . . . . 0.0 110.946 165.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -134.41 -15.56 2.17 Favored 'General case' 0 C--N 1.35 0.614 0 C-N-CA 125.407 1.483 . . . . 0.0 114.365 -169.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 35.6 t -65.05 136.13 56.39 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 123.905 0.882 . . . . 0.0 110.611 -175.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.4 t -113.07 14.57 19.59 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.721 1.608 . . . . 0.0 111.217 -174.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 51.3 mt -123.2 -42.34 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 125.363 1.465 . . . . 0.0 108.71 173.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 47.28 -7.59 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 131.453 3.901 . . . . 0.0 119.59 171.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 66.1 m95 -139.0 134.84 33.6 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.466 1.907 . . . . 0.0 109.259 170.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . 0.586 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 7.8 m-85 -142.01 157.09 45.34 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.362 1.465 . . . . 0.0 109.075 -169.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -77.0 148.6 36.15 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 169.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 14.4 m-30 -51.92 -51.62 55.69 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.89 167.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.51 -14.18 62.41 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 6.5 m -79.38 -6.67 57.32 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 119.748 1.158 . . . . 0.0 112.766 173.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.9 p -120.87 -12.62 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 125.965 1.706 . . . . 0.0 112.113 169.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 96.31 16.87 36.07 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.509 1.528 . . . . 0.0 113.317 178.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 13.7 mt -71.82 159.46 34.27 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.581 1.191 . . . . 0.0 111.068 175.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 24.4 m -133.17 -5.52 3.04 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.115 1.766 . . . . 0.0 110.41 177.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 80.1 p -142.51 179.62 6.85 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.815 2.046 . . . . 0.0 109.398 -178.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -112.33 97.32 39.18 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 124.232 1.013 . . . . 0.0 109.528 178.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -70.6 167.73 24.71 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.425 2.084 . . . . 0.0 110.255 169.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -140.69 131.72 26.22 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.981 0.896 . . . . 0.0 109.084 175.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 138.88 -173.43 22.62 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 126.577 2.037 . . . . 0.0 109.688 -169.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -70.83 126.99 31.11 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.729 0.776 . . . . 0.0 109.68 170.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 39.0 t90 -133.51 144.58 49.5 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.864 2.066 . . . . 0.0 108.493 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -126.21 131.2 52.02 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.568 1.147 . . . . 0.0 108.935 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 3.7 p -61.82 167.04 5.08 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 126.106 1.763 . . . . 0.0 112.63 -175.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.77 -36.41 32.19 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.026 1.15 . . . . 0.0 112.097 -170.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 60.8 mtt-85 -78.31 10.93 2.66 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.496 1.119 . . . . 0.0 112.907 178.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 19.1 m -129.37 -13.56 4.36 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.431 1.892 . . . . 0.0 113.883 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 35.7 t -149.77 -42.43 0.14 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.884 0.766 . . . . 0.0 112.561 -176.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 47.3 tp60 -75.2 -18.43 60.15 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 118.494 -0.765 . . . . 0.0 112.834 -177.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 . . . . . 0 CA--C 1.538 0.504 0 CA-C-N 119.371 0.987 . . . . 0.0 111.709 172.828 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo . . . . . 0 CA--C 1.535 0.564 0 CA-C-O 121.157 0.399 . . . . 0.0 112.063 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 64.4 p -144.43 175.22 10.28 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.067 1.347 . . . . 0.0 110.327 -174.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -134.4 -81.26 0.45 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 117.328 -1.32 . . . . 0.0 113.26 -170.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.9 t -54.77 167.09 0.4 Allowed 'General case' 0 C--N 1.35 0.594 0 C-N-CA 125.078 1.351 . . . . 0.0 113.174 -176.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 4.2 pp -60.17 -11.0 5.11 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.207 1.003 . . . . 0.0 112.715 169.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 72.3 m -74.38 -24.0 59.07 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.551 1.94 . . . . 0.0 112.906 172.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 54.63 69.65 0.7 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 127.291 2.236 . . . . 0.0 111.925 -170.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.6 162.21 27.82 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.832 1.653 . . . . 0.0 111.689 173.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.477 HG12 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -70.28 -177.9 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 126.04 1.736 . . . . 0.0 111.686 -176.469 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.477 ' H ' HG12 ' A' ' 204' ' ' VAL . 40.5 m -44.34 150.34 0.32 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 128.2 2.6 . . . . 0.0 114.497 177.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -158.06 170.27 22.67 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.034 1.733 . . . . 0.0 110.553 -169.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -78.38 -66.52 1.73 Allowed Glycine 0 CA--C 1.529 0.956 0 CA-C-O 119.438 -0.645 . . . . 0.0 113.149 -170.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -100.54 122.41 43.19 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 123.684 0.794 . . . . 0.0 110.745 -173.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -144.11 146.52 32.85 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -167.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 13.7 tt -144.01 153.96 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 125.006 1.322 . . . . 0.0 109.922 169.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -132.81 145.47 17.42 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 123.97 0.795 . . . . 0.0 112.01 -170.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 4.2 t -70.07 142.76 52.63 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.971 0.891 . . . . 0.0 110.863 -173.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -78.32 -5.43 52.11 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.109 1.764 . . . . 0.0 113.57 -174.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 -80.77 144.63 56.28 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 118.816 0.734 . . . . 0.0 111.231 -169.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -75.67 4.84 4.73 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 123.564 2.843 . . . . 0.0 112.071 168.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -122.95 -6.61 8.44 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.214 1.806 . . . . 0.0 112.358 -173.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 36.7 t -65.25 136.5 56.68 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.305 1.042 . . . . 0.0 109.782 174.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 8.7 t -119.05 10.75 12.24 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.83 1.652 . . . . 0.0 111.248 -175.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 35.5 mm -118.64 -32.82 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 126.197 1.799 . . . . 0.0 109.261 175.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 50.02 -13.64 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.617 1 C-N-CA 131.769 4.028 . . . . 0.0 119.378 175.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 63.1 m95 -143.1 152.03 41.38 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.89 1.676 . . . . 0.0 110.365 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -154.05 154.66 34.08 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.555 1.542 . . . . 0.0 109.885 -172.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -77.47 148.8 35.18 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 170.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -52.62 -51.55 59.52 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.782 168.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.69 -13.25 61.68 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 118.325 -0.845 . . . . 0.0 113.261 -177.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 5.3 m -78.23 -6.11 53.94 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 119.713 1.142 . . . . 0.0 112.633 172.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 6.2 p -121.86 -16.77 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 125.659 1.584 . . . . 0.0 112.232 169.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 99.79 17.85 24.53 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.776 1.655 . . . . 0.0 113.667 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 18.9 mt -71.15 158.0 37.19 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 119.01 1.405 . . . . 0.0 111.104 177.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 90.0 m -134.53 -22.97 1.67 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.692 1.597 . . . . 0.0 110.973 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 48.6 p -140.73 143.57 35.07 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.91 1.684 . . . . 0.0 108.455 174.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -70.05 126.19 92.32 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-O 118.688 -0.672 . . . . 0.0 110.573 -176.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -76.57 -172.42 1.39 Allowed 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 123.813 3.009 . . . . 0.0 111.278 171.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -144.28 139.14 28.41 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 124.816 1.246 . . . . 0.0 108.466 176.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 97.23 -170.32 25.83 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.357 1.456 . . . . 0.0 111.675 -172.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -57.79 138.4 55.63 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.885 1.274 . . . . 0.0 111.177 175.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 52.6 t90 -142.25 153.8 44.23 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 127.301 2.24 . . . . 0.0 109.032 -177.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -130.71 132.76 45.55 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.853 1.261 . . . . 0.0 110.59 -174.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -67.08 167.35 14.71 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.232 1.013 . . . . 0.0 111.651 177.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.73 -27.0 27.16 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.303 1.335 . . . . 0.0 113.354 -172.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -87.3 9.8 19.23 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.435 1.094 . . . . 0.0 112.369 174.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 17.3 m -126.38 -17.58 5.12 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.565 1.546 . . . . 0.0 113.784 -176.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 33.8 t -152.97 -36.1 0.11 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.542 1.065 . . . . 0.0 112.959 174.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -68.49 -19.7 64.55 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 118.292 0.496 . . . . 0.0 112.134 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 . . . . . 0 CA--C 1.542 0.668 0 C-N-CA 125.009 1.323 . . . . 0.0 112.326 177.488 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo . . . . . 0 CA--C 1.534 0.499 0 CA-C-O 121.28 0.45 . . . . 0.0 111.942 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 71.2 p -144.49 175.43 10.13 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.902 1.281 . . . . 0.0 110.54 -172.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -136.57 -79.62 0.4 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 117.215 -1.374 . . . . 0.0 113.095 -170.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.41 ' H ' HE22 ' A' ' 203' ' ' GLN . 0.8 OUTLIER -56.31 169.09 0.45 Allowed 'General case' 0 C--N 1.349 0.572 0 CA-C-N 120.013 1.279 . . . . 0.0 113.403 -175.573 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 4.6 pp -57.95 -11.13 2.15 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.897 1.279 . . . . 0.0 113.147 169.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 71.6 m -78.66 -23.3 45.81 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 126.927 2.091 . . . . 0.0 113.416 176.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 33.7 m170 59.02 66.61 1.03 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.473 1.909 . . . . 0.0 110.835 -169.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . 0.41 HE22 ' H ' ' A' ' 199' ' ' CYS . 0.0 OUTLIER -130.1 160.84 32.5 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.823 1.249 . . . . 0.0 112.247 174.048 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.536 HG12 ' H ' ' A' ' 205' ' ' SER . 0.6 OUTLIER -69.05 -179.26 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 126.125 1.77 . . . . 0.0 111.355 -175.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.536 ' H ' HG12 ' A' ' 204' ' ' VAL . 84.8 p -47.91 153.65 0.61 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.82 2.448 . . . . 0.0 114.689 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -154.87 169.16 24.66 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.223 1.809 . . . . 0.0 110.484 -169.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -79.52 -40.4 15.57 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.673 -1.07 . . . . 0.0 115.29 -168.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.12 119.0 21.29 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 118.57 1.185 . . . . 0.0 110.137 -168.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -142.08 152.37 43.24 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -164.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 15.7 tt -148.49 153.23 11.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 126.091 1.756 . . . . 0.0 109.516 167.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -131.99 146.45 18.07 Favored Glycine 0 C--N 1.336 0.529 0 C-N-CA 124.267 0.937 . . . . 0.0 111.634 -170.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 3.9 t -70.29 140.84 52.38 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-O 121.941 0.876 . . . . 0.0 111.042 -171.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -76.87 -5.09 46.99 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.311 1.844 . . . . 0.0 113.842 -174.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -78.45 147.59 72.22 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 118.846 0.748 . . . . 0.0 111.633 -169.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.51 8.42 2.99 Favored 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 124.135 3.223 . . . . 0.0 112.589 169.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -133.32 -9.53 2.91 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.011 1.724 . . . . 0.0 112.394 -169.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.9 t -61.22 133.91 56.44 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.932 0.893 . . . . 0.0 109.845 173.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 68.6 m -119.83 14.9 12.56 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.921 1.688 . . . . 0.0 111.171 -175.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 37.6 mm -119.99 -32.39 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 126.739 2.016 . . . . 0.0 109.164 174.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 51.51 -15.68 0.0 OUTLIER 'General case' 0 C--N 1.35 0.587 1 C-N-CA 131.955 4.102 . . . . 0.0 119.305 173.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -143.01 151.04 40.4 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.64 1.576 . . . . 0.0 110.587 178.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -153.01 155.24 36.54 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.782 1.233 . . . . 0.0 110.418 -173.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -79.29 146.74 32.8 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 169.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -53.47 -48.78 68.58 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.463 168.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.07 -14.85 62.86 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.77 -13.54 60.3 Favored 'General case' 0 C--N 1.348 0.535 0 CA-C-N 119.712 1.142 . . . . 0.0 112.711 173.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.7 p -115.04 -13.33 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 126.014 1.725 . . . . 0.0 111.801 172.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 91.65 20.11 38.52 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 125.869 1.7 . . . . 0.0 113.49 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 12.0 mt -75.36 160.06 30.73 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-N 118.747 1.273 . . . . 0.0 111.801 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 91.1 m -133.87 -20.2 1.99 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.862 1.665 . . . . 0.0 111.131 -177.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 89.3 m -142.03 135.74 29.54 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 125.577 1.551 . . . . 0.0 107.906 178.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -70.55 115.69 37.8 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 125.208 1.403 . . . . 0.0 111.545 -176.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -79.87 162.17 23.89 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.025 2.483 . . . . 0.0 110.049 168.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 65.4 ttp85 -150.34 136.7 18.8 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-O 121.891 0.853 . . . . 0.0 110.232 -178.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 136.86 -61.84 0.6 Allowed Glycine 0 CA--C 1.529 0.906 0 C-N-CA 127.347 2.403 . . . . 0.0 108.758 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -161.54 145.68 12.94 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 126.614 1.966 . . . . 0.0 108.514 168.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 68.4 t90 -146.89 153.16 39.81 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 125.838 1.655 . . . . 0.0 109.417 -177.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -128.89 128.95 44.84 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.856 1.263 . . . . 0.0 110.037 -175.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.17 168.39 7.78 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 124.526 1.131 . . . . 0.0 112.246 178.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.91 -28.89 35.42 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 121.347 1.365 . . . . 0.0 112.684 -174.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 26.5 mtp180 -88.19 13.36 11.55 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.54 1.136 . . . . 0.0 112.877 175.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 16.1 m -129.28 -15.74 4.08 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.707 1.603 . . . . 0.0 113.364 -178.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 35.9 t -151.67 -33.28 0.14 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.077 0.853 . . . . 0.0 112.991 175.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -74.26 -13.97 60.85 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 118.872 0.76 . . . . 0.0 112.684 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 . . . . . 0 CA--C 1.545 0.772 0 CA-C-N 119.231 0.923 . . . . 0.0 112.912 169.802 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo . . . . . 0 CA--C 1.535 0.528 0 N-CA-C 111.104 -0.383 . . . . 0.0 111.104 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 69.3 p -144.89 173.66 11.68 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.512 1.125 . . . . 0.0 110.67 -176.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -135.09 -76.92 0.45 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 117.189 -1.386 . . . . 0.0 112.524 178.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 1.9 t -58.66 169.18 1.0 Allowed 'General case' 0 C--N 1.35 0.604 0 CA-C-N 119.935 1.243 . . . . 0.0 113.841 -172.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.1 pp -57.47 -13.37 3.53 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.109 1.363 . . . . 0.0 112.769 169.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 84.5 m -78.12 -19.47 54.02 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.331 1.853 . . . . 0.0 113.208 175.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 52.87 66.68 1.16 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.989 2.116 . . . . 0.0 112.332 -172.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.35 160.22 33.74 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.662 1.985 . . . . 0.0 111.136 174.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.471 HG12 ' H ' ' A' ' 205' ' ' SER . 0.3 OUTLIER -66.0 -179.89 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 125.846 1.658 . . . . 0.0 111.524 -179.82 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.471 ' H ' HG12 ' A' ' 204' ' ' VAL . 24.6 m -47.24 150.81 0.79 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.146 2.178 . . . . 0.0 113.931 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -151.79 166.67 30.67 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.655 1.582 . . . . 0.0 110.926 -173.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -76.23 -60.68 3.01 Favored Glycine 0 C--N 1.342 0.894 0 C-N-CA 124.252 0.929 . . . . 0.0 113.352 -171.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.425 ' HB2' ' CD2' ' A' ' 224' ' ' PHE . 3.1 pt-20 -79.29 121.52 25.2 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.331 1.052 . . . . 0.0 111.063 177.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 14.3 mtp -143.88 139.71 29.37 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -173.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 20.3 tt -138.63 145.99 27.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 125.284 1.433 . . . . 0.0 109.844 168.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -125.19 137.29 10.29 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.779 1.18 . . . . 0.0 112.438 -169.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . 0.59 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 2.0 m -78.22 124.11 27.69 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 125.26 1.424 . . . . 0.0 111.564 -168.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -69.64 -3.61 15.82 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.187 1.795 . . . . 0.0 113.564 -175.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -65.78 147.28 98.82 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 123.36 0.664 . . . . 0.0 111.485 -174.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -81.33 5.1 6.48 Favored 'Trans proline' 0 CA--C 1.55 1.284 0 C-N-CA 122.909 2.406 . . . . 0.0 111.511 166.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -134.59 -11.51 2.39 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 125.215 1.406 . . . . 0.0 114.448 -169.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 36.3 t -64.19 135.45 56.31 Favored 'General case' 0 C--N 1.344 0.326 0 CA-C-N 119.257 0.935 . . . . 0.0 110.608 -177.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.4 t -112.8 14.53 19.9 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.917 1.687 . . . . 0.0 111.361 -174.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 48.9 mt -122.02 -42.05 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 125.428 1.491 . . . . 0.0 108.527 172.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 48.83 -11.24 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 131.646 3.978 . . . . 0.0 119.687 170.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 52.3 m95 -138.83 136.82 36.01 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.654 1.982 . . . . 0.0 110.042 169.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . 0.59 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 5.2 m-85 -142.72 156.23 44.99 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 125.698 1.599 . . . . 0.0 109.303 -169.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -71.77 149.02 45.75 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 167.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . 0.425 ' CD2' ' HB2' ' A' ' 208' ' ' GLU . 17.4 m-30 -50.88 -50.93 56.06 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.708 165.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.16 -13.64 62.01 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -177.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 2.0 m -78.04 -6.33 54.21 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.885 1.22 . . . . 0.0 112.785 172.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.4 p -121.84 -13.07 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 126.132 1.773 . . . . 0.0 111.995 169.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 97.73 14.83 39.02 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.829 1.681 . . . . 0.0 113.446 177.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 29.8 mt -73.93 161.88 29.66 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 118.92 1.36 . . . . 0.0 111.329 177.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 67.4 p -132.75 -10.88 3.08 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.819 1.648 . . . . 0.0 111.64 176.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 53.2 p -145.72 151.09 37.44 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.652 1.981 . . . . 0.0 108.576 177.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -81.27 128.37 70.61 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-O 118.776 -0.631 . . . . 0.0 110.103 178.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -77.3 -178.35 4.52 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.635 2.89 . . . . 0.0 110.774 169.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 53.2 ttt180 -141.48 131.94 25.29 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 169.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 121.26 -168.77 14.28 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 126.064 1.793 . . . . 0.0 109.889 -168.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.28 145.0 51.6 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 122.242 1.02 . . . . 0.0 110.832 174.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . 0.496 ' HZ3' ' HG ' ' A' ' 212' ' ' CYS . 62.1 t90 -146.2 137.37 24.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 127.116 2.167 . . . . 0.0 108.915 175.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -114.27 136.72 52.65 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.96 0.904 . . . . 0.0 108.94 171.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . 0.411 ' HB2' ' HD2' ' A' ' 240' ' ' PRO . 5.0 p -63.32 168.72 4.67 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 126.308 1.843 . . . . 0.0 113.094 -177.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 36.3 Cg_endo -67.08 -33.37 31.93 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 121.306 1.337 . . . . 0.0 112.442 -171.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 -72.59 1.29 8.49 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.175 1.39 . . . . 0.0 113.079 176.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 21.6 m -127.84 -13.39 5.24 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.033 1.733 . . . . 0.0 113.982 -172.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 34.9 t -150.61 -40.9 0.13 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.717 0.689 . . . . 0.0 112.291 -177.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 40.4 tp60 -76.53 -16.25 59.67 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 118.792 -0.623 . . . . 0.0 112.679 -177.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 . . . . . 0 CA--C 1.541 0.603 0 C-N-CA 124.184 0.993 . . . . 0.0 113.027 172.354 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo . . . . . 0 CA--C 1.536 0.623 0 N-CA-C 111.075 -0.394 . . . . 0.0 111.075 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 71.3 p -143.07 173.46 11.54 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.638 1.175 . . . . 0.0 110.118 -177.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -135.77 -82.68 0.4 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 117.414 -1.279 . . . . 0.0 113.274 -168.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.4 t -54.28 166.03 0.46 Allowed 'General case' 0 C--N 1.35 0.614 0 C-N-CA 125.05 1.34 . . . . 0.0 112.731 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.9 pp -58.9 -11.12 2.95 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.471 1.108 . . . . 0.0 112.87 170.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 75.1 m -76.04 -19.93 58.21 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.667 1.987 . . . . 0.0 113.171 175.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 21.4 m170 57.9 62.92 1.93 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.996 2.118 . . . . 0.0 111.785 -173.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.7 159.65 33.09 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.356 1.462 . . . . 0.0 112.32 175.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.492 HG12 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -70.7 -178.45 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 126.267 1.827 . . . . 0.0 111.472 -176.811 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.492 ' H ' HG12 ' A' ' 204' ' ' VAL . 49.4 m -43.87 148.15 0.41 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 128.024 2.53 . . . . 0.0 113.915 178.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . 0.404 ' CE2' ' CD2' ' A' ' 223' ' ' HIS . 10.3 p90 -154.4 167.4 30.14 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.498 1.519 . . . . 0.0 111.103 -167.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -73.17 -43.86 37.75 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-O 118.719 -1.045 . . . . 0.0 115.136 -168.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -129.88 122.96 29.66 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 118.368 1.084 . . . . 0.0 110.654 -169.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -143.05 146.65 34.02 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -165.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 16.2 tt -140.62 155.94 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 126.278 1.831 . . . . 0.0 109.511 169.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -136.18 144.97 16.87 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 123.921 0.772 . . . . 0.0 112.261 -173.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 7.4 t -69.34 145.32 53.06 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-O 122.184 0.993 . . . . 0.0 110.938 -174.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -80.64 -6.75 58.79 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.704 2.001 . . . . 0.0 113.508 -174.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -80.55 145.78 59.63 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 118.557 0.617 . . . . 0.0 111.675 -169.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.42 6.13 4.21 Favored 'Trans proline' 0 CA--C 1.547 1.145 0 C-N-CA 123.629 2.886 . . . . 0.0 111.779 168.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -126.34 -8.12 6.39 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.074 1.749 . . . . 0.0 112.815 -172.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.9 t -65.4 133.36 51.17 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.822 0.849 . . . . 0.0 109.576 175.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 10.7 t -113.21 10.96 18.63 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.626 1.571 . . . . 0.0 111.702 -175.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 35.0 mm -118.84 -33.39 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 126.393 1.877 . . . . 0.0 109.242 176.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 50.45 -15.17 0.0 OUTLIER 'General case' 0 C--N 1.351 0.667 0 C-N-CA 131.591 3.956 . . . . 0.0 119.253 176.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -141.12 152.33 44.64 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.897 1.679 . . . . 0.0 110.427 178.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -154.22 154.49 33.58 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.71 1.604 . . . . 0.0 110.109 -170.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . 0.404 ' CD2' ' CE2' ' A' ' 206' ' ' TYR . 20.2 m170 -78.34 148.64 33.68 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 170.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -53.78 -50.69 65.51 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.719 167.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.62 -13.22 61.69 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 118.258 -0.877 . . . . 0.0 113.312 -176.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 3.5 m -76.41 -11.25 59.86 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.737 1.153 . . . . 0.0 112.441 172.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.2 p -117.69 -15.84 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 126.193 1.797 . . . . 0.0 112.269 171.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 94.87 20.06 29.64 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.888 1.709 . . . . 0.0 113.485 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 13.9 mt -71.61 156.98 38.78 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 118.854 1.327 . . . . 0.0 111.335 178.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 82.7 p -137.83 -11.84 1.52 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.419 1.487 . . . . 0.0 112.435 -178.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 59.2 m -148.48 134.07 18.75 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 126.263 1.825 . . . . 0.0 107.232 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -73.59 120.49 81.44 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 123.541 0.736 . . . . 0.0 111.587 -173.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -82.11 177.32 7.36 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.705 2.937 . . . . 0.0 111.194 170.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 36.0 ttp180 -142.58 135.0 27.78 Favored 'General case' 0 C--N 1.344 0.346 0 C-N-CA 124.239 1.016 . . . . 0.0 108.453 170.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 125.92 -167.49 18.31 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.65 1.595 . . . . 0.0 111.485 -177.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -59.39 119.41 7.41 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 124.601 1.16 . . . . 0.0 109.76 172.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 62.2 t90 -136.62 138.86 41.61 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 127.029 2.132 . . . . 0.0 108.103 175.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -115.88 132.71 56.56 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.346 1.059 . . . . 0.0 108.748 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 1.8 p -68.05 166.62 22.51 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 124.731 1.212 . . . . 0.0 112.467 -175.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -73.93 3.9 4.63 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.615 2.21 . . . . 0.0 114.698 -173.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 38.2 mtp180 -122.47 21.23 10.27 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.374 1.87 . . . . 0.0 111.017 171.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 18.6 m -133.45 -20.33 2.09 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.275 1.83 . . . . 0.0 112.506 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 31.2 t -150.29 -36.29 0.15 Allowed 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.635 1.107 . . . . 0.0 113.029 177.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 24.6 tp60 -74.17 -14.07 60.9 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.339 0.518 . . . . 0.0 112.087 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 . . . . . 0 CA--C 1.543 0.709 0 C-N-CA 125.793 1.637 . . . . 0.0 113.18 179.087 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo . . . . . 0 CA--C 1.536 0.594 0 N-CA-C 110.667 -0.551 . . . . 0.0 110.667 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 74.4 p -142.53 172.35 12.81 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.395 1.078 . . . . 0.0 110.204 -176.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -135.56 -83.88 0.39 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 117.327 -1.32 . . . . 0.0 112.765 -168.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.405 ' H ' HE22 ' A' ' 203' ' ' GLN . 2.0 t -55.82 168.48 0.44 Allowed 'General case' 0 C--N 1.351 0.646 0 CA-C-N 119.784 1.175 . . . . 0.0 113.173 -177.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.3 pp -57.24 -12.6 2.44 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.839 1.255 . . . . 0.0 112.902 170.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 75.2 m -77.6 -18.62 56.67 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.02 2.128 . . . . 0.0 113.171 176.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 27.6 m170 56.65 61.98 2.45 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.887 2.075 . . . . 0.0 111.729 -173.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . 0.405 HE22 ' H ' ' A' ' 199' ' ' CYS . 0.0 OUTLIER -126.38 158.96 34.57 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.287 1.435 . . . . 0.0 112.306 176.838 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.47 HG12 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -69.76 -178.97 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 126.347 1.859 . . . . 0.0 111.432 -177.192 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.47 ' H ' HG12 ' A' ' 204' ' ' VAL . 93.6 p -44.04 148.14 0.44 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.354 2.262 . . . . 0.0 113.754 177.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -153.04 167.02 30.6 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.775 1.23 . . . . 0.0 111.963 -167.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -68.79 -49.44 42.59 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.718 1.152 . . . . 0.0 114.68 -168.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -128.01 125.09 38.74 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 118.206 1.003 . . . . 0.0 109.978 -171.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -142.88 145.84 33.5 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -166.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 19.7 tt -134.64 150.57 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 125.5 1.52 . . . . 0.0 109.878 172.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -127.45 138.93 10.8 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.729 1.157 . . . . 0.0 112.575 -170.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . 0.59 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 2.2 m -77.86 126.09 30.33 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.568 1.547 . . . . 0.0 111.453 -168.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -70.18 -0.03 7.1 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.373 1.869 . . . . 0.0 113.533 -175.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -67.36 149.09 98.58 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 123.785 0.834 . . . . 0.0 111.635 -176.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -83.37 8.19 4.76 Favored 'Trans proline' 0 CA--C 1.549 1.235 0 C-N-CA 123.656 2.904 . . . . 0.0 111.431 166.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -144.52 -10.94 0.62 Allowed 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 -167.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 37.2 t -61.38 132.43 53.49 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 119.469 1.031 . . . . 0.0 110.671 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 9.3 t -103.95 4.45 34.67 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.696 1.599 . . . . 0.0 111.786 -172.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 41.8 mm -114.67 -41.81 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 125.599 1.559 . . . . 0.0 108.773 175.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 46.98 -8.08 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 131.567 3.947 . . . . 0.0 119.8 171.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 60.9 m95 -140.71 136.6 32.75 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 126.993 2.117 . . . . 0.0 109.391 171.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . 0.59 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 6.3 m-85 -144.75 153.93 42.2 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 125.47 1.508 . . . . 0.0 109.529 -169.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 29.1 m80 -70.93 149.41 46.74 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 168.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -52.37 -51.27 59.85 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 115.19 -0.913 . . . . 0.0 109.626 167.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.22 -14.22 62.52 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -177.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 3.3 m -78.08 -7.03 56.42 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.753 1.16 . . . . 0.0 112.628 172.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.2 p -122.19 -10.76 8.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 126.241 1.816 . . . . 0.0 112.276 169.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 94.16 16.52 43.72 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.736 1.636 . . . . 0.0 113.374 178.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 10.2 mt -70.48 157.65 37.48 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.554 1.177 . . . . 0.0 111.176 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 73.4 m -131.19 -5.02 3.86 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.369 1.868 . . . . 0.0 110.214 177.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 81.9 p -141.55 -175.31 4.32 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.007 2.123 . . . . 0.0 109.206 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -124.84 111.1 27.41 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 124.033 0.933 . . . . 0.0 109.077 177.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -74.19 177.4 8.31 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.473 2.782 . . . . 0.0 111.235 173.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 60.4 ttt-85 -139.1 132.2 29.65 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 171.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 115.97 -170.29 13.28 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.579 1.561 . . . . 0.0 110.855 -169.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.6 135.77 57.03 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.47 1.108 . . . . 0.0 111.468 177.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . 0.438 ' HZ3' ' HG ' ' A' ' 212' ' ' CYS . 58.2 t90 -142.49 143.84 32.73 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 127.556 2.342 . . . . 0.0 108.853 173.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -128.29 128.85 45.4 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.313 1.045 . . . . 0.0 109.372 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . 0.421 ' HB2' ' HD2' ' A' ' 240' ' ' PRO . 3.7 p -62.71 170.12 2.73 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 126.681 1.992 . . . . 0.0 113.845 -172.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.421 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 72.9 Cg_endo -74.1 0.23 8.69 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.672 2.248 . . . . 0.0 115.788 -169.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 76.5 mtm180 -117.97 17.01 14.22 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.224 1.41 . . . . 0.0 111.251 171.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 33.9 m -131.32 -17.67 2.96 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 126.166 1.786 . . . . 0.0 113.305 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 36.6 t -152.61 -40.02 0.1 Allowed 'General case' 0 C--N 1.343 0.292 0 CA-C-N 118.976 0.807 . . . . 0.0 112.55 176.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -74.82 -16.18 60.71 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 119.177 -0.439 . . . . 0.0 112.167 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.54 0.56 0 C-N-CA 124.376 1.071 . . . . 0.0 112.697 -178.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo . . . . . 0 N--CA 1.455 -0.765 0 N-CA-C 109.795 -0.887 . . . . 0.0 109.795 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 64.7 p -141.21 171.87 13.46 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.064 0.946 . . . . 0.0 110.118 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -133.45 -83.98 0.46 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 117.145 -1.407 . . . . 0.0 113.046 -168.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.484 ' H ' HE22 ' A' ' 203' ' ' GLN . 2.3 t -55.13 170.11 0.21 Allowed 'General case' 0 C--N 1.35 0.602 0 C-N-CA 124.841 1.256 . . . . 0.0 113.784 -175.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.2 pp -58.49 -13.91 6.67 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.175 0.99 . . . . 0.0 112.624 169.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 73.0 m -75.83 -23.4 55.75 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.887 2.075 . . . . 0.0 112.835 173.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 52.93 69.15 0.73 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 127.56 2.344 . . . . 0.0 112.045 -171.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . 0.484 HE22 ' H ' ' A' ' 199' ' ' CYS . 0.0 OUTLIER -124.43 160.45 28.17 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.887 1.675 . . . . 0.0 111.203 173.716 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.467 HG12 ' H ' ' A' ' 205' ' ' SER . 0.3 OUTLIER -68.51 -179.84 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 125.548 1.539 . . . . 0.0 111.129 -178.928 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.467 ' H ' HG12 ' A' ' 204' ' ' VAL . 83.2 p -44.39 145.82 0.78 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.972 2.109 . . . . 0.0 113.374 177.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . 0.455 ' CE2' ' HG2' ' A' ' 209' ' ' MET . 13.3 p90 -152.98 164.35 38.14 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.992 1.317 . . . . 0.0 111.466 -167.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -72.36 -60.51 4.05 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.273 0.939 . . . . 0.0 114.095 -169.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . 0.411 ' HB2' ' CD2' ' A' ' 224' ' ' PHE . 22.9 pt-20 -99.26 120.83 40.19 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 118.048 0.924 . . . . 0.0 110.284 -174.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . 0.455 ' HG2' ' CE2' ' A' ' 206' ' ' TYR . 17.6 mtp -141.51 143.1 33.63 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 -168.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 19.0 tt -134.64 157.94 41.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 126.185 1.794 . . . . 0.0 108.995 169.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -135.24 139.79 11.12 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 124.129 0.871 . . . . 0.0 112.466 -174.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . 0.606 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 5.6 m -75.47 124.82 27.81 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 125.029 1.331 . . . . 0.0 110.901 -168.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -71.88 -0.7 11.97 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.398 1.479 . . . . 0.0 113.221 -176.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -66.81 146.47 99.08 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 123.616 0.766 . . . . 0.0 111.065 -177.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -81.17 6.95 5.24 Favored 'Trans proline' 0 CA--C 1.549 1.271 0 C-N-CA 123.029 2.486 . . . . 0.0 111.376 166.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -134.44 -13.38 2.33 Favored 'General case' 0 C--N 1.35 0.593 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -169.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.5 t -64.63 135.09 55.57 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 119.145 0.884 . . . . 0.0 110.524 -175.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 32.2 m -108.32 7.69 27.32 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.766 1.626 . . . . 0.0 111.923 -174.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 37.8 mm -117.09 -41.2 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 125.732 1.613 . . . . 0.0 108.647 175.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 48.31 -9.71 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 131.623 3.969 . . . . 0.0 119.818 169.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -140.75 136.1 32.19 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.663 1.985 . . . . 0.0 109.032 171.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . 0.606 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 6.9 m-85 -144.56 156.8 44.32 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 125.939 1.695 . . . . 0.0 109.609 -169.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -73.24 148.9 43.24 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 167.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . 0.411 ' CD2' ' HB2' ' A' ' 208' ' ' GLU . 15.5 m-30 -51.63 -52.12 50.27 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.8 166.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.21 -12.99 61.77 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -177.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 2.0 m -77.56 -6.29 53.17 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.823 1.192 . . . . 0.0 112.665 172.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.62 -11.74 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 126.242 1.817 . . . . 0.0 112.396 170.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 96.3 16.33 38.02 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.604 1.574 . . . . 0.0 113.563 177.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 24.8 mt -72.4 163.29 28.23 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.777 1.289 . . . . 0.0 111.33 175.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 39.7 m -134.62 -21.69 1.72 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.595 1.558 . . . . 0.0 111.08 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 58.1 p -141.01 151.01 43.76 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 125.998 1.719 . . . . 0.0 108.826 176.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -76.55 125.56 87.24 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-O 118.846 -0.597 . . . . 0.0 110.248 -178.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -77.9 179.55 6.4 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.802 3.001 . . . . 0.0 111.441 174.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.08 125.37 21.74 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 124.966 1.307 . . . . 0.0 107.784 172.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 122.55 -174.8 16.36 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.545 1.545 . . . . 0.0 110.779 -169.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.25 142.19 55.69 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 122.133 0.968 . . . . 0.0 110.618 175.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . 0.446 ' HZ3' ' HG ' ' A' ' 212' ' ' CYS . 62.9 t90 -140.31 139.46 35.45 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.646 1.978 . . . . 0.0 109.234 175.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -125.43 123.56 39.53 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.029 1.331 . . . . 0.0 108.196 -178.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . 0.462 ' HB3' ' SG ' ' A' ' 212' ' ' CYS . 5.0 p -60.61 172.72 0.75 Allowed Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 127.799 2.44 . . . . 0.0 114.776 -170.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.447 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 68.5 Cg_endo -73.28 -0.35 9.06 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.778 2.319 . . . . 0.0 115.783 -169.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -117.48 15.95 14.67 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.617 1.567 . . . . 0.0 111.212 172.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 27.0 m -133.53 -15.94 2.4 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.725 2.01 . . . . 0.0 112.723 -176.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 35.1 t -151.1 -42.87 0.12 Allowed 'General case' 0 C--N 1.342 0.272 0 C-N-CA 123.857 0.863 . . . . 0.0 112.061 177.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -75.11 -13.65 60.5 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 . . . . . 0 CA--C 1.538 0.486 0 C-N-CA 126.178 1.791 . . . . 0.0 111.35 172.328 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo . . . . . 0 CA--C 1.535 0.567 0 CA-C-O 121.964 0.735 . . . . 0.0 113.005 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 32.6 p -142.53 179.12 7.15 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.451 1.9 . . . . 0.0 108.819 -178.495 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -138.08 -63.74 0.55 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.636 0.774 . . . . 0.0 111.83 176.042 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.446 ' SG ' ' HB2' ' A' ' 201' ' ' CYS . 4.8 p -59.8 165.6 3.04 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 128.489 2.716 . . . . 0.0 114.094 179.714 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 2.7 pp -77.93 0.53 23.85 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.565 167.319 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . 0.446 ' HB2' ' SG ' ' A' ' 199' ' ' CYS . 80.3 m -78.26 -26.93 47.41 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.917 0.887 . . . . 0.0 110.4 168.711 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . 0.282 82.3 m-70 70.32 53.4 0.33 Allowed 'General case' 0 C--N 1.343 0.286 0 C-N-CA 127.29 2.236 . . . . 0.0 113.095 169.605 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.24 172.9 12.22 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.608 -1.178 . . . . 0.0 109.587 166.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.436 HG12 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -62.49 174.09 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 125.229 1.412 . . . . 0.0 111.862 -174.981 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.436 ' H ' HG12 ' A' ' 204' ' ' VAL . 88.6 p -50.76 158.73 0.62 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.759 2.024 . . . . 0.0 114.833 -173.725 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -139.32 160.08 40.65 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.03 1.732 . . . . 0.0 110.484 -169.192 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -63.97 -35.36 91.9 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.36 0.981 . . . . 0.0 113.85 -171.279 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.05 118.04 16.34 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 124.589 1.156 . . . . 0.0 109.337 -170.767 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 1.3 mtm -135.68 151.2 49.96 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.074 -0.966 . . . . 0.0 113.329 -165.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 19.3 tt -142.71 146.36 22.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.274 0 C-N-CA 125.511 1.524 . . . . 0.0 110.794 169.076 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -122.53 142.44 14.78 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 125.189 1.376 . . . . 0.0 112.755 -170.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . 0.573 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 1.9 m -79.5 127.27 31.93 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 126.074 1.75 . . . . 0.0 112.051 -167.302 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -69.58 -0.99 7.59 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.28 1.832 . . . . 0.0 113.751 -176.61 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -68.42 146.36 97.79 Favored Pre-proline 0 CA--C 1.539 0.521 0 O-C-N 121.469 -0.769 . . . . 0.0 111.283 -175.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -82.01 6.75 5.49 Favored 'Trans proline' 0 CA--C 1.551 1.337 0 C-N-CA 123.1 2.534 . . . . 0.0 111.208 165.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -135.02 -13.15 2.15 Favored 'General case' 0 C--N 1.351 0.638 0 C-N-CA 125.25 1.42 . . . . 0.0 114.703 -169.261 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 36.5 t -64.92 134.31 53.69 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 119.139 0.881 . . . . 0.0 110.57 -176.126 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.9 t -108.71 8.61 26.95 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.679 1.591 . . . . 0.0 111.535 -173.275 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 38.9 mm -116.84 -42.29 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 125.728 1.611 . . . . 0.0 108.659 173.604 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 47.32 -7.68 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.737 1 C-N-CA 131.817 4.047 . . . . 0.0 119.453 171.838 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 51.2 m95 -140.85 139.82 34.51 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.851 2.06 . . . . 0.0 109.827 169.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . 0.573 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 6.7 m-85 -147.34 153.01 39.16 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.485 1.514 . . . . 0.0 108.479 -169.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -67.08 150.98 48.44 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 166.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -54.07 -47.76 71.36 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.915 167.037 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -69.44 -14.81 63.09 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 178.402 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 5.4 t -68.79 -18.56 64.21 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.841 0.856 . . . . 0.0 112.422 173.138 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.9 p -117.36 -12.62 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 126.244 1.818 . . . . 0.0 112.137 173.233 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 93.55 18.6 37.81 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.827 1.679 . . . . 0.0 113.512 179.069 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 11.5 mt -72.12 157.44 37.77 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-N 119.006 1.403 . . . . 0.0 111.419 178.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 39.7 m -131.95 0.57 3.87 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.384 1.874 . . . . 0.0 110.185 179.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 9.5 t -148.41 172.62 14.14 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.095 1.758 . . . . 0.0 109.876 179.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -110.18 94.28 17.78 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 125.164 1.386 . . . . 0.0 108.986 179.613 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.98 162.15 41.1 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.693 2.262 . . . . 0.0 110.937 170.109 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -145.4 134.55 22.78 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 124.333 1.053 . . . . 0.0 109.242 -178.654 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 138.22 -64.07 0.56 Allowed Glycine 0 CA--C 1.525 0.683 0 C-N-CA 127.13 2.3 . . . . 0.0 108.519 179.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -167.99 149.9 5.42 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 126.011 1.724 . . . . 0.0 110.486 169.611 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 48.3 t90 -146.46 148.63 32.45 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 126.701 2.0 . . . . 0.0 109.128 178.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -129.35 130.82 46.56 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.343 1.057 . . . . 0.0 109.701 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . 0.422 ' HB2' ' HD2' ' A' ' 240' ' ' PRO . 3.9 p -65.5 170.62 4.42 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 126.7 2.0 . . . . 0.0 113.716 -173.152 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 59.4 Cg_endo -70.09 -19.64 34.31 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.052 1.835 . . . . 0.0 113.768 -170.814 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 16.8 mmp_? -87.2 3.45 46.44 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.536 1.534 . . . . 0.0 112.606 175.207 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 34.6 m -132.94 -17.61 2.42 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.618 1.567 . . . . 0.0 113.931 -169.789 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 29.0 t -149.9 -33.76 0.18 Allowed 'General case' 0 C--N 1.342 0.255 0 CA-C-N 118.862 0.755 . . . . 0.0 112.973 -177.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -70.97 -23.78 62.28 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 118.211 -0.9 . . . . 0.0 111.329 177.143 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 . . . . . 0 C--N 1.348 0.527 0 C-N-CA 125.675 1.59 . . . . 0.0 113.56 175.114 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo . . . . . 0 CA--C 1.535 0.536 0 CA-C-O 121.296 0.457 . . . . 0.0 112.082 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 66.4 p -143.77 175.09 10.25 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.098 1.359 . . . . 0.0 110.335 -175.544 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -135.51 -79.89 0.43 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 117.291 -1.338 . . . . 0.0 112.537 -173.109 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.1 t -55.38 164.6 0.94 Allowed 'General case' 0 C--N 1.349 0.566 0 CA-C-N 119.692 1.133 . . . . 0.0 112.784 -177.35 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.17 -5.36 3.15 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.005 0.922 . . . . 0.0 112.849 170.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 89.0 m -76.35 -21.97 55.46 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.165 1.786 . . . . 0.0 113.141 169.8 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 55.93 69.25 0.76 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 127.051 2.141 . . . . 0.0 111.951 -169.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.82 159.05 37.76 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.488 1.515 . . . . 0.0 111.886 172.317 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.506 HG12 ' H ' ' A' ' 205' ' ' SER . 0.7 OUTLIER -67.78 -177.9 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 126.263 1.825 . . . . 0.0 110.934 -179.039 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.506 ' H ' HG12 ' A' ' 204' ' ' VAL . 88.3 p -44.1 149.43 0.34 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.416 2.287 . . . . 0.0 113.9 176.054 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -153.53 168.92 24.55 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.205 1.402 . . . . 0.0 111.583 -167.226 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -72.66 -49.25 19.19 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-O 118.811 -0.994 . . . . 0.0 114.638 -169.092 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -124.96 121.78 35.44 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 118.233 1.016 . . . . 0.0 110.136 -170.062 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -140.36 146.32 38.26 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -166.016 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 20.1 tt -135.25 150.21 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 125.533 1.533 . . . . 0.0 109.802 170.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -127.33 138.84 10.76 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.539 1.066 . . . . 0.0 112.2 -172.798 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . 0.601 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 3.0 m -76.16 123.42 25.82 Favored 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 125.06 1.344 . . . . 0.0 110.779 -168.738 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -72.54 4.32 4.0 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.915 1.686 . . . . 0.0 112.938 -175.817 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -68.3 149.17 98.17 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 124.214 1.006 . . . . 0.0 111.469 -179.612 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -81.85 1.04 9.5 Favored 'Trans proline' 0 CA--C 1.549 1.235 0 C-N-CA 123.184 2.589 . . . . 0.0 111.831 166.447 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -135.53 -7.82 2.2 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -169.33 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.2 t -63.42 134.64 56.02 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 119.84 1.2 . . . . 0.0 110.836 -178.464 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 10.7 t -107.98 9.17 28.62 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.71 1.604 . . . . 0.0 111.712 -173.095 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 38.2 mm -118.64 -41.36 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 125.419 1.488 . . . . 0.0 108.771 173.678 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 48.11 -9.14 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 131.537 3.935 . . . . 0.0 119.644 171.014 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 60.9 m95 -139.8 136.29 33.91 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.834 2.054 . . . . 0.0 109.411 170.156 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . 0.601 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 7.2 m-85 -143.85 154.91 43.86 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 125.599 1.56 . . . . 0.0 109.276 -169.212 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 20.7 m170 -72.84 148.75 44.17 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 169.113 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 15.4 m-30 -51.93 -50.58 60.88 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.937 167.685 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.13 -14.0 62.14 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -177.721 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 7.5 m -78.37 -1.93 35.78 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.799 1.181 . . . . 0.0 112.657 172.714 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 6.1 p -128.22 -13.64 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 125.841 1.656 . . . . 0.0 112.659 169.11 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 99.53 16.44 29.23 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.66 1.6 . . . . 0.0 113.535 178.135 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 18.5 mt -74.39 163.19 28.08 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.799 1.299 . . . . 0.0 111.537 177.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 41.6 m -136.51 -21.81 1.31 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.581 1.552 . . . . 0.0 111.256 -178.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 89.1 m -141.03 142.77 34.18 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 125.713 1.605 . . . . 0.0 108.033 -179.207 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -68.45 120.53 75.78 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 123.957 0.903 . . . . 0.0 110.459 -178.721 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -79.46 -174.21 2.18 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.785 2.99 . . . . 0.0 111.135 173.655 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -143.96 133.68 23.72 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.58 1.152 . . . . 0.0 108.439 174.847 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 105.46 -169.05 15.86 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.114 1.34 . . . . 0.0 112.199 -176.234 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.83 123.61 15.63 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 125.712 1.605 . . . . 0.0 110.953 178.046 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . 0.411 ' HZ3' ' HG ' ' A' ' 212' ' ' CYS . 61.1 t90 -134.18 133.95 41.54 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.424 1.89 . . . . 0.0 108.865 171.042 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -119.08 128.25 54.15 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.696 1.198 . . . . 0.0 108.086 178.41 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . 0.467 ' HB2' ' HD2' ' A' ' 240' ' ' PRO . 12.3 p -62.1 172.55 1.16 Allowed Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 127.382 2.273 . . . . 0.0 113.865 -173.124 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 42.2 Cg_endo -68.31 -26.05 35.75 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 121.653 1.569 . . . . 0.0 114.423 -169.376 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -82.34 6.65 16.32 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.821 1.249 . . . . 0.0 112.931 173.696 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 32.9 m -134.41 -15.09 2.2 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.385 1.474 . . . . 0.0 114.223 -170.19 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.6 t -152.27 -31.0 0.15 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.924 0.783 . . . . 0.0 112.885 179.056 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -86.24 -12.3 50.04 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 118.83 -0.605 . . . . 0.0 112.624 -177.247 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 . . . . . 0 C--N 1.346 0.437 0 C-N-CA 123.744 0.818 . . . . 0.0 109.916 -178.594 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo . . . . . 0 CA--C 1.535 0.557 0 CA-C-O 121.216 0.423 . . . . 0.0 111.87 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 72.0 p -143.18 174.42 10.72 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.834 1.254 . . . . 0.0 110.613 -173.204 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -135.27 -79.17 0.44 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 117.389 -1.291 . . . . 0.0 113.312 -171.329 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.5 t -56.64 168.61 0.57 Allowed 'General case' 0 C--N 1.349 0.574 0 C-N-CA 124.998 1.319 . . . . 0.0 113.374 -174.823 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 4.3 pp -59.17 -11.81 4.34 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.439 1.096 . . . . 0.0 112.744 169.299 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 73.4 m -76.09 -24.39 55.03 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.649 1.98 . . . . 0.0 112.927 173.483 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 55.04 69.57 0.72 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 127.218 2.207 . . . . 0.0 111.621 -170.063 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.48 163.61 25.53 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.556 1.542 . . . . 0.0 111.557 173.344 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.513 HG12 ' H ' ' A' ' 205' ' ' SER . 0.4 OUTLIER -68.88 -179.44 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 125.694 1.597 . . . . 0.0 111.427 -176.738 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.513 ' H ' HG12 ' A' ' 204' ' ' VAL . 83.6 p -47.61 153.37 0.57 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.587 2.355 . . . . 0.0 114.592 178.461 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -154.49 167.47 29.95 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.278 1.831 . . . . 0.0 110.395 -169.062 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -77.93 -39.5 23.95 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 118.673 -1.07 . . . . 0.0 115.224 -168.697 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.65 118.93 19.75 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.614 1.207 . . . . 0.0 110.199 -168.49 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -141.81 152.29 43.56 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -164.282 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 15.2 tt -147.84 152.54 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 126.055 1.742 . . . . 0.0 109.859 168.168 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -132.44 146.66 18.37 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 124.118 0.866 . . . . 0.0 112.04 -169.819 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 4.2 t -70.48 144.08 51.52 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-O 122.016 0.913 . . . . 0.0 111.368 -172.158 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -78.91 -8.54 58.95 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.265 1.826 . . . . 0.0 113.686 -174.536 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 25.6 m-20 -77.28 146.1 73.81 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-N 118.533 0.606 . . . . 0.0 111.933 -168.361 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.4 8.83 2.76 Favored 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 124.135 3.223 . . . . 0.0 112.372 169.047 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -132.69 -8.19 3.19 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.365 1.866 . . . . 0.0 112.191 -170.478 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 39.0 t -62.97 136.12 57.67 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.956 0.902 . . . . 0.0 109.864 172.585 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.9 t -121.24 14.31 11.28 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.885 1.674 . . . . 0.0 111.062 -176.003 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 35.9 mm -119.6 -32.67 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 126.646 1.978 . . . . 0.0 109.235 175.41 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 51.26 -16.52 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.664 1 C-N-CA 132.007 4.123 . . . . 0.0 119.292 174.702 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 55.0 m95 -141.93 151.51 42.66 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.843 1.657 . . . . 0.0 110.468 179.007 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -153.68 154.86 34.92 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.103 1.361 . . . . 0.0 110.152 -172.265 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -77.18 147.65 36.36 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 169.767 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -54.75 -49.53 70.63 Favored 'General case' 0 C--O 1.222 -0.342 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.928 167.665 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -68.6 -16.14 63.76 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -179.551 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 2.6 m -76.66 -18.37 58.6 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 119.866 1.212 . . . . 0.0 112.616 174.787 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.8 p -105.5 -14.49 8.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 124.913 1.285 . . . . 0.0 111.524 168.686 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 92.58 20.88 33.22 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.786 1.66 . . . . 0.0 113.378 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 10.1 mt -74.91 157.61 34.74 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 118.738 1.269 . . . . 0.0 111.35 178.508 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 50.0 m -127.76 -9.55 5.55 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.34 1.856 . . . . 0.0 110.265 179.422 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 77.3 p -140.91 178.05 7.62 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.786 2.035 . . . . 0.0 109.427 179.143 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -110.94 107.21 57.81 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 124.1 0.96 . . . . 0.0 108.926 178.145 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -71.28 176.46 7.87 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.547 2.831 . . . . 0.0 111.848 175.547 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.14 133.22 36.99 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.042 1.337 . . . . 0.0 108.256 -175.123 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 107.41 -162.8 13.23 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.413 1.482 . . . . 0.0 111.464 -174.657 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -61.25 127.18 30.25 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.0 1.32 . . . . 0.0 109.195 173.731 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -132.26 149.18 52.43 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.397 1.879 . . . . 0.0 109.118 178.377 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -128.68 130.29 46.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.116 1.366 . . . . 0.0 109.994 -174.152 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.26 167.41 10.23 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.411 175.211 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.66 -37.49 16.34 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 120.907 1.071 . . . . 0.0 111.972 -174.051 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 64.9 mtp85 -72.84 1.89 7.77 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.063 1.345 . . . . 0.0 113.084 176.073 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 9.2 m -120.13 -13.9 8.9 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.401 1.481 . . . . 0.0 114.328 -175.041 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 33.3 t -151.92 -38.52 0.12 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.545 1.066 . . . . 0.0 113.12 176.552 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -73.62 -27.88 61.51 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.372 0.669 . . . . 0.0 112.174 -178.68 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 . . . . . 0 CA--C 1.543 0.687 0 C-N-CA 124.97 1.308 . . . . 0.0 112.834 -174.702 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo . . . . . 0 CA--C 1.536 0.582 0 CA-C-O 121.776 0.656 . . . . 0.0 113.135 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 33.8 p -140.99 175.14 9.86 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.36 1.864 . . . . 0.0 108.97 178.46 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -135.36 -68.71 0.51 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.842 0.857 . . . . 0.0 111.166 176.022 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.432 ' SG ' ' HB2' ' A' ' 201' ' ' CYS . 5.5 p -53.74 163.71 0.66 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 128.352 2.661 . . . . 0.0 114.089 177.253 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.0 pp -77.17 -1.5 29.68 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.781 167.86 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . 0.432 ' HB2' ' SG ' ' A' ' 199' ' ' CYS . 78.2 m -75.19 -28.73 60.13 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.942 0.897 . . . . 0.0 110.207 168.551 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . 0.297 88.3 m-70 70.48 54.72 0.29 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 127.727 2.411 . . . . 0.0 113.309 169.605 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -137.3 172.88 12.33 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 114.559 -1.201 . . . . 0.0 109.484 166.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.421 HG12 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -62.67 173.88 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 125.116 1.366 . . . . 0.0 111.803 -174.961 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.421 ' H ' HG12 ' A' ' 204' ' ' VAL . 87.7 p -50.62 158.58 0.62 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.73 2.012 . . . . 0.0 114.889 -173.793 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -139.85 161.22 38.1 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.016 1.726 . . . . 0.0 110.708 -169.118 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -64.14 -35.76 92.39 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.449 1.023 . . . . 0.0 113.838 -171.651 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.63 118.48 17.24 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 124.495 1.118 . . . . 0.0 109.289 -170.74 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 1.2 mtm -134.36 149.58 50.85 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.203 -0.908 . . . . 0.0 113.402 -166.096 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 21.3 tt -139.71 145.5 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 C-N-CA 125.758 1.623 . . . . 0.0 110.544 169.987 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -124.91 139.54 11.78 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.873 1.225 . . . . 0.0 112.732 -170.429 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . 0.597 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 2.8 m -78.27 124.93 28.64 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 126.078 1.751 . . . . 0.0 111.664 -167.715 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -70.43 -2.77 14.82 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.064 1.745 . . . . 0.0 113.467 -176.898 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -62.72 149.07 90.15 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 123.724 0.81 . . . . 0.0 111.598 -174.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -81.23 6.75 5.39 Favored 'Trans proline' 0 CA--C 1.548 1.2 0 C-N-CA 123.491 2.794 . . . . 0.0 111.798 167.464 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -146.37 -8.85 0.51 Allowed 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -167.75 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 37.3 t -61.35 134.35 56.84 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-N 119.866 1.212 . . . . 0.0 110.851 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 27.1 m -108.14 7.67 27.68 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.647 1.579 . . . . 0.0 111.657 -173.155 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 39.1 mm -116.33 -42.22 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 125.668 1.587 . . . . 0.0 108.536 175.007 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 48.7 -9.62 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 131.509 3.924 . . . . 0.0 119.49 171.191 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 50.2 m95 -140.15 140.46 35.96 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.94 2.096 . . . . 0.0 109.662 169.632 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . 0.597 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 6.8 m-85 -147.71 155.18 41.47 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.936 1.694 . . . . 0.0 108.604 -169.481 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -68.68 150.39 47.99 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 166.245 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -53.64 -48.06 69.72 Favored 'General case' 0 C--O 1.223 -0.334 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 166.786 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -68.55 -15.13 63.43 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 178.625 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 8.7 t -68.93 -24.71 64.32 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.075 0.852 . . . . 0.0 112.261 174.205 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.3 p -106.61 -15.8 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.787 1.635 . . . . 0.0 112.119 171.204 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 97.05 17.66 31.6 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.956 1.741 . . . . 0.0 113.487 178.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 16.8 mt -72.91 158.5 35.38 Favored 'General case' 0 C--N 1.345 0.411 0 CA-C-N 119.093 1.446 . . . . 0.0 111.543 178.527 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.5 t -135.86 -0.53 2.55 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.153 1.781 . . . . 0.0 111.794 179.408 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 40.1 p -143.41 162.18 36.45 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.056 2.142 . . . . 0.0 109.279 175.43 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -98.05 114.42 65.08 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 123.811 0.844 . . . . 0.0 109.613 178.043 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -78.24 179.02 6.89 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 123.758 2.972 . . . . 0.0 111.531 175.502 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 15.3 ttm180 -139.36 135.32 33.59 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.028 1.331 . . . . 0.0 107.489 169.685 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 117.14 -166.84 12.52 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.314 1.435 . . . . 0.0 111.476 -176.573 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -65.88 120.58 13.32 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.629 1.172 . . . . 0.0 110.128 177.028 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 70.0 t90 -129.27 137.66 51.19 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 126.111 1.764 . . . . 0.0 108.984 174.195 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -125.97 125.14 42.23 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.778 1.231 . . . . 0.0 108.681 -178.027 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . 0.442 ' HB2' ' HD2' ' A' ' 240' ' ' PRO . 2.9 p -59.18 171.97 0.64 Allowed Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 127.7 2.4 . . . . 0.0 114.412 -172.429 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . 0.442 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 43.1 Cg_endo -68.3 -23.43 38.59 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 121.761 1.641 . . . . 0.0 113.913 -169.628 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -92.41 12.65 22.0 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.645 1.178 . . . . 0.0 112.583 174.86 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 27.6 m -131.7 -14.21 3.22 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.018 1.727 . . . . 0.0 113.397 -176.664 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 32.4 t -149.69 -40.1 0.14 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.838 0.855 . . . . 0.0 112.012 178.618 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -77.63 -13.71 59.83 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -175.041 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 . . . . . 0 CA--C 1.541 0.609 0 C-N-CA 123.996 0.918 . . . . 0.0 112.863 171.604 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo . . . . . 0 CA--C 1.535 0.529 0 CA-C-O 121.348 0.478 . . . . 0.0 112.229 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 33.4 p -145.28 173.96 11.52 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.924 1.689 . . . . 0.0 109.308 -178.087 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -135.83 -72.79 0.46 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.952 0.901 . . . . 0.0 112.392 -176.829 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 199' ' ' CYS . . . . . 0.424 ' SG ' ' HB2' ' A' ' 201' ' ' CYS . 2.6 p -51.62 163.6 0.28 Allowed 'General case' 0 C--N 1.339 0.111 0 C-N-CA 129.342 3.057 . . . . 0.0 114.627 176.203 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 4.1 pp -69.5 -7.62 39.73 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.982 167.352 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 201' ' ' CYS . . . . . 0.424 ' HB2' ' SG ' ' A' ' 199' ' ' CYS . 83.3 m -77.06 -30.39 55.52 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.59 1.156 . . . . 0.0 111.017 172.488 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 202' ' ' HIS . . . . . . . . . . . . 0.291 89.2 m-70 69.14 57.93 0.36 Allowed 'General case' 0 C--N 1.339 0.15 0 C-N-CA 127.487 2.315 . . . . 0.0 113.267 169.809 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -136.42 171.61 14.22 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 114.119 -1.401 . . . . 0.0 109.427 166.398 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 204' ' ' VAL . . . . . 0.488 HG12 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -64.23 175.71 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 125.093 1.357 . . . . 0.0 111.939 -175.311 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 205' ' ' SER . . . . . 0.488 ' H ' HG12 ' A' ' 204' ' ' VAL . 20.1 m -45.19 154.42 0.16 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 128.128 2.571 . . . . 0.0 115.245 -173.53 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -142.08 158.45 43.74 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.107 1.763 . . . . 0.0 110.037 -173.569 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -62.66 -36.34 93.13 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.188 0.899 . . . . 0.0 114.08 -169.801 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.96 117.95 15.31 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 124.446 1.098 . . . . 0.0 109.742 -170.354 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 1.4 mtm -136.33 150.4 48.84 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.257 -0.883 . . . . 0.0 113.107 -166.801 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 13.1 tt -146.68 149.65 15.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 126.363 1.865 . . . . 0.0 110.077 169.38 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -134.02 147.23 18.99 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 124.063 0.84 . . . . 0.0 112.767 -169.538 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 3.0 t -70.8 143.69 51.07 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-O 121.893 0.854 . . . . 0.0 111.073 -173.128 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -83.9 -6.03 59.34 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 113.529 -1.669 . . . . 0.0 113.252 -174.261 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 22.9 m-20 -73.98 147.61 86.22 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 118.589 0.631 . . . . 0.0 111.696 -168.701 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -75.78 8.9 2.5 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 124.116 3.211 . . . . 0.0 112.554 169.343 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -135.25 -6.7 2.3 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.107 1.763 . . . . 0.0 112.327 -170.044 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.7 t -62.98 136.03 57.62 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.035 0.934 . . . . 0.0 110.01 172.998 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 11.8 t -118.9 12.79 12.97 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.771 1.629 . . . . 0.0 111.202 -175.846 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 25.5 mm -122.14 -32.18 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 126.065 1.746 . . . . 0.0 109.608 177.491 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 50.49 -11.29 0.0 OUTLIER 'General case' 0 C--N 1.349 0.576 0 C-N-CA 131.065 3.746 . . . . 0.0 119.131 177.359 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 52.4 m95 -145.59 156.09 43.46 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.768 1.627 . . . . 0.0 111.417 179.403 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -158.81 155.4 27.81 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 126.716 2.006 . . . . 0.0 109.081 -175.402 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 51.4 m80 -70.8 151.35 44.91 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 166.932 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -55.47 -47.06 76.69 Favored 'General case' 0 C--O 1.223 -0.29 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 166.592 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -66.73 -14.21 62.28 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 177.504 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 2.6 t -67.09 -31.29 71.68 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.24 0.927 . . . . 0.0 112.106 174.016 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.4 p -101.28 -14.41 8.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 125.964 1.705 . . . . 0.0 112.216 171.665 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 89.81 22.57 35.85 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.697 1.618 . . . . 0.0 113.256 -178.967 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 8.8 mt -69.83 157.94 36.43 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-N 118.886 1.343 . . . . 0.0 111.59 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 74.7 p -128.36 -1.9 5.62 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.047 1.739 . . . . 0.0 111.605 -178.252 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 11.3 t -152.76 170.16 20.98 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.151 1.78 . . . . 0.0 109.578 178.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -97.92 110.49 55.84 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.25 1.02 . . . . 0.0 108.876 175.231 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -71.34 -176.23 1.85 Allowed 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 124.016 3.144 . . . . 0.0 111.788 174.148 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -142.85 135.4 27.67 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.606 1.162 . . . . 0.0 108.668 -176.048 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 93.82 -172.52 32.63 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 125.041 1.305 . . . . 0.0 111.452 -170.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.36 136.02 49.64 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.926 1.291 . . . . 0.0 111.716 176.425 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 61.6 t90 -139.9 153.11 46.89 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 127.15 2.18 . . . . 0.0 108.972 -177.813 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -128.69 130.7 47.52 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.86 1.264 . . . . 0.0 110.048 -173.303 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -66.27 169.1 7.83 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.839 1.256 . . . . 0.0 112.985 -177.131 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.9 0.72 8.95 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.479 2.12 . . . . 0.0 114.65 -171.412 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 81.8 mtt-85 -128.68 24.31 5.76 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.835 1.254 . . . . 0.0 110.541 168.741 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 11.6 m -123.79 -17.13 6.45 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 126.494 1.918 . . . . 0.0 112.059 171.974 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 36.8 t -150.92 -32.03 0.17 Allowed 'General case' 0 C--N 1.348 0.529 0 CA-C-N 119.477 1.035 . . . . 0.0 113.316 173.418 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -70.58 -18.42 62.9 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 118.969 0.804 . . . . 0.0 112.462 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 . . . . . 0 CA--C 1.542 0.638 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 172.082 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 77.2 mtm . . . . . 0 N--CA 1.476 0.871 0 N-CA-C 110.197 -0.297 . . . . 0.0 110.197 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 16.2 m-20 56.38 -164.03 0.15 Allowed 'General case' 0 CA--C 1.543 0.69 0 C-N-CA 125.554 1.542 . . . . 0.0 112.857 179.737 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 2.4 mpt? -131.52 66.33 78.08 Favored Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 125.077 1.351 . . . . 0.0 109.263 179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -70.16 168.52 21.84 Favored 'Trans proline' 0 C--N 1.353 0.773 0 C-N-CA 123.601 2.867 . . . . 0.0 112.088 179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.483 HG12 ' H ' ' A' ' 192' ' ' ASP . 1.4 t -140.88 176.49 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 C-N-CA 125.963 1.705 . . . . 0.0 107.456 -178.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.483 ' H ' HG12 ' A' ' 191' ' ' VAL . 10.6 m-20 -54.59 157.72 4.91 Favored Pre-proline 0 CA--C 1.542 0.65 0 C-N-CA 127.006 2.123 . . . . 0.0 112.956 179.202 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -71.41 10.28 0.78 Allowed 'Trans proline' 0 CA--C 1.546 1.125 0 C-N-CA 123.859 3.039 . . . . 0.0 112.926 169.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 -117.96 36.03 4.49 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.853 2.061 . . . . 0.0 110.325 -178.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -133.09 97.01 16.99 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 125.748 1.619 . . . . 0.0 108.384 -171.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 91.0 Cg_endo -78.53 149.28 23.94 Favored 'Trans proline' 0 C--N 1.351 0.696 0 C-N-CA 123.592 2.862 . . . . 0.0 111.593 -178.189 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 81.7 p -129.35 173.86 10.15 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.091 1.356 . . . . 0.0 110.559 -171.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 98.4 m-85 -133.56 -81.97 0.47 Allowed 'General case' 0 CA--C 1.536 0.406 0 CA-C-O 117.464 -1.255 . . . . 0.0 113.283 -168.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.3 t -55.53 166.65 0.61 Allowed 'General case' 0 C--N 1.35 0.607 0 C-N-CA 124.996 1.318 . . . . 0.0 112.814 -178.83 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 4.1 pp -58.86 -11.45 3.3 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.695 1.198 . . . . 0.0 112.806 170.51 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 73.6 m -76.38 -19.48 58.12 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 126.501 1.92 . . . . 0.0 113.042 175.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 17.0 m170 57.75 62.07 2.22 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 126.846 2.059 . . . . 0.0 111.56 -173.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.5 162.42 25.67 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.337 1.455 . . . . 0.0 112.277 176.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -66.77 179.92 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.737 0 C-N-CA 125.912 1.685 . . . . 0.0 112.367 -176.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . . . . . . . . . 87.4 p -49.04 153.48 0.9 Allowed 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.195 2.198 . . . . 0.0 113.913 175.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 10.1 p90 -158.24 170.84 21.36 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 125.7 1.6 . . . . 0.0 110.761 -167.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -77.2 -62.35 2.47 Favored Glycine 0 CA--C 1.529 0.923 0 CA-C-O 119.196 -0.78 . . . . 0.0 113.569 -170.005 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 25.6 pt-20 -105.89 121.87 44.95 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 117.815 0.808 . . . . 0.0 110.63 -172.151 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -143.88 145.89 32.62 Favored 'General case' 0 C--N 1.341 0.214 0 N-CA-C 112.813 0.671 . . . . 0.0 112.813 -167.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 15.6 tt -142.64 154.28 17.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 125.412 1.485 . . . . 0.0 109.28 169.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -133.25 144.99 17.07 Favored Glycine 0 CA--C 1.522 0.5 0 C-N-CA 123.727 0.68 . . . . 0.0 112.242 -169.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 11.9 t -67.99 145.92 54.05 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-O 122.036 0.922 . . . . 0.0 110.467 -174.106 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -94.4 2.46 55.78 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 113.509 -1.678 . . . . 0.0 112.694 -171.53 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 87.9 m-20 -77.63 147.06 74.23 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 119.172 0.896 . . . . 0.0 110.473 177.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 82.3 Cg_endo -76.71 8.07 3.23 Favored 'Trans proline' 0 CA--C 1.547 1.14 0 C-N-CA 123.542 2.828 . . . . 0.0 111.775 167.77 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 18.5 m-20 -127.46 -6.77 5.81 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.344 1.857 . . . . 0.0 112.436 -171.532 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 37.9 t -64.45 131.22 46.52 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 123.651 0.78 . . . . 0.0 109.742 175.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.7 t -109.15 9.72 26.06 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.42 1.488 . . . . 0.0 111.743 -173.577 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 32.7 mm -121.95 -31.92 1.39 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 C-N-CA 126.058 1.743 . . . . 0.0 109.677 176.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 51.6 -15.7 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 131.318 3.847 . . . . 0.0 119.327 175.413 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 58.1 m95 -139.04 151.04 46.47 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.713 1.605 . . . . 0.0 110.578 178.088 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 88.0 m-85 -152.95 152.69 31.73 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 125.175 1.39 . . . . 0.0 110.233 -171.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 19.6 m170 -76.28 149.4 37.12 Favored 'General case' 0 N--CA 1.454 -0.237 0 CA-C-N 115.407 -0.815 . . . . 0.0 108.959 169.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 8.9 m-30 -52.31 -51.2 60.0 Favored 'General case' 0 C--O 1.224 -0.245 0 CA-C-N 115.06 -0.973 . . . . 0.0 109.829 167.731 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.82 -14.08 62.28 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-O 118.361 -0.828 . . . . 0.0 113.2 -177.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 9.4 m -79.04 -2.42 40.3 Favored 'General case' 0 N--CA 1.446 -0.667 0 CA-C-N 119.586 1.085 . . . . 0.0 112.511 172.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 1.2 p -126.61 -14.08 3.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 125.32 1.448 . . . . 0.0 112.456 169.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 97.16 20.33 23.54 Favored Glycine 0 CA--C 1.534 1.255 0 C-N-CA 125.485 1.517 . . . . 0.0 113.642 -179.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 10.9 mt -75.41 160.31 30.39 Favored 'General case' 0 CA--C 1.535 0.376 0 CA-C-N 118.803 1.301 . . . . 0.0 111.544 178.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 38.4 m -132.31 -10.74 3.26 Favored 'General case' 0 CA--C 1.545 0.766 0 C-N-CA 126.288 1.835 . . . . 0.0 110.648 178.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 77.5 p -142.27 -174.88 4.24 Favored 'General case' 0 CA--C 1.541 0.618 0 C-N-CA 126.798 2.039 . . . . 0.0 109.15 179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 76.8 tttt -120.92 98.66 47.46 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 123.856 0.862 . . . . 0.0 110.451 -176.103 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -70.94 170.68 17.4 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.685 2.257 . . . . 0.0 111.002 169.803 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 42.9 ttp180 -141.74 133.54 27.22 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.716 1.206 . . . . 0.0 108.492 179.125 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 129.85 -163.57 22.8 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 126.022 1.772 . . . . 0.0 110.85 -174.127 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.7 ttmp? -61.8 115.63 4.16 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.109 0.963 . . . . 0.0 109.284 169.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 53.0 t90 -132.93 142.7 49.03 Favored 'General case' 0 N--CA 1.449 -0.515 0 C-N-CA 126.31 1.844 . . . . 0.0 107.825 175.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 21.1 m-30 -125.49 139.37 53.69 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.154 0.981 . . . . 0.0 110.801 -178.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . 0.4 ' HB2' ' HD2' ' A' ' 240' ' ' PRO . 7.4 p -71.46 173.36 5.22 Favored Pre-proline 0 CA--C 1.546 0.819 0 C-N-CA 125.888 1.675 . . . . 0.0 111.888 -179.174 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.4 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 68.8 Cg_endo -70.31 -33.2 14.94 Favored 'Trans proline' 0 C--N 1.351 0.665 0 C-N-CA 121.217 1.278 . . . . 0.0 113.655 -168.86 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -75.13 -4.72 40.35 Favored 'General case' 0 CA--C 1.537 0.451 0 N-CA-C 113.551 0.945 . . . . 0.0 113.551 173.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 22.2 m -112.99 -17.95 12.33 Favored 'General case' 0 N--CA 1.45 -0.466 0 C-N-CA 124.745 1.218 . . . . 0.0 113.459 -171.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 22.1 t -152.94 -35.18 0.11 Allowed 'General case' 0 C--N 1.343 0.303 0 CA-C-N 119.093 0.861 . . . . 0.0 113.294 177.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 2.3 tp-100 -72.41 -14.59 61.74 Favored 'General case' 0 CA--C 1.542 0.655 0 CA-C-N 118.23 0.468 . . . . 0.0 112.164 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -64.71 -25.06 67.77 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.494 1.117 . . . . 0.0 111.804 177.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 51.2 ttt180 -80.1 53.03 1.64 Allowed 'General case' 0 CA--C 1.545 0.777 0 C-N-CA 125.793 1.637 . . . . 0.0 111.407 178.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 6.6 tmtt? -140.36 37.31 1.88 Allowed 'General case' 0 CA--C 1.544 0.716 0 C-N-CA 125.673 1.589 . . . . 0.0 109.81 -178.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 23.1 ttmm 51.12 63.84 2.08 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.46 1.904 . . . . 0.0 112.001 -178.223 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 6.5 tmtm? . . . . . 0 C--O 1.251 1.143 0 C-N-CA 126.551 1.941 . . . . 0.0 111.204 179.737 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 1.9 mpt? . . . . . 0 N--CA 1.479 0.98 0 CA-C-O 118.725 -0.655 . . . . 0.0 111.915 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 38.5 t70 -141.95 160.66 39.75 Favored 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 124.721 1.209 . . . . 0.0 110.508 -176.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 65.6 mtt -144.28 154.69 57.61 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 125.538 1.535 . . . . 0.0 110.168 -178.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -74.07 84.19 1.53 Allowed 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 124.382 3.388 . . . . 0.0 109.899 172.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . 0.313 2.7 m 53.43 148.61 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.471 0 C-N-CA 130.537 3.535 . . . . 0.0 115.394 -169.069 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -71.33 154.34 93.69 Favored Pre-proline 0 CA--C 1.539 0.52 0 CA-C-N 114.806 -1.088 . . . . 0.0 111.55 178.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -74.39 8.14 2.32 Favored 'Trans proline' 0 CA--C 1.547 1.146 0 C-N-CA 123.632 2.888 . . . . 0.0 112.245 168.885 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 30.2 m-80 -120.18 33.34 5.64 Favored 'General case' 0 CA--C 1.54 0.593 0 C-N-CA 126.805 2.042 . . . . 0.0 110.606 -176.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 27.7 tp10 -141.88 125.18 9.67 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 125.539 1.536 . . . . 0.0 108.481 -170.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 61.8 Cg_endo -71.12 161.11 47.05 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 123.106 2.538 . . . . 0.0 112.77 -177.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 34.2 p -142.83 175.32 9.91 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 126.116 1.766 . . . . 0.0 109.223 -178.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 19.9 m-85 -136.3 -67.34 0.52 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.995 0.918 . . . . 0.0 111.573 178.767 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.438 ' SG ' ' HB2' ' A' ' 201' ' ' CYS . 4.5 p -56.71 163.72 1.76 Allowed 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 128.388 2.675 . . . . 0.0 113.811 176.308 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.3 pp -77.02 -1.13 27.31 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.865 -1.062 . . . . 0.0 111.704 167.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . 0.438 ' HB2' ' SG ' ' A' ' 199' ' ' CYS . 77.0 m -75.45 -29.16 59.56 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.943 0.897 . . . . 0.0 110.2 168.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . 0.302 89.1 m-70 71.1 54.69 0.23 Allowed 'General case' 0 C--N 1.342 0.255 0 C-N-CA 127.619 2.367 . . . . 0.0 113.689 169.468 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -137.49 172.69 12.6 Favored 'General case' 0 CA--C 1.54 0.595 0 CA-C-N 114.466 -1.243 . . . . 0.0 109.617 166.491 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.409 HG23 ' H ' ' A' ' 204' ' ' VAL . 0.2 OUTLIER -63.16 174.37 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.739 0 C-N-CA 125.189 1.396 . . . . 0.0 111.877 -175.384 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.409 ' H ' HG12 ' A' ' 204' ' ' VAL . 83.5 p -47.81 156.71 0.31 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 126.935 2.094 . . . . 0.0 115.063 -174.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 3.4 p90 -144.36 163.49 33.59 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.477 1.511 . . . . 0.0 111.101 -168.54 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -61.5 -40.7 99.05 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 124.851 1.215 . . . . 0.0 114.702 -169.441 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -130.54 122.91 28.44 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.115 0.966 . . . . 0.0 110.355 -173.514 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 1.4 mtm -139.69 144.5 37.6 Favored 'General case' 0 C--O 1.232 0.178 0 N-CA-C 112.65 0.611 . . . . 0.0 112.65 -167.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 21.2 tt -136.82 146.37 28.56 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.232 0 C-N-CA 125.605 1.562 . . . . 0.0 110.232 171.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -124.2 139.54 12.01 Favored Glycine 0 CA--C 1.528 0.874 0 C-N-CA 124.573 1.082 . . . . 0.0 112.819 -170.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . 0.597 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 4.5 m -76.09 125.09 28.49 Favored 'General case' 0 N--CA 1.462 0.158 0 C-N-CA 125.746 1.618 . . . . 0.0 111.441 -168.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -74.54 4.59 5.84 Favored 'General case' 0 CA--C 1.548 0.872 0 C-N-CA 125.718 1.607 . . . . 0.0 113.21 -177.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -69.13 148.19 97.62 Favored Pre-proline 0 CA--C 1.538 0.51 0 O-C-N 121.29 -0.881 . . . . 0.0 111.018 -179.709 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 83.4 Cg_endo -81.36 3.85 7.47 Favored 'Trans proline' 0 CA--C 1.549 1.253 0 C-N-CA 123.2 2.6 . . . . 0.0 111.666 166.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 32.6 m-20 -134.67 -10.42 2.41 Favored 'General case' 0 C--N 1.35 0.61 0 N-CA-C 114.787 1.403 . . . . 0.0 114.787 -169.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 36.9 t -64.13 135.28 56.2 Favored 'General case' 0 C--N 1.343 0.292 0 CA-C-N 119.438 1.017 . . . . 0.0 110.811 -177.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.7 t -110.97 10.9 22.2 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.779 1.632 . . . . 0.0 111.498 -173.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 36.5 mm -117.19 -42.46 2.93 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 125.263 1.425 . . . . 0.0 108.581 171.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 49.8 -10.18 0.0 OUTLIER 'General case' 0 CA--C 1.545 0.781 0 C-N-CA 131.068 3.747 . . . . 0.0 119.309 172.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 45.1 m95 -139.14 140.96 38.05 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 127.051 2.14 . . . . 0.0 109.913 169.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . 0.597 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 8.4 m-85 -147.45 150.83 35.36 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 125.81 1.644 . . . . 0.0 108.866 -169.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 62.4 m80 -66.01 153.2 42.83 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 166.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 14.2 m-30 -52.7 -49.41 65.4 Favored 'General case' 0 N--CA 1.467 0.423 0 N-CA-C 109.435 -0.579 . . . . 0.0 109.435 166.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -69.43 -12.81 61.96 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 -178.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 1.8 t -68.17 -14.91 63.33 Favored 'General case' 0 CA--C 1.542 0.663 0 CA-C-N 118.752 0.705 . . . . 0.0 112.71 171.332 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 6.4 p -126.55 -10.11 4.74 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 126.479 1.912 . . . . 0.0 112.539 174.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 91.76 20.26 37.69 Favored Glycine 0 CA--C 1.534 1.258 0 C-N-CA 125.623 1.582 . . . . 0.0 113.469 179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 5.9 mt -69.57 160.7 31.02 Favored 'General case' 0 CA--C 1.535 0.384 0 CA-C-N 118.643 1.222 . . . . 0.0 112.018 -179.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 96.9 m -139.35 -29.21 0.75 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 125.163 1.385 . . . . 0.0 111.307 -174.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 88.0 m -140.96 123.59 16.04 Favored 'General case' 0 C--N 1.343 0.325 0 C-N-CA 125.117 1.367 . . . . 0.0 107.582 178.782 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 34.3 ttpt -65.9 121.66 76.99 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 123.96 0.904 . . . . 0.0 111.712 -169.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 45.0 Cg_endo -78.77 -174.96 2.49 Favored 'Trans proline' 0 CA--C 1.544 0.985 0 C-N-CA 124.253 3.302 . . . . 0.0 111.228 170.708 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 3.1 ttp85 -145.53 151.41 38.1 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.794 1.238 . . . . 0.0 108.811 170.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 94.99 -155.88 21.64 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.817 1.199 . . . . 0.0 111.48 -177.314 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.4 tmtm? -57.21 108.92 0.58 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.526 1.53 . . . . 0.0 110.952 178.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . 0.457 ' HZ3' ' HG ' ' A' ' 212' ' ' CYS . 65.7 t90 -131.06 129.2 41.65 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 126.049 1.739 . . . . 0.0 107.952 169.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -117.75 126.1 51.84 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . 0.469 ' HB3' ' SG ' ' A' ' 212' ' ' CYS . 3.3 p -58.46 171.87 0.56 Allowed Pre-proline 0 CA--C 1.543 0.691 0 C-N-CA 127.689 2.396 . . . . 0.0 113.876 -173.616 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.444 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 37.0 Cg_endo -66.19 -33.78 38.74 Favored 'Trans proline' 0 C--N 1.351 0.674 0 C-N-CA 121.323 1.349 . . . . 0.0 112.767 -170.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 66.7 mtt180 -79.06 9.19 4.62 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.805 1.242 . . . . 0.0 112.785 177.219 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 27.6 m -131.05 -12.21 3.66 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 126.216 1.806 . . . . 0.0 114.1 -174.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 33.2 t -152.79 -39.59 0.1 Allowed 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.882 0.873 . . . . 0.0 112.388 178.561 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -77.89 -13.34 59.92 Favored 'General case' 0 CA--C 1.543 0.686 0 N-CA-C 113.062 0.764 . . . . 0.0 113.062 -175.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 10.3 mm-40 -64.78 -15.81 62.15 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 123.773 0.829 . . . . 0.0 112.654 172.273 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 51.0 ttt85 -62.5 -12.36 21.83 Favored 'General case' 0 CA--C 1.544 0.749 0 C-N-CA 125.223 1.409 . . . . 0.0 112.765 169.762 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -128.23 1.37 5.77 Favored 'General case' 0 CA--C 1.54 0.59 0 C-N-CA 125.739 1.616 . . . . 0.0 112.881 -179.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 15.6 tppt? 38.79 80.92 0.03 OUTLIER 'General case' 0 C--N 1.35 0.599 0 C-N-CA 127.426 2.29 . . . . 0.0 113.56 172.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 63.1 tttp . . . . . 0 C--O 1.249 1.066 0 CA-C-O 116.677 -1.63 . . . . 0.0 110.14 -178.899 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 53.9 ttm . . . . . 0 N--CA 1.474 0.774 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -156.55 46.84 0.44 Allowed 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 124.312 1.045 . . . . 0.0 110.312 -173.117 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 25.7 ttt -138.74 75.42 36.96 Favored Pre-proline 0 CA--C 1.542 0.665 0 C-N-CA 124.103 0.961 . . . . 0.0 110.405 -175.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_endo -74.06 178.62 6.67 Favored 'Trans proline' 0 CA--C 1.541 0.867 0 C-N-CA 123.86 3.04 . . . . 0.0 111.634 173.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 5.4 m -133.86 140.02 47.32 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.503 0 C-N-CA 126.226 1.81 . . . . 0.0 108.325 175.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -66.49 158.11 79.83 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 125.483 1.513 . . . . 0.0 112.293 -178.82 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -73.18 5.98 2.83 Favored 'Trans proline' 0 CA--C 1.546 1.114 0 C-N-CA 123.602 2.868 . . . . 0.0 112.316 168.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 37.1 m-80 -116.16 34.77 4.82 Favored 'General case' 0 CA--C 1.54 0.579 0 C-N-CA 126.932 2.093 . . . . 0.0 110.332 -177.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 31.1 tp10 -143.46 129.91 10.36 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 125.849 1.66 . . . . 0.0 108.048 -171.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -71.0 154.57 62.78 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.937 2.424 . . . . 0.0 111.632 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 62.9 p -145.47 174.07 11.46 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 124.703 1.201 . . . . 0.0 110.502 -175.372 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 98.7 m-85 -137.51 -80.93 0.36 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 117.696 -1.145 . . . . 0.0 112.639 -169.904 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 1.8 t -56.58 167.14 0.77 Allowed 'General case' 0 C--N 1.351 0.649 0 C-N-CA 124.543 1.137 . . . . 0.0 112.942 -177.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.0 pp -58.3 -11.97 3.25 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 125.031 1.332 . . . . 0.0 112.759 171.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 71.4 m -76.34 -20.43 57.24 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 126.552 1.941 . . . . 0.0 113.166 176.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 50.8 m170 56.71 65.99 1.28 Allowed 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 126.855 2.062 . . . . 0.0 111.585 -170.047 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.93 157.65 41.03 Favored 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.029 1.332 . . . . 0.0 112.338 174.001 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.513 HG12 ' H ' ' A' ' 205' ' ' SER . 0.7 OUTLIER -67.92 -178.89 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.816 0 C-N-CA 126.292 1.837 . . . . 0.0 111.113 -177.858 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.513 ' H ' HG12 ' A' ' 204' ' ' VAL . 87.9 p -45.57 149.83 0.54 Allowed 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 127.47 2.308 . . . . 0.0 113.827 178.641 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . 0.469 ' CE2' ' HG2' ' A' ' 209' ' ' MET . 16.3 p90 -154.34 165.62 35.77 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.22 1.408 . . . . 0.0 111.077 -167.493 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -74.91 -41.54 32.88 Favored Glycine 0 CA--C 1.531 1.065 0 CA-C-O 118.511 -1.16 . . . . 0.0 115.204 -168.777 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -126.35 120.3 29.52 Favored 'General case' 0 C--N 1.343 0.286 0 CA-C-N 118.582 1.191 . . . . 0.0 110.506 -169.449 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . 0.469 ' HG2' ' CE2' ' A' ' 206' ' ' TYR . 3.1 mtp -139.74 149.2 43.32 Favored 'General case' 0 N--CA 1.462 0.174 0 N-CA-C 114.26 1.207 . . . . 0.0 114.26 -165.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 15.2 tt -137.79 155.61 30.73 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 CA-C-N 113.768 -1.56 . . . . 0.0 109.553 168.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -133.04 138.87 10.47 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.698 1.142 . . . . 0.0 112.51 -171.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . 0.591 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 1.6 m -79.3 126.21 30.5 Favored 'General case' 0 N--CA 1.465 0.3 0 C-N-CA 125.554 1.542 . . . . 0.0 112.311 -167.675 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 25.1 t70 -69.67 -1.85 10.13 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.776 2.03 . . . . 0.0 113.718 -176.238 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -66.56 148.86 98.52 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 123.717 0.807 . . . . 0.0 111.827 -174.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -83.34 7.92 4.92 Favored 'Trans proline' 0 CA--C 1.549 1.25 0 C-N-CA 123.661 2.908 . . . . 0.0 111.404 166.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -144.58 -10.43 0.62 Allowed 'General case' 0 CA--C 1.543 0.678 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 -167.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 37.3 t -61.58 133.42 55.65 Favored 'General case' 0 C--N 1.343 0.32 0 CA-C-N 119.562 1.074 . . . . 0.0 110.62 179.255 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.9 t -107.16 8.54 30.14 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.652 1.581 . . . . 0.0 111.588 -172.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 41.3 mm -117.66 -42.58 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 C-N-CA 125.675 1.59 . . . . 0.0 108.735 174.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 46.95 -9.77 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.834 1 C-N-CA 131.706 4.002 . . . . 0.0 119.703 172.803 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 63.8 m95 -136.85 135.84 38.25 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 126.652 1.981 . . . . 0.0 109.166 170.171 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . 0.591 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 7.6 m-85 -141.45 155.86 45.82 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 125.129 1.371 . . . . 0.0 109.074 -169.323 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 20.9 m170 -76.22 149.01 37.28 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.525 -0.917 . . . . 0.0 108.525 169.174 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 15.5 m-30 -52.39 -50.61 62.13 Favored 'General case' 0 C--O 1.222 -0.349 0 CA-C-N 115.217 -0.901 . . . . 0.0 110.094 167.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.32 -14.59 62.65 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 113.355 0.872 . . . . 0.0 113.355 -177.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 9.5 m -79.14 -4.05 48.53 Favored 'General case' 0 N--CA 1.446 -0.655 0 CA-C-N 119.676 1.126 . . . . 0.0 112.861 172.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.6 p -123.93 -13.84 5.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 C-N-CA 126.049 1.739 . . . . 0.0 112.383 169.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 96.57 17.53 33.23 Favored Glycine 0 CA--C 1.534 1.261 0 C-N-CA 125.683 1.611 . . . . 0.0 113.206 179.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 9.6 mt -73.31 162.67 29.09 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.38 1.09 . . . . 0.0 111.606 178.247 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.7 t -139.47 -2.79 1.56 Allowed 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 125.923 1.689 . . . . 0.0 112.15 179.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 46.0 p -143.37 179.77 6.89 Favored 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 126.977 2.111 . . . . 0.0 109.61 177.002 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 39.0 ttmt -110.89 92.72 15.36 Favored Pre-proline 0 CA--C 1.539 0.541 0 C-N-CA 124.707 1.203 . . . . 0.0 109.546 178.374 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 79.7 Cg_endo -69.01 164.68 32.85 Favored 'Trans proline' 0 CA--C 1.539 0.733 0 C-N-CA 122.252 1.968 . . . . 0.0 110.295 169.656 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 47.9 ttp180 -142.47 131.52 23.16 Favored 'General case' 0 N--CA 1.455 -0.196 0 CA-C-O 122.211 1.005 . . . . 0.0 109.012 -178.886 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 135.58 -170.56 23.0 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 126.721 2.105 . . . . 0.0 109.886 -169.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 60.0 pttt -67.53 121.23 15.37 Favored 'General case' 0 CA--C 1.532 0.259 0 CA-C-O 121.709 0.766 . . . . 0.0 109.892 171.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 47.7 t90 -131.41 141.59 49.88 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 126.793 2.037 . . . . 0.0 108.313 177.059 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 66.6 m-85 -125.08 130.74 52.87 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.29 1.036 . . . . 0.0 108.868 -179.518 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 2.4 p -61.28 167.63 3.8 Favored Pre-proline 0 CA--C 1.54 0.575 0 C-N-CA 126.089 1.756 . . . . 0.0 112.705 -175.5 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 33.2 Cg_endo -65.61 -33.72 44.43 Favored 'Trans proline' 0 N--CA 1.455 -0.737 0 C-N-CA 121.29 1.326 . . . . 0.0 112.671 -169.833 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 75.1 mtt-85 -79.43 6.29 10.6 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.137 0.975 . . . . 0.0 113.049 177.778 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 22.6 m -125.9 -15.38 5.92 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.835 1.654 . . . . 0.0 114.023 -175.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 22.9 t -150.24 -32.51 0.19 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.89 0.768 . . . . 0.0 112.997 -179.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 30.1 tp60 -86.44 -20.62 27.89 Favored 'General case' 0 CA--C 1.54 0.562 0 N-CA-C 112.717 0.636 . . . . 0.0 112.717 -176.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -75.69 -20.05 58.68 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 124.556 1.142 . . . . 0.0 112.046 -176.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 59.6 ttt85 -79.75 83.16 5.74 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.374 1.469 . . . . 0.0 108.822 170.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 35.4 ttpt -146.06 56.35 1.19 Allowed 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 124.462 1.105 . . . . 0.0 110.493 -170.77 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 60.8 mtpt -78.03 75.97 4.56 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 124.75 1.22 . . . . 0.0 108.306 169.786 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.251 1.175 0 C-N-CA 126.784 2.034 . . . . 0.0 110.193 -168.342 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 63.4 mtt . . . . . 0 N--CA 1.477 0.879 0 CA-C-O 118.992 -0.528 . . . . 0.0 110.961 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -61.27 100.26 0.12 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 126.111 1.764 . . . . 0.0 111.747 -175.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.522 ' H ' ' HD2' ' A' ' 190' ' ' PRO . 1.7 mmt -156.4 -50.33 0.01 OUTLIER Pre-proline 0 CA--C 1.542 0.647 0 C-N-CA 126.194 1.798 . . . . 0.0 111.231 -179.384 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.522 ' HD2' ' H ' ' A' ' 189' ' ' MET . 86.5 Cg_endo -79.74 99.51 1.21 Allowed 'Trans proline' 0 C--N 1.355 0.883 0 C-N-CA 122.578 2.186 . . . . 0.0 110.678 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 2.3 m -139.89 126.02 22.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 C-N-CA 125.679 1.591 . . . . 0.0 108.516 176.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 21.0 m-20 -75.4 156.4 85.36 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 124.598 1.159 . . . . 0.0 111.417 178.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -72.0 -4.33 14.94 Favored 'Trans proline' 0 CA--C 1.544 1.005 0 C-N-CA 123.506 2.804 . . . . 0.0 112.807 169.873 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -71.39 85.05 0.81 Allowed 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 126.976 2.11 . . . . 0.0 110.295 177.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -142.49 125.27 9.19 Favored Pre-proline 0 CA--C 1.54 0.583 0 C-N-CA 124.979 1.312 . . . . 0.0 108.821 -177.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 95.4 Cg_endo -79.41 166.18 22.48 Favored 'Trans proline' 0 C--N 1.349 0.602 0 C-N-CA 123.179 2.586 . . . . 0.0 112.205 -178.107 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 44.6 p -141.59 169.83 16.86 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.033 1.733 . . . . 0.0 108.466 174.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 22.6 m-85 -137.83 -55.13 0.67 Allowed 'General case' 0 CA--C 1.534 0.339 0 N-CA-C 112.738 0.644 . . . . 0.0 112.738 -177.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.452 ' SG ' ' HB2' ' A' ' 201' ' ' CYS . 3.6 p -67.48 165.68 16.23 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 128.531 2.732 . . . . 0.0 113.664 178.189 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.4 pp -72.11 -4.71 30.58 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-N 115.899 -0.591 . . . . 0.0 111.648 166.517 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . 0.452 ' HB2' ' SG ' ' A' ' 199' ' ' CYS . 74.1 m -80.07 -25.81 39.9 Favored 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 124.867 1.267 . . . . 0.0 111.342 174.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . 0.285 9.9 m-70 71.37 52.01 0.25 Allowed 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 126.886 2.074 . . . . 0.0 112.71 169.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -137.41 171.37 14.58 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 115.012 -0.995 . . . . 0.0 110.22 167.104 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.416 HG12 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -63.9 174.12 0.44 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.736 0 C-N-CA 125.349 1.459 . . . . 0.0 111.998 -173.87 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.416 ' H ' HG12 ' A' ' 204' ' ' VAL . 89.4 p -47.57 155.12 0.39 Allowed 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 127.339 2.256 . . . . 0.0 115.481 -173.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 5.1 p90 -145.46 160.41 41.63 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 125.962 1.705 . . . . 0.0 110.377 -169.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -60.46 -38.77 95.33 Favored Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.653 1.12 . . . . 0.0 114.783 -169.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -131.86 121.45 24.08 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 124.0 0.92 . . . . 0.0 110.722 -171.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 1.4 mtm -138.33 144.92 40.61 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 112.721 0.637 . . . . 0.0 112.721 -168.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 21.3 tt -143.33 147.91 19.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 126.358 1.863 . . . . 0.0 109.202 173.497 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -137.19 145.85 17.68 Favored Glycine 0 CA--C 1.521 0.436 0 C-N-CA 123.698 0.666 . . . . 0.0 113.086 -169.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 6.9 t -72.13 145.3 48.22 Favored 'General case' 0 C--N 1.343 0.313 0 CA-C-O 122.234 1.016 . . . . 0.0 111.124 -172.201 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 31.7 t70 -77.78 -9.56 59.09 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 126.648 1.979 . . . . 0.0 113.92 -176.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 56.9 m-20 -76.71 145.91 75.6 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-N 118.676 0.671 . . . . 0.0 111.782 -169.121 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.35 8.95 2.69 Favored 'Trans proline' 0 CA--C 1.546 1.09 0 C-N-CA 124.072 3.181 . . . . 0.0 112.209 169.003 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -134.23 -8.8 2.61 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.285 1.834 . . . . 0.0 112.34 -169.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 46.9 t -63.07 125.1 22.9 Favored 'General case' 0 C--N 1.345 0.401 0 C-N-CA 123.52 0.728 . . . . 0.0 109.708 172.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 10.0 t -97.84 1.78 48.59 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 125.835 1.654 . . . . 0.0 112.014 -172.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 28.3 mm -117.43 -32.03 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.597 0 C-N-CA 125.949 1.7 . . . . 0.0 109.7 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 50.07 -12.61 0.0 OUTLIER 'General case' 0 CA--C 1.542 0.655 0 C-N-CA 130.529 3.532 . . . . 0.0 118.985 -178.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 46.3 m95 -141.96 157.18 45.26 Favored 'General case' 0 N--CA 1.453 -0.287 0 CA-C-N 120.588 1.54 . . . . 0.0 112.104 -179.092 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 65.3 m-85 -158.72 153.3 24.46 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 126.203 1.801 . . . . 0.0 109.349 -174.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 62.0 m80 -68.69 155.55 39.88 Favored 'General case' 0 C--O 1.234 0.247 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 166.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 11.1 m-30 -52.81 -51.11 62.1 Favored 'General case' 0 N--CA 1.468 0.447 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 166.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -68.68 -12.55 61.53 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 123.893 0.877 . . . . 0.0 113.255 -177.894 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 1.1 t -67.08 -20.29 65.79 Favored 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 123.488 0.715 . . . . 0.0 112.584 172.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 5.5 p -118.69 -15.48 8.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 C-N-CA 125.971 1.709 . . . . 0.0 112.155 173.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 101.28 16.99 23.55 Favored Glycine 0 CA--C 1.534 1.228 0 C-N-CA 125.797 1.665 . . . . 0.0 113.665 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 11.7 mt -71.6 166.49 21.74 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 119.065 1.433 . . . . 0.0 111.652 177.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 88.2 m -132.42 -14.5 2.91 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 125.909 1.683 . . . . 0.0 110.828 178.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 75.9 p -142.03 169.49 17.49 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.996 1.718 . . . . 0.0 109.983 -177.453 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -98.77 114.4 65.38 Favored Pre-proline 0 CA--C 1.542 0.645 0 C-N-CA 123.829 0.852 . . . . 0.0 109.13 175.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -75.32 -178.81 4.5 Favored 'Trans proline' 0 CA--C 1.541 0.842 0 C-N-CA 123.991 3.128 . . . . 0.0 110.748 172.181 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -138.37 129.52 27.19 Favored 'General case' 0 C--N 1.341 0.214 0 C-N-CA 123.964 0.906 . . . . 0.0 108.868 174.148 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 123.31 -178.42 16.39 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 125.978 1.752 . . . . 0.0 110.981 -170.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 19.8 ptmt -67.33 137.31 55.94 Favored 'General case' 0 N--CA 1.451 -0.375 0 CA-C-O 122.298 1.047 . . . . 0.0 110.625 173.097 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 49.4 t90 -141.89 154.88 45.44 Favored 'General case' 0 N--CA 1.447 -0.605 0 C-N-CA 127.439 2.296 . . . . 0.0 109.109 -176.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -128.42 132.5 48.46 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.9 1.28 . . . . 0.0 110.487 -174.481 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 1.8 p -71.47 170.07 13.22 Favored Pre-proline 0 CA--C 1.543 0.702 0 C-N-CA 125.045 1.338 . . . . 0.0 112.186 -178.172 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -72.79 -15.28 26.82 Favored 'Trans proline' 0 C--N 1.35 0.645 0 C-N-CA 121.789 1.659 . . . . 0.0 114.09 -169.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 85.2 mtp180 -96.92 9.25 42.46 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 125.882 1.673 . . . . 0.0 111.948 173.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 20.0 m -130.65 -18.32 3.13 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.589 1.556 . . . . 0.0 113.637 -172.722 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 45.1 t -151.17 -38.67 0.13 Allowed 'General case' 0 N--CA 1.466 0.371 0 CA-C-N 119.464 1.029 . . . . 0.0 112.746 174.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 33.2 tp60 -69.11 -19.07 64.04 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.131 0.423 . . . . 0.0 112.004 179.504 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 25.4 tt0 -62.45 -18.86 62.74 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 126.564 1.946 . . . . 0.0 113.078 177.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 82.4 mtt85 -86.1 24.78 1.26 Allowed 'General case' 0 CA--C 1.543 0.691 0 C-N-CA 125.497 1.519 . . . . 0.0 112.868 -178.652 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 93.6 mttt -131.72 115.69 16.33 Favored 'General case' 0 C--N 1.342 0.275 0 C-N-CA 124.815 1.246 . . . . 0.0 108.639 171.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 24.3 ttmm -73.2 98.11 2.55 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 125.173 1.389 . . . . 0.0 109.938 -178.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 73.9 mmtt . . . . . 0 C--O 1.25 1.114 0 C-N-CA 126.005 1.722 . . . . 0.0 109.131 -178.911 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 28.2 ttt . . . . . 0 N--CA 1.475 0.792 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -140.1 -107.52 0.16 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.066 0.946 . . . . 0.0 108.828 -169.022 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 64.5 mtt -140.73 59.51 11.58 Favored Pre-proline 0 CA--C 1.545 0.768 0 C-N-CA 125.179 1.392 . . . . 0.0 109.942 178.874 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -68.13 -42.05 6.45 Favored 'Trans proline' 0 C--N 1.353 0.797 0 C-N-CA 122.795 2.33 . . . . 0.0 112.662 -175.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -155.75 144.98 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.498 0 C-N-CA 128.537 2.735 . . . . 0.0 107.458 175.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -84.53 154.09 62.07 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 123.942 0.897 . . . . 0.0 110.56 169.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 96.7 Cg_endo -74.58 5.65 3.66 Favored 'Trans proline' 0 CA--C 1.546 1.098 0 C-N-CA 123.616 2.878 . . . . 0.0 112.35 169.082 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 39.5 m-80 -114.45 38.76 2.98 Favored 'General case' 0 CA--C 1.54 0.576 0 C-N-CA 126.877 2.071 . . . . 0.0 110.172 -174.807 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 27.1 tp10 -140.69 127.92 12.15 Favored Pre-proline 0 CA--C 1.54 0.558 0 C-N-CA 125.436 1.494 . . . . 0.0 108.205 -169.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 63.7 Cg_endo -70.51 158.17 56.75 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 122.883 2.389 . . . . 0.0 111.962 -179.22 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 63.9 p -144.48 175.23 10.28 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.85 1.26 . . . . 0.0 110.452 -173.77 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 99.6 m-85 -135.19 -81.2 0.43 Allowed 'General case' 0 CA--C 1.534 0.355 0 CA-C-O 117.436 -1.269 . . . . 0.0 112.992 -169.031 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -56.02 168.93 0.42 Allowed 'General case' 0 C--N 1.349 0.581 0 C-N-CA 124.887 1.275 . . . . 0.0 113.32 -177.435 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.9 pp -57.87 -12.14 2.91 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 125.015 1.326 . . . . 0.0 113.015 169.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 72.1 m -76.62 -23.74 53.38 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 127.002 2.121 . . . . 0.0 113.261 176.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 17.3 m170 58.85 66.44 1.06 Allowed 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 126.574 1.949 . . . . 0.0 111.001 -169.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.18 159.44 36.03 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.966 1.306 . . . . 0.0 112.273 174.281 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.577 HG12 ' H ' ' A' ' 205' ' ' SER . 0.8 OUTLIER -70.96 -177.96 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.862 0 C-N-CA 126.186 1.794 . . . . 0.0 111.231 -175.79 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.577 ' H ' HG12 ' A' ' 204' ' ' VAL . 49.6 m -46.83 151.69 0.58 Allowed 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 128.289 2.636 . . . . 0.0 114.221 -178.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . 0.454 ' CE2' ' HG2' ' A' ' 209' ' ' MET . 11.9 p90 -155.7 162.95 40.46 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.742 1.617 . . . . 0.0 110.819 -168.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -70.59 -47.17 43.14 Favored Glycine 0 CA--C 1.53 1.029 0 CA-C-O 118.695 -1.058 . . . . 0.0 114.526 -169.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 10.7 pt-20 -127.94 123.0 33.83 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-N 118.376 1.088 . . . . 0.0 110.289 -169.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . 0.454 ' HG2' ' CE2' ' A' ' 206' ' ' TYR . 5.1 mtp -135.17 153.63 51.9 Favored 'General case' 0 N--CA 1.463 0.217 0 N-CA-C 114.153 1.168 . . . . 0.0 114.153 -165.844 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 18.4 tt -142.94 158.81 18.13 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.309 0 C-N-CA 126.799 2.04 . . . . 0.0 108.752 169.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -141.64 143.42 13.04 Favored Glycine 0 CA--C 1.522 0.47 0 C-N-CA 123.564 0.602 . . . . 0.0 111.79 -173.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 4.1 t -71.55 142.32 50.07 Favored 'General case' 0 C--N 1.345 0.383 0 CA-C-O 121.674 0.749 . . . . 0.0 111.04 -173.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -75.97 -10.65 59.59 Favored 'General case' 0 CA--C 1.541 0.627 0 C-N-CA 125.682 1.593 . . . . 0.0 114.036 -174.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 18.8 m-20 -78.84 145.04 65.38 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 118.66 0.664 . . . . 0.0 112.064 -167.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 81.9 Cg_endo -75.64 1.98 7.44 Favored 'Trans proline' 0 CA--C 1.545 1.039 0 C-N-CA 123.603 2.869 . . . . 0.0 111.989 168.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -118.77 -6.61 10.58 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 126.217 1.807 . . . . 0.0 112.224 -175.141 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 39.0 t -64.91 136.86 57.32 Favored 'General case' 0 N--CA 1.448 -0.53 0 C-N-CA 124.305 1.042 . . . . 0.0 109.682 173.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 8.5 t -121.05 12.4 11.13 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 125.805 1.642 . . . . 0.0 111.202 -175.56 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 36.4 mm -119.98 -32.88 1.54 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 C-N-CA 126.206 1.802 . . . . 0.0 109.383 175.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 50.83 -16.27 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.687 1 C-N-CA 131.769 4.028 . . . . 0.0 119.309 175.439 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 61.5 m95 -140.86 150.81 43.73 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 125.549 1.54 . . . . 0.0 110.188 179.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -154.31 154.44 33.37 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.288 1.435 . . . . 0.0 110.278 -170.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -79.07 143.92 35.11 Favored 'General case' 0 C--O 1.234 0.271 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 168.839 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 45.5 m-85 -51.67 -50.07 61.13 Favored 'General case' 0 C--O 1.223 -0.297 0 CA-C-N 115.151 -0.931 . . . . 0.0 110.337 167.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -68.88 -13.93 62.72 Favored 'General case' 0 CA--C 1.539 0.523 0 N-CA-C 113.747 1.018 . . . . 0.0 113.747 -179.357 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -74.38 -21.94 59.42 Favored 'General case' 0 C--N 1.349 0.55 0 CA-C-N 119.942 1.247 . . . . 0.0 112.647 174.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.6 p -104.9 -13.46 9.1 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 125.604 1.562 . . . . 0.0 111.785 170.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 90.68 20.3 41.02 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.83 1.681 . . . . 0.0 113.24 179.624 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 12.9 mt -73.45 157.82 36.12 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 118.873 1.336 . . . . 0.0 111.382 179.162 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 69.0 p -131.52 -1.33 3.9 Favored 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 126.293 1.837 . . . . 0.0 111.403 176.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 60.5 p -145.23 175.69 10.09 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.551 2.34 . . . . 0.0 108.956 179.783 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 22.7 ttpp -119.13 125.44 27.62 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 123.946 0.899 . . . . 0.0 109.515 179.061 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -76.17 -171.09 0.98 Allowed 'Trans proline' 0 CA--C 1.541 0.865 0 C-N-CA 124.513 3.475 . . . . 0.0 111.127 174.026 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 7.0 tpt180 -148.3 138.72 22.75 Favored 'General case' 0 N--CA 1.451 -0.397 0 C-N-CA 124.187 0.995 . . . . 0.0 109.34 178.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 102.58 -62.23 0.48 Allowed Glycine 0 CA--C 1.529 0.911 0 C-N-CA 125.919 1.723 . . . . 0.0 112.065 173.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.1 mptp? -148.74 142.27 25.37 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 125.475 1.51 . . . . 0.0 110.306 -178.47 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 77.6 t90 -150.73 154.02 36.6 Favored 'General case' 0 N--CA 1.447 -0.623 0 C-N-CA 126.223 1.809 . . . . 0.0 109.834 171.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -128.42 127.51 42.7 Favored 'General case' 0 N--CA 1.456 -0.17 0 C-N-CA 125.054 1.342 . . . . 0.0 109.919 -177.135 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.62 167.54 10.75 Favored Pre-proline 0 CA--C 1.542 0.664 0 C-N-CA 124.79 1.236 . . . . 0.0 113.311 -177.115 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_endo -74.29 -0.65 9.92 Favored 'Trans proline' 0 CA--C 1.538 0.696 0 C-N-CA 122.507 2.138 . . . . 0.0 114.19 -174.2 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 35.0 mtp180 -123.9 27.39 7.25 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.02 1.328 . . . . 0.0 111.322 168.662 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 10.3 m -131.67 -14.89 3.16 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 126.357 1.863 . . . . 0.0 112.224 173.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 41.9 t -149.17 -34.82 0.19 Allowed 'General case' 0 C--N 1.345 0.402 0 CA-C-N 118.994 0.815 . . . . 0.0 112.704 174.868 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -75.27 -12.98 60.39 Favored 'General case' 0 CA--C 1.544 0.712 0 N-CA-C 113.038 0.755 . . . . 0.0 113.038 -176.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -66.52 -9.14 31.75 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 118.936 0.789 . . . . 0.0 112.75 169.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 56.1 ttt180 -75.33 -20.87 58.81 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 124.564 1.146 . . . . 0.0 112.423 173.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 47.6 mtpt -142.74 63.24 1.39 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.459 1.503 . . . . 0.0 109.947 179.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 45.2 mtpt -62.72 139.43 58.67 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 123.986 0.915 . . . . 0.0 110.118 174.522 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 26.3 tptp . . . . . 0 C--O 1.251 1.162 0 CA-C-O 116.589 -1.672 . . . . 0.0 110.44 -173.943 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 60.1 ttm . . . . . 0 N--CA 1.476 0.837 0 CA-C-O 119.476 -0.297 . . . . 0.0 110.565 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -147.89 -176.19 5.17 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 125.498 1.519 . . . . 0.0 110.383 -174.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 25.7 ttt 50.26 68.47 3.39 Favored Pre-proline 0 CA--C 1.548 0.876 0 C-N-CA 125.999 1.72 . . . . 0.0 112.016 -175.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 40.7 Cg_endo -80.65 45.39 1.97 Allowed 'Trans proline' 0 CA--C 1.547 1.158 0 C-N-CA 125.23 3.953 . . . . 0.0 112.866 -172.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 2.7 m -125.79 109.97 22.93 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.321 0 C-N-CA 125.739 1.616 . . . . 0.0 108.999 -177.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -70.46 156.6 91.66 Favored Pre-proline 0 CA--C 1.54 0.57 0 C-N-CA 125.016 1.326 . . . . 0.0 112.262 -177.055 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -73.28 2.71 5.33 Favored 'Trans proline' 0 CA--C 1.545 1.041 0 C-N-CA 123.956 3.104 . . . . 0.0 113.08 170.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -70.97 81.38 0.66 Allowed 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 126.658 1.983 . . . . 0.0 110.367 177.587 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -152.37 138.39 11.72 Favored Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 125.544 1.537 . . . . 0.0 108.307 -170.766 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -71.46 152.55 60.37 Favored 'Trans proline' 0 C--N 1.351 0.676 0 C-N-CA 122.765 2.31 . . . . 0.0 111.693 -178.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 80.4 p -144.41 172.76 12.5 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.767 1.227 . . . . 0.0 110.377 -175.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 99.0 m-85 -136.38 -81.18 0.39 Allowed 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 117.511 -1.233 . . . . 0.0 113.076 -169.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.8 t -55.43 166.55 0.61 Allowed 'General case' 0 C--N 1.35 0.594 0 C-N-CA 125.161 1.385 . . . . 0.0 112.871 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 4.7 pp -59.52 -9.72 2.78 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.543 1.137 . . . . 0.0 112.873 170.115 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 73.3 m -77.06 -20.87 55.3 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 126.694 1.997 . . . . 0.0 113.052 174.82 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 13.3 m170 59.2 62.55 1.8 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 126.881 2.072 . . . . 0.0 111.499 -173.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.31 160.43 32.21 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.269 1.428 . . . . 0.0 112.409 176.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.487 HG12 ' H ' ' A' ' 205' ' ' SER . 0.3 OUTLIER -69.2 -179.62 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 126.366 1.866 . . . . 0.0 111.718 -176.325 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.487 ' H ' HG12 ' A' ' 204' ' ' VAL . 80.4 p -45.67 150.16 0.53 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 127.873 2.469 . . . . 0.0 114.329 178.125 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . 0.4 ' CE2' ' CD2' ' A' ' 223' ' ' HIS . 10.1 p90 -155.37 168.69 26.28 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.767 1.627 . . . . 0.0 110.875 -167.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -76.04 -43.68 21.04 Favored Glycine 0 CA--C 1.53 1.024 0 CA-C-O 118.676 -1.069 . . . . 0.0 115.101 -168.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -127.73 121.78 31.18 Favored 'General case' 0 C--N 1.342 0.246 0 CA-C-N 118.425 1.113 . . . . 0.0 110.784 -169.454 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -143.76 146.74 33.36 Favored 'General case' 0 N--CA 1.463 0.186 0 N-CA-C 114.154 1.168 . . . . 0.0 114.154 -165.762 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 13.6 tt -143.7 154.9 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.281 0 C-N-CA 125.8 1.64 . . . . 0.0 109.346 168.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -136.23 147.01 19.0 Favored Glycine 0 C--N 1.335 0.476 0 C-N-CA 123.741 0.686 . . . . 0.0 112.299 -169.621 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 6.1 t -70.12 144.47 52.05 Favored 'General case' 0 C--N 1.344 0.331 0 CA-C-O 122.179 0.99 . . . . 0.0 111.058 -174.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 26.1 t70 -79.14 -5.94 55.34 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.763 2.025 . . . . 0.0 113.671 -174.091 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 60.6 m-20 -82.22 145.48 52.51 Favored Pre-proline 0 CA--C 1.535 0.404 0 CA-C-N 118.81 0.732 . . . . 0.0 111.464 -169.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -76.74 6.28 4.24 Favored 'Trans proline' 0 CA--C 1.547 1.133 0 C-N-CA 123.544 2.829 . . . . 0.0 111.702 167.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 17.6 m-20 -124.18 -9.23 7.61 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 126.301 1.841 . . . . 0.0 112.502 -172.303 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 43.9 t -64.92 133.6 52.17 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.239 1.016 . . . . 0.0 109.893 175.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 37.9 m -110.39 8.39 23.25 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.531 1.532 . . . . 0.0 111.845 -174.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 33.3 mm -119.83 -33.06 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 C-N-CA 126.256 1.822 . . . . 0.0 109.446 177.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 50.14 -15.7 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.659 1 C-N-CA 131.757 4.023 . . . . 0.0 119.338 177.118 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 58.3 m95 -140.47 152.14 45.4 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 125.795 1.638 . . . . 0.0 110.437 178.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -153.07 154.95 35.91 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 125.333 1.453 . . . . 0.0 110.015 -173.039 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . 0.4 ' CD2' ' CE2' ' A' ' 206' ' ' TYR . 19.5 m170 -77.71 149.75 34.56 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 170.599 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -53.71 -50.75 65.22 Favored 'General case' 0 C--O 1.223 -0.33 0 CA-C-N 115.268 -0.878 . . . . 0.0 109.634 167.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -69.91 -14.82 62.91 Favored 'General case' 0 N--CA 1.449 -0.483 0 CA-C-O 118.296 -0.859 . . . . 0.0 113.229 -177.342 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 7.4 m -78.85 -6.46 56.12 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-N 119.667 1.122 . . . . 0.0 112.858 173.146 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.3 p -121.17 -12.58 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 C-N-CA 125.864 1.666 . . . . 0.0 112.065 169.28 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 92.96 19.86 35.3 Favored Glycine 0 CA--C 1.533 1.189 0 C-N-CA 125.524 1.535 . . . . 0.0 113.313 -179.655 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 6.2 mt -72.51 158.29 36.0 Favored 'General case' 0 C--N 1.343 0.316 0 CA-C-N 118.397 1.098 . . . . 0.0 111.082 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 68.7 p -134.14 1.9 3.28 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.195 1.798 . . . . 0.0 111.263 176.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 81.9 p -142.95 179.89 6.76 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 127.051 2.141 . . . . 0.0 109.664 -175.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 61.2 tttp -121.65 89.55 47.63 Favored Pre-proline 0 CA--C 1.537 0.464 0 C-N-CA 124.603 1.161 . . . . 0.0 109.055 178.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -68.65 169.04 18.29 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.801 2.334 . . . . 0.0 111.304 174.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 77.0 ttt180 -140.02 133.7 30.39 Favored 'General case' 0 C--N 1.34 0.179 0 C-N-CA 124.917 1.287 . . . . 0.0 108.564 -177.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 126.46 -169.59 18.38 Favored Glycine 0 CA--C 1.531 1.089 0 C-N-CA 126.319 1.914 . . . . 0.0 110.277 -169.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.95 130.4 43.91 Favored 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 122.093 0.949 . . . . 0.0 109.195 169.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 53.0 t90 -136.74 146.63 46.03 Favored 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 127.072 2.149 . . . . 0.0 108.312 178.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 11.8 m-85 -129.97 131.65 46.0 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 124.678 1.191 . . . . 0.0 109.637 -173.549 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 1.5 p -68.78 166.68 24.9 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 124.27 1.028 . . . . 0.0 112.074 -179.661 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -76.37 9.43 2.52 Favored 'Trans proline' 0 CA--C 1.538 0.716 0 C-N-CA 122.539 2.159 . . . . 0.0 114.57 -175.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 99.3 mtt180 -122.79 15.93 10.17 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 126.512 1.925 . . . . 0.0 110.856 171.062 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 30.1 m -133.19 -22.76 1.98 Allowed 'General case' 0 N--CA 1.447 -0.585 0 C-N-CA 125.962 1.705 . . . . 0.0 113.111 -178.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.1 t -153.71 -34.07 0.11 Allowed 'General case' 0 C--N 1.346 0.426 0 CA-C-N 119.724 1.147 . . . . 0.0 113.501 173.6 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 10.7 tp60 -76.03 -8.05 56.08 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 118.928 0.785 . . . . 0.0 112.006 176.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -67.83 -26.37 66.02 Favored 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.057 1.343 . . . . 0.0 111.628 169.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 12.9 tpt180 -75.85 163.24 27.42 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.356 1.462 . . . . 0.0 110.087 171.066 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 27.3 tptt -110.44 104.73 13.51 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.393 1.077 . . . . 0.0 108.557 179.344 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 39.3 ttmt 43.78 72.62 0.18 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 126.671 1.988 . . . . 0.0 112.302 -170.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? . . . . . 0 C--O 1.25 1.108 0 CA-C-O 116.704 -1.617 . . . . 0.0 110.789 175.966 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 47.9 ttp . . . . . 0 N--CA 1.474 0.736 0 CA-C-O 121.273 0.558 . . . . 0.0 109.767 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.2 p-10 -73.67 110.24 7.81 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.505 1.522 . . . . 0.0 110.329 178.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . 0.576 ' H ' ' HD2' ' A' ' 190' ' ' PRO . 54.2 mtm -146.0 -49.4 0.02 OUTLIER Pre-proline 0 CA--C 1.542 0.659 0 CA-C-O 116.85 -1.548 . . . . 0.0 111.922 177.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . 0.576 ' HD2' ' H ' ' A' ' 189' ' ' MET . 87.3 Cg_endo -77.18 -12.25 17.47 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 122.152 1.901 . . . . 0.0 112.92 174.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 14.4 p -158.01 158.25 3.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.341 0 C-N-CA 127.102 2.161 . . . . 0.0 107.831 177.678 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 11.6 m-20 -56.42 158.46 7.88 Favored Pre-proline 0 CA--C 1.541 0.629 0 C-N-CA 126.388 1.875 . . . . 0.0 112.367 173.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -72.15 11.55 0.73 Allowed 'Trans proline' 0 CA--C 1.546 1.099 0 C-N-CA 123.777 2.985 . . . . 0.0 112.896 169.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 41.7 m-80 -129.96 111.3 12.4 Favored 'General case' 0 C--N 1.343 0.31 0 C-N-CA 126.509 1.924 . . . . 0.0 107.642 178.17 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -149.47 131.22 7.52 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.762 1.225 . . . . 0.0 108.803 -177.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -75.99 151.61 35.36 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.982 2.455 . . . . 0.0 111.431 176.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 49.0 p -143.31 173.14 11.86 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 125.573 1.549 . . . . 0.0 109.108 -177.461 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 62.6 m-85 -139.46 -67.29 0.45 Allowed 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.83 0.852 . . . . 0.0 111.782 -173.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.438 ' SG ' ' HB2' ' A' ' 201' ' ' CYS . 4.6 p -59.37 165.15 2.89 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 128.484 2.714 . . . . 0.0 113.595 176.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 2.9 pp -77.66 -0.36 26.37 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 114.984 -1.007 . . . . 0.0 111.595 167.454 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . 0.438 ' HB2' ' SG ' ' A' ' 199' ' ' CYS . 74.2 m -76.78 -28.22 55.58 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.889 0.875 . . . . 0.0 110.226 168.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . 0.293 93.4 m-70 72.45 52.2 0.17 Allowed 'General case' 0 C--N 1.342 0.242 0 C-N-CA 127.828 2.451 . . . . 0.0 113.84 169.001 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -136.85 173.61 11.51 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.528 1.131 . . . . 0.0 109.864 166.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.473 HG12 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -62.55 174.49 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.743 0 C-N-CA 125.238 1.415 . . . . 0.0 111.813 -176.17 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.473 ' H ' HG12 ' A' ' 204' ' ' VAL . 80.5 p -47.94 157.44 0.28 Allowed 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 127.516 2.326 . . . . 0.0 114.899 -175.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -142.36 163.2 33.49 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.82 1.648 . . . . 0.0 110.984 -168.583 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -61.3 -42.31 99.74 Favored Glycine 0 CA--C 1.531 1.064 0 C-N-CA 124.824 1.202 . . . . 0.0 114.37 -169.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -127.98 124.12 36.47 Favored 'General case' 0 N--CA 1.454 -0.24 0 C-N-CA 124.462 1.105 . . . . 0.0 110.116 -178.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 1.6 mtm -138.42 145.63 41.2 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 115.977 -0.556 . . . . 0.0 112.003 -168.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 21.4 tt -137.06 144.67 31.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.187 0 C-N-CA 125.126 1.37 . . . . 0.0 110.53 172.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -120.24 139.68 13.92 Favored Glycine 0 CA--C 1.528 0.849 0 C-N-CA 125.238 1.399 . . . . 0.0 112.241 -171.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . 0.576 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 1.2 m -80.0 123.88 28.21 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.737 1.615 . . . . 0.0 111.451 -167.657 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.25 14.48 1.19 Allowed 'General case' 0 CA--C 1.549 0.914 0 C-N-CA 125.256 1.422 . . . . 0.0 112.458 -175.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -74.23 148.77 86.58 Favored Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 124.295 1.038 . . . . 0.0 111.484 179.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -84.92 8.92 4.37 Favored 'Trans proline' 0 CA--C 1.551 1.347 0 C-N-CA 123.342 2.695 . . . . 0.0 110.944 165.116 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -134.58 -16.71 2.03 Favored 'General case' 0 C--N 1.351 0.631 0 N-CA-C 114.812 1.412 . . . . 0.0 114.812 -168.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 28.2 t -65.59 135.6 55.29 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 123.594 0.758 . . . . 0.0 111.119 -172.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 10.2 t -110.77 12.08 22.48 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 125.726 1.61 . . . . 0.0 111.588 -174.482 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 34.0 mm -122.06 -40.96 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 C-N-CA 125.758 1.623 . . . . 0.0 108.852 174.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 48.36 -7.75 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.811 0 C-N-CA 131.424 3.89 . . . . 0.0 119.435 172.203 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 49.3 m95 -140.49 140.31 35.28 Favored 'General case' 0 N--CA 1.455 -0.224 0 C-N-CA 126.904 2.082 . . . . 0.0 110.211 169.58 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . 0.576 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 8.4 m-85 -148.93 153.4 37.93 Favored 'General case' 0 C--N 1.332 -0.177 0 C-N-CA 125.441 1.496 . . . . 0.0 109.141 -169.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 50.8 m80 -66.73 151.75 46.81 Favored 'General case' 0 CA--C 1.532 0.25 0 N-CA-C 109.086 -0.709 . . . . 0.0 109.086 166.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 12.2 m-30 -51.19 -50.82 58.29 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.001 -0.545 . . . . 0.0 109.757 166.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.07 -12.38 61.56 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 113.267 0.84 . . . . 0.0 113.267 -178.651 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 1.9 t -67.63 -18.12 64.85 Favored 'General case' 0 CA--C 1.541 0.624 0 CA-C-N 118.821 0.737 . . . . 0.0 112.588 172.132 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.4 p -121.3 -15.61 6.8 Favored 'Isoleucine or valine' 0 C--N 1.345 0.396 0 C-N-CA 126.039 1.736 . . . . 0.0 112.396 175.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 102.32 17.33 20.27 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.693 1.616 . . . . 0.0 113.653 178.127 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 20.3 mt -71.32 158.63 36.01 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.244 1.522 . . . . 0.0 111.414 177.101 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 71.2 m -136.12 -23.44 1.32 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.727 1.611 . . . . 0.0 111.135 -177.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 92.2 m -140.04 137.13 34.35 Favored 'General case' 0 C--N 1.343 0.294 0 C-N-CA 125.957 1.703 . . . . 0.0 107.264 176.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 55.4 tttm -67.72 125.51 91.38 Favored Pre-proline 0 CA--C 1.543 0.696 0 CA-C-O 118.871 -0.585 . . . . 0.0 110.954 -173.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 52.0 Cg_endo -77.84 -170.09 0.89 Allowed 'Trans proline' 0 CA--C 1.542 0.912 0 C-N-CA 124.151 3.234 . . . . 0.0 111.191 173.567 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 17.5 tpp180 -142.78 138.98 30.81 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 125.134 1.374 . . . . 0.0 108.118 178.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 81.32 -159.46 41.03 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 124.552 1.072 . . . . 0.0 112.754 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 27.6 mttp -50.65 120.72 4.96 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 126.753 2.021 . . . . 0.0 112.848 -177.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 62.7 t90 -138.48 138.47 38.12 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 126.239 1.816 . . . . 0.0 109.012 173.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 -120.53 127.39 52.13 Favored 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 124.707 1.203 . . . . 0.0 108.405 179.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . 0.543 ' HB2' ' HD2' ' A' ' 240' ' ' PRO . 14.7 p -59.25 172.51 0.58 Allowed Pre-proline 0 CA--C 1.544 0.712 0 C-N-CA 127.851 2.46 . . . . 0.0 114.334 -173.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.543 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 43.1 Cg_endo -64.2 -38.64 34.7 Favored 'Trans proline' 0 N--CA 1.455 -0.78 0 C-N-CA 121.658 1.572 . . . . 0.0 113.14 -168.045 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 66.0 mtt85 -88.02 20.53 3.09 Favored 'General case' 0 CA--C 1.532 0.266 0 CA-C-N 119.42 1.009 . . . . 0.0 112.554 177.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 16.7 m -131.3 -10.4 3.69 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 126.316 1.846 . . . . 0.0 113.344 179.015 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 22.7 t -157.08 -39.59 0.07 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-N 119.144 0.884 . . . . 0.0 113.147 174.874 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -75.2 -15.04 60.58 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 123.537 0.735 . . . . 0.0 112.525 -179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 42.2 tt0 -153.02 141.5 20.76 Favored 'General case' 0 C--O 1.234 0.28 0 C-N-CA 128.26 2.624 . . . . 0.0 106.026 -175.351 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 18.0 ttp180 -101.01 34.54 2.47 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 124.191 0.997 . . . . 0.0 111.776 -169.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 23.4 tptm -59.87 -30.71 69.17 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.7 1.6 . . . . 0.0 113.16 -179.611 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 16.2 ttpp -150.8 50.42 0.86 Allowed 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.702 1.201 . . . . 0.0 109.893 179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 6.1 mmtp . . . . . 0 C--O 1.25 1.09 0 CA-C-O 116.199 -1.858 . . . . 0.0 111.204 -177.143 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 23.5 mmt . . . . . 0 N--CA 1.478 0.938 0 N-CA-C 110.788 -0.079 . . . . 0.0 110.788 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 14.9 m-20 54.31 29.26 10.49 Favored 'General case' 0 CA--C 1.544 0.734 0 C-N-CA 125.552 1.541 . . . . 0.0 113.32 -179.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 93.8 mtp -69.81 153.79 95.24 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 125.42 1.488 . . . . 0.0 111.695 -173.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -80.84 30.79 0.51 Allowed 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 124.789 3.66 . . . . 0.0 113.63 -174.618 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 2.5 m -121.98 97.59 5.04 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.306 0 C-N-CA 125.545 1.538 . . . . 0.0 109.619 -175.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 19.1 m-20 -69.8 156.79 91.12 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 125.207 1.403 . . . . 0.0 111.882 178.456 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -72.6 0.31 7.75 Favored 'Trans proline' 0 CA--C 1.544 0.995 0 C-N-CA 123.807 3.005 . . . . 0.0 113.055 170.719 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -71.49 80.11 0.79 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 126.643 1.977 . . . . 0.0 110.369 177.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 43.4 tt0 -151.1 137.11 11.01 Favored Pre-proline 0 CA--C 1.542 0.642 0 C-N-CA 125.141 1.377 . . . . 0.0 108.776 -170.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -73.28 159.89 46.13 Favored 'Trans proline' 0 C--N 1.35 0.635 0 C-N-CA 122.979 2.452 . . . . 0.0 112.657 -176.209 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 34.7 p -144.77 172.98 12.25 Favored 'General case' 0 CA--C 1.535 0.391 0 C-N-CA 126.094 1.757 . . . . 0.0 109.284 -177.843 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 18.4 m-85 -139.04 -54.1 0.58 Allowed 'General case' 0 CA--C 1.535 0.396 0 N-CA-C 113.426 0.899 . . . . 0.0 113.426 -179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.45 ' SG ' ' HB2' ' A' ' 201' ' ' CYS . 2.4 p -68.82 165.62 19.33 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 128.431 2.693 . . . . 0.0 113.272 178.491 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.5 pp -71.94 -5.62 36.07 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.77 166.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . 0.45 ' HB2' ' SG ' ' A' ' 199' ' ' CYS . 74.8 m -78.07 -29.09 48.97 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.807 1.243 . . . . 0.0 110.831 173.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . 0.303 90.9 m-70 71.09 54.86 0.23 Allowed 'General case' 0 C--N 1.34 0.167 0 C-N-CA 127.529 2.332 . . . . 0.0 113.391 169.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -136.6 171.37 14.59 Favored 'General case' 0 CA--C 1.541 0.599 0 CA-C-N 114.44 -1.254 . . . . 0.0 109.697 166.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.483 HG12 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -64.97 175.97 0.38 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.761 0 C-N-CA 125.274 1.43 . . . . 0.0 112.105 -173.18 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.483 ' H ' HG12 ' A' ' 204' ' ' VAL . 20.3 m -43.39 152.78 0.12 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 128.421 2.689 . . . . 0.0 115.569 -173.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . 0.411 ' CD1' ' HG2' ' A' ' 209' ' ' MET . 7.4 p90 -147.63 157.05 43.38 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.59 1.556 . . . . 0.0 110.497 -172.001 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -65.75 -38.53 94.54 Favored Glycine 0 CA--C 1.531 1.054 0 C-N-CA 124.432 1.015 . . . . 0.0 115.095 -169.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 26.8 pt-20 -119.33 122.08 41.05 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 118.164 0.982 . . . . 0.0 110.345 -174.758 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . 0.411 ' HG2' ' CD1' ' A' ' 206' ' ' TYR . 14.6 mtp -141.84 141.14 33.09 Favored 'General case' 0 C--O 1.232 0.149 0 N-CA-C 113.781 1.03 . . . . 0.0 113.781 -167.67 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 16.8 tt -144.17 151.53 16.1 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.234 0 C-N-CA 125.817 1.647 . . . . 0.0 109.636 169.436 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -138.29 145.98 17.61 Favored Glycine 0 CA--C 1.522 0.476 0 C-N-CA 123.874 0.75 . . . . 0.0 112.629 -169.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 6.5 t -69.88 145.78 51.74 Favored 'General case' 0 C--N 1.343 0.29 0 CA-C-O 122.228 1.013 . . . . 0.0 111.182 -172.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -81.29 -6.5 58.95 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.713 2.005 . . . . 0.0 113.442 -175.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 51.8 m-20 -78.78 146.08 67.94 Favored Pre-proline 0 CA--C 1.536 0.424 0 CA-C-N 118.696 0.68 . . . . 0.0 111.568 -169.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -76.95 6.71 4.03 Favored 'Trans proline' 0 CA--C 1.547 1.172 0 C-N-CA 123.58 2.853 . . . . 0.0 111.718 167.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 20.5 m-20 -126.72 -7.71 6.18 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.137 1.775 . . . . 0.0 112.628 -172.173 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 39.0 t -66.02 133.39 50.69 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.074 0.95 . . . . 0.0 109.791 174.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 50.2 m -112.1 10.47 20.32 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 125.639 1.576 . . . . 0.0 111.708 -174.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 22.0 mm -120.32 -33.62 1.5 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.613 0 C-N-CA 125.905 1.682 . . . . 0.0 109.472 175.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.7 pt-20 50.33 -10.21 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 130.624 3.57 . . . . 0.0 118.917 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 54.9 m95 -144.5 156.9 44.39 Favored 'General case' 0 N--CA 1.452 -0.343 0 C-N-CA 125.395 1.478 . . . . 0.0 111.83 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 48.1 m-85 -158.88 154.35 25.88 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 126.362 1.865 . . . . 0.0 109.377 -176.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 44.3 m80 -69.37 154.51 41.91 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 166.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 13.9 m-30 -52.33 -50.68 61.82 Favored 'General case' 0 N--CA 1.47 0.55 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 166.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -69.5 -13.08 62.15 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 113.205 0.817 . . . . 0.0 113.205 -178.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 4.8 t -69.16 -19.1 64.0 Favored 'General case' 0 CA--C 1.541 0.629 0 C-N-CA 123.646 0.778 . . . . 0.0 112.476 172.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.0 p -114.82 -21.52 5.3 Favored 'Isoleucine or valine' 0 C--N 1.347 0.466 0 C-N-CA 125.605 1.562 . . . . 0.0 112.275 172.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 105.71 17.95 12.46 Favored Glycine 0 CA--C 1.536 1.364 0 C-N-CA 126.029 1.776 . . . . 0.0 113.752 -179.14 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 13.5 mt -71.76 162.53 29.31 Favored 'General case' 0 CA--C 1.537 0.454 0 CA-C-N 119.271 1.536 . . . . 0.0 111.854 179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 36.0 m -138.42 -24.81 0.95 Allowed 'General case' 0 CA--C 1.54 0.561 0 C-N-CA 125.348 1.459 . . . . 0.0 111.417 -176.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 46.2 p -139.15 140.59 37.93 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.681 1.592 . . . . 0.0 108.432 176.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 59.6 tttm -78.14 119.22 76.53 Favored Pre-proline 0 CA--C 1.544 0.72 0 C-N-CA 123.413 0.685 . . . . 0.0 112.03 -169.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 43.6 Cg_endo -81.21 175.93 9.27 Favored 'Trans proline' 0 CA--C 1.543 0.954 0 C-N-CA 123.692 2.928 . . . . 0.0 111.015 169.21 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 13.5 ttp85 -145.0 134.78 23.54 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 124.035 0.934 . . . . 0.0 109.019 172.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 127.38 -165.07 20.65 Favored Glycine 0 CA--C 1.53 1.015 0 C-N-CA 125.807 1.67 . . . . 0.0 111.136 -175.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.72 120.91 10.99 Favored 'General case' 0 C--N 1.342 0.241 0 C-N-CA 124.203 1.001 . . . . 0.0 109.686 171.272 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 58.5 t90 -138.56 144.29 39.8 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 127.257 2.223 . . . . 0.0 108.482 175.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -120.27 135.85 54.86 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 124.468 1.107 . . . . 0.0 109.309 -178.101 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -67.46 168.78 10.72 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 124.279 1.031 . . . . 0.0 111.72 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -66.38 -36.09 28.59 Favored 'Trans proline' 0 C--N 1.35 0.631 0 C-N-CA 121.108 1.205 . . . . 0.0 112.681 -172.137 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 67.6 mtt-85 -75.55 0.06 18.67 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 124.373 1.069 . . . . 0.0 113.405 175.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 24.7 m -115.06 -21.27 10.1 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.029 1.331 . . . . 0.0 113.821 -176.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.1 t -151.22 -28.14 0.2 Allowed 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.545 1.066 . . . . 0.0 113.56 178.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 11.5 tt0 -76.57 -13.54 60.07 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 118.903 0.774 . . . . 0.0 112.299 179.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 15.1 mm-40 -71.59 -10.46 59.8 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 123.706 0.803 . . . . 0.0 112.54 169.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 2.5 tpm_? -81.66 28.97 0.39 Allowed 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 124.986 1.315 . . . . 0.0 111.833 173.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 6.9 ttpm? -58.0 -19.35 30.34 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 126.26 1.824 . . . . 0.0 113.627 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -76.86 76.57 3.46 Favored 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 125.164 1.386 . . . . 0.0 109.746 169.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 56.0 tttp . . . . . 0 C--O 1.252 1.212 0 C-N-CA 127.177 2.191 . . . . 0.0 112.158 -173.268 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 20.8 ptp . . . . . 0 N--CA 1.478 0.931 0 CA-C-O 121.948 0.88 . . . . 0.0 110.195 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.6 m-20 -79.2 155.86 28.44 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 124.692 1.197 . . . . 0.0 111.761 -172.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 17.6 ptm -149.01 76.26 9.58 Favored Pre-proline 0 CA--C 1.542 0.67 0 C-N-CA 124.857 1.263 . . . . 0.0 109.593 177.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -77.19 29.95 0.42 Allowed 'Trans proline' 0 CA--C 1.548 1.218 0 C-N-CA 124.754 3.636 . . . . 0.0 112.865 -178.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 2.8 m -135.33 122.67 36.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 C-N-CA 126.539 1.936 . . . . 0.0 108.978 -171.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -77.34 157.27 80.75 Favored Pre-proline 0 CA--C 1.54 0.586 0 C-N-CA 125.089 1.355 . . . . 0.0 111.711 178.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -73.42 0.84 7.48 Favored 'Trans proline' 0 CA--C 1.544 1.002 0 C-N-CA 123.82 3.013 . . . . 0.0 113.07 170.034 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -71.33 83.5 0.77 Allowed 'General case' 0 CA--C 1.538 0.481 0 C-N-CA 126.789 2.035 . . . . 0.0 110.268 178.422 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 41.7 tt0 -151.52 137.56 11.26 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 125.361 1.464 . . . . 0.0 108.592 -171.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -72.95 154.02 52.9 Favored 'Trans proline' 0 C--N 1.35 0.606 0 C-N-CA 122.893 2.396 . . . . 0.0 111.78 -178.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 68.0 p -146.57 175.02 10.89 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.743 1.217 . . . . 0.0 110.66 -174.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -137.61 -83.66 0.32 Allowed 'General case' 0 CA--C 1.536 0.421 0 CA-C-O 117.337 -1.316 . . . . 0.0 112.588 -170.463 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.1 t -55.67 168.21 0.45 Allowed 'General case' 0 C--N 1.352 0.692 0 CA-C-N 119.844 1.202 . . . . 0.0 113.336 -177.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.1 pp -57.49 -12.73 2.87 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 124.882 1.273 . . . . 0.0 112.861 170.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 71.7 m -76.82 -19.87 57.04 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.899 2.079 . . . . 0.0 113.275 176.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 22.3 m170 57.86 64.01 1.65 Allowed 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.907 2.083 . . . . 0.0 111.543 -173.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.77 157.61 40.97 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 125.124 1.37 . . . . 0.0 112.561 175.484 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.5 HG12 ' H ' ' A' ' 205' ' ' SER . 0.4 OUTLIER -68.57 -178.72 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.809 0 C-N-CA 126.45 1.9 . . . . 0.0 111.325 -177.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.5 ' H ' HG12 ' A' ' 204' ' ' VAL . 49.8 m -42.35 145.65 0.38 Allowed 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 128.012 2.525 . . . . 0.0 113.472 177.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . 0.44 ' CE2' ' HG2' ' A' ' 209' ' ' MET . 13.2 p90 -152.03 165.31 35.07 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 124.837 1.255 . . . . 0.0 111.935 -167.605 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -67.98 -47.91 57.25 Favored Glycine 0 CA--C 1.53 0.992 0 C-N-CA 124.76 1.172 . . . . 0.0 115.018 -168.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -127.8 125.38 39.72 Favored 'General case' 0 C--N 1.343 0.288 0 CA-C-N 118.401 1.1 . . . . 0.0 109.849 -170.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . 0.44 ' HG2' ' CE2' ' A' ' 206' ' ' TYR . 9.1 mtp -140.47 147.9 40.32 Favored 'General case' 0 C--O 1.232 0.159 0 N-CA-C 113.835 1.05 . . . . 0.0 113.835 -166.312 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 17.0 tt -135.05 155.68 38.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 C-N-CA 125.843 1.657 . . . . 0.0 109.557 168.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -132.73 139.18 10.72 Favored Glycine 0 CA--C 1.529 0.939 0 C-N-CA 124.668 1.127 . . . . 0.0 112.45 -172.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . 0.592 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 1.8 m -79.51 127.12 31.75 Favored 'General case' 0 N--CA 1.465 0.304 0 C-N-CA 125.487 1.515 . . . . 0.0 112.19 -167.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -70.22 -3.61 17.81 Favored 'General case' 0 CA--C 1.544 0.712 0 C-N-CA 126.35 1.86 . . . . 0.0 113.692 -175.582 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -67.77 146.95 98.61 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 123.547 0.739 . . . . 0.0 111.469 -174.825 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.83 5.65 6.18 Favored 'Trans proline' 0 CA--C 1.55 1.3 0 C-N-CA 123.138 2.559 . . . . 0.0 111.372 166.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 22.5 m-20 -134.13 -13.51 2.42 Favored 'General case' 0 C--N 1.35 0.603 0 C-N-CA 125.21 1.404 . . . . 0.0 114.381 -169.45 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 36.8 t -63.72 132.57 51.43 Favored 'General case' 0 C--N 1.343 0.296 0 CA-C-N 118.973 0.806 . . . . 0.0 110.335 -176.702 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 69.7 m -109.29 11.72 25.17 Favored 'General case' 0 CA--C 1.536 0.423 0 CA-C-N 113.637 -1.62 . . . . 0.0 111.602 -173.22 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 39.4 mm -119.3 -41.35 2.19 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.621 0 C-N-CA 125.838 1.655 . . . . 0.0 108.604 173.177 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 47.67 -9.47 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.832 1 C-N-CA 131.717 4.007 . . . . 0.0 119.725 171.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 66.8 m95 -139.83 135.95 33.51 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 126.744 2.017 . . . . 0.0 109.197 172.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . 0.592 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 6.4 m-85 -143.47 155.82 44.47 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 125.376 1.471 . . . . 0.0 109.53 -169.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 21.9 m80 -73.55 148.62 42.84 Favored 'General case' 0 C--O 1.234 0.245 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 168.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 16.8 m-30 -52.19 -51.11 60.11 Favored 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.751 167.057 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.19 -14.34 62.59 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 113.499 0.925 . . . . 0.0 113.499 -177.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 2.8 m -78.12 -8.56 58.42 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 119.76 1.164 . . . . 0.0 112.777 173.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.7 p -119.07 -14.08 9.37 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 C-N-CA 126.009 1.724 . . . . 0.0 112.198 169.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 96.8 17.4 33.01 Favored Glycine 0 CA--C 1.532 1.099 0 C-N-CA 125.693 1.616 . . . . 0.0 113.306 178.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 12.5 mt -71.55 160.37 32.81 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-N 118.582 1.191 . . . . 0.0 111.272 176.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 16.0 m -134.03 -1.4 2.98 Favored 'General case' 0 CA--C 1.546 0.802 0 C-N-CA 125.998 1.719 . . . . 0.0 110.37 179.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 9.3 t -150.58 177.11 10.35 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 126.284 1.834 . . . . 0.0 109.674 -179.001 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 59.2 tttp -108.92 105.67 57.54 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 124.305 1.042 . . . . 0.0 109.391 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -73.48 175.52 10.53 Favored 'Trans proline' 0 CA--C 1.54 0.79 0 C-N-CA 123.221 2.614 . . . . 0.0 111.435 173.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 37.3 ttm180 -140.1 133.57 30.06 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 124.856 1.262 . . . . 0.0 108.229 173.428 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 124.24 -175.89 16.95 Favored Glycine 0 CA--C 1.53 1.026 0 C-N-CA 126.156 1.836 . . . . 0.0 110.845 -170.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 61.1 pttt -66.69 131.65 46.43 Favored 'General case' 0 N--CA 1.452 -0.37 0 CA-C-O 121.996 0.903 . . . . 0.0 110.368 173.605 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 52.8 t90 -136.99 141.55 42.57 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 127.011 2.125 . . . . 0.0 108.779 177.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -124.5 127.38 47.37 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 124.467 1.107 . . . . 0.0 108.828 -179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . 0.414 ' HB2' ' HD2' ' A' ' 240' ' ' PRO . 6.2 p -60.73 167.57 3.29 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 126.465 1.906 . . . . 0.0 113.299 -173.251 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.414 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 33.4 Cg_endo -65.33 -30.3 53.94 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 121.491 1.461 . . . . 0.0 112.809 -170.977 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 53.7 mtt-85 -86.96 13.58 8.87 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.302 1.041 . . . . 0.0 112.747 178.47 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 20.1 m -131.01 -14.03 3.51 Favored 'General case' 0 N--CA 1.449 -0.481 0 C-N-CA 126.159 1.784 . . . . 0.0 113.518 -179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 32.1 t -149.33 -39.47 0.15 Allowed 'General case' 0 CA--C 1.533 0.31 0 C-N-CA 123.72 0.808 . . . . 0.0 112.414 -178.061 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 3.0 tp60 -82.09 -11.38 58.8 Favored 'General case' 0 CA--C 1.542 0.673 0 N-CA-C 113.128 0.788 . . . . 0.0 113.128 -175.15 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 51.1 mm-40 -69.11 -8.48 45.74 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.92 0.888 . . . . 0.0 112.717 172.164 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 40.1 ttm180 -63.2 104.56 0.6 Allowed 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 125.463 1.505 . . . . 0.0 110.724 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 28.7 ttpt 50.09 29.4 3.53 Favored 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 126.858 2.063 . . . . 0.0 113.926 -178.365 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -154.44 143.37 21.01 Favored 'General case' 0 C--N 1.343 0.324 0 C-N-CA 124.73 1.212 . . . . 0.0 109.737 -179.476 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 83.3 tttt . . . . . 0 C--O 1.251 1.15 0 C-N-CA 124.754 1.222 . . . . 0.0 108.619 169.009 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 20.8 mmt . . . . . 0 N--CA 1.475 0.809 0 N-CA-C 109.422 -0.584 . . . . 0.0 109.422 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 8.3 m-20 -140.98 5.79 1.95 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 124.957 1.303 . . . . 0.0 111.683 -169.473 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 89.8 mtp -146.65 159.66 43.54 Favored Pre-proline 0 CA--C 1.541 0.622 0 C-N-CA 126.512 1.925 . . . . 0.0 109.421 -176.179 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -74.34 14.81 0.7 Allowed 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 124.172 3.248 . . . . 0.0 113.517 175.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 3.3 m -134.15 137.43 51.94 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.527 0 C-N-CA 126.712 2.005 . . . . 0.0 108.782 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -66.1 161.44 55.93 Favored Pre-proline 0 CA--C 1.541 0.6 0 C-N-CA 126.343 1.857 . . . . 0.0 111.875 175.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 93.7 Cg_endo -70.28 -7.4 21.13 Favored 'Trans proline' 0 CA--C 1.543 0.971 0 C-N-CA 123.084 2.523 . . . . 0.0 112.212 168.389 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -88.18 38.59 0.86 Allowed 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 127.089 2.156 . . . . 0.0 111.068 178.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 28.8 tp10 -143.03 129.35 10.46 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 125.689 1.596 . . . . 0.0 108.103 -170.895 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -70.57 159.04 54.14 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.016 2.477 . . . . 0.0 112.063 -179.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 72.9 p -144.23 175.96 9.69 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 124.904 1.281 . . . . 0.0 110.453 -174.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 26.1 m-85 -136.66 -80.68 0.39 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 117.275 -1.345 . . . . 0.0 113.213 -171.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 3.1 t -55.97 167.81 0.55 Allowed 'General case' 0 C--N 1.35 0.609 0 CA-C-N 119.963 1.256 . . . . 0.0 113.115 -176.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.9 pp -59.4 -10.06 2.89 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 124.417 1.087 . . . . 0.0 112.717 169.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 75.2 m -77.04 -21.86 53.86 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.658 1.983 . . . . 0.0 113.19 174.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 21.8 m-70 54.29 68.83 0.79 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.752 2.021 . . . . 0.0 111.629 -170.068 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.9 160.6 33.06 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 125.688 1.595 . . . . 0.0 111.468 173.088 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.531 HG12 ' H ' ' A' ' 205' ' ' SER . 0.6 OUTLIER -70.29 -178.94 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.902 0 C-N-CA 125.62 1.568 . . . . 0.0 111.142 -178.158 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.531 ' H ' HG12 ' A' ' 204' ' ' VAL . 28.3 m -46.34 151.05 0.56 Allowed 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 128.093 2.557 . . . . 0.0 114.348 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 13.3 p90 -154.17 168.47 26.41 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.351 1.46 . . . . 0.0 111.413 -169.263 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -70.61 -50.85 23.4 Favored Glycine 0 CA--C 1.53 0.969 0 C-N-CA 124.379 0.99 . . . . 0.0 114.651 -169.004 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -125.53 122.34 36.29 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 118.091 0.945 . . . . 0.0 110.297 -170.12 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -144.09 147.01 33.19 Favored 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 -166.433 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 16.2 tt -142.04 152.77 18.57 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.276 0 C-N-CA 125.47 1.508 . . . . 0.0 109.783 169.146 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -132.35 147.01 18.65 Favored Glycine 0 C--N 1.335 0.51 0 C-N-CA 124.051 0.834 . . . . 0.0 112.456 -169.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 7.0 t -71.2 143.4 50.48 Favored 'General case' 0 C--N 1.343 0.312 0 CA-C-O 122.019 0.914 . . . . 0.0 111.369 -172.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 32.4 t70 -79.36 -8.98 59.48 Favored 'General case' 0 CA--C 1.543 0.677 0 C-N-CA 126.786 2.034 . . . . 0.0 114.193 -176.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 87.8 m-20 -74.39 144.03 80.51 Favored Pre-proline 0 CA--C 1.537 0.459 0 CA-C-N 119.458 1.027 . . . . 0.0 111.041 -174.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_endo -75.63 6.02 3.92 Favored 'Trans proline' 0 CA--C 1.546 1.081 0 C-N-CA 123.471 2.781 . . . . 0.0 111.802 168.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -124.89 -6.19 7.36 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.533 1.933 . . . . 0.0 112.28 -173.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 49.8 t -63.7 133.42 53.55 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 123.899 0.879 . . . . 0.0 109.703 174.385 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 10.4 t -114.75 11.24 16.75 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 125.644 1.578 . . . . 0.0 111.611 -174.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 33.0 mm -120.25 -31.97 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.676 0 C-N-CA 126.229 1.812 . . . . 0.0 109.411 176.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 50.36 -13.81 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.625 0 C-N-CA 131.539 3.936 . . . . 0.0 119.204 176.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 58.2 m95 -143.62 152.53 41.49 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 125.645 1.578 . . . . 0.0 110.755 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 74.5 m-85 -154.33 150.87 28.43 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 125.376 1.471 . . . . 0.0 110.473 -174.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 40.2 m80 -71.59 150.17 44.96 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-O 121.26 0.552 . . . . 0.0 109.816 168.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 11.4 m-30 -53.49 -51.28 63.29 Favored 'General case' 0 C--O 1.222 -0.372 0 CA-C-N 114.964 -1.016 . . . . 0.0 109.469 167.247 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.82 -12.85 61.48 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 113.463 0.912 . . . . 0.0 113.463 -177.634 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 1.7 m -76.56 -12.31 60.0 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.771 1.169 . . . . 0.0 112.299 172.449 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.1 p -116.56 -15.46 9.5 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 126.172 1.789 . . . . 0.0 112.185 171.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 95.07 20.43 28.1 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.792 1.663 . . . . 0.0 113.663 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 20.4 mt -71.49 157.98 37.06 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 118.987 1.394 . . . . 0.0 111.407 177.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 91.4 m -131.41 -25.09 2.21 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 125.828 1.651 . . . . 0.0 110.772 -177.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 61.1 p -138.73 150.85 46.59 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.182 1.793 . . . . 0.0 108.271 172.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 62.4 tttp -79.77 119.34 76.44 Favored Pre-proline 0 CA--C 1.542 0.637 0 CA-C-O 118.533 -0.746 . . . . 0.0 110.756 -174.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -76.67 165.92 28.02 Favored 'Trans proline' 0 CA--C 1.538 0.725 0 C-N-CA 122.922 2.415 . . . . 0.0 110.39 169.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 61.6 ttt180 -138.03 130.92 29.9 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-O 122.195 0.997 . . . . 0.0 109.06 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 127.82 -165.9 20.68 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 126.757 2.123 . . . . 0.0 109.407 -168.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.92 142.7 54.67 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-O 122.469 1.128 . . . . 0.0 109.771 169.614 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 55.0 t90 -147.31 146.15 29.61 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 127.254 2.222 . . . . 0.0 108.203 -177.438 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 15.8 m-30 -124.13 137.2 54.58 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.421 1.089 . . . . 0.0 110.197 178.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 0.7 OUTLIER -69.08 169.91 10.25 Favored Pre-proline 0 CA--C 1.543 0.68 0 C-N-CA 125.186 1.394 . . . . 0.0 112.581 -177.31 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -74.51 1.04 7.89 Favored 'Trans proline' 0 CA--C 1.538 0.676 0 C-N-CA 122.398 2.066 . . . . 0.0 114.506 -175.393 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 79.9 mtp180 -117.63 16.72 14.52 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 126.53 1.932 . . . . 0.0 110.883 172.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 22.2 m -134.39 -16.99 2.07 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 126.367 1.867 . . . . 0.0 112.744 -177.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 32.8 t -154.01 -40.91 0.09 Allowed 'General case' 0 C--N 1.345 0.377 0 CA-C-N 118.975 0.807 . . . . 0.0 112.775 175.622 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 8.8 tt0 -74.82 -6.16 47.49 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.189 0.44 . . . . 0.0 112.189 179.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -71.36 4.41 2.96 Favored 'General case' 0 CA--C 1.548 0.884 0 C-N-CA 126.186 1.795 . . . . 0.0 112.671 173.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 52.7 ttm-85 -142.99 154.54 44.12 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 126.793 2.037 . . . . 0.0 109.437 -179.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -132.13 40.04 3.37 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 125.855 1.662 . . . . 0.0 110.41 -176.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 66.1 tttm -149.86 130.13 13.72 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 125.343 1.457 . . . . 0.0 108.555 177.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 59.3 tttm . . . . . 0 C--O 1.25 1.091 0 CA-C-O 115.961 -1.971 . . . . 0.0 111.589 -169.97 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 98.5 mtp . . . . . 0 N--CA 1.477 0.879 0 CA-C-O 119.393 -0.337 . . . . 0.0 110.451 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 8.0 p-10 -60.83 149.65 35.32 Favored 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 124.822 1.249 . . . . 0.0 112.195 176.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 53.3 mtt -146.8 87.8 6.19 Favored Pre-proline 0 CA--C 1.539 0.525 0 C-N-CA 125.59 1.556 . . . . 0.0 107.884 176.729 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -68.72 -11.59 32.29 Favored 'Trans proline' 0 CA--C 1.541 0.851 0 C-N-CA 123.094 2.529 . . . . 0.0 112.849 175.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 12.7 p -153.83 151.55 11.1 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.288 0 C-N-CA 127.186 2.195 . . . . 0.0 107.479 169.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -64.63 151.48 92.0 Favored Pre-proline 0 CA--C 1.54 0.572 0 C-N-CA 124.504 1.121 . . . . 0.0 111.707 178.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_endo -74.16 8.54 2.07 Favored 'Trans proline' 0 CA--C 1.546 1.109 0 C-N-CA 123.894 3.063 . . . . 0.0 112.526 169.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -116.73 37.33 3.82 Favored 'General case' 0 CA--C 1.54 0.569 0 C-N-CA 126.633 1.973 . . . . 0.0 110.543 -173.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -138.95 111.05 7.96 Favored Pre-proline 0 CA--C 1.54 0.582 0 C-N-CA 125.192 1.397 . . . . 0.0 108.83 -169.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -72.09 159.76 49.17 Favored 'Trans proline' 0 C--N 1.351 0.689 0 C-N-CA 122.899 2.399 . . . . 0.0 111.719 177.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 66.0 p -143.69 175.02 10.29 Favored 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 125.009 1.324 . . . . 0.0 110.188 -176.482 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 98.1 m-85 -133.98 -83.83 0.44 Allowed 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 117.293 -1.337 . . . . 0.0 113.05 -169.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.446 ' H ' HE22 ' A' ' 203' ' ' GLN . 2.4 t -55.28 170.19 0.23 Allowed 'General case' 0 C--N 1.351 0.651 0 C-N-CA 124.948 1.299 . . . . 0.0 113.901 -175.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.3 pp -58.38 -14.12 6.87 Favored 'General case' 0 CA--C 1.539 0.558 0 C-N-CA 124.32 1.048 . . . . 0.0 112.605 169.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 75.2 m -75.79 -23.66 55.9 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 127.029 2.132 . . . . 0.0 112.895 174.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 98.5 m-70 53.08 69.42 0.7 Allowed 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 127.434 2.294 . . . . 0.0 112.156 -171.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . 0.446 HE22 ' H ' ' A' ' 199' ' ' CYS . 0.0 OUTLIER -125.46 160.63 28.99 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 126.091 1.756 . . . . 0.0 111.37 172.844 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.538 HG12 ' H ' ' A' ' 205' ' ' SER . 0.8 OUTLIER -69.24 -178.67 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.818 0 C-N-CA 125.705 1.602 . . . . 0.0 110.883 -178.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.538 ' H ' HG12 ' A' ' 204' ' ' VAL . 85.8 p -44.3 148.2 0.47 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.566 2.347 . . . . 0.0 113.713 178.263 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 11.0 p90 -152.44 168.96 23.78 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.723 1.209 . . . . 0.0 112.168 -167.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -69.11 -53.05 20.23 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 124.807 1.194 . . . . 0.0 114.743 -168.905 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.9 pm0 -125.07 125.64 44.12 Favored 'General case' 0 C--N 1.342 0.245 0 CA-C-N 118.271 1.036 . . . . 0.0 109.711 -172.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -142.55 145.54 33.71 Favored 'General case' 0 C--N 1.34 0.169 0 N-CA-C 113.378 0.881 . . . . 0.0 113.378 -166.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 20.6 tt -134.8 150.77 30.4 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.236 0 C-N-CA 125.705 1.602 . . . . 0.0 109.644 173.159 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -128.59 139.06 10.73 Favored Glycine 0 CA--C 1.527 0.818 0 C-N-CA 124.528 1.061 . . . . 0.0 112.576 -171.597 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . 0.6 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 5.5 m -75.11 125.78 29.66 Favored 'General case' 0 N--CA 1.464 0.255 0 C-N-CA 125.362 1.465 . . . . 0.0 111.325 -168.356 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 27.8 t70 -70.03 -4.04 19.09 Favored 'General case' 0 CA--C 1.543 0.704 0 C-N-CA 125.495 1.518 . . . . 0.0 113.452 -177.541 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -68.02 145.6 97.81 Favored Pre-proline 0 CA--C 1.538 0.518 0 O-C-N 121.544 -0.723 . . . . 0.0 110.905 -175.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -80.92 8.32 4.39 Favored 'Trans proline' 0 CA--C 1.549 1.258 0 C-N-CA 123.049 2.499 . . . . 0.0 111.296 166.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -133.81 -14.06 2.47 Favored 'General case' 0 C--N 1.349 0.583 0 C-N-CA 125.21 1.404 . . . . 0.0 114.323 -169.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.5 t -65.29 134.33 53.36 Favored 'General case' 0 C--N 1.343 0.29 0 C-N-CA 123.721 0.809 . . . . 0.0 110.699 -176.207 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 96.6 p -107.27 7.97 29.61 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 125.972 1.709 . . . . 0.0 112.188 -173.736 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 37.5 mm -118.95 -41.03 2.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 125.815 1.646 . . . . 0.0 108.676 177.164 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 48.16 -8.55 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.803 0 C-N-CA 131.461 3.904 . . . . 0.0 119.697 170.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 61.7 m95 -141.28 137.43 32.48 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 126.781 2.032 . . . . 0.0 109.625 171.513 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . 0.6 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 6.9 m-85 -145.46 156.96 44.06 Favored 'General case' 0 C--O 1.232 0.139 0 C-N-CA 125.738 1.615 . . . . 0.0 109.69 -169.634 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 33.1 m80 -73.97 149.07 41.55 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.284 -0.635 . . . . 0.0 109.284 167.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 14.3 m-30 -51.7 -52.03 51.43 Favored 'General case' 0 C--O 1.223 -0.294 0 CA-C-N 115.253 -0.885 . . . . 0.0 109.746 167.124 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.78 -13.82 62.19 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 113.433 0.901 . . . . 0.0 113.433 -177.139 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 2.1 m -77.54 -11.13 59.82 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-N 119.785 1.175 . . . . 0.0 112.594 173.554 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 10.6 p -116.09 -16.47 8.76 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.392 0 C-N-CA 125.799 1.64 . . . . 0.0 112.134 170.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 102.27 14.87 27.15 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 125.781 1.657 . . . . 0.0 113.395 177.804 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 26.0 mt -72.89 160.06 32.73 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-N 118.828 1.314 . . . . 0.0 110.928 175.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 67.4 p -131.71 -7.96 3.6 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 125.833 1.653 . . . . 0.0 111.598 177.234 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 73.8 p -144.73 166.2 25.9 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 127.006 2.122 . . . . 0.0 108.766 177.256 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 31.0 ttpt -90.21 121.17 68.93 Favored Pre-proline 0 CA--C 1.541 0.616 0 CA-C-O 118.821 -0.609 . . . . 0.0 109.497 175.281 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 68.3 Cg_endo -75.91 178.94 6.78 Favored 'Trans proline' 0 CA--C 1.542 0.876 0 C-N-CA 123.569 2.846 . . . . 0.0 110.78 169.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 61.7 ttt180 -141.59 132.55 26.03 Favored 'General case' 0 N--CA 1.455 -0.224 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 170.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 120.69 -170.88 14.55 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 126.06 1.79 . . . . 0.0 110.166 -168.856 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -69.5 144.98 53.04 Favored 'General case' 0 N--CA 1.451 -0.421 0 CA-C-O 122.252 1.025 . . . . 0.0 110.849 174.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . 0.494 ' HZ3' ' HG ' ' A' ' 212' ' ' CYS . 60.2 t90 -145.93 138.96 25.88 Favored 'General case' 0 N--CA 1.45 -0.461 0 C-N-CA 126.994 2.118 . . . . 0.0 109.406 177.753 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 14.4 m-30 -118.4 131.91 56.27 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.717 1.207 . . . . 0.0 109.261 175.044 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . 0.475 ' HB2' ' HD2' ' A' ' 240' ' ' PRO . 4.0 p -63.32 173.23 1.25 Allowed Pre-proline 0 CA--C 1.544 0.744 0 C-N-CA 127.61 2.364 . . . . 0.0 114.675 -174.195 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.475 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 72.6 Cg_endo -72.87 -3.33 13.4 Favored 'Trans proline' 0 C--N 1.353 0.784 0 C-N-CA 122.815 2.343 . . . . 0.0 114.858 -171.034 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 93.1 mtt180 -111.61 13.62 21.26 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.589 1.555 . . . . 0.0 111.234 174.034 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 39.0 m -135.94 -16.0 1.73 Allowed 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 126.565 1.946 . . . . 0.0 113.234 -174.338 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 46.6 t -150.98 -41.6 0.12 Allowed 'General case' 0 N--CA 1.465 0.289 0 C-N-CA 123.763 0.825 . . . . 0.0 112.446 177.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 1.4 tp-100 -71.71 -23.43 61.63 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 118.012 0.369 . . . . 0.0 111.527 178.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.1 tm-20 -65.19 -7.67 13.82 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 126.547 1.939 . . . . 0.0 113.42 175.364 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 31.7 ttt-85 -127.37 23.85 6.33 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.29 1.436 . . . . 0.0 111.032 178.62 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 55.5 mtpt -130.86 -21.65 2.7 Favored 'General case' 0 CA--C 1.538 0.518 0 C-N-CA 126.272 1.829 . . . . 0.0 111.539 176.897 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 62.8 tttm -154.11 147.32 24.77 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.347 1.459 . . . . 0.0 109.436 177.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 3.3 mppt? . . . . . 0 C--O 1.253 1.287 0 C-N-CA 124.667 1.187 . . . . 0.0 108.718 169.324 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 99.8 mtp . . . . . 0 N--CA 1.476 0.856 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -163.83 170.38 16.93 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 125.403 1.481 . . . . 0.0 110.035 -169.131 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER 42.06 65.85 4.54 Favored Pre-proline 0 CA--C 1.547 0.845 0 C-N-CA 126.448 1.899 . . . . 0.0 112.614 -179.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -74.41 77.78 2.83 Favored 'Trans proline' 0 C--N 1.354 0.839 0 C-N-CA 124.877 3.718 . . . . 0.0 111.917 -173.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . 0.555 HG22 ' H ' ' A' ' 192' ' ' ASP . 9.5 p -153.26 -174.74 0.16 Allowed 'Isoleucine or valine' 0 CA--C 1.544 0.712 0 C-N-CA 127.161 2.184 . . . . 0.0 107.546 -179.83 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . 0.555 ' H ' HG22 ' A' ' 191' ' ' VAL . 9.5 m-20 -52.87 153.55 5.86 Favored Pre-proline 0 CA--C 1.543 0.695 0 C-N-CA 126.131 1.772 . . . . 0.0 112.698 176.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -71.46 5.98 2.12 Favored 'Trans proline' 0 CA--C 1.545 1.063 0 C-N-CA 123.889 3.059 . . . . 0.0 112.992 172.205 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 63.6 m-80 -106.2 62.61 0.65 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 126.737 2.015 . . . . 0.0 108.985 -176.172 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -132.86 106.57 12.69 Favored Pre-proline 0 CA--C 1.538 0.51 0 C-N-CA 125.068 1.347 . . . . 0.0 108.361 -172.375 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 92.1 Cg_endo -75.04 157.13 42.79 Favored 'Trans proline' 0 N--CA 1.457 -0.643 0 C-N-CA 122.65 2.233 . . . . 0.0 110.587 174.653 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 80.4 p -141.68 172.22 12.98 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.47 1.108 . . . . 0.0 110.005 -177.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 98.2 m-85 -134.47 -83.97 0.43 Allowed 'General case' 0 CA--C 1.535 0.388 0 CA-C-O 117.316 -1.325 . . . . 0.0 112.885 -168.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.419 ' H ' HE22 ' A' ' 203' ' ' GLN . 1.9 t -55.17 168.5 0.33 Allowed 'General case' 0 C--N 1.351 0.667 0 C-N-CA 124.957 1.303 . . . . 0.0 113.274 -176.564 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.2 pp -57.05 -12.42 2.08 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 125.23 1.412 . . . . 0.0 113.145 170.404 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 71.3 m -78.76 -18.94 53.38 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 126.593 1.957 . . . . 0.0 113.208 176.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 23.3 m170 57.32 62.21 2.26 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 126.874 2.069 . . . . 0.0 111.663 -173.053 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . 0.419 HE22 ' H ' ' A' ' 199' ' ' CYS . 0.0 OUTLIER -125.65 158.75 33.95 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 125.022 1.329 . . . . 0.0 112.435 176.6 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.47 HG12 ' H ' ' A' ' 205' ' ' SER . 0.3 OUTLIER -69.17 -179.4 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.767 0 C-N-CA 126.355 1.862 . . . . 0.0 111.366 -176.976 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.47 ' H ' HG12 ' A' ' 204' ' ' VAL . 79.5 p -45.37 147.62 0.77 Allowed 'General case' 0 CA--C 1.537 0.445 0 C-N-CA 127.42 2.288 . . . . 0.0 113.911 178.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 17.0 p90 -154.08 173.54 15.9 Favored 'General case' 0 CA--C 1.537 0.463 0 C-N-CA 125.537 1.535 . . . . 0.0 111.223 -167.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -80.96 -71.36 1.29 Allowed Glycine 0 CA--C 1.528 0.893 0 C-N-CA 123.831 0.729 . . . . 0.0 112.959 -170.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -91.84 120.4 32.51 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 123.632 0.773 . . . . 0.0 111.117 -174.284 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -142.02 143.86 33.36 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 -168.611 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 19.8 tt -134.97 150.36 29.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.237 0 C-N-CA 125.541 1.537 . . . . 0.0 109.939 172.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -127.99 139.29 10.99 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.788 1.185 . . . . 0.0 112.641 -171.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . 0.592 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 1.9 m -78.75 126.12 30.29 Favored 'General case' 0 N--CA 1.464 0.26 0 C-N-CA 125.582 1.553 . . . . 0.0 111.802 -168.078 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -69.39 -2.36 10.77 Favored 'General case' 0 CA--C 1.545 0.753 0 C-N-CA 126.58 1.952 . . . . 0.0 113.808 -175.601 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -66.49 149.98 97.63 Favored Pre-proline 0 CA--C 1.54 0.568 0 C-N-CA 123.769 0.828 . . . . 0.0 112.12 -174.264 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 42.8 Cg_endo -83.76 7.76 5.01 Favored 'Trans proline' 0 CA--C 1.549 1.262 0 C-N-CA 123.725 2.95 . . . . 0.0 111.342 166.613 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -144.39 -10.86 0.63 Allowed 'General case' 0 CA--C 1.544 0.72 0 N-CA-C 114.857 1.429 . . . . 0.0 114.857 -167.531 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 36.7 t -60.93 134.09 56.74 Favored 'General case' 0 C--N 1.344 0.353 0 CA-C-N 119.465 1.03 . . . . 0.0 110.468 179.597 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.5 t -110.47 14.24 22.57 Favored 'General case' 0 CA--C 1.541 0.62 0 C-N-CA 125.762 1.625 . . . . 0.0 111.124 -173.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 51.7 mt -122.75 -41.97 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 C-N-CA 125.327 1.451 . . . . 0.0 108.577 172.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 47.63 -8.59 0.0 OUTLIER 'General case' 0 CA--C 1.546 0.792 0 C-N-CA 131.351 3.861 . . . . 0.0 119.552 172.117 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 62.3 m95 -139.62 136.07 33.98 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 126.497 1.919 . . . . 0.0 109.603 170.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . 0.592 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 7.2 m-85 -142.49 158.69 43.42 Favored 'General case' 0 C--O 1.233 0.211 0 C-N-CA 125.572 1.549 . . . . 0.0 109.179 -169.17 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 20.8 m170 -78.45 148.14 33.68 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 108.679 -0.86 . . . . 0.0 108.679 169.75 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 12.3 m-30 -51.74 -51.37 56.68 Favored 'General case' 0 C--O 1.222 -0.354 0 CA-C-N 115.295 -0.866 . . . . 0.0 109.937 167.789 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.84 -13.23 61.62 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 -176.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 4.8 m -78.29 -8.1 57.99 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 119.81 1.186 . . . . 0.0 112.608 172.648 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.8 p -120.9 -12.68 8.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 C-N-CA 126.319 1.847 . . . . 0.0 112.185 170.815 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 94.28 18.24 36.98 Favored Glycine 0 CA--C 1.532 1.147 0 C-N-CA 125.693 1.616 . . . . 0.0 113.4 178.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 19.4 mt -72.05 158.34 36.13 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.749 1.275 . . . . 0.0 111.327 176.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 59.7 m -134.86 -18.38 1.86 Allowed 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.782 1.633 . . . . 0.0 111.145 -177.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 62.7 m -144.33 139.62 28.63 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 125.692 1.597 . . . . 0.0 107.82 178.166 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -70.58 122.6 87.1 Favored Pre-proline 0 CA--C 1.541 0.632 0 C-N-CA 123.519 0.727 . . . . 0.0 110.836 -176.218 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -81.48 -179.8 5.21 Favored 'Trans proline' 0 CA--C 1.542 0.901 0 C-N-CA 123.769 2.979 . . . . 0.0 111.617 173.08 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 13.1 ttm180 -139.62 135.82 33.71 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 125.031 1.332 . . . . 0.0 107.475 169.615 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 116.54 -174.61 15.32 Favored Glycine 0 CA--C 1.528 0.893 0 C-N-CA 125.405 1.478 . . . . 0.0 111.747 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 14.0 ptmm? -62.34 122.72 16.38 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.883 1.273 . . . . 0.0 111.09 177.152 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 44.7 t90 -132.98 143.02 49.17 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 127.201 2.2 . . . . 0.0 108.6 178.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 56.6 m-85 -126.92 126.77 43.81 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.564 1.146 . . . . 0.0 109.003 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . 0.424 ' HB2' ' HD2' ' A' ' 240' ' ' PRO . 5.8 p -61.23 169.08 2.38 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 126.857 2.063 . . . . 0.0 114.007 -172.05 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.424 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 57.5 Cg_endo -72.44 1.48 6.14 Favored 'Trans proline' 0 C--N 1.351 0.709 0 C-N-CA 122.559 2.173 . . . . 0.0 115.221 -171.068 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 38.3 mtp180 -117.42 17.58 14.55 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.224 1.41 . . . . 0.0 112.106 170.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 31.7 m -133.52 -14.0 2.57 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.434 1.894 . . . . 0.0 112.763 -179.133 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 33.0 t -147.87 -33.06 0.26 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.058 0.943 . . . . 0.0 112.195 177.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -86.8 -13.48 44.99 Favored 'General case' 0 CA--C 1.541 0.623 0 N-CA-C 113.356 0.873 . . . . 0.0 113.356 -173.794 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 -72.04 -0.76 12.49 Favored 'General case' 0 CA--C 1.544 0.738 0 CA-C-N 119.443 1.02 . . . . 0.0 112.531 169.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 53.7 ttp180 -63.47 122.86 17.3 Favored 'General case' 0 CA--C 1.536 0.408 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 168.427 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 29.8 ttpt 48.65 56.14 8.04 Favored 'General case' 0 CA--C 1.542 0.65 0 C-N-CA 125.381 1.473 . . . . 0.0 112.11 -169.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -55.76 138.04 48.57 Favored 'General case' 0 CA--C 1.539 0.519 0 C-N-CA 124.606 1.162 . . . . 0.0 109.598 172.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--O 1.251 1.158 0 C-N-CA 126.015 1.726 . . . . 0.0 109.838 -167.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 93.0 mtp . . . . . 0 N--CA 1.475 0.806 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -155.33 131.1 9.91 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.306 1.043 . . . . 0.0 109.432 172.661 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 18.8 ptm -160.55 91.11 1.66 Allowed Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 125.072 1.349 . . . . 0.0 108.774 172.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -74.44 10.95 1.39 Allowed 'Trans proline' 0 CA--C 1.545 1.055 0 C-N-CA 123.755 2.97 . . . . 0.0 113.171 178.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 10.6 m -138.52 154.01 26.68 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.74 0 C-N-CA 127.999 2.519 . . . . 0.0 108.22 -179.024 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -64.48 156.84 75.57 Favored Pre-proline 0 CA--C 1.541 0.598 0 C-N-CA 125.379 1.472 . . . . 0.0 111.809 175.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 85.1 Cg_endo -71.9 -7.35 20.93 Favored 'Trans proline' 0 CA--C 1.545 1.033 0 C-N-CA 123.155 2.57 . . . . 0.0 112.041 168.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 65.9 m-80 -93.6 72.55 4.33 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 126.878 2.071 . . . . 0.0 108.734 179.295 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 24.1 tp10 -142.98 128.19 10.02 Favored Pre-proline 0 CA--C 1.539 0.544 0 C-N-CA 124.905 1.282 . . . . 0.0 108.351 -169.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -70.94 155.59 61.77 Favored 'Trans proline' 0 C--N 1.351 0.67 0 C-N-CA 122.942 2.428 . . . . 0.0 111.978 -179.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 65.6 p -146.04 176.39 9.75 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.864 1.266 . . . . 0.0 110.536 -173.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -135.34 -83.59 0.41 Allowed 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 117.508 -1.234 . . . . 0.0 112.707 -169.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.0 t -55.88 167.81 0.54 Allowed 'General case' 0 C--N 1.351 0.66 0 CA-C-N 119.741 1.155 . . . . 0.0 113.129 -178.118 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 2.9 pp -57.66 -12.66 3.05 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 124.92 1.288 . . . . 0.0 112.768 171.105 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 74.6 m -76.64 -19.65 57.56 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 126.544 1.938 . . . . 0.0 113.214 176.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 29.9 m170 56.8 64.52 1.64 Allowed 'General case' 0 CA--C 1.536 0.43 0 C-N-CA 126.729 2.011 . . . . 0.0 111.396 -172.251 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.41 156.98 39.71 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 125.231 1.412 . . . . 0.0 112.13 174.577 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.553 HG12 ' H ' ' A' ' 205' ' ' SER . 0.9 OUTLIER -69.61 -178.21 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 C-N-CA 126.114 1.766 . . . . 0.0 110.916 -178.39 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.553 ' H ' HG12 ' A' ' 204' ' ' VAL . 88.0 p -45.51 148.77 0.64 Allowed 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 127.53 2.332 . . . . 0.0 113.964 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 10.8 p90 -154.97 173.67 16.22 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.276 1.43 . . . . 0.0 111.346 -167.64 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -80.75 -73.2 1.18 Allowed Glycine 0 C--N 1.341 0.852 0 C-N-CA 123.877 0.751 . . . . 0.0 112.784 -171.005 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 17.9 pt-20 -88.54 119.44 29.0 Favored 'General case' 0 C--N 1.341 0.224 0 C-N-CA 123.597 0.759 . . . . 0.0 111.238 -176.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -142.52 143.77 32.66 Favored 'General case' 0 C--N 1.341 0.216 0 N-CA-C 112.813 0.672 . . . . 0.0 112.813 -169.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 21.3 tt -136.53 152.0 28.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.295 0 C-N-CA 125.729 1.612 . . . . 0.0 109.706 173.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -129.5 139.23 10.8 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 124.514 1.054 . . . . 0.0 112.914 -172.004 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . 0.602 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 7.3 m -75.77 127.74 33.68 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 125.898 1.679 . . . . 0.0 111.548 -168.57 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 24.0 t70 -71.02 -1.86 13.52 Favored 'General case' 0 CA--C 1.546 0.824 0 C-N-CA 125.973 1.709 . . . . 0.0 113.591 -177.157 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.9 m120 -67.02 148.15 98.94 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 123.661 0.784 . . . . 0.0 111.523 -175.377 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -82.43 8.05 4.77 Favored 'Trans proline' 0 CA--C 1.548 1.201 0 C-N-CA 123.592 2.861 . . . . 0.0 111.631 167.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.7 t70 -144.16 -9.87 0.67 Allowed 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.678 1.362 . . . . 0.0 114.678 -167.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.8 t -62.39 133.47 55.1 Favored 'General case' 0 C--N 1.344 0.359 0 CA-C-N 119.607 1.094 . . . . 0.0 110.443 178.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 9.4 t -106.21 4.65 29.13 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.705 1.602 . . . . 0.0 111.687 -173.439 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 42.8 mm -112.18 -42.32 4.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.512 0 C-N-CA 125.736 1.614 . . . . 0.0 108.777 175.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 48.82 -11.15 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 131.556 3.943 . . . . 0.0 119.597 171.544 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 62.4 m95 -138.8 137.82 36.99 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.778 2.031 . . . . 0.0 109.387 170.838 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . 0.602 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 7.3 m-85 -144.39 157.08 44.44 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.527 1.531 . . . . 0.0 109.654 -169.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 47.0 m80 -74.46 149.75 40.21 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 109.449 -0.574 . . . . 0.0 109.449 167.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 10.0 m-30 -51.4 -52.81 42.71 Favored 'General case' 0 C--O 1.222 -0.348 0 CA-C-N 115.037 -0.983 . . . . 0.0 109.727 167.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.47 -12.44 61.39 Favored 'General case' 0 N--CA 1.45 -0.456 0 CA-C-O 118.253 -0.88 . . . . 0.0 113.253 -176.395 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 2.0 m -77.43 -8.49 57.81 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 119.759 1.163 . . . . 0.0 112.5 172.009 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.6 p -121.77 -14.08 7.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 126.082 1.753 . . . . 0.0 112.514 170.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 98.66 16.53 31.12 Favored Glycine 0 CA--C 1.533 1.199 0 C-N-CA 125.856 1.693 . . . . 0.0 113.513 178.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 19.6 mt -71.49 162.17 29.87 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-N 118.908 1.354 . . . . 0.0 111.66 177.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 14.7 t -139.22 -14.5 1.14 Allowed 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 125.51 1.524 . . . . 0.0 112.512 -178.573 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 59.7 m -146.86 139.54 25.05 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 126.019 1.728 . . . . 0.0 107.287 177.189 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 36.8 ttmt -69.35 119.5 70.86 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-O 118.721 -0.657 . . . . 0.0 110.55 -177.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -78.29 174.63 12.13 Favored 'Trans proline' 0 CA--C 1.54 0.82 0 C-N-CA 123.463 2.776 . . . . 0.0 110.67 170.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 30.1 ttp-105 -143.16 130.98 21.49 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 121.923 0.868 . . . . 0.0 108.795 170.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 126.4 -174.38 17.96 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 126.343 1.925 . . . . 0.0 110.409 -169.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 59.6 pttt -66.4 128.84 37.73 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 124.18 0.992 . . . . 0.0 110.761 175.173 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . 0.429 ' HZ3' ' HG ' ' A' ' 212' ' ' CYS . 54.8 t90 -135.74 145.01 46.17 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 127.304 2.242 . . . . 0.0 109.134 178.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 68.5 m-85 -130.6 124.8 32.54 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.691 1.196 . . . . 0.0 109.6 -176.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . 0.429 ' HB3' ' SG ' ' A' ' 212' ' ' CYS . 1.9 p -61.25 172.92 0.81 Allowed Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 128.1 2.56 . . . . 0.0 114.835 -171.474 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.427 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 94.7 Cg_endo -76.06 12.82 1.4 Allowed 'Trans proline' 0 C--N 1.353 0.776 0 C-N-CA 123.608 2.872 . . . . 0.0 115.365 -171.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 35.8 mtp180 -125.53 13.82 8.15 Favored 'General case' 0 CA--C 1.54 0.558 0 C-N-CA 125.716 1.606 . . . . 0.0 111.058 169.055 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 66.6 m -135.73 -22.28 1.45 Allowed 'General case' 0 N--CA 1.446 -0.656 0 C-N-CA 125.939 1.695 . . . . 0.0 113.714 -174.448 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 27.8 t -151.65 -42.08 0.11 Allowed 'General case' 0 C--N 1.342 0.278 0 CA-C-N 119.004 0.82 . . . . 0.0 112.614 175.526 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 7.7 tm0? -77.25 -13.85 59.86 Favored 'General case' 0 CA--C 1.541 0.613 0 CA-C-O 119.337 -0.363 . . . . 0.0 111.65 -178.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 20.2 tt0 -58.65 -27.72 65.03 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 124.842 1.257 . . . . 0.0 113.18 178.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 95.1 mtm-85 -77.92 4.29 12.4 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.406 1.483 . . . . 0.0 113.314 179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 59.3 tptt -138.64 -36.87 0.55 Allowed 'General case' 0 C--N 1.344 0.347 0 C-N-CA 124.288 1.035 . . . . 0.0 112.177 -173.1 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 25.1 tptt -159.78 175.82 12.68 Favored 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 123.828 0.851 . . . . 0.0 110.981 176.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.251 1.147 0 C-N-CA 126.16 1.784 . . . . 0.0 107.339 178.058 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 21.6 ptp . . . . . 0 N--CA 1.478 0.94 0 CA-C-O 118.46 -0.781 . . . . 0.0 112.708 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 19.3 m-20 -139.18 154.79 48.11 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.725 1.21 . . . . 0.0 110.246 179.836 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.94 158.94 31.49 Favored Pre-proline 0 CA--C 1.542 0.658 0 C-N-CA 125.213 1.405 . . . . 0.0 110.39 -175.504 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -67.74 149.39 78.67 Favored 'Trans proline' 0 C--N 1.35 0.64 0 C-N-CA 122.743 2.295 . . . . 0.0 110.586 169.689 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . 0.306 2.8 m 51.92 153.76 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 130.002 3.321 . . . . 0.0 115.751 -169.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -64.93 154.27 86.63 Favored Pre-proline 0 CA--C 1.539 0.544 0 CA-C-N 114.307 -1.315 . . . . 0.0 111.919 179.027 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_endo -74.79 8.35 2.38 Favored 'Trans proline' 0 CA--C 1.547 1.161 0 C-N-CA 123.631 2.887 . . . . 0.0 112.231 169.124 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 34.8 m-80 -119.65 38.53 3.87 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 126.97 2.108 . . . . 0.0 110.012 -176.132 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -125.74 99.22 32.79 Favored Pre-proline 0 CA--C 1.539 0.535 0 C-N-CA 125.365 1.466 . . . . 0.0 108.674 -169.538 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -73.08 159.56 47.41 Favored 'Trans proline' 0 C--N 1.35 0.62 0 C-N-CA 123.128 2.552 . . . . 0.0 111.554 -178.388 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 67.6 p -145.07 173.6 11.77 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 124.578 1.151 . . . . 0.0 110.715 -175.015 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 99.3 m-85 -136.79 -83.27 0.36 Allowed 'General case' 0 CA--C 1.534 0.352 0 CA-C-O 117.355 -1.307 . . . . 0.0 112.565 -170.231 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.0 t -55.6 168.21 0.44 Allowed 'General case' 0 C--N 1.351 0.641 0 C-N-CA 125.013 1.325 . . . . 0.0 113.378 -176.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.0 pp -57.45 -12.69 2.79 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.079 1.352 . . . . 0.0 113.031 170.511 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 72.7 m -77.17 -19.9 56.17 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 126.461 1.904 . . . . 0.0 113.223 176.301 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 21.8 m170 57.75 63.92 1.69 Allowed 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 126.868 2.067 . . . . 0.0 111.565 -172.11 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.22 158.13 38.96 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.079 1.352 . . . . 0.0 112.496 175.585 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.544 HG12 ' H ' ' A' ' 205' ' ' SER . 0.9 OUTLIER -67.83 -179.1 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 126.389 1.876 . . . . 0.0 111.144 -177.82 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.544 ' H ' HG12 ' A' ' 204' ' ' VAL . 88.3 p -46.31 150.17 0.66 Allowed 'General case' 0 CA--C 1.537 0.456 0 C-N-CA 127.562 2.345 . . . . 0.0 113.84 179.127 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . 0.466 ' CE2' ' HG2' ' A' ' 209' ' ' MET . 18.3 p90 -155.55 164.87 38.09 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 125.127 1.371 . . . . 0.0 111.227 -167.512 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -73.8 -49.44 13.85 Favored Glycine 0 CA--C 1.531 1.057 0 CA-C-O 118.666 -1.074 . . . . 0.0 114.814 -169.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 25.3 pt-20 -117.2 121.33 40.92 Favored 'General case' 0 C--N 1.343 0.303 0 CA-C-N 118.478 1.139 . . . . 0.0 110.362 -170.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . 0.466 ' HG2' ' CE2' ' A' ' 206' ' ' TYR . 2.8 mtp -140.48 148.66 41.46 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 113.911 1.078 . . . . 0.0 113.911 -166.255 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 14.5 tt -136.91 156.55 34.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 C-N-CA 125.57 1.548 . . . . 0.0 109.32 168.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -133.75 139.18 10.68 Favored Glycine 0 CA--C 1.529 0.965 0 C-N-CA 124.488 1.042 . . . . 0.0 112.4 -171.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . 0.586 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 1.1 m -79.61 125.99 30.32 Favored 'General case' 0 N--CA 1.467 0.393 0 C-N-CA 125.191 1.397 . . . . 0.0 112.233 -167.605 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 28.2 t70 -69.37 -4.96 20.49 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.598 1.959 . . . . 0.0 113.888 -175.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -66.43 145.65 98.98 Favored Pre-proline 0 CA--C 1.539 0.524 0 C-N-CA 123.424 0.689 . . . . 0.0 111.396 -173.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 70.2 Cg_endo -81.92 9.21 4.04 Favored 'Trans proline' 0 CA--C 1.551 1.343 0 C-N-CA 123.074 2.516 . . . . 0.0 110.946 165.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 11.1 m-20 -134.41 -15.56 2.17 Favored 'General case' 0 C--N 1.35 0.614 0 C-N-CA 125.407 1.483 . . . . 0.0 114.365 -169.271 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 35.6 t -65.05 136.13 56.39 Favored 'General case' 0 C--N 1.342 0.28 0 C-N-CA 123.905 0.882 . . . . 0.0 110.611 -175.915 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.4 t -113.07 14.57 19.59 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 125.721 1.608 . . . . 0.0 111.217 -174.274 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 51.3 mt -123.2 -42.34 1.55 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 125.363 1.465 . . . . 0.0 108.71 173.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 47.28 -7.59 0.0 OUTLIER 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 131.453 3.901 . . . . 0.0 119.59 171.534 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 66.1 m95 -139.0 134.84 33.6 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 126.466 1.907 . . . . 0.0 109.259 170.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . 0.586 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 7.8 m-85 -142.01 157.09 45.34 Favored 'General case' 0 C--O 1.233 0.195 0 C-N-CA 125.362 1.465 . . . . 0.0 109.075 -169.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 19.7 m170 -77.0 148.6 36.15 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 169.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 14.4 m-30 -51.92 -51.62 55.69 Favored 'General case' 0 C--O 1.224 -0.275 0 CA-C-N 115.086 -0.961 . . . . 0.0 109.89 167.441 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.51 -14.18 62.41 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 113.411 0.893 . . . . 0.0 113.411 -177.387 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 6.5 m -79.38 -6.67 57.32 Favored 'General case' 0 N--CA 1.448 -0.568 0 CA-C-N 119.748 1.158 . . . . 0.0 112.766 173.247 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.9 p -120.87 -12.62 8.86 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 125.965 1.706 . . . . 0.0 112.113 169.62 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 96.31 16.87 36.07 Favored Glycine 0 CA--C 1.532 1.115 0 C-N-CA 125.509 1.528 . . . . 0.0 113.317 178.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 13.7 mt -71.82 159.46 34.27 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 118.581 1.191 . . . . 0.0 111.068 175.71 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 24.4 m -133.17 -5.52 3.04 Favored 'General case' 0 CA--C 1.544 0.731 0 C-N-CA 126.115 1.766 . . . . 0.0 110.41 177.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 80.1 p -142.51 179.62 6.85 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 126.815 2.046 . . . . 0.0 109.398 -178.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 59.6 tttp -112.33 97.32 39.18 Favored Pre-proline 0 CA--C 1.537 0.463 0 C-N-CA 124.232 1.013 . . . . 0.0 109.528 178.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -70.6 167.73 24.71 Favored 'Trans proline' 0 CA--C 1.538 0.715 0 C-N-CA 122.425 2.084 . . . . 0.0 110.255 169.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 9.2 tpt180 -140.69 131.72 26.22 Favored 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 121.981 0.896 . . . . 0.0 109.084 175.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 138.88 -173.43 22.62 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 126.577 2.037 . . . . 0.0 109.688 -169.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 19.4 ptmt -70.83 126.99 31.11 Favored 'General case' 0 N--CA 1.453 -0.305 0 CA-C-O 121.729 0.776 . . . . 0.0 109.68 170.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 39.0 t90 -133.51 144.58 49.5 Favored 'General case' 0 N--CA 1.45 -0.464 0 C-N-CA 126.864 2.066 . . . . 0.0 108.493 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 53.4 m-85 -126.21 131.2 52.02 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.568 1.147 . . . . 0.0 108.935 -179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 3.7 p -61.82 167.04 5.08 Favored Pre-proline 0 CA--C 1.538 0.49 0 C-N-CA 126.106 1.763 . . . . 0.0 112.63 -175.616 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -65.77 -36.41 32.19 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 121.026 1.15 . . . . 0.0 112.097 -170.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 60.8 mtt-85 -78.31 10.93 2.66 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 124.496 1.119 . . . . 0.0 112.907 178.708 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 19.1 m -129.37 -13.56 4.36 Favored 'General case' 0 N--CA 1.449 -0.522 0 C-N-CA 126.431 1.892 . . . . 0.0 113.883 -179.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 35.7 t -149.77 -42.43 0.14 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 118.884 0.766 . . . . 0.0 112.561 -176.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 47.3 tp60 -75.2 -18.43 60.15 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 118.494 -0.765 . . . . 0.0 112.834 -177.415 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -63.11 -22.18 66.69 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-N 119.371 0.987 . . . . 0.0 111.709 172.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 1.8 tpt180 -86.38 15.32 5.48 Favored 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 124.84 1.256 . . . . 0.0 112.609 175.638 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 2.4 mptp? -137.77 -67.93 0.47 Allowed 'General case' 0 C--N 1.345 0.405 0 C-N-CA 125.307 1.443 . . . . 0.0 109.001 175.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 85.4 tttt -165.19 92.34 0.56 Allowed 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.496 1.518 . . . . 0.0 109.369 176.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 3.4 ttmp? . . . . . 0 C--O 1.249 1.071 0 C-N-CA 128.249 2.62 . . . . 0.0 114.901 175.958 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 76.3 mtm . . . . . 0 N--CA 1.476 0.844 0 N-CA-C 109.271 -0.641 . . . . 0.0 109.271 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 2.9 p-10 -159.7 170.06 22.35 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 125.156 1.382 . . . . 0.0 110.273 -169.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 27.3 ptt? -62.75 144.97 96.18 Favored Pre-proline 0 CA--C 1.543 0.676 0 C-N-CA 123.925 0.89 . . . . 0.0 111.921 -178.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -75.62 117.26 4.71 Favored 'Trans proline' 0 N--CA 1.457 -0.634 0 C-N-CA 123.112 2.541 . . . . 0.0 110.119 174.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 2.4 m -142.66 129.76 18.89 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.335 0 C-N-CA 125.562 1.545 . . . . 0.0 108.595 177.586 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -76.96 156.4 82.35 Favored Pre-proline 0 CA--C 1.54 0.565 0 C-N-CA 124.583 1.153 . . . . 0.0 111.327 177.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -72.98 0.34 7.94 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.759 2.972 . . . . 0.0 113.04 170.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -71.92 80.8 0.91 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 126.75 2.02 . . . . 0.0 110.529 178.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 46.2 tt0 -151.53 138.66 12.14 Favored Pre-proline 0 CA--C 1.542 0.646 0 C-N-CA 125.569 1.548 . . . . 0.0 108.282 -172.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 63.6 Cg_endo -70.66 154.89 63.9 Favored 'Trans proline' 0 C--N 1.35 0.61 0 C-N-CA 122.796 2.33 . . . . 0.0 112.063 -178.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 64.4 p -144.43 175.22 10.28 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 125.067 1.347 . . . . 0.0 110.327 -174.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 70.5 m-85 -134.4 -81.26 0.45 Allowed 'General case' 0 CA--C 1.535 0.389 0 CA-C-O 117.328 -1.32 . . . . 0.0 113.26 -170.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.9 t -54.77 167.09 0.4 Allowed 'General case' 0 C--N 1.35 0.594 0 C-N-CA 125.078 1.351 . . . . 0.0 113.174 -176.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 4.2 pp -60.17 -11.0 5.11 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.207 1.003 . . . . 0.0 112.715 169.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 72.3 m -74.38 -24.0 59.07 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.551 1.94 . . . . 0.0 112.906 172.377 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 54.63 69.65 0.7 Allowed 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 127.291 2.236 . . . . 0.0 111.925 -170.268 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -128.6 162.21 27.82 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 125.832 1.653 . . . . 0.0 111.689 173.219 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.477 HG12 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -70.28 -177.9 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.855 0 C-N-CA 126.04 1.736 . . . . 0.0 111.686 -176.469 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.477 ' H ' HG12 ' A' ' 204' ' ' VAL . 40.5 m -44.34 150.34 0.32 Allowed 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 128.2 2.6 . . . . 0.0 114.497 177.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 12.0 p90 -158.06 170.27 22.67 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 126.034 1.733 . . . . 0.0 110.553 -169.394 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -78.38 -66.52 1.73 Allowed Glycine 0 CA--C 1.529 0.956 0 CA-C-O 119.438 -0.645 . . . . 0.0 113.149 -170.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 25.4 pt-20 -100.54 122.41 43.19 Favored 'General case' 0 C--N 1.342 0.267 0 C-N-CA 123.684 0.794 . . . . 0.0 110.745 -173.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -144.11 146.52 32.85 Favored 'General case' 0 C--O 1.233 0.187 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 -167.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 13.7 tt -144.01 153.96 15.62 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 125.006 1.322 . . . . 0.0 109.922 169.116 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -132.81 145.47 17.42 Favored Glycine 0 C--N 1.335 0.488 0 C-N-CA 123.97 0.795 . . . . 0.0 112.01 -170.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 4.2 t -70.07 142.76 52.63 Favored 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 121.971 0.891 . . . . 0.0 110.863 -173.599 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 23.1 t70 -78.32 -5.43 52.11 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.109 1.764 . . . . 0.0 113.57 -174.232 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 26.2 m-20 -80.77 144.63 56.28 Favored Pre-proline 0 CA--C 1.537 0.47 0 CA-C-N 118.816 0.734 . . . . 0.0 111.231 -169.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -75.67 4.84 4.73 Favored 'Trans proline' 0 CA--C 1.546 1.096 0 C-N-CA 123.564 2.843 . . . . 0.0 112.071 168.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -122.95 -6.61 8.44 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 126.214 1.806 . . . . 0.0 112.358 -173.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 36.7 t -65.25 136.5 56.68 Favored 'General case' 0 N--CA 1.448 -0.55 0 C-N-CA 124.305 1.042 . . . . 0.0 109.782 174.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 8.7 t -119.05 10.75 12.24 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 125.83 1.652 . . . . 0.0 111.248 -175.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 35.5 mm -118.64 -32.82 1.67 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 C-N-CA 126.197 1.799 . . . . 0.0 109.261 175.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 50.02 -13.64 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.617 1 C-N-CA 131.769 4.028 . . . . 0.0 119.378 175.669 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 63.1 m95 -143.1 152.03 41.38 Favored 'General case' 0 N--CA 1.447 -0.58 0 C-N-CA 125.89 1.676 . . . . 0.0 110.365 177.653 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -154.05 154.66 34.08 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.555 1.542 . . . . 0.0 109.885 -172.258 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 19.4 m170 -77.47 148.8 35.18 Favored 'General case' 0 C--O 1.232 0.171 0 N-CA-C 109.048 -0.723 . . . . 0.0 109.048 170.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 9.4 m-30 -52.62 -51.55 59.52 Favored 'General case' 0 C--O 1.223 -0.303 0 CA-C-N 115.052 -0.976 . . . . 0.0 109.782 168.02 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.69 -13.25 61.68 Favored 'General case' 0 N--CA 1.449 -0.494 0 CA-C-O 118.325 -0.845 . . . . 0.0 113.261 -177.104 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 5.3 m -78.23 -6.11 53.94 Favored 'General case' 0 N--CA 1.447 -0.605 0 CA-C-N 119.713 1.142 . . . . 0.0 112.633 172.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 6.2 p -121.86 -16.77 5.8 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 C-N-CA 125.659 1.584 . . . . 0.0 112.232 169.8 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 99.79 17.85 24.53 Favored Glycine 0 CA--C 1.534 1.23 0 C-N-CA 125.776 1.655 . . . . 0.0 113.667 179.751 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 18.9 mt -71.15 158.0 37.19 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 119.01 1.405 . . . . 0.0 111.104 177.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 90.0 m -134.53 -22.97 1.67 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 125.692 1.597 . . . . 0.0 110.973 -179.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 48.6 p -140.73 143.57 35.07 Favored 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.91 1.684 . . . . 0.0 108.455 174.714 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 33.8 ttpt -70.05 126.19 92.32 Favored Pre-proline 0 CA--C 1.545 0.757 0 CA-C-O 118.688 -0.672 . . . . 0.0 110.573 -176.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -76.57 -172.42 1.39 Allowed 'Trans proline' 0 CA--C 1.544 1.019 0 C-N-CA 123.813 3.009 . . . . 0.0 111.278 171.245 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -144.28 139.14 28.41 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 124.816 1.246 . . . . 0.0 108.466 176.246 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 97.23 -170.32 25.83 Favored Glycine 0 CA--C 1.533 1.173 0 C-N-CA 125.357 1.456 . . . . 0.0 111.675 -172.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 26.1 pttm -57.79 138.4 55.63 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.885 1.274 . . . . 0.0 111.177 175.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 52.6 t90 -142.25 153.8 44.23 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 127.301 2.24 . . . . 0.0 109.032 -177.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 26.0 m-85 -130.71 132.76 45.55 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.853 1.261 . . . . 0.0 110.59 -174.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -67.08 167.35 14.71 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.232 1.013 . . . . 0.0 111.651 177.071 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -69.73 -27.0 27.16 Favored 'Trans proline' 0 N--CA 1.457 -0.629 0 C-N-CA 121.303 1.335 . . . . 0.0 113.354 -172.707 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 51.5 mtp180 -87.3 9.8 19.23 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.435 1.094 . . . . 0.0 112.369 174.821 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 17.3 m -126.38 -17.58 5.12 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 125.565 1.546 . . . . 0.0 113.784 -176.111 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 33.8 t -152.97 -36.1 0.11 Allowed 'General case' 0 N--CA 1.467 0.393 0 CA-C-N 119.542 1.065 . . . . 0.0 112.959 174.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 15.2 tt0 -68.49 -19.7 64.55 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 118.292 0.496 . . . . 0.0 112.134 -179.798 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -60.15 -22.2 62.58 Favored 'General case' 0 CA--C 1.542 0.668 0 C-N-CA 125.009 1.323 . . . . 0.0 112.326 177.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 2.6 tpm_? -61.17 -22.24 64.54 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 125.826 1.65 . . . . 0.0 113.437 177.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 51.0 mtmt -139.28 -9.79 1.27 Allowed 'General case' 0 N--CA 1.468 0.472 0 C-N-CA 124.265 1.026 . . . . 0.0 113.638 -177.029 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 56.5 tptt -150.78 110.33 4.02 Favored 'General case' 0 C--N 1.343 0.298 0 CA-C-N 119.139 0.881 . . . . 0.0 110.218 -178.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 8.4 tmtm? . . . . . 0 C--O 1.252 1.233 0 C-N-CA 125.197 1.399 . . . . 0.0 109.156 169.433 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 94.1 mtp . . . . . 0 N--CA 1.477 0.924 0 CA-C-O 121.09 0.471 . . . . 0.0 111.248 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -138.78 20.93 2.68 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 126.617 1.967 . . . . 0.0 110.961 -171.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 64.7 mtt -133.91 157.59 77.41 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 125.336 1.455 . . . . 0.0 110.623 -168.163 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -77.23 23.47 0.53 Allowed 'Trans proline' 0 CA--C 1.546 1.104 0 C-N-CA 124.553 3.502 . . . . 0.0 113.599 -178.816 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 3.4 m -132.2 135.73 57.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 126.617 1.967 . . . . 0.0 108.551 179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 5.6 m-20 -69.37 161.27 74.77 Favored Pre-proline 0 CA--C 1.54 0.58 0 C-N-CA 125.973 1.709 . . . . 0.0 111.905 176.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -71.72 -8.35 22.96 Favored 'Trans proline' 0 CA--C 1.544 1.0 0 C-N-CA 123.014 2.476 . . . . 0.0 111.735 167.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 61.7 m-80 -89.01 40.58 0.99 Allowed 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 127.452 2.301 . . . . 0.0 110.822 179.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 27.2 tp10 -140.14 127.86 12.73 Favored Pre-proline 0 CA--C 1.539 0.536 0 C-N-CA 125.672 1.589 . . . . 0.0 107.95 -170.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -70.49 156.69 60.91 Favored 'Trans proline' 0 C--N 1.349 0.59 0 C-N-CA 122.87 2.38 . . . . 0.0 111.942 -179.328 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 71.2 p -144.49 175.43 10.13 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.902 1.281 . . . . 0.0 110.54 -172.106 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 61.5 m-85 -136.57 -79.62 0.4 Allowed 'General case' 0 CA--C 1.534 0.341 0 CA-C-O 117.215 -1.374 . . . . 0.0 113.095 -170.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.41 ' H ' HE22 ' A' ' 203' ' ' GLN . 0.8 OUTLIER -56.31 169.09 0.45 Allowed 'General case' 0 C--N 1.349 0.572 0 CA-C-N 120.013 1.279 . . . . 0.0 113.403 -175.573 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 4.6 pp -57.95 -11.13 2.15 Favored 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 124.897 1.279 . . . . 0.0 113.147 169.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 71.6 m -78.66 -23.3 45.81 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 126.927 2.091 . . . . 0.0 113.416 176.261 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 33.7 m170 59.02 66.61 1.03 Allowed 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 126.473 1.909 . . . . 0.0 110.835 -169.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . 0.41 HE22 ' H ' ' A' ' 199' ' ' CYS . 0.0 OUTLIER -130.1 160.84 32.5 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 124.823 1.249 . . . . 0.0 112.247 174.048 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.536 HG12 ' H ' ' A' ' 205' ' ' SER . 0.6 OUTLIER -69.05 -179.26 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.89 0 C-N-CA 126.125 1.77 . . . . 0.0 111.355 -175.994 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.536 ' H ' HG12 ' A' ' 204' ' ' VAL . 84.8 p -47.91 153.65 0.61 Allowed 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 127.82 2.448 . . . . 0.0 114.689 179.322 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 11.8 p90 -154.87 169.16 24.66 Favored 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 126.223 1.809 . . . . 0.0 110.484 -169.18 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -79.52 -40.4 15.57 Favored Glycine 0 CA--C 1.53 1.031 0 CA-C-O 118.673 -1.07 . . . . 0.0 115.29 -168.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.12 119.0 21.29 Favored 'General case' 0 N--CA 1.451 -0.407 0 CA-C-N 118.57 1.185 . . . . 0.0 110.137 -168.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -142.08 152.37 43.24 Favored 'General case' 0 N--CA 1.465 0.28 0 N-CA-C 114.872 1.434 . . . . 0.0 114.872 -164.197 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 15.7 tt -148.49 153.23 11.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 C-N-CA 126.091 1.756 . . . . 0.0 109.516 167.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -131.99 146.45 18.07 Favored Glycine 0 C--N 1.336 0.529 0 C-N-CA 124.267 0.937 . . . . 0.0 111.634 -170.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 3.9 t -70.29 140.84 52.38 Favored 'General case' 0 C--N 1.343 0.299 0 CA-C-O 121.941 0.876 . . . . 0.0 111.042 -171.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -76.87 -5.09 46.99 Favored 'General case' 0 CA--C 1.542 0.661 0 C-N-CA 126.311 1.844 . . . . 0.0 113.842 -174.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 36.1 m-20 -78.45 147.59 72.22 Favored Pre-proline 0 CA--C 1.539 0.548 0 CA-C-N 118.846 0.748 . . . . 0.0 111.633 -169.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -76.51 8.42 2.99 Favored 'Trans proline' 0 CA--C 1.546 1.105 0 C-N-CA 124.135 3.223 . . . . 0.0 112.589 169.398 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -133.32 -9.53 2.91 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 126.011 1.724 . . . . 0.0 112.394 -169.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.9 t -61.22 133.91 56.44 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.932 0.893 . . . . 0.0 109.845 173.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 68.6 m -119.83 14.9 12.56 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 125.921 1.688 . . . . 0.0 111.171 -175.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 37.6 mm -119.99 -32.39 1.56 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.706 0 C-N-CA 126.739 2.016 . . . . 0.0 109.164 174.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 51.51 -15.68 0.0 OUTLIER 'General case' 0 C--N 1.35 0.587 1 C-N-CA 131.955 4.102 . . . . 0.0 119.305 173.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 56.7 m95 -143.01 151.04 40.4 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.64 1.576 . . . . 0.0 110.587 178.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 73.8 m-85 -153.01 155.24 36.54 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 124.782 1.233 . . . . 0.0 110.418 -173.248 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 11.7 m170 -79.29 146.74 32.8 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 169.34 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 24.7 m-85 -53.47 -48.78 68.58 Favored 'General case' 0 C--O 1.222 -0.345 0 CA-C-N 114.754 -1.112 . . . . 0.0 110.463 168.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.07 -14.85 62.86 Favored 'General case' 0 CA--C 1.539 0.531 0 N-CA-C 113.498 0.925 . . . . 0.0 113.498 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -75.77 -13.54 60.3 Favored 'General case' 0 C--N 1.348 0.535 0 CA-C-N 119.712 1.142 . . . . 0.0 112.711 173.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.7 p -115.04 -13.33 11.4 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.477 0 C-N-CA 126.014 1.725 . . . . 0.0 111.801 172.126 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 91.65 20.11 38.52 Favored Glycine 0 CA--C 1.534 1.238 0 C-N-CA 125.869 1.7 . . . . 0.0 113.49 179.422 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 12.0 mt -75.36 160.06 30.73 Favored 'General case' 0 C--N 1.344 0.362 0 CA-C-N 118.747 1.273 . . . . 0.0 111.801 -179.5 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 91.1 m -133.87 -20.2 1.99 Allowed 'General case' 0 CA--C 1.542 0.645 0 C-N-CA 125.862 1.665 . . . . 0.0 111.131 -177.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 89.3 m -142.03 135.74 29.54 Favored 'General case' 0 C--N 1.344 0.347 0 C-N-CA 125.577 1.551 . . . . 0.0 107.906 178.079 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 40.9 ttmt -70.55 115.69 37.8 Favored Pre-proline 0 CA--C 1.544 0.732 0 C-N-CA 125.208 1.403 . . . . 0.0 111.545 -176.417 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -79.87 162.17 23.89 Favored 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 123.025 2.483 . . . . 0.0 110.049 168.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 65.4 ttp85 -150.34 136.7 18.8 Favored 'General case' 0 C--N 1.341 0.232 0 CA-C-O 121.891 0.853 . . . . 0.0 110.232 -178.489 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 136.86 -61.84 0.6 Allowed Glycine 0 CA--C 1.529 0.906 0 C-N-CA 127.347 2.403 . . . . 0.0 108.758 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 25.5 pttm -161.54 145.68 12.94 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 126.614 1.966 . . . . 0.0 108.514 168.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 68.4 t90 -146.89 153.16 39.81 Favored 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 125.838 1.655 . . . . 0.0 109.417 -177.295 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 25.8 m-85 -128.89 128.95 44.84 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.856 1.263 . . . . 0.0 110.037 -175.078 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.17 168.39 7.78 Favored Pre-proline 0 CA--C 1.542 0.635 0 C-N-CA 124.526 1.131 . . . . 0.0 112.246 178.044 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -67.91 -28.89 35.42 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 121.347 1.365 . . . . 0.0 112.684 -174.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 26.5 mtp180 -88.19 13.36 11.55 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.54 1.136 . . . . 0.0 112.877 175.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 16.1 m -129.28 -15.74 4.08 Favored 'General case' 0 N--CA 1.449 -0.52 0 C-N-CA 125.707 1.603 . . . . 0.0 113.364 -178.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 35.9 t -151.67 -33.28 0.14 Allowed 'General case' 0 CA--C 1.532 0.277 0 CA-C-N 119.077 0.853 . . . . 0.0 112.991 175.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -74.26 -13.97 60.85 Favored 'General case' 0 CA--C 1.543 0.697 0 CA-C-N 118.872 0.76 . . . . 0.0 112.684 -178.229 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 31.4 mt-10 -68.17 -5.21 16.84 Favored 'General case' 0 CA--C 1.545 0.772 0 CA-C-N 119.231 0.923 . . . . 0.0 112.912 169.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 15.6 tpt180 -68.58 -22.74 64.44 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.585 1.154 . . . . 0.0 112.016 169.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 40.6 ttmt -146.59 71.82 1.26 Allowed 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.336 1.454 . . . . 0.0 108.965 179.683 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -63.17 143.75 57.52 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.644 1.178 . . . . 0.0 111.036 178.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 96.5 mttt . . . . . 0 C--O 1.251 1.176 0 C-N-CA 125.727 1.611 . . . . 0.0 109.125 177.983 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 26.4 ttt . . . . . 0 N--CA 1.475 0.821 0 CA-C-O 119.328 -0.368 . . . . 0.0 111.04 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.9 p-10 -137.98 164.38 29.19 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 125.471 1.508 . . . . 0.0 110.459 -177.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 5.5 ptp -154.3 56.35 1.5 Allowed Pre-proline 0 CA--C 1.547 0.838 0 C-N-CA 124.371 1.068 . . . . 0.0 111.797 -169.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 56.6 Cg_endo -65.98 -47.21 3.82 Favored 'Trans proline' 0 C--N 1.352 0.733 0 C-N-CA 123.044 2.496 . . . . 0.0 112.964 -173.699 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 2.1 m -155.67 153.56 7.49 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.616 0 C-N-CA 128.022 2.529 . . . . 0.0 108.539 179.85 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -73.89 160.17 82.51 Favored Pre-proline 0 CA--C 1.542 0.641 0 C-N-CA 124.93 1.292 . . . . 0.0 110.698 168.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 91.1 Cg_endo -74.86 15.5 0.71 Allowed 'Trans proline' 0 CA--C 1.55 1.276 0 C-N-CA 123.726 2.951 . . . . 0.0 112.16 168.428 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 38.9 m-80 -126.07 -158.96 0.88 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 127.761 2.424 . . . . 0.0 108.535 -177.603 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 44.4 tt0 -142.65 130.68 11.39 Favored Pre-proline 0 CA--C 1.54 0.579 0 C-N-CA 125.495 1.518 . . . . 0.0 108.684 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -74.73 153.46 43.24 Favored 'Trans proline' 0 C--N 1.35 0.655 0 C-N-CA 123.102 2.535 . . . . 0.0 111.104 179.049 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 69.3 p -144.89 173.66 11.68 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 124.512 1.125 . . . . 0.0 110.67 -176.082 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 35.0 m-85 -135.09 -76.92 0.45 Allowed 'General case' 0 CA--C 1.534 0.356 0 CA-C-O 117.189 -1.386 . . . . 0.0 112.524 178.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 1.9 t -58.66 169.18 1.0 Allowed 'General case' 0 C--N 1.35 0.604 0 CA-C-N 119.935 1.243 . . . . 0.0 113.841 -172.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.1 pp -57.47 -13.37 3.53 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 125.109 1.363 . . . . 0.0 112.769 169.543 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 84.5 m -78.12 -19.47 54.02 Favored 'General case' 0 CA--C 1.536 0.408 0 C-N-CA 126.331 1.853 . . . . 0.0 113.208 175.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 98.0 m-70 52.87 66.68 1.16 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.989 2.116 . . . . 0.0 112.332 -172.323 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.35 160.22 33.74 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 126.662 1.985 . . . . 0.0 111.136 174.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.471 HG12 ' H ' ' A' ' 205' ' ' SER . 0.3 OUTLIER -66.0 -179.89 0.21 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.829 0 C-N-CA 125.846 1.658 . . . . 0.0 111.524 -179.82 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.471 ' H ' HG12 ' A' ' 204' ' ' VAL . 24.6 m -47.24 150.81 0.79 Allowed 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 127.146 2.178 . . . . 0.0 113.931 179.863 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 5.2 p90 -151.79 166.67 30.67 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 125.655 1.582 . . . . 0.0 110.926 -173.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -76.23 -60.68 3.01 Favored Glycine 0 C--N 1.342 0.894 0 C-N-CA 124.252 0.929 . . . . 0.0 113.352 -171.235 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.425 ' HB2' ' CD2' ' A' ' 224' ' ' PHE . 3.1 pt-20 -79.29 121.52 25.2 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 124.331 1.052 . . . . 0.0 111.063 177.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 14.3 mtp -143.88 139.71 29.37 Favored 'General case' 0 C--N 1.34 0.159 0 N-CA-C 113.28 0.844 . . . . 0.0 113.28 -173.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 20.3 tt -138.63 145.99 27.15 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 125.284 1.433 . . . . 0.0 109.844 168.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -125.19 137.29 10.29 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 124.779 1.18 . . . . 0.0 112.438 -169.696 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . 0.59 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 2.0 m -78.22 124.11 27.69 Favored 'General case' 0 N--CA 1.462 0.164 0 C-N-CA 125.26 1.424 . . . . 0.0 111.564 -168.074 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 25.4 t70 -69.64 -3.61 15.82 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 126.187 1.795 . . . . 0.0 113.564 -175.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -65.78 147.28 98.82 Favored Pre-proline 0 CA--C 1.539 0.521 0 C-N-CA 123.36 0.664 . . . . 0.0 111.485 -174.893 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 81.5 Cg_endo -81.33 5.1 6.48 Favored 'Trans proline' 0 CA--C 1.55 1.284 0 C-N-CA 122.909 2.406 . . . . 0.0 111.511 166.374 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -134.59 -11.51 2.39 Favored 'General case' 0 C--N 1.35 0.626 0 C-N-CA 125.215 1.406 . . . . 0.0 114.448 -169.508 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 36.3 t -64.19 135.45 56.31 Favored 'General case' 0 C--N 1.344 0.326 0 CA-C-N 119.257 0.935 . . . . 0.0 110.608 -177.546 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.4 t -112.8 14.53 19.9 Favored 'General case' 0 CA--C 1.54 0.582 0 C-N-CA 125.917 1.687 . . . . 0.0 111.361 -174.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 48.9 mt -122.02 -42.05 1.73 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 C-N-CA 125.428 1.491 . . . . 0.0 108.527 172.889 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 48.83 -11.24 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.791 0 C-N-CA 131.646 3.978 . . . . 0.0 119.687 170.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 52.3 m95 -138.83 136.82 36.01 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.654 1.982 . . . . 0.0 110.042 169.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . 0.59 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 5.2 m-85 -142.72 156.23 44.99 Favored 'General case' 0 C--N 1.332 -0.193 0 C-N-CA 125.698 1.599 . . . . 0.0 109.303 -169.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 41.2 m80 -71.77 149.02 45.75 Favored 'General case' 0 C--O 1.233 0.213 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 167.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . 0.425 ' CD2' ' HB2' ' A' ' 208' ' ' GLU . 17.4 m-30 -50.88 -50.93 56.06 Favored 'General case' 0 N--CA 1.468 0.445 0 CA-C-N 115.877 -0.601 . . . . 0.0 109.708 165.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.16 -13.64 62.01 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 113.663 0.986 . . . . 0.0 113.663 -177.29 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 2.0 m -78.04 -6.33 54.21 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 119.885 1.22 . . . . 0.0 112.785 172.784 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.4 p -121.84 -13.07 7.81 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.417 0 C-N-CA 126.132 1.773 . . . . 0.0 111.995 169.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 97.73 14.83 39.02 Favored Glycine 0 CA--C 1.531 1.082 0 C-N-CA 125.829 1.681 . . . . 0.0 113.446 177.265 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 29.8 mt -73.93 161.88 29.66 Favored 'General case' 0 C--N 1.345 0.394 0 CA-C-N 118.92 1.36 . . . . 0.0 111.329 177.426 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 67.4 p -132.75 -10.88 3.08 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 125.819 1.648 . . . . 0.0 111.64 176.276 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 53.2 p -145.72 151.09 37.44 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 126.652 1.981 . . . . 0.0 108.576 177.138 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 21.1 ttpp -81.27 128.37 70.61 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-O 118.776 -0.631 . . . . 0.0 110.103 178.436 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_endo -77.3 -178.35 4.52 Favored 'Trans proline' 0 CA--C 1.542 0.886 0 C-N-CA 123.635 2.89 . . . . 0.0 110.774 169.542 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 53.2 ttt180 -141.48 131.94 25.29 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.212 -1.033 . . . . 0.0 108.212 169.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 121.26 -168.77 14.28 Favored Glycine 0 CA--C 1.532 1.142 0 C-N-CA 126.064 1.793 . . . . 0.0 109.889 -168.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.28 145.0 51.6 Favored 'General case' 0 N--CA 1.45 -0.433 0 CA-C-O 122.242 1.02 . . . . 0.0 110.832 174.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . 0.496 ' HZ3' ' HG ' ' A' ' 212' ' ' CYS . 62.1 t90 -146.2 137.37 24.53 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 127.116 2.167 . . . . 0.0 108.915 175.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 18.8 m-30 -114.27 136.72 52.65 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 123.96 0.904 . . . . 0.0 108.94 171.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . 0.411 ' HB2' ' HD2' ' A' ' 240' ' ' PRO . 5.0 p -63.32 168.72 4.67 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 126.308 1.843 . . . . 0.0 113.094 -177.893 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 36.3 Cg_endo -67.08 -33.37 31.93 Favored 'Trans proline' 0 N--CA 1.457 -0.637 0 C-N-CA 121.306 1.337 . . . . 0.0 112.442 -171.166 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 60.3 mtp180 -72.59 1.29 8.49 Favored 'General case' 0 CA--C 1.542 0.639 0 C-N-CA 125.175 1.39 . . . . 0.0 113.079 176.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 21.6 m -127.84 -13.39 5.24 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.033 1.733 . . . . 0.0 113.982 -172.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 34.9 t -150.61 -40.9 0.13 Allowed 'General case' 0 N--CA 1.464 0.231 0 CA-C-N 118.717 0.689 . . . . 0.0 112.291 -177.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 40.4 tp60 -76.53 -16.25 59.67 Favored 'General case' 0 CA--C 1.541 0.631 0 CA-C-O 118.792 -0.623 . . . . 0.0 112.679 -177.089 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 21.5 mm-40 -64.99 -12.18 47.3 Favored 'General case' 0 CA--C 1.541 0.603 0 C-N-CA 124.184 0.993 . . . . 0.0 113.027 172.354 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 38.6 ttt-85 -72.62 -0.91 14.24 Favored 'General case' 0 CA--C 1.549 0.923 0 C-N-CA 124.194 0.998 . . . . 0.0 112.139 169.4 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -140.91 175.48 9.58 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 127.768 2.427 . . . . 0.0 108.498 -179.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 9.8 tmtt? -68.46 110.45 4.16 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.822 1.249 . . . . 0.0 109.167 176.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 23.1 tptm . . . . . 0 C--O 1.25 1.122 0 C-N-CA 127.942 2.497 . . . . 0.0 113.717 -179.827 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.88 0 CA-C-O 120.752 0.31 . . . . 0.0 111.511 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.2 p-10 -131.49 12.43 4.96 Favored 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 126.355 1.862 . . . . 0.0 111.832 -172.707 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 19.4 ptp -140.09 73.66 31.94 Favored Pre-proline 0 CA--C 1.543 0.7 0 C-N-CA 125.63 1.572 . . . . 0.0 110.085 -169.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 69.7 Cg_endo -76.25 68.2 6.78 Favored 'Trans proline' 0 CA--C 1.542 0.917 0 C-N-CA 125.028 3.819 . . . . 0.0 111.175 178.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 14.9 p -151.51 149.94 13.59 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 125.694 1.598 . . . . 0.0 109.227 -176.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -65.05 151.94 92.43 Favored Pre-proline 0 CA--C 1.54 0.594 0 C-N-CA 125.64 1.576 . . . . 0.0 112.343 179.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 89.5 Cg_endo -74.34 -5.48 17.0 Favored 'Trans proline' 0 CA--C 1.543 0.968 0 C-N-CA 123.642 2.895 . . . . 0.0 112.165 168.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 62.1 m-80 -91.31 40.48 1.03 Allowed 'General case' 0 CA--C 1.542 0.642 0 C-N-CA 126.903 2.081 . . . . 0.0 111.198 -174.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 40.8 tt0 -141.95 118.25 7.14 Favored Pre-proline 0 CA--C 1.539 0.553 0 C-N-CA 124.705 1.202 . . . . 0.0 109.22 -169.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -77.27 158.64 33.34 Favored 'Trans proline' 0 CA--C 1.536 0.623 0 C-N-CA 123.047 2.498 . . . . 0.0 111.075 176.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 71.3 p -143.07 173.46 11.54 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 124.638 1.175 . . . . 0.0 110.118 -177.661 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -135.77 -82.68 0.4 Allowed 'General case' 0 CA--C 1.535 0.373 0 CA-C-O 117.414 -1.279 . . . . 0.0 113.274 -168.641 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.4 t -54.28 166.03 0.46 Allowed 'General case' 0 C--N 1.35 0.614 0 C-N-CA 125.05 1.34 . . . . 0.0 112.731 -179.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.9 pp -58.9 -11.12 2.95 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.471 1.108 . . . . 0.0 112.87 170.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 75.1 m -76.04 -19.93 58.21 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 126.667 1.987 . . . . 0.0 113.171 175.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 21.4 m170 57.9 62.92 1.93 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.996 2.118 . . . . 0.0 111.785 -173.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.7 159.65 33.09 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 125.356 1.462 . . . . 0.0 112.32 175.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.492 HG12 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -70.7 -178.45 0.26 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.81 0 C-N-CA 126.267 1.827 . . . . 0.0 111.472 -176.811 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.492 ' H ' HG12 ' A' ' 204' ' ' VAL . 49.4 m -43.87 148.15 0.41 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 128.024 2.53 . . . . 0.0 113.915 178.281 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . 0.404 ' CE2' ' CD2' ' A' ' 223' ' ' HIS . 10.3 p90 -154.4 167.4 30.14 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.498 1.519 . . . . 0.0 111.103 -167.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -73.17 -43.86 37.75 Favored Glycine 0 CA--C 1.53 0.994 0 CA-C-O 118.719 -1.045 . . . . 0.0 115.136 -168.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.1 pm0 -129.88 122.96 29.66 Favored 'General case' 0 C--N 1.342 0.264 0 CA-C-N 118.368 1.084 . . . . 0.0 110.654 -169.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -143.05 146.65 34.02 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -165.803 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 16.2 tt -140.62 155.94 22.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.283 0 C-N-CA 126.278 1.831 . . . . 0.0 109.511 169.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -136.18 144.97 16.87 Favored Glycine 0 C--N 1.335 0.507 0 C-N-CA 123.921 0.772 . . . . 0.0 112.261 -173.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 7.4 t -69.34 145.32 53.06 Favored 'General case' 0 C--N 1.344 0.344 0 CA-C-O 122.184 0.993 . . . . 0.0 110.938 -174.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -80.64 -6.75 58.79 Favored 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 126.704 2.001 . . . . 0.0 113.508 -174.241 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 47.8 m-20 -80.55 145.78 59.63 Favored Pre-proline 0 CA--C 1.536 0.438 0 CA-C-N 118.557 0.617 . . . . 0.0 111.675 -169.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 71.8 Cg_endo -76.42 6.13 4.21 Favored 'Trans proline' 0 CA--C 1.547 1.145 0 C-N-CA 123.629 2.886 . . . . 0.0 111.779 168.271 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 21.8 m-20 -126.34 -8.12 6.39 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 126.074 1.749 . . . . 0.0 112.815 -172.367 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.9 t -65.4 133.36 51.17 Favored 'General case' 0 N--CA 1.452 -0.341 0 C-N-CA 123.822 0.849 . . . . 0.0 109.576 175.116 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 10.7 t -113.21 10.96 18.63 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 125.626 1.571 . . . . 0.0 111.702 -175.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 35.0 mm -118.84 -33.39 1.64 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.622 0 C-N-CA 126.393 1.877 . . . . 0.0 109.242 176.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 50.45 -15.17 0.0 OUTLIER 'General case' 0 C--N 1.351 0.667 0 C-N-CA 131.591 3.956 . . . . 0.0 119.253 176.106 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 61.4 m95 -141.12 152.33 44.64 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.897 1.679 . . . . 0.0 110.427 178.424 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -154.22 154.49 33.58 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.71 1.604 . . . . 0.0 110.109 -170.326 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . 0.404 ' CD2' ' CE2' ' A' ' 206' ' ' TYR . 20.2 m170 -78.34 148.64 33.68 Favored 'General case' 0 C--O 1.233 0.206 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 170.747 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 15.0 m-30 -53.78 -50.69 65.51 Favored 'General case' 0 C--O 1.223 -0.304 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.719 167.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.62 -13.22 61.69 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-O 118.258 -0.877 . . . . 0.0 113.312 -176.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 3.5 m -76.41 -11.25 59.86 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 119.737 1.153 . . . . 0.0 112.441 172.457 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.2 p -117.69 -15.84 8.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 126.193 1.797 . . . . 0.0 112.269 171.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 94.87 20.06 29.64 Favored Glycine 0 CA--C 1.535 1.295 0 C-N-CA 125.888 1.709 . . . . 0.0 113.485 -179.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 13.9 mt -71.61 156.98 38.78 Favored 'General case' 0 C--N 1.345 0.371 0 CA-C-N 118.854 1.327 . . . . 0.0 111.335 178.428 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 82.7 p -137.83 -11.84 1.52 Allowed 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.419 1.487 . . . . 0.0 112.435 -178.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 59.2 m -148.48 134.07 18.75 Favored 'General case' 0 N--CA 1.465 0.302 0 C-N-CA 126.263 1.825 . . . . 0.0 107.232 177.366 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 61.5 tttm -73.59 120.49 81.44 Favored Pre-proline 0 CA--C 1.543 0.71 0 C-N-CA 123.541 0.736 . . . . 0.0 111.587 -173.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -82.11 177.32 7.36 Favored 'Trans proline' 0 CA--C 1.543 0.953 0 C-N-CA 123.705 2.937 . . . . 0.0 111.194 170.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 36.0 ttp180 -142.58 135.0 27.78 Favored 'General case' 0 C--N 1.344 0.346 0 C-N-CA 124.239 1.016 . . . . 0.0 108.453 170.658 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 125.92 -167.49 18.31 Favored Glycine 0 CA--C 1.53 1.0 0 C-N-CA 125.65 1.595 . . . . 0.0 111.485 -177.024 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 1.5 tmmt? -59.39 119.41 7.41 Favored 'General case' 0 C--N 1.341 0.235 0 C-N-CA 124.601 1.16 . . . . 0.0 109.76 172.508 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 62.2 t90 -136.62 138.86 41.61 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 127.029 2.132 . . . . 0.0 108.103 175.634 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 3.3 m-85 -115.88 132.71 56.56 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.346 1.059 . . . . 0.0 108.748 -178.964 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 1.8 p -68.05 166.62 22.51 Favored Pre-proline 0 CA--C 1.544 0.714 0 C-N-CA 124.731 1.212 . . . . 0.0 112.467 -175.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 66.1 Cg_endo -73.93 3.9 4.63 Favored 'Trans proline' 0 CA--C 1.539 0.761 0 C-N-CA 122.615 2.21 . . . . 0.0 114.698 -173.323 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 38.2 mtp180 -122.47 21.23 10.27 Favored 'General case' 0 CA--C 1.539 0.53 0 C-N-CA 126.374 1.87 . . . . 0.0 111.017 171.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 18.6 m -133.45 -20.33 2.09 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.275 1.83 . . . . 0.0 112.506 178.932 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 31.2 t -150.29 -36.29 0.15 Allowed 'General case' 0 C--N 1.347 0.459 0 CA-C-N 119.635 1.107 . . . . 0.0 113.029 177.151 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 24.6 tp60 -74.17 -14.07 60.9 Favored 'General case' 0 CA--C 1.542 0.642 0 CA-C-N 118.339 0.518 . . . . 0.0 112.087 178.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 17.5 tt0 -74.99 -0.83 20.11 Favored 'General case' 0 CA--C 1.543 0.709 0 C-N-CA 125.793 1.637 . . . . 0.0 113.18 179.087 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -57.03 118.4 4.96 Favored 'General case' 0 C--N 1.347 0.457 0 C-N-CA 124.58 1.152 . . . . 0.0 110.846 -179.61 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 1.9 tmtp? -149.73 -33.21 0.19 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 125.773 1.629 . . . . 0.0 110.492 -178.599 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -63.64 147.79 50.63 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.748 1.219 . . . . 0.0 109.672 168.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 13.9 mptt . . . . . 0 C--O 1.25 1.103 0 CA-C-O 117.74 -1.124 . . . . 0.0 109.17 -176.372 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 22.3 ptp . . . . . 0 N--CA 1.479 0.993 0 CA-C-O 121.175 0.512 . . . . 0.0 110.277 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -144.91 163.63 33.57 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 124.103 0.961 . . . . 0.0 111.312 -167.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -67.98 157.12 87.91 Favored Pre-proline 0 CA--C 1.544 0.74 0 C-N-CA 124.648 1.179 . . . . 0.0 110.937 173.069 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -75.24 13.54 1.06 Allowed 'Trans proline' 0 CA--C 1.547 1.129 0 C-N-CA 124.367 3.378 . . . . 0.0 113.139 173.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 14.7 p -147.17 158.59 9.56 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 126.921 2.088 . . . . 0.0 108.161 -178.536 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -53.23 152.2 8.44 Favored Pre-proline 0 CA--C 1.541 0.627 0 C-N-CA 126.839 2.055 . . . . 0.0 113.715 -175.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -72.42 -5.86 17.96 Favored 'Trans proline' 0 CA--C 1.541 0.858 0 C-N-CA 123.728 2.952 . . . . 0.0 112.526 169.578 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 66.7 m-80 -81.95 41.35 0.66 Allowed 'General case' 0 CA--C 1.544 0.714 0 C-N-CA 127.11 2.164 . . . . 0.0 111.183 178.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -142.13 115.17 6.46 Favored Pre-proline 0 CA--C 1.538 0.497 0 C-N-CA 125.343 1.457 . . . . 0.0 108.726 -169.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.51 155.91 40.68 Favored 'Trans proline' 0 C--N 1.35 0.638 0 C-N-CA 122.804 2.336 . . . . 0.0 110.667 174.415 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 74.4 p -142.53 172.35 12.81 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.395 1.078 . . . . 0.0 110.204 -176.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 99.2 m-85 -135.56 -83.88 0.39 Allowed 'General case' 0 CA--C 1.535 0.394 0 CA-C-O 117.327 -1.32 . . . . 0.0 112.765 -168.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.405 ' H ' HE22 ' A' ' 203' ' ' GLN . 2.0 t -55.82 168.48 0.44 Allowed 'General case' 0 C--N 1.351 0.646 0 CA-C-N 119.784 1.175 . . . . 0.0 113.173 -177.133 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.3 pp -57.24 -12.6 2.44 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.839 1.255 . . . . 0.0 112.902 170.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 75.2 m -77.6 -18.62 56.67 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 127.02 2.128 . . . . 0.0 113.171 176.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 27.6 m170 56.65 61.98 2.45 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 126.887 2.075 . . . . 0.0 111.729 -173.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . 0.405 HE22 ' H ' ' A' ' 199' ' ' CYS . 0.0 OUTLIER -126.38 158.96 34.57 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 125.287 1.435 . . . . 0.0 112.306 176.838 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.47 HG12 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -69.76 -178.97 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.79 0 C-N-CA 126.347 1.859 . . . . 0.0 111.432 -177.192 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.47 ' H ' HG12 ' A' ' 204' ' ' VAL . 93.6 p -44.04 148.14 0.44 Allowed 'General case' 0 CA--C 1.538 0.501 0 C-N-CA 127.354 2.262 . . . . 0.0 113.754 177.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 8.3 p90 -153.04 167.02 30.6 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 124.775 1.23 . . . . 0.0 111.963 -167.086 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -68.79 -49.44 42.59 Favored Glycine 0 CA--C 1.529 0.961 0 C-N-CA 124.718 1.152 . . . . 0.0 114.68 -168.948 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -128.01 125.09 38.74 Favored 'General case' 0 C--N 1.343 0.293 0 CA-C-N 118.206 1.003 . . . . 0.0 109.978 -171.328 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -142.88 145.84 33.5 Favored 'General case' 0 C--O 1.233 0.192 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -166.638 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 19.7 tt -134.64 150.57 30.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 125.5 1.52 . . . . 0.0 109.878 172.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -127.45 138.93 10.8 Favored Glycine 0 CA--C 1.528 0.845 0 C-N-CA 124.729 1.157 . . . . 0.0 112.575 -170.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . 0.59 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 2.2 m -77.86 126.09 30.33 Favored 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 125.568 1.547 . . . . 0.0 111.453 -168.233 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -70.18 -0.03 7.1 Favored 'General case' 0 CA--C 1.545 0.779 0 C-N-CA 126.373 1.869 . . . . 0.0 113.533 -175.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 4.0 m120 -67.36 149.09 98.58 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 123.785 0.834 . . . . 0.0 111.635 -176.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -83.37 8.19 4.76 Favored 'Trans proline' 0 CA--C 1.549 1.235 0 C-N-CA 123.656 2.904 . . . . 0.0 111.431 166.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 34.8 t70 -144.52 -10.94 0.62 Allowed 'General case' 0 CA--C 1.543 0.695 0 N-CA-C 114.857 1.428 . . . . 0.0 114.857 -167.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 37.2 t -61.38 132.43 53.49 Favored 'General case' 0 C--N 1.344 0.354 0 CA-C-N 119.469 1.031 . . . . 0.0 110.671 -179.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 9.3 t -103.95 4.45 34.67 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.696 1.599 . . . . 0.0 111.786 -172.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 41.8 mm -114.67 -41.81 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 125.599 1.559 . . . . 0.0 108.773 175.332 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 46.98 -8.08 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 131.567 3.947 . . . . 0.0 119.8 171.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 60.9 m95 -140.71 136.6 32.75 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 126.993 2.117 . . . . 0.0 109.391 171.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . 0.59 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 6.3 m-85 -144.75 153.93 42.2 Favored 'General case' 0 C--N 1.332 -0.158 0 C-N-CA 125.47 1.508 . . . . 0.0 109.529 -169.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 29.1 m80 -70.93 149.41 46.74 Favored 'General case' 0 C--O 1.233 0.217 0 N-CA-C 109.492 -0.559 . . . . 0.0 109.492 168.418 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 14.6 m-30 -52.37 -51.27 59.85 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 115.19 -0.913 . . . . 0.0 109.626 167.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -70.22 -14.22 62.52 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 113.425 0.898 . . . . 0.0 113.425 -177.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 3.3 m -78.08 -7.03 56.42 Favored 'General case' 0 CA--C 1.542 0.659 0 CA-C-N 119.753 1.16 . . . . 0.0 112.628 172.638 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.2 p -122.19 -10.76 8.43 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 C-N-CA 126.241 1.816 . . . . 0.0 112.276 169.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 94.16 16.52 43.72 Favored Glycine 0 CA--C 1.534 1.222 0 C-N-CA 125.736 1.636 . . . . 0.0 113.374 178.374 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 10.2 mt -70.48 157.65 37.48 Favored 'General case' 0 CA--C 1.535 0.387 0 CA-C-N 118.554 1.177 . . . . 0.0 111.176 177.179 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 73.4 m -131.19 -5.02 3.86 Favored 'General case' 0 CA--C 1.546 0.813 0 C-N-CA 126.369 1.868 . . . . 0.0 110.214 177.223 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 81.9 p -141.55 -175.31 4.32 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 127.007 2.123 . . . . 0.0 109.206 -177.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 36.8 ttpt -124.84 111.1 27.41 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 124.033 0.933 . . . . 0.0 109.077 177.122 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -74.19 177.4 8.31 Favored 'Trans proline' 0 CA--C 1.539 0.753 0 C-N-CA 123.473 2.782 . . . . 0.0 111.235 173.833 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 60.4 ttt-85 -139.1 132.2 29.65 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 108.022 -1.103 . . . . 0.0 108.022 171.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 115.97 -170.29 13.28 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.579 1.561 . . . . 0.0 110.855 -169.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -63.6 135.77 57.03 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.47 1.108 . . . . 0.0 111.468 177.967 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . 0.438 ' HZ3' ' HG ' ' A' ' 212' ' ' CYS . 58.2 t90 -142.49 143.84 32.73 Favored 'General case' 0 N--CA 1.449 -0.517 0 C-N-CA 127.556 2.342 . . . . 0.0 108.853 173.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 60.5 m-85 -128.29 128.85 45.4 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.313 1.045 . . . . 0.0 109.372 -178.962 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . 0.421 ' HB2' ' HD2' ' A' ' 240' ' ' PRO . 3.7 p -62.71 170.12 2.73 Favored Pre-proline 0 CA--C 1.544 0.725 0 C-N-CA 126.681 1.992 . . . . 0.0 113.845 -172.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.421 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 72.9 Cg_endo -74.1 0.23 8.69 Favored 'Trans proline' 0 C--N 1.351 0.703 0 C-N-CA 122.672 2.248 . . . . 0.0 115.788 -169.226 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 76.5 mtm180 -117.97 17.01 14.22 Favored 'General case' 0 CA--C 1.538 0.502 0 C-N-CA 125.224 1.41 . . . . 0.0 111.251 171.65 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 33.9 m -131.32 -17.67 2.96 Favored 'General case' 0 N--CA 1.445 -0.704 0 C-N-CA 126.166 1.786 . . . . 0.0 113.305 -179.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 36.6 t -152.61 -40.02 0.1 Allowed 'General case' 0 C--N 1.343 0.292 0 CA-C-N 118.976 0.807 . . . . 0.0 112.55 176.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -74.82 -16.18 60.71 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 119.177 -0.439 . . . . 0.0 112.167 -178.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -63.85 -24.31 67.7 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.376 1.071 . . . . 0.0 112.697 -178.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 13.2 ttp180 -81.71 14.66 2.52 Favored 'General case' 0 CA--C 1.545 0.785 0 C-N-CA 124.84 1.256 . . . . 0.0 113.273 -176.783 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -63.6 -16.59 61.31 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 124.593 1.157 . . . . 0.0 113.962 -178.54 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 4.0 ttmp? -151.06 134.95 16.57 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.982 1.313 . . . . 0.0 108.645 177.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 62.9 mtpt . . . . . 0 C--O 1.251 1.165 0 C-N-CA 126.706 2.002 . . . . 0.0 111.935 -176.149 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 65.1 mtt . . . . . 0 N--CA 1.476 0.871 0 CA-C-O 119.131 -0.462 . . . . 0.0 110.927 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -59.82 -32.84 71.02 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.182 1.393 . . . . 0.0 113.599 -172.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 65.8 mtt 34.0 67.61 1.19 Allowed Pre-proline 0 CA--C 1.545 0.758 0 C-N-CA 127.743 2.417 . . . . 0.0 113.679 174.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -76.63 22.99 0.51 Allowed 'Trans proline' 0 CA--C 1.546 1.106 0 C-N-CA 124.849 3.699 . . . . 0.0 113.7 -174.157 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 13.0 p -146.15 153.77 13.11 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.296 0 C-N-CA 125.961 1.704 . . . . 0.0 108.916 -179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 4.9 m-20 -57.39 153.63 26.84 Favored Pre-proline 0 CA--C 1.54 0.581 0 C-N-CA 126.687 1.995 . . . . 0.0 113.144 -177.242 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 89.8 Cg_endo -71.87 -7.24 20.72 Favored 'Trans proline' 0 CA--C 1.542 0.896 0 C-N-CA 123.61 2.874 . . . . 0.0 112.287 168.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 65.5 m-80 -82.04 45.09 0.89 Allowed 'General case' 0 CA--C 1.543 0.685 0 C-N-CA 127.324 2.25 . . . . 0.0 110.795 177.09 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -136.51 106.84 9.21 Favored Pre-proline 0 CA--C 1.536 0.432 0 C-N-CA 125.355 1.462 . . . . 0.0 108.326 -170.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 97.7 Cg_endo -73.23 151.66 49.24 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.261 1.974 . . . . 0.0 109.795 170.449 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 64.7 p -141.21 171.87 13.46 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.064 0.946 . . . . 0.0 110.118 -177.742 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 95.5 m-85 -133.45 -83.98 0.46 Allowed 'General case' 0 CA--C 1.536 0.412 0 CA-C-O 117.145 -1.407 . . . . 0.0 113.046 -168.421 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.484 ' H ' HE22 ' A' ' 203' ' ' GLN . 2.3 t -55.13 170.11 0.21 Allowed 'General case' 0 C--N 1.35 0.602 0 C-N-CA 124.841 1.256 . . . . 0.0 113.784 -175.626 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.2 pp -58.49 -13.91 6.67 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.175 0.99 . . . . 0.0 112.624 169.476 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 73.0 m -75.83 -23.4 55.75 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 126.887 2.075 . . . . 0.0 112.835 173.748 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 98.1 m-70 52.93 69.15 0.73 Allowed 'General case' 0 CA--C 1.53 0.182 0 C-N-CA 127.56 2.344 . . . . 0.0 112.045 -171.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . 0.484 HE22 ' H ' ' A' ' 199' ' ' CYS . 0.0 OUTLIER -124.43 160.45 28.17 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 125.887 1.675 . . . . 0.0 111.203 173.716 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.467 HG12 ' H ' ' A' ' 205' ' ' SER . 0.3 OUTLIER -68.51 -179.84 0.28 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.708 0 C-N-CA 125.548 1.539 . . . . 0.0 111.129 -178.928 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.467 ' H ' HG12 ' A' ' 204' ' ' VAL . 83.2 p -44.39 145.82 0.78 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.972 2.109 . . . . 0.0 113.374 177.984 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . 0.455 ' CE2' ' HG2' ' A' ' 209' ' ' MET . 13.3 p90 -152.98 164.35 38.14 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 124.992 1.317 . . . . 0.0 111.466 -167.211 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -72.36 -60.51 4.05 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 124.273 0.939 . . . . 0.0 114.095 -169.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . 0.411 ' HB2' ' CD2' ' A' ' 224' ' ' PHE . 22.9 pt-20 -99.26 120.83 40.19 Favored 'General case' 0 C--N 1.342 0.272 0 CA-C-N 118.048 0.924 . . . . 0.0 110.284 -174.431 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . 0.455 ' HG2' ' CE2' ' A' ' 206' ' ' TYR . 17.6 mtp -141.51 143.1 33.63 Favored 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 113.785 1.032 . . . . 0.0 113.785 -168.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 19.0 tt -134.64 157.94 41.43 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.347 0 C-N-CA 126.185 1.794 . . . . 0.0 108.995 169.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -135.24 139.79 11.12 Favored Glycine 0 CA--C 1.527 0.819 0 C-N-CA 124.129 0.871 . . . . 0.0 112.466 -174.602 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . 0.606 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 5.6 m -75.47 124.82 27.81 Favored 'General case' 0 C--N 1.341 0.202 0 C-N-CA 125.029 1.331 . . . . 0.0 110.901 -168.515 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 14.2 t70 -71.88 -0.7 11.97 Favored 'General case' 0 CA--C 1.546 0.797 0 C-N-CA 125.398 1.479 . . . . 0.0 113.221 -176.19 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 2.3 m120 -66.81 146.47 99.08 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 123.616 0.766 . . . . 0.0 111.065 -177.365 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -81.17 6.95 5.24 Favored 'Trans proline' 0 CA--C 1.549 1.271 0 C-N-CA 123.029 2.486 . . . . 0.0 111.376 166.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -134.44 -13.38 2.33 Favored 'General case' 0 C--N 1.35 0.593 0 N-CA-C 114.653 1.353 . . . . 0.0 114.653 -169.317 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.5 t -64.63 135.09 55.57 Favored 'General case' 0 C--N 1.342 0.278 0 CA-C-N 119.145 0.884 . . . . 0.0 110.524 -175.88 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 32.2 m -108.32 7.69 27.32 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 125.766 1.626 . . . . 0.0 111.923 -174.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 37.8 mm -117.09 -41.2 2.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 125.732 1.613 . . . . 0.0 108.647 175.791 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.2 pt-20 48.31 -9.71 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.802 0 C-N-CA 131.623 3.969 . . . . 0.0 119.818 169.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 70.4 m95 -140.75 136.1 32.19 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 126.663 1.985 . . . . 0.0 109.032 171.84 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . 0.606 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 6.9 m-85 -144.56 156.8 44.32 Favored 'General case' 0 C--N 1.333 -0.147 0 C-N-CA 125.939 1.695 . . . . 0.0 109.609 -169.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 50.0 m80 -73.24 148.9 43.24 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 109.496 -0.557 . . . . 0.0 109.496 167.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . 0.411 ' CD2' ' HB2' ' A' ' 208' ' ' GLU . 15.5 m-30 -51.63 -52.12 50.27 Favored 'General case' 0 C--O 1.223 -0.302 0 CA-C-N 115.02 -0.991 . . . . 0.0 109.8 166.389 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.21 -12.99 61.77 Favored 'General case' 0 CA--C 1.537 0.456 0 N-CA-C 113.478 0.918 . . . . 0.0 113.478 -177.074 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 2.0 m -77.56 -6.29 53.17 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-N 119.823 1.192 . . . . 0.0 112.665 172.312 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 7.2 p -124.62 -11.74 5.94 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.467 0 C-N-CA 126.242 1.817 . . . . 0.0 112.396 170.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 96.3 16.33 38.02 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 125.604 1.574 . . . . 0.0 113.563 177.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 24.8 mt -72.4 163.29 28.23 Favored 'General case' 0 CA--C 1.537 0.446 0 CA-C-N 118.777 1.289 . . . . 0.0 111.33 175.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 39.7 m -134.62 -21.69 1.72 Allowed 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.595 1.558 . . . . 0.0 111.08 -179.59 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 58.1 p -141.01 151.01 43.76 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 125.998 1.719 . . . . 0.0 108.826 176.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 54.1 tttm -76.55 125.56 87.24 Favored Pre-proline 0 CA--C 1.541 0.633 0 CA-C-O 118.846 -0.597 . . . . 0.0 110.248 -178.55 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 65.4 Cg_endo -77.9 179.55 6.4 Favored 'Trans proline' 0 CA--C 1.54 0.796 0 C-N-CA 123.802 3.001 . . . . 0.0 111.441 174.518 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -138.08 125.37 21.74 Favored 'General case' 0 C--N 1.34 0.195 0 C-N-CA 124.966 1.307 . . . . 0.0 107.784 172.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 122.55 -174.8 16.36 Favored Glycine 0 CA--C 1.532 1.139 0 C-N-CA 125.545 1.545 . . . . 0.0 110.779 -169.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.25 142.19 55.69 Favored 'General case' 0 N--CA 1.45 -0.447 0 CA-C-O 122.133 0.968 . . . . 0.0 110.618 175.142 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . 0.446 ' HZ3' ' HG ' ' A' ' 212' ' ' CYS . 62.9 t90 -140.31 139.46 35.45 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 126.646 1.978 . . . . 0.0 109.234 175.257 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 15.0 m-85 -125.43 123.56 39.53 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 125.029 1.331 . . . . 0.0 108.196 -178.028 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . 0.462 ' HB3' ' SG ' ' A' ' 212' ' ' CYS . 5.0 p -60.61 172.72 0.75 Allowed Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 127.799 2.44 . . . . 0.0 114.776 -170.46 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.447 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 68.5 Cg_endo -73.28 -0.35 9.06 Favored 'Trans proline' 0 C--N 1.353 0.808 0 C-N-CA 122.778 2.319 . . . . 0.0 115.783 -169.275 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 76.2 mtt180 -117.48 15.95 14.67 Favored 'General case' 0 CA--C 1.538 0.508 0 C-N-CA 125.617 1.567 . . . . 0.0 111.212 172.208 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 27.0 m -133.53 -15.94 2.4 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 126.725 2.01 . . . . 0.0 112.723 -176.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 35.1 t -151.1 -42.87 0.12 Allowed 'General case' 0 C--N 1.342 0.272 0 C-N-CA 123.857 0.863 . . . . 0.0 112.061 177.087 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -75.11 -13.65 60.5 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 112.332 0.493 . . . . 0.0 112.332 -179.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 8.7 tm-20 -53.69 -36.13 61.86 Favored 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 126.178 1.791 . . . . 0.0 111.35 172.328 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 46.2 ttm-85 -70.45 0.56 6.43 Favored 'General case' 0 CA--C 1.546 0.805 0 C-N-CA 126.183 1.793 . . . . 0.0 113.754 -178.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 88.6 tttt -129.47 -30.15 2.14 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 125.554 1.542 . . . . 0.0 111.186 175.411 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 88.3 tttt -151.57 108.3 3.51 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 124.885 1.274 . . . . 0.0 108.43 173.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 24.9 ttmm . . . . . 0 C--O 1.252 1.228 0 C-N-CA 125.292 1.437 . . . . 0.0 111.166 176.784 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 63.2 ttp . . . . . 0 N--CA 1.475 0.8 0 N-CA-C 108.616 -0.883 . . . . 0.0 108.616 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -163.58 175.0 11.08 Favored 'General case' 0 CA--C 1.538 0.507 0 C-N-CA 124.881 1.272 . . . . 0.0 110.758 -168.333 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 2.0 mpt? -137.41 154.35 75.26 Favored Pre-proline 0 CA--C 1.541 0.602 0 C-N-CA 125.453 1.501 . . . . 0.0 109.84 179.933 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -72.6 -2.12 11.34 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 123.918 3.079 . . . . 0.0 113.879 178.853 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 7.1 p -146.25 139.07 20.27 Favored 'Isoleucine or valine' 0 C--N 1.341 0.237 0 C-N-CA 125.367 1.467 . . . . 0.0 108.521 170.805 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 10.0 m-20 -74.98 155.55 86.52 Favored Pre-proline 0 CA--C 1.538 0.501 0 C-N-CA 124.991 1.316 . . . . 0.0 112.09 -175.059 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 92.0 Cg_endo -74.12 3.54 5.04 Favored 'Trans proline' 0 CA--C 1.546 1.095 0 C-N-CA 123.475 2.784 . . . . 0.0 112.046 168.301 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -115.79 30.69 7.19 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.814 2.046 . . . . 0.0 110.822 -178.464 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -143.45 129.91 10.38 Favored Pre-proline 0 CA--C 1.54 0.593 0 C-N-CA 126.099 1.76 . . . . 0.0 108.158 -173.633 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -70.4 164.57 34.7 Favored 'Trans proline' 0 C--N 1.351 0.662 0 C-N-CA 123.154 2.57 . . . . 0.0 113.005 -176.102 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 32.6 p -142.53 179.12 7.15 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 126.451 1.9 . . . . 0.0 108.819 -178.495 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 20.8 m-85 -138.08 -63.74 0.55 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 123.636 0.774 . . . . 0.0 111.83 176.042 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.446 ' SG ' ' HB2' ' A' ' 201' ' ' CYS . 4.8 p -59.8 165.6 3.04 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 128.489 2.716 . . . . 0.0 114.094 179.714 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 2.7 pp -77.93 0.53 23.85 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 114.863 -1.062 . . . . 0.0 111.565 167.319 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . 0.446 ' HB2' ' SG ' ' A' ' 199' ' ' CYS . 80.3 m -78.26 -26.93 47.41 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.917 0.887 . . . . 0.0 110.4 168.711 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . 0.282 82.3 m-70 70.32 53.4 0.33 Allowed 'General case' 0 C--N 1.343 0.286 0 C-N-CA 127.29 2.236 . . . . 0.0 113.095 169.605 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -138.24 172.9 12.22 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 114.608 -1.178 . . . . 0.0 109.587 166.882 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.436 HG12 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -62.49 174.09 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.82 0 C-N-CA 125.229 1.412 . . . . 0.0 111.862 -174.981 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.436 ' H ' HG12 ' A' ' 204' ' ' VAL . 88.6 p -50.76 158.73 0.62 Allowed 'General case' 0 CA--C 1.536 0.418 0 C-N-CA 126.759 2.024 . . . . 0.0 114.833 -173.725 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -139.32 160.08 40.65 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 126.03 1.732 . . . . 0.0 110.484 -169.192 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -63.97 -35.36 91.9 Favored Glycine 0 CA--C 1.529 0.925 0 C-N-CA 124.36 0.981 . . . . 0.0 113.85 -171.279 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.05 118.04 16.34 Favored 'General case' 0 N--CA 1.444 -0.752 0 C-N-CA 124.589 1.156 . . . . 0.0 109.337 -170.767 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 1.3 mtm -135.68 151.2 49.96 Favored 'General case' 0 N--CA 1.466 0.343 0 CA-C-N 115.074 -0.966 . . . . 0.0 113.329 -165.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 19.3 tt -142.71 146.36 22.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.274 0 C-N-CA 125.511 1.524 . . . . 0.0 110.794 169.076 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -122.53 142.44 14.78 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 125.189 1.376 . . . . 0.0 112.755 -170.938 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . 0.573 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 1.9 m -79.5 127.27 31.93 Favored 'General case' 0 N--CA 1.464 0.252 0 C-N-CA 126.074 1.75 . . . . 0.0 112.051 -167.302 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -69.58 -0.99 7.59 Favored 'General case' 0 CA--C 1.545 0.756 0 C-N-CA 126.28 1.832 . . . . 0.0 113.751 -176.61 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 3.0 m120 -68.42 146.36 97.79 Favored Pre-proline 0 CA--C 1.539 0.521 0 O-C-N 121.469 -0.769 . . . . 0.0 111.283 -175.893 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 71.5 Cg_endo -82.01 6.75 5.49 Favored 'Trans proline' 0 CA--C 1.551 1.337 0 C-N-CA 123.1 2.534 . . . . 0.0 111.208 165.909 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 21.1 m-20 -135.02 -13.15 2.15 Favored 'General case' 0 C--N 1.351 0.638 0 C-N-CA 125.25 1.42 . . . . 0.0 114.703 -169.261 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 36.5 t -64.92 134.31 53.69 Favored 'General case' 0 C--N 1.343 0.322 0 CA-C-N 119.139 0.881 . . . . 0.0 110.57 -176.126 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.9 t -108.71 8.61 26.95 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 125.679 1.591 . . . . 0.0 111.535 -173.275 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 38.9 mm -116.84 -42.29 2.99 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.552 0 C-N-CA 125.728 1.611 . . . . 0.0 108.659 173.604 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 47.32 -7.68 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.737 1 C-N-CA 131.817 4.047 . . . . 0.0 119.453 171.838 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 51.2 m95 -140.85 139.82 34.51 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 126.851 2.06 . . . . 0.0 109.827 169.84 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . 0.573 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 6.7 m-85 -147.34 153.01 39.16 Favored 'General case' 0 C--O 1.233 0.194 0 C-N-CA 125.485 1.514 . . . . 0.0 108.479 -169.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 34.1 m80 -67.08 150.98 48.44 Favored 'General case' 0 CA--C 1.531 0.226 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 166.912 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -54.07 -47.76 71.36 Favored 'General case' 0 C--O 1.223 -0.321 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.915 167.037 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -69.44 -14.81 63.09 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 113.739 1.015 . . . . 0.0 113.739 178.402 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 5.4 t -68.79 -18.56 64.21 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.841 0.856 . . . . 0.0 112.422 173.138 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.9 p -117.36 -12.62 11.22 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.422 0 C-N-CA 126.244 1.818 . . . . 0.0 112.137 173.233 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 93.55 18.6 37.81 Favored Glycine 0 CA--C 1.532 1.135 0 C-N-CA 125.827 1.679 . . . . 0.0 113.512 179.069 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 11.5 mt -72.12 157.44 37.77 Favored 'General case' 0 C--N 1.345 0.404 0 CA-C-N 119.006 1.403 . . . . 0.0 111.419 178.92 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 39.7 m -131.95 0.57 3.87 Favored 'General case' 0 CA--C 1.546 0.825 0 C-N-CA 126.384 1.874 . . . . 0.0 110.185 179.801 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 9.5 t -148.41 172.62 14.14 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 126.095 1.758 . . . . 0.0 109.876 179.91 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -110.18 94.28 17.78 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 125.164 1.386 . . . . 0.0 108.986 179.613 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo -67.98 162.15 41.1 Favored 'Trans proline' 0 C--N 1.351 0.668 0 C-N-CA 122.693 2.262 . . . . 0.0 110.937 170.109 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -145.4 134.55 22.78 Favored 'General case' 0 C--N 1.341 0.205 0 C-N-CA 124.333 1.053 . . . . 0.0 109.242 -178.654 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 138.22 -64.07 0.56 Allowed Glycine 0 CA--C 1.525 0.683 0 C-N-CA 127.13 2.3 . . . . 0.0 108.519 179.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 16.4 ptpt -167.99 149.9 5.42 Favored 'General case' 0 C--N 1.343 0.313 0 C-N-CA 126.011 1.724 . . . . 0.0 110.486 169.611 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 48.3 t90 -146.46 148.63 32.45 Favored 'General case' 0 N--CA 1.447 -0.583 0 C-N-CA 126.701 2.0 . . . . 0.0 109.128 178.811 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 61.8 m-85 -129.35 130.82 46.56 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.343 1.057 . . . . 0.0 109.701 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . 0.422 ' HB2' ' HD2' ' A' ' 240' ' ' PRO . 3.9 p -65.5 170.62 4.42 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 126.7 2.0 . . . . 0.0 113.716 -173.152 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.422 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 59.4 Cg_endo -70.09 -19.64 34.31 Favored 'Trans proline' 0 C--N 1.351 0.701 0 C-N-CA 122.052 1.835 . . . . 0.0 113.768 -170.814 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 16.8 mmp_? -87.2 3.45 46.44 Favored 'General case' 0 CA--C 1.541 0.622 0 C-N-CA 125.536 1.534 . . . . 0.0 112.606 175.207 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 34.6 m -132.94 -17.61 2.42 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.618 1.567 . . . . 0.0 113.931 -169.789 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 29.0 t -149.9 -33.76 0.18 Allowed 'General case' 0 C--N 1.342 0.255 0 CA-C-N 118.862 0.755 . . . . 0.0 112.973 -177.731 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -70.97 -23.78 62.28 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-O 118.211 -0.9 . . . . 0.0 111.329 177.143 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 60.6 mm-40 -50.21 -28.89 8.31 Favored 'General case' 0 C--N 1.348 0.527 0 C-N-CA 125.675 1.59 . . . . 0.0 113.56 175.114 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 12.0 tpt180 -64.76 131.71 47.58 Favored 'General case' 0 CA--C 1.534 0.334 0 C-N-CA 124.347 1.059 . . . . 0.0 109.907 178.162 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 6.8 ttpm? 75.27 -37.58 0.34 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.98 2.512 . . . . 0.0 113.435 -175.084 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 37.8 ttpt -159.22 136.34 9.69 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 124.219 1.008 . . . . 0.0 110.218 179.607 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 36.4 ttmt . . . . . 0 C--O 1.249 1.067 0 CA-C-O 116.852 -1.546 . . . . 0.0 111.319 171.683 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 63.2 ttp . . . . . 0 N--CA 1.476 0.828 0 N-CA-C 108.61 -0.885 . . . . 0.0 108.61 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -166.74 -174.48 2.77 Favored 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 125.11 1.364 . . . . 0.0 110.45 -168.301 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -133.56 105.74 11.94 Favored Pre-proline 0 CA--C 1.541 0.62 0 C-N-CA 125.406 1.482 . . . . 0.0 107.629 169.786 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 63.5 Cg_endo -80.01 14.78 1.82 Allowed 'Trans proline' 0 CA--C 1.543 0.941 0 C-N-CA 124.05 3.167 . . . . 0.0 113.324 -172.778 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 5.3 m -136.37 137.76 47.66 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 C-N-CA 126.536 1.934 . . . . 0.0 108.665 -174.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -67.71 159.16 80.23 Favored Pre-proline 0 CA--C 1.539 0.534 0 C-N-CA 125.829 1.651 . . . . 0.0 112.075 178.534 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 83.7 Cg_endo -72.61 2.37 5.29 Favored 'Trans proline' 0 CA--C 1.546 1.082 0 C-N-CA 123.436 2.757 . . . . 0.0 112.111 168.223 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 44.4 m-80 -108.9 35.22 3.31 Favored 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 126.987 2.115 . . . . 0.0 110.481 -177.904 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 32.0 tp10 -141.75 128.94 11.53 Favored Pre-proline 0 CA--C 1.539 0.547 0 C-N-CA 125.944 1.698 . . . . 0.0 107.893 -172.295 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -69.69 157.47 60.42 Favored 'Trans proline' 0 C--N 1.35 0.612 0 C-N-CA 122.952 2.435 . . . . 0.0 112.082 -178.644 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 66.4 p -143.77 175.09 10.25 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 125.098 1.359 . . . . 0.0 110.335 -175.544 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -135.51 -79.89 0.43 Allowed 'General case' 0 CA--C 1.533 0.309 0 CA-C-O 117.291 -1.338 . . . . 0.0 112.537 -173.109 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.1 t -55.38 164.6 0.94 Allowed 'General case' 0 C--N 1.349 0.566 0 CA-C-N 119.692 1.133 . . . . 0.0 112.784 -177.35 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -63.17 -5.36 3.15 Favored 'General case' 0 CA--C 1.542 0.664 0 C-N-CA 124.005 0.922 . . . . 0.0 112.849 170.98 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 89.0 m -76.35 -21.97 55.46 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 126.165 1.786 . . . . 0.0 113.141 169.8 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 89.9 m-70 55.93 69.25 0.76 Allowed 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 127.051 2.141 . . . . 0.0 111.951 -169.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.82 159.05 37.76 Favored 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 125.488 1.515 . . . . 0.0 111.886 172.317 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.506 HG12 ' H ' ' A' ' 205' ' ' SER . 0.7 OUTLIER -67.78 -177.9 0.18 Allowed 'Isoleucine or valine' 0 CA--C 1.546 0.789 0 C-N-CA 126.263 1.825 . . . . 0.0 110.934 -179.039 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.506 ' H ' HG12 ' A' ' 204' ' ' VAL . 88.3 p -44.1 149.43 0.34 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 127.416 2.287 . . . . 0.0 113.9 176.054 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 13.9 p90 -153.53 168.92 24.55 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.205 1.402 . . . . 0.0 111.583 -167.226 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -72.66 -49.25 19.19 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-O 118.811 -0.994 . . . . 0.0 114.638 -169.092 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 1.2 pm0 -124.96 121.78 35.44 Favored 'General case' 0 C--N 1.343 0.285 0 CA-C-N 118.233 1.016 . . . . 0.0 110.136 -170.062 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -140.36 146.32 38.26 Favored 'General case' 0 C--O 1.232 0.166 0 N-CA-C 113.879 1.066 . . . . 0.0 113.879 -166.016 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 20.1 tt -135.25 150.21 29.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.178 0 C-N-CA 125.533 1.533 . . . . 0.0 109.802 170.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -127.33 138.84 10.76 Favored Glycine 0 CA--C 1.526 0.772 0 C-N-CA 124.539 1.066 . . . . 0.0 112.2 -172.798 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . 0.601 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 3.0 m -76.16 123.42 25.82 Favored 'General case' 0 N--CA 1.462 0.13 0 C-N-CA 125.06 1.344 . . . . 0.0 110.779 -168.738 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -72.54 4.32 4.0 Favored 'General case' 0 CA--C 1.547 0.845 0 C-N-CA 125.915 1.686 . . . . 0.0 112.938 -175.817 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 4.1 m120 -68.3 149.17 98.17 Favored Pre-proline 0 CA--C 1.538 0.517 0 C-N-CA 124.214 1.006 . . . . 0.0 111.469 -179.612 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 86.8 Cg_endo -81.85 1.04 9.5 Favored 'Trans proline' 0 CA--C 1.549 1.235 0 C-N-CA 123.184 2.589 . . . . 0.0 111.831 166.447 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 56.0 m-20 -135.53 -7.82 2.2 Favored 'General case' 0 CA--C 1.541 0.633 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -169.33 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.2 t -63.42 134.64 56.02 Favored 'General case' 0 C--N 1.344 0.339 0 CA-C-N 119.84 1.2 . . . . 0.0 110.836 -178.464 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 10.7 t -107.98 9.17 28.62 Favored 'General case' 0 CA--C 1.538 0.516 0 C-N-CA 125.71 1.604 . . . . 0.0 111.712 -173.095 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 38.2 mm -118.64 -41.36 2.34 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.592 0 C-N-CA 125.419 1.488 . . . . 0.0 108.771 173.678 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 48.11 -9.14 0.0 OUTLIER 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 131.537 3.935 . . . . 0.0 119.644 171.014 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 60.9 m95 -139.8 136.29 33.91 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 126.834 2.054 . . . . 0.0 109.411 170.156 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . 0.601 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 7.2 m-85 -143.85 154.91 43.86 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 125.599 1.56 . . . . 0.0 109.276 -169.212 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 20.7 m170 -72.84 148.75 44.17 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 108.693 -0.855 . . . . 0.0 108.693 169.113 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 15.4 m-30 -51.93 -50.58 60.88 Favored 'General case' 0 C--O 1.223 -0.305 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.937 167.685 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -71.13 -14.0 62.14 Favored 'General case' 0 CA--C 1.537 0.472 0 N-CA-C 113.488 0.921 . . . . 0.0 113.488 -177.721 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 7.5 m -78.37 -1.93 35.78 Favored 'General case' 0 CA--C 1.543 0.689 0 CA-C-N 119.799 1.181 . . . . 0.0 112.657 172.714 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 6.1 p -128.22 -13.64 3.05 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 C-N-CA 125.841 1.656 . . . . 0.0 112.659 169.11 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 99.53 16.44 29.23 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 125.66 1.6 . . . . 0.0 113.535 178.135 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 18.5 mt -74.39 163.19 28.08 Favored 'General case' 0 CA--C 1.535 0.395 0 CA-C-N 118.799 1.299 . . . . 0.0 111.537 177.708 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 41.6 m -136.51 -21.81 1.31 Allowed 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 125.581 1.552 . . . . 0.0 111.256 -178.987 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 89.1 m -141.03 142.77 34.18 Favored 'General case' 0 C--N 1.343 0.307 0 C-N-CA 125.713 1.605 . . . . 0.0 108.033 -179.207 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -68.45 120.53 75.78 Favored Pre-proline 0 CA--C 1.544 0.717 0 C-N-CA 123.957 0.903 . . . . 0.0 110.459 -178.721 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -79.46 -174.21 2.18 Favored 'Trans proline' 0 CA--C 1.541 0.87 0 C-N-CA 123.785 2.99 . . . . 0.0 111.135 173.655 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 4.9 tpt180 -143.96 133.68 23.72 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.58 1.152 . . . . 0.0 108.439 174.847 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 105.46 -169.05 15.86 Favored Glycine 0 CA--C 1.532 1.148 0 C-N-CA 125.114 1.34 . . . . 0.0 112.199 -176.234 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.83 123.61 15.63 Favored 'General case' 0 C--N 1.341 0.213 0 C-N-CA 125.712 1.605 . . . . 0.0 110.953 178.046 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . 0.411 ' HZ3' ' HG ' ' A' ' 212' ' ' CYS . 61.1 t90 -134.18 133.95 41.54 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 126.424 1.89 . . . . 0.0 108.865 171.042 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -119.08 128.25 54.15 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 124.696 1.198 . . . . 0.0 108.086 178.41 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . 0.467 ' HB2' ' HD2' ' A' ' 240' ' ' PRO . 12.3 p -62.1 172.55 1.16 Allowed Pre-proline 0 CA--C 1.547 0.837 0 C-N-CA 127.382 2.273 . . . . 0.0 113.865 -173.124 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 42.2 Cg_endo -68.31 -26.05 35.75 Favored 'Trans proline' 0 C--N 1.352 0.734 0 C-N-CA 121.653 1.569 . . . . 0.0 114.423 -169.376 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 38.3 mmt180 -82.34 6.65 16.32 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.821 1.249 . . . . 0.0 112.931 173.696 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 32.9 m -134.41 -15.09 2.2 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.385 1.474 . . . . 0.0 114.223 -170.19 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 23.6 t -152.27 -31.0 0.15 Allowed 'General case' 0 CA--C 1.533 0.304 0 CA-C-N 118.924 0.783 . . . . 0.0 112.885 179.056 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 1.7 tp-100 -86.24 -12.3 50.04 Favored 'General case' 0 CA--C 1.541 0.6 0 CA-C-O 118.83 -0.605 . . . . 0.0 112.624 -177.247 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -63.84 -61.15 2.48 Favored 'General case' 0 C--N 1.346 0.437 0 C-N-CA 123.744 0.818 . . . . 0.0 109.916 -178.594 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 24.4 ttp180 37.92 40.72 0.3 Allowed 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 128.426 2.69 . . . . 0.0 115.598 170.794 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 16.4 ttpp -147.94 -13.2 0.37 Allowed 'General case' 0 CA--C 1.54 0.593 0 N-CA-C 113.53 0.937 . . . . 0.0 113.53 -177.258 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 3.8 tmtm? -146.93 33.49 0.92 Allowed 'General case' 0 CA--C 1.541 0.623 0 C-N-CA 124.515 1.126 . . . . 0.0 111.238 -179.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.252 1.217 0 C-N-CA 127.715 2.406 . . . . 0.0 112.176 178.898 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 15.1 tpt . . . . . 0 N--CA 1.474 0.768 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 9.9 m-20 -145.33 114.87 7.2 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.734 0.814 . . . . 0.0 109.654 -168.798 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 18.8 ptp -157.55 123.04 2.38 Favored Pre-proline 0 CA--C 1.542 0.653 0 C-N-CA 124.6 1.16 . . . . 0.0 109.12 171.826 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -82.3 9.13 4.13 Favored 'Trans proline' 0 CA--C 1.543 0.972 0 C-N-CA 123.9 3.066 . . . . 0.0 113.114 179.996 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 4.3 m -138.19 145.07 29.11 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.596 0 C-N-CA 126.523 1.929 . . . . 0.0 109.078 -173.068 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -67.49 160.51 71.83 Favored Pre-proline 0 CA--C 1.54 0.573 0 C-N-CA 126.181 1.793 . . . . 0.0 111.97 175.73 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -72.31 3.52 4.05 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 123.439 2.759 . . . . 0.0 112.33 168.268 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -109.63 37.27 2.68 Favored 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 127.021 2.128 . . . . 0.0 110.33 -177.769 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -136.46 115.13 10.62 Favored Pre-proline 0 CA--C 1.541 0.605 0 C-N-CA 125.859 1.663 . . . . 0.0 107.927 -171.273 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 62.3 Cg_endo -70.27 159.34 53.36 Favored 'Trans proline' 0 C--N 1.35 0.651 0 C-N-CA 122.975 2.45 . . . . 0.0 111.87 -179.942 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 72.0 p -143.18 174.42 10.72 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 124.834 1.254 . . . . 0.0 110.613 -173.204 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 64.0 m-85 -135.27 -79.17 0.44 Allowed 'General case' 0 CA--C 1.535 0.374 0 CA-C-O 117.389 -1.291 . . . . 0.0 113.312 -171.329 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . . . . . . . . . 2.5 t -56.64 168.61 0.57 Allowed 'General case' 0 C--N 1.349 0.574 0 C-N-CA 124.998 1.319 . . . . 0.0 113.374 -174.823 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 4.3 pp -59.17 -11.81 4.34 Favored 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.439 1.096 . . . . 0.0 112.744 169.299 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . . . . . . . . . 73.4 m -76.09 -24.39 55.03 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 126.649 1.98 . . . . 0.0 112.927 173.483 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . . 94.1 m-70 55.04 69.57 0.72 Allowed 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 127.218 2.207 . . . . 0.0 111.621 -170.063 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.48 163.61 25.53 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 125.556 1.542 . . . . 0.0 111.557 173.344 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.513 HG12 ' H ' ' A' ' 205' ' ' SER . 0.4 OUTLIER -68.88 -179.44 0.27 Allowed 'Isoleucine or valine' 0 CA--C 1.548 0.879 0 C-N-CA 125.694 1.597 . . . . 0.0 111.427 -176.738 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.513 ' H ' HG12 ' A' ' 204' ' ' VAL . 83.6 p -47.61 153.37 0.57 Allowed 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 127.587 2.355 . . . . 0.0 114.592 178.461 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 10.0 p90 -154.49 167.47 29.95 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 126.278 1.831 . . . . 0.0 110.395 -169.062 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -77.93 -39.5 23.95 Favored Glycine 0 CA--C 1.53 1.018 0 CA-C-O 118.673 -1.07 . . . . 0.0 115.224 -168.697 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -132.65 118.93 19.75 Favored 'General case' 0 N--CA 1.45 -0.469 0 CA-C-N 118.614 1.207 . . . . 0.0 110.199 -168.49 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -141.81 152.29 43.56 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 114.762 1.393 . . . . 0.0 114.762 -164.282 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 15.2 tt -147.84 152.54 12.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.304 0 C-N-CA 126.055 1.742 . . . . 0.0 109.859 168.168 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -132.44 146.66 18.37 Favored Glycine 0 C--N 1.336 0.551 0 C-N-CA 124.118 0.866 . . . . 0.0 112.04 -169.819 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 4.2 t -70.48 144.08 51.52 Favored 'General case' 0 C--N 1.344 0.333 0 CA-C-O 122.016 0.913 . . . . 0.0 111.368 -172.158 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -78.91 -8.54 58.95 Favored 'General case' 0 CA--C 1.541 0.633 0 C-N-CA 126.265 1.826 . . . . 0.0 113.686 -174.536 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 25.6 m-20 -77.28 146.1 73.81 Favored Pre-proline 0 CA--C 1.538 0.504 0 CA-C-N 118.533 0.606 . . . . 0.0 111.933 -168.361 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 61.4 Cg_endo -76.4 8.83 2.76 Favored 'Trans proline' 0 CA--C 1.546 1.1 0 C-N-CA 124.135 3.223 . . . . 0.0 112.372 169.047 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -132.69 -8.19 3.19 Favored 'General case' 0 CA--C 1.541 0.611 0 C-N-CA 126.365 1.866 . . . . 0.0 112.191 -170.478 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 39.0 t -62.97 136.12 57.67 Favored 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 123.956 0.902 . . . . 0.0 109.864 172.585 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 7.9 t -121.24 14.31 11.28 Favored 'General case' 0 CA--C 1.542 0.653 0 C-N-CA 125.885 1.674 . . . . 0.0 111.062 -176.003 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 35.9 mm -119.6 -32.67 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.543 0.684 0 C-N-CA 126.646 1.978 . . . . 0.0 109.235 175.41 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 7.1 pt-20 51.26 -16.52 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.664 1 C-N-CA 132.007 4.123 . . . . 0.0 119.292 174.702 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 55.0 m95 -141.93 151.51 42.66 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 125.843 1.657 . . . . 0.0 110.468 179.007 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 78.7 m-85 -153.68 154.86 34.92 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.103 1.361 . . . . 0.0 110.152 -172.265 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 18.4 m170 -77.18 147.65 36.36 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 169.767 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 25.3 m-85 -54.75 -49.53 70.63 Favored 'General case' 0 C--O 1.222 -0.342 0 CA-C-N 115.128 -0.942 . . . . 0.0 109.928 167.665 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -68.6 -16.14 63.76 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 113.676 0.991 . . . . 0.0 113.676 -179.551 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 2.6 m -76.66 -18.37 58.6 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 119.866 1.212 . . . . 0.0 112.616 174.787 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 4.8 p -105.5 -14.49 8.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 C-N-CA 124.913 1.285 . . . . 0.0 111.524 168.686 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 92.58 20.88 33.22 Favored Glycine 0 CA--C 1.534 1.22 0 C-N-CA 125.786 1.66 . . . . 0.0 113.378 -179.642 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 10.1 mt -74.91 157.61 34.74 Favored 'General case' 0 C--N 1.344 0.358 0 CA-C-N 118.738 1.269 . . . . 0.0 111.35 178.508 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 50.0 m -127.76 -9.55 5.55 Favored 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.34 1.856 . . . . 0.0 110.265 179.422 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 77.3 p -140.91 178.05 7.62 Favored 'General case' 0 CA--C 1.538 0.519 0 C-N-CA 126.786 2.035 . . . . 0.0 109.427 179.143 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -110.94 107.21 57.81 Favored Pre-proline 0 CA--C 1.539 0.546 0 C-N-CA 124.1 0.96 . . . . 0.0 108.926 178.145 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_endo -71.28 176.46 7.87 Favored 'Trans proline' 0 CA--C 1.539 0.748 0 C-N-CA 123.547 2.831 . . . . 0.0 111.848 175.547 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -136.14 133.22 36.99 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.042 1.337 . . . . 0.0 108.256 -175.123 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 107.41 -162.8 13.23 Favored Glycine 0 CA--C 1.531 1.057 0 C-N-CA 125.413 1.482 . . . . 0.0 111.464 -174.657 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 9.5 mptt -61.25 127.18 30.25 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.0 1.32 . . . . 0.0 109.195 173.731 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 71.7 t90 -132.26 149.18 52.43 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 126.397 1.879 . . . . 0.0 109.118 178.377 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 31.4 m-85 -128.68 130.29 46.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.116 1.366 . . . . 0.0 109.994 -174.152 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -65.26 167.41 10.23 Favored Pre-proline 0 CA--C 1.541 0.599 0 CA-C-N 114.809 -1.087 . . . . 0.0 111.411 175.211 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 55.8 Cg_endo -67.66 -37.49 16.34 Favored 'Trans proline' 0 N--CA 1.455 -0.767 0 C-N-CA 120.907 1.071 . . . . 0.0 111.972 -174.051 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 64.9 mtp85 -72.84 1.89 7.77 Favored 'General case' 0 CA--C 1.54 0.565 0 C-N-CA 125.063 1.345 . . . . 0.0 113.084 176.073 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 9.2 m -120.13 -13.9 8.9 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.401 1.481 . . . . 0.0 114.328 -175.041 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 33.3 t -151.92 -38.52 0.12 Allowed 'General case' 0 N--CA 1.467 0.378 0 CA-C-N 119.545 1.066 . . . . 0.0 113.12 176.552 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -73.62 -27.88 61.51 Favored 'General case' 0 CA--C 1.539 0.539 0 C-N-CA 123.372 0.669 . . . . 0.0 112.174 -178.68 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -78.6 2.07 20.55 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.97 1.308 . . . . 0.0 112.834 -174.702 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 30.2 ttp-105 -52.05 -44.42 64.25 Favored 'General case' 0 C--N 1.347 0.486 0 C-N-CA 125.088 1.355 . . . . 0.0 112.409 179.106 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 13.9 tppt? 29.84 61.11 0.18 Allowed 'General case' 0 CA--C 1.546 0.804 0 C-N-CA 128.182 2.593 . . . . 0.0 114.386 169.787 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 82.7 tttt 55.94 73.36 0.44 Allowed 'General case' 0 CA--C 1.542 0.651 0 C-N-CA 125.863 1.665 . . . . 0.0 112.267 -173.513 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 85.4 tttt . . . . . 0 C--O 1.25 1.127 0 C-N-CA 127.894 2.478 . . . . 0.0 113.774 -179.423 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 24.8 mmt . . . . . 0 N--CA 1.476 0.848 0 N-CA-C 108.948 -0.76 . . . . 0.0 108.948 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -143.62 129.41 19.36 Favored 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.874 0.87 . . . . 0.0 109.637 -169.02 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 18.1 ptm -154.67 106.15 2.34 Favored Pre-proline 0 CA--C 1.542 0.649 0 C-N-CA 124.782 1.233 . . . . 0.0 108.733 177.454 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -78.98 15.72 1.46 Allowed 'Trans proline' 0 CA--C 1.544 0.998 0 C-N-CA 124.019 3.146 . . . . 0.0 112.81 178.826 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 11.3 m -137.65 147.34 26.39 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 C-N-CA 127.415 2.286 . . . . 0.0 108.264 -174.102 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -70.66 157.16 90.79 Favored Pre-proline 0 CA--C 1.539 0.543 0 C-N-CA 125.107 1.363 . . . . 0.0 111.738 176.509 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 83.1 Cg_endo -72.43 -0.19 8.37 Favored 'Trans proline' 0 CA--C 1.545 1.075 0 C-N-CA 123.329 2.686 . . . . 0.0 112.219 168.188 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 57.5 m-80 -105.29 58.26 0.68 Allowed 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 127.061 2.145 . . . . 0.0 109.069 -178.598 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -135.62 132.82 19.83 Favored Pre-proline 0 CA--C 1.54 0.566 0 C-N-CA 125.186 1.394 . . . . 0.0 108.491 -170.517 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -76.12 168.05 24.79 Favored 'Trans proline' 0 C--N 1.35 0.647 0 C-N-CA 122.874 2.383 . . . . 0.0 113.135 -170.538 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 33.8 p -140.99 175.14 9.86 Favored 'General case' 0 CA--C 1.535 0.369 0 C-N-CA 126.36 1.864 . . . . 0.0 108.97 178.46 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 12.1 m-85 -135.36 -68.71 0.51 Allowed 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 123.842 0.857 . . . . 0.0 111.166 176.022 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.432 ' SG ' ' HB2' ' A' ' 201' ' ' CYS . 5.5 p -53.74 163.71 0.66 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 128.352 2.661 . . . . 0.0 114.089 177.253 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 3.0 pp -77.17 -1.5 29.68 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 114.8 -1.091 . . . . 0.0 111.781 167.86 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . 0.432 ' HB2' ' SG ' ' A' ' 199' ' ' CYS . 78.2 m -75.19 -28.73 60.13 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 123.942 0.897 . . . . 0.0 110.207 168.551 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . 0.297 88.3 m-70 70.48 54.72 0.29 Allowed 'General case' 0 C--N 1.341 0.228 0 C-N-CA 127.727 2.411 . . . . 0.0 113.309 169.605 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -137.3 172.88 12.33 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 114.559 -1.201 . . . . 0.0 109.484 166.726 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.421 HG12 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -62.67 173.88 0.39 Allowed 'Isoleucine or valine' 0 CA--C 1.545 0.769 0 C-N-CA 125.116 1.366 . . . . 0.0 111.803 -174.961 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.421 ' H ' HG12 ' A' ' 204' ' ' VAL . 87.7 p -50.62 158.58 0.62 Allowed 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.73 2.012 . . . . 0.0 114.889 -173.793 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -139.85 161.22 38.1 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 126.016 1.726 . . . . 0.0 110.708 -169.118 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -64.14 -35.76 92.39 Favored Glycine 0 CA--C 1.528 0.903 0 C-N-CA 124.449 1.023 . . . . 0.0 113.838 -171.651 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -134.63 118.48 17.24 Favored 'General case' 0 N--CA 1.445 -0.723 0 C-N-CA 124.495 1.118 . . . . 0.0 109.289 -170.74 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 1.2 mtm -134.36 149.58 50.85 Favored 'General case' 0 CA--C 1.534 0.356 0 CA-C-N 115.203 -0.908 . . . . 0.0 113.402 -166.096 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 21.3 tt -139.71 145.5 26.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.264 0 C-N-CA 125.758 1.623 . . . . 0.0 110.544 169.987 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -124.91 139.54 11.78 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 124.873 1.225 . . . . 0.0 112.732 -170.429 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . 0.597 ' SG ' ' CE1' ' A' ' 222' ' ' PHE . 2.8 m -78.27 124.93 28.64 Favored 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 126.078 1.751 . . . . 0.0 111.664 -167.715 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -70.43 -2.77 14.82 Favored 'General case' 0 CA--C 1.543 0.681 0 C-N-CA 126.064 1.745 . . . . 0.0 113.467 -176.898 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 3.8 m120 -62.72 149.07 90.15 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 123.724 0.81 . . . . 0.0 111.598 -174.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -81.23 6.75 5.39 Favored 'Trans proline' 0 CA--C 1.548 1.2 0 C-N-CA 123.491 2.794 . . . . 0.0 111.798 167.464 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 35.1 t70 -146.37 -8.85 0.51 Allowed 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 115.026 1.491 . . . . 0.0 115.026 -167.75 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 37.3 t -61.35 134.35 56.84 Favored 'General case' 0 C--N 1.345 0.393 0 CA-C-N 119.866 1.212 . . . . 0.0 110.851 179.875 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 27.1 m -108.14 7.67 27.68 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 125.647 1.579 . . . . 0.0 111.657 -173.155 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 39.1 mm -116.33 -42.22 3.12 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 125.668 1.587 . . . . 0.0 108.536 175.007 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 8.3 pt-20 48.7 -9.62 0.0 OUTLIER 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 131.509 3.924 . . . . 0.0 119.49 171.191 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 50.2 m95 -140.15 140.46 35.96 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 126.94 2.096 . . . . 0.0 109.662 169.632 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . 0.597 ' CE1' ' SG ' ' A' ' 212' ' ' CYS . 6.8 m-85 -147.71 155.18 41.47 Favored 'General case' 0 C--O 1.232 0.148 0 C-N-CA 125.936 1.694 . . . . 0.0 108.604 -169.481 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 45.1 m80 -68.68 150.39 47.99 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 108.088 -1.078 . . . . 0.0 108.088 166.245 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 44.4 m-85 -53.64 -48.06 69.72 Favored 'General case' 0 C--O 1.223 -0.334 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 166.786 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -68.55 -15.13 63.43 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 113.826 1.047 . . . . 0.0 113.826 178.625 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 8.7 t -68.93 -24.71 64.32 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-N 119.075 0.852 . . . . 0.0 112.261 174.205 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 9.3 p -106.61 -15.8 8.62 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 C-N-CA 125.787 1.635 . . . . 0.0 112.119 171.204 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 97.05 17.66 31.6 Favored Glycine 0 CA--C 1.533 1.168 0 C-N-CA 125.956 1.741 . . . . 0.0 113.487 178.897 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 16.8 mt -72.91 158.5 35.38 Favored 'General case' 0 C--N 1.345 0.411 0 CA-C-N 119.093 1.446 . . . . 0.0 111.543 178.527 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 11.5 t -135.86 -0.53 2.55 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 126.153 1.781 . . . . 0.0 111.794 179.408 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 40.1 p -143.41 162.18 36.45 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 127.056 2.142 . . . . 0.0 109.279 175.43 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 87.7 tttt -98.05 114.42 65.08 Favored Pre-proline 0 CA--C 1.54 0.569 0 C-N-CA 123.811 0.844 . . . . 0.0 109.613 178.043 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 62.6 Cg_endo -78.24 179.02 6.89 Favored 'Trans proline' 0 CA--C 1.54 0.825 0 C-N-CA 123.758 2.972 . . . . 0.0 111.531 175.502 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 15.3 ttm180 -139.36 135.32 33.59 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 125.028 1.331 . . . . 0.0 107.489 169.685 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 117.14 -166.84 12.52 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 125.314 1.435 . . . . 0.0 111.476 -176.573 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -65.88 120.58 13.32 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 124.629 1.172 . . . . 0.0 110.128 177.028 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 70.0 t90 -129.27 137.66 51.19 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 126.111 1.764 . . . . 0.0 108.984 174.195 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -125.97 125.14 42.23 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.778 1.231 . . . . 0.0 108.681 -178.027 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . 0.442 ' HB2' ' HD2' ' A' ' 240' ' ' PRO . 2.9 p -59.18 171.97 0.64 Allowed Pre-proline 0 CA--C 1.543 0.705 0 C-N-CA 127.7 2.4 . . . . 0.0 114.412 -172.429 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . 0.442 ' HD2' ' HB2' ' A' ' 239' ' ' CYS . 43.1 Cg_endo -68.3 -23.43 38.59 Favored 'Trans proline' 0 C--N 1.352 0.726 0 C-N-CA 121.761 1.641 . . . . 0.0 113.913 -169.628 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 91.3 mtt-85 -92.41 12.65 22.0 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 124.645 1.178 . . . . 0.0 112.583 174.86 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 27.6 m -131.7 -14.21 3.22 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 126.018 1.727 . . . . 0.0 113.397 -176.664 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 32.4 t -149.69 -40.1 0.14 Allowed 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.838 0.855 . . . . 0.0 112.012 178.618 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 37.6 tp60 -77.63 -13.71 59.83 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 113.127 0.788 . . . . 0.0 113.127 -175.041 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 15.3 mm-40 -65.81 -12.43 54.17 Favored 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 123.996 0.918 . . . . 0.0 112.863 171.604 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 32.4 ttm180 -75.12 76.91 2.28 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.225 1.41 . . . . 0.0 110.032 172.957 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 88.5 tttt -151.25 -37.38 0.13 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 125.099 1.36 . . . . 0.0 111.015 178.274 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -77.38 116.41 17.95 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.825 0.85 . . . . 0.0 109.261 175.894 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 2.2 ttpm? . . . . . 0 C--O 1.252 1.223 0 C-N-CA 126.876 2.07 . . . . 0.0 112.077 -175.041 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 187' ' ' MET . . . . . . . . . . . . . 63.4 mtt . . . . . 0 N--CA 1.474 0.757 0 N-CA-C 109.933 -0.395 . . . . 0.0 109.933 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 188' ' ' ASP . . . . . . . . . . . . . 4.7 p-10 -155.02 166.59 33.12 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 125.236 1.414 . . . . 0.0 110.199 -175.46 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 189' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -153.74 154.51 30.33 Favored Pre-proline 0 CA--C 1.543 0.674 0 C-N-CA 124.523 1.129 . . . . 0.0 110.707 -176.069 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 190' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_endo -81.16 32.54 0.52 Allowed 'Trans proline' 0 CA--C 1.547 1.126 0 C-N-CA 124.647 3.565 . . . . 0.0 112.987 -178.459 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 191' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.23 140.19 24.54 Favored 'Isoleucine or valine' 0 C--N 1.342 0.255 0 C-N-CA 125.02 1.328 . . . . 0.0 109.592 -179.599 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 192' ' ' ASP . . . . . . . . . . . . . 18.7 m-20 -71.98 157.98 88.51 Favored Pre-proline 0 CA--C 1.541 0.616 0 C-N-CA 126.003 1.721 . . . . 0.0 112.237 -177.102 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 193' ' ' PRO . . . . . . . . . . . . . 84.7 Cg_endo -72.32 -0.05 8.11 Favored 'Trans proline' 0 CA--C 1.544 1.018 0 C-N-CA 123.7 2.933 . . . . 0.0 112.993 169.643 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 194' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -71.04 79.63 0.66 Allowed 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 126.82 2.048 . . . . 0.0 110.374 176.571 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 195' ' ' GLU . . . . . . . . . . . . . 44.2 tt0 -151.78 137.25 10.95 Favored Pre-proline 0 CA--C 1.541 0.633 0 C-N-CA 125.134 1.374 . . . . 0.0 108.627 -170.443 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 196' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -72.75 154.87 54.24 Favored 'Trans proline' 0 C--N 1.351 0.68 0 C-N-CA 122.859 2.373 . . . . 0.0 112.229 -177.984 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 197' ' ' THR . . . . . . . . . . . . . 33.4 p -145.28 173.96 11.52 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 125.924 1.689 . . . . 0.0 109.308 -178.087 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 198' ' ' TYR . . . . . . . . . . . . . 9.5 m-85 -135.83 -72.79 0.46 Allowed 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 123.952 0.901 . . . . 0.0 112.392 -176.829 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 199' ' ' CYS . . . . . 0.424 ' SG ' ' HB2' ' A' ' 201' ' ' CYS . 2.6 p -51.62 163.6 0.28 Allowed 'General case' 0 C--N 1.339 0.111 0 C-N-CA 129.342 3.057 . . . . 0.0 114.627 176.203 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 200' ' ' LEU . . . . . . . . . . . . . 4.1 pp -69.5 -7.62 39.73 Favored 'General case' 0 CA--C 1.54 0.572 0 CA-C-N 115.097 -0.956 . . . . 0.0 111.982 167.352 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 201' ' ' CYS . . . . . 0.424 ' HB2' ' SG ' ' A' ' 199' ' ' CYS . 83.3 m -77.06 -30.39 55.52 Favored 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 124.59 1.156 . . . . 0.0 111.017 172.488 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 202' ' ' HIS . . . . . . . . . . . . 0.291 89.2 m-70 69.14 57.93 0.36 Allowed 'General case' 0 C--N 1.339 0.15 0 C-N-CA 127.487 2.315 . . . . 0.0 113.267 169.809 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 203' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -136.42 171.61 14.22 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 114.119 -1.401 . . . . 0.0 109.427 166.398 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 204' ' ' VAL . . . . . 0.488 HG12 ' H ' ' A' ' 205' ' ' SER . 0.2 OUTLIER -64.23 175.71 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 C-N-CA 125.093 1.357 . . . . 0.0 111.939 -175.311 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 205' ' ' SER . . . . . 0.488 ' H ' HG12 ' A' ' 204' ' ' VAL . 20.1 m -45.19 154.42 0.16 Allowed 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 128.128 2.571 . . . . 0.0 115.245 -173.53 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 206' ' ' TYR . . . . . . . . . . . . . 1.9 p90 -142.08 158.45 43.74 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 126.107 1.763 . . . . 0.0 110.037 -173.569 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 207' ' ' GLY . . . . . . . . . . . . . . . -62.66 -36.34 93.13 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.188 0.899 . . . . 0.0 114.08 -169.801 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -135.96 117.95 15.31 Favored 'General case' 0 N--CA 1.443 -0.815 0 C-N-CA 124.446 1.098 . . . . 0.0 109.742 -170.354 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 209' ' ' MET . . . . . . . . . . . . . 1.4 mtm -136.33 150.4 48.84 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 115.257 -0.883 . . . . 0.0 113.107 -166.801 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 210' ' ' ILE . . . . . . . . . . . . . 13.1 tt -146.68 149.65 15.7 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 C-N-CA 126.363 1.865 . . . . 0.0 110.077 169.38 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 211' ' ' GLY . . . . . . . . . . . . . . . -134.02 147.23 18.99 Favored Glycine 0 C--N 1.337 0.587 0 C-N-CA 124.063 0.84 . . . . 0.0 112.767 -169.538 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 212' ' ' CYS . . . . . . . . . . . . . 3.0 t -70.8 143.69 51.07 Favored 'General case' 0 C--N 1.344 0.33 0 CA-C-O 121.893 0.854 . . . . 0.0 111.073 -173.128 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 213' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -83.9 -6.03 59.34 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 113.529 -1.669 . . . . 0.0 113.252 -174.261 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 214' ' ' ASN . . . . . . . . . . . . . 22.9 m-20 -73.98 147.61 86.22 Favored Pre-proline 0 CA--C 1.539 0.546 0 CA-C-N 118.589 0.631 . . . . 0.0 111.696 -168.701 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 215' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -75.78 8.9 2.5 Favored 'Trans proline' 0 CA--C 1.546 1.084 0 C-N-CA 124.116 3.211 . . . . 0.0 112.554 169.343 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 216' ' ' ASP . . . . . . . . . . . . . 35.4 t70 -135.25 -6.7 2.3 Favored 'General case' 0 CA--C 1.541 0.631 0 C-N-CA 126.107 1.763 . . . . 0.0 112.327 -170.044 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 217' ' ' CYS . . . . . . . . . . . . . 38.7 t -62.98 136.03 57.62 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.035 0.934 . . . . 0.0 110.01 172.998 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 218' ' ' SER . . . . . . . . . . . . . 11.8 t -118.9 12.79 12.97 Favored 'General case' 0 CA--C 1.54 0.596 0 C-N-CA 125.771 1.629 . . . . 0.0 111.202 -175.846 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 219' ' ' ILE . . . . . . . . . . . . . 25.5 mm -122.14 -32.18 1.36 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 C-N-CA 126.065 1.746 . . . . 0.0 109.608 177.491 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 220' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 50.49 -11.29 0.0 OUTLIER 'General case' 0 C--N 1.349 0.576 0 C-N-CA 131.065 3.746 . . . . 0.0 119.131 177.359 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 221' ' ' TRP . . . . . . . . . . . . . 52.4 m95 -145.59 156.09 43.46 Favored 'General case' 0 N--CA 1.451 -0.395 0 C-N-CA 125.768 1.627 . . . . 0.0 111.417 179.403 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 222' ' ' PHE . . . . . . . . . . . . . 57.7 m-85 -158.81 155.4 27.81 Favored 'General case' 0 N--CA 1.463 0.19 0 C-N-CA 126.716 2.006 . . . . 0.0 109.081 -175.402 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 51.4 m80 -70.8 151.35 44.91 Favored 'General case' 0 C--O 1.233 0.224 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 166.932 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 224' ' ' PHE . . . . . . . . . . . . . 43.1 m-85 -55.47 -47.06 76.69 Favored 'General case' 0 C--O 1.223 -0.29 0 N-CA-C 109.696 -0.483 . . . . 0.0 109.696 166.592 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 225' ' ' ALA . . . . . . . . . . . . . . . -66.73 -14.21 62.28 Favored 'General case' 0 CA--C 1.539 0.542 0 N-CA-C 113.784 1.031 . . . . 0.0 113.784 177.504 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 226' ' ' CYS . . . . . . . . . . . . . 2.6 t -67.09 -31.29 71.68 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 119.24 0.927 . . . . 0.0 112.106 174.016 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 227' ' ' VAL . . . . . . . . . . . . . 8.4 p -101.28 -14.41 8.01 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 C-N-CA 125.964 1.705 . . . . 0.0 112.216 171.665 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 228' ' ' GLY . . . . . . . . . . . . . . . 89.81 22.57 35.85 Favored Glycine 0 CA--C 1.532 1.125 0 C-N-CA 125.697 1.618 . . . . 0.0 113.256 -178.967 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 229' ' ' LEU . . . . . . . . . . . . . 8.8 mt -69.83 157.94 36.43 Favored 'General case' 0 C--N 1.345 0.395 0 CA-C-N 118.886 1.343 . . . . 0.0 111.59 -179.997 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 230' ' ' THR . . . . . . . . . . . . . 74.7 p -128.36 -1.9 5.62 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 126.047 1.739 . . . . 0.0 111.605 -178.252 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 231' ' ' THR . . . . . . . . . . . . . 11.3 t -152.76 170.16 20.98 Favored 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.151 1.78 . . . . 0.0 109.578 178.923 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 232' ' ' LYS . . . . . . . . . . . . . 40.7 ttmt -97.92 110.49 55.84 Favored Pre-proline 0 CA--C 1.543 0.693 0 C-N-CA 124.25 1.02 . . . . 0.0 108.876 175.231 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 233' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -71.34 -176.23 1.85 Allowed 'Trans proline' 0 CA--C 1.541 0.864 0 C-N-CA 124.016 3.144 . . . . 0.0 111.788 174.148 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 234' ' ' ARG . . . . . . . . . . . . . 3.4 tpt180 -142.85 135.4 27.67 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 124.606 1.162 . . . . 0.0 108.668 -176.048 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 235' ' ' GLY . . . . . . . . . . . . . . . 93.82 -172.52 32.63 Favored Glycine 0 CA--C 1.533 1.205 0 C-N-CA 125.041 1.305 . . . . 0.0 111.452 -170.917 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 236' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -55.36 136.02 49.64 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.926 1.291 . . . . 0.0 111.716 176.425 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 237' ' ' TRP . . . . . . . . . . . . . 61.6 t90 -139.9 153.11 46.89 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 127.15 2.18 . . . . 0.0 108.972 -177.813 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 238' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -128.69 130.7 47.52 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 124.86 1.264 . . . . 0.0 110.048 -173.303 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 239' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -66.27 169.1 7.83 Favored Pre-proline 0 CA--C 1.544 0.731 0 C-N-CA 124.839 1.256 . . . . 0.0 112.985 -177.131 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 240' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -75.9 0.72 8.95 Favored 'Trans proline' 0 CA--C 1.537 0.651 0 C-N-CA 122.479 2.12 . . . . 0.0 114.65 -171.412 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 241' ' ' ARG . . . . . . . . . . . . . 81.8 mtt-85 -128.68 24.31 5.76 Favored 'General case' 0 CA--C 1.536 0.404 0 C-N-CA 124.835 1.254 . . . . 0.0 110.541 168.741 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 242' ' ' CYS . . . . . . . . . . . . . 11.6 m -123.79 -17.13 6.45 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 126.494 1.918 . . . . 0.0 112.059 171.974 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 243' ' ' SER . . . . . . . . . . . . . 36.8 t -150.92 -32.03 0.17 Allowed 'General case' 0 C--N 1.348 0.529 0 CA-C-N 119.477 1.035 . . . . 0.0 113.316 173.418 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 244' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -70.58 -18.42 62.9 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 118.969 0.804 . . . . 0.0 112.462 -179.941 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 245' ' ' GLU . . . . . . . . . . . . . 4.5 mm-40 -70.35 -5.68 29.84 Favored 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 113.731 1.012 . . . . 0.0 113.731 172.082 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 246' ' ' ARG . . . . . . . . . . . . . 46.9 ttm-85 -60.19 -22.23 62.7 Favored 'General case' 0 CA--C 1.54 0.585 0 CA-C-N 119.22 0.918 . . . . 0.0 112.228 169.56 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 247' ' ' LYS . . . . . . . . . . . . . 57.5 mtpt -112.48 -81.19 0.59 Allowed 'General case' 0 C--N 1.343 0.283 0 C-N-CA 124.365 1.066 . . . . 0.0 108.191 -179.792 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 248' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -168.81 142.78 3.06 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 126.004 1.721 . . . . 0.0 108.001 173.143 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 249' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--O 1.251 1.172 0 CA-C-O 116.578 -1.677 . . . . 0.0 110.625 -179.891 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 250' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 251' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_